<SEC-DOCUMENT>0001360604-23-000043.txt : 20230509
<SEC-HEADER>0001360604-23-000043.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230509063230
ACCESSION NUMBER:		0001360604-23-000043
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		80
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Healthcare Realty Trust Inc
		CENTRAL INDEX KEY:			0001360604
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35568
		FILM NUMBER:		23899821

	BUSINESS ADDRESS:	
		STREET 1:		3310 WEST END AVENUE,  SUITE 700
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-269-8175

	MAIL ADDRESS:	
		STREET 1:		3310 WEST END AVENUE,  SUITE 700
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHCARE TRUST OF AMERICA, INC.
		DATE OF NAME CHANGE:	20160802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Trust of America Holdings, Inc.
		DATE OF NAME CHANGE:	20160802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Trust of America Holdings, LP
		DATE OF NAME CHANGE:	20160802
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hr-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:388a749e-3c99-4328-89c5-127682212508,g:16eafbb3-991c-406c-96b0-65d8e7977cec,d:7ef30c9bd2924f189bb8c35e1049bb40--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:hr="http://healthcarerealty.com/20230331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hr-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM180LTEtMS0xLTE1ODU1Mg_5b63d404-babf-462f-80f2-797a804e76f2">0001360604</ix:nonNumeric><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM181LTEtMS0xLTE1ODU1Mg_046bffd5-d57e-45e5-9acb-7c3ac5170140">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM185LTEtMS0xLTE1ODU1Mg_5085633e-e2b4-4857-95ef-610d640620ac">2023</ix:nonNumeric><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM18xMC0xLTEtMS0xNTg1NTI_095e12fb-e490-4a44-988f-906c67328116">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM18xMS0xLTEtMS0xNTg1NTI_21664c4b-a8d2-4c27-8c4e-669694258ee4">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:TypeOfRevenueExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0wLTEtMS0xNTg1NTI_40306376-6a4c-4b48-9029-df11dce3de2c">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" name="us-gaap:TypeOfRevenueExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0wLTEtMS0xNTg1NTI_c64a5623-d436-4d99-b18b-fd81af6432d4">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="i0c00c677ede345b0a56c5a63cb8ec5b8_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI3NQ_6ca16896-73b0-44f5-a3a0-a5bc0b29e940">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hr-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79bdc2ed21874d32b1b6f9ffbc9c5869_I20230502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1641a82fd53448279f743e919d3e08b3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ee4952dd5042e1985f1a054d1950b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia75cc38ea5ec4ad8850297f36dd63583_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b0a185d73934641a877bc76aa2044db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if468b8ca453d4bf19389e61cd9809e62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb2002d8c6d84f4da515c0db9530384d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5da7ae82734c4db38e815b5c361e35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if01ffbea98ac470eb82da6fd52cf6386_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2adb5feae81642dab43ef13b1005c686_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29d03d95236f4962848c499be4324419_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e911b72c3da4719a3d272ba0d92cf3e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181797bf9c4c415f87f43a136f4c8ecb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bdf82ba6dfa4a2ab45ab2a25b586dda_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d5339011cdb49409add3e0359d4d234_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe7ed1db8704e09b2408dfbcbe34ff2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870fd274e1024059a5692743eaf92e98_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd49fc556404cc88d55daa4ab3d7340_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d5b61f7901043e3a556d968f6d61ded_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c65d76e0814dcabee7dac8d1342535_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87844637281d4d8b9949441898948c60_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6d8e2030aa445ce95661811675e94d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a0ab9ea386f4d648d280a8e0986c84e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i888e6ab385484db59802ccaa138669cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i290d83ded5944529b00324bf10c29c5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedac472c8ec4dcfb0431ac1e84e3e61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f1ddce63b34147a4e501072582d084_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4fe5a5fedc449b89509f79262e0912_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86534f62dd7648db9d787382c8966202_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a37fba94472444e866a3ce898b6e671_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c951ed7666477093b2d8cac71d81e7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e5855b50bdc47b6a5bbbd3d256a70a0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf73c42f4034daf8884c9aa069853fd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cad1329072a4ad9aed8fa84a66de166_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba23fc68cdfa4c51b94dfc9b1cd39211_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8453ec6e13a4ca9b4aaea77eb059be6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b6af45f46f4248a7942a21c71bdd30_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38c470fb138540ceae43a17b211a2504_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied1e48d84ca64c058e35c69ae07d90c4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="property"><xbrli:measure>hr:property</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>hr:state</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i755c42838b7b431480fbfbdf30a6e9ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hr:RealEstatePropertiesHeldInJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="building"><xbrli:measure>hr:building</xbrli:measure></xbrli:unit><xbrli:context id="i51484a2f360e4b42bdb84e7d753ea660_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:PropertyEntitiesNotDeterminedToBeVIEsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0322c2eebd454faf9eed6b856d8741ba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aac4bb4c06647b5ad4f91577c69c51e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ce96e024674f9b87df4e61c55f6764_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="variable_interest_entity"><xbrli:measure>hr:variable_interest_entity</xbrli:measure></xbrli:unit><xbrli:context id="i0458b77080714c6888c6e3f362854f15_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="note_receivable"><xbrli:measure>hr:note_receivable</xbrli:measure></xbrli:unit><xbrli:context id="i4fee5ed06fc349219d14427a4e38fc89_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="joint_venture"><xbrli:measure>hr:joint_venture</xbrli:measure></xbrli:unit><xbrli:context id="i892f855ceda549059585643902bde99c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTexasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33a33b3d8f3f49099605a5a0d1738e6b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12840b99f3724aff95ff5318afa01dd3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoansTexasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanTexasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b0d5e420094983ab1ab22d723321e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanNorthCarolinaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanFloridaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a56f63d400c4079a7e865561ecc32b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic44363c5ccfa4dff9ff72967d841833c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e0ace30abe440c2bd816870af7d7806_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b0486b528146ec8fdc0d6d9e4c4d6c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="financing_receivable"><xbrli:measure>hr:financing_receivable</xbrli:measure></xbrli:unit><xbrli:context id="i05be39577b12415cba92b235a157f559_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8415018b6934f1cb08cc146d7ceb279_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf0cfc90ab23411db24b52116a274e8c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838dbabd027b451d9500ea47a7f339ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i568f996d95dc4950803db835d3ec9a81_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3f3967d66744ae79640534476f9540f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia98275e8045c4a51b9dd61d72cdae95d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfe566f51e494b1d8cc1a790d694cd86_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i083d3ca006554b74ba98857c37529cb4_I20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38dceeb615dc429ea313b8089bb30136_D20220720-20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb262bbfd5c64c4b80a95b4c0088494d_I20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b8bd90675e2482da72656d93ecd84ff_I20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia43b38198f184947bc8289aeeeea08a6_I20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d73087fbab144d6b3552bf9cf41f68f_D20220720-20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087f313f8ce8406b9f00ee7f55180463_I20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e0ee7220bb44c8a851edf13b274871_D20220720-20220720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08326621b774b35a49a98cb55264ae0_D20230401-20230509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-05-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68c69926be842d69e158e3aa65f496d_D20230310-20230310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-10</xbrli:startDate><xbrli:endDate>2023-03-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc48b9d4935147f39fab2c5a1786b320_I20230310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf9b62f2ccf74d1caf0fe1cb85aa8f53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4cd843d7ed430a94355ee7d8beda1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56812fb447b14ad19ca71a303ab09954_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07320f4bb515447592164daec5eb7b4f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia37031f8ec15470d97f1001738e8c72e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01f64aacd4d546bb928367d1fc3b2934_I20230112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725103bec26f4bffb5131168df379059_D20230112-20230112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-12</xbrli:startDate><xbrli:endDate>2023-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-30</xbrli:startDate><xbrli:endDate>2023-01-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe535f3ab724e7f8cc93404389ae2d3_D20220729-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-29</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a3ca7980f634d5a877d7ea584c4b463_D20230323-20230323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-03-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2af2c84b56b24addb398070e5b1786eb_I20230330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8386a9bdaee48faab027ec1bc916259_D20230330-20230330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i529066ab980943059fbf1ea25e1ecf1a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5bcc13d9ac1449aafbef97302a864de_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="disposition_transaction"><xbrli:measure>hr:disposition_transaction</xbrli:measure></xbrli:unit><xbrli:context id="i0fbb705c06f14ee2aba7350a87fa6205_I20230330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="land_parcel"><xbrli:measure>hr:land_parcel</xbrli:measure></xbrli:unit><xbrli:context id="icdfe172a798c48d69a472a992f819b18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i520bdadf3a0e4877a0654af6dea318b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedc8351cf7d14a358450c7736f9cb778_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>hr:lease</xbrli:measure></xbrli:unit><xbrli:context id="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i916dc090ae94426d8365fc31b03034ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf083f5601064f69b4d4536ff89ad8f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id093a3a1c949408d9c5b971d33e5ce57_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58696a25f6f645418747fe03e651cd67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12ab1a1468da462cb3ba734034491aa2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6153dc8f1005474aafde2cd37e112967_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40d414655d314601a88d81663bcb05c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2e5ddf6b16b48c1ba4b6ccbd0e86c5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada6b4520347441c86e7b036a38806a3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9996d5e89ffb48608cdbb710a8391d3e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3797ac41724d4c88869e5d72d41a8977_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b8e9ac04b994ee090d110a7cb42566c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4c13532ed774effa341fc31c9a9b88a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i947183f1bc48403a94ac6a0e12abb930_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc42205d2ec44d118886e5720e43151a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if239ca1557c647539fcb388cfb1692af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e35fb4f52e34980a36f861ff287417b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c2524e41edf4411a107a30240fcf406_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48cbfe26eacb4823b267d3ad193c58c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8628a7ba5394269893e6d58812b1de8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee5360caf654c3984323ba0ea3efdd6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea6204a6cfe4280a12e77772723e04e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fcf72f9e010488e953762beaa4a3236_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9641fb3901af4361a7453aa207869a13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8faa35bf9c54ffda60fcf39d1de6969_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb93c500efca462290474ea705de1cc7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i208a8c86222841e7aa4e2d3d1eb58ff6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic657cdc8fa32443a98553b45427e1d49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5456995c1764da0b948401cfc09b9a0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ab89d4ecf44dfeb1d870f49ac25015_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05db10f2ba654b51b0c0030478bf971b_I20230509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative"><xbrli:measure>hr:derivative</xbrli:measure></xbrli:unit><xbrli:context id="ic1986a74cc37403c9b2e18925bc459c4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJanuary152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab4351c9c9144c7a0456de49fc1c374_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6634c65cb6af485bafe3b895bca1c259_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55a92723cb045e5b3f7b226e366666a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300d1ad46f444edcb5259c5aa4ad9337_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9626e0785d714a62aa74354221bfd9f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9005e1dd794d208a4b797ae4621183_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e64e9ed9c9e4205bdf1ad560e251d42_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwaps2017And2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b1c53bc0034d898edcf92852e6d9c1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwaps20172018And2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i650c8e7c68644e95a14ecf31d3e81688_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i550aa973ad90483f8a3c4a0347e5a824_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib038cb82071844b18a5969f43fb847cc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i418ef205b37644f6bf094af1cdb1378e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5358b41917b54b188e9b758ea6d034d1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52ecd11079f348afb8d796b899502b99_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i343a27ce736844daa7c02c4fc4bd7e3e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0ecdde728be4819bf1b77c1ef19342c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a708e51b4c414fa037bdb830248ffc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4e75ffc38cf443b8a2bb92046cf883d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i955d126813cf4d4ca1a06c68c07ebe2e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80188dd2e888438dabd7b24526b877bb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic07f754abe7f444f8948c8f16a37eeba_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0caf5935d6d4f239926e7d14b5e7270_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:ActiveInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i862a64f8ce9a48429a007343ae162af5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:SettledInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic21e61620e9b4d199d0bd8544198530a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3247f43eeeb46f2a5e62592bb20c4af_D20221102-20221102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-02</xbrli:startDate><xbrli:endDate>2022-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib953f604b4cf42b7b51ce9268a732918_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc16940055742359e8967874631f262_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66c615d105954779b0ea4386c88b686c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976d48bf9470465e96587107d27c128b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c00c677ede345b0a56c5a63cb8ec5b8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de73055e02748f88fb8b29c46b0f7cd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dbd3d23d82a4283a8336822e94b019b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35005495bb2d4a14950ce05e7d3751b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if554654baa2c4fab887bd8e8ce1280d5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d92d2b7a9d842d6a5b22b3d68c57a01_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3514f2b646db4405a1eec8c9a17c0ba3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04f3449a44e04c04843366fd629f5f2f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i479dcf12323a45868421febd4b7d7c82_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026d56f8612c468fb9c1628088387b24_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f3253796ed4156b94a25fac13c6991_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic19e24e6e4d646fcacc85aeea31d807b_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i165032ae420b46b7bbba8d14fe0aba12_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fdfd62e90e34b9f8d96116f557c9787_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad26162143ea47dfa49d4366d8a0dba7_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c057c6178b345c9b3e881d858993552_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad942920f150409cad42db1a3f7dc7c2_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1917ae1a54ca4c99b9c7f284e6873fa3_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i000748c9059c48ff9b5003e987126ae1_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32164c0659084310957f7adb36c144a1_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb8d9ba9fcb4cd3a86450f082750fed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb54b7f31d5417da8f8112e9b8c756e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24141fc9eb4b43ab8baf38ba6ac04b2e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i896e8bc913c24d9fb4ecb2ce94992aee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf810aaefd344b08133b9065f0521e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5e1cd5751f4fd29eaceeb6e25007d8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b140e579a2c4968935d45253779bfed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786dc6592f45460895333b89bf32a577_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_1"></div><div style="min-height:18pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:12pt;font-weight:400;line-height:140%"> UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Bold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTky_cfb0a455-cf66-4b4a-a712-d357235f7200">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:490.50pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:121.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:345.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Mark One)</span></div><div><span><br/></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWNiMjViODEzYjhkNGJkM2FjM2I4MDNiOGFhY2ExYjEvdGFibGVyYW5nZTo1Y2IyNWI4MTNiOGQ0YmQzYWMzYjgwM2I4YWFjYTFiMV8xLTAtMS0xLTE1ODU1Mg_37d65366-e7fa-4832-9b42-2b11b53b1c28">&#9746;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">For the quarterly period ended: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWNiMjViODEzYjhkNGJkM2FjM2I4MDNiOGFhY2ExYjEvdGFibGVyYW5nZTo1Y2IyNWI4MTNiOGQ0YmQzYWMzYjgwM2I4YWFjYTFiMV8yLTItMS0xLTE1ODU1Mg_ec1da167-b223-47e0-aff5-e6c2b113b390">March 31, 2023</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OR</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWNiMjViODEzYjhkNGJkM2FjM2I4MDNiOGFhY2ExYjEvdGFibGVyYW5nZTo1Y2IyNWI4MTNiOGQ0YmQzYWMzYjgwM2I4YWFjYTFiMV80LTAtMS0xLTE1ODU1Mg_b9090e5a-eb7d-4d9b-8920-2c85d84f57a8">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div><span><br/></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%">Commission File Number: <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg4_004dabde-6416-4177-8b7c-83defcd15f3b">001-35568</ix:nonNumeric> (Healthcare Realty Trust Incorporated)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Bold',sans-serif;font-size:12pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg5_93310f2f-09b9-4f72-a2d3-128514bd01b4">HEALTHCARE REALTY TRUST INCORPORATED</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.194%"><tr><td style="width:1.0%"></td><td style="width:19.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MzFiM2NhODAwOTkxNGUzZjlhODNlMzYwMmZhOWQzYWIvdGFibGVyYW5nZTozMWIzY2E4MDA5OTE0ZTNmOWE4M2UzNjAyZmE5ZDNhYl8wLTAtMS0xLTE1ODU1Mg_88c3cb53-750b-49bc-8208-6d3912d1e754">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MzFiM2NhODAwOTkxNGUzZjlhODNlMzYwMmZhOWQzYWIvdGFibGVyYW5nZTozMWIzY2E4MDA5OTE0ZTNmOWE4M2UzNjAyZmE5ZDNhYl8wLTItMS0xLTE1ODU1Mg_de791eac-c9a1-4a12-a009-1f0bbeffe3ac">20-4738467</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTkx_abfbc504-6f9d-4a8f-816c-7bf11aa9c483">3310 West End Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg1_84c12b27-ff29-418e-80aa-9ae426b5a995">Suite 700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTkz_dfc10ba2-5e10-4824-90ed-d89f31d90b4d">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg2_06831646-805b-4f86-b09c-85656231b3fd">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg3_619aa54c-2d25-45b3-bdd7-fb9ca6b1cc4c">37203</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:140%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%">(<ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTk0_e2f97c36-d2fb-4668-86c8-83061592e017">615</ix:nonNumeric>) <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTk1_404bfed3-f3c4-4b7d-80dd-ee09149fc41f">269-8175</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:140%">(Registrant's telephone number, including area code)</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">www.healthcarerealty.com</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Internet address)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.472%"><tr><td style="width:1.0%"></td><td style="width:39.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MTQ5ZjI2YjAzMzc5NDYwYzk1NDY5ZTM0NTVhYzZhN2MvdGFibGVyYW5nZToxNDlmMjZiMDMzNzk0NjBjOTU0NjllMzQ1NWFjNmE3Y18xLTAtMS0xLTE1ODU1Mg_e3303f09-ab3e-4005-8b4e-5a238b76f80b">Class A Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MTQ5ZjI2YjAzMzc5NDYwYzk1NDY5ZTM0NTVhYzZhN2MvdGFibGVyYW5nZToxNDlmMjZiMDMzNzk0NjBjOTU0NjllMzQ1NWFjNmE3Y18xLTItMS0xLTE1ODU1Mg_6c9abe29-a412-41ac-909e-253b69406a3e">HR</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MTQ5ZjI2YjAzMzc5NDYwYzk1NDY5ZTM0NTVhYzZhN2MvdGFibGVyYW5nZToxNDlmMjZiMDMzNzk0NjBjOTU0NjllMzQ1NWFjNmE3Y18xLTQtMS0xLTE1ODU1Mg_87633ac3-fba1-4d10-8eaa-ecd18fd733ff">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Sections&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.  &#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:123.00pt"><tr><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWY2YThiNmIxODQwNGJlMmI4Y2RhMzE4Y2YyZTk5MDYvdGFibGVyYW5nZTo1ZjZhOGI2YjE4NDA0YmUyYjhjZGEzMThjZjJlOTkwNl8wLTItMS0xLTE1ODU1Mg_35d51315-e0b8-4b65-9dac-30d0a0f980e3">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.777%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.754%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6YWE5ODNhZjFkZDBjNDY0N2FiN2FkZTA4NjEzN2FkZTYvdGFibGVyYW5nZTphYTk4M2FmMWRkMGM0NjQ3YWI3YWRlMDg2MTM3YWRlNl8wLTItMS0xLTE1ODU1Mg_f0d41c6e-1c6d-4622-a82b-fb29ad3206f9">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.194%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:3.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6ZjI4NWZkMDUwNTE0NDg5OThlZDQwYzYzN2RhZjU0NGUvdGFibGVyYW5nZTpmMjg1ZmQwNTA1MTQ0ODk5OGVkNDBjNjM3ZGFmNTQ0ZV8wLTItMS0xLTE1ODU1Mg_f1a1ec67-4af7-4af6-8b81-a779c7923204">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Non-accelerated filer </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.888%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NzE5OTYwZDdkMjMwNDAxNWEzYjkzMTQwOTBiN2ZhMjkvdGFibGVyYW5nZTo3MTk5NjBkN2QyMzA0MDE1YTNiOTMxNDA5MGI3ZmEyOV8wLTEtMS0xLTE1ODU1Mg_2aa28a0b-0903-4a45-a7ac-c7d52bdcbc8f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NzE5OTYwZDdkMjMwNDAxNWEzYjkzMTQwOTBiN2ZhMjkvdGFibGVyYW5nZTo3MTk5NjBkN2QyMzA0MDE1YTNiOTMxNDA5MGI3ZmEyOV8wLTMtMS0xLTE1ODU1Mg_3dacaa27-99ec-4ad3-86fd-ecd7fd4dcece">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.444%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6OTAzZDI4MTIxODUxNDI5ODliNTY2NjllZjU4ZjMwM2IvdGFibGVyYW5nZTo5MDNkMjgxMjE4NTE0Mjk4OWI1NjY2OWVmNThmMzAzYl8wLTEtMS0xLTE1ODU1Mg_a05fe72e-cc87-41b3-8f3d-36842dcc20fd">&#9744;</ix:nonNumeric></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.638%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6ZTBkZjM3ZWY1YTYyNGJjMDhkNzIxMTI3OGRjYmQwZDIvdGFibGVyYW5nZTplMGRmMzdlZjVhNjI0YmMwOGQ3MjExMjc4ZGNiZDBkMl8wLTEtMS0xLTE1ODU1Mg_9ec5116c-a2ab-4d0a-aa4e-cd49c4cdd079">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">As of May&#160;2, 2023, the Registrant had </span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%"><ix:nonFraction unitRef="shares" contextRef="i79bdc2ed21874d32b1b6f9ffbc9c5869_I20230502" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTQ4_23a6ea0d-3063-40d3-babd-da255fc6160a">380,816,937</ix:nonFraction> s</span><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">hares of Common Stock outstanding.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.348%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_10"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Explanatory Note </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022 (the &#8220;Merger Agreement&#8221;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#8220;OP&#8221;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;).  Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to &#8220;HRTI, LLC&#8221; and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;.  In addition, the equity interests of Legacy HR were contributed by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP. As a result, Legacy HR became a part of an umbrella partnership REIT (&#8220;UPREIT&#8221;) structure, which is intended to align the corporate structure of the combined company after giving effect to the Merger and the UPREIT reorganization and to provide a platform for the combined company to more efficiently acquire properties in a tax-deferred manner. The combined company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For accounting purposes, the Merger was treated as a &#8220;reverse acquisition&#8221; in which Legacy HR was considered the accounting acquirer.  As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company, as defined below. Periodic reports for periods ending following the Merger will reflect financial and other information of the Company. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">Business Combinations</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> (&#8220;ASC 805&#8221;), which requires, among other things, the assets acquired and the liabilities assumed to be recognized at their acquisition date fair value. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to the combined company after giving effect to the Merger. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, the OP has issued unsecured notes described in Note 6 to our Condensed Consolidated Financial Statements included in this report. All unsecured notes are fully and unconditionally guaranteed by the Company, and the OP is 98.8% owned by the Company. Effective January 4, 2021, the Securities and Exchange Commission (the &#8220;SEC&#8221;) adopted amendments to the financial disclosure requirements which permit subsidiary issuers of obligations guaranteed by the parent to omit separate financial statements if the consolidated financial statements of the parent company have been filed, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and the security is guaranteed fully and unconditionally by the parent. Accordingly, separate consolidated financial statements of the OP have not been presented. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Additionally, as permitted under Rule 13-01(a)(4)(vi) of Regulation S-X, the Company has excluded the summarized financial information for the OP because the assets, liabilities, and results of operations of the OP are not materially different than the corresponding amounts in the Company's consolidated financial statements and management believes such summarized financial information would be repetitive and would not provide incremental value to investors. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.348%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_13"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">HEALTHCARE REALTY TRUST INCORPORATED</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">March&#160;31, 2023 </span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Table of Contents</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.006%"><tr><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">PART I - FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_19">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_19">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_28">Condensed Consolidated Statements of </a><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_28">Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_28">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_31">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_31">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_34">Condensed Consolidated Statements of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_34">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_40">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_40">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_43">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_43">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_82">Item&#160;2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_82">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_97">Item 3</a>&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_97">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_97">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_100">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_100">34</a></span></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">PART II - OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_106">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_106">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_109">Item&#160;1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_109">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_112">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_112">Unregistered Sales of Equity and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_112">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_115">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_115">34</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">SIGNATURE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_118">36</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_16"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_19"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1.  Financial Statements</span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_22"></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.498%"><tr><td style="width:1.0%"></td><td style="width:62.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MARCH 31, 2023</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Real estate properties</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMy0xLTEtMS0xNTg1NTI_c6639493-c181-4781-a215-f556dd199944">1,412,805</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMy0yLTEtMS0xNTg1NTI_a3df23b9-30d7-4a77-962f-7d41c9c5a764">1,439,798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNC0xLTEtMS0xNTg1NTI_e796b76d-e623-435a-ae53-e157aacc22cd">11,196,297</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNC0yLTEtMS0xNTg1NTI_03c76dd0-2b76-479d-959f-9e6444af0530">11,332,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNS0xLTEtMS0xNTg1NTI_55e18a9e-5b80-496b-a4a7-53f633e9fd01">929,008</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNS0yLTEtMS0xNTg1NTI_3a2cda13-0e8c-4ada-aca2-37305d152053">959,998</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Personal property</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:PersonalProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNi0xLTEtMS0xNTg1NTI_cfb428fa-db2b-45f2-b884-ba9d53db460f">11,945</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:PersonalProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNi0yLTEtMS0xNTg1NTI_84bf7934-e053-47d9-a42a-6f2b77aa3b5d">11,907</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in financing receivable, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNy0xLTEtMS0xNTg1NTI_b8153e02-31b3-4e87-ab1d-95e28c6e6159">120,692</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNy0yLTEtMS0xNTg1NTI_fa19e92e-093d-41e9-94e5-b935af229b45">120,236</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOC0xLTEtMS0xNTg1NTI_3090b890-e370-47a2-b9ba-3e5092645b5b">83,420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOC0yLTEtMS0xNTg1NTI_d0d1e643-c6a8-4e94-8e99-5d02d63f2af9">83,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOS0xLTEtMS0xNTg1NTI_9f6b6541-4090-4191-9c3b-5e4cc119779a">42,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOS0yLTEtMS0xNTg1NTI_e1ffe3f8-c697-4dbc-b45e-b52a1672dc0f">35,560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTAtMS0xLTEtMTU4NTUy_ddf5be8b-dd33-4103-b949-522f5b72f033">69,575</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTAtMi0xLTEtMTU4NTUy_2497dabd-d6db-4c13-926b-8973f21e0c1c">74,265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total real estate properties</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTEtMS0xLTEtMTU4NTUy_1699f234-b087-423a-9dc1-14135fd61fb4">13,866,357</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTEtMi0xLTEtMTU4NTUy_a26353f5-4010-4a97-9ea4-0b1002ed810a">14,057,625</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTItMS0xLTEtMTU4NTUy_d90736e3-a5e8-4566-81b4-6649fdbb1e9c">1,810,093</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTItMi0xLTEtMTU4NTUy_8da1b87a-e938-44dd-972a-41d0a0e0685d">1,645,271</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total real estate properties, net</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTMtMS0xLTEtMTU4NTUy_e692a36f-c9e1-4344-9a4f-ae65c8dffe4e">12,056,264</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTMtMi0xLTEtMTU4NTUy_64ea4b8a-0765-48f5-b74c-b8475293524d">12,412,354</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTQtMS0xLTEtMTU4NTUy_dfb07543-93bf-4a94-999b-6bfc25ccfd20">49,941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTQtMi0xLTEtMTU4NTUy_0899e774-3d7a-4532-b4c4-bda83d55090c">60,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTctMS0xLTEtMTU4NTUy_393c2cac-4ed6-4390-9bb1-aba04efda5c4">3,579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTctMi0xLTEtMTU4NTUy_c0897e06-4b2d-4da8-a9a2-256c079485c5">18,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTgtMS0xLTEtMTU4NTUy_e449c823-9d2c-4ec3-8d92-08740063d4f5">336,112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTgtMi0xLTEtMTU4NTUy_06387a0a-74c1-4a9c-a4ab-09ae7c665428">336,983</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTktMS0xLTEtMTU4NTUy_46a7d1d2-5c11-4555-bea0-5c8e8516f9fe">327,746</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTktMi0xLTEtMTU4NTUy_5b23ffe9-1027-44de-af28-fc4e7d538665">327,248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjAtMS0xLTEtMTU4NTUy_ee0d7404-e8ac-4cbc-b0f1-a12b78c1d9a2">260,822</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjAtMi0xLTEtMTU4NTUy_cf789062-7a04-49eb-8d20-b8bfcdfb1a8e">223,202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjEtMS0xLTEtMTU5NzU2_a8704174-679c-421d-8060-eaf8fc4c8a11">534,420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjEtMi0xLTEtMTU4NTUy_9087d373-fc4b-464e-b9ac-e1ef615d566f">469,990</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjItMS0xLTEtMTU4NTUy_afa2167f-223b-4dad-b6d0-dafc67dbd647">13,568,884</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjItMi0xLTEtMTU4NTUy_9a4f4d3e-b1e9-465c-a3d3-dc7049a220be">13,849,631</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjYtMS0xLTEtMTU4NTUy_bc803403-5051-41ec-9994-c4e919031490">5,361,699</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjYtMi0xLTEtMTU4NTUy_ae9fc30b-1f7d-4782-aac6-5a459554d874">5,351,827</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjctMS0xLTEtMTU4NTUy_3b3aa480-bc8a-465f-ad45-fd2feae73a5c">155,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjctMi0xLTEtMTU4NTUy_02b4904c-5873-46b2-b88a-8a3e88fd2cfe">244,033</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjgtMS0xLTEtMTU4NTUy_c77bf960-922b-4107-832b-42d75d05f5f7">277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjgtMi0xLTEtMTU4NTUy_8d70a995-1d53-4549-9308-4d6c56a555ce">437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjktMS0xLTEtMTU4NTUy_68435a2f-54b5-41e9-825a-20828f4c0952">279,637</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjktMi0xLTEtMTU4NTUy_07dbbd54-a8e2-4270-8daf-204d9b34bd50">279,895</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzAtMS0xLTEtMTU4NTUy_3e065015-2a56-4bcf-8130-e280a3861611">73,193</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzAtMi0xLTEtMTU4NTUy_89f1120b-5b5c-40ba-b4b8-06c6152f3061">72,939</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzEtMS0xLTEtMTU4NTUy_fbd95560-f691-466e-8a7c-b4ea5b9c56cf">232,029</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzEtMi0xLTEtMTU4NTUy_0316ba12-ba12-4447-8818-4eae3b285f68">218,668</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzItMS0xLTEtMTU4NTUy_84253429-27b5-46f8-a8f6-2d4d42fc3c3c">6,102,045</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzItMi0xLTEtMTU4NTUy_60f8d9cb-a8b4-4505-a0d2-fc848fc45082">6,167,799</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzMtMS0xLTEtMTU4NTUy_241811cb-c059-4d2b-b30c-9fb2aac3323e"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzMtMi0xLTEtMTU4NTUy_3054bae9-6d14-417c-a372-248c5dcca376"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzQtMS0xLTEtMTczMDU2_61f5bf2b-902b-4c92-afe9-6463a93f8a26">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzQtMi0xLTEtMTczMDY1_9135933a-2a35-484f-84ef-69319dcc2fa8">2,014</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfMjE_1efb1316-62d5-4fbf-baea-17c1c9fe5feb"><ix:nonFraction unitRef="usdPerShare" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfMjE_c94579a3-4768-4db4-b293-de5bf88fec7c">.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNDU_219385bd-af9d-459f-b116-44dc8f0bc99a"><ix:nonFraction unitRef="shares" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNDU_f74cfaed-f92d-42ab-8aff-c626cbee207f">200,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_1349f189-91c0-46a2-bb10-53001ca82949"><ix:nonFraction unitRef="shares" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_7ffe9bda-6e84-4f1c-a715-60f1c2542f02"><ix:nonFraction unitRef="shares" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_a012d737-4ee6-4f4e-8ad7-23563c51d42c"><ix:nonFraction unitRef="shares" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_b5d9486a-f2a2-4541-9a9f-9e56943c7fcc">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMS0xLTEtMTU4NTUy_164d942b-2eb2-4040-a49e-858bd23f2daa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMi0xLTEtMTU4NTUy_a8592f19-2238-4250-a66b-1ed661426aaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Class A Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfMjY_e42160d9-6315-48fc-a8b6-de95068c4471"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfMjY_f59288cd-271f-4529-a188-3c0d67909600">.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNTA_855c0e91-13f5-49e2-9ab5-3af44fca0b9f"><ix:nonFraction unitRef="shares" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNTA_ecc99c74-ac88-413c-9e22-d1905ad0e1fe">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzI_70124e60-7080-4de6-8763-6a24f78e2cc5"><ix:nonFraction unitRef="shares" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzI_cc2ed2ad-b8ab-4b03-9952-c6dc7a11de5d">380,816</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzk_478f57fb-f0e0-459b-85d5-7f8a37fc644a"><ix:nonFraction unitRef="shares" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzk_5e0e4109-b83c-4b65-b8d0-371e392723a5">380,590</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMS0xLTEtMTU4NTUy_52d150a6-de85-43d7-9c73-8879cd3cc5ad">3,808</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMi0xLTEtMTU4NTUy_5dfa93df-95ba-4236-b601-a79e7687cc66">3,806</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzctMS0xLTEtMTU4NTUy_92b0c6a6-2806-4640-8d21-f4f16e568208">9,591,194</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzctMi0xLTEtMTU4NTUy_36c8db95-3f25-4e72-b4d6-6626870cbbf0">9,587,637</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzgtMS0xLTEtMTU4NTUy_7f5e28ec-47fc-47b9-8df1-aa087001f34f">8,554</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzgtMi0xLTEtMTU4NTUy_a7fa4da7-6909-42e8-90a5-49db0becd86d">2,140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative net income attributable to common stockholders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:CumulativeNetIncomeAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzktMS0xLTEtMTU4NTUy_180def0d-61c4-4573-a95e-bda7097b72af">1,219,930</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:CumulativeNetIncomeAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzktMi0xLTEtMTU4NTUy_dfbdfb6a-3aa9-4622-b125-53e2cd3ad671">1,307,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:CumulativeDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDAtMS0xLTEtMTU4NTUy_c1b5797a-aaf2-4cd4-84fa-56d3a0696e5d">3,447,750</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:CumulativeDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDAtMi0xLTEtMTU4NTUy_a4356598-335d-49bd-8c7d-0801b4b3a98b">3,329,562</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDEtMS0xLTEtMTU4NTUy_95a91f03-e484-4ece-97c8-4136712c8cae">7,358,628</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDEtMi0xLTEtMTU4NTUy_e5feaf4a-f6c5-4910-b5f5-53dcd89d237b">7,571,076</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDItMS0xLTEtMTU4NTUy_5c2d7b3c-3ede-4922-ae4e-e1c8a80f46e6">106,211</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDItMi0xLTEtMTU4NTUy_de7808a8-4187-4a4a-9df7-de084447a46b">108,742</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDMtMS0xLTEtMTU4NTUy_b7ea6524-c0f7-40af-9f13-1f3e846ab222">7,464,839</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDMtMi0xLTEtMTU4NTUy_8a16784e-1f22-494c-afba-b0cc2e55528c">7,679,818</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDQtMS0xLTEtMTU4NTUy_48592c67-d38c-44dd-831e-e2feabe2464d">13,568,884</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDQtMi0xLTEtMTU4NTUy_9d509371-4bef-45ac-8af3-5ad259152720">13,849,631</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_28"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three Months Ended March&#160;31, 2023 and 2022 </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.042%"><tr><td style="width:1.0%"></td><td style="width:67.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Rental income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMy0xLTEtMS0xNTg1NTI_e92a349a-9ce1-46e9-9524-8ed51005c4cd">324,093</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMy0yLTEtMS0xNTg1NTI_d5d9e8b7-3a7a-4096-8fce-3e5005b9bea2">138,489</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNC0xLTEtMS0xNTg1NTI_3f2d90d6-2660-4c5c-990e-dbe82ba91085">4,214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNC0yLTEtMS0xNTg1NTI_91bf66fb-c859-4706-8027-4a96bd00ab38">1,930</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0wLTEtMS0xNTg1NTI_40306376-6a4c-4b48-9029-df11dce3de2c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0wLTEtMS0xNTg1NTI_c64a5623-d436-4d99-b18b-fd81af6432d4">Other operating</span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0xLTEtMS0xNTg1NTI_367036a4-9136-4818-8264-8c71cd2e58d8">4,618</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0yLTEtMS0xNTg1NTI_792d14ed-6bd1-469f-a4b1-bc1b6c0da8ae">2,475</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNy0xLTEtMS0xNTg1NTI_41c66b04-3e17-481a-beb3-ab932bbcca91">332,925</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNy0yLTEtMS0xNTg1NTI_2581ec8d-d523-4866-b64f-2a4f722ea20b">142,894</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Property operating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfOS0xLTEtMS0xNTg1NTI_3c4c1841-cfc9-400b-99d3-7419efbdb05f">122,040</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfOS0yLTEtMS0xNTg1NTI_e564a425-72c6-4200-9f5b-6352512bf0fd">57,464</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTAtMS0xLTEtMTU4NTUy_6e0df6f4-72b9-4795-81d9-84bb6290dcf7">14,935</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTAtMi0xLTEtMTU4NTUy_2cc0330e-ffa5-40f9-824a-97b3b9df29ee">11,036</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition and pursuit costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTEtMS0xLTEtMTU4NTUy_bec59a7a-4f44-4ba6-8203-a8f372459598">287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTEtMi0xLTEtMTU4NTUy_cd26fffd-e404-4898-a719-63a3efe23bdb">1,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTItMS0xLTEtMTU4NTUy_21f754e9-10e8-4c03-ada3-1d8a939f1165">4,855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTItMi0xLTEtMTU4NTUy_c4bd0dfd-6cbf-4883-bfe5-d868e6e01e53">6,116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTMtMS0xLTEtMTU4NTUy_ec7f0fa2-e534-49b2-ae66-b60a5dd424a2">184,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTMtMi0xLTEtMTU4NTUy_2a7562f3-983a-4955-96e2-d54ccf665e37">54,041</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTYtMS0xLTEtMTU4NTUy_a16498d3-1590-496a-a625-24089504c447">326,596</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTYtMi0xLTEtMTU4NTUy_7ed06c89-8b1f-4328-bcc1-c4ceee09efdd">129,960</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTgtMS0xLTEtMTU4NTUy_ff97e0e9-34ab-455b-b022-ea2179d6d785">1,007</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTgtMi0xLTEtMTU4NTUy_f4ab2853-038c-4731-98ea-a909f3021b83">44,784</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTktMS0xLTEtMTU4NTUy_00dc63f1-db8a-4495-ae81-0ca38ec989bb">63,759</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTktMi0xLTEtMTU4NTUy_510afbb7-3650-45f4-8ac9-2a8099bdee30">13,661</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjAtMS0xLTEtMTU4NTUy_c04e7872-ee53-4067-a2fd-17cfefe14225">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjAtMi0xLTEtMTU4NTUy_44668297-f04a-4136-98d5-b3c934af5ca9">1,429</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties and credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:ImpairmentOfRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjItMS0xLTEtMTU4NTUy_3d2f4daa-568c-4b42-9f9d-ea4968a5f624">31,422</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ImpairmentOfRealEstate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjItMi0xLTEtMTU4NTUy_222ae55d-3515-4638-9ab9-df3feb9865c9">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss from unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjMtMS0xLTEtMTU4NTUy_c46c7518-3284-4ab9-aa52-8b463c1f7011">780</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjMtMi0xLTEtMTU4NTUy_f050df2d-5eea-4046-9419-2d44129db885">345</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest and other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjQtMS0xLTEtMTU4NTUy_fdad30ff-d164-4862-b3b4-24e4e9abd783">547</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjQtMi0xLTEtMTU4NTUy_dd356d44-29d6-4f2c-aaf8-2b4b0cef903e">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjUtMS0xLTEtMTU4NTUy_f02d6d82-b28f-4406-8ac5-07431eb19792">94,407</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjUtMi0xLTEtMTU4NTUy_23df8e5e-7a0c-4c5c-8266-835f3478856d">29,293</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #242424;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income </span></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzItMS0xLTEtMTU4NTUy_2b7cdb89-fcad-44b5-8b90-0a2e71fee35e">88,078</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzItMi0xLTEtMTU4NTUy_9fefed9a-38ef-4f33-97f3-8f959bdd23a8">42,227</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzMtMS0xLTEtMTU4NTUy_3126ac08-f746-4d4e-9432-9cc4d357d462">953</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzMtMi0xLTEtMTU4NTUy_710263a2-7a3f-45ee-b6e5-0b296ed1f687">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #242424;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income attributable to common stockholders</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzQtMS0xLTEtMTU4NTUy_01c527f5-866a-4d69-869d-4697dc5d3149">87,125</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzQtMi0xLTEtMTU4NTUy_1da45b59-d927-42b1-aded-98af24770982">42,227</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzgtMS0xLTEtMTU4NTUy_7f164331-53f2-4d9e-bd52-e05b87b6278f">0.23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzgtMi0xLTEtMTU4NTUy_4f980585-e5ab-4fb5-9dcf-93b7f89e2aef">0.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDEtMS0xLTEtMTU4NTUy_a0083771-1e47-494f-9164-2b10cb876d05">0.23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDEtMi0xLTEtMTU4NTUy_40b6ec3f-488b-4354-8af3-20c9306d6598">0.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDMtMS0xLTEtMTU4NTUy_acd3c4c3-d6af-4ef6-bfbe-81eae9f1ee07">378,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDMtMi0xLTEtMTU4NTUy_fd3058ef-444f-4d85-8991-5645e789b29e">148,963</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDQtMS0xLTEtMTU4NTUy_f6ecaf06-48ee-4f51-9ef3-9580a2edb868">378,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDQtMi0xLTEtMTU4NTUy_59b2b956-0653-443a-9a7e-ef3b8f9b2c7b">149,051</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_31"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three Months Ended March&#160;31, 2023 and 2022 </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.730%"><tr><td style="width:1.0%"></td><td style="width:76.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income </span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMi0xLTEtMS0xNTg1NTI_2b7cdb89-fcad-44b5-8b90-0a2e71fee35e">88,078</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMi0yLTEtMS0xNTg1NTI_9fefed9a-38ef-4f33-97f3-8f959bdd23a8">42,227</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for (gains) losses included in net income (interest expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfNy0xLTEtMS0xNTg1NTI_471de02c-afaa-43e7-8944-d775040e0fd8">2,284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfNy0yLTEtMS0xNTg1NTI_fd32510e-2bd8-48d0-a24c-f73e9cb9e2e9">1,086</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Losses) gains arising during the period on interest rate swaps</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1641a82fd53448279f743e919d3e08b3_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfOC0xLTEtMS0xNTg1NTI_f561489b-328c-4e4e-a6a0-b2b8f54b3d25">8,541</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ee4952dd5042e1985f1a054d1950b5_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfOC0yLTEtMS0xNTg1NTI_a7275e45-c5fc-483b-8353-d35301db87ac">5,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTAtMS0xLTEtMTU4NTUy_466442fb-8883-41e7-9827-082570a328dc">10,825</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTAtMi0xLTEtMTU4NTUy_94386271-33ac-4541-aa4c-e452c64b2300">6,245</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Comprehensive (loss) income </span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTEtMS0xLTEtMTU4NTUy_6d7a1dbe-f6fb-467b-8830-349b1bfd2c1a">98,903</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTEtMi0xLTEtMTU4NTUy_e54cfa05-9c3d-498f-a33e-ed93c9a7c97d">48,472</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Less: comprehensive loss attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTItMS0xLTEtMTU4NTUy_3aa462e0-876b-49dd-8fbc-e2358c668958">1,084</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTItMi0xLTEtMTU4NTUy_065b9a50-d7f0-4d85-9ac4-bd0607bcb7f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Comprehensive (loss) income attributable to common stockholders</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTMtMS0xLTEtMTU4NTUy_5f7a47a6-0951-4602-a192-b1eb4852d915">97,819</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTMtMi0xLTEtMTU4NTUy_a91c8e21-e6bf-4679-9dcf-33005833cb5d">48,472</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span></div><div style="margin-bottom:6pt;margin-top:14pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_34"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three Months Ended March&#160;31, 2023 and 2022</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative <br/>Net Income </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75cc38ea5ec4ad8850297f36dd63583_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS0xLTEtMS0xNTg1NTI_00315c69-8fc6-4fbf-94e6-dabac7eebfa8">3,806</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0a185d73934641a877bc76aa2044db_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS0yLTEtMS0xNTg1NTI_42bf9091-fc80-4d3d-83d6-2cd64af18824">9,587,637</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if468b8ca453d4bf19389e61cd9809e62_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS0zLTEtMS0xNTg1NTI_cb931b47-7172-45ce-9da6-c3f70ade8623">2,140</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb2002d8c6d84f4da515c0db9530384d_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS00LTEtMS0xNTg1NTI_929c655e-edf8-4029-8a76-b2fc00fc2d8a">1,307,055</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e5da7ae82734c4db38e815b5c361e35_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS01LTEtMS0xNTg1NTI_deabf90f-cf27-4c77-8dec-2dc692885f51">3,329,562</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if01ffbea98ac470eb82da6fd52cf6386_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS02LTEtMS0xNTg1NTI_acfec3ee-169a-415e-af4a-af0ccae171eb">7,571,076</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2adb5feae81642dab43ef13b1005c686_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS03LTEtMS0xNTg1NTI_5c23ada8-dbbf-4526-b26e-977038ee64b0">108,742</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS04LTEtMS0xNTg1NTI_254c66e1-be49-488b-a077-596d5300861a">7,679,818</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d03d95236f4962848c499be4324419_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMi0yLTEtMS0xNTg1NTI_2730ebcf-956f-4dde-864d-4a539529fa40">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMi02LTEtMS0xNTg1NTI_57c50924-10a5-43a0-9f77-2b22e05ab94d">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMi04LTEtMS0xNTg1NTI_bfe88237-b2b8-4e67-9454-336e3f6af728">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS0xLTEtMS0xNTg1NTI_d52a845e-d606-40e4-9d7a-375708b7a532">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29d03d95236f4962848c499be4324419_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS0yLTEtMS0xNTg1NTI_537ce650-6ee6-466d-8b86-603130c51ad0">1,483</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS02LTEtMS0xNTg1NTI_32bd58ad-1f60-486e-8ad6-2b8c4ae2d75c">1,484</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS04LTEtMS0xNTg1NTI_08256c11-1119-4552-9605-d8b6425edca9">1,484</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi0xLTEtMS0xNTg1NTI_3d4c452e-8c8f-441b-bd8a-914ee886ae6f">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d03d95236f4962848c499be4324419_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi0yLTEtMS0xNTg1NTI_7f36270b-1156-4d77-9a85-4deffd33cfb8">4,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi02LTEtMS0xNTg1NTI_262d66c1-7609-484c-8a5c-a9313ce0324e">4,992</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi04LTEtMS0xNTg1NTI_202095ff-924b-40f7-89bf-395a40feadb3">4,992</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e911b72c3da4719a3d272ba0d92cf3e_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC00LTEtMS0xNTg1NTI_ae92f20c-49c1-463c-a7f1-59395736a9d8">87,125</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC02LTEtMS0xNTg1NTI_a76c1583-3ddb-48a4-be3a-9289f2187511">87,125</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC03LTEtMS0xNTg1NTI_803c9a62-1416-4d99-aab4-fbfce6708809">953</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC04LTEtMS0xNTg1NTI_3bf0c038-61f8-4543-a374-a06facdb5564">88,078</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i181797bf9c4c415f87f43a136f4c8ecb_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS0zLTEtMS0xNTg1NTI_8ebee2d7-d9a9-4a02-8374-7bb5ead7bc1d">2,256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS02LTEtMS0xNTg1NTI_95d39036-d2ee-4dc6-b243-5c7d6a5d2c98">2,256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS03LTEtMS0xNTg1NTI_3ffce4eb-8c53-498d-916f-9e80fc509b92">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS04LTEtMS0xNTg1NTI_0a4c1181-854c-479e-972f-9b818748da19">2,284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on <br/>interest rate swaps <br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i181797bf9c4c415f87f43a136f4c8ecb_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtMy0xLTEtMTU4NTUy_5878aa2e-32bf-4255-9f07-7d5a6b63699d">8,438</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtNi0xLTEtMTU4NTUy_13f64bae-9cd7-4c5f-837d-0171e6bdd7df">8,438</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtNy0xLTEtMTU4NTUy_6d780c7f-2fac-4ead-8ece-4a04731f500a">103</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtOC0xLTEtMTU4NTUy_67d098cb-c3a1-4e7b-a991-a665c83cc8e1">8,541</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usdPerShare" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjNhYWJlMTRmMzFiNGFiOTgwNzRjNTI2N2IwNDNlYmRfNDA_45458d9f-c347-41f8-9aaa-9ec9146475fd">0.31</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bdf82ba6dfa4a2ab45ab2a25b586dda_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtNS0xLTEtMTU4NTUy_56d54150-edd9-478e-af7b-d35a3a78a776">118,188</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtNi0xLTEtMTU4NTUy_33da2cbd-26e7-481e-8a46-08a24daffbc7">118,188</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtNy0xLTEtMTU4NTUy_57097e93-6300-44cf-8451-4bb36c249e5c">1,447</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtOC0xLTEtMTU4NTUy_41bcdfac-7379-4118-9df8-656838d8180f">119,635</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItMS0xLTEtMTU4NTUy_c015dbc2-d6d2-499b-92b8-98b261d21d1e">3,808</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe7ed1db8704e09b2408dfbcbe34ff2_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItMi0xLTEtMTU4NTUy_50540f64-f288-4bc3-842c-f0cd8520a270">9,591,194</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i870fd274e1024059a5692743eaf92e98_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItMy0xLTEtMTU4NTUy_25467466-ec8a-4b13-8780-1aae8dd56cf3">8,554</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd49fc556404cc88d55daa4ab3d7340_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNC0xLTEtMTU4NTUy_83519e89-6938-4669-94c9-9353aaab231f">1,219,930</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d5b61f7901043e3a556d968f6d61ded_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNS0xLTEtMTU4NTUy_d980afb6-795f-46b2-8d9d-ad97b6b646b5">3,447,750</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c65d76e0814dcabee7dac8d1342535_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNi0xLTEtMTU4NTUy_e3040c21-1236-4c85-acec-e622b049678b">7,358,628</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87844637281d4d8b9949441898948c60_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNy0xLTEtMTU4NTUy_8a42ef87-53c9-40eb-aff2-ce4ae63b2692">106,211</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItOC0xLTEtMTU4NTUy_463be242-6b18-442f-9aef-2c62ee2b9c63">7,464,839</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Net Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtMS0xLTEtMTU4NTUy_1b004711-43b9-4274-8767-374fb0595787">1,505</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d8e2030aa445ce95661811675e94d1_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtMi0xLTEtMTU4NTUy_bd624373-e179-43fe-81c0-288db09877a3">3,972,917</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a0ab9ea386f4d648d280a8e0986c84e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtMy0xLTEtMTU4NTUy_23efae9a-e352-44bd-9fa8-16a1356ebf47">9,981</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888e6ab385484db59802ccaa138669cc_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNC0xLTEtMTU4NTUy_c3593be8-3f7f-46d1-8299-eb461f927d4b">1,266,158</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i290d83ded5944529b00324bf10c29c5f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNS0xLTEtMTU4NTUy_c207c8cc-9ac5-4385-9109-e039c7161659">3,045,483</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedac472c8ec4dcfb0431ac1e84e3e61_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNi0xLTEtMTU4NTUy_44d9b77c-9d8f-4fe5-ac52-0ae0f58414c2">2,185,116</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f1ddce63b34147a4e501072582d084_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNy0xLTEtMTU4NTUy_1be410b1-ded2-4b6d-b3b3-9557ee802d7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4fe5a5fedc449b89509f79262e0912_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtOC0xLTEtMTU4NTUy_211f602c-0408-4e8e-babb-071c3466ad03">2,185,116</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86534f62dd7648db9d787382c8966202_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtMS0xLTEtMTU4NTUy_2df91390-1e5e-44b2-954d-12267124cc87">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtMi0xLTEtMTU4NTUy_6a009327-9ab6-4f81-888a-a6975ba90b6b">22,654</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtNi0xLTEtMTU4NTUy_a82ab346-aa77-4e84-aab4-24ed69d1d863">22,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtOC0xLTEtMTU4NTUy_aea7072b-f974-43a4-b74b-50c0faca059c">22,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTctMi0xLTEtMTU4NTUy_ae1a1d37-2fd8-4fa8-8e4b-1384ce3ccda2">206</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTctNi0xLTEtMTU4NTUy_a77a3bd5-a8f5-497c-b776-aa3d04b2e835">206</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTctOC0xLTEtMTU4NTUy_12b2e08f-97f6-4457-b15b-283d6a9763fc">206</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86534f62dd7648db9d787382c8966202_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtMS0xLTEtMTU4NTUy_73609e21-3bcc-4148-a64e-f2e59a7e0f2a">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtMi0xLTEtMTU4NTUy_241e93cb-6cfc-470f-8a28-ea205366c242">3,695</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtNi0xLTEtMTU4NTUy_66c79b2a-5c1e-461d-9078-59a2d7312079">3,699</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtOC0xLTEtMTU4NTUy_bbf71021-f393-4a03-93b9-0d6b55c37ab9">3,699</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a37fba94472444e866a3ce898b6e671_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTktNC0xLTEtMTU4NTUy_32bf9990-f61f-4316-b220-ad5570ff5e40">42,227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTktNi0xLTEtMTU4NTUy_defd96ae-2bc5-4945-a869-a5e6b14b265d">42,227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTktOC0xLTEtMTU4NTUy_2ca8434f-5fb2-489f-94fc-60b98f6700e0">42,227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for losses included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c951ed7666477093b2d8cac71d81e7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjAtMy0xLTEtMTU4NTUy_955ea93a-81c8-4563-9ef4-fb5bfdcc65b2">1,086</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjAtNi0xLTEtMTU4NTUy_ebc05bab-1ea3-4d33-8714-6403c16f5282">1,086</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjAtOC0xLTEtMTU4NTUy_f676d1e3-b1d9-4eac-ace1-1d60a4f124e9">1,086</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Losses arising during the period on interest rate swaps<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c951ed7666477093b2d8cac71d81e7_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjEtMy0xLTEtMTU4NTUy_930b1439-cf46-4e13-8b13-5dc2ce400cc2">5,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjEtNi0xLTEtMTU4NTUy_72ea57f2-8d80-4c30-bcf9-0cbdb337d9a2">5,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjEtOC0xLTEtMTU4NTUy_3d346725-a1d4-4d14-9046-4c75e92885e7">5,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItMC0xLTEtMTU4NTUyL3RleHRyZWdpb246MGVhMWY5YjU0ZDU4NDU3YzhlMzVhNDJiYjQ3ODA4YzlfMzk_eb0afa17-e6c7-41a9-babc-1eed6318b8fc">0.31</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e5855b50bdc47b6a5bbbd3d256a70a0_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItNS0xLTEtMTU4NTUy_0bb0cd31-32a0-4a64-b300-75e5344e3cc2">46,860</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItNi0xLTEtMTU4NTUy_0b7c9dd3-420f-4c78-8ac0-72e02e994759">46,860</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItOC0xLTEtMTU4NTUy_9d3f92dd-82bb-4077-9450-ad862df2a4e4">46,860</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf73c42f4034daf8884c9aa069853fd_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtMS0xLTEtMTU4NTUy_8bb493fa-c8c5-4030-bfab-c849bb240028">1,516</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cad1329072a4ad9aed8fa84a66de166_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtMi0xLTEtMTU4NTUy_24d7d740-ef54-4e80-ab52-ef01f09cfc7a">3,999,060</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba23fc68cdfa4c51b94dfc9b1cd39211_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtMy0xLTEtMTU4NTUy_cae1f5f2-3de9-4b32-8c41-b20cbc2b7090">3,736</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8453ec6e13a4ca9b4aaea77eb059be6_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNC0xLTEtMTU4NTUy_d1c35b66-0b2c-41cd-aab7-60ce10ce0c44">1,308,385</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45b6af45f46f4248a7942a21c71bdd30_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNS0xLTEtMTU4NTUy_f223f65f-0bf9-4f53-b30e-fcbb9963d200">3,092,343</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c470fb138540ceae43a17b211a2504_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNi0xLTEtMTU4NTUy_cdf192db-b3e9-4dd8-8a62-0823fb3dc3e4">2,212,882</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied1e48d84ca64c058e35c69ae07d90c4_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNy0xLTEtMTU4NTUy_5e337e3d-d3ae-48dc-aeb4-8bd18c67c984">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtOC0xLTEtMTU4NTUy_3fa9b015-1a5c-4520-9cfe-421af8fe6e78">2,212,882</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_40"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Healthcare</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three Months Ended March&#160;31, 2023 and 2022 </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.168%"><tr><td style="width:1.0%"></td><td style="width:75.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMy0xLTEtMS0xNTg1NTI_307a632c-a88e-47df-8ebd-d5c9a9616d61">88,078</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMy0yLTEtMS0xNTg1NTI_b834835c-45fe-42da-80cc-931e4457304e">42,227</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNS0xLTEtMS0xNTg1NTI_68142f0b-c4ec-4292-9b5e-1070056d6470">184,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNS0yLTEtMS0xNTg1NTI_9b04e518-8c3f-4f77-bf12-e35ded566dde">54,041</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNi0xLTEtMS0xNTg1NTI_dbf80b36-3ed9-471e-b754-aea548122ce1">11,104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNi0yLTEtMS0xNTg1NTI_218eaf6e-c3b4-4f37-8af7-ad5d489dc505">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNy0xLTEtMS0xNTg1NTI_9fcf7dca-909b-44cc-a80c-9823738388ce">4,992</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNy0yLTEtMS0xNTg1NTI_2b0a91d4-61e8-41f7-82f3-f7f4fb2ff0d8">3,699</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of straight-line rent receivable (lessor)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:StraightLineRentReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOC0xLTEtMS0xNTg1NTI_408747cb-9a4f-4fc1-aa2e-d70954b1b812">9,783</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:StraightLineRentReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOC0yLTEtMS0xNTg1NTI_9d6d0f8d-e572-4aaf-8184-34f4ce3a88e9">1,587</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of straight-line rent on operating leases (lessee)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:StraightlineRentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOS0xLTEtMS0xNTg1NTI_bb07ff41-1f6f-4bb3-947e-0e4fecd2009e">1,537</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:StraightlineRentLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOS0yLTEtMS0xNTg1NTI_caeaa854-ab3b-4313-bc70-0ad8e1abbd5b">378</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTAtMS0xLTEtMTU4NTUy_dc562749-3a2e-4bcf-a5b5-55338796496a">1,007</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTAtMi0xLTEtMTU4NTUy_65b93f5c-0bc9-4e60-adf8-9d38a467a019">44,784</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTEtMS0xLTEtMTU4NTUy_e77d0dde-afab-4b68-851e-6ffad6e559ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTEtMi0xLTEtMTU4NTUy_aae4d75f-fcc2-41a1-9d7c-286a621afb92">1,429</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties and credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTItMS0xLTEtMTU4NTUy_565da261-b5c5-4de0-a289-40bea967f032">31,422</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTItMi0xLTEtMTU4NTUy_55b68680-f19e-4feb-8135-0d04740d3962">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss from unconsolidated joint ventures </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTMtMS0xLTEtMTU4NTUy_7d8dc339-752a-45dd-92c2-f5b842bc3abe">780</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTMtMi0xLTEtMTU4NTUy_b46b54c1-6cf0-4577-9c3f-95e289244546">345</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distributions from unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTQtMS0xLTEtMTU4NTUy_cf5d7425-83c9-43e2-827a-5eed6b39b309">2,542</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTQtMi0xLTEtMTU4NTUy_b2bc61fd-bc09-4707-b9b3-912dc448b3e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash interest from financing and notes receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:InterestIncomeFinancingReceivableNoncash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTYtMS0xLTEtMTU4NTUy_4add8969-c090-4a77-8104-c4272db2feb6">1,385</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:InterestIncomeFinancingReceivableNoncash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTYtMi0xLTEtMTU4NTUy_4dcc8bd1-2a77-4f16-853b-f2d950a822ab">199</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, including right-of-use-assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTgtMS0xLTEtMTU4NTUy_6dd60b83-73c6-49ba-9cc8-1628b1163793">8,360</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTgtMi0xLTEtMTU4NTUy_157be315-a0cf-4025-a11c-6d095d59004f">2,563</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTktMS0xLTEtMTU4NTUy_80f6fa99-26fc-442d-aff4-34c83d5eddb4">66,954</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTktMi0xLTEtMTU4NTUy_ee69079e-b846-450c-9fcd-12acc9f21901">12,212</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjAtMS0xLTEtMTU4NTUy_27ac68eb-4e8e-4160-bbfe-9750475dce52">7,901</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjAtMi0xLTEtMTU4NTUy_87624d60-a57b-44ef-ad16-a78f9fd63e45">1,830</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjEtMS0xLTEtMTU4NTUy_4b985a4f-7f99-4f4a-920f-738f7c64682e">69,190</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjEtMi0xLTEtMTU4NTUy_8f872acd-48a2-4e18-beb3-b2e70419c483">43,771</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisitions of real estate</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjQtMS0xLTEtMTU4NTUy_3a3a51d5-09fd-42e1-bcdb-2febd959b0db">30,725</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjQtMi0xLTEtMTU4NTUy_24850c99-4797-4506-a89b-70e4255b151a">121,964</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Development of real estate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjUtMS0xLTEtMTU4NTUy_d985c344-1de5-45a2-a39d-cd2f3d715fa0">6,707</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjUtMi0xLTEtMTU4NTUy_0208d6bd-a236-4a94-9986-dbaea14c7cfd">3,754</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional long-lived assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjYtMS0xLTEtMTU4NTUy_d85878fb-f304-437f-a471-d23338aafa08">60,159</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjYtMi0xLTEtMTU4NTUy_1ba74173-4e46-489e-9b8a-8ce2527246c6">23,326</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Funding of mortgages and notes receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjctMS0xLTEtMTU4NTUy_cbffbc7c-a607-44b0-ad87-2f57f66ffc30">6,230</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjctMi0xLTEtMTU4NTUy_0c933797-adac-4d0b-98c5-efb6b0f9a516">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjgtMS0xLTEtMTU4NTUy_36d3b1c7-28dd-4a4a-b9c5-76323c647316">3,824</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjgtMi0xLTEtMTU4NTUy_f8eb3746-39d4-4847-8253-9ebfa4700ecc">49,598</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in financing receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireFinanceReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjktMS0xLTEtMTU4NTUy_62096fac-bf3c-41a8-9dc5-300f2873f00a">302</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjktMi0xLTEtMTU4NTUy_eb7d7233-33f5-4896-a0dc-a8f2298a2405">492</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from sales of real estate properties and additional long-lived assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzAtMS0xLTEtMTU4NTUy_79d3199f-e0b7-4bb6-8ba8-3511676b7fe4">149,171</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzAtMi0xLTEtMTU4NTUy_1f41931d-7734-4945-9422-6855f8d886a5">84,883</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from notes receivable repayments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzEtMS0xLTEtMTU4NTUy_65e14ef7-3563-4c5c-821e-7741c9b90eaf">336</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzEtMi0xLTEtMTU4NTUy_fe6ad553-6423-42bf-b2c5-3adf79acbafc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzQtMS0xLTEtMTU4NTUy_8b7bd9ff-eadb-4c62-8b51-50ff07e5109c">41,560</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzQtMi0xLTEtMTU4NTUy_3a3ffaa2-8419-4e84-a4c1-1a557a4cf3e2">113,267</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net borrowings on unsecured credit facility</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzctMS0xLTEtMTU4NTUy_31977a19-57bc-4f19-9525-f72e06b44bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzctMi0xLTEtMTU4NTUy_bdaece3e-260e-4a92-a626-b9d811663308">124,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repayments of notes and bonds payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDEtMS0xLTEtMTU4NTUy_0341059f-0ca7-439c-b0ad-50386fd4912b">667</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDEtMi0xLTEtMTU4NTUy_70bf571b-405b-49d4-9857-e961e44c331a">17,573</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redemption of notes and bonds payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDMtMS0xLTEtMTU4NTUy_80bf0f7a-7306-4585-8df4-93e3bbf8ed7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDMtMi0xLTEtMTU4NTUy_11ce40bd-f94d-4569-a321-2caabe4f1add">2,184</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDQtMS0xLTEtMTU4NTUy_198e114a-deeb-4207-b082-8ef182977c15">118,052</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDQtMi0xLTEtMTU4NTUy_f7d3ef75-e360-467c-b046-18b70c1cc82f">46,768</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDctMS0xLTEtMTU4NTUy_04107cb4-212a-41c1-aae0-d96b931e1829">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDctMi0xLTEtMTU4NTUy_45bcfc49-d323-47be-b560-bf09951363bb">22,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDgtMS0xLTEtMTU4NTUy_1ba6533b-e0b8-470e-bc30-50112003e4fc">1,729</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDgtMi0xLTEtMTU4NTUy_3faa6f24-56f0-42ee-b369-3cfddf00612b">852</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distributions to non-controlling interest holders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDktMS0xLTEtMTU4NTUy_b72c5fcd-35c3-44ae-825a-cdbbf759c156">1,272</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDktMi0xLTEtMTU4NTUy_eb3d7d9d-2d7c-4118-b964-7df7686ca392">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments made on finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTMtMS0xLTEtMTU4NTUy_034816df-62f9-4719-8e3c-a2ae7c276eea">101</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTMtMi0xLTEtMTU4NTUy_53fda7cf-f0c0-4181-bcd6-6c6ca905f2aa">257</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTQtMS0xLTEtMTU4NTUy_6151fd91-921d-44a0-99fa-5b02f45e6cee">121,770</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTQtMi0xLTEtMTU4NTUy_eeaeff19-4feb-41fd-9d24-a4838900e6ec">79,015</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTYtMS0xLTEtMTU4NTUy_18158ec1-a2f4-48ee-8f42-09f9f2aaeda9">11,020</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTYtMi0xLTEtMTU4NTUy_adcda859-ca50-4864-9d05-65245efad681">9,519</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTctMS0xLTEtMTU4NTUy_2ca91659-a85f-4830-b10f-f3ec9cc1d7d9">60,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4fe5a5fedc449b89509f79262e0912_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTctMi0xLTEtMTU4NTUy_af479666-1b4e-4c1c-897b-1359574ae235">13,175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTgtMS0xLTEtMTU4NTUy_718bc399-2e17-4b52-85b3-678c40bd33fb">49,941</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTgtMi0xLTEtMTU4NTUy_08e9c107-8255-415d-89dd-9d76d2a46b0a">22,694</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjEtMS0xLTEtMTg0MDc0_2a2175ae-2dfa-4a64-8a73-f0a2c0237229">75,082</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjEtMi0xLTEtMTg0MDc0_44ee1e8a-a5a1-4de3-8042-32f58134a3bc">16,227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage note receivable taken in connection with sale of real estate</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMS0xLTEtMTg3Nzg2_fb4ddc6b-9760-44d0-8a21-9d137a67a031">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMi0xLTEtMTg3Nzkw_a5291c24-d955-40db-b030-a331ab4c4c2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Invoices accrued for construction, tenant improvements and other capitalized costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMS0xLTEtMTg0MDc0_2f3cd66d-090d-4681-8392-a89a6f3353c6">28,138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMi0xLTEtMTg0MDc0_9a51d6da-6fb8-468b-81c3-65d8fbcf56fe">13,516</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjAtMS0xLTEtMTU4NTUy_b3d24ec7-5eb5-4f5d-8ab4-db4d7349237d">570</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjAtMi0xLTEtMTU4NTUy_0aeba30b-9451-4828-94cd-3da557a878aa">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_43"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80My9mcmFnOjM2NGEzNGM4NDBjNjQ4OWNhNDAyZGI2NjdmMDU4MTJiL3RleHRyZWdpb246MzY0YTM0Yzg0MGM2NDg5Y2E0MDJkYjY2N2YwNTgxMmJfNTQ_0ad4a241-2657-446a-b22b-65687c178c10" continuedAt="i70cc006bb6a74a2cb6c94eeb4eeec27b" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_46"></div><ix:continuation id="i70cc006bb6a74a2cb6c94eeb4eeec27b" continuedAt="i09c4cd51137d400597ef7c3ea2df73eb"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="hr:NatureOfOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4Mzc_80ab03bb-7d4b-47bf-bbbe-aef5bb146409" continuedAt="ic191f2a25aea4cccb574825287218294" escape="true">Business Overview</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="ic191f2a25aea4cccb574825287218294" continuedAt="i0172f28f53a546f8a6cef59d120ae575">Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March&#160;31, 2023, the Company had gross investments of approximately $<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-8" name="hr:InvestmentInRealEstatePropertiesAndMortgageNotes" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzgw_8ee08961-76a6-40bb-af68-d837fffc9562">13.9</ix:nonFraction>&#160;billion in <ix:nonFraction unitRef="property" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfRealEstateInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzg2_8c19e761-e973-437f-bf81-3cb520b16c3d">681</ix:nonFraction> real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's <ix:nonFraction unitRef="property" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODI2ODE2_5061c7c2-31ec-4dce-9c26-0dc8c7b7f3c2">681</ix:nonFraction> real estate properties are located in <ix:nonFraction unitRef="state" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNjIy_488d8c58-d949-4e7d-8eac-a79041fe437d">35</ix:nonFraction> states and total approximately <ix:nonFraction unitRef="sqft" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:ApproximateSquareFeetInvestedInByCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNjU2_61c52399-7f81-4389-b653-033bbfc08401">39.9</ix:nonFraction>&#160;million square feet. The Company provided leasing and property management services to approximately <ix:nonFraction unitRef="sqft" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:ApproximateSquareFeetProvidedByCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNzUx_9c04e084-f44f-4e96-a7fa-edbf540e2468">39.5</ix:nonFraction> million square feet nationwide.   As of March&#160;31, 2023, the Company had a weighted average ownership interest of approximately <ix:nonFraction unitRef="number" contextRef="i755c42838b7b431480fbfbdf30a6e9ed_I20230331" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfODYx_33f2f703-b8c4-4157-850a-a8047a7fca35">44</ix:nonFraction>% in <ix:nonFraction unitRef="building" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfBuildingsOwnedByJointVenture" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfODY3_06fa3aa9-c3a2-4a43-a7c3-26e8501492a9">34</ix:nonFraction> real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="i0172f28f53a546f8a6cef59d120ae575">Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review.</ix:continuation> </span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NTg_c2671386-beda-40c8-b08e-91a822c69c75" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NTI_66114f00-f67c-4fe1-abb7-0c6bd0ac3406" continuedAt="i3fab73e571f64c53b104818a054e16e2" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i09c4cd51137d400597ef7c3ea2df73eb" continuedAt="i94334eee52c94b559670827db20978b5"><ix:continuation id="i3fab73e571f64c53b104818a054e16e2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns <ix:nonFraction unitRef="number" contextRef="i51484a2f360e4b42bdb84e7d753ea660_I20230331" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTU5_a1a750bf-3cd8-4a3b-abad-794fbf3b27a2">100</ix:nonFraction>% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than <ix:nonFraction unitRef="number" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:EquityOwnershipForConsolidationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTcw_2f8ffb65-f8a0-47da-9035-784449bf8c33">100</ix:nonFraction>% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Holdings, L.P. (the "OP") is <ix:nonFraction unitRef="number" contextRef="i0322c2eebd454faf9eed6b856d8741ba_I20230331" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjIw_ab5a3522-a1a2-4508-90b6-3111ae8bb89a">98.8</ix:nonFraction>% owned by the Company.  Holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of March&#160;31, 2023, there were approximately <ix:nonFraction unitRef="shares" contextRef="i5aac4bb4c06647b5ad4f91577c69c51e_I20230331" decimals="-5" name="us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUyMA_8fd08fed-9ddf-4cd6-b48a-b0645ffc3786">4.7</ix:nonFraction>&#160;million, or <ix:nonFraction unitRef="number" contextRef="i82ce96e024674f9b87df4e61c55f6764_D20230101-20230331" decimals="3" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTgx_41441c74-d6ac-48ca-a2a0-eb97bc7b6383">1.2</ix:nonFraction>%, of OP Units issued and outstanding held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had <ix:nonFraction unitRef="variable_interest_entity" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTQ1_289bfeac-1db1-4384-82ee-97c7b390c64d">three</ix:nonFraction> consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUzMg_770b36dd-590c-4634-b467-0a8985009b1e" continuedAt="i681215c291554a9290aa6962b4e2eef5" escape="true">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="i681215c291554a9290aa6962b4e2eef5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"><tr><td style="width:1.0%"></td><td style="width:67.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfMi0xLTEtMS0xNzY4NTg_f013481d-3d12-4b9a-9660-0f787ae20200">48,079</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfMy0xLTEtMS0xNzY4NTg_0b8efa2b-ee6c-4b9d-84b3-ee04ad2461fe">1,517</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="hr:ReceivablesAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfNC0xLTEtMS0xNzY4NTg_65b14429-b45b-4987-a2b3-4ddf0040c188">2,339</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfNS0xLTEtMS0xNzY4NTg_c640d5b7-b4b6-4377-82b1-85ca71943335">51,935</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfNy0xLTEtMS0xNzY4Nzk_3edff36e-d843-4f3b-9716-af88a978def1">12,010</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfOC0xLTEtMS0xNzY4Nzk_c3e5bd90-16c5-4160-8399-a3b0f4823569">39,925</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0458b77080714c6888c6e3f362854f15_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfOS0xLTEtMS0xNzY4Nzk_ac1a1c9f-e3b4-4ad7-90f8-7b8b7667bb92">51,935</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had <ix:nonFraction unitRef="variable_interest_entity" contextRef="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331" decimals="INF" name="hr:NumberOfVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjMy_f76b6895-9a9a-408e-a263-aa164982ede6">three</ix:nonFraction> unconsolidated VIEs consisting of <ix:nonFraction unitRef="note_receivable" contextRef="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331" decimals="INF" name="hr:NumberOfNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjQ0_ee203329-f0a6-49c9-8fbe-b583fc68d717">two</ix:nonFraction> notes receivables and <ix:nonFraction unitRef="joint_venture" contextRef="i4fee5ed06fc349219d14427a4e38fc89_D20230101-20230331" decimals="INF" name="hr:NumberOfJointVentures" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjU0_75ccb7b4-c218-478c-bf1c-e3a6900a6aaf">one</ix:nonFraction> joint venture.  The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result<ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUzMw_82cbfe76-2a9e-4373-b031-2459de600a88" continuedAt="i11a72293fe8d46ef9309ba1067d39544" escape="true">, the Company accounts for the <ix:nonFraction unitRef="note_receivable" contextRef="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331" decimals="INF" name="hr:NumberOfNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjY0_4a2b6864-e023-4e1e-8b93-1ba5a9fce1b0">two</ix:nonFraction> notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</ix:nonNumeric></span></div><ix:continuation id="i11a72293fe8d46ef9309ba1067d39544"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"></td><td style="width:21.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i892f855ceda549059585643902bde99c_I20230331" decimals="-3" name="hr:NotesReceivableCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMS0zLTEtMS0xNzcwMzU_b0c11410-0188-4cd1-89d5-a2270b1e667e">30,839</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i892f855ceda549059585643902bde99c_I20230331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMS00LTEtMS0xNzcwMzU_a9d6bf0c-e2db-45bc-ad36-d2b50492ed3f">31,150</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i33a33b3d8f3f49099605a5a0d1738e6b_I20230331" decimals="-3" name="hr:NotesReceivableCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMi0zLTEtMS0xNzcwMzU_ba2c5ff0-ca99-4c39-9fec-a5ecacfe286d">5,639</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i33a33b3d8f3f49099605a5a0d1738e6b_I20230331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMi00LTEtMS0xNzcwMzU_cd7a5799-b722-483f-b013-61e103f502ca">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i12840b99f3724aff95ff5318afa01dd3_I20230331" decimals="-3" name="hr:JointVentureCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMy0zLTEtMS0xNzcwMzU_9b1c366a-6cb7-411a-88b9-cd27b36a2c45">66,038</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i12840b99f3724aff95ff5318afa01dd3_I20230331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMy00LTEtMS0xNzcwMzU_7f4359c2-8842-49b4-b5c6-c2092d531fdf">66,038</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in <ix:nonFraction unitRef="property" contextRef="i12840b99f3724aff95ff5318afa01dd3_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODQzNjIy_c9256e47-54f0-4558-a64c-90983d9b58e2">seven</ix:nonFraction> properties.</span></div></ix:continuation></ix:continuation></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><div style="margin-bottom:6pt"><span><br/></span></div><ix:continuation id="i94334eee52c94b559670827db20978b5" continuedAt="ifbd28df6f79e42f98a4e4c04a3a2d76e"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NzA_20c782ac-9239-4c82-9407-e7eb5a913e8f" escape="true">As of March&#160;31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.</ix:nonNumeric>  See Note 3 below for more details regarding the Company's unconsolidated joint ventures.</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI3OTM_ced0f2bd-4675-4543-9064-5a3e228f7666" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NDM_1c2c7db8-1e2a-45d5-9e26-0984f3636a47" continuedAt="i0db824edf7914bc792bafb41c8dc4375" escape="true">Reclassifications </ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="i0db824edf7914bc792bafb41c8dc4375">Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.</ix:continuation> </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">                                            &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwOTY5Mw_e52079ec-b865-4fbf-88f7-b18cc21fcd76" continuedAt="ic01aa3e9202e460a81f3b2e0b808e815" escape="true">Redeemable Non-Controlling Interests</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="ic01aa3e9202e460a81f3b2e0b808e815">The Company accounts for redeemable equity securities in accordance with Accounting Standards Codification Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheet.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.</ix:continuation>  As of March&#160;31, 2023, the Company had redeemable non-controlling interests of $<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODQwMTc5_e952bf27-20c5-4d12-99d6-2f5e71968765">2.0</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:LessorLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4MTI_1d51e52f-5f7d-4e88-a09f-2639720e8ad5" continuedAt="i337d84a007a0492eaabd7884a51739b5" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In accordance with ASC 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 &#8220;Receivables&#8221;.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of March&#160;31, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:RealEstateNotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfOTQwNg_ed82ff77-d838-492d-af06-f8ca245b5156">147.3</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUzNg_f1c4a77a-2d08-4c72-9be2-48235e0462b0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"><tr><td style="width:1.0%"></td><td style="width:25.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loan</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMi0zLTEtMS0xNzcyOTk_066aae2e-16d1-499a-9004-c23feecaac25">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMi00LTEtMS0xNzcyOTk_fdc2e0be-c2a6-4679-a989-593df2eaaf42">54,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331" decimals="-3" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMi01LTEtMS0xNzcyOTk_970a1e0b-5f12-45c1-8a42-dca2095ffd44">54,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi0zLTEtMS0xNzczMDM_9b281f02-93de-4fe8-a7bd-b82edf1adb93">7.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi00LTEtMS0xNzczMDM_14168f6e-563c-4502-aba1-8c11e2e2b510">31,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331" decimals="-3" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi01LTEtMS0xNzczMDM_c8bc0526-e632-4f4a-bd9b-b54d93b4c659">31,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i62b0d5e420094983ab1ab22d723321e0_I20230331" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi0zLTEtMS0xODY2MjE_a9725947-3c77-40b9-9769-a3ad29497c0c">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i62b0d5e420094983ab1ab22d723321e0_I20230331" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi00LTEtMS0xODY2MjQ_c535be47-c62e-488f-8054-93ff4d653c93">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i62b0d5e420094983ab1ab22d723321e0_I20230331" decimals="-3" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi01LTEtMS0xODY2MjY_fb4bd3b1-437b-4a53-af98-d61e3136b3cc">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNy0zLTEtMS0xNzczMDM_e4a6b01b-835c-4855-b13f-7a423cc1bee3">6.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNy00LTEtMS0xNzczMDM_e6193c44-a57a-4c5d-8e5d-96f83dce1631">65,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331" decimals="-3" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNy01LTEtMS0xNzczMDM_618ea7e3-5ce6-4760-9600-99fd176ed24f">19,367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7a56f63d400c4079a7e865561ecc32b1_I20230331" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC0zLTEtMS0xODE0NzA_3d32ca54-9a5f-4fe6-bdac-c92707e015cc">6.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a56f63d400c4079a7e865561ecc32b1_I20230331" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC00LTEtMS0xODE0NzI_dbd9f2c0-5c35-4613-acce-d802ecaf7b71">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a56f63d400c4079a7e865561ecc32b1_I20230331" decimals="-3" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC01LTEtMS0xODE0NzQ_728f2fda-f04e-4e37-8287-5027bd287356">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic44363c5ccfa4dff9ff72967d841833c_I20230331" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC00LTEtMS0xNzczMDc_f6c05e99-1b41-427c-b33f-2596b7aa2f0d">147,150</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic44363c5ccfa4dff9ff72967d841833c_I20230331" decimals="-3" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC01LTEtMS0xNzczMDU_9d8ba264-c883-40f7-9d6e-af9da014c3f0">101,517</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOS01LTEtMS0xNzczMDU_64fbbd39-74ad-4aa7-9b1b-1deb5fb048ef">1,428</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMTEtNS0xLTEtMTg4NTIw_f129e33c-bbb8-43c5-bb08-4fb6554bf972">5,196</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair-value discount and fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:NotesReceivableFairValueDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMTAtNS0xLTEtMTc3MzA1_640405e8-8074-4554-b105-2d45cd8e766d">4,542</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5e0ace30abe440c2bd816870af7d7806_I20230331" decimals="-3" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMTEtNS0xLTEtMTc3MzA1_3b92ae49-13af-4021-94e2-21a71ef31e2f">147,326</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="ifbd28df6f79e42f98a4e4c04a3a2d76e" continuedAt="i28b577fd1d0946858d184505bcc902c5"><ix:continuation id="i337d84a007a0492eaabd7884a51739b5" continuedAt="i73e71498742b4836881d48484cf36bc3"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the three months ended March 31, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote.  Consequently, the Company recorded a credit loss reserve of $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMjc0ODc3OTEwNDAyMg_1ecaa382-3d60-46b2-8087-e1a672e896c3">5.2</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkxNzc1NA_b1b9d12f-e5d2-4a98-8db2-be1900af953b" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"></td><td style="width:62.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMi0xLTEtMS0xODg1MjY_6dd2cd18-3c37-460c-b8a4-f5f3a043ee4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4fe5a5fedc449b89509f79262e0912_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMi0yLTEtMS0xODg1MjY_e39386a9-b0cc-48cf-8057-a1834255714f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMy0xLTEtMS0xODg1MjY_b34d8a87-1273-48b2-9319-01d906be3c91">5,196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i62b0486b528146ec8fdc0d6d9e4c4d6c_D20220101-20221231" decimals="-3" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMy0yLTEtMS0xODg1MjY_2d38728f-e1a7-4e98-8084-b1660a04c426">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfNC0xLTEtMS0xODg1MjY_8ba3ec68-f640-4ef7-90ce-14b20ff65dfc">5,196</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfNC0yLTEtMS0xODg1MjY_252692f4-61e3-4362-bec4-9c5e6c516a2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the three months ended March&#160;31, 2023, the Company recognized the related income from <ix:nonFraction unitRef="financing_receivable" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfRecognizedLeaseFinancialReceivables" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfOTU1Mw_95837986-e7d5-4bed-9612-123d71c5d2fe">two</ix:nonFraction> financing receivables totaling $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfOTU4OA_6a98c200-7a54-4703-a7bf-ea5fb86d40c4">1.5</ix:nonFraction>&#160;million based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="i73e71498742b4836881d48484cf36bc3">During the three months ended March&#160;31, 2023, the Company recognized interest income of $<ix:nonFraction unitRef="usd" contextRef="i05be39577b12415cba92b235a157f559_D20230101-20230331" decimals="-5" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTAzMjQ_44e609bb-c081-4408-a4d4-5f09574afcb4"><ix:nonFraction unitRef="usd" contextRef="if8415018b6934f1cb08cc146d7ceb279_D20220101-20220331" decimals="-5" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTAzMjQ_c46bf870-0f96-4a82-a8ac-d2000da24f3f">2.0</ix:nonFraction></ix:nonFraction>&#160;million related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of March&#160;31, 2023, the Company placed <ix:nonFraction unitRef="financing_receivable" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfRealEstateNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMjc0ODc3OTEwNDAzNQ_6bef788f-0c4d-4b96-887d-73f3d9b77efe">two</ix:nonFraction> of its real estate notes receivable with a principal balance of $<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="us-gaap:FinancingReceivableRecordedInvestmentNonaccrualStatus" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMjc0ODc3OTEwNDAwNw_0960a235-24cc-4274-a6ff-7daa75eead2b">54.1</ix:nonFraction>&#160;million on non-accrual status and accordingly did not recognize any interest income for the quarter.</ix:continuation> </span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4MjU_0627acf1-47a2-4bf5-abfe-9bb3d10bfaf5" continuedAt="ic4a9bf73f3304a0f9425563c635faea5" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i28b577fd1d0946858d184505bcc902c5"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="ic4a9bf73f3304a0f9425563c635faea5" continuedAt="i6e9767e3fbb5456e9b4313160fbe832a">Revenue that is accounted for under Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.</ix:continuation> <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NDg_c6524fda-6d2d-4011-aa80-9b5d7abeb0ac" continuedAt="i9d988e325b00435a8883ed9548c26309" escape="true">Below is a detail of the amounts by category:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt"><ix:continuation id="i9d988e325b00435a8883ed9548c26309" continuedAt="i9b0559b1329949a486c255a68693b9e8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.896%"><tr><td style="width:1.0%"></td><td style="width:49.994%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.354%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0cfc90ab23411db24b52116a274e8c_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfMy0xLTEtMS0xNTg1NTI_c642556d-73a9-4560-90ba-27ff0a476b9d">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838dbabd027b451d9500ea47a7f339ec_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfMy0yLTEtMS0xNTg1NTI_3c11666c-2db1-4a72-824f-6027fb42f487">1,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i568f996d95dc4950803db835d3ec9a81_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNS0xLTEtMS0xNTg1NTI_b90b67b7-94c2-4c55-b24c-bf389cf3037e">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3f3967d66744ae79640534476f9540f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNS0yLTEtMS0xNTg1NTI_7eb5b08f-bb59-49a6-9199-0b1a2e1a01df">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98275e8045c4a51b9dd61d72cdae95d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNi0xLTEtMS0xNTg1NTI_7b10d81c-7552-4a49-972f-9d7004d61f57">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe566f51e494b1d8cc1a790d694cd86_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNi0yLTEtMS0xNTg1NTI_4f6b44c3-42ee-420c-a835-02683b06253b">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNy0xLTEtMS0xNTg1NTI_0f2609ff-1ab2-49b5-8321-e2494e27af7e">4,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNy0yLTEtMS0xNTg1NTI_e983f081-6166-45fd-ba50-4f3fe39b5e7e">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="i9b0559b1329949a486c255a68693b9e8">1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.</ix:continuation>           </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="i6e9767e3fbb5456e9b4313160fbe832a">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</ix:continuation></span></div></ix:continuation><div><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwNw_6eea600a-2fec-47c7-aa15-82791321b882" continuedAt="i1226a327668647358592f97e2b3bed11" escape="true">Merger with HTA </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1226a327668647358592f97e2b3bed11" continuedAt="i4a68219219d745449af9acb51f05f81f"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022 (the &#8220;Closing Date&#8221;), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the &#8220;Merger Agreement&#8221;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On the Closing Date, each outstanding share of Legacy HR common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i083d3ca006554b74ba98857c37529cb4_I20220720" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODg1_d1d24760-1a71-4b07-89b5-a97f2cdbbdab">0.01</ix:nonFraction> par value per share (the &#8220;Legacy HR Common Stock&#8221;), was cancelled and converted into the right to receive <ix:nonFraction unitRef="shares" contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720" decimals="INF" name="hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfOTk0_f1ed2dfe-16ce-49db-b3dd-2f5582b76f12">one</ix:nonFraction> share of Legacy HTA class A common stock at a fixed ratio of <ix:nonFraction unitRef="shares" contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720" decimals="INF" name="hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTA1OA_abcf0b91-04df-4c60-8910-33bd05752fe3">1.00</ix:nonFraction> to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i38dceeb615dc429ea313b8089bb30136_D20220720-20220720" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTE1MQ_1c736b69-ff10-45ee-b4eb-3b135e5d7535">4.82</ix:nonFraction> (the &#8220;Special Dividend&#8221;) for each outstanding share of Legacy HTA class A common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTI0Mg_cd05bf98-9b7b-4e42-bf39-673a4adfb879">0.01</ix:nonFraction> par value per share ( the &#8220;Legacy HTA Common Stock&#8221;), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP.  The Company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="icb262bbfd5c64c4b80a95b4c0088494d_I20220720" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTQ5NzU1ODI2OTM1_7b3c81fb-c50f-4021-a87c-4233f099b972">0.01</ix:nonFraction> par value per share, trade on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For accounting purposes, the Merger was treated as a &#8220;reverse acquisition&#8221; in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwMw_6f72763f-3a62-46c8-95e0-f8e18f1700fe" continuedAt="ibd7b034c914649abb7298e88853d1339" escape="true">The implied consideration transferred on the Closing Date is as follows: </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i4a68219219d745449af9acb51f05f81f" continuedAt="i5376e387a30a45248adcfe551c86d7c9"><ix:continuation id="ibd7b034c914649abb7298e88853d1339" continuedAt="i47e0da7411a44fa984a1c10ffcd26eb8"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"><tr><td style="width:1.0%"></td><td style="width:77.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands, except for per share data</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfMS0xLTEtMS0xNTg1NTI_45663e16-e8f3-491f-9fcf-162523ae1bd2">228,520,990</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exchange ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720" decimals="2" name="hr:RecapitalizationExchangeRatio" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfMi0xLTEtMS0xNTg1NTI_cd639986-e9f7-4cb0-b19e-38f06c5b348b">1.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Implied shares of Legacy HR Common Stock issued</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfMy0xLTEtMS0xNTg1NTI_03ff9aaf-a7c5-4aaa-91d5-dadd926aed8a">228,520,990</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjusted closing price of Legacy HR Common Stock on July 20, 2022</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="2" name="us-gaap:SaleOfStockPricePerShare" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNC0xLTEtMS0xNTg1NTI_48b3d697-ef86-4a67-b194-9795ad07473d">24.37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Value of implied Legacy HR Common Stock issued</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="INF" name="hr:ReverseRecapitalizationNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNS0xLTEtMS0xNTg1NTI_d6f36a93-2e06-4f1a-83cb-552b04762323">5,569,057</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNi0xLTEtMS0xNTg1NTI_9d90140c-1161-4c65-b1b1-376eece6b410">7,406</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Consideration transferred</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNy0xLTEtMS0xNTg1NTI_e8eb889f-d480-4ce6-9e66-3ecb1a7947a6">5,576,463</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The number of shares of Legacy HTA Common Stock presented above was based on <ix:nonFraction unitRef="shares" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwNA_5ff85c87-02a3-4e6f-92c5-222a11c50908">228,857,717</ix:nonFraction> total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less <ix:nonFraction unitRef="shares" contextRef="i38dceeb615dc429ea313b8089bb30136_D20220720-20220720" decimals="INF" name="hr:CommonStockFractionalShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzczMA_153433d7-869e-471a-9478-916d598fc9bf">192</ix:nonFraction> HTA fractional shares that were cancelled in lieu of cash and less <ix:nonFraction unitRef="shares" contextRef="ia43b38198f184947bc8289aeeeea08a6_I20220720" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzc4Mw_0e492517-d18d-40d5-ab57-ffbc6b817111">336,535</ix:nonFraction> shares of Legacy HTA restricted stock (net of <ix:nonFraction unitRef="shares" contextRef="i5d73087fbab144d6b3552bf9cf41f68f_D20220720-20220720" decimals="INF" name="hr:CommonStockSharesWithheld" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzgzMg_9f06a64b-05cd-4e86-bbfc-3853e8ab0772">215,764</ix:nonFraction> shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720" decimals="2" name="hr:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzk5OA_f307d46b-cbdc-4793-ab56-67723459dd15">1.00</ix:nonFraction> share of Legacy HR Common Stock per share of Legacy HTA Common Stock. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.</span></div></ix:continuation><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="i47e0da7411a44fa984a1c10ffcd26eb8">(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i5376e387a30a45248adcfe551c86d7c9" continuedAt="i0a07b5590639487387146d8c6b2291ea"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Preliminary Purchase Price Allocation </span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwNQ_4d0dac20-8b50-40a3-a5f6-115aaf0451f7" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:36.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MEASUREMENT PERIOD ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Real estate investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMy0xLTEtMS0xODI4Mzc_2d526b1c-4bc0-4102-85d9-bf18e7a3d45f">985,926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMy0yLTEtMS0xODY2NDQ_1b013815-799c-4dbc-af79-0b25961457ae">6,285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMy0zLTEtMS0xODY2NTE_ba375375-f3bf-4efe-82ae-056efda5a4eb">992,211</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNC0xLTEtMS0xODI4Mzc_1f968ca4-7acd-49be-8e73-afbeda95a225">6,960,418</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNC0yLTEtMS0xODY2NDQ_092839a7-0e8c-4495-aa40-bf7d982203fb">121,413</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNC0zLTEtMS0xODY2NTE_4886e680-e90a-499a-a5ec-6a7872c12cd3">6,839,005</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible assets</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNS0xLTEtMS0xODI4Mzc_600f2c2c-a146-4247-a9b6-18fd8a24f7d7">831,920</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNS0yLTEtMS0xODY2NDQ_d9019b1a-2336-4de2-80af-6df66d18024e">1,847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNS0zLTEtMS0xODY2NTE_dae64982-711b-4306-9f4e-c5e9c190adff">833,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNi0xLTEtMS0xODI4Mzc_0e0ef474-80eb-48ff-a95d-9c9097ce9f45">9,874</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNi0yLTEtMS0xODY2NDQ_24122245-be42-429f-b36c-da701e61539c">3,146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNi0zLTEtMS0xODY2NTE_4e0e2af3-e1e2-450c-90ad-63f4800c5d22">13,020</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNy0xLTEtMS0xODI4Mzc_7268b132-a621-4a43-9cc0-734758bb6f7a">10,071</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNy0yLTEtMS0xODY2NDQ_b2c8ca00-0993-413b-9973-665cea4f341f">6,744</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNy0zLTEtMS0xODY2NTE_a22a3ac4-4ba3-4b4d-8fb0-a66d9e0d8e2a">3,327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOC0xLTEtMS0xODI4Mzc_30d20e86-525a-4f73-8284-060fe819c1f3">46,538</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOC0zLTEtMS0xODY2NTE_b829c81c-ac5c-4d74-be8d-e2bd729ff109">46,538</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate investments</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOS0xLTEtMS0xODI4Mzc_0d2dd27c-06fd-4405-bcbb-40b163839ffe">8,844,747</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOS0yLTEtMS0xODY2NDQ_b3f79862-3693-4225-9433-46258f09ce7a">116,879</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOS0zLTEtMS0xODY2NTE_f64ea953-5a6f-44af-bf33-a39d7bf9c1c3">8,727,868</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTAtMS0xLTEtMTgyODM3_0ff7d6fd-3f99-46a6-bbf3-04504e32a22f">707,442</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTAtMi0xLTEtMTg2NjQ0_600f1866-0d5d-47e0-82d2-71680cc93f07">7,946</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTAtMy0xLTEtMTg2NjUx_160f3fdb-be0c-48e6-95d7-350b70d3951a">699,496</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTEtMS0xLTEtMTgyODM3_eb6037c8-5e9f-46a2-83c4-abbf1032f9fa">67,892</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTEtMy0xLTEtMTg2NjUx_24f85acd-5034-4fca-bd33-27dc8be4b847">67,892</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTItMS0xLTEtMTgyODM3_a468c011-c71e-447f-9323-159ca47bdcfa">26,034</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTItMi0xLTEtMTg2NjQ0_58abe307-30ac-4fe4-9d31-5ba8effa7235">11,403</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTItMy0xLTEtMTg2NjUx_64ecb398-a70e-4008-8974-6fd201400a23">37,437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTMtMS0xLTEtMTgyODM3_11ad7af9-d042-40f4-b598-6a7ab0f6d73a">1,123,647</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTMtMi0xLTEtMTg2NjQ0_4c439055-6f78-47c9-bc87-5f278542a333">1,247</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTMtMy0xLTEtMTg2NjUx_5f24f763-81f7-40de-9630-9d49eea44d4c">1,122,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTQtMS0xLTEtMTgyODM3_b48017be-6b97-4197-a4c6-d699531d13d1">198,261</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTQtMi0xLTEtMTg2NjQ0_58411fb8-93b3-4ed9-9039-217bbb4665e3">17,786</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTQtMy0xLTEtMTg2NjUx_2065b5e9-c5f2-4a3b-bf79-ce39fd1239d4">216,047</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b) (c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTUtMS0xLTEtMTgyODM3_cb439496-6b03-4a3a-9586-7f7e4e33e5e5">209,163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTUtMi0xLTEtMTg2NjQ0_2df6deef-b4ac-4f4d-8e69-8c2d107c83a8">3,840</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTUtMy0xLTEtMTg2NjUx_bd5a7af1-a699-42a9-9baf-acbbfe23b8b4">205,323</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total assets acquired</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTYtMS0xLTEtMTgyODM3_ef913ee3-3a66-46b3-9da5-6bac95b12e7d">11,177,186</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTYtMi0xLTEtMTg2NjQ0_e132fe0e-edd5-4ee7-bff1-56df878172bd">100,723</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTYtMy0xLTEtMTg2NjUx_46ac3e4b-23d8-4ce2-96b4-794d203cdfdd">11,076,463</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">LIABILITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTktMS0xLTEtMTgyODQx_16dd7f0e-4b53-4192-bccd-03a4187c5f58">3,991,300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTktMy0xLTEtMTg2NjUz_80db88a4-3212-4527-8fef-fb149b143d66">3,991,300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjAtMS0xLTEtMTgyODQx_0b2b71fd-ad1b-4e2f-b505-99c8b5e378eb">1,227,570</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjAtMi0xLTEtMTg2NjQ5_3db248ed-b0e5-4ce3-b51a-68bda2bf260a">17,374</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjAtMy0xLTEtMTg2NjUz_3f6ad7dc-ea7c-433e-82de-02816f0a2e6b">1,244,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjEtMS0xLTEtMTgyODQx_28c2ebcb-2504-4f75-bf71-fb54faf1da3a">28,677</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjEtMi0xLTEtMTg2NjQ5_3d8bc62e-b0f8-463e-ab20-5f6c7a82785f">3,939</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjEtMy0xLTEtMTg2NjUz_3c668898-56ff-4879-a331-d1b85e62344c">24,738</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjItMS0xLTEtMTgyODQx_be8f199b-8323-4153-a703-800bfc61e465">173,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjItMi0xLTEtMTg2NjQ5_2cf369be-0176-4dda-a2cb-ff86d32288b8">10,173</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjItMy0xLTEtMTg2NjUz_71215ccd-fc9b-4506-a4dd-fff027631fa0">184,121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjMtMS0xLTEtMTgyODQx_10b1561d-a45b-4a21-ae20-d9a55f234153">10,720</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjMtMi0xLTEtMTg2NjQ5_f20a4fc4-ccd0-4fc5-8b31-b873dd69eed1">855</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjMtMy0xLTEtMTg2NjUz_e30b8080-4dd9-45eb-abb3-160a095da883">9,865</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjQtMS0xLTEtMTgyODQx_54e9d913-98e0-4369-83ca-5d2ea13df129">203,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjQtMi0xLTEtMTg2NjQ5_efe2b622-cb4a-4d6a-bec2-19eb2477b90f">11,544</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjQtMy0xLTEtMTg2NjUz_64d99a05-bb35-4b00-9536-73f53e2b6509">191,666</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total liabilities assumed</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjUtMS0xLTEtMTgyODQx_d7e58d84-8f81-4741-8efc-66165bc8938c">5,635,425</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjUtMi0xLTEtMTg2NjQ5_1cf0fc09-c08e-4000-8e7f-fccb8a9790e2">11,209</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjUtMy0xLTEtMTg2NjUz_57dbf7a2-2855-40d7-a8fb-0386b68ca412">5,646,634</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjYtMS0xLTEtMTgyODQx_f4ac25ee-56f4-4072-938c-b59be3688734">5,541,761</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjYtMi0xLTEtMTg2NjQ5_9b690d61-5da6-4905-a991-5dc1b371f667">111,932</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjYtMy0xLTEtMTg2NjUz_7c4714a4-1d2e-48b2-aa5a-14b0a592bfd7">5,429,829</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjctMS0xLTEtMTgyODQx_59c2d199-223d-45bd-99e3-99befd64d123">110,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjctMy0xLTEtMTg2NjUz_6736492e-069f-4855-891c-a319a8119116">110,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjgtMS0xLTEtMTgyODQx_33fbbef9-842f-41ef-836f-11f7daf48190">145,404</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjgtMi0xLTEtMTg2NjQ5_19594b42-6383-4a4d-b1d3-973c095c4653">111,932</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjgtMy0xLTEtMTg2NjUz_79618943-0f2b-478b-8a75-e8bd4cd0dafd">257,336</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The weighted average amortization period for the acquired lease intangible assets is approximately <ix:nonNumeric contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjktMC0xLTEtMTgyODI0L3RleHRyZWdpb246NjAzNGNmNWM0MWE1NDM3OThiMzNhM2NjMzZkZjM5OGNfNTQ5NzU1ODE0MDA5_e6502daf-3034-4714-8f06-c0aacf90265e">6</ix:nonNumeric> years.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) Includes $<ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-5" name="us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMzAtMC0xLTEtMTgyODI0L3RleHRyZWdpb246OTM2MDA3YmQzOGIzNDA2NjllMTVmZGFjMjYyYTI0ZWRfNTQ5NzU1ODEzOTc0_2e52eec1-73db-4ff1-b08c-08a42f1cfdee">15.9</ix:nonFraction> million of contractual accounts receivable, which approximates fair value.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c)  Includes $<ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-5" name="hr:BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMzEtMC0xLTEtMTgyODI0L3RleHRyZWdpb246MDg5YmIzNzkzMDI1NDc4NjgwMzc5ZGJmMGM4YmI1NzBfNTQ5NzU1ODE0MTQ5_e082cca3-0c33-4216-846c-f08a193c15aa">78.7</ix:nonFraction> million of gross contractual real estate notes receivable, the fair value of which was $<ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-5" name="hr:GrossContractualRealEstateNotesReceivableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMzEtMC0xLTEtMTgyODI0L3RleHRyZWdpb246MDg5YmIzNzkzMDI1NDc4NjgwMzc5ZGJmMGM4YmI1NzBfNTQ5NzU1ODE0MTY2_2a010c12-f835-4e4c-a213-e45faa93eb3c">74.8</ix:nonFraction> million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.</span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The cumulative measurement period adjustments recorded through March&#160;31, 2023 primarily resulted from updated valuations related to the Company&#8217;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $<ix:nonFraction unitRef="usd" contextRef="i84e0ee7220bb44c8a851edf13b274871_D20220720-20220720" decimals="-5" name="hr:BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTQ5NzU1ODI3NjQy_fe9650cd-28f7-4403-b215-937e167f1bc1">111.9</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had not finalized the determination of fair value of certain tangible and intangible assets acquired and liabilities assumed, including, but not limited to real estate assets and liabilities, notes receivables and goodwill. As such, the assessment of fair value of assets acquired and liabilities assumed is preliminary and was based on information that was available at the time the Condensed Consolidated Financial Statements were prepared. The finalization of the purchase accounting assessment could result in material changes to the Company&#8217;s determination of the fair value of assets acquired and liabilities assumed, which will be recorded as measurement period adjustments in the period in which they are identified, up to one year from the Closing Date.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i0a07b5590639487387146d8c6b2291ea" continuedAt="i2cc5c7659abd4ad9bb8f4597efb097f4"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A preliminary estimate of approximately $<ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTQ5Nw_04390739-f9f1-4ad3-b057-acce99465c50">257.3</ix:nonFraction>&#160;million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger.  <ix:nonFraction unitRef="usd" contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720" decimals="INF" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTk2Mw_72a2f05b-fb21-4521-a568-881ce3ef7fbd">None</ix:nonFraction> of the goodwill recognized is expected to be deductible for tax purposes. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Merger-related Costs</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="i2cc5c7659abd4ad9bb8f4597efb097f4">The Company incurred Merger-related costs of $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNjEzOQ_b710b880-e9eb-496c-b86d-043ca155a697">4.9</ix:nonFraction> million during the three months ended March&#160;31, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services.  Subsequent to March&#160;31, 2023, the Company received a refund of $<ix:nonFraction unitRef="usd" contextRef="ic08326621b774b35a49a98cb55264ae0_D20230401-20230509" decimals="-5" name="hr:BusinessCombinationRefundOfTransferTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTg2OTE2OTc2OTEwMTc_bd92e4d9-f278-4a6b-9ffb-1bee7c164b46">17.8</ix:nonFraction>&#160;million for transfer taxes paid during the year ended December&#160;31, 2022 in connection with the Merger.  The Company will record this as a reduction of Merger-related costs in the second quarter of 2023.</ix:continuation>   </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="hr:AcquisitionsAndDispositionsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMzI5ODUzNDg5MjMwMA_809de784-7e55-4472-9d7e-97d4b852abab" continuedAt="i1c8199b2b9c54af395137d9ce82985f1" escape="true">Real Estate Investments</ix:nonNumeric></span></div><ix:continuation id="i1c8199b2b9c54af395137d9ce82985f1" continuedAt="i9a147761ca9f4c6584cc68d90b8dac45"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Acquisition Activity</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjk5Nw_1cc74baa-02b3-4d68-8602-b81df397fa94" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's real estate acquisition activity for the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"></td><td style="width:28.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CASH<br/>CONSIDERATION </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">REAL <br/>ESTATE </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68c69926be842d69e158e3aa65f496d_D20230310-20230310" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS0yLTEtMS0xNTg1NTI_1027103e-a9b2-4920-ad88-8914da75ca36">31,500</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68c69926be842d69e158e3aa65f496d_D20230310-20230310" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS01LTEtMS0xNTg1NTI_beb9f3cd-00a2-4b5d-bbc5-aee41df59d16">30,499</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc48b9d4935147f39fab2c5a1786b320_I20230310" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS02LTEtMS0xNTg1NTI_9b7eccea-66cd-4168-9468-f60c3b28cab1">30,596</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc48b9d4935147f39fab2c5a1786b320_I20230310" decimals="-3" sign="-" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS03LTEtMS0xNTg1NTI_7596e949-e9ae-4bee-8294-921dd96ab964">97</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="icc48b9d4935147f39fab2c5a1786b320_I20230310" decimals="0" name="hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS04LTEtMS0xNTg1NTI_5bf335d1-052e-4a6a-8a71-d2452e3d6ab2">115,867</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Unconsolidated Joint Ventures</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMzAwMA_e5302cf7-10e7-4eb5-94b8-c2e05d281720" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three months ended March&#160;31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.993%"><tr><td style="width:1.0%"></td><td style="width:71.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.784%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9b62f2ccf74d1caf0fe1cb85aa8f53_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfMy0xLTEtMS0xNTg1NTI_bbc0e41f-5bc0-43d7-bbae-6513c3a06af5">327,248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4cd843d7ed430a94355ee7d8beda1b_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfMy0yLTEtMS0xNTg1NTI_cf503d8a-e183-4819-bc09-bcf97db9a8ac">161,942</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNC0xLTEtMS0xNTg1NTI_19a50626-6bb1-47e1-9d54-b2fac761b70e">3,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNC0yLTEtMS0xNTg1NTI_92323744-22d8-4fe8-82aa-841c2745bd53">49,598</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNS0xLTEtMS0xNTg1NTI_b553ef9d-d851-41c4-98ad-24faa975eaf2">780</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNS0yLTEtMS0xNTg1NTI_34261443-9818-4fb0-9b04-152414cfd121">345</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNy0xLTEtMS0xNTg1NTI_92826ee9-af21-4200-aa0a-42c9aa228d41">2,546</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNy0yLTEtMS0xNTg1NTI_83fcbc2b-cad0-4342-bd81-f3a5fcc5af7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56812fb447b14ad19ca71a303ab09954_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfOC0xLTEtMS0xNTg1NTI_41c152ac-6200-40ef-9003-b9578015803d">327,746</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07320f4bb515447592164daec5eb7b4f_I20220331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfOC0yLTEtMS0xNTg1NTI_969a4a3b-7aa0-45fa-b4eb-90e5b8d62a32">211,195</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">This was an additional investment in an existing joint venture representing a <ix:nonFraction unitRef="number" contextRef="ia37031f8ec15470d97f1001738e8c72e_D20230101-20230331" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMTQwNQ_d63a7625-a2d8-46c1-909b-d021112d39e9">40</ix:nonFraction>% ownership interest in a property in Dallas, Texas. Also, see 2023 Real Estate Asset Dispositions below for additional information.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i9a147761ca9f4c6584cc68d90b8dac45"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Real Estate Asset Dispositions</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="hr:AssetDispositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjk3MQ_1288df7b-f6d8-4ae3-8d39-bffaa6d5a87e" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions for the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">COMPANY-FINANCED MORTGAGE NOTES</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL &amp; Miami, FL</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS0yLTEtMS0xNTg1NTI_e8b2e492-ce82-4f27-a347-a8ce41a8a4ce">93,250</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS0zLTEtMS0xNTg1NTI_cf0f8f67-3506-4e2a-b496-e72ed6d4f1f5">5,875</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS00LTEtMS0xNzU2NTg_47c1c826-0a5b-4ca0-a71f-0e30775b9a01">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725103bec26f4bffb5131168df379059_D20230112-20230112" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS00LTEtMS0xNTg1NTI_2a2f4019-2005-492a-a3c6-3295407a4dab">87,375</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS01LTEtMS0xNTg1NTI_42c4762f-fc8b-4ac4-8935-7d068a975380">87,302</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS02LTEtMS0xNTg1NTI_e28c5512-b462-4622-a0f2-19f8661d5d7d">888</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725103bec26f4bffb5131168df379059_D20230112-20230112" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS03LTEtMS0xNTg1NTI_24df2d00-719d-49c9-aa41-df0bf6cfd50a">961</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS04LTEtMS0xNTg1NTI_00241005-9071-4362-a258-5eac6452ea54">224,037</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi0yLTEtMS0xNTg1NTI_a379d805-5b7a-404a-9200-30a67752a7c2">19,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi0zLTEtMS0xNTg1NTI_0d443edf-5eef-4fca-8c44-95071d9aa3a5">141</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi00LTEtMS0xNzU2Mzc_72cd05ec-9753-44c7-95dc-3bd7ede8aedf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi00LTEtMS0xNTg1NTI_e9407062-3726-4e72-be55-f27ff3e25173">19,069</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi01LTEtMS0xNTg1NTI_5cbaf3f3-f107-4131-8130-38bcc3856bf2">18,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130" decimals="-3" name="hr:RealEstateOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi02LTEtMS0xNTg1NTI_16802499-06f8-4196-ae6e-6e53c63bd895">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi03LTEtMS0xNTg1NTI_b96e5e61-3a56-4352-abc7-13732286696f">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi04LTEtMS0xNTg1NTI_73b37993-585e-4c3d-a62f-f307a47c8704">36,691</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210" decimals="-3" name="hr:DispositionSalesPrice" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy0yLTEtMS0xNTg1NTI_ef584e75-8aca-44ae-9ab8-a91ed6329dca">350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy0zLTEtMS0xNTg1NTI_63421e70-ef97-4f77-be48-3894135cf794">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy00LTEtMS0xNzU2Mzc_9d88730b-acf0-401e-a3ea-19fcc4f28c94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe535f3ab724e7f8cc93404389ae2d3_D20220729-20220729" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy00LTEtMS0xNTg1NTI_779a3b0b-43dc-4007-86b6-81951111d7b4">332</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy01LTEtMS0xNTg1NTI_6b814d7a-052d-4c22-bb4f-fe92fbee43bf">398</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210" decimals="-3" name="hr:RealEstateOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy02LTEtMS0xNTg1NTI_d311fd32-283e-4898-8275-2c6be6bc6997">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe535f3ab724e7f8cc93404389ae2d3_D20220729-20220729" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy03LTEtMS0xNTg1NTI_69b2c21a-bf2b-41be-9dc6-bd71206ce705">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy04LTEtMS0xNTg1NTI_fbf9ede1-19e6-4f04-9595-f1ad0ce529ae">6,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC0yLTEtMS0xNTg1NTI_e0759a7f-eec9-41a7-84d4-cf0abc2770bb">21,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC0zLTEtMS0xNTg1NTI_5c217a74-6452-4873-9697-3b74d9832d60">526</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC00LTEtMS0xNzU2Mzc_f71c9c8d-2f16-40c2-b9b6-a1bd0dab819a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a3ca7980f634d5a877d7ea584c4b463_D20230323-20230323" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC00LTEtMS0xNTg1NTI_1308a905-bbec-43a3-b491-f4feadf14d43">20,474</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC01LTEtMS0xNTg1NTI_dcaa8008-9d10-435f-a9a1-a224c447d3f2">20,610</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323" decimals="-3" name="hr:RealEstateOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC02LTEtMS0xNTg1NTI_76f0e2f4-3ddd-49e9-aa48-3dfe2c4ccce9">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a3ca7980f634d5a877d7ea584c4b463_D20230323-20230323" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC03LTEtMS0xNTg1NTI_0ff7f68b-4690-4264-9373-6bf2b3cd2db3">188</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC04LTEtMS0xNTg1NTI_811b3453-7c7c-4500-9e17-660f172a0e76">37,165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS0yLTEtMS0xNTg1NTI_2cbf0b2c-68ec-4a35-bff0-2314e8e76b3d">75,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS0zLTEtMS0xNTg1NTI_df0a4b64-51b5-4873-b5d0-150955fe82bb">8,079</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS00LTEtMS0xNzU2Mzc_3b48e3bf-80ab-49a2-8c3a-bf7be13b268a">45,000</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8386a9bdaee48faab027ec1bc916259_D20230330-20230330" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS00LTEtMS0xNTg1NTI_59445be4-eea9-4df0-a8a7-6fa1cc7281ae">21,921</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS01LTEtMS0xNTg1NTI_960c98af-b03e-47bd-b405-d1dda7256380">88,624</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS02LTEtMS0xNTg1NTI_e859e36a-df6f-46b1-9558-ba680ac9a5ac">803</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8386a9bdaee48faab027ec1bc916259_D20230330-20230330" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS03LTEtMS0xNTg1NTI_df2bc436-df18-41f3-9cc8-be7542942dea">20,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS04LTEtMS0xNTg1NTI_4a1639ec-311b-4aa0-9689-fd95ea7f5b50">147,078</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS0yLTEtMS0xNTg1NTI_75f974ac-ddd4-4c64-b688-c0dd0c0a6a48">208,810</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS0zLTEtMS0xNTg1NTI_083d76b6-5bed-40f1-a5bf-091a078e784d">14,639</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS00LTEtMS0xNzczODU_4f1f5c69-f267-4d10-88fa-4f35aa0fd4fb">45,000</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bcc13d9ac1449aafbef97302a864de_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS00LTEtMS0xNTg1NTI_67faf0dd-54e5-4f67-b055-60297557fcc7">149,171</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS01LTEtMS0xNTg1NTI_2564aa3e-81a0-4cb0-91ac-72f479863a21">215,920</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331" decimals="-3" sign="-" name="hr:RealEstateOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS02LTEtMS0xNTg1NTI_dba5998d-07c3-4065-b572-1c7d5e452950">1,596</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5bcc13d9ac1449aafbef97302a864de_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS03LTEtMS0xNTg1NTI_3cec691c-47aa-409a-9aab-21d259318b97">20,153</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS04LTEtMS0xNTg1NTI_8c93bc72-e45c-4357-ad26-c4125f739282">451,471</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes straight-line rent receivables, leasing commissions and lease inducements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes <ix:nonFraction unitRef="property" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM1Nw_b55ebf54-be2f-4a30-8cea-755d591b0725">two</ix:nonFraction> properties, sold in <ix:nonFraction unitRef="disposition_transaction" contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112" decimals="INF" name="hr:NumberOfPropertyDispositions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM1Ng_1d60eefd-ede3-4b4d-a8a3-33a356bf0714">two</ix:nonFraction> separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company sold this property to a joint venture in which it retained a <ix:nonFraction unitRef="number" contextRef="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjEwMg_7d741d09-5654-4500-8d55-3717e52be1cc">40</ix:nonFraction>% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company entered into a mortgage note agreement with the buyer for $<ix:nonFraction unitRef="usd" contextRef="i0fbb705c06f14ee2aba7350a87fa6205_I20230330" decimals="-6" name="hr:MortgageNote" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMzg0ODI5MDcwNDIxNw_533d3fee-e152-4b2b-9c35-dfd2be8e5f73">45</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Assets Held for Sale</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had <ix:nonFraction unitRef="property" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfPropertiesClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM3Mw_e599f0dc-bd3f-4a9b-862d-3a28837cb3b3">three</ix:nonFraction> properties and <ix:nonFraction unitRef="land_parcel" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberOfLandParcelsClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM3NA_f10f54a9-e05a-4ff9-8665-a539a7fa4063">one</ix:nonFraction> land parcel classified as assets held for sale as of March&#160;31, 2023. The net real estate assets held for sale includes $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:ImpairmentChargeOnRealEstateAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMTc1OTIxODYwNTQzOTk_cad5263e-fb9d-49bc-80d0-b4e8df35775e">5.1</ix:nonFraction>&#160;million of impairment charges.  As of December 31, 2022, the Company had <ix:nonFraction unitRef="property" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="INF" name="hr:NumberOfPropertiesClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM3NQ_8c112e0a-284e-4eae-9ae5-cab79b840b30">one</ix:nonFraction> property classified as assets held for sale as of December&#160;31, 2022, which was sold in the first quarter of 2023.  <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjk3Mg_3f992f1f-c2dc-40e9-802d-8c2f664c7416" continuedAt="if432b7795cac4ca7a2cf9ac1f1a4c7cf" escape="true">The table below reflects the assets and liabilities classified as held for sale as of March&#160;31, 2023 and December&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="if432b7795cac4ca7a2cf9ac1f1a4c7cf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:Land" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMi0yLTEtMS0xNTg1NTI_a343ebca-9992-4f2b-81b8-bf013bcfc6c9">205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMi00LTEtMS0xNTg1NTI_f32c0372-91c3-4940-b6bb-db96f3db8f80">1,700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMy0yLTEtMS0xNTg1NTI_eebd7296-14f6-49e8-b26e-b8ceb1f16b3b">1,736</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMy00LTEtMS0xNTg1NTI_95d08fef-20ea-42d8-ace1-c53e622a6a6a">15,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="hr:LeaseIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNC0yLTEtMS0xNTg1NTI_b2da23f6-2399-46b1-b47b-9692795931f8">2,242</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="hr:LeaseIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNC00LTEtMS0xNTg1NTI_88fa0b12-f2ec-47ba-9b0d-eae218c144ca">1,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC0yLTEtMS0xNzQyMzc_15a39ea7-4117-4d14-be7b-2dc77bf3b7a4">3,251</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC00LTEtMS0xNzQyMzc_99b16896-2324-452a-b322-619338111dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNy0yLTEtMS0xNTg1NTI_259803b1-f9d8-460b-99ad-c634bb0bcb54">7,434</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNy00LTEtMS0xNTg1NTI_9c2d3386-8d75-43c3-9f81-a167077d5e12">18,850</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC0yLTEtMS0xNTg1NTI_ddc47e04-6a30-4bda-bf9d-efc713a5e984">4,183</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC00LTEtMS0xNTg1NTI_3ed8909e-1324-4a22-bfc9-7522ccb3135a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOS0yLTEtMS0xNTg1NTI_342e4198-223a-49d6-961d-714af01b293f">3,251</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOS00LTEtMS0xNTg1NTI_dfdcdd71-4194-48a2-a18c-feb101dbe435">18,850</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTEtMi0xLTEtMTU4NTUy_9a06debd-4a92-4e2b-b896-e781ff1d98c0">328</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTEtNC0xLTEtMTU4NTUy_6ea7ccb4-f36d-4f00-bbaa-2feb60a7d8ad">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTItMi0xLTEtMTU4NTUy_c89c9fb8-d80b-4356-97e1-0bf081817d54">3,579</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTItNC0xLTEtMTU4NTUy_7909e128-c81c-461b-830c-e3d824369b18">18,893</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTQtMi0xLTEtMTU4NTUy_93953301-114e-41cb-8b90-f1ff071779fa">277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTQtNC0xLTEtMTU4NTUy_5603198c-6848-4caa-8eb4-20f7a9d866fb">282</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTctMi0xLTEtMTU4NTUy_673a721a-be27-4caf-ac0a-d12a99fc43d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTctNC0xLTEtMTU4NTUy_5259f1fb-56f0-4866-adc0-df35d9052e85">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icdfe172a798c48d69a472a992f819b18_I20230331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTgtMi0xLTEtMTU4NTUy_7ff84873-56e7-45cf-b1bb-039a4db8471e">277</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTgtNC0xLTEtMTU4NTUy_4288ee81-33e8-499d-8a50-40cf40a13d9e">437</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i7ef30c9bd2924f189bb8c35e1049bb40_55"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3MA_408889f8-8594-4dbb-9559-ef328414755f" continuedAt="ie0f811b76fcc43308aa4a517f8e6f484" escape="true"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3MQ_e3776140-6d3b-451d-8605-a9fde89e4a0d" continuedAt="ia9bd1a8017de49dcad5d3af8f5a8e890" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ie0f811b76fcc43308aa4a517f8e6f484" continuedAt="i3a1a8e1e72bf49899c2e5b3f65542bd3"><ix:continuation id="ia9bd1a8017de49dcad5d3af8f5a8e890" continuedAt="i2eb0737bd7d6464999a1f57bf895af00"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i3a1a8e1e72bf49899c2e5b3f65542bd3" continuedAt="i92537b084bb34ef9aee58e62e176e9ec"><ix:continuation id="i2eb0737bd7d6464999a1f57bf895af00" continuedAt="ieb929f07a09545f58fc09b6c2c42c26d"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three months ended March&#160;31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMTM3MQ_fbc39013-9bb4-46de-a115-715866e3aee5">324.1</ix:nonFraction> million.  Lease income for the Company's operating leases recognized for the three months ended March 31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMTUxNA_c1494214-211a-4b37-9f3e-a6ec8f4795ef">138.5</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3NA_028d70f8-749f-47bd-a7e5-f51983fc7344" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfMS0xLTEtMS0xNTg1NTI_d7a7e463-e8fe-4567-8257-506f809bfacf">695,787</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfMi0xLTEtMS0xNTg1NTI_7fbbe295-2901-4fc6-8c6f-fe6774f98e54">833,006</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfMy0xLTEtMS0xNTg1NTI_dc53ebec-c831-4a82-8d6c-a7f095a7759e">720,985</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNC0xLTEtMS0xNTg1NTI_9a136dce-a7c6-4e34-b360-1ad077f901f4">620,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNS0xLTEtMS0xNTg1NTI_2430f8de-b5e1-41c7-89af-d64907632c3b">539,486</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNi0xLTEtMS0xNTg1NTI_dd26b15a-983c-470b-ab16-5ca94723aa69">1,854,402</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNy0xLTEtMS0xNTg1NTI_c840e231-5e7f-4772-b747-37d9b7c99b6d">5,263,784</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of March&#160;31, 2023, the Company had <ix:nonFraction unitRef="property" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:NumberOfPropertiesSubjectToGroundLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjI5NA_58b7295f-917c-491e-92ef-50fdea78c37d">242</ix:nonFraction> properties totaling <ix:nonFraction unitRef="sqft" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="hr:SquareFeetSubjecttoGroundLeases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjMxNw_7904b269-f091-4a5f-a0cb-c5443eacbad3">17.8</ix:nonFraction> million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of <ix:nonNumeric contextRef="i520bdadf3a0e4877a0654af6dea318b7_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjU0MA_e2a8560e-51c7-4b8b-951e-595893cc6b89">40</ix:nonNumeric> to <ix:nonNumeric contextRef="iedc8351cf7d14a358450c7736f9cb778_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjU0Ng_2e18af8d-355e-4501-b85b-9ac0ef467e0c">99</ix:nonNumeric> years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally either stated or based on CPI. The Company had <ix:nonFraction unitRef="lease" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="INF" name="hr:NumberofGroundLeasesPrepaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjcxMA_d078e269-f597-4b78-b459-c84992bd8332">75</ix:nonFraction> prepaid ground leases as of March&#160;31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjg2MQ_7fcd20c0-0330-4360-b90e-1fdae4eb0241">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjg2OA_bafc4944-fc0e-434d-af16-ad9db0c53603">0.1</ix:nonFraction>&#160;million of the Company&#8217;s rental expense for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3Nw_fd957f5f-c1c5-4d58-9435-8fde9ca2ec41" escape="true"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI4NQ_52b73c8a-b701-4386-8413-5598eb8db40d" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its <ix:nonFraction unitRef="property" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="hr:NumberofGroundLeasesExcludingPrepaidLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzA5NQ_1a5b3a74-8c50-4825-9fce-34f2cbe64246">167</ix:nonFraction> non-prepaid ground leases) as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMS0xLTEtMS0xNTg1NTI_7ad9b2d5-a8c1-4328-9c43-2a7be19fa3f7">11,188</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMS0yLTEtMS0xNTg1NTI_96ddfe08-c3d5-40cd-aac1-c79a00fd74b0">1,491</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMi0xLTEtMS0xNTg1NTI_8d8b435d-2df4-48ae-a37c-a11800d9899d">15,239</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMi0yLTEtMS0xNTg1NTI_db5959a5-b06e-42a8-a0bf-b765175cf23b">2,182</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMy0xLTEtMS0xNTg1NTI_c3c8a0f8-7626-47df-98df-f3b802a96c85">14,827</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMy0yLTEtMS0xNTg1NTI_d92eba19-71c0-4c87-ac54-ae6845bbf529">2,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNC0xLTEtMS0xNTg1NTI_d2b20319-5fda-44e9-bf73-97e6f76de1a8">14,863</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNC0yLTEtMS0xNTg1NTI_7e7c5e0d-b91c-414c-9634-e187ee76d153">2,255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNS0xLTEtMS0xNTg1NTI_d0200b11-300d-49c8-8483-0159a2f9382e">14,933</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNS0yLTEtMS0xNTg1NTI_086f5104-4b20-4eb2-a283-84f40697d4c1">2,294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNi0xLTEtMS0xNTg1NTI_7f62f893-cb0e-4fc1-b8ac-7640215faeb4">939,392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:FinanceLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNi0yLTEtMS0xNTg1NTI_9495fa7e-0718-411c-9f5d-f8217fc799e5">396,398</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNy0xLTEtMS0xNTg1NTI_821eae9e-d540-4c44-b7f4-47475619742c">1,010,442</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNy0yLTEtMS0xNTg1NTI_894f6929-e4e7-4281-a985-99269d21a9a7">406,838</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOC0xLTEtMS0xNTg1NTI_8afe8e38-7810-4fc3-88be-dea0c8603536">730,805</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOC0yLTEtMS0xNTg1NTI_310c31bf-4e80-4e3f-948e-c7f37c353a62">333,645</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOS0xLTEtMS0xNTg1NTI_b7ad7897-0f01-46ef-8c26-8c4f9dc482d4">279,637</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOS0yLTEtMS0xNTg1NTI_ca475f03-aaf1-458d-b379-6c4353c603a1">73,193</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i92537b084bb34ef9aee58e62e176e9ec"><ix:continuation id="ieb929f07a09545f58fc09b6c2c42c26d"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI4Mw_04399857-2e90-404b-90cd-fcdedff4c204" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"><tr><td style="width:1.0%"></td><td style="width:75.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.458%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMy0xLTEtMS0xNTg1NTI_f2515288-82a3-4f92-a092-3b2b0234e203">5,107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMy0yLTEtMS0xNTg1NTI_702d5c2c-cc57-4f71-850a-ef3ad30509ed">1,215</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNC0xLTEtMS0xNTg1NTI_0317912c-1011-474b-a310-5a4ea74e675c">2,136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNC0yLTEtMS0xNTg1NTI_1400f9bb-d847-46f4-a2f4-3785ae45a8f0">1,024</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNy0xLTEtMS0xNTg1NTI_c54eb0d4-2ff3-4a50-a6be-a70c3a846f7d">388</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNy0yLTEtMS0xNTg1NTI_11c35288-8f04-466e-a583-2552f2420cb0">172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOC0xLTEtMS0xNTg1NTI_74b95696-5e7f-4d0b-b743-0f0bbf5a0c90">918</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOC0yLTEtMS0xNTg1NTI_4a33b5ab-df17-45e1-9a02-730a41100176">287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOS0xLTEtMS0xNTg1NTI_7c1dbdc0-2015-444d-ae67-bae6a5983ef6">8,549</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOS0yLTEtMS0xNTg1NTI_6d3a0af5-77cf-4b39-bd63-175e030a7df8">2,698</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTItMS0xLTEtMTU4NTUy_6c236a3a-7d5a-4dfb-81be-de51e556e8d0">5,960</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTItMi0xLTEtMTU4NTUy_9b27af37-f913-4a8d-ad75-bfbadc634110">2,797</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTMtMS0xLTEtMTU4NTUy_6899285a-d833-40dc-8bb3-20d4f89defd1">553</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTMtMi0xLTEtMTU4NTUy_2a8cf01c-1a3a-489e-8f87-55af1782f974">258</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTQtMS0xLTEtMTU4NTUy_37473488-725f-4926-ae97-5de1a7ef6c58">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTQtMi0xLTEtMTU4NTUy_089e1026-20db-453f-9cce-5efd9558efda">257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTUtMS0xLTEtMTU4NTUy_9aa7b44f-0c68-468d-9412-9629b8f46386">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTUtMi0xLTEtMTU4NTUy_5b277c58-3db4-4640-b37a-e9aefd89aceb">40,589</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTgtMS0xLTEtMTU4NTUy_6d071692-3ed0-4a3c-948d-2ec634e114bf">47.4</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTgtMi0xLTEtMTU4NTUy_faadff33-8dfb-4e2a-8f9b-0969ffb41421">47.6</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTktMS0xLTEtMTU4NTUy_057af760-801b-4cbf-9232-ed44769a9d54">58.7</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTktMi0xLTEtMTU4NTUy_97765c37-5ac8-4190-8341-0b1ece7f29ea">61.9</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjAtMS0xLTEtMTU4NTUy_45bd1b56-96e9-4fc6-8d3c-8e32553a3121">5.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjAtMi0xLTEtMTU4NTUy_6daf6fc7-a64e-4016-a931-e26883f9c4d3">5.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjEtMS0xLTEtMTU4NTUy_e644bcc7-45e5-4589-8ca3-8cbe1b935466">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjEtMi0xLTEtMTU4NTUy_f523b400-a91a-435b-841e-2a0a062ed8ec">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_58"></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTA5_c5051520-71f8-44bb-93ec-7c2af6b57b90" continuedAt="ic7a8f0bd2fbb4c64beb770a36f018cc6" escape="true">Other Assets and Liabilitie</ix:nonNumeric></span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic7a8f0bd2fbb4c64beb770a36f018cc6" continuedAt="ibafc184916aa4dc4a0f63e78a8a57534">s</ix:continuation></span></div><ix:continuation id="ibafc184916aa4dc4a0f63e78a8a57534" continuedAt="i8459e0dc0e7e4297beda77ccdd10e4bb"><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other Assets</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTEw_8daf13b5-528c-41b0-a0fc-9183f8767219" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022 are detailed in the table below:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:RealEstateNotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMS0yLTEtMS0xNTg1NTI_09c3087e-d7de-47fb-b82b-669200ea1f35">147,326</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:RealEstateNotesReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMS00LTEtMS0xNTg1NTI_4eeec86e-2c60-4a05-9aa8-b3b9742656d3">99,643</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMi0yLTEtMS0xNTg1NTI_ff924b36-15c0-4eb1-ac74-1fcfb5fe1873">98,923</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMi00LTEtMS0xNTg1NTI_58a921e9-72ec-4081-b733-b81413ec5cb0">88,868</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMy0yLTEtMS0xNTg1NTI_de3ad6ee-66b6-45ff-998a-2df9901317f6">88,694</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMy00LTEtMS0xNTg1NTI_ac1f1a4a-e11b-43b8-b4a5-d7bd7ee3fd96">81,900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Above-market intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:AboveMarketLeaseIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNC0yLTEtMS0xNTg1NTI_04bf1f63-89fa-4491-a6b8-528fecc38eda">85,100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:AboveMarketLeaseIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNC00LTEtMS0xNTg1NTI_971fe456-7770-4389-9198-d501cf5c7191">80,720</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNS0yLTEtMS0xNTg1NTI_667e8136-2737-4862-a866-5781f1868e3e">48,676</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNS00LTEtMS0xNTg1NTI_a0704fee-d5bc-4dd8-868d-c667b2366c00">47,498</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional long-lived assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNi0yLTEtMS0xNTg1NTI_b271758f-d023-4016-b29d-d5dc5b47afa9">22,173</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNi00LTEtMS0xNTg1NTI_92ea52c2-fbd9-4f45-b7e0-d7d893bc3e85">21,446</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swap assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNy0yLTEtMS0xNTg1NTI_a9e1ff94-ed1d-4327-9b50-eebb0184c2a7">9,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNy00LTEtMS0xNTg1NTI_604e3f84-d930-4049-8486-2ffa5b589dfa">14,512</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in securities</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC0yLTEtMS0xNzY5NzA_0b0c42eb-e59c-40c8-b83f-96de74e34b42">6,011</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC00LTEtMS0xNzY5NzM_964a2482-7a61-4d34-baef-f2f8a4e6652b">6,011</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other receivables, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:GroundLeaseModificationNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC0yLTEtMS0xNTg1NTI_7a75426a-4025-4d2e-86c4-4705f163b8ea">5,962</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:GroundLeaseModificationNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC00LTEtMS0xNTg1NTI_b3468e9d-44f5-4c4c-869e-258eef22ea94">7,169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTAtMi0xLTEtMTU4NTUy_79bb9c1b-5b87-43d0-bed3-972fada7469d">5,449</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTAtNC0xLTEtMTU4NTUy_9d95f85b-65d9-458d-a537-de545be8ea4f">5,977</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Project costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:ConstructionActivityTotalFundingToDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTEtMi0xLTEtMTU4NTUy_310df92f-449c-4403-a6d9-27d7f5c4bb08">4,900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:ConstructionActivityTotalFundingToDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTEtNC0xLTEtMTU4NTUy_305a6a7b-3502-44d4-8bfd-532659f2fe3a">4,337</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net investment in lease</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:NetInvestmentInLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTItMi0xLTEtMTU4NTUy_7a5e93e1-c493-4abc-a542-5f0742211cbd">1,828</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:NetInvestmentInLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTItNC0xLTEtMTU4NTUy_bf87e7db-7d65-4f82-a8c4-3c984432eba6">1,828</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Customer relationship intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTMtMi0xLTEtMTU4NTUy_c1b034df-0684-485a-9d4a-72362761865e">1,106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTMtNC0xLTEtMTU4NTUy_927de071-5630-490c-8ceb-c7bcd186d3a1">1,120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherAssetsMiscellaneous" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTQtMi0xLTEtMTU4NTUy_87420a5c-35fd-4cbb-9cff-d9cc005912bc">8,505</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneous" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTQtNC0xLTEtMTU4NTUy_0a70192d-ffcb-437b-bf06-486500fdc878">8,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTUtMi0xLTEtMTU5NzYw_7762ff96-075c-4101-9691-e1c643e13304">534,420</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTUtNC0xLTEtMTU4NTUy_9db07734-57fa-4e13-abe5-2a141aa5cc06">469,990</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">This amount includes an allowance for credit losses.  See Note 1 for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">This amount represents the value of the Company's preferred stock investment in a data analytics platform.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i8459e0dc0e7e4297beda77ccdd10e4bb"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Accounts Payable and Accrued Liabilities</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTEx_9a3a6338-99c7-4085-a873-7b4f63e79d2e" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued property taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:AccruedPropertyTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMS0yLTEtMS0xNTg1NTI_f391c4e0-30ef-4f07-9f88-855f5ee1a35b">48,629</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:AccruedPropertyTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMS00LTEtMS0xNTg1NTI_afb2ad75-a53d-4aa4-8142-590c9b962a71">78,185</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and capital expenditures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="hr:AccountsPayableAndCapitalExpendituresCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMi0yLTEtMS0xNTg1NTI_9ca50ff1-d0ca-4f89-aafe-431ddc7cc6ec">35,128</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="hr:AccountsPayableAndCapitalExpendituresCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMi00LTEtMS0xNTg1NTI_7d20b698-3f0f-4c48-a3cc-cbdc78ccff89">57,352</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMy0yLTEtMS0xNTg1NTI_489b2426-409c-4789-b117-72f85702e008">28,483</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMy00LTEtMS0xNTg1NTI_e376be70-5ee6-421f-9c9c-cce90a7ed07a">50,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other operating accruals</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfNC0yLTEtMS0xNTg1NTI_2d5f094c-e37d-4a7a-a9e8-96583a919e41">42,970</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfNC00LTEtMS0xNTg1NTI_c72b2881-6098-46d1-aa31-f269f339b851">58,459</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMTMtMi0xLTEtMTU4NTUy_142791d6-94df-4b6d-b3c7-60501f41875d">155,210</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMTMtNC0xLTEtMTU4NTUy_a5107d14-c6c0-429e-b564-ef2bbe3722ac">244,033</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Liabilities</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTEy_496d157d-0f9f-4dd6-81c8-9ea2d19df451" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Below-market intangible liabilities, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:BelowMarketLeaseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMS0yLTEtMS0xNTg1NTI_47b8a440-69df-4a54-a661-60dfb9a3f9ed">96,214</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:BelowMarketLeaseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMS00LTEtMS0xNTg1NTI_dda512f0-63be-4e35-a197-f391b8d22c31">97,935</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMi0yLTEtMS0xNTg1NTI_b1d5dff1-e3c6-4570-a75a-32bd9412d8f7">90,979</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMi00LTEtMS0xNTg1NTI_6fb9ceee-ccd6-43f8-9711-d19bf3423bed">87,325</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Security deposits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:SecurityDepositLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMy0yLTEtMS0xNTg1NTI_5385996c-6915-49a1-a27d-3912b59cf759">29,020</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:SecurityDepositLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMy00LTEtMS0xNTg1NTI_16ab1b91-f30f-494c-9ae3-9f0311413bc5">28,521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swap liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNC0yLTEtMS0xNTg1NTI_2e75f455-e8fe-492d-9d30-eaf9ae06c27b">11,927</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNC00LTEtMS0xNTg1NTI_5ef4b084-3e02-4378-a5bf-6f097bf8fa8f">4,269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherSundryLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNS0yLTEtMS0xNTg1NTI_6a11aa7b-4b90-40b0-b947-6eb49f6368cd">3,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherSundryLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNS00LTEtMS0xNTg1NTI_ba70f268-3e2a-4bed-bfd7-33ef25bd0dfb">618</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMTMtMi0xLTEtMTU4NTUy_9d79aa89-47b5-4b18-87d8-31bf22dae78f">232,029</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMTMtNC0xLTEtMTU4NTUy_3ed04ea3-2e72-45b9-996f-5faa6d0b32ce">218,668</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7ef30c9bd2924f189bb8c35e1049bb40_61"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfMzI5ODUzNDg5MjcwNw_e9de862e-d4fc-4339-9cb1-ce9191a2c512" continuedAt="i41ce3f0e342849f4903a0188de051a4f" escape="true">Notes and Bonds Payable</ix:nonNumeric></span></div><ix:continuation id="i41ce3f0e342849f4903a0188de051a4f" continuedAt="ibea4c30ecbc148f9bdad5c40e883c6a2"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfOTA4NA_7d14eb58-9d92-4771-99f3-0f251c9590a7" continuedAt="i303e0ee7669645d6a31790b3cb8bd78d" escape="true"><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of March 31, 2023 and December 31, 2022.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"></td><td style="width:39.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATES </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 3/31/2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">3/31/2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjplNjNjNmZmN2I1Nzc0MmUzYWQ2NmYzMzViMDY1YTBiNl81_113fb67a-a8ed-4371-b125-c2d4c53a280f">1.5</ix:nonFraction> billion Unsecured Credit Facility </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi0yLTEtMS0xNTg1NTI_e20a31da-560b-4c3e-8c4b-320dce910f02">385,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i916dc090ae94426d8365fc31b03034ac_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi0zLTEtMS0xNTg1NTI_5c29c487-c308-4019-9bde-9c8eb0895fa9">385,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi00LTEtMS0xNTg1NTI_41f4d882-7024-4afd-b74f-4bd187291e25">5.76</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjpkNzgxYmZmMjIxYWI0MzBiYmEzNGIzZTVjZDVhMThiNV81_91f7da15-f9b5-4502-a904-ee3cda941716">350</ix:nonFraction> million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/23</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS0yLTEtMS0xNTg1NTI_86170f8c-6a6d-4345-8cc9-f84e9e86ba44">349,494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf083f5601064f69b4d4536ff89ad8f4_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS0zLTEtMS0xNTg1NTI_7ed669ac-3034-4e78-9441-18ec1062f22e">349,114</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS00LTEtMS0xNTg1NTI_f27a5425-8fa8-4edf-b847-091aa0d823a5">5.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id093a3a1c949408d9c5b971d33e5ce57_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjo5ZWUzZGZjMDIyYWI0OGU5OGUyZDMxMmE5MmQ0OWRlMV81_056c0e31-c564-4c50-94ab-0a55649fc949">200</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/24</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id093a3a1c949408d9c5b971d33e5ce57_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi0yLTEtMS0xNTg1NTI_bb9d05db-51db-452d-aa1f-deb7a1464812">199,728</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58696a25f6f645418747fe03e651cd67_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi0zLTEtMS0xNTg1NTI_1a775d51-bdba-4d39-9336-3ec13a9fcd8a">199,670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id093a3a1c949408d9c5b971d33e5ce57_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi00LTEtMS0xNTg1NTI_2733975a-cb65-48a6-8234-be44267c6838">5.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i12ab1a1468da462cb3ba734034491aa2_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjo2ZDFiZGIzYjg1Zjg0Mjg5ODk1YWY3MmQxYmJlOGRlNl81_689a8027-1b5b-44c8-80df-8584332c13aa">300</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ab1a1468da462cb3ba734034491aa2_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy0yLTEtMS0xNTg1NTI_288c4faa-fc2b-44ee-8149-799e5f6722f9">299,941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6153dc8f1005474aafde2cd37e112967_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy0zLTEtMS0xNTg1NTI_b3399fed-bd80-42ae-8e3a-2fe0ea204702">299,936</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12ab1a1468da462cb3ba734034491aa2_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy00LTEtMS0xNTg1NTI_4eed99ec-ddad-4c06-89d8-27e8f2c2eb2a">5.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjoxZGY2MTY3YTRjYjQ0YTY0YjBiMTBjOWRjNDg3Yjc3Ml81_852eb03f-d556-4e60-8049-8c39da9def7d">150</ix:nonFraction> million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC0yLTEtMS0xNTg1NTI_b811a883-c920-4ade-8ca5-9c53dbccb30f">149,532</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d414655d314601a88d81663bcb05c1_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC0zLTEtMS0xNTg1NTI_a6ec362c-149f-4e1c-afa1-5a8c813263df">149,495</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC00LTEtMS0xNTg1NTI_c26c2a3b-d405-44ba-b698-355c3f228082">5.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjoyNjIwMWI0YWUzYjg0ZjcyYThhNDU0OTgxYTBlNTcwY181_50b91894-3e34-464e-b617-abbf1d2c5079">200</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS0yLTEtMS0xNTg1NTI_713c40b8-d821-4fa6-8a2c-4713be2e5eea">199,397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2e5ddf6b16b48c1ba4b6ccbd0e86c5b_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS0zLTEtMS0xNTg1NTI_28d2be11-3057-4a8d-be78-74871c83c7cc">199,362</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS00LTEtMS0xNTg1NTI_f934f05a-9e8c-4d43-a45b-07c4ea7bdb80">5.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iada6b4520347441c86e7b036a38806a3_I20230331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246M2FlY2M4ZDM2ZjUxNDQ1ZTk4OTc4OTYwZWRjZTgwZjNfNQ_aa9d58ad-d7ec-435b-aab1-31c66ca2736a">300</ix:nonFraction> million Unsecured Term Loan</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iada6b4520347441c86e7b036a38806a3_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtMi0xLTEtMTU4NTUy_603c23f7-0259-4142-b96f-0341c2e5df2a">297,974</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9996d5e89ffb48608cdbb710a8391d3e_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtMy0xLTEtMTU4NTUy_01093940-73da-4940-8486-61e5f4a1a51e">297,869</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iada6b4520347441c86e7b036a38806a3_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtNC0xLTEtMTU4NTUy_603ddc4c-e0e9-4960-9cf4-ee96f7140567">5.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3797ac41724d4c88869e5d72d41a8977_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTEtMi0xLTEtMTU4NTUy_44486053-9e26-42af-8039-44863a305853">249,206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b8e9ac04b994ee090d110a7cb42566c_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTEtMy0xLTEtMTU4NTUy_596f25ad-2916-45e3-895d-c6e8902ee255">249,115</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3797ac41724d4c88869e5d72d41a8977_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTEtNC0xLTEtMTU4NTUy_791bbc12-f774-4762-b3e5-3580c87a4aef">4.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4c13532ed774effa341fc31c9a9b88a_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTItMi0xLTEtMTU4NTUy_de5fe4be-f119-4c09-a340-181da7d00e68">573,410</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i947183f1bc48403a94ac6a0e12abb930_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTItMy0xLTEtMTU4NTUy_fac68d68-2f9d-40ed-84e3-361c9f81245a">571,587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4c13532ed774effa341fc31c9a9b88a_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTItNC0xLTEtMTU4NTUy_718cfd4c-afca-493d-be8d-839396b9cbc0">4.94</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc42205d2ec44d118886e5720e43151a_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTMtMi0xLTEtMTU4NTUy_de3facf7-0962-45a3-9e96-152e2f4500fb">480,578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if239ca1557c647539fcb388cfb1692af_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTMtMy0xLTEtMTU4NTUy_f4b228d7-8b36-4c86-b410-af733930d77f">479,553</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc42205d2ec44d118886e5720e43151a_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTMtNC0xLTEtMTU4NTUy_7a4d37d6-ead9-4ac3-ae64-501c8aeed74b">4.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e35fb4f52e34980a36f861ff287417b_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTQtMi0xLTEtMTU4NTUy_9e9c9999-5737-4298-85f8-6d9591a8b61c">296,995</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2524e41edf4411a107a30240fcf406_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTQtMy0xLTEtMTU4NTUy_a75c3f32-0a6b-4ea0-bf3e-5897c8576477">296,852</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e35fb4f52e34980a36f861ff287417b_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTQtNC0xLTEtMTU4NTUy_0ed7a9d4-a81d-41c1-9c20-2e4c0e56f953">3.85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48cbfe26eacb4823b267d3ad193c58c3_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTUtMi0xLTEtMTU4NTUy_5e61e790-bc4f-456b-8dd6-08628aa2d2fb">567,863</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8628a7ba5394269893e6d58812b1de8_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTUtMy0xLTEtMTU4NTUy_a0f17913-90e7-4aa4-a4a8-1714385c24bf">565,402</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48cbfe26eacb4823b267d3ad193c58c3_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTUtNC0xLTEtMTU4NTUy_55dea544-8dfc-4465-8de8-0b7ce17eb70b">5.30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee5360caf654c3984323ba0ea3efdd6_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTYtMi0xLTEtMTU4NTUy_42c2692a-6059-4ee2-8f80-b6d37b734c7a">296,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea6204a6cfe4280a12e77772723e04e_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTYtMy0xLTEtMTU4NTUy_597415a7-3ba2-4e0a-bd59-a8639b2d28ef">296,385</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaee5360caf654c3984323ba0ea3efdd6_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTYtNC0xLTEtMTU4NTUy_822b2c2e-7907-48ec-887c-3a1cfb369793">2.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fcf72f9e010488e953762beaa4a3236_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTctMi0xLTEtMTU4NTUy_a475cd42-ed56-4c87-add0-02cd86db9377">295,671</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641fb3901af4361a7453aa207869a13_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTctMy0xLTEtMTU4NTUy_49414ac3-874c-4937-a760-ec0299f6631b">295,547</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fcf72f9e010488e953762beaa4a3236_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTctNC0xLTEtMTU4NTUy_175c4490-b679-43e2-b169-329c7e99d864">2.25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8faa35bf9c54ffda60fcf39d1de6969_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTgtMi0xLTEtMTU4NTUy_c435a980-5ff5-4f85-a851-2c96e75965e6">636,819</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb93c500efca462290474ea705de1cc7_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTgtMy0xLTEtMTU4NTUy_0553bb62-981a-4678-b67f-ba48b7ee52d7">632,693</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8faa35bf9c54ffda60fcf39d1de6969_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTgtNC0xLTEtMTU4NTUy_1cc8e5b1-2e33-4153-97da-562fe5c7cab7">5.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/23-12/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208a8c86222841e7aa4e2d3d1eb58ff6_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktMi0xLTEtMTU4NTUy_86f64140-155a-46ed-85f3-8a38522b54c2">83,612</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic657cdc8fa32443a98553b45427e1d49_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktMy0xLTEtMTU4NTUy_9f99d3bd-4891-40e5-a803-34de25e0ff8c">84,247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5456995c1764da0b948401cfc09b9a0_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktNC0xLTEtMTU4NTUyL3RleHRyZWdpb246ZmViNjRkMGVmYWFiNDBjYWE4OGZhOWNkYzI4NTZlOTdfNTQ5NzU1ODEzOTAz_403c7715-ff67-4bc6-953b-eca20b7f0285">3.57</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i42ab89d4ecf44dfeb1d870f49ac25015_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktNC0xLTEtMTU4NTUyL3RleHRyZWdpb246ZmViNjRkMGVmYWFiNDBjYWE4OGZhOWNkYzI4NTZlOTdfNTQ5NzU1ODEzOTE0_5cca30dd-dcd6-47a4-a34a-d113a9260992">4.84</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMjAtMi0xLTEtMTU4NTUy_3c2acc65-db7a-4865-919e-ddb23c8b1a6f">5,361,699</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMjAtMy0xLTEtMTU4NTUy_45b90581-e0b3-4779-a682-eabc3493f123">5,351,827</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="ibea4c30ecbc148f9bdad5c40e883c6a2" continuedAt="i174a4c5b3bf74a95a92e7d826d6a042e"><ix:continuation id="i303e0ee7669645d6a31790b3cb8bd78d" continuedAt="i95f02c08fe094265b43092fa58f538a2">2</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"><ix:continuation id="i174a4c5b3bf74a95a92e7d826d6a042e"><ix:continuation id="i95f02c08fe094265b43092fa58f538a2">Subsequent to March 31, 2023, the Company exercised its option to extend the maturity date for <ix:nonNumeric contextRef="ic08326621b774b35a49a98cb55264ae0_D20230401-20230509" name="hr:DebtInstrumentExtensionPeriodForMaturityDate" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfMjE5OTAyMzI3NDU3NQ_958e912e-7050-44e2-a9a4-7b88dad4f7cb">one year</ix:nonNumeric> for a fee of approximately $<ix:nonFraction unitRef="usd" contextRef="i05db10f2ba654b51b0c0030478bf971b_I20230509" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfMzI5ODUzNDkwMjAzMQ_ed503868-e035-4ffa-bf5b-054dd1515bdf">0.4</ix:nonFraction>&#160;million.</ix:continuation></ix:continuation>   </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_67"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDIxMQ_35a6ee83-965f-4328-9813-6be0f4720ed9" continuedAt="ic3bae6bfc46d49169b9a22e7beb24486" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="ic3bae6bfc46d49169b9a22e7beb24486" continuedAt="i1bc2130d56f34e1b9d53a6382a7a8529"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Cash Flow Hedges of Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. </span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDIxMw_65140a0b-6b2b-4498-b628-81abfbaf3ba5" continuedAt="i98f65c35f07640b0ae9595ebea9c907e" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had <ix:nonFraction unitRef="derivative" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfMzI5ODUzNDg4ODI2Mg_a7166666-8049-41c5-9570-b6df9c5fa9d8">14</ix:nonFraction> outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"></td><td style="width:41.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1986a74cc37403c9b2e18925bc459c4_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMS0xLTEtMS0xNTg1NTI_5f95457c-e2a6-47f3-b1d6-851001dd65c8">200,000</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1986a74cc37403c9b2e18925bc459c4_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMS0yLTEtMS0xNTg1NTI_96f0965a-172f-43ed-94a7-bf0e83c50ea4">1.21</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab4351c9c9144c7a0456de49fc1c374_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMi0xLTEtMS0xNTg1NTI_ca5e5aa9-cb6c-4a33-b5b3-7e4ce3dc30b3">100,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ab4351c9c9144c7a0456de49fc1c374_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMi0yLTEtMS0xNTg1NTI_8b9d292e-f3ad-4735-825c-d4ddea97f682">2.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6634c65cb6af485bafe3b895bca1c259_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMy0xLTEtMS0xNTg1NTI_b307bce0-0a85-4c9c-9d4d-05217361ccaf">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6634c65cb6af485bafe3b895bca1c259_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMy0yLTEtMS0xNTg1NTI_920356eb-5bba-485b-af10-f65e9255bf59">3.83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55a92723cb045e5b3f7b226e366666a_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0xLTEtMS0xODE1MDQ_3e862366-cde0-4d5e-bd7c-af597c37919f">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib55a92723cb045e5b3f7b226e366666a_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0yLTEtMS0xODE1MDY_9cefb66b-962b-41eb-bb6e-96ee974a5cf2">3.84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300d1ad46f444edcb5259c5aa4ad9337_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0xLTEtMS0xODE1MDg_99d4504d-463f-43f3-a60f-dcb64fb1c42d">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i300d1ad46f444edcb5259c5aa4ad9337_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0yLTEtMS0xODE1MTA_3ec0eb2e-54ac-4c60-8b2a-24b34cca5193">4.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9626e0785d714a62aa74354221bfd9f6_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0xLTEtMS0xNTg1NTI_8393bb33-6cd0-436e-a4dc-bac8a4f761c3">250,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9626e0785d714a62aa74354221bfd9f6_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0yLTEtMS0xNTg1NTI_31a5b9f9-5bdd-4215-a8d9-94e082e8c1ec">3.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e9005e1dd794d208a4b797ae4621183_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0xLTEtMS0xNTg1NTI_20565404-d067-4120-9af0-229a9c10c69a">1,000,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e9005e1dd794d208a4b797ae4621183_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0yLTEtMS0xNTg1NTI_0bebec82-6dd6-47b7-a762-617d8463033b">3.17</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDIzNA_3508b48d-e3fb-4ef6-9305-a7e49b0ef1c5" continuedAt="i3a47669e4d2d4066a7163896515ab162" escape="true">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of March&#160;31, 2023.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt"><ix:continuation id="i3a47669e4d2d4066a7163896515ab162"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e64e9ed9c9e4205bdf1ad560e251d42_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmFmMDRjMzQ0NGVmZTRlZGQ4MTVmMzg3N2MyODU1ZWYyL3RhYmxlcmFuZ2U6YWYwNGMzNDQ0ZWZlNGVkZDgxNWYzODc3YzI4NTVlZjJfMy0yLTEtMS0xNTg1NTI_043a2076-29ff-4655-b2c4-095beddbc554">11,927</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b1c53bc0034d898edcf92852e6d9c1_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmFmMDRjMzQ0NGVmZTRlZGQ4MTVmMzg3N2MyODU1ZWYyL3RhYmxlcmFuZ2U6YWYwNGMzNDQ0ZWZlNGVkZDgxNWYzODc3YzI4NTVlZjJfNC0yLTEtMS0xNTg1NTI_f8d41dcb-e9de-4621-a7fa-030975fdeaf3">9,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i650c8e7c68644e95a14ecf31d3e81688_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmFmMDRjMzQ0NGVmZTRlZGQ4MTVmMzg3N2MyODU1ZWYyL3RhYmxlcmFuZ2U6YWYwNGMzNDQ0ZWZlNGVkZDgxNWYzODc3YzI4NTVlZjJfNS0yLTEtMS0xNTg1NTI_48bf6036-f6c7-402f-a705-662b7ea64387">2,160</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">   </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="i98f65c35f07640b0ae9595ebea9c907e" continuedAt="if1d342ed3b09403e90d1de2e50692e8a">The table below presents the effect of cash flow hedge accounting on AOCI during the three months ended March&#160;31, 2023 and 2022 related to the Company's outstanding interest rate swaps.</ix:continuation></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="i1bc2130d56f34e1b9d53a6382a7a8529"><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><ix:continuation id="if1d342ed3b09403e90d1de2e50692e8a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended March 31,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i550aa973ad90483f8a3c4a0347e5a824_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi0xLTEtMS0xNTg1NTI_cbaaac4e-ab98-49e1-bde5-f5ec81501fd3">8,541</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib038cb82071844b18a5969f43fb847cc_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi0yLTEtMS0xNTg1NTI_8055cab7-596a-4f19-9f24-116a045b4404">5,159</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i418ef205b37644f6bf094af1cdb1378e_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi00LTEtMS0xNTg1NTI_fb2f8f13-ccf4-40ae-ba56-d3c47f00e36d">2,433</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5358b41917b54b188e9b758ea6d034d1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi01LTEtMS0xNTg1NTI_dde19587-6a99-4f5f-9199-837452692431">937</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ecd11079f348afb8d796b899502b99_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy0xLTEtMS0xNTg1NTI_732f05cd-6133-46c3-9724-4daa49a0a9dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i343a27ce736844daa7c02c4fc4bd7e3e_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy0yLTEtMS0xNTg1NTI_f2282850-5ff2-4439-a8db-4578e63b7ee3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0ecdde728be4819bf1b77c1ef19342c_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy00LTEtMS0xNTg1NTI_7a554674-9a2b-4e30-929b-47e3de27f786">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a708e51b4c414fa037bdb830248ffc_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy01LTEtMS0xNTg1NTI_3dfe7358-617c-4af7-8fa1-f5532bb06a83">107</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1641a82fd53448279f743e919d3e08b3_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC0xLTEtMS0xNTg1NTI_c8382ff1-f06c-4855-aabc-62c6feaa12a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ee4952dd5042e1985f1a054d1950b5_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC0yLTEtMS0xNTg1NTI_bb8e2823-f684-49e5-a2c7-a511c64ff1fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e75ffc38cf443b8a2bb92046cf883d_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC00LTEtMS0xNTg1NTI_91c5a1c0-1bd8-43ad-b134-efc48f7e1730">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i955d126813cf4d4ca1a06c68c07ebe2e_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC01LTEtMS0xNTg1NTI_ca02f259-e475-4b71-b2b9-abf1ff6c430d">42</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS0xLTEtMS0xNTg1NTI_2cd5bea2-a085-42f2-8e4d-d20498004144">8,541</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS0yLTEtMS0xNTg1NTI_4752369f-d557-4bbd-84ea-2228dda347db">5,159</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80188dd2e888438dabd7b24526b877bb_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS00LTEtMS0xNTg1NTI_942d7307-9134-4403-98c8-36cb1b12c607">2,284</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07f754abe7f444f8948c8f16a37eeba_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS01LTEtMS0xNTg1NTI_a10f27c6-9a8a-488f-9911-61afb03ca858">1,086</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="ib0caf5935d6d4f239926e7d14b5e7270_I20230331" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfMzI5Mw_6a8482ca-12a5-4288-9364-7b4a0ec4b2f6">9.5</ix:nonFraction> million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $<ix:nonFraction unitRef="usd" contextRef="i862a64f8ce9a48429a007343ae162af5_I20230331" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfMzQzMw_fd5ffc08-988a-4cdc-8dc8-c7b9f1065214">0.6</ix:nonFraction>&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Credit-risk-related Contingent Features</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender due to the Company's&#160;default on the indebtedness.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$<ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:DerivativeNetAssetPositionAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDA4Nw_40a8fc9f-632e-40a6-a172-834ecd4524f1">7.0</ix:nonFraction>&#160;million. As of March&#160;31, 2023, the Company has not posted any collateral related to these agreements and was not in breach of any agreement.</span></div></ix:continuation><div id="i7ef30c9bd2924f189bb8c35e1049bb40_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83MC9mcmFnOmYwYmNlZTlhMGEwNzQ2YmFiOTE0Y2IwMGUxMTA1ZGIxL3RleHRyZWdpb246ZjBiY2VlOWEwYTA3NDZiYWI5MTRjYjAwZTExMDVkYjFfMjY3OA_a849f0d4-72da-4fcf-9146-734001ba9a0e" continuedAt="i6db33a55f39e4ff5a16af6e529abd098" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i6db33a55f39e4ff5a16af6e529abd098"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Development and Redevelopment Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the first quarter of 2023, the Company funded $<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83MC9mcmFnOmYwYmNlZTlhMGEwNzQ2YmFiOTE0Y2IwMGUxMTA1ZGIxL3RleHRyZWdpb246ZjBiY2VlOWEwYTA3NDZiYWI5MTRjYjAwZTExMDVkYjFfMzI5ODUzNDg5MTIzMQ_74e95eeb-3469-4357-96ac-4e91ab679e26">16.9</ix:nonFraction>&#160;million toward the development and redevelopment of properties.</span></div></ix:continuation><div id="i7ef30c9bd2924f189bb8c35e1049bb40_73"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI0OQ_cabef3cc-1210-43db-b8d1-7853a0fdbed3" continuedAt="i6965942bb99446d99717a64f1cb6c6a6" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="i6965942bb99446d99717a64f1cb6c6a6" continuedAt="i929abbe0f18245ae82cc0d9f3f61a60b"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI1Ng_c6785345-ca6a-4c26-80ab-c020cf71ee51" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the three months ended March&#160;31, 2023 and the twelve months ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia75cc38ea5ec4ad8850297f36dd63583_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMS0xLTEtMS0xNTg1NTI_37f8afab-5269-4fa7-ac4b-c694322aa15c">380,589,894</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMS0yLTEtMS0xNTg1NTI_aa1006b4-b251-4022-ad83-c0b13bbc0c28">150,457,433</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMi0xLTEtMS0xNTg1NTI_6ba62ecd-570d-4857-8765-0dba5c215232">3,130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic21e61620e9b4d199d0bd8544198530a_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMi0yLTEtMS0xNTg1NTI_c5e11437-3649-4694-ae56-1155bff3b2f0">229,618,304</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMy0xLTEtMS0xNTg1NTI_4409f06c-bc24-4c15-9ae3-2039ced07b03">223,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic21e61620e9b4d199d0bd8544198530a_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMy0yLTEtMS0xNTg1NTI_da066d42-a2ab-4050-8b18-adc96da80987">514,157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfNC0xLTEtMS0xNTg1NTI_70b1c27a-67aa-4d85-8365-aa627e31208a">380,816,429</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia75cc38ea5ec4ad8850297f36dd63583_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfNC0yLTEtMS0xNTg1NTI_1f59dd4d-8478-43bc-b719-7695250210c7">380,589,894</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">At-The-Market Equity Offering Program</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:130%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company has equity distribution agreements with various sales agents with respect to the at-the-market (&#8220;ATM&#8221;) offering program of common stock with an aggregate sales amount of up to $<ix:nonFraction unitRef="usd" contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331" decimals="INF" name="hr:EquityOfferingProgramAvailableForIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDQ1_7ab9963c-0cd6-4591-a73b-6361707c9fd7">750.0</ix:nonFraction> million.  As of March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331" decimals="INF" name="hr:EquityOfferingProgramAvailableForIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDYw_b623dc2c-6c3a-4537-a9d0-ad438a39a44d">750.0</ix:nonFraction> million remained available for issuance under our current ATM offering program.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM offering program.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="i929abbe0f18245ae82cc0d9f3f61a60b" continuedAt="i310086250f294f5bb1880f48088ca848"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Dividends</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company declared and paid common stock dividends totaling $<ix:nonFraction unitRef="usdPerShare" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNjUx_79216633-a14e-48ab-b04e-d050b70acfe6">0.31</ix:nonFraction> per share.  On May 2, 2023, the Company declared a quarterly common stock dividend in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic3247f43eeeb46f2a5e62592bb20c4af_D20221102-20221102" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNzU5_4afd4566-be4f-40f4-a3f7-4172932a3bc4">0.31</ix:nonFraction> per share payable on June 2, 2023 to stockholders of record on May 16, 2023.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Earnings Per Common Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. </span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI5NQ_7d97e2e3-63a0-4212-9236-f33f0b32c38a" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.617%"><tr><td style="width:1.0%"></td><td style="width:64.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.114%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMy0xLTEtMS0xNTg1NTI_8e729c2c-a548-45f5-9ae4-305bfe0bc972">380,796,773</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMy0yLTEtMS0xNTg1NTI_47909c7d-bcc4-4e7b-ad8f-b9e2503c5701">150,834,888</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNC0xLTEtMS0xNTg1NTI_c7aa8feb-8e4f-445b-9c6f-dd2ee9cac57a">1,956,353</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNC0yLTEtMS0xNTg1NTI_3d2ea1bd-0f8d-41e0-9dc2-61ed4eda1239">1,871,858</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNS0xLTEtMS0xNTg1NTI_3019d1da-64ef-4f16-a890-7063e1f3f36e">378,840,420</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNS0yLTEtMS0xNTg1NTI_39a90d2f-1f4e-46ab-b58a-a37b6a112fab">148,963,030</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNy0xLTEtMS0xNTg1NTI_04007e15-642d-4800-aea0-81af2f426af8">378,840,420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNy0yLTEtMS0xNTg1NTI_d27a39ac-30c0-4126-9375-3b1a8c0acc44">148,963,030</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of employee stock purchase plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTAtMS0xLTEtMTU4NTUy_b962688e-3223-45ea-80b3-7e942107eacf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTAtMi0xLTEtMTU4NTUy_863ef4af-43eb-4d6b-af33-4d64ca57d58a">88,234</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTEtMS0xLTEtMTU4NTUy_c3a05003-2878-4aa0-992d-4249fbf3b2a5">378,840,420</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTEtMi0xLTEtMTU4NTUy_7dd224b3-258a-4817-a0ba-4bb7810f0478">149,051,264</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income  attributable to common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTMtMS0xLTEtMTU4NTUy_01c527f5-866a-4d69-869d-4697dc5d3149">87,125</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTMtMi0xLTEtMTU4NTUy_80c3c2e2-4dc6-4eaf-ae28-da1c08989a20">42,227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends paid on nonvested share-based awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" name="us-gaap:DividendsShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTQtMS0xLTEtMTU4NTUy_85ef1b32-8548-4e2d-a2fa-492205307bf8">605</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="us-gaap:DividendsShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTQtMi0xLTEtMTU4NTUy_aeb02507-ac44-43df-a4a2-6c8486268920">605</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income applicable to common stockholders - basic</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTUtMS0xLTEtMTU4NTUy_2f3a2f9c-56df-4854-a61d-21179abe4d10">87,730</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="-3" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTUtMi0xLTEtMTU4NTUy_22f8f076-ecd9-4753-9125-7dd83f46b13f">41,622</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjEtMS0xLTEtMTU4NTUy_ed14ae17-d59e-4f53-9483-b5f971b07177">0.23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjEtMi0xLTEtMTU4NTUy_a49b9ac2-ce0d-42d3-b8aa-41eea60db735">0.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjQtMS0xLTEtMTU4NTUy_798380ac-219b-4f52-9b76-3479379db186">0.23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjQtMi0xLTEtMTU4NTUy_7311a4ff-fc6b-42a3-b4b4-8d6a00aff0cc">0.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The effect of OP units totaling <ix:nonFraction unitRef="shares" contextRef="ib953f604b4cf42b7b51ce9268a732918_I20230331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTMxOTQxMzk1NDcxNjI_798ed710-b86a-49ee-9067-8ec692bbd237">4,042,993</ix:nonFraction> shares, non-vested stock awards totaling <ix:nonFraction unitRef="shares" contextRef="i5cc16940055742359e8967874631f262_I20230331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkyMTM_9d853eda-b529-455d-982e-4cab8ef1dd2c">401,937</ix:nonFraction> shares, and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling <ix:nonFraction unitRef="shares" contextRef="i66c615d105954779b0ea4386c88b686c_D20230101-20230331" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkyMzk_1affcf91-b4a1-4b0c-b9b0-7f999f6e6c37">49,322</ix:nonFraction> shares for the three months ended March&#160;31, 2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Incentive Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Restricted Common Shares</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i976d48bf9470465e96587107d27c128b_D20230101-20230331" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjE4MQ_535b14d5-5756-4928-82bc-4ae06478eb08">5.4</ix:nonFraction>&#160;million, which consisted of an aggregate of <ix:nonFraction unitRef="shares" contextRef="i976d48bf9470465e96587107d27c128b_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjIyMA_1aa22001-c34c-449d-9a2c-5c491f1af4d9">270,494</ix:nonFraction> non-vested shares with vesting periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI3NQ_6ca16896-73b0-44f5-a3a0-a5bc0b29e940">three</span> to <ix:nonNumeric contextRef="i0de73055e02748f88fb8b29c46b0f7cd_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI4MQ_186f7759-c062-4e20-a6b7-d972fb729fff">eight years</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI0NQ_969ad1b0-9bcb-4a2b-9992-e9d81ce0065a" continuedAt="ifd295b1700a14e3b82c8a34548f2f465" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A summary of the activity under the Company's share-based incentive plans for the three months ended March&#160;31, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"></td><td style="width:64.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.149%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dbd3d23d82a4283a8336822e94b019b_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMi0xLTEtMS0xNTg1NTI_023ccf28-4a7b-45f7-846c-cecc95dd09e9">1,795,128</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35005495bb2d4a14950ce05e7d3751b8_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMi0yLTEtMS0xNTg1NTI_61115a7a-83db-4e4d-ac1e-e279c64f85e8">1,562,028</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMy0xLTEtMS0xNTg1NTI_018e25b6-6ac6-45c9-8919-de21649c8a12">282,540</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMy0yLTEtMS0xNTg1NTI_7d3ba652-cfdc-4b5c-a343-2dd4894ddc11">415,184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNC0xLTEtMS0xNTg1NTI_55c040a0-c590-4b81-879a-5cbc680d02d7">101,720</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNC0yLTEtMS0xNTg1NTI_44109bb7-2d0c-44a4-89f5-88528a0c04f4">24,365</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNS0xLTEtMS0xNTg1NTI_da36e011-f78c-49c7-8ce7-4434cb57fdd4">20,503</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNS0yLTEtMS0xNTg1NTI_1a69bb0c-1106-4b5c-9d4c-6c54cf779776">1,296</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if554654baa2c4fab887bd8e8ce1280d5_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNi0xLTEtMS0xNTg1NTI_f9a71110-b28b-44c8-8b69-8b5f9c569921">1,955,445</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d92d2b7a9d842d6a5b22b3d68c57a01_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNi0yLTEtMS0xNTg1NTI_d99c230e-6b1e-4a03-8da2-9f55d37bad8b">1,951,551</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023 and 2022, the Company withheld <ix:nonFraction unitRef="shares" contextRef="i3514f2b646db4405a1eec8c9a17c0ba3_D20230101-20230331" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkzOTA_fca7f1dc-db04-4733-a713-f18f57bdac89">38,632</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i04f3449a44e04c04843366fd629f5f2f_D20220101-20220331" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkzOTQ_65996d82-001c-406f-9cb1-4fb3cf2c4868">6,727</ix:nonFraction> shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="i310086250f294f5bb1880f48088ca848" continuedAt="i189c1c9e3eae42bca07e722f10f270af"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Restricted Stock Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI0OA_9e89b8c3-32a4-43d5-b781-c1bec69fb465">three-year</ix:nonNumeric> forward-looking performance targets. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i479dcf12323a45868421febd4b7d7c82_D20230104-20230104" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzgxMQ_ef5e5243-ca0c-4920-a814-ed54a4f8a2ef">3.7</ix:nonFraction> million, which consisted of an aggregate <ix:nonFraction unitRef="shares" contextRef="i479dcf12323a45868421febd4b7d7c82_D20230104-20230104" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzg0Nw_846ae9a9-dadb-41df-94c8-95f6dba6779c">165,174</ix:nonFraction> RSUs with a <ix:nonNumeric contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI4Mw_0241e2d3-65ae-4f32-962b-d51bbee83d31">five-year</ix:nonNumeric> vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately <ix:nonFraction unitRef="number" contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNTk4_1b129d95-b5fb-43dc-a2df-3c705e0f152e">43</ix:nonFraction>% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="i026d56f8612c468fb9c1628088387b24_D20220101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDIyMw_a6d7e8e3-6af9-4eab-aa10-524ab9e01328">24.23</ix:nonFraction> for the absolute TSR component and $<ix:nonFraction unitRef="usdPerShare" contextRef="i54f3253796ed4156b94a25fac13c6991_D20220101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDI2MQ_f08cd98d-80ff-4397-8b73-bffcbab938e3">27.84</ix:nonFraction> for the relative TSR component for the January 2023 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI3OA_04b2c136-548f-46f6-b1dc-b5172e3e3942" continuedAt="i934b95bd22584114acb9ab175cdafcd2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfMS0zLTEtMS0xNTg1NTI_a1e0af3d-f49e-4cd6-b212-bbaf3bac4e54">34.0</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfMy0zLTEtMS0xNTg1NTI_f4bd490d-2657-4c33-a7c0-c7cf87c0e2ba">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfNC0zLTEtMS0xNTg1NTI_43f21c1c-76c1-4d73-8081-fdf9f061ce49">4.42</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfNS0zLTEtMS0xNTg1NTI_4cfb1461-11c6-496e-86d2-bbff5070d074">20.21</ix:nonFraction></span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining <ix:nonFraction unitRef="number" contextRef="ic19e24e6e4d646fcacc85aeea31d807b_D20230104-20230104" decimals="INF" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjA0_40061dd6-daf4-42c8-a150-37f06255941f">57</ix:nonFraction>% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $<ix:nonFraction unitRef="usdPerShare" contextRef="ic19e24e6e4d646fcacc85aeea31d807b_D20230104-20230104" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjE4_8db84743-e852-463c-8524-004c866bbe70">20.21</ix:nonFraction> based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $<ix:nonFraction unitRef="usdPerShare" contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDcxNw_2f88d456-c14c-4df6-8dbd-ac0ba9ed01d5">22.55</ix:nonFraction> per share.</span></div><ix:continuation id="ifd295b1700a14e3b82c8a34548f2f465"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following is a summary of the RSU activity during the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"></td><td style="width:64.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.149%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, beginning of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i165032ae420b46b7bbba8d14fe0aba12_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMi0xLTEtMS0xNTg1NTI_804a22f4-0b45-4240-8bdc-f0d56fe716a2">294,932</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i165032ae420b46b7bbba8d14fe0aba12_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMi0yLTEtMS0xNTg1NTI_e0227f6a-4548-444b-8f99-c932531d5364">33.04</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMy0xLTEtMS0xNTg1NTI_7a89b3f7-7e38-4106-ace1-8d7e93ef8c28">165,174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMy0yLTEtMS0xNTg1NTI_f01f3e2c-6a76-4ad3-a43e-77f8df0ead00">22.55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested/Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNC0xLTEtMS0xNTg1NTI_edf1155c-8d5d-40b4-a4ce-c10a10415c2f">17,606</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNC0yLTEtMS0xNTg1NTI_aa823400-c6b3-41a9-ad58-941a7dc265b2">33.04</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Probability adjustment of 2022 RSUs </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331" decimals="INF" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNS0xLTEtMS0xNzQxMzE_2dfc255c-65e8-476c-899a-c883f7c32ff9">79,250</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNS0yLTEtMS0xNzgyODY_98051269-4391-49b4-aade-d2f3f68b7a26">31.68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fdfd62e90e34b9f8d96116f557c9787_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNS0xLTEtMS0xNTg1NTI_af786012-4a64-43a5-8a18-61c86196823b">363,250</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fdfd62e90e34b9f8d96116f557c9787_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNi0yLTEtMS0xNzg0NjM_9691731c-99c9-405f-81dd-95a28c8a729f">28.57</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">LTIP Series C Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units are granted with <ix:nonNumeric contextRef="iad26162143ea47dfa49d4366d8a0dba7_D20230101-20230131" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjE5OTAyMzI3MDY4OA_3f9c39d5-b74b-4ce9-a869-2f1c32d10f89">three-year</ix:nonNumeric> forward-looking performance targets, with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i0c057c6178b345c9b3e881d858993552_D20230104-20230104" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTg2Mjg_028e0e9b-3ba9-4bf4-82f5-578b0155f346">7.1</ix:nonFraction>&#160;million, which consisted of an aggregate <ix:nonFraction unitRef="shares" contextRef="iad942920f150409cad42db1a3f7dc7c2_D20230104-20230104" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTg2NTA_c7162ba7-ba7a-4036-a34a-c458c9ae65e9">448,249</ix:nonFraction> LTIP-C units with a <ix:nonNumeric contextRef="iad942920f150409cad42db1a3f7dc7c2_D20230104-20230104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzg0ODI5MDcxMTAxOQ_38058991-c15e-44d2-8981-8a9b0de49b28">five-year</ix:nonNumeric> vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately <ix:nonFraction unitRef="number" contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjEw_f16fea56-1ae0-42ba-93be-f4f96cf73216">43</ix:nonFraction>% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1917ae1a54ca4c99b9c7f284e6873fa3_D20220101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjE5OTAyMzI3MjI1Mg_821558f6-0a6d-41d5-aac9-93a34d1b8fca">12.24</ix:nonFraction> for the absolute TSR component and $<ix:nonFraction unitRef="usdPerShare" contextRef="i000748c9059c48ff9b5003e987126ae1_D20220101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTc1OTIxODYwNjEwOTc_0c729dcd-fff2-4b94-9228-a89b7038b3b3">13.98</ix:nonFraction> for the relative TSR component for the January 2023 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i934b95bd22584114acb9ab175cdafcd2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfMS0zLTEtMS0xOTAzODg_0b0a6c5c-ee58-4828-9e45-f1f78fccbcc2">34.0</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfMy0zLTEtMS0xOTAzODg_9695ba87-11f4-4c8a-b449-05354385a271">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfNC0zLTEtMS0xOTAzODg_e569b12e-70e2-4cfa-a12f-ad001f4ba39b">4.42</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfNS0zLTEtMS0xOTAzODg_f1e3f012-ae49-47e0-acf9-dd8c7fe16220">20.21</ix:nonFraction></span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="i189c1c9e3eae42bca07e722f10f270af"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining <ix:nonFraction unitRef="number" contextRef="i32164c0659084310957f7adb36c144a1_D20230104-20230104" decimals="INF" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjE0_70419c23-0fef-4407-989c-fcaa193df99b">57</ix:nonFraction>% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $<ix:nonFraction unitRef="usdPerShare" contextRef="i32164c0659084310957f7adb36c144a1_D20230104-20230104" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjM0_2badd980-2dc2-4d91-8d3a-e893d774e7ab">20.21</ix:nonFraction> based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $<ix:nonFraction unitRef="usdPerShare" contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTc1OTIxODYwNjExMDY_00457edc-fd9a-4c1c-b323-984a9aca75a0">15.85</ix:nonFraction> per share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI4OQ_00ae3684-72d1-412c-901c-7c0595535558" continuedAt="ie9cf85d73f0e40788ac2247d50f0d509" escape="true">A summary of the activity under the ESPP for the three months ended March&#160;31, 2023 and 2022 is included in the table below.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><ix:continuation id="ie9cf85d73f0e40788ac2247d50f0d509"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"></td><td style="width:64.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.149%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, beginning of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0eb8d9ba9fcb4cd3a86450f082750fed_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMi0xLTEtMS0xNTg1NTI_691fa834-952e-4d92-8484-db5cc9bcc89b">340,976</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9eb54b7f31d5417da8f8112e9b8c756e_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMi0yLTEtMS0xNTg1NTI_cdf4ce65-4c6d-4ef7-a8cd-d3b0fe720ef8">348,514</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMy0xLTEtMS0xNTg1NTI_18d1af6a-7725-442c-a994-cd8c01fcbb27">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMy0yLTEtMS0xNTg1NTI_bdf42c80-ed87-4471-b678-ee14a7f27b7a">255,960</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNC0xLTEtMS0xNTg1NTI_90193e62-57f1-4e43-9e68-e8adb514b6df">3,130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNC0yLTEtMS0xNTg1NTI_fd6f4c5a-4fd0-4c7a-ad45-208159265405">10,553</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNS0xLTEtMS0xNTg1NTI_071f90b5-11bc-4704-a485-5c17903a2bec">21,421</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNS0yLTEtMS0xNTg1NTI_fa30710d-dd40-4688-93d9-8169b7a2283f">25,486</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNi0xLTEtMS0xNTg1NTI_360fdcac-e274-41c1-81a0-8083a607c1e5">132,999</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNi0yLTEtMS0xNTg1NTI_506ddb1c-2a59-4510-8b5f-afa6deed76b4">140,633</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24141fc9eb4b43ab8baf38ba6ac04b2e_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNy0xLTEtMS0xNTg1NTI_25fc0056-7569-4334-947e-28310eece845">183,426</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i896e8bc913c24d9fb4ecb2ce94992aee_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNy0yLTEtMS0xNTg1NTI_1a7ea104-406c-4fd7-a06f-c6c36b59827b">427,802</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzI5ODUzNDg5ODY2MA_f8b4c05e-13b2-42cd-a018-edbc72e9ac4b" escape="true"><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested shares issued as of March 31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"></td><td style="width:48.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfMS0xLTEtMS0xOTAyMDM_c3b4431f-6ede-4901-9218-2d081ce93ebc">10.5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfMi0xLTEtMS0xOTAyMDM_158cf36d-f5be-489d-a5d6-7a72a750abc3">12.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfMy0xLTEtMS0xOTAyMDM_85d5cd67-2ed3-403c-ad2e-6ee442605d78">10.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNC0xLTEtMS0xOTAyMDM_fdec72a7-9abc-4b48-983f-352e6bcc7078">8.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNS0xLTEtMS0xOTAyMDM_5ee43c83-7f4a-4551-a7a7-8aeb67472f2e">2.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNi0xLTEtMS0xOTAyMDM_3ff192a1-0bce-4264-8755-897bd9b0e683">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNy0xLTEtMS0xOTAyNDM_e5c33a83-74e3-4084-9071-2a93971e2e0d">44.8</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7ef30c9bd2924f189bb8c35e1049bb40_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RleHRyZWdpb246MjBiZDA5NGFhMGMwNGU5NmJmYjM0YmNkZDVmMGE2ZmZfMTU2MQ_0b7f8984-664d-4cfd-b944-0579efdbc0d1" continuedAt="i3b9981373a6944aa919bd764e1f3ad1a" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i3b9981373a6944aa919bd764e1f3ad1a" continuedAt="i7c890810d69b48648d970a60938b523e"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Cash and cash equivalents</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value due to the short term maturity of these investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Real estate notes receivabl</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements.</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Senior Notes and Mortgage Notes payable</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#8217;s current interest rates for similar types of borrowing arrangements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Interest rate swap agreements</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">22</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="i7c890810d69b48648d970a60938b523e"><ix:nonNumeric contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RleHRyZWdpb246MjBiZDA5NGFhMGMwNGU5NmJmYjM0YmNkZDVmMGE2ZmZfMTU3Nw_2cf0a74a-07ee-48f2-a276-cf1bd850f07f" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"></td><td style="width:26.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf810aaefd344b08133b9065f0521e0_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi0xLTEtMS0xNTg1NTI_3f3c7c4a-7e09-4a21-8c37-503fe78339fc">5,361.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5e1cd5751f4fd29eaceeb6e25007d8_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi0yLTEtMS0xNTg1NTI_8a5fcc74-3db7-4b54-b548-353c040a10e9">5,185.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b140e579a2c4968935d45253779bfed_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi0zLTEtMS0xNTg1NTI_e441888f-8c72-4ce4-80d0-1f2e661a301c">5,351.8</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786dc6592f45460895333b89bf32a577_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi00LTEtMS0xNTg1NTI_fdee90f8-01e0-42df-971b-9b24a7de69d4">5,149.6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf810aaefd344b08133b9065f0521e0_I20230331" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy0xLTEtMS0xNjI5ODg_8e6932be-6505-4ca6-a046-5043cdaec88e">147.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5e1cd5751f4fd29eaceeb6e25007d8_I20230331" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy0yLTEtMS0xNjI5ODg_c2b9f843-f1f9-431c-8347-d77d5add95f8">146.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b140e579a2c4968935d45253779bfed_I20221231" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy0zLTEtMS0xNjI5ODg_1cc57f13-6cc2-4eb4-9a5c-0a6c946c1752">99.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786dc6592f45460895333b89bf32a577_I20221231" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy00LTEtMS0xNjI5ODg_df11d3ee-d8e6-4569-aa3e-f09261f2f488">99.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_82"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_85"></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Disclosure Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">This report and other materials the Company has filed or may file with the SEC, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, disclosures that are &#8220;forward-looking statements.&#8221; Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;target,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;should,&#8221; &#8220;could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: failure to realize the expected benefits of the Merger; the risk that the Company&#8217;s and HTA&#8217;s respective businesses will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company&#8217;s common stock could decline; pandemics or other health crises, such as COVID-19; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption &#8220;Risk Factors&#8221; and elsewhere in the Company&#8217;s filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company&#8217;s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">For a detailed discussion of the Company&#8217;s risk factors, please refer to the Company's filings with the SEC, including this report and Item 1A. Risk Factors herein and the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_88"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Merger with Healthcare Trust of America</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Completed Merger&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, Legacy HR, Legacy HTA, the OP and Merger Sub completed the Merger in accordance with the terms of the Merger Agreement. Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to &#8220;HRTI, LLC&#8221; and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP. As a result, Legacy HR became a part of an umbrella partnership REIT (&#8220;UPREIT&#8221;) structure, which is intended to align the corporate structure of the combined company after giving effect to the Merger and the UPREIT reorganization and to provide a platform for the combined company to more efficiently acquire properties in a tax-deferred manner. The Company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the ticker symbol &#8220;HR&#8221;.  For additional information on the Merger, see Note 2 to the Condensed Consolidated Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Because Legacy HR was the accounting acquirer under GAAP in the transaction, its historical financial statements became the historical financial statements of the Company.  For additional information, please refer to the Explanatory Note in this report.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Sources and Uses of Cash</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s primary sources of cash include rent receipts from its real estate portfolio based on contractual arrangements with its tenants, proceeds from the sales of real estate properties, joint ventures, and proceeds from public or private debt or equity offerings.  After the refinancing of its bank facilities in connection with the Merger, as of March&#160;31, 2023, the Company had $1.1 billion available to be drawn on its &#160;&#160;&#160;&#160;Unsecured Credit Facility and $49.9 million in cash.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company expects to continue to meet its liquidity needs, including funding additional investments, paying dividends, and funding debt service, through cash flows from operations and liquidity sources, including the Unsecured Credit Facility. Management believes that the Company's liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Dividends paid by the Company for the three months ended March 31, 2023 were funded from cash flows from operations and the Unsecured Credit Facility, as cash flows from operations were not adequate to fully fund dividends, primarily as a result of the timing of interest payments. The Company expects that cash flows from property operations will generate sufficient cash flows such that dividends for the full year 2023 can be funded by cash flows from operations or other sources of liquidity described above.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows provided by investing activities for the three months ended March&#160;31, 2023 were approximately $41.6 million. Below is a summary of significant investing activities. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's sole acquisition for the three months ended March&#160;31, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.813%"><tr><td style="width:1.0%"></td><td style="width:23.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ASSOCIATED HEALTH SYSTEM/TENANCY </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MILES TO CAMPUS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BayCare Health</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,867</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.06</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes buildings located on-campus, adjacent and off-campus that are anchored by healthcare systems or located within two miles of a hospital campus.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Dispositions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company disposed of six properties during the three months ended March&#160;31, 2023 for a total sales price of $208.8 million, including cash proceeds of $149.2 million. The following table details these dispositions for the three months ended March 31, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.351%"><tr><td style="width:1.0%"></td><td style="width:35.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Date Disposed</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Sales Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Square Footage</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL &amp; Miami, FL </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93,250&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">224,037</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36,691</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,500</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,165</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,078</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">208,810&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">451,471&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes two properties, sold in two separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company entered into a mortgage note agreement with the buyer for $45&#160;million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Capital Funding</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company funded $45.9 million toward the following capital expenditures:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$16.9 million toward the development and redevelopment of properties; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$11.2 million toward first generation tenant improvements and planned capital expenditures for acquisitions; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$8.9 million toward second generation tenant improvements; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$8.9 million toward capital expenditures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Financing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows used in financing activities for the three months ended March&#160;31, 2023 were approximately $121.8 million.  See Notes 6 and 9 to the Condensed Consolidated Financial Statements accompanying this report for more information about capital markets and financing activities. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Common Stock Issuances</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">At-The-Market Equity Offering Program</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">The Company has equity distribution agreements with various sales agents with respect to our ATM offering program of common stock with an aggregate sales amount of up to $750.0 million. As of March&#160;31, 2023, $750.0 million remained available for issuance under our current ATM offering program.</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Debt Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March 31, 2023, the Company had outstanding interest rate derivatives totaling $1.0 billion to hedge one-month Term SOFR. The following details the amount and rate of each swap (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.672%"><tr><td style="width:1.0%"></td><td style="width:42.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Operating Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows provided by operating activities increased from $43.8 million for the three months ended March&#160;31, 2022 to $69.2 million for the three months ended March&#160;31, 2023. Items impacting cash flows from operations include, but are not limited to, cash generated from property operations, interest payments and the timing related to the payment of invoices and other expenses.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may, from time to time, sell properties and redeploy cash from property sales into new investments. To the extent revenues related to the properties being sold exceed income from these new investments, the Company's results of operations and cash flows could be adversely affected.</span></div><div><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_91"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Trends and Matters Impacting Operating Results</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management monitors factors and trends important to the Company and the REIT industry to gauge the potential impact on the operations of the Company. In addition to the matters discussed in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, below are some of the factors and trends that management believes may impact future operations of the Company.  </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Economic and Market Conditions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rising interest rates and increased volatility in the capital markets have increased the Company&#8217;s cost and availability of debt and equity capital. Limited availability and increases in the cost of capital could adversely impact </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">the Company&#8217;s ability to finance operations and acquire and develop properties. To the extent the Company&#8217;s tenants experience increased costs or financing difficulties due to the economic and market conditions, they may be unable or unwilling to make payments or perform their obligations when due. Additionally, increased interest rates may also result in less liquid property markets, limiting the Company&#8217;s ability to sell existing assets or obtain joint venture capital. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expiring Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company expects that approximately 15% of its leases will expire each year in the ordinary course of business. There are 1,169 leases totaling 3.3 million square feet that will expire during the remainder of 2023.  Approximately 74% of the leases expiring during the remainder of 2023 are for space in buildings located on or adjacent to hospital campuses, are distributed throughout the portfolio, and are not concentrated with any one tenant, health system or market area. The Company typically expects to retain 75% to 90% of tenants upon expiration, and the retention ratio for the first three months of the year was within this range. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Operating Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company historically has experienced increases in property taxes throughout its portfolio as a result of increasing assessments and tax rates levied across the country. The Company continues its efforts to appeal property tax increases and manage the impact of the increases. In addition, the Company historically has incurred variability in portfolio utilities expense based on seasonality, with the first and third quarters usually reflecting greater amounts. The effects of these operating expense increases are mitigated in leases that have provisions for operating expense reimbursement. As of March&#160;31, 2023, leases for approximately 92% of the Company's total leased square footage allow for some recovery of operating expenses, with approximately 28% having modified gross lease structures and approximately 64% having net lease structures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Purchase Options</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Information about the Company's unexercised purchase options and the amount and basis for determination of the purchase price is detailed in the table below (dollars in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.024%"><tr><td style="width:1.0%"></td><td style="width:36.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">YEAR EXERCISABLE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NUMBER OF PROPERTIES</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS REAL ESTATE INVESTMENT AS OF </span></div><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MARCH 31, 2023 </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">112,313&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">133,068&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">180,186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">110,129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">133,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">81,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2031</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">108,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2032</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2033 and thereafter </span><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">335,885&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,220,548&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes three properties totaling $44.6 million with stated purchase prices or prices based on fixed capitalization rates. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">These purchase options have been exercisable for an average of 13.2 years.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Includes two medical office buildings that are recorded in the line item Investment in financing receivable, net on the Company's Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures and Key Performance Indicators</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management considers certain non-GAAP financial measures and key performance indicators to be useful supplemental measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors, as well as reconciliations of these measures to the most directly comparable GAAP financial measures.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The non-GAAP financial measures and key performance indicators presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs. Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented in the Condensed Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Funds from Operations ("FFO"), Normalized FFO and Funds Available for Distribution ("FAD")</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts (&#8220;NAREIT&#8221;). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT&#8217;s operating performance equal to &#8220;net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus depreciation and amortization, impairment, and after adjustments for unconsolidated partnerships and joint ventures.&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition to FFO, the Company presents Normalized FFO and FAD. Normalized FFO is presented by adding to FFO acquisition-related costs, acceleration of debt issuance costs, debt extinguishment costs and other Company-defined normalizing items to evaluate operating performance. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, non-cash financing receivable amortization, loan origination cost amortization, deferred financing fees amortization, stock-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD should not be considered as an alternative to net income as an indicator of the Company's financial performance or to cash flow from operating activities as an indicator of the Company's liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management believes FFO, Normalized FFO, FFO per common share, Normalized FFO per share and FAD ("Non-GAAP Measures") provide an understanding of the operating performance of the Company&#8217;s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, impairments and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, Non-GAAP Measures can facilitate comparisons of operating performance between periods. The Company reports Non-GAAP Measures because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these Non-GAAP Measures. However, none of these measures represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. Further, these measures should not be considered as an alternative to net income as an indicator of the Company&#8217;s operating performance or as an alternative to cash flow from operating activities as a measure of liquidity. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below reconciles net income to FFO, Normalized FFO and FAD for the three months ended March&#160;31, 2023 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.036%"><tr><td style="width:1.0%"></td><td style="width:71.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Amounts in thousands, except per share data</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(87,125)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,227&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:120%">Net (loss) income attributable to common stockholders per share </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(0.23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.28&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(44,784)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">26,227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate depreciation and amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">186,109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">55,658&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling income from operating partnership units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proportionate share of unconsolidated joint ventures</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">FFO adjustments</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">215,103&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,218&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">FFO adjustments per common share - diluted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">7</span></div></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.09&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FFO attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">127,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">55,445&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">FFO attributable to common stockholders per common share - diluted </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">7</span></div></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.37&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition and pursuit costs </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger-related costs </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,116&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Merger-related fair value adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-routine legal costs/forfeited earnest money received </span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Allowance for credit losses </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Debt financing costs</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Unconsolidated JV normalizing items </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Normalized FFO adjustments</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24,868&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,343&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">Normalized FFO adjustments per common share - diluted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">8</span></div></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.06&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Normalized FFO attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">152,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">64,788&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:120%">Normalized FFO attributable to common stockholders per common share - diluted </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">8</span></div></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.43&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-real estate depreciation and amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash interest amortization </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Rent reserves, net</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent, net</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,209)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock-based compensation </span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,699&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Unconsolidated JV non-cash items </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(227)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(271)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Normalized FFO adjusted for non-cash items</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,775&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">68,321&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2nd generation TI</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,882)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,899)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Leasing commissions paid</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,013)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,767)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Capital additions</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,620)</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FAD</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">125,934&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57,035&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FFO weighted average common shares outstanding - diluted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 8</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">383,335&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,856&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Potential common shares are not included in the computation of diluted earnings per share when a loss exists as the effect would be an antidilutive per share amount.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Acquisition and pursuit costs include third-party and travel costs related to the pursuit of acquisitions and developments. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Includes costs incurred related to the Merger.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">Includes a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Operations and $3.4 million reserve included in &#8220;Rental Income&#8221; on the Statement of Operations for previously deferred rent and straight line rent for three skilled nursing facilities.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt">Includes the Company's proportionate share of acquisition and pursuit costs related to unconsolidated joint ventures.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">6</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.96pt">Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">7</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.28pt">Includes the Company's proportionate share of straight-line rent, net related to unconsolidated joint ventures.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">8</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.07pt">The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 401,937 and 804,415, respectively, for the three months ended March 31, 2023 and 2022, and the diluted impact of 4,042,993 OP units outstanding for the three months ended March 31, 2023. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">29</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Cash Net Operating Income ("NOI") and Same Store Cash NOI</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income, interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, financing receivable amortization, tenant improvement amortization and leasing commission amortization. The Company also excludes cash lease termination fees. Cash NOI is historical and not necessarily indicative of future results. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale or intended for sale, properties undergoing redevelopment, and newly redeveloped or developed properties. Legacy HTA properties that met the same store criteria are included in both periods shown as if they were owned by the Company for the full analysis period.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.  These properties are described in additional detail in Note 6 to the Condensed Consolidated Financial Statements included elsewhere in this report.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table reflects the Company's same store cash NOI for the three months ended March&#160;31, 2023 and 2022. </span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.287%"><tr><td style="width:1.0%"></td><td style="width:33.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.160%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NUMBER OF PROPERTIES</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS INVESTMENT<br/>at March 31, 2023</span></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SAME STORE CASH  NOI for the three months ended March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Same store properties</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,688,867&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">178,560&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">173,649&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following tables reconcile net income to same store NOI and the same store property metrics to the total owned real estate portfolio for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Reconciliation of Same Store Cash NOI</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.385%"><tr><td style="width:1.0%"></td><td style="width:53.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(87,125)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,227&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">94,407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(29,293)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,935&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,036&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">184,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">54,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expenses</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent revenue, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,209)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other revenue</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,686)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,044)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">209,474&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">86,739&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Pre-Merger Legacy HTA NOI</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">127,363&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash NOI</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">209,474&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">214,102&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash NOI not included in same store</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(30,914)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(40,453)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Same store cash NOI</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">178,560&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">173,649&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes acquisition and pursuit costs, Merger-related costs, rent reserves, above and below market ground lease intangible amortization, leasing commission amortization and ground lease straight-line rent expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease terminations and tenant improvement overage amortization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Reconciliation of Same Store Properties</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.076%"><tr><td style="width:1.0%"></td><td style="width:40.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">AS OF MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars and square feet in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PROPERTY COUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS INVESTMENT </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE <br/>FEET</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OCCUPANCY</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Same store properties</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,688,867&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">34,471&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,253,422&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Development completions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">189,871&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redevelopments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">330,957&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Planned Dispositions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165,243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total owned real estate properties</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,628,360&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39,855&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Excludes assets held for sale, construction in progress, land held for development, corporate property and financing lease right-of-use assets unrelated to an imputed lease arrangement as a result of a sale leaseback transaction.  </span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Three Months Ended March&#160;31, 2023 Compared to Three Months Ended March&#160;31, 2022 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s results of operations for the three months ended March&#160;31, 2023 compared to the same period in 2022 were impacted by the Merger, acquisitions, developments, dispositions, gains on sale, and capital markets transactions. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenues</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rental income increased $185.6 million, or 134.0%, for the three months ended March&#160;31, 2023 compared to the prior year period. This increase is comprised of the following:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 contributed $9.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Leasing activity, including contractual rent increases, contributed $4.5 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $8.1 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger contributed $180.2 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest income increased $2.3 million, or 118.3%, for the three months ended March&#160;31, 2023 compared to the prior year period primarily as a result of interest from notes receivables assumed in the Merger.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other operating income increased $2.1 million, or 86.6%, for the three months ended March&#160;31, 2023 compared to the prior year period primarily as a result of variable parking and asset management fees assumed in the Merger.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Property operating expenses increased $64.6 million, or 112.4%, for the three months ended March&#160;31, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 resulted in an increase of $3.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increases in portfolio operating expenses as follows: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Utilities expense of $0.3 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Maintenance and repair of $0.4 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Administrative, leasing commissions, and other legal expense of $0.6 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Janitorial expense of $0.6 million; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Insurance expense of $0.4 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Property taxes decreased $0.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Compensation expense decreased $0.5 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $3.8 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger resulted in an increase of $64.2 million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">General and administrative expenses increased approximately $3.9 million, or 35.3%, for the three months ended March&#160;31, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Compensation expense increases of $0.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Travel and related expenses increased $0.8 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Net increases, including professional fees, audit services, insurance and other administrative costs, of $1.6 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger resulted in an increase of $0.8 million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Merger-related costs decreased $1.3 million, or 20.6%, for the three months ended March 31, 2023 compared to the prior year period. These costs consisted primarily of legal and consulting services in connection with the Merger.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Depreciation and amortization expense increased $130.4 million, or 241.4%, for the three months ended March&#160;31, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 resulted in an increase of $4.4 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Various building and tenant improvement expenditures resulted in an increase of $3.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $2.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Assets that became fully depreciated resulted in a decrease of $3.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger resulted in an increase of $128.0 million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Income (Expense)</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Gains on sale of real estate properties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the first quarter of 2023, the Company recognized gains of approximately $1.0 million.  In the first quarter of 2022, the Company recognized gains of approximately $44.8 million.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Interest expense</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">32</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest expense increased $50.1 million, or 366.7%, for the three months ended March&#160;31, 2023 compared to the prior year period. The components of interest expense are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.415%"><tr><td style="width:1.0%"></td><td style="width:45.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">CHANGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50,766&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,502&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">38,264&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">306.1&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net discount/premium accretion</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,082.0&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107.6&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of interest rate swap settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of treasury hedge settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair value derivative</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest cost capitalization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(570)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(532)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,400.0&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">219.9&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">63,759&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,661&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50,098&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">366.7&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Contractual interest expense increased $38.3 million, or 306.1%, for the three months ended March 31, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Senior notes and unsecured term loans assumed in the Merger accounted for an increase of approximately $26.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">New unsecured term loans executed with the amended credit facility accounted for an increase of approximately $9.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Company's Unsecured Term Loan due 2024 and 2026 accounted for an increase of approximately $3.9 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Credit Facility accounted for an increase of approximately $4.4 million due to an increased weighted average balance outstanding and an increase in the weighted average interest rate.  </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Active interest rate derivatives accounted for a decrease of $4.8 million. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Mortgage note repayments, net of assumptions, accounted for a decrease of approximately $0.2 million.</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">  </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Impairment of Real Estate Properties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the first quarter of 2023, the Company recognized impairments totaling $26.2 million due to four properties that were sold and three properties and one land parcel reclassified to held for sale. In addition, the Company recorded $5.2 million in credit loss reserves related to notes receivables. See Note 1 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's notes receivables and credit loss reserves.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Equity loss from unconsolidated joint ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized its proportionate share of losses from its unconsolidated joint ventures. These losses are primarily attributable to non-cash depreciation expense.  See Note 3 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's unconsolidated joint ventures.</span></div><div style="margin-top:3pt"><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_97"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;3.  Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to market risk in the form of changing interest rates on its debt and mortgage notes. Management uses regular monitoring of market conditions and analysis techniques to manage this risk. During the three months ended March&#160;31, 2023, there were no material changes in the quantitative and qualitative disclosures about market risks presented in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_100"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;4.  Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), as of the end of the period covered by this report. Based on this evaluation, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company&#8217;s disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports it files or submits under the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">There have not been any changes in the Company&#8217;s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_103"></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_106"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_109"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1A.  Risk Factors</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition to the other information set forth in this report, an investor should carefully consider the factors discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in the Company&#8217;s  Annual Report on Form 10-K for the year ended December&#160;31, 2022, which could materially affect the Company&#8217;s business, financial condition or future results. The risks, as described in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are not the only risks facing the Company. Additional risks and uncertainties not currently known to management or that management currently deems immaterial also may materially, adversely affect the Company&#8217;s business, financial condition, operating results or cash flows.</span></div><div><span><br/></span></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_112"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company withheld and canceled shares of Company common stock to satisfy employee tax withholding obligations payable upon the vesting of non-vested shares, as follows:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">PERIOD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">TOTAL NUMBER OF SHARES PURCHASED</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">AVERAGE PRICE PAID per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">TOTAL NUMBER OF SHARES purchased as part of publicly announced plans of programs</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">MAXIMUM NUMBER OF SHARES that may yet be purchased under the plans or programs</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 1 - January 31</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">February 1 - February 28</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">March 1 - March 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38,632&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_115"></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXHIBIT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.1</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060414000020/hta_-xfifthxarticlesxofxam.htm">Fifth Articles of Amendment and Restatement of the Company, effective March 22, 2014</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060414000020/hta_-xfifthxarticlesxofxam.htm">.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060414000020/hta_-xfifthxarticlesxofxam.htm">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060414000077/ex3120141216.htm">Articles of Amendment of the Company, effective December 15, 2014</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060414000077/ex3120141216.htm">.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060414000077/ex3120141216.htm">2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000119312522202185/d384978dex31.htm">Articles of Amendment of the Company, effective July 20, 2022</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000119312522202185/d384978dex31.htm">.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline" href="http://www.sec.gov/Archives/edgar/data/1360604/000119312522202185/d384978dex31.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060417000072/ex31articlessupplmentary.htm">Articles Supplementary of the Company, effective July 14, 2017</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060417000072/ex31articlessupplmentary.htm">.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060417000072/ex31articlessupplmentary.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.5</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060420000037/ex31.htm">Fourth Amended and Restated Bylaws of the Company</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060420000037/ex31.htm">.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060420000037/ex31.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1360604/000119312522202185/d384978dex32.htm">Certificate of Amendment to Limited Partnership of Healthcare Realty Holdings, L.P.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:underline;top:-2.62pt;vertical-align:baseline" href="http://www.sec.gov/Archives/edgar/data/1360604/000119312522202185/d384978dex32.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023331xex311.htm">Exhibit </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023331xex311.htm">22</a>.1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="hr-2023331xex221.htm">Subsidiary Issuers of Guaranteed Securities. (filed herewith)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023331xex311.htm">Exhibit 31.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="hr-2023331xex311.htm">Certification of the Chief Executive Officer of Healthcare Realty Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023331xex32.htm">Exhibit&#160;31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="hr-2023331xex312.htm">Certification of the Chief Financial Officer of Healthcare Realty Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023331xex32.htm">Exhibit&#160;32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:underline" href="hr-2023331xex32.htm">Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Schema Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Calculation Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Labels Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Definition Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.PRE</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Presentation Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1&#160;&#160;&#160;&#160;Filed as an exhibit to Legacy HTA's (File No. 001-35568) Form 8-K filed with the SEC on March 11, 2014 and hereby incorporated by reference.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2&#160;&#160;&#160;&#160;Filed as an exhibit to Legacy HTA's (File No. 001-35568) Form 8-K filed with the SEC on December 16, 2014 and hereby incorporated by         reference.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3&#160;&#160;&#160;&#160;Filed as an exhibit to the Company's (File No. 001-35568) Form 8-K filed with the SEC on July 26, 2022 and hereby incorporated by reference.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4&#160;&#160;&#160;&#160;Filed as an exhibit to Legacy HTA's (File No. 001-35568) Form 8-K filed with the SEC on July 14, 2017 and hereby incorporated by reference.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5&#160;&#160;&#160;&#160;Filed as an exhibit to Legacy HTA's (File No. 001-35568) Form 8-K filed with the SEC on April 29, 2020 and hereby incorporated by reference.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i7ef30c9bd2924f189bb8c35e1049bb40_118"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7ef30c9bd2924f189bb8c35e1049bb40_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.427%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">HEALTHCARE REALTY TRUST INCORPORATED</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">/s/ J. CHRISTOPHER DOUGLAS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">J. Christopher Douglas</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22.1
<SEQUENCE>2
<FILENAME>hr-2023331xex221.htm
<DESCRIPTION>EX-22.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9a08ebf6c0eb40d1a5889c4767106e03_33"></div><div style="min-height:72pt;width:100%"><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 22.1</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">LIST OF SUBSIDIARY ISSUERS OF GUARANTEED SECURITIES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">As of March 31, 2023, Healthcare Realty Trust Incorporated is the guarantor of the outstanding debt securities of its subsidiaries, as listed below.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Debt Instrument</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Issuer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.88% Senior Notes due 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.50% Senior Notes due 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.75% Senior Notes due 2027</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.63% Senior Notes due 2028</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.10% Senior Notes due 2030</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.40% Senior Notes due 2030</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.05% Senior Notes due 2031</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.00% Senior Notes due 2031</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>hr-2023331xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib80b3785f4454a77b32b0e3041c18178_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Todd J. Meredith, certify that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; TODD J. MEREDITH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd J. Meredith</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>hr-2023331xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifebac0a4b7f24e02bf55e8cc47d9a26b_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, J. Christopher Douglas, certify that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; J. CHRISTOPHER DOUGLAS</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Christopher Douglas</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>hr-2023331xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1bc62d1f9c13473eb577c6be39da6fad_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 SECTION 906</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18 U.S.C. Section&#160;1350,</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">as Adopted Pursuant to</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Quarterly Report of Healthcare Realty Trust Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Todd J. Meredith, President and Chief Executive Officer of the Company, and I, J. Christopher Douglas, Executive Vice President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; TODD J. MEREDITH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd J. Meredith</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. CHRISTOPHER DOUGLAS</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Christopher Douglas</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hr-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:388a749e-3c99-4328-89c5-127682212508,g:16eafbb3-991c-406c-96b0-65d8e7977cec-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hr="http://healthcarerealty.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthcarerealty.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://healthcarerealty.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEquity" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEquityParenthetical" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityParenthetical">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTA" roleURI="http://healthcarerealty.com/role/MergerwithHTA">
        <link:definition>0000010 - Disclosure - Merger with HTA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestments" roleURI="http://healthcarerealty.com/role/RealEstateInvestments">
        <link:definition>0000011 - Disclosure - Real Estate Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://healthcarerealty.com/role/Leases">
        <link:definition>0000012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilities" roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilities">
        <link:definition>0000013 - Disclosure - Other Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayable" roleURI="http://healthcarerealty.com/role/NotesandBondsPayable">
        <link:definition>0000014 - Disclosure - Notes and Bonds Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstruments">
        <link:definition>0000015 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://healthcarerealty.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://healthcarerealty.com/role/StockholdersEquity">
        <link:definition>0000017 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstruments">
        <link:definition>0000018 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000020 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTATables" roleURI="http://healthcarerealty.com/role/MergerwithHTATables">
        <link:definition>0000021 - Disclosure - Merger with HTA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsTables" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsTables">
        <link:definition>0000022 - Disclosure - Real Estate Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://healthcarerealty.com/role/LeasesTables">
        <link:definition>0000023 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesTables" roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables">
        <link:definition>0000024 - Disclosure - Other Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableTables" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableTables">
        <link:definition>0000025 - Disclosure - Notes and Bonds Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>0000026 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://healthcarerealty.com/role/StockholdersEquityTables">
        <link:definition>0000027 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>0000028 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>0000029 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails">
        <link:definition>0000030 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails">
        <link:definition>0000031 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails">
        <link:definition>0000032 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails">
        <link:definition>0000033 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>0000034 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTANarrativeDetails" roleURI="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails">
        <link:definition>0000035 - Disclosure - Merger with HTA - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTADetails" roleURI="http://healthcarerealty.com/role/MergerwithHTADetails">
        <link:definition>0000036 - Disclosure - Merger with HTA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>0000037 - Disclosure - Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsAcquisitionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails">
        <link:definition>0000038 - Disclosure - Real Estate Investments - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails">
        <link:definition>0000039 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsDispositionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails">
        <link:definition>0000040 - Disclosure - Real Estate Investments - Dispositions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsAssetsHeldforSaleDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails">
        <link:definition>0000041 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseIncomeDetails" roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails">
        <link:definition>0000042 - Disclosure - Leases - Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLessorAccountingDetails" roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails">
        <link:definition>0000043 - Disclosure - Leases - Lessor Accounting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesGroundLeasesDetails" roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails">
        <link:definition>0000044 - Disclosure - Leases - Ground Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails" roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails">
        <link:definition>0000045 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails_1" roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>0000045 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails">
        <link:definition>0000046 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherAssetsDetails" roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails">
        <link:definition>0000047 - Disclosure - Other Assets and Liabilities - Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails" roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>0000048 - Disclosure - Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherLiabilitiesDetails" roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails">
        <link:definition>0000049 - Disclosure - Other Assets and Liabilities - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableDetails" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails">
        <link:definition>0000050 - Disclosure - Notes and Bonds Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails">
        <link:definition>0000051 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails">
        <link:definition>0000052 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails">
        <link:definition>0000053 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>0000054 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesNarrativeDetails" roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails">
        <link:definition>0000055 - Disclosure - Commitment and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails">
        <link:definition>0000056 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockTransactionsNarrativeDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails">
        <link:definition>0000057 - Disclosure - Stockholders' Equity (Stock Transactions - Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails">
        <link:definition>0000058 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails">
        <link:definition>0000059 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails">
        <link:definition>0000060 - Disclosure - Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails">
        <link:definition>0000061 - Disclosure - Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails">
        <link:definition>0000062 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsDetails" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails">
        <link:definition>0000063 - Disclosure - Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hr_InterestIncomeFinancingReceivableNoncash" abstract="false" name="InterestIncomeFinancingReceivableNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CumulativeDividendsMember" abstract="true" name="CumulativeDividendsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="hr_AboveMarketLeaseIntangibleAssetsNet" abstract="false" name="AboveMarketLeaseIntangibleAssetsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_HealthcareTrustofAmericaHoldingsLPMember" abstract="true" name="HealthcareTrustofAmericaHoldingsLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NotesReceivableFairValueDiscount" abstract="false" name="NotesReceivableFairValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LimitedLiabilityCompanyOneMember" abstract="true" name="LimitedLiabilityCompanyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ExecutiveIncentiveProgramMember" abstract="true" name="ExecutiveIncentiveProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_FinanceLeasePrincipalOnlyPayments" abstract="false" name="FinanceLeasePrincipalOnlyPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoanDue2023Member" abstract="true" name="TermLoanDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NumberOfPropertyDispositions" abstract="false" name="NumberOfPropertyDispositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_ReceivablesAndOtherAssets" abstract="false" name="ReceivablesAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ConstructionActivityTotalFundingToDate" abstract="false" name="ConstructionActivityTotalFundingToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfRecognizedLeaseFinancialReceivables" abstract="false" name="NumberOfRecognizedLeaseFinancialReceivables" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_RealEstateNotesReceivableNet" abstract="false" name="RealEstateNotesReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJanuary152024Member" abstract="true" name="InterestRateSwapExpiringJanuary152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InterestRateSwaps20172018And2019Member" abstract="true" name="InterestRateSwaps20172018And2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfBuildingsOwnedByJointVenture" abstract="false" name="NumberOfBuildingsOwnedByJointVenture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" abstract="false" name="BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwaps2017And2018Member" abstract="true" name="InterestRateSwaps2017And2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_HealthCareRealtyTrustIncorporatedMember" abstract="true" name="HealthCareRealtyTrustIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MedicalOfficeBuildingMember" abstract="true" name="MedicalOfficeBuildingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NumberofGroundLeasesPrepaid" abstract="false" name="NumberofGroundLeasesPrepaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_ScheduleOfRealEstateDispositionsTable" abstract="true" name="ScheduleOfRealEstateDispositionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="hr_SeniorNotesdue2030Member" abstract="true" name="SeniorNotesdue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ActiveInterestRateSwapsMember" abstract="true" name="ActiveInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LeaseIntangibles" abstract="false" name="LeaseIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DirectorsMember" abstract="true" name="DirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_StraightlineRentLiability" abstract="false" name="StraightlineRentLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageNotesPayableNetMember" abstract="true" name="MortgageNotesPayableNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InvestmentInRealEstatePropertiesAndMortgageNotes" abstract="false" name="InvestmentInRealEstatePropertiesAndMortgageNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SeniorNotesDue2026Member" abstract="true" name="SeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstateInvestmentNetDisposedOfDuringPeriod" abstract="false" name="RealEstateInvestmentNetDisposedOfDuringPeriod" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageNote" abstract="false" name="MortgageNote" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfLandParcelsClassifiedAsHeldForSale" abstract="false" name="NumberOfLandParcelsClassifiedAsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_SeniorNotesdue2028Member" abstract="true" name="SeniorNotesdue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_TermLoanDue2028Member" abstract="true" name="TermLoanDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MezzanineLoansTexasMember" abstract="true" name="MezzanineLoansTexasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" abstract="false" name="ImpairmentChargeOnRealEstateAssetsHeldForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PercentageOfRestrictedStockUnits" abstract="false" name="PercentageOfRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hr_NotesReceivableCarryingAmount" abstract="false" name="NotesReceivableCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" abstract="false" name="ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hr_BusinessCombinationRefundOfTransferTaxesPaid" abstract="false" name="BusinessCombinationRefundOfTransferTaxesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" abstract="true" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" abstract="false" name="BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CumulativeNetIncomeMember" abstract="true" name="CumulativeNetIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" abstract="false" name="RealEstateInvestmentsPropertyOwnedInNumberOfStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJune12026Member" abstract="true" name="InterestRateSwapExpiringJune12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MarketCondition1Member" abstract="true" name="MarketCondition1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_PropertyEntitiesNotDeterminedToBeVIEsMember" abstract="true" name="PropertyEntitiesNotDeterminedToBeVIEsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_TampaFLMiamiFLMember" abstract="true" name="TampaFLMiamiFLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NonVestedStockAwardMember" abstract="true" name="NonVestedStockAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" abstract="true" name="SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_ApproximateSquareFeetInvestedInByCompany" abstract="false" name="ApproximateSquareFeetInvestedInByCompany" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="hr_CommonStockFractionalShares" abstract="false" name="CommonStockFractionalShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ParkingIncomeMember" abstract="true" name="ParkingIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_StraightLineRentReceivable" abstract="false" name="StraightLineRentReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJune12027Member" abstract="true" name="InterestRateSwapExpiringJune12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_FinancingReceivableAllowanceForCreditLossReserves" abstract="false" name="FinancingReceivableAllowanceForCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_HealthCareRealtyTrustIncMember" abstract="true" name="HealthCareRealtyTrustIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_TermLoanDue2027Member" abstract="true" name="TermLoanDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_StockIssuanceProgramDomain" abstract="true" name="StockIssuanceProgramDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_DerivativeNetAssetPositionAggregateFairValue" abstract="false" name="DerivativeNetAssetPositionAggregateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageLoanCaliforniaMember" abstract="true" name="MortgageLoanCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SeniorNotesDue2031Member" abstract="true" name="SeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_OperatingPartnershipPerformanceUnitsMember" abstract="true" name="OperatingPartnershipPerformanceUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_HealthcareTrustOfAmericaIncMember" abstract="true" name="HealthcareTrustOfAmericaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CumulativeNetIncomeAttributableToCommonStockholders" abstract="false" name="CumulativeNetIncomeAttributableToCommonStockholders" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MarketCondition2Member" abstract="true" name="MarketCondition2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SettledInterestRateSwapsMember" abstract="true" name="SettledInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" abstract="false" name="NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PerformanceConditionsMember" abstract="true" name="PerformanceConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" abstract="false" name="BusinessAcquisitionPurchasePriceAllocationSquareFootage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateDispositionsLineItems" abstract="true" name="RealEstateDispositionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hr_OperatingExpensesandCostofGoodsSold" abstract="false" name="OperatingExpensesandCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageLoanMember" abstract="true" name="MortgageLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MortgageLoanTexasMember" abstract="true" name="MortgageLoanTexasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" abstract="true" name="SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SeniorNotesdue2025Member" abstract="true" name="SeniorNotesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ConstructionActivityTotalFundingDuringthePeriod" abstract="false" name="ConstructionActivityTotalFundingDuringthePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" abstract="false" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" abstract="false" name="ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateOther" abstract="false" name="RealEstateOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringDecember12027Member" abstract="true" name="InterestRateSwapExpiringDecember12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringMay12026Member" abstract="true" name="InterestRateSwapExpiringMay12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ReverseRecapitalizationNet" abstract="false" name="ReverseRecapitalizationNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AccountsPayableAndCapitalExpendituresCurrent" abstract="false" name="AccountsPayableAndCapitalExpendituresCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NotesReceivableInterestRate" abstract="false" name="NotesReceivableInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hr_NumberOfRealEstateInvestments" abstract="false" name="NumberOfRealEstateInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_TermLoandue2026Member" abstract="true" name="TermLoandue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NonControllingInterestHoldersMember" abstract="true" name="NonControllingInterestHoldersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_StockIncentivePlanMember" abstract="true" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstatePropertiesHeldInJointVenturesMember" abstract="true" name="RealEstatePropertiesHeldInJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ApproximateSquareFeetProvidedByCompany" abstract="false" name="ApproximateSquareFeetProvidedByCompany" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="hr_AmortizationofPrepaidRent" abstract="false" name="AmortizationofPrepaidRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AccruedPropertyTaxes" abstract="false" name="AccruedPropertyTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DispositionSalesPrice" abstract="false" name="DispositionSalesPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" abstract="false" name="AssetsHeldForSaleAndDiscontinuedOperationsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_JointVentureCarryingAmount" abstract="false" name="JointVentureCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_GroundLeaseModificationNet" abstract="false" name="GroundLeaseModificationNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CommonStockSharesWithheld" abstract="false" name="CommonStockSharesWithheld" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_RecapitalizationExchangeRatio" abstract="false" name="RecapitalizationExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hr_ClosingAdjustmentsDisposedEntity" abstract="false" name="ClosingAdjustmentsDisposedEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" abstract="false" name="LessorOperatingLeasePaymenttobeReceivedafterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DebtInstrumentExtensionPeriodForMaturityDate" abstract="false" name="DebtInstrumentExtensionPeriodForMaturityDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PersonalProperty" abstract="false" name="PersonalProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_AssetDispositionsTableTextBlock" abstract="false" name="AssetDispositionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hr_GrossContractualRealEstateNotesReceivableFairValue" abstract="false" name="GrossContractualRealEstateNotesReceivableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateDispositionsMember" abstract="true" name="RealEstateDispositionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SquareFeetSubjecttoGroundLeases" abstract="false" name="SquareFeetSubjecttoGroundLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringDecember12026Member" abstract="true" name="InterestRateSwapExpiringDecember12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" abstract="true" name="RealEstateDispositionsAndMortgageNoteRepaymentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_StockIssuanceProgramAxis" abstract="true" name="StockIssuanceProgramAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_EquityMethodInvestmentsRollForward" abstract="true" name="EquityMethodInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_NumberOfRealEstateNotesReceivable" abstract="false" name="NumberOfRealEstateNotesReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessOverviewAbstract" abstract="true" name="BusinessOverviewAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_STLouisMoMember" abstract="true" name="STLouisMoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NumberOfNotesReceivable" abstract="false" name="NumberOfNotesReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_NotesReceivableMaximumLoanCommitment" abstract="false" name="NotesReceivableMaximumLoanCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoandue2024Member" abstract="true" name="TermLoandue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_EquityOwnershipForConsolidationPercent" abstract="false" name="EquityOwnershipForConsolidationPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_MergerRelatedCosts" abstract="false" name="MergerRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NatureOfOperationsPolicyTextBlock" abstract="false" name="NatureOfOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hr_JointVentureOwnershipPercentage" abstract="false" name="JointVentureOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hr_TermLoanDue2025Member" abstract="true" name="TermLoanDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NumberOfPropertiesClassifiedAsHeldForSale" abstract="false" name="NumberOfPropertiesClassifiedAsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AcquisitionsAndDispositionsTextBlock" abstract="false" name="AcquisitionsAndDispositionsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hr_MortgageLoanNorthCarolinaMember" abstract="true" name="MortgageLoanNorthCarolinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" abstract="false" name="GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_FiniteLivedCustomerRelationshipsNet" abstract="false" name="FiniteLivedCustomerRelationshipsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TampaFLMember" abstract="true" name="TampaFLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_FinanceMortgageNotes" abstract="false" name="FinanceMortgageNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_VariableInterestEntityMember" abstract="true" name="VariableInterestEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" abstract="false" name="AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="hr_NumberOfJointVentures" abstract="false" name="NumberOfJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_LosAngelesCaliforniaMember" abstract="true" name="LosAngelesCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_NumberofGroundLeasesExcludingPrepaidLeases" abstract="false" name="NumberofGroundLeasesExcludingPrepaidLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_UnsecuredCreditFacilityOneMember" abstract="true" name="UnsecuredCreditFacilityOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MiscellaneousMember" abstract="true" name="MiscellaneousMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfVariableInterestEntities" abstract="false" name="NumberOfVariableInterestEntities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_HoustonTexasMember" abstract="true" name="HoustonTexasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DallasTXMember" abstract="true" name="DallasTXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MortgageLoanFloridaMember" abstract="true" name="MortgageLoanFloridaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" abstract="true" name="ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_SeniorNotesDue2027Member" abstract="true" name="SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ManagementFeeIncomeMember" abstract="true" name="ManagementFeeIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_EquityOfferingProgramAvailableForIssuance" abstract="false" name="EquityOfferingProgramAvailableForIssuance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" abstract="true" name="RealEstateDispositionsAndMortgageNoteRepaymentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hr-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:388a749e-3c99-4328-89c5-127682212508,g:16eafbb3-991c-406c-96b0-65d8e7977cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_aa61ec3a-4e26-4370-a241-f6f1ad90680f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_5db60ace-4a83-498f-bfa1-20dec66bf5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_aa61ec3a-4e26-4370-a241-f6f1ad90680f" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_5db60ace-4a83-498f-bfa1-20dec66bf5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_bf60649b-00dd-444c-9a9d-a9b49f0e461a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_aa61ec3a-4e26-4370-a241-f6f1ad90680f" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_bf60649b-00dd-444c-9a9d-a9b49f0e461a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef7ba2c2-75fe-409f-8be9-a049b784915c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b2fb3556-2ab3-428f-9b41-95781b0a2d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef7ba2c2-75fe-409f-8be9-a049b784915c" xlink:to="loc_us-gaap_Liabilities_b2fb3556-2ab3-428f-9b41-95781b0a2d84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_33400add-9d49-4131-94f4-5e92d6938491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef7ba2c2-75fe-409f-8be9-a049b784915c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_33400add-9d49-4131-94f4-5e92d6938491" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d7e0d59b-4649-44af-bcbe-fd4a58e8de76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef7ba2c2-75fe-409f-8be9-a049b784915c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d7e0d59b-4649-44af-bcbe-fd4a58e8de76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_734617f9-be01-4d57-99ed-9092a62eb104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ef7ba2c2-75fe-409f-8be9-a049b784915c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_734617f9-be01-4d57-99ed-9092a62eb104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_0a2d3246-26d8-4bf3-aebf-4d48fe1476f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_Land_0a2d3246-26d8-4bf3-aebf-4d48fe1476f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_7c0ad974-ff73-4f09-8d90-d2e0b9621898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_7c0ad974-ff73-4f09-8d90-d2e0b9621898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_851a74a7-d7a6-4f8c-b8ad-0edfb3410532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_851a74a7-d7a6-4f8c-b8ad-0edfb3410532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty_0dae0b79-6fde-46e8-a132-39e935d71a85" xlink:href="hr-20230331.xsd#hr_PersonalProperty"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_hr_PersonalProperty_0dae0b79-6fde-46e8-a132-39e935d71a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_fb1ed190-b18c-42bd-b44a-6f91f5eb6ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_NotesReceivableNet_fb1ed190-b18c-42bd-b44a-6f91f5eb6ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_c8ad8e36-4ba4-42d9-ba3d-1bae8d2f050e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_c8ad8e36-4ba4-42d9-ba3d-1bae8d2f050e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_9774cce8-dbbb-4dba-9af2-74e16e53a4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_DevelopmentInProcess_9774cce8-dbbb-4dba-9af2-74e16e53a4b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_1dd27b43-ad71-4c3f-888c-0613032594f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_41736400-b24e-4451-9a40-ff93ab0d669d" xlink:to="loc_us-gaap_LandAvailableForDevelopment_1dd27b43-ad71-4c3f-888c-0613032594f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ec07754-f071-4d9e-8076-6cabe72bd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_42d9c975-43dc-4cd6-8ea0-5bc41040a9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ec07754-f071-4d9e-8076-6cabe72bd0ad" xlink:to="loc_us-gaap_StockholdersEquity_42d9c975-43dc-4cd6-8ea0-5bc41040a9c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4fade6df-00cc-4c00-a76c-9a6b4107856e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ec07754-f071-4d9e-8076-6cabe72bd0ad" xlink:to="loc_us-gaap_MinorityInterest_4fade6df-00cc-4c00-a76c-9a6b4107856e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6be90574-1c28-4382-b6ce-1db5342a35be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:to="loc_us-gaap_LongTermDebt_6be90574-1c28-4382-b6ce-1db5342a35be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_3bf19f1d-d4b8-47fc-a155-faf4956679cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_3bf19f1d-d4b8-47fc-a155-faf4956679cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3aa47f5b-c079-468c-a553-d0f82ba10f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3aa47f5b-c079-468c-a553-d0f82ba10f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2cbe39c6-b8c1-4923-828f-7cec4689de7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:to="loc_us-gaap_OperatingLeaseLiability_2cbe39c6-b8c1-4923-828f-7cec4689de7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_499a9063-a53f-4b87-bcb5-644c52d58c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:to="loc_us-gaap_FinanceLeaseLiability_499a9063-a53f-4b87-bcb5-644c52d58c1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_2a380c94-6884-4cbd-a478-9766cfbb4ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e7263d95-9c7a-44d0-b199-43c3ad577488" xlink:to="loc_us-gaap_OtherLiabilities_2a380c94-6884-4cbd-a478-9766cfbb4ca2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_269dc399-f630-4718-9519-d63fcd85ef29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_269dc399-f630-4718-9519-d63fcd85ef29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01e4370f-bd1c-4091-9214-a9724173a181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01e4370f-bd1c-4091-9214-a9724173a181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_4fd7f558-4a23-4ad2-88c3-7cb1037fa76b" xlink:href="hr-20230331.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_4fd7f558-4a23-4ad2-88c3-7cb1037fa76b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7db1b3f9-074a-44f3-b710-bdbc349d5d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7db1b3f9-074a-44f3-b710-bdbc349d5d25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e87b8d30-1ece-4c5d-9268-e564eff59853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e87b8d30-1ece-4c5d-9268-e564eff59853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b9072aac-9628-4429-a02d-2d24a799942e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_us-gaap_Goodwill_b9072aac-9628-4429-a02d-2d24a799942e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_5ef2ab0c-1f78-4901-9d20-d0fe5c4e8819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f3ea842-af2f-4af4-a7ec-6ee35e19104d" xlink:to="loc_us-gaap_OtherAssets_5ef2ab0c-1f78-4901-9d20-d0fe5c4e8819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends_b20d0947-21db-4a8b-963d-78f11182a6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:to="loc_us-gaap_CumulativeDividends_b20d0947-21db-4a8b-963d-78f11182a6d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_6387b8cd-1f1e-477c-90a4-bde8f2a2cb9a" xlink:href="hr-20230331.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:to="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_6387b8cd-1f1e-477c-90a4-bde8f2a2cb9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3cfdbc9e-e8dc-4906-9fb8-cdadbd7b4229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3cfdbc9e-e8dc-4906-9fb8-cdadbd7b4229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7c130a5b-717d-469e-afb3-62a5f6c8ac5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7c130a5b-717d-469e-afb3-62a5f6c8ac5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_551399e2-afcb-4a2f-a2ea-33841f7c8630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:to="loc_us-gaap_CommonStockValue_551399e2-afcb-4a2f-a2ea-33841f7c8630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fafccbd5-78b2-44a8-9478-94c033c8fc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d5471740-755f-4765-9331-9998e03459d2" xlink:to="loc_us-gaap_PreferredStockValue_fafccbd5-78b2-44a8-9478-94c033c8fc22" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_540515cb-7049-4210-a91a-ca05902efe16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b2e14fb-bbb2-4de1-9d9b-62299a577f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_540515cb-7049-4210-a91a-ca05902efe16" xlink:to="loc_us-gaap_Revenues_3b2e14fb-bbb2-4de1-9d9b-62299a577f3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_431f2b89-a380-4719-9084-14fca7d7611e" xlink:href="hr-20230331.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_540515cb-7049-4210-a91a-ca05902efe16" xlink:to="loc_hr_OperatingExpensesandCostofGoodsSold_431f2b89-a380-4719-9084-14fca7d7611e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ec064f99-4848-4ffd-96ad-0aa770d21a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_540515cb-7049-4210-a91a-ca05902efe16" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ec064f99-4848-4ffd-96ad-0aa770d21a87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2da2a570-f0fb-404e-8523-a93e3f6dbf75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c3d4e486-699a-4728-8883-7b499f43f374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2da2a570-f0fb-404e-8523-a93e3f6dbf75" xlink:to="loc_us-gaap_ProfitLoss_c3d4e486-699a-4728-8883-7b499f43f374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5d0b8d7c-a2de-4e52-9f4c-6e75cee05e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2da2a570-f0fb-404e-8523-a93e3f6dbf75" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5d0b8d7c-a2de-4e52-9f4c-6e75cee05e8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_13d50d79-e004-4a88-934b-10dfc20fb5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_13d50d79-e004-4a88-934b-10dfc20fb5a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8c1a88cd-d40a-414c-befe-111ed05f2e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:to="loc_us-gaap_InterestExpense_8c1a88cd-d40a-414c-befe-111ed05f2e43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6bd045ff-07ea-4e35-87c2-1be699e2b94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6bd045ff-07ea-4e35-87c2-1be699e2b94b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_e185f217-f5bc-42cc-9da0-f0f43ed59f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_e185f217-f5bc-42cc-9da0-f0f43ed59f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0642b548-e495-4ff9-a2c0-3c6828154af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0642b548-e495-4ff9-a2c0-3c6828154af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4d16cbfd-b829-4c10-b46a-40a5c5f86395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_75fa604e-c273-4c4f-85dc-d44ad9bac03b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4d16cbfd-b829-4c10-b46a-40a5c5f86395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b95ac050-2740-4399-9f86-0ad226065ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_6acd1bf3-c652-4b37-83f4-e44c8657dda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_b95ac050-2740-4399-9f86-0ad226065ad1" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_6acd1bf3-c652-4b37-83f4-e44c8657dda1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_a2f2b204-3d18-4d29-b1ff-9a3074043bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_b95ac050-2740-4399-9f86-0ad226065ad1" xlink:to="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_a2f2b204-3d18-4d29-b1ff-9a3074043bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3aab879f-bbf7-4131-8bb1-b645127b29ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_b95ac050-2740-4399-9f86-0ad226065ad1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3aab879f-bbf7-4131-8bb1-b645127b29ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_da76e2b8-9213-4470-be67-9cbb7df3fee5" xlink:href="hr-20230331.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_9d3773e7-1337-4aa1-bc1f-a3aecf8d1381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_da76e2b8-9213-4470-be67-9cbb7df3fee5" xlink:to="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_9d3773e7-1337-4aa1-bc1f-a3aecf8d1381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1923c928-386c-416f-8e64-bc0a7315b91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_da76e2b8-9213-4470-be67-9cbb7df3fee5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1923c928-386c-416f-8e64-bc0a7315b91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_89a0db36-916b-4c8c-ad35-83d5b574f85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_da76e2b8-9213-4470-be67-9cbb7df3fee5" xlink:to="loc_us-gaap_AcquisitionCosts_89a0db36-916b-4c8c-ad35-83d5b574f85d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_7276dca3-17d3-4d8d-9769-06e671681ff8" xlink:href="hr-20230331.xsd#hr_MergerRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_da76e2b8-9213-4470-be67-9cbb7df3fee5" xlink:to="loc_hr_MergerRelatedCosts_7276dca3-17d3-4d8d-9769-06e671681ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7ad9f245-893c-4d7f-92a9-4d3b76607b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_da76e2b8-9213-4470-be67-9cbb7df3fee5" xlink:to="loc_us-gaap_DepreciationAndAmortization_7ad9f245-893c-4d7f-92a9-4d3b76607b7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f9955c04-1213-4e9f-b99d-bbe9c0f5ad79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_457ce6d0-105e-48ca-9a46-5bec8822e1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f9955c04-1213-4e9f-b99d-bbe9c0f5ad79" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_457ce6d0-105e-48ca-9a46-5bec8822e1c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_440e99ba-b710-4ad6-b15b-1735829748a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f9955c04-1213-4e9f-b99d-bbe9c0f5ad79" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_440e99ba-b710-4ad6-b15b-1735829748a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_51c7df8c-7389-449c-ab73-c04c8b57265f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_75fdd2d4-ba3f-466c-9ac2-6fb3e6728606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_51c7df8c-7389-449c-ab73-c04c8b57265f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_75fdd2d4-ba3f-466c-9ac2-6fb3e6728606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ecada7c4-fb2f-4f2b-9187-539d6899f796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_51c7df8c-7389-449c-ab73-c04c8b57265f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ecada7c4-fb2f-4f2b-9187-539d6899f796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_143c0bff-9d71-4722-aa6e-7cc1a2af6896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cf94676e-ac1b-41c5-a4a1-0460645eb134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_143c0bff-9d71-4722-aa6e-7cc1a2af6896" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cf94676e-ac1b-41c5-a4a1-0460645eb134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_248864c0-fd7a-4f99-8c21-fe915d3e9a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_143c0bff-9d71-4722-aa6e-7cc1a2af6896" xlink:to="loc_us-gaap_ProfitLoss_248864c0-fd7a-4f99-8c21-fe915d3e9a48" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_f77f0b8f-575d-4366-b3f4-c7f5e8ef7092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_f77f0b8f-575d-4366-b3f4-c7f5e8ef7092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_466f43ab-82b4-43b8-8452-c17e15e73c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_466f43ab-82b4-43b8-8452-c17e15e73c38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_b317d485-bc0b-463c-a8ce-7bd53f30e893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_b317d485-bc0b-463c-a8ce-7bd53f30e893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_771fb260-06f0-438e-9389-d1f9171c5dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_771fb260-06f0-438e-9389-d1f9171c5dd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_fddb608d-f6b6-4c10-8e9e-8f7c40bcab5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_fddb608d-f6b6-4c10-8e9e-8f7c40bcab5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_e94e1c0f-252f-4407-ae49-c8c3d243b591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_e94e1c0f-252f-4407-ae49-c8c3d243b591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_176e1d63-e380-4fdd-8612-8f5f92f1e2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_176e1d63-e380-4fdd-8612-8f5f92f1e2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_55539b72-40fa-4beb-ad28-695d58e6a40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_55539b72-40fa-4beb-ad28-695d58e6a40a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_467ec6b4-c54c-4650-ac75-c91b01dc3527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_036f546f-b14c-46a3-8c55-d7ce53d7ddb9" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_467ec6b4-c54c-4650-ac75-c91b01dc3527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d17bb568-0009-4a45-be8d-fccea167db00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_ProfitLoss_d17bb568-0009-4a45-be8d-fccea167db00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b5a6f657-ead7-461d-b748-e9d8090206b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b5a6f657-ead7-461d-b748-e9d8090206b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_966bbe43-3596-47aa-993d-c364c6ffb215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_966bbe43-3596-47aa-993d-c364c6ffb215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2d7c59be-dcd6-474d-81a6-65e681f1394c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_ShareBasedCompensation_2d7c59be-dcd6-474d-81a6-65e681f1394c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable_7dbd19ba-8c1a-4615-9ad7-b90ce88eda3a" xlink:href="hr-20230331.xsd#hr_StraightLineRentReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_hr_StraightLineRentReceivable_7dbd19ba-8c1a-4615-9ad7-b90ce88eda3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability_c6e8f0a5-40c7-4529-89f6-364236756ebc" xlink:href="hr-20230331.xsd#hr_StraightlineRentLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_hr_StraightlineRentLiability_c6e8f0a5-40c7-4529-89f6-364236756ebc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_ba304c08-b36e-4466-9329-ed973b705483" xlink:href="hr-20230331.xsd#hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_ba304c08-b36e-4466-9329-ed973b705483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_543ffcfc-a9c7-4082-9089-23ec8a277d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_543ffcfc-a9c7-4082-9089-23ec8a277d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_f4615ba8-9375-463d-a94c-692fc893602f" xlink:href="hr-20230331.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_f4615ba8-9375-463d-a94c-692fc893602f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7e725c31-3691-4615-b6f8-31450214f42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7e725c31-3691-4615-b6f8-31450214f42e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_3ee72bab-30e7-4512-a236-5137355ee4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_3ee72bab-30e7-4512-a236-5137355ee4a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash_4fe800aa-93dd-433f-bb7f-e4b46dc02b6b" xlink:href="hr-20230331.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_hr_InterestIncomeFinancingReceivableNoncash_4fe800aa-93dd-433f-bb7f-e4b46dc02b6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_778ea4d7-5f76-4c46-96c5-6b81ee6e13fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_778ea4d7-5f76-4c46-96c5-6b81ee6e13fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b719c442-f30f-4acd-9560-04d3797b4bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b719c442-f30f-4acd-9560-04d3797b4bf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_53e958f6-d52d-4971-89fb-837a9914eaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c513f0db-d414-4d17-935c-b2114614d291" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_53e958f6-d52d-4971-89fb-837a9914eaf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_daf1bfe4-f557-4daa-848d-714920c0921f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_daf1bfe4-f557-4daa-848d-714920c0921f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_fc153887-07d1-47b5-9568-6f0e92c7a489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_RepaymentsOfDebt_fc153887-07d1-47b5-9568-6f0e92c7a489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_6620c1a1-8da0-4964-8a4d-6bdfd16aea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_6620c1a1-8da0-4964-8a4d-6bdfd16aea6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_322ca226-64e2-473f-ba3c-460dc3939d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_322ca226-64e2-473f-ba3c-460dc3939d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_39fde145-d144-4c6f-a997-c0d0868c8ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_39fde145-d144-4c6f-a997-c0d0868c8ce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_423e726d-12cd-4537-968d-91a133b6d2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_423e726d-12cd-4537-968d-91a133b6d2cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_482e693a-fff7-4b61-8f22-4f0b73e9d861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_482e693a-fff7-4b61-8f22-4f0b73e9d861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_caa3cd85-3f72-442b-ac79-51ff882ccbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a21707b-0317-420a-8a1b-06dacc27c589" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_caa3cd85-3f72-442b-ac79-51ff882ccbc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d132720d-4306-496a-b74c-841118b168d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cb46597-7cd0-4926-a59e-029306ce0af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d132720d-4306-496a-b74c-841118b168d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cb46597-7cd0-4926-a59e-029306ce0af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d32ed55c-eeb1-4edb-893f-c1baad27a7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d132720d-4306-496a-b74c-841118b168d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d32ed55c-eeb1-4edb-893f-c1baad27a7e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95b253a9-0329-460f-8c68-3eb82f596b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d132720d-4306-496a-b74c-841118b168d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95b253a9-0329-460f-8c68-3eb82f596b01" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12ac1a36-02f0-4ce0-b04b-3d55311d496f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_d93a1c7b-2482-464d-b5e3-ab6a05132150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12ac1a36-02f0-4ce0-b04b-3d55311d496f" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_d93a1c7b-2482-464d-b5e3-ab6a05132150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_58b1a0c2-5105-4ec3-937c-65d83c687b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12ac1a36-02f0-4ce0-b04b-3d55311d496f" xlink:to="loc_us-gaap_StockholdersEquity_58b1a0c2-5105-4ec3-937c-65d83c687b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_773c40d5-052b-4531-8563-f4d33c1ae4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_1f1a11ea-9cbf-402f-97af-add1943d07b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_773c40d5-052b-4531-8563-f4d33c1ae4a4" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_1f1a11ea-9cbf-402f-97af-add1943d07b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9539d855-2421-4b45-af10-b7ad8c479ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_773c40d5-052b-4531-8563-f4d33c1ae4a4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9539d855-2421-4b45-af10-b7ad8c479ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_ab2a449b-feb3-4a33-8754-9346dbf2f232" xlink:href="hr-20230331.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_773c40d5-052b-4531-8563-f4d33c1ae4a4" xlink:to="loc_hr_ReceivablesAndOtherAssets_ab2a449b-feb3-4a33-8754-9346dbf2f232" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_b87df953-b289-4fc8-8f21-97d879c95e6a" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_b87df953-b289-4fc8-8f21-97d879c95e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_228b57c4-75a8-430e-b701-b2c8a724719a" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_228b57c4-75a8-430e-b701-b2c8a724719a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_ffb5497d-5e06-49c7-a67c-28113984766d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_ffb5497d-5e06-49c7-a67c-28113984766d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_8d969196-89ce-4c83-924e-695406bcf0c7" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_8d969196-89ce-4c83-924e-695406bcf0c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_e06b3149-3bda-48d5-b51f-ecc2955b8c04" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_e06b3149-3bda-48d5-b51f-ecc2955b8c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_547d2f62-54f5-4d5c-9786-383e60a5ed34" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_30eda2a8-52c7-4421-8eac-bf1f0bd95ae3" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_547d2f62-54f5-4d5c-9786-383e60a5ed34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_70e47908-e545-4d3f-ad7e-ac95f07c5df0" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_4036acc1-a147-4146-be0d-d5c3d0006ed7" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_70e47908-e545-4d3f-ad7e-ac95f07c5df0" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_4036acc1-a147-4146-be0d-d5c3d0006ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_09d572c1-0560-42eb-ab90-f6c0c2ba90b0" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_70e47908-e545-4d3f-ad7e-ac95f07c5df0" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_09d572c1-0560-42eb-ab90-f6c0c2ba90b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_cd18241e-04f7-46c7-ab07-5c35e70f6c80" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_70e47908-e545-4d3f-ad7e-ac95f07c5df0" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_cd18241e-04f7-46c7-ab07-5c35e70f6c80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_dd902cb5-57c6-4312-a5e3-21671faa0c52" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_70e47908-e545-4d3f-ad7e-ac95f07c5df0" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_dd902cb5-57c6-4312-a5e3-21671faa0c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_26aff64a-076d-4497-a602-810218d3a9bc" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_70e47908-e545-4d3f-ad7e-ac95f07c5df0" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_26aff64a-076d-4497-a602-810218d3a9bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_b14667fd-1ccc-4e16-b36f-e07bf694fde3" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_b14667fd-1ccc-4e16-b36f-e07bf694fde3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_b454cf13-bb28-4767-b28b-e2132f4a37df" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_b454cf13-bb28-4767-b28b-e2132f4a37df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_724a6ab6-e1ee-4863-9159-d565c60d2426" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_724a6ab6-e1ee-4863-9159-d565c60d2426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_adfd3194-5dec-4084-a348-c910d274cd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_adfd3194-5dec-4084-a348-c910d274cd15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_bc6e4d20-cb71-49d1-90e4-855956437196" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_bc6e4d20-cb71-49d1-90e4-855956437196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_dad7d196-4681-4532-b584-1fe07a1110c5" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_dad7d196-4681-4532-b584-1fe07a1110c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_17f08cef-c353-4641-9cd4-b0f1561c5399" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_49f1d450-8080-4441-83c3-6016b441b975" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_17f08cef-c353-4641-9cd4-b0f1561c5399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_18dc43db-1bb7-45fc-a9df-e2e094976f47" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_875e81f0-6b7b-43b2-b0d8-683a172a22dc" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_18dc43db-1bb7-45fc-a9df-e2e094976f47" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_875e81f0-6b7b-43b2-b0d8-683a172a22dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_6fe91904-2162-4a46-beca-87da23c1360c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_18dc43db-1bb7-45fc-a9df-e2e094976f47" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_6fe91904-2162-4a46-beca-87da23c1360c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_eaff92cd-9347-4511-b38b-d94cdc6eec38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_eaff92cd-9347-4511-b38b-d94cdc6eec38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d6f13c63-3ed3-4431-842f-78974af40390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d6f13c63-3ed3-4431-842f-78974af40390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_d4077438-6f16-4a41-a51b-591e23b36350" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_d4077438-6f16-4a41-a51b-591e23b36350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_257e809a-5ea4-42a3-8821-43d3979f56cd" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_257e809a-5ea4-42a3-8821-43d3979f56cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_daea2cc7-04f5-4330-ba8b-7d47824c90f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_daea2cc7-04f5-4330-ba8b-7d47824c90f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_fce41b79-4e85-4776-8a20-5865cb918d8c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1bbb101f-e715-481a-be0b-3e7822715e56" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_fce41b79-4e85-4776-8a20-5865cb918d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_7cd5ca13-3b15-4006-9293-de8150c62c1a" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_385530ed-8499-40b2-a98b-935777f11bb9" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_7cd5ca13-3b15-4006-9293-de8150c62c1a" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_385530ed-8499-40b2-a98b-935777f11bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_2d4ea942-fda5-476c-b4b5-f7a1419b1a22" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_7cd5ca13-3b15-4006-9293-de8150c62c1a" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_2d4ea942-fda5-476c-b4b5-f7a1419b1a22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_899279d0-0b07-4e43-85a7-48a53bbddce0" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_7cd5ca13-3b15-4006-9293-de8150c62c1a" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_899279d0-0b07-4e43-85a7-48a53bbddce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_96852880-5405-4e9b-b655-379fa0dbc4de" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_7cd5ca13-3b15-4006-9293-de8150c62c1a" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_96852880-5405-4e9b-b655-379fa0dbc4de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_962574db-b701-4a01-92b4-b3f236d80467" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_7cd5ca13-3b15-4006-9293-de8150c62c1a" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_962574db-b701-4a01-92b4-b3f236d80467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1bc7c716-3898-4bae-b959-8c22e800039d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0bc7e8d1-6abf-43a1-b666-a16a294f3f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1bc7c716-3898-4bae-b959-8c22e800039d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0bc7e8d1-6abf-43a1-b666-a16a294f3f50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8ffe4963-e471-4575-9daa-fee0d9bd35a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1bc7c716-3898-4bae-b959-8c22e800039d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8ffe4963-e471-4575-9daa-fee0d9bd35a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_92eff61e-bcdf-4734-b287-5c815dec0780" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_92eff61e-bcdf-4734-b287-5c815dec0780" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_7293922e-a090-453f-9cac-d803849f65a3" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_7293922e-a090-453f-9cac-d803849f65a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_11af3242-51c3-4db9-bc67-323679af1ac1" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_11af3242-51c3-4db9-bc67-323679af1ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_83d54a1a-0813-4b20-90b7-04e4ead7b078" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_83d54a1a-0813-4b20-90b7-04e4ead7b078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_067936d0-b81d-461d-94b0-37995b71985b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_067936d0-b81d-461d-94b0-37995b71985b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_32cfe8a5-6d34-4311-ba9c-c2ae88606761" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_923345d4-eb9a-42dd-a600-6f7c87881ccc" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_32cfe8a5-6d34-4311-ba9c-c2ae88606761" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ed24b2aa-2174-4407-98d0-34e5743f7733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_ca3559e5-0ea7-40e5-b53e-40c44ae1cea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ed24b2aa-2174-4407-98d0-34e5743f7733" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_ca3559e5-0ea7-40e5-b53e-40c44ae1cea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_1095c018-8fe6-441a-a575-f80158d54153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ed24b2aa-2174-4407-98d0-34e5743f7733" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_1095c018-8fe6-441a-a575-f80158d54153" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesLessorAccountingDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_711eea92-d821-4d08-bf9b-adf0b979792e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_711eea92-d821-4d08-bf9b-adf0b979792e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_b75c5fba-d520-46ec-bb41-eb28902cd1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_b75c5fba-d520-46ec-bb41-eb28902cd1f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_3c5fbc22-46a9-4fc4-bf9d-7d69518a9f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_3c5fbc22-46a9-4fc4-bf9d-7d69518a9f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_f6d7b4a3-10b5-431c-b0c6-031bc82b746c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_f6d7b4a3-10b5-431c-b0c6-031bc82b746c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_de521c1c-9d1f-4b9e-b03a-129a116603fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_de521c1c-9d1f-4b9e-b03a-129a116603fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_799d1768-f09b-48c1-9f62-afbe591f7d50" xlink:href="hr-20230331.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bc576dcd-1a09-447b-be17-60d8b6222caa" xlink:to="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_799d1768-f09b-48c1-9f62-afbe591f7d50" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7611387d-f96c-48d2-9ec8-1ad01ca00b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_25c16535-2ecc-44e7-b393-a77b8da039e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7611387d-f96c-48d2-9ec8-1ad01ca00b5c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_25c16535-2ecc-44e7-b393-a77b8da039e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7363b133-531e-4120-b44b-00b8289aef3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7611387d-f96c-48d2-9ec8-1ad01ca00b5c" xlink:to="loc_us-gaap_OperatingLeaseLiability_7363b133-531e-4120-b44b-00b8289aef3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_e5d272e9-c154-42b2-af3f-8fc1eb9bb4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_e5d272e9-c154-42b2-af3f-8fc1eb9bb4f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_03fdb389-fb50-47ef-a77a-4308e8577bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_03fdb389-fb50-47ef-a77a-4308e8577bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b5642396-4662-4230-badc-de150f6a132f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b5642396-4662-4230-badc-de150f6a132f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f0497c10-52ea-4e06-8149-3afaead447e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f0497c10-52ea-4e06-8149-3afaead447e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_21fd49bb-5aba-4443-a4ae-539c308a55a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_21fd49bb-5aba-4443-a4ae-539c308a55a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_b3cdd0f4-daa9-46d6-b5a5-b367a97bb916" xlink:href="hr-20230331.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e67ddb85-7a70-4160-b309-09c628afcffe" xlink:to="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_b3cdd0f4-daa9-46d6-b5a5-b367a97bb916" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_98cc2db6-8e8f-4541-9f17-7a4ce98c8deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_98cc2db6-8e8f-4541-9f17-7a4ce98c8deb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6090aa8c-35df-4fa4-8488-95d58910006e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6090aa8c-35df-4fa4-8488-95d58910006e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_82841787-0e27-45df-86f1-d3d4d93b9103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_82841787-0e27-45df-86f1-d3d4d93b9103" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e11b990e-4f2f-4c8d-8cdb-8bbad1378ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e11b990e-4f2f-4c8d-8cdb-8bbad1378ab2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a15cff80-e07d-44de-9a94-e04443a211f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a15cff80-e07d-44de-9a94-e04443a211f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_44a7c0bd-78b1-4f73-84e2-f69d6c6c1499" xlink:href="hr-20230331.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b4050ec-5abc-4341-8038-4800a517cea9" xlink:to="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_44a7c0bd-78b1-4f73-84e2-f69d6c6c1499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_00c375f5-a10a-4ddd-a72b-81ff4e842d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d249c848-3180-4d79-b8b0-9ea5992c9d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_00c375f5-a10a-4ddd-a72b-81ff4e842d2d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d249c848-3180-4d79-b8b0-9ea5992c9d24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_616fde05-5af2-469f-9c75-c4d6552e74e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_00c375f5-a10a-4ddd-a72b-81ff4e842d2d" xlink:to="loc_us-gaap_FinanceLeaseLiability_616fde05-5af2-469f-9c75-c4d6552e74e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ff8354f7-f877-4574-a4d8-9fdc415ccdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1948dbdf-08a1-4ce2-b870-8158f65adfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ff8354f7-f877-4574-a4d8-9fdc415ccdec" xlink:to="loc_us-gaap_OperatingLeaseCost_1948dbdf-08a1-4ce2-b870-8158f65adfe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_53217df6-e553-4d12-b567-f9156dc1cf91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ff8354f7-f877-4574-a4d8-9fdc415ccdec" xlink:to="loc_us-gaap_VariableLeaseCost_53217df6-e553-4d12-b567-f9156dc1cf91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b30403ca-813f-44bb-86f2-53682c5e4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ff8354f7-f877-4574-a4d8-9fdc415ccdec" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b30403ca-813f-44bb-86f2-53682c5e4bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_85d8dddb-6aec-4a60-a622-9eda3885cdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ff8354f7-f877-4574-a4d8-9fdc415ccdec" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_85d8dddb-6aec-4a60-a622-9eda3885cdf6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AboveMarketLeaseIntangibleAssetsNet_846db1fc-107d-42d5-99a0-937e192d97db" xlink:href="hr-20230331.xsd#hr_AboveMarketLeaseIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_hr_AboveMarketLeaseIntangibleAssetsNet_846db1fc-107d-42d5-99a0-937e192d97db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_b30834c8-0677-4840-90cf-d2cb9ddb1dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_b30834c8-0677-4840-90cf-d2cb9ddb1dcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet_97534b99-fd16-4cf3-9aa8-ffd8ac1a5b52" xlink:href="hr-20230331.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_hr_RealEstateNotesReceivableNet_97534b99-fd16-4cf3-9aa8-ffd8ac1a5b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_ecb8ddfd-a589-4f61-a026-922151ad4b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_ecb8ddfd-a589-4f61-a026-922151ad4b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_c0916266-0a64-42fb-b638-d44c0820c106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_AccountsReceivableNet_c0916266-0a64-42fb-b638-d44c0820c106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_a11baff8-8c25-4294-a107-a19ba11df3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_NoncurrentAssets_a11baff8-8c25-4294-a107-a19ba11df3cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_862e4183-f893-4add-a7b5-bff501809eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_DerivativeAssets_862e4183-f893-4add-a7b5-bff501809eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GroundLeaseModificationNet_67c2b415-71cd-4004-9b5e-e26b3f20b5c2" xlink:href="hr-20230331.xsd#hr_GroundLeaseModificationNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_hr_GroundLeaseModificationNet_67c2b415-71cd-4004-9b5e-e26b3f20b5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_1cd2a5c3-7696-4373-94c0-a294d43ae5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_OtherReceivables_1cd2a5c3-7696-4373-94c0-a294d43ae5d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9429487b-bd96-4760-bd71-b3dc6c8766dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9429487b-bd96-4760-bd71-b3dc6c8766dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingToDate_edd5e3b0-290f-4c81-997a-ec0caa3908ed" xlink:href="hr-20230331.xsd#hr_ConstructionActivityTotalFundingToDate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_hr_ConstructionActivityTotalFundingToDate_edd5e3b0-290f-4c81-997a-ec0caa3908ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentInLease_c0b0e936-9efa-492a-999a-bb2daf60af1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLease"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_NetInvestmentInLease_c0b0e936-9efa-492a-999a-bb2daf60af1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FiniteLivedCustomerRelationshipsNet_aa867450-36c6-49f9-9bd3-56d193b057b5" xlink:href="hr-20230331.xsd#hr_FiniteLivedCustomerRelationshipsNet"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_hr_FiniteLivedCustomerRelationshipsNet_aa867450-36c6-49f9-9bd3-56d193b057b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_2310632b-9a93-4c5c-b833-9ca687bddf21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets_df1b3b59-be1e-4915-9f13-909ee2590942" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_2310632b-9a93-4c5c-b833-9ca687bddf21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_605ec89b-884d-4955-9b17-ffc9bbeb27d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AccruedPropertyTaxes_9e118206-e32e-4009-ac58-a67fd8f03d25" xlink:href="hr-20230331.xsd#hr_AccruedPropertyTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_605ec89b-884d-4955-9b17-ffc9bbeb27d3" xlink:to="loc_hr_AccruedPropertyTaxes_9e118206-e32e-4009-ac58-a67fd8f03d25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AccountsPayableAndCapitalExpendituresCurrent_6d953b1d-0176-4a3a-9986-0e3cd71c7475" xlink:href="hr-20230331.xsd#hr_AccountsPayableAndCapitalExpendituresCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_605ec89b-884d-4955-9b17-ffc9bbeb27d3" xlink:to="loc_hr_AccountsPayableAndCapitalExpendituresCurrent_6d953b1d-0176-4a3a-9986-0e3cd71c7475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_d2649aa9-3b13-442a-b613-fedff767e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_605ec89b-884d-4955-9b17-ffc9bbeb27d3" xlink:to="loc_us-gaap_InterestPayableCurrent_d2649aa9-3b13-442a-b613-fedff767e5f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_39f996c1-e4c9-4d80-a5c7-fd4e22704b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_605ec89b-884d-4955-9b17-ffc9bbeb27d3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_39f996c1-e4c9-4d80-a5c7-fd4e22704b38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_78c961b8-0011-4b96-9938-cdabcf18c406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BelowMarketLeaseNet_cdaccdb4-4ba3-4340-87fa-1146b44766e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BelowMarketLeaseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilities_78c961b8-0011-4b96-9938-cdabcf18c406" xlink:to="loc_us-gaap_BelowMarketLeaseNet_cdaccdb4-4ba3-4340-87fa-1146b44766e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_382021f3-edd2-4a1e-b877-714a6368b31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilities_78c961b8-0011-4b96-9938-cdabcf18c406" xlink:to="loc_us-gaap_ContractWithCustomerLiability_382021f3-edd2-4a1e-b877-714a6368b31c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDepositLiability_9f8f3a40-6782-4f40-a29b-d110cc7ad55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDepositLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilities_78c961b8-0011-4b96-9938-cdabcf18c406" xlink:to="loc_us-gaap_SecurityDepositLiability_9f8f3a40-6782-4f40-a29b-d110cc7ad55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_97f3e017-d2e3-4441-9448-6d885de96d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilities_78c961b8-0011-4b96-9938-cdabcf18c406" xlink:to="loc_us-gaap_DerivativeLiabilities_97f3e017-d2e3-4441-9448-6d885de96d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilities_6d617c45-2e19-44dd-b551-86765e17818a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilities_78c961b8-0011-4b96-9938-cdabcf18c406" xlink:to="loc_us-gaap_OtherSundryLiabilities_6d617c45-2e19-44dd-b551-86765e17818a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baf054e7-2633-4a61-83bd-dd3f1385f3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_35e114af-02e1-46cd-8559-1c6305b8e141" xlink:href="hr-20230331.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baf054e7-2633-4a61-83bd-dd3f1385f3a1" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_35e114af-02e1-46cd-8559-1c6305b8e141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ce4ff78f-eef5-44c9-abdf-0aba54db6c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baf054e7-2633-4a61-83bd-dd3f1385f3a1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ce4ff78f-eef5-44c9-abdf-0aba54db6c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20eef2cc-2f45-4307-9ea3-a2f879c3cf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_27fdd451-7c32-4c6a-90a5-a90cdabd631d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20eef2cc-2f45-4307-9ea3-a2f879c3cf1f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_27fdd451-7c32-4c6a-90a5-a90cdabd631d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_5105b887-6b25-4c55-8817-5c264ca68c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20eef2cc-2f45-4307-9ea3-a2f879c3cf1f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_5105b887-6b25-4c55-8817-5c264ca68c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_bee4afef-85f9-4a17-87d4-a7cd8b62ad98" xlink:href="hr-20230331.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_75709729-4fe0-4c01-aade-d8331b92ce08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_bee4afef-85f9-4a17-87d4-a7cd8b62ad98" xlink:to="loc_us-gaap_NetIncomeLoss_75709729-4fe0-4c01-aade-d8331b92ce08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsShareBasedCompensation_82f6a35c-042f-4ceb-9df6-90a611467844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_bee4afef-85f9-4a17-87d4-a7cd8b62ad98" xlink:to="loc_us-gaap_DividendsShareBasedCompensation_82f6a35c-042f-4ceb-9df6-90a611467844" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_b58e3a3d-afa1-45c3-addb-3b6c6d05c938" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_b58e3a3d-afa1-45c3-addb-3b6c6d05c938" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_28f35b08-f680-4a88-bf97-ac5edf3d6f28" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_28f35b08-f680-4a88-bf97-ac5edf3d6f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_caf5287f-64c1-4085-a97a-e75612f49ce4" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_caf5287f-64c1-4085-a97a-e75612f49ce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_22b85b66-f5ff-4bb9-9d58-2dbe29e1a23c" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_22b85b66-f5ff-4bb9-9d58-2dbe29e1a23c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_aed8710f-04cd-4dde-973b-08c8f8ce0610" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_aed8710f-04cd-4dde-973b-08c8f8ce0610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_e1b44faa-a939-4e10-888d-9af4ae01c04b" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cae78e60-06b7-4c8b-8ed4-570e52ede4af" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_e1b44faa-a939-4e10-888d-9af4ae01c04b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hr-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:388a749e-3c99-4328-89c5-127682212508,g:16eafbb3-991c-406c-96b0-65d8e7977cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i48ab2f44934e4f28ae65a1b15de48ac8_CondensedConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_af237bd7-3612-4827-9163-7c9a5a89e693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ProfitLoss_af237bd7-3612-4827-9163-7c9a5a89e693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_93a17d9b-62d7-4985-b168-d064b82cef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_93a17d9b-62d7-4985-b168-d064b82cef8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e6493783-7f81-4a8a-8f7a-e62881d5241f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e6493783-7f81-4a8a-8f7a-e62881d5241f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23c100a2-bb0d-4d40-a26b-2063cbefc60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23c100a2-bb0d-4d40-a26b-2063cbefc60a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1bf236b3-bdde-4861-94af-a3209a26a136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1bf236b3-bdde-4861-94af-a3209a26a136" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d80e0c17-620e-4591-995f-227950eaa368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d80e0c17-620e-4591-995f-227950eaa368" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddf5cd6c-7b17-4512-b2ac-6c5a646f2987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddf5cd6c-7b17-4512-b2ac-6c5a646f2987" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c4c31f9-1b42-4656-9e4f-6106fe8c6779_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c4c31f9-1b42-4656-9e4f-6106fe8c6779_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_084f4831-c449-4758-88d4-6d339fab9317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_084f4831-c449-4758-88d4-6d339fab9317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_245332cc-da6f-4d8d-9662-2aea08dd9b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_084f4831-c449-4758-88d4-6d339fab9317" xlink:to="loc_us-gaap_InterestRateSwapMember_245332cc-da6f-4d8d-9662-2aea08dd9b64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity" xlink:type="extended" id="ibd015928209d467e9d0706ce02e8ebef_CondensedConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_22aabc69-3f02-48fd-aaee-ae2edfbebf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22aabc69-3f02-48fd-aaee-ae2edfbebf17" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e022ba94-c1b4-4f7d-bf56-6886841a45bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e022ba94-c1b4-4f7d-bf56-6886841a45bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0693f512-119d-4a1b-b295-044936bc636f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0693f512-119d-4a1b-b295-044936bc636f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5470908-02c5-458b-b27a-6e856aa3ea6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5470908-02c5-458b-b27a-6e856aa3ea6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d3114ec-a4fe-48f6-9026-1ef36e6027bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d3114ec-a4fe-48f6-9026-1ef36e6027bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a97715d3-7e60-413d-8cab-bce850c5118d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_ProfitLoss_a97715d3-7e60-413d-8cab-bce850c5118d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_333ea94c-ce9e-4698-8c86-8bcc8189e142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_333ea94c-ce9e-4698-8c86-8bcc8189e142" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ed4b44b7-8b73-4905-8a44-b33ec477a2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ed4b44b7-8b73-4905-8a44-b33ec477a2db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3799c031-4e7f-4b54-b3c4-9ceadb1af9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_DividendsCommonStockCash_3799c031-4e7f-4b54-b3c4-9ceadb1af9fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_36e45e3d-f19c-4dff-800a-05a849e554d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_22aabc69-3f02-48fd-aaee-ae2edfbebf17" xlink:to="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a8d25458-789b-45b9-864c-ff87809fdccb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:to="loc_us-gaap_EquityComponentDomain_a8d25458-789b-45b9-864c-ff87809fdccb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:to="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:to="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dbde959b-5209-4c49-b405-78da5e523778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_us-gaap_CommonStockMember_dbde959b-5209-4c49-b405-78da5e523778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_989ecd89-1ee7-4c26-9fee-dd7dcba6ed7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_989ecd89-1ee7-4c26-9fee-dd7dcba6ed7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fa62934f-c056-4c2a-8f72-2bf42a944fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fa62934f-c056-4c2a-8f72-2bf42a944fe3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember_49c5a5c7-546b-42fd-a120-086059ed6d06" xlink:href="hr-20230331.xsd#hr_CumulativeNetIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_hr_CumulativeNetIncomeMember_49c5a5c7-546b-42fd-a120-086059ed6d06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember_6e0aa36b-91ea-4878-b36a-8c441bafdfd0" xlink:href="hr-20230331.xsd#hr_CumulativeDividendsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_hr_CumulativeDividendsMember_6e0aa36b-91ea-4878-b36a-8c441bafdfd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d49cbccd-ee50-444b-94ae-6a883cb287ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d49cbccd-ee50-444b-94ae-6a883cb287ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="i4c15aa0475444baaa895e1365bf10ee9_SummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:href="hr-20230331.xsd#hr_BusinessOverviewAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_fcb11c78-1772-459e-be02-e93ad8605182" xlink:href="hr-20230331.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_fcb11c78-1772-459e-be02-e93ad8605182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments_84153479-9074-4f2b-aa16-81e55b0ada64" xlink:href="hr-20230331.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_NumberOfRealEstateInvestments_84153479-9074-4f2b-aa16-81e55b0ada64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_9fd96fb2-3cb0-4b7e-8781-bea3e3c8991f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_9fd96fb2-3cb0-4b7e-8781-bea3e3c8991f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_ffaf26e6-b28d-42db-938d-8d7fa11ddef5" xlink:href="hr-20230331.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_ffaf26e6-b28d-42db-938d-8d7fa11ddef5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany_76bb29b6-ba4c-48e0-a9e5-857c1e45ec85" xlink:href="hr-20230331.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_ApproximateSquareFeetInvestedInByCompany_76bb29b6-ba4c-48e0-a9e5-857c1e45ec85" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetProvidedByCompany_bc7f108f-8a6b-4a5e-a248-c01a82473ad6" xlink:href="hr-20230331.xsd#hr_ApproximateSquareFeetProvidedByCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_ApproximateSquareFeetProvidedByCompany_bc7f108f-8a6b-4a5e-a248-c01a82473ad6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f7f7713f-0a5f-4460-abf9-1e72f569bd48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f7f7713f-0a5f-4460-abf9-1e72f569bd48" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfBuildingsOwnedByJointVenture_7095e200-5586-4eb5-86dd-bc238675f8ce" xlink:href="hr-20230331.xsd#hr_NumberOfBuildingsOwnedByJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_NumberOfBuildingsOwnedByJointVenture_7095e200-5586-4eb5-86dd-bc238675f8ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_c2ca8971-f762-4bda-855b-0fe3bc95df84" xlink:href="hr-20230331.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_NumberOfVariableInterestEntities_c2ca8971-f762-4bda-855b-0fe3bc95df84" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent_6fb54c96-9a24-4557-bf9a-328cada67ead" xlink:href="hr-20230331.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_EquityOwnershipForConsolidationPercent_6fb54c96-9a24-4557-bf9a-328cada67ead" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_799709d6-772c-4955-bddc-46db402f668e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_799709d6-772c-4955-bddc-46db402f668e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5e5ed1d-c75a-4b82-8499-df653c5b0288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5e5ed1d-c75a-4b82-8499-df653c5b0288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_93c5bac4-f575-4d21-b3b8-ff3f32e285e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_ebd9d354-fc06-449d-a76b-f102e0797104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_ebd9d354-fc06-449d-a76b-f102e0797104" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_efdff33a-fe01-4c7a-95b8-b9b6a4e967fc" xlink:href="hr-20230331.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_b076b125-244e-49b4-baba-55f8c7504870" xlink:href="hr-20230331.xsd#hr_NumberOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_hr_NumberOfNotesReceivable_b076b125-244e-49b4-baba-55f8c7504870" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures_0419cd96-4df4-4dea-827b-7d7423576854" xlink:href="hr-20230331.xsd#hr_NumberOfJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_hr_NumberOfJointVentures_0419cd96-4df4-4dea-827b-7d7423576854" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_85ab266b-583c-4a1e-bb79-6cda742e7b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_85ab266b-583c-4a1e-bb79-6cda742e7b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e069078e-af3e-4b58-8c77-de33b6524b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_85ab266b-583c-4a1e-bb79-6cda742e7b57" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e069078e-af3e-4b58-8c77-de33b6524b15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_ec0749fd-9f44-40b8-bc63-98380df59bab" xlink:href="hr-20230331.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_ec0749fd-9f44-40b8-bc63-98380df59bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_dfb03872-53cf-4ac2-b414-5584a0dc92d2" xlink:href="hr-20230331.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_dfb03872-53cf-4ac2-b414-5584a0dc92d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_f9fee1be-3137-40c9-bf00-1ba499cd2f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_f9fee1be-3137-40c9-bf00-1ba499cd2f86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_6270b7cb-dc46-492f-a5ef-e71a7f0f7ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_us-gaap_InterestIncomeOperating_6270b7cb-dc46-492f-a5ef-e71a7f0f7ea2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable_876915f6-c9a4-4f2f-b3a4-a3ccdbd281d4" xlink:href="hr-20230331.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_hr_NumberOfRealEstateNotesReceivable_876915f6-c9a4-4f2f-b3a4-a3ccdbd281d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus_70d94428-d8af-48b4-bb07-e09f44428613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus_70d94428-d8af-48b4-bb07-e09f44428613" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_300d2e83-87da-4647-ad66-3b587ad16858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_300d2e83-87da-4647-ad66-3b587ad16858" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_6e77a49c-9903-4970-ad07-14c80297d10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_300d2e83-87da-4647-ad66-3b587ad16858" xlink:to="loc_us-gaap_NotesReceivableMember_6e77a49c-9903-4970-ad07-14c80297d10b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3c032649-b001-40cf-8971-66669fdaf47d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3c032649-b001-40cf-8971-66669fdaf47d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_452333f4-cf60-4294-92bf-43709dc04f11" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_452333f4-cf60-4294-92bf-43709dc04f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b2560230-8ac3-4a37-ae4b-7259fa9935a9" xlink:href="hr-20230331.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_452333f4-cf60-4294-92bf-43709dc04f11" xlink:to="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b2560230-8ac3-4a37-ae4b-7259fa9935a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f7ae495-3daf-44d1-ae23-34282c68b361_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f7ae495-3daf-44d1-ae23-34282c68b361_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_cce00825-9b6a-4ea6-8178-4c5898b8972d" xlink:href="hr-20230331.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:to="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_cce00825-9b6a-4ea6-8178-4c5898b8972d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_2a3ea44c-f0d3-42c9-9e01-aadc725ac6d7" xlink:href="hr-20230331.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_2a3ea44c-f0d3-42c9-9e01-aadc725ac6d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_55f7acb9-e03c-44c0-9392-5a2bd4816e74_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:to="loc_srt_OwnershipDomain_55f7acb9-e03c-44c0-9392-5a2bd4816e74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_645c298a-4647-4a41-9d07-3d4806d1d1fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:to="loc_srt_OwnershipDomain_645c298a-4647-4a41-9d07-3d4806d1d1fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember_67ede1cc-5443-4e67-b483-3d0e25966318" xlink:href="hr-20230331.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_645c298a-4647-4a41-9d07-3d4806d1d1fa" xlink:to="loc_hr_NonControllingInterestHoldersMember_67ede1cc-5443-4e67-b483-3d0e25966318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd20bfae-ebdb-4fec-bee8-18591ad096f1_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:to="loc_dei_EntityDomain_bd20bfae-ebdb-4fec-bee8-18591ad096f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a9c0114-228d-4024-aced-01898548cf99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:to="loc_dei_EntityDomain_8a9c0114-228d-4024-aced-01898548cf99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_00edc63a-e475-4c5b-ab50-d7837d723c3b" xlink:href="hr-20230331.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8a9c0114-228d-4024-aced-01898548cf99" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_00edc63a-e475-4c5b-ab50-d7837d723c3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9b70a556-e6da-4fd1-a95f-220bd735afea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9b70a556-e6da-4fd1-a95f-220bd735afea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_3e813be0-0f18-4a9b-bc04-87ad54899f56" xlink:href="hr-20230331.xsd#hr_VariableInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9b70a556-e6da-4fd1-a95f-220bd735afea" xlink:to="loc_hr_VariableInterestEntityMember_3e813be0-0f18-4a9b-bc04-87ad54899f56" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended" id="i6e94077377934f0ca2212aaf2648e913_SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:to="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_b4d70471-01b3-42ae-9e56-48c6f374399d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_b4d70471-01b3-42ae-9e56-48c6f374399d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_11128bda-d94a-4665-ae2a-035c0607c9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_11128bda-d94a-4665-ae2a-035c0607c9a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_a5235f82-957f-4698-bf0e-4fc7df715013" xlink:href="hr-20230331.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_hr_ReceivablesAndOtherAssets_a5235f82-957f-4698-bf0e-4fc7df715013" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_47d6e7c8-cd47-415d-a9b8-79f1df8f94d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_us-gaap_Assets_47d6e7c8-cd47-415d-a9b8-79f1df8f94d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_f8beeb3d-5efb-41e2-9557-2d161dad4dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_f8beeb3d-5efb-41e2-9557-2d161dad4dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_579d9f4e-b02c-4da2-a67c-746e1ccec13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:to="loc_us-gaap_StockholdersEquity_579d9f4e-b02c-4da2-a67c-746e1ccec13c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2b2808c-e9ea-4d31-ad6c-57125be7d975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2b2808c-e9ea-4d31-ad6c-57125be7d975" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e1e44a92-52d0-4304-ad4d-94b3f8762651_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e1e44a92-52d0-4304-ad4d-94b3f8762651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bd9261ec-42eb-46d0-a670-acf581462818" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bd9261ec-42eb-46d0-a670-acf581462818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_116250d8-09ee-4ffd-bef2-8c378622c538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_bd9261ec-42eb-46d0-a670-acf581462818" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_116250d8-09ee-4ffd-bef2-8c378622c538" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="extended" id="ie2990bcd611f4dd293af835eb5e8734f_SummaryofSignificantAccountingPoliciesVariableinterestentityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount_44f70e6a-0267-4b58-ace2-04988e1de01e" xlink:href="hr-20230331.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_hr_NotesReceivableCarryingAmount_44f70e6a-0267-4b58-ace2-04988e1de01e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount_2817443e-2aff-4307-a16f-11e93355250b" xlink:href="hr-20230331.xsd#hr_JointVentureCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_hr_JointVentureCarryingAmount_2817443e-2aff-4307-a16f-11e93355250b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f6a4dec-f588-4791-9f84-c4759924af3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f6a4dec-f588-4791-9f84-c4759924af3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_f32092ba-18bf-4d43-9bfb-dc0df9c488f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_f32092ba-18bf-4d43-9bfb-dc0df9c488f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:to="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_64f05bd6-a719-4852-95a5-62e2e310b538_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:to="loc_srt_SegmentGeographicalDomain_64f05bd6-a719-4852-95a5-62e2e310b538_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:to="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember_ace3985b-dc1d-4c2c-8d9d-831802e7e05c" xlink:href="hr-20230331.xsd#hr_HoustonTexasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:to="loc_hr_HoustonTexasMember_ace3985b-dc1d-4c2c-8d9d-831802e7e05c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_ccff0db5-c7ec-4e54-9a09-3e571f6ff483" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:to="loc_stpr_NC_ccff0db5-c7ec-4e54-9a09-3e571f6ff483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_b070a3b8-0c86-4af4-bb70-a25fe4007635" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:to="loc_stpr_TX_b070a3b8-0c86-4af4-bb70-a25fe4007635" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d8e696a2-1773-47e8-8744-89b03bd380c3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d8e696a2-1773-47e8-8744-89b03bd380c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:to="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_e06c9ae4-b103-4771-97ac-5ce09ec24f0f" xlink:href="hr-20230331.xsd#hr_VariableInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:to="loc_hr_VariableInterestEntityMember_e06c9ae4-b103-4771-97ac-5ce09ec24f0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c0f66147-d409-43b6-a364-9ff459755b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c0f66147-d409-43b6-a364-9ff459755b75" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="extended" id="i0f906be22abf406cb6aa54615a2f46ea_SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate_f3aa7d70-b567-406b-b091-86d469cb3271" xlink:href="hr-20230331.xsd#hr_NotesReceivableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_hr_NotesReceivableInterestRate_f3aa7d70-b567-406b-b091-86d469cb3271" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment_f3d97cfa-cb3b-4292-a7ad-7cc2e5818178" xlink:href="hr-20230331.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_hr_NotesReceivableMaximumLoanCommitment_f3d97cfa-cb3b-4292-a7ad-7cc2e5818178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_9ba5c761-d801-4bc5-807b-7b7bff17a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_NotesReceivableGross_9ba5c761-d801-4bc5-807b-7b7bff17a7e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_3786adde-3f80-46ee-9f3e-7842cebe7df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_InterestReceivable_3786adde-3f80-46ee-9f3e-7842cebe7df7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_41dcb55c-6904-454d-bc8f-d6f98a270089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_41dcb55c-6904-454d-bc8f-d6f98a270089" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableFairValueDiscount_35aeca0f-5100-43d0-8bac-8569804a79b2" xlink:href="hr-20230331.xsd#hr_NotesReceivableFairValueDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_hr_NotesReceivableFairValueDiscount_35aeca0f-5100-43d0-8bac-8569804a79b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_d15126f7-94e5-4771-a5b9-821699554380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_NotesReceivableNet_d15126f7-94e5-4771-a5b9-821699554380" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e3c01c6a-afca-4d77-9a05-3c97b43ffda0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e3c01c6a-afca-4d77-9a05-3c97b43ffda0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoansTexasMember_6700a232-3bc8-4ad8-a165-f11943071495" xlink:href="hr-20230331.xsd#hr_MezzanineLoansTexasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MezzanineLoansTexasMember_6700a232-3bc8-4ad8-a165-f11943071495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanTexasMember_a8f94bdd-e1b1-4501-8bff-ca4420f63a1c" xlink:href="hr-20230331.xsd#hr_MortgageLoanTexasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanTexasMember_a8f94bdd-e1b1-4501-8bff-ca4420f63a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanNorthCarolinaMember_f0dbd689-0a9e-44d4-88fe-14a21ca24cd6" xlink:href="hr-20230331.xsd#hr_MortgageLoanNorthCarolinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanNorthCarolinaMember_f0dbd689-0a9e-44d4-88fe-14a21ca24cd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanFloridaMember_8d3905fb-d474-4d30-8812-804129103c32" xlink:href="hr-20230331.xsd#hr_MortgageLoanFloridaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanFloridaMember_8d3905fb-d474-4d30-8812-804129103c32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanCaliforniaMember_7a39f2ea-2c90-4c63-bfe6-7a68eae6e7b7" xlink:href="hr-20230331.xsd#hr_MortgageLoanCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanCaliforniaMember_7a39f2ea-2c90-4c63-bfe6-7a68eae6e7b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember_2feec5a1-fdb9-4e77-8d04-845ce534c84b" xlink:href="hr-20230331.xsd#hr_MortgageLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanMember_2feec5a1-fdb9-4e77-8d04-845ce534c84b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2556544a-ac27-47ad-89e0-0c28d3fdd3d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2556544a-ac27-47ad-89e0-0c28d3fdd3d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1608c170-d5f0-4452-869a-d6e9dcbd663a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1608c170-d5f0-4452-869a-d6e9dcbd663a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_be5ef049-041f-4a95-81e7-c37405d1d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1608c170-d5f0-4452-869a-d6e9dcbd663a" xlink:to="loc_us-gaap_OtherAssetsMember_be5ef049-041f-4a95-81e7-c37405d1d24b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended" id="ib3bc5efb0f8b464093cb0173f1a87a44_SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_65c5c1b9-bcd1-4138-86c0-debdd37069f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d852bc45-02f3-400c-8563-5d89fbefe8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_65c5c1b9-bcd1-4138-86c0-debdd37069f9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d852bc45-02f3-400c-8563-5d89fbefe8f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_65c5c1b9-bcd1-4138-86c0-debdd37069f9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:to="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ca509a42-70dd-4a70-8c44-94b30384f4b4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:to="loc_srt_ProductsAndServicesDomain_ca509a42-70dd-4a70-8c44-94b30384f4b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:to="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember_c23bbafe-c265-442c-b3c0-21afc33f0066" xlink:href="hr-20230331.xsd#hr_ParkingIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:to="loc_hr_ParkingIncomeMember_c23bbafe-c265-442c-b3c0-21afc33f0066" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember_5ddc9d92-070c-45be-a1e2-94272471eaf3" xlink:href="hr-20230331.xsd#hr_ManagementFeeIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:to="loc_hr_ManagementFeeIncomeMember_5ddc9d92-070c-45be-a1e2-94272471eaf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MiscellaneousMember_e15a2e71-0fb4-4bb1-9399-c12bfd4f37b2" xlink:href="hr-20230331.xsd#hr_MiscellaneousMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:to="loc_hr_MiscellaneousMember_e15a2e71-0fb4-4bb1-9399-c12bfd4f37b2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTANarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="extended" id="i298cc081be0443558635239bb4b11142_MergerwithHTANarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_878cc4e2-a246-45ba-bc12-0bc79c0be45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_878cc4e2-a246-45ba-bc12-0bc79c0be45b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_a4e74cca-d28b-4e8f-8798-43f38bdb4b34" xlink:href="hr-20230331.xsd#hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_a4e74cca-d28b-4e8f-8798-43f38bdb4b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_dd5fdbba-00b3-42a4-83df-c97f3d1ce9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_dd5fdbba-00b3-42a4-83df-c97f3d1ce9f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_49d5c3ff-26b3-44cc-a5a2-7b251718103f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_Goodwill_49d5c3ff-26b3-44cc-a5a2-7b251718103f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0aab3cd1-081c-4708-98de-35dce34f605f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0aab3cd1-081c-4708-98de-35dce34f605f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_2146219a-395a-477a-bb37-76a2b7aa6701" xlink:href="hr-20230331.xsd#hr_MergerRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_hr_MergerRelatedCosts_2146219a-395a-477a-bb37-76a2b7aa6701" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_e2d540a8-a280-4c83-a7c3-7af1e964d85f" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRefundOfTransferTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_e2d540a8-a280-4c83-a7c3-7af1e964d85f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_23788676-057f-403c-9ceb-26195cccb057_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:to="loc_dei_EntityDomain_23788676-057f-403c-9ceb-26195cccb057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_99031e97-ec4b-4ac3-8a76-e982242c4e08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:to="loc_dei_EntityDomain_99031e97-ec4b-4ac3-8a76-e982242c4e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:href="hr-20230331.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_99031e97-ec4b-4ac3-8a76-e982242c4e08" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncMember_718c9c0b-6e2e-4090-a01a-54a60978ab7b" xlink:href="hr-20230331.xsd#hr_HealthCareRealtyTrustIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:to="loc_hr_HealthCareRealtyTrustIncMember_718c9c0b-6e2e-4090-a01a-54a60978ab7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_bda3901a-dd0a-4290-993b-9e81ca743805" xlink:href="hr-20230331.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_bda3901a-dd0a-4290-993b-9e81ca743805" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b0e477ef-308a-4972-bdbb-e19a0462340d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:to="loc_us-gaap_ClassOfStockDomain_b0e477ef-308a-4972-bdbb-e19a0462340d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8713d9b2-0f27-402e-bdc6-1b336d7785f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:to="loc_us-gaap_ClassOfStockDomain_8713d9b2-0f27-402e-bdc6-1b336d7785f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d2a55588-b38c-4d6d-9f07-5ced1484c594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8713d9b2-0f27-402e-bdc6-1b336d7785f8" xlink:to="loc_us-gaap_CommonClassAMember_d2a55588-b38c-4d6d-9f07-5ced1484c594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2ee0110e-18f0-4e85-ab41-9e2b36fd9344_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2ee0110e-18f0-4e85-ab41-9e2b36fd9344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b415339e-9229-4021-b0a9-018a4716610d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b415339e-9229-4021-b0a9-018a4716610d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7279f6c9-393f-47c4-aa56-7e007148b748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b415339e-9229-4021-b0a9-018a4716610d" xlink:to="loc_us-gaap_SubsequentEventMember_7279f6c9-393f-47c4-aa56-7e007148b748" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTADetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="extended" id="ia9ba103ba33d436786cb661ae4723799_MergerwithHTADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_47974867-719f-4403-92fa-dbff672e221d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_47974867-719f-4403-92fa-dbff672e221d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RecapitalizationExchangeRatio_cb0c6fb4-9ae0-467d-990f-224fe51f0cdc" xlink:href="hr-20230331.xsd#hr_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_RecapitalizationExchangeRatio_cb0c6fb4-9ae0-467d-990f-224fe51f0cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8ceb72c2-6bfc-48a9-8445-09b481dd1a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8ceb72c2-6bfc-48a9-8445-09b481dd1a95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_4da23d21-99e1-40e8-b3d4-9a70acb84edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_4da23d21-99e1-40e8-b3d4-9a70acb84edb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReverseRecapitalizationNet_5437287b-5f9b-46c3-80f7-b99965f4affe" xlink:href="hr-20230331.xsd#hr_ReverseRecapitalizationNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_ReverseRecapitalizationNet_5437287b-5f9b-46c3-80f7-b99965f4affe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_243d53fa-9c83-47c6-b80c-f5482f54d53f" xlink:href="hr-20230331.xsd#hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_243d53fa-9c83-47c6-b80c-f5482f54d53f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_afe04cc1-ac0f-421e-b079-1aa1d6d4d7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_afe04cc1-ac0f-421e-b079-1aa1d6d4d7d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockFractionalShares_9f05be45-c420-4d51-ab9a-4e027206260f" xlink:href="hr-20230331.xsd#hr_CommonStockFractionalShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_CommonStockFractionalShares_9f05be45-c420-4d51-ab9a-4e027206260f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockSharesWithheld_f580110d-6644-4fa0-ac45-79a724d922ca" xlink:href="hr-20230331.xsd#hr_CommonStockSharesWithheld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_CommonStockSharesWithheld_f580110d-6644-4fa0-ac45-79a724d922ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:to="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_669f8aad-7075-4b0b-b4b5-1ce25d64e75c_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:to="loc_dei_EntityDomain_669f8aad-7075-4b0b-b4b5-1ce25d64e75c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5c34b539-1636-4469-93d5-b06f4f1d70b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:to="loc_dei_EntityDomain_5c34b539-1636-4469-93d5-b06f4f1d70b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_d6019852-6ced-4cc0-8909-6e61bd7eec54" xlink:href="hr-20230331.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5c34b539-1636-4469-93d5-b06f4f1d70b2" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_d6019852-6ced-4cc0-8909-6e61bd7eec54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:to="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23fb2b13-8c3e-41bb-a194-611a91b9f740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23fb2b13-8c3e-41bb-a194-611a91b9f740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_966573a2-065d-4493-b699-c78cd764ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23fb2b13-8c3e-41bb-a194-611a91b9f740" xlink:to="loc_us-gaap_RestrictedStockMember_966573a2-065d-4493-b699-c78cd764ce9e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended" id="i8ac992b166224e3dbf715d441fefc499_MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_447bef18-e82e-4432-b4c7-f218ee664687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_447bef18-e82e-4432-b4c7-f218ee664687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_c29f7662-75b5-4136-a2a1-6e21316ac3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_c29f7662-75b5-4136-a2a1-6e21316ac3da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_42c6540c-195d-49e0-8dbb-a0eb9e4b6fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_42c6540c-195d-49e0-8dbb-a0eb9e4b6fde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_1b0a327d-7c71-4b7e-87ce-efa91bd8ffac" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_1b0a327d-7c71-4b7e-87ce-efa91bd8ffac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_b837c41c-63e1-4f5d-b8f1-97840f8d4e9a" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_b837c41c-63e1-4f5d-b8f1-97840f8d4e9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_a2743674-b20e-4f84-8e23-0638217fb7fc" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_a2743674-b20e-4f84-8e23-0638217fb7fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_f2244a2b-57d0-4735-ab3b-dc70d0208200" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_f2244a2b-57d0-4735-ab3b-dc70d0208200" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_6d935908-2809-4d8d-a489-84204b863917" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_6d935908-2809-4d8d-a489-84204b863917" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_ff0ddef2-9524-4ad8-8741-2af20c12786d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_ff0ddef2-9524-4ad8-8741-2af20c12786d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6eac72b6-773c-4dc5-b866-c684c6bd7816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6eac72b6-773c-4dc5-b866-c684c6bd7816" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f646426d-e31f-42c6-b98d-abfa8fef3639" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f646426d-e31f-42c6-b98d-abfa8fef3639" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41eed182-401f-409b-9894-f1bd359910ad" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41eed182-401f-409b-9894-f1bd359910ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_ea0f282f-728d-4480-bd56-0aceba998896" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_ea0f282f-728d-4480-bd56-0aceba998896" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8605b46d-ca7d-4423-b324-5d1456f167f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8605b46d-ca7d-4423-b324-5d1456f167f8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_415b67ff-84ef-4ff8-b6af-7fef483b1b28" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_415b67ff-84ef-4ff8-b6af-7fef483b1b28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_0ed00778-be84-4dc8-83f2-ecd5e6604a90" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_0ed00778-be84-4dc8-83f2-ecd5e6604a90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f6c5f4d4-447f-4e02-9915-5110fcf63e2b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f6c5f4d4-447f-4e02-9915-5110fcf63e2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_b9664412-f677-4dae-be17-5bdd6d93f2ab" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_b9664412-f677-4dae-be17-5bdd6d93f2ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_d0cdac7c-36cb-4451-8362-3424c9dbd9c4" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_d0cdac7c-36cb-4451-8362-3424c9dbd9c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_cad76b9c-f907-4d71-aca0-915b956cb2ae" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_cad76b9c-f907-4d71-aca0-915b956cb2ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_86176227-166f-42f7-9414-16d9cc2638a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_86176227-166f-42f7-9414-16d9cc2638a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e7c00dad-ad61-4779-940f-950fa11651fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e7c00dad-ad61-4779-940f-950fa11651fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_79529127-0e47-4ff3-bebe-44ce6ab5bca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_79529127-0e47-4ff3-bebe-44ce6ab5bca4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37f18891-ff45-4095-a99e-e49978ab0d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_Goodwill_37f18891-ff45-4095-a99e-e49978ab0d24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5d91a797-d6ef-4be4-bb71-eee9a85a9f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5d91a797-d6ef-4be4-bb71-eee9a85a9f74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_aa928bac-6deb-4057-8432-866154af0455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_aa928bac-6deb-4057-8432-866154af0455" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_05284ce3-5e83-4cfd-a5fb-62a1a0ab477b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_05284ce3-5e83-4cfd-a5fb-62a1a0ab477b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_dafce0f9-2b66-46a9-a9bf-70769de6ada6" xlink:href="hr-20230331.xsd#hr_GrossContractualRealEstateNotesReceivableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_dafce0f9-2b66-46a9-a9bf-70769de6ada6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_588fe433-69c8-4305-82ef-be11b335c801" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_588fe433-69c8-4305-82ef-be11b335c801" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_782e9967-ddc0-45da-8c25-16369371b1f7" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_782e9967-ddc0-45da-8c25-16369371b1f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_d2ad10b8-e95f-434f-b156-3c931d42da65" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_d2ad10b8-e95f-434f-b156-3c931d42da65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_1f7ff269-1fe0-4c74-a547-de0109f6169e" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_1f7ff269-1fe0-4c74-a547-de0109f6169e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_42b905ac-4dae-4fe8-adc3-f5f55cd5833f" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_42b905ac-4dae-4fe8-adc3-f5f55cd5833f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_4857151f-d287-4a4d-8545-a1f771ef98cf" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_4857151f-d287-4a4d-8545-a1f771ef98cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_7c1c2d3a-1d7c-4620-a30c-ab09f1523b3d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_7c1c2d3a-1d7c-4620-a30c-ab09f1523b3d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_6a0a33a8-20eb-45f1-abdb-d3d87ec59a91" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_6a0a33a8-20eb-45f1-abdb-d3d87ec59a91" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_148dc1ec-19f0-49d4-9f4b-9592492f8143" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_148dc1ec-19f0-49d4-9f4b-9592492f8143" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_d874913b-c574-4065-9451-0582d8468100" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_d874913b-c574-4065-9451-0582d8468100" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_05dbfd5b-6c45-4991-8847-5055f65db87c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_05dbfd5b-6c45-4991-8847-5055f65db87c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_faab4061-486e-446e-ab74-81ccaacff45d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_faab4061-486e-446e-ab74-81ccaacff45d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_24bdd917-b3ae-41fc-98b6-775f19bbfbbf" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_24bdd917-b3ae-41fc-98b6-775f19bbfbbf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_4c712920-6953-4787-9a25-76a83f389b1d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_4c712920-6953-4787-9a25-76a83f389b1d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_8cdcd678-3430-4656-a4fe-b510b6de31e4" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_8cdcd678-3430-4656-a4fe-b510b6de31e4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_76a1494f-3458-41cb-ba48-8e3e7b954948" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_76a1494f-3458-41cb-ba48-8e3e7b954948" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_5b1f154b-9f53-46d7-abdd-036cd62f21a1" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_5b1f154b-9f53-46d7-abdd-036cd62f21a1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_f5ba2513-afa4-4030-aacc-f882fdfebf95" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_f5ba2513-afa4-4030-aacc-f882fdfebf95" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_9643e30e-e8e2-410e-a836-b0f499aba760" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_9643e30e-e8e2-410e-a836-b0f499aba760" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_576d157b-0b26-4eee-bb78-af8a2629fa5c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_576d157b-0b26-4eee-bb78-af8a2629fa5c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_20ff998a-15c8-4974-896a-5b9cf29ba51b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_20ff998a-15c8-4974-896a-5b9cf29ba51b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:to="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e4371af6-c54c-47f3-9b12-a369c23d37bf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:to="loc_srt_RestatementDomain_e4371af6-c54c-47f3-9b12-a369c23d37bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:to="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_c2e9296f-3b8b-4b4a-af31-c3e41ee814fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_c2e9296f-3b8b-4b4a-af31-c3e41ee814fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_a64fc554-b462-4f0e-8072-5cd3c9bfb178" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:to="loc_srt_RestatementAdjustmentMember_a64fc554-b462-4f0e-8072-5cd3c9bfb178" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails" xlink:type="extended" id="i104077ee7e994c37a4978d6d6aabe2d7_RealEstateInvestmentsAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8b0e4be9-c355-4bc8-8369-659b2ec9c0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8b0e4be9-c355-4bc8-8369-659b2ec9c0cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_32d297dd-88aa-49bc-8c26-be00dfa88d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_32d297dd-88aa-49bc-8c26-be00dfa88d61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d23a17fe-e87e-4c6c-a208-b9793c9e2e02" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d23a17fe-e87e-4c6c-a208-b9793c9e2e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_d0eb4321-7431-4cb9-8292-b1b098743768" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_d0eb4321-7431-4cb9-8292-b1b098743768" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_1de7c77d-0e3e-4d5d-b00a-61232c3fb47f" xlink:href="hr-20230331.xsd#hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_1de7c77d-0e3e-4d5d-b00a-61232c3fb47f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:to="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_30771e77-780d-441e-9d9b-f4f3c63aef26_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:to="loc_srt_SegmentGeographicalDomain_30771e77-780d-441e-9d9b-f4f3c63aef26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_835df273-4840-48f6-b497-47e97fba0913" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:to="loc_srt_SegmentGeographicalDomain_835df273-4840-48f6-b497-47e97fba0913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMember_cf69e31c-444a-451d-83ea-59a8fd40e078" xlink:href="hr-20230331.xsd#hr_TampaFLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_835df273-4840-48f6-b497-47e97fba0913" xlink:to="loc_hr_TampaFLMember_cf69e31c-444a-451d-83ea-59a8fd40e078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d025e3dd-880f-4024-8151-2077c1366507_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d025e3dd-880f-4024-8151-2077c1366507_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a4ce094b-e4e7-4dbd-b95a-40d86dbcb976" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a4ce094b-e4e7-4dbd-b95a-40d86dbcb976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember_abb06fbb-fd64-4e56-962b-176afc40aa7b" xlink:href="hr-20230331.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a4ce094b-e4e7-4dbd-b95a-40d86dbcb976" xlink:to="loc_hr_MedicalOfficeBuildingMember_abb06fbb-fd64-4e56-962b-176afc40aa7b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="extended" id="icdcc89baa8bd40ac9dbe04d45b4dff30_RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:href="hr-20230331.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:to="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_55e75180-84a2-42a7-aaf1-d57b9e62898e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_55e75180-84a2-42a7-aaf1-d57b9e62898e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_c268b3d3-3e81-4e46-866e-e28c09a36ffc" xlink:href="hr-20230331.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_c268b3d3-3e81-4e46-866e-e28c09a36ffc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_02325c36-68ef-44cf-9913-7b10fec1e276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_02325c36-68ef-44cf-9913-7b10fec1e276" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_177df562-1388-4044-8fc8-37a618cf2782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_177df562-1388-4044-8fc8-37a618cf2782" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8437605-8ccf-4d95-ae2f-cdaa6649c4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_867446d9-7ff6-4796-ad10-0ebbaa4aa8a6" xlink:href="hr-20230331.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:to="loc_hr_JointVentureOwnershipPercentage_867446d9-7ff6-4796-ad10-0ebbaa4aa8a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:to="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_add61fbf-bb91-42df-a233-9826c3dc16d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_add61fbf-bb91-42df-a233-9826c3dc16d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_723f1068-3263-4321-88e4-db66a74ad60b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_add61fbf-bb91-42df-a233-9826c3dc16d3" xlink:to="loc_srt_OtherPropertyMember_723f1068-3263-4321-88e4-db66a74ad60b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:to="loc_srt_SegmentGeographicalDomain_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d93b1085-92c8-4f21-9c82-701d341ab6a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:to="loc_srt_SegmentGeographicalDomain_d93b1085-92c8-4f21-9c82-701d341ab6a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_27a8d476-76be-47ad-a396-e8dd530b88c3" xlink:href="hr-20230331.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d93b1085-92c8-4f21-9c82-701d341ab6a9" xlink:to="loc_hr_LosAngelesCaliforniaMember_27a8d476-76be-47ad-a396-e8dd530b88c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_0e267693-6d8a-455a-84c9-a46ac871a931_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:to="loc_srt_OwnershipDomain_0e267693-6d8a-455a-84c9-a46ac871a931_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8a3a4235-cd4a-414e-b5c9-bfb9e1a2dd87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:to="loc_srt_OwnershipDomain_8a3a4235-cd4a-414e-b5c9-bfb9e1a2dd87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember_20fc3040-8afd-4296-94fa-a3ac2e7678d0" xlink:href="hr-20230331.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_8a3a4235-cd4a-414e-b5c9-bfb9e1a2dd87" xlink:to="loc_hr_LimitedLiabilityCompanyOneMember_20fc3040-8afd-4296-94fa-a3ac2e7678d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsDispositionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="extended" id="i2f60be0232e640309830ae8288442209_RealEstateInvestmentsDispositionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice_4c6567ed-f75a-466c-86d5-5b0a63e8bc72" xlink:href="hr-20230331.xsd#hr_DispositionSalesPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_DispositionSalesPrice_4c6567ed-f75a-466c-86d5-5b0a63e8bc72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity_11106f57-bf11-4ee0-949e-76d9d1cafc39" xlink:href="hr-20230331.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_ClosingAdjustmentsDisposedEntity_11106f57-bf11-4ee0-949e-76d9d1cafc39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceMortgageNotes_0b190c45-5f5f-484f-96c0-c82578cafc77" xlink:href="hr-20230331.xsd#hr_FinanceMortgageNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_FinanceMortgageNotes_0b190c45-5f5f-484f-96c0-c82578cafc77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_4fac5f5e-eac3-4bb0-a0c0-54d50b2c9d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_4fac5f5e-eac3-4bb0-a0c0-54d50b2c9d74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_41b97500-a495-4fbb-9ec9-86619379ff88" xlink:href="hr-20230331.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_41b97500-a495-4fbb-9ec9-86619379ff88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther_46ceb9bf-c2fd-4ad9-9d56-df942db16989" xlink:href="hr-20230331.xsd#hr_RealEstateOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_RealEstateOther_46ceb9bf-c2fd-4ad9-9d56-df942db16989" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_11e71946-71e1-4fc6-a207-43f33cb4adbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_11e71946-71e1-4fc6-a207-43f33cb4adbd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_0bc8caa5-cd47-4919-9633-aa3bca75b324" xlink:href="hr-20230331.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_0bc8caa5-cd47-4919-9633-aa3bca75b324" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_00496a90-950a-4ff2-9c71-fd7d914f631b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_00496a90-950a-4ff2-9c71-fd7d914f631b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertyDispositions_331fced8-6cc9-49a8-a378-4d0ed40d46d7" xlink:href="hr-20230331.xsd#hr_NumberOfPropertyDispositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_NumberOfPropertyDispositions_331fced8-6cc9-49a8-a378-4d0ed40d46d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_93d5681a-913d-42ed-aa31-8d0b57f65544" xlink:href="hr-20230331.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_JointVentureOwnershipPercentage_93d5681a-913d-42ed-aa31-8d0b57f65544" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNote_156506b3-66a5-4d11-a1c7-6d4ee266fee0" xlink:href="hr-20230331.xsd#hr_MortgageNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_MortgageNote_156506b3-66a5-4d11-a1c7-6d4ee266fee0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:href="hr-20230331.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:to="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bd1fba70-d3fd-49bd-81ab-0cc4507da223_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:to="loc_srt_SegmentGeographicalDomain_bd1fba70-d3fd-49bd-81ab-0cc4507da223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:to="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMiamiFLMember_4dad9c6b-e3dd-4ebc-af28-c1c962cc39be" xlink:href="hr-20230331.xsd#hr_TampaFLMiamiFLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_TampaFLMiamiFLMember_4dad9c6b-e3dd-4ebc-af28-c1c962cc39be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DallasTXMember_25ac5488-97d2-47d9-bc21-921e5e14d149" xlink:href="hr-20230331.xsd#hr_DallasTXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_DallasTXMember_25ac5488-97d2-47d9-bc21-921e5e14d149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_STLouisMoMember_90a46d34-9166-4fa1-9519-65772e4f363d" xlink:href="hr-20230331.xsd#hr_STLouisMoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_STLouisMoMember_90a46d34-9166-4fa1-9519-65772e4f363d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_c1cff59f-f219-49d9-a806-5c3f9ad19ee4" xlink:href="hr-20230331.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_LosAngelesCaliforniaMember_c1cff59f-f219-49d9-a806-5c3f9ad19ee4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4_default" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2cf83f19-96dd-4d01-ac52-09b4bbba3b2c" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2cf83f19-96dd-4d01-ac52-09b4bbba3b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember_c1b6b6a5-fdb1-4a63-8fee-3196cc921d36" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2cf83f19-96dd-4d01-ac52-09b4bbba3b2c" xlink:to="loc_hr_RealEstateDispositionsMember_c1b6b6a5-fdb1-4a63-8fee-3196cc921d36" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended" id="iedf36e657d1248399163684b7b9289dd_RealEstateInvestmentsAssetsHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_2df7ccaa-d390-46f6-8e22-760065bf813a" xlink:href="hr-20230331.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_2df7ccaa-d390-46f6-8e22-760065bf813a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfLandParcelsClassifiedAsHeldForSale_c879c2b7-f089-4269-8be8-d649e37f0363" xlink:href="hr-20230331.xsd#hr_NumberOfLandParcelsClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_NumberOfLandParcelsClassifiedAsHeldForSale_c879c2b7-f089-4269-8be8-d649e37f0363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_d92f1c67-7741-4e68-801d-956887456686" xlink:href="hr-20230331.xsd#hr_ImpairmentChargeOnRealEstateAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_d92f1c67-7741-4e68-801d-956887456686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_37212aad-6841-424b-bd0d-555536295108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_Land_37212aad-6841-424b-bd0d-555536295108" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_fc0f4217-ff01-4da3-9b14-965ee31a1a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_fc0f4217-ff01-4da3-9b14-965ee31a1a32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_22bd2285-3a04-4461-a691-8ee7a2597a7a" xlink:href="hr-20230331.xsd#hr_LeaseIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_LeaseIntangibles_22bd2285-3a04-4461-a691-8ee7a2597a7a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_17a0001d-99c7-4c9b-937f-ccd60993446f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_LandAvailableForDevelopment_17a0001d-99c7-4c9b-937f-ccd60993446f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d2648ea1-dd6e-4be0-88c0-6ec27b60f0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d2648ea1-dd6e-4be0-88c0-6ec27b60f0d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_91183ae9-e100-483f-8aaf-4243fea9f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_91183ae9-e100-483f-8aaf-4243fea9f4a7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_999ed601-2d51-4c3b-a643-35fdb7004fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_999ed601-2d51-4c3b-a643-35fdb7004fa2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_fb324d1a-7ed7-4a2d-b9a5-172b918f0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_fb324d1a-7ed7-4a2d-b9a5-172b918f0e33" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_ae1229ab-9c4a-4406-8282-886cd6b4992d" xlink:href="hr-20230331.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_ae1229ab-9c4a-4406-8282-886cd6b4992d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_51e0b40e-48ea-4da9-b164-589e9a2bb116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_51e0b40e-48ea-4da9-b164-589e9a2bb116" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_c8b1120d-d828-4fea-8103-b102f312df61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_c8b1120d-d828-4fea-8103-b102f312df61" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_24d65f88-d1cd-4f93-b0b6-a0944e0aa62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_24d65f88-d1cd-4f93-b0b6-a0944e0aa62a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_517651ad-f443-4e46-af33-9b382a30c517_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_517651ad-f443-4e46-af33-9b382a30c517_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6cd36677-e96a-4f8a-aae2-7cda4f77d862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6cd36677-e96a-4f8a-aae2-7cda4f77d862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ee5fb1dc-b948-4f37-884c-9977d2b91894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6cd36677-e96a-4f8a-aae2-7cda4f77d862" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ee5fb1dc-b948-4f37-884c-9977d2b91894" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesLeaseIncomeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="extended" id="ib7ff4c4807264240aa2ef8bfa96b6657_LeasesLeaseIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_b00a78eb-4ebc-48e5-9bab-86e4c746abe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_fcc1843d-608c-4768-841c-0fa1f3e0fd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b00a78eb-4ebc-48e5-9bab-86e4c746abe0" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_fcc1843d-608c-4768-841c-0fa1f3e0fd3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b00a78eb-4ebc-48e5-9bab-86e4c746abe0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:to="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_81289260-ffec-486d-a183-d4ec2fab470e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:to="loc_srt_SegmentGeographicalDomain_81289260-ffec-486d-a183-d4ec2fab470e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1c903f38-d3e6-4a8b-8f81-7cf456f5c687" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:to="loc_srt_SegmentGeographicalDomain_1c903f38-d3e6-4a8b-8f81-7cf456f5c687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_54bafa3b-76a2-43c5-b02c-a2287ddb6804" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1c903f38-d3e6-4a8b-8f81-7cf456f5c687" xlink:to="loc_stpr_TX_54bafa3b-76a2-43c5-b02c-a2287ddb6804" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesGroundLeasesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="extended" id="i6a61b246e0fd40c8998d8fbd94d46f85_LeasesGroundLeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_30af4dc8-7801-423f-adff-0eefcadd36cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_30af4dc8-7801-423f-adff-0eefcadd36cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases_4de716be-cfa3-415a-a550-e853dab87da4" xlink:href="hr-20230331.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_SquareFeetSubjecttoGroundLeases_4de716be-cfa3-415a-a550-e853dab87da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3018fcd3-ee7c-4244-8c17-b4a0127a28a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3018fcd3-ee7c-4244-8c17-b4a0127a28a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid_8177f0b7-834f-4b6a-a061-3d03d7c968e9" xlink:href="hr-20230331.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_NumberofGroundLeasesPrepaid_8177f0b7-834f-4b6a-a061-3d03d7c968e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent_abf10120-eb5d-45f2-a930-b944575a56c6" xlink:href="hr-20230331.xsd#hr_AmortizationofPrepaidRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_AmortizationofPrepaidRent_abf10120-eb5d-45f2-a930-b944575a56c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_4569caa2-45c4-4ec2-a891-7f33beb8704e" xlink:href="hr-20230331.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_4569caa2-45c4-4ec2-a891-7f33beb8704e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:to="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_077959dc-117c-4d43-9494-c775fcd664aa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:to="loc_srt_RangeMember_077959dc-117c-4d43-9494-c775fcd664aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:to="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cf86ab05-e7aa-4968-bfa1-88c13ad5ceac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:to="loc_srt_MinimumMember_cf86ab05-e7aa-4968-bfa1-88c13ad5ceac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ba7058d-8f25-4850-ac9a-eb6ac2b9ba0a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:to="loc_srt_MaximumMember_2ba7058d-8f25-4850-ac9a-eb6ac2b9ba0a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#NotesandBondsPayableDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="extended" id="ie4e017fc0ea646b0962b89a4e8dfa45a_NotesandBondsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cdc9a388-f51f-48ad-87da-cb0c0349ff50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_LongTermDebt_cdc9a388-f51f-48ad-87da-cb0c0349ff50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d34b0071-1fb1-4fe8-b240-6d6d3a3c7d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d34b0071-1fb1-4fe8-b240-6d6d3a3c7d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_24606955-cc48-4a90-ad6d-d78ec7c2e283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_24606955-cc48-4a90-ad6d-d78ec7c2e283" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fea3ff72-ef60-4727-9424-3e81e9ef945c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fea3ff72-ef60-4727-9424-3e81e9ef945c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_a6dceee3-ff3a-4003-aec4-914798c5b3f3" xlink:href="hr-20230331.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_a6dceee3-ff3a-4003-aec4-914798c5b3f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_fe2579a6-18b1-43c2-b1be-70970ba3ed8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_fe2579a6-18b1-43c2-b1be-70970ba3ed8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c4bc1576-3765-4c63-b7e0-f819939bab49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c4bc1576-3765-4c63-b7e0-f819939bab49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e3a2f47e-8e87-49bc-9117-734d3a4054dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_LineOfCreditMember_e3a2f47e-8e87-49bc-9117-734d3a4054dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_f080f428-7850-444c-a95b-6decae6dfda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_MediumTermNotesMember_f080f428-7850-444c-a95b-6decae6dfda3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_457f1bd5-253a-448a-9b89-062fc89006b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_SeniorNotesMember_457f1bd5-253a-448a-9b89-062fc89006b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_bc73d965-04fe-4a9b-8b27-41fa41c88be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_MortgagesMember_bc73d965-04fe-4a9b-8b27-41fa41c88be6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_71789274-4489-4c1e-997a-69e3f72c2765_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_71789274-4489-4c1e-997a-69e3f72c2765_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4e02d1f1-c618-4420-81ba-03779a90a1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4e02d1f1-c618-4420-81ba-03779a90a1e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_df12bb03-0913-4cc3-b1c8-ee754585fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4e02d1f1-c618-4420-81ba-03779a90a1e6" xlink:to="loc_us-gaap_MortgagesMember_df12bb03-0913-4cc3-b1c8-ee754585fa9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember_a26fede4-6195-4ed1-97fe-99f8bb3cb1b6" xlink:href="hr-20230331.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_UnsecuredCreditFacilityOneMember_a26fede4-6195-4ed1-97fe-99f8bb3cb1b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2023Member_1f2e8082-7979-47a9-bbbb-9ce49dbec98b" xlink:href="hr-20230331.xsd#hr_TermLoanDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2023Member_1f2e8082-7979-47a9-bbbb-9ce49dbec98b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2024Member_7978d559-40e1-4ad3-ae77-904d4312af8e" xlink:href="hr-20230331.xsd#hr_TermLoandue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoandue2024Member_7978d559-40e1-4ad3-ae77-904d4312af8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member_6ef00867-4863-45e2-b4b2-b2a8e38eeedb" xlink:href="hr-20230331.xsd#hr_TermLoanDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2025Member_6ef00867-4863-45e2-b4b2-b2a8e38eeedb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member_b9fd2e58-d9e9-429b-9f80-8b7a78a2bf24" xlink:href="hr-20230331.xsd#hr_TermLoandue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoandue2026Member_b9fd2e58-d9e9-429b-9f80-8b7a78a2bf24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member_88db1519-51cf-4dd1-b012-30f7490e7c9a" xlink:href="hr-20230331.xsd#hr_TermLoanDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2027Member_88db1519-51cf-4dd1-b012-30f7490e7c9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member_709332f4-a5ff-4b71-abb3-43225f1877f3" xlink:href="hr-20230331.xsd#hr_TermLoanDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2028Member_709332f4-a5ff-4b71-abb3-43225f1877f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member_d16684a5-1cca-4f58-b11b-d0be64c88849" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesdue2025Member_d16684a5-1cca-4f58-b11b-d0be64c88849" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member_4d377c5d-33da-4e8e-9d43-cad93d0380c6" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2026Member_4d377c5d-33da-4e8e-9d43-cad93d0380c6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member_25ace3d0-ce2d-4e8a-9336-e53075f62282" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2027Member_25ace3d0-ce2d-4e8a-9336-e53075f62282" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member_3f890823-23c3-40fa-a359-8cbad5efcdf2" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesdue2028Member_3f890823-23c3-40fa-a359-8cbad5efcdf2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_6924f099-7a9b-4501-b1bb-81c88aa9444c" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_6924f099-7a9b-4501-b1bb-81c88aa9444c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member_7c0675af-069a-4b43-b69a-f5cd5bf02a01" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesdue2030Member_7c0675af-069a-4b43-b69a-f5cd5bf02a01" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member_1fc70efa-852b-432d-94c3-9b14f0e6a0d6" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2031Member_1fc70efa-852b-432d-94c3-9b14f0e6a0d6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_b4af4054-d962-42d1-b8f6-65ba8c19591e" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_b4af4054-d962-42d1-b8f6-65ba8c19591e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_b0fb4673-7c11-497c-9f45-539dfe7df86f" xlink:href="hr-20230331.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_MortgageNotesPayableNetMember_b0fb4673-7c11-497c-9f45-539dfe7df86f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_292e5241-c6ef-4e3e-a394-3b35b430d722_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_292e5241-c6ef-4e3e-a394-3b35b430d722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_527266ae-e213-4fa5-a165-2551585783d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_527266ae-e213-4fa5-a165-2551585783d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_81008ed3-3a4c-4fa7-9e43-bef23dbdfaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_527266ae-e213-4fa5-a165-2551585783d1" xlink:to="loc_us-gaap_SubsequentEventMember_81008ed3-3a4c-4fa7-9e43-bef23dbdfaee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b862e8c3-687a-43fe-97ac-b52929393957_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:to="loc_srt_RangeMember_b862e8c3-687a-43fe-97ac-b52929393957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:to="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32c1b79f-c958-4206-9d88-629d445d68a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:to="loc_srt_MinimumMember_32c1b79f-c958-4206-9d88-629d445d68a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a0a81991-760d-4407-a771-13e19cdb0b8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:to="loc_srt_MaximumMember_a0a81991-760d-4407-a771-13e19cdb0b8c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="extended" id="i85518a42c4b54926ba38b0eb600ad314_DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5acd3134-0a85-496d-96c1-7c736a7bd132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5acd3134-0a85-496d-96c1-7c736a7bd132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_47d9c252-546f-4112-a198-a55b09d009a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_DerivativeNotionalAmount_47d9c252-546f-4112-a198-a55b09d009a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_73f4ee70-60e2-43f6-b5bd-3908a6e09b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_73f4ee70-60e2-43f6-b5bd-3908a6e09b15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_90293ad0-95b1-41a0-b47b-61777dc37453_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_90293ad0-95b1-41a0-b47b-61777dc37453_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_559d8399-e9a6-4126-86e0-1c01377c678b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_559d8399-e9a6-4126-86e0-1c01377c678b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559d8399-e9a6-4126-86e0-1c01377c678b" xlink:to="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJanuary152024Member_e9e65653-05a2-470f-899e-9f5fb64dce0e" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJanuary152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringJanuary152024Member_e9e65653-05a2-470f-899e-9f5fb64dce0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member_b0aad2b4-4e49-4fb0-ba5d-4b4d6c134cb0" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringMay12026Member_b0aad2b4-4e49-4fb0-ba5d-4b4d6c134cb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member_3d5e32d7-74d9-42c3-a463-4707d8909a21" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringJune12026Member_3d5e32d7-74d9-42c3-a463-4707d8909a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member_4784ef2e-014b-4a8c-998f-ba6fcd9b861b" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringDecember12026Member_4784ef2e-014b-4a8c-998f-ba6fcd9b861b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member_249baffe-bbe1-484e-9b64-e28eb5c22d65" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringJune12027Member_249baffe-bbe1-484e-9b64-e28eb5c22d65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member_38c8608d-dd61-437e-a8c8-c8897f1c8656" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringDecember12027Member_38c8608d-dd61-437e-a8c8-c8897f1c8656" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1875444b-ad2d-45ee-9418-76ce7252f0ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1875444b-ad2d-45ee-9418-76ce7252f0ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_05bb7242-55f5-4b04-a1eb-a3608060b566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:to="loc_us-gaap_HedgingRelationshipDomain_05bb7242-55f5-4b04-a1eb-a3608060b566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4ff8a4de-a948-4264-ac2a-2be1488ee54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_05bb7242-55f5-4b04-a1eb-a3608060b566" xlink:to="loc_us-gaap_CashFlowHedgingMember_4ff8a4de-a948-4264-ac2a-2be1488ee54e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_69b1dc3f-e958-4f0d-b2f6-d2b8ce845c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_69b1dc3f-e958-4f0d-b2f6-d2b8ce845c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bac70c62-73cb-476d-ab6d-006c14a468e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_69b1dc3f-e958-4f0d-b2f6-d2b8ce845c46" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bac70c62-73cb-476d-ab6d-006c14a468e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="extended" id="iec14d65f00b947c49a40e5f9c435b258_DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f9ce0962-54db-4f33-97aa-7dc1d32df6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0493b3c0-d5b0-4d7e-81e9-2fb88f4d4232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f9ce0962-54db-4f33-97aa-7dc1d32df6d9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0493b3c0-d5b0-4d7e-81e9-2fb88f4d4232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_f9ce0962-54db-4f33-97aa-7dc1d32df6d9" xlink:to="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_feed0e94-8678-44f4-a159-385872aec5a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_feed0e94-8678-44f4-a159-385872aec5a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_ebb137e8-a856-427b-b4c1-1f3e53672d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:to="loc_us-gaap_OtherLiabilitiesMember_ebb137e8-a856-427b-b4c1-1f3e53672d82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_9d52cc2e-6cc0-4542-b742-15de37072f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:to="loc_us-gaap_OtherAssetsMember_9d52cc2e-6cc0-4542-b742-15de37072f89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3d9e1084-fc7d-47cc-a647-b97c0fd708a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_3d9e1084-fc7d-47cc-a647-b97c0fd708a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_931fa55e-cb43-474d-8803-4b5459700706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_931fa55e-cb43-474d-8803-4b5459700706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac2979f0-3f67-4242-af65-c152abd7837b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_931fa55e-cb43-474d-8803-4b5459700706" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac2979f0-3f67-4242-af65-c152abd7837b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwaps2017And2018Member_3b55b656-5555-4c2c-996f-7bb29e4bbb21" xlink:href="hr-20230331.xsd#hr_InterestRateSwaps2017And2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:to="loc_hr_InterestRateSwaps2017And2018Member_3b55b656-5555-4c2c-996f-7bb29e4bbb21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwaps20172018And2019Member_c8346721-fb29-42ed-8bba-c1db161f06a7" xlink:href="hr-20230331.xsd#hr_InterestRateSwaps20172018And2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:to="loc_hr_InterestRateSwaps20172018And2019Member_c8346721-fb29-42ed-8bba-c1db161f06a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_85d61f9a-b81e-44d3-9725-e59cdaa79ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:to="loc_us-gaap_InterestRateSwapMember_85d61f9a-b81e-44d3-9725-e59cdaa79ee7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="extended" id="i7618b9beeb9d4e949d9ea51ed40565ba_DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_24e7b48d-aa7d-44da-9205-11e021c01fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_24e7b48d-aa7d-44da-9205-11e021c01fe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b68aeafb-af1a-43fb-a03c-a46049024bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b68aeafb-af1a-43fb-a03c-a46049024bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:to="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8a085541-5a4d-485d-9751-65ae68725577_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8a085541-5a4d-485d-9751-65ae68725577_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_cdb21a85-8ade-44a6-943e-4464e186e08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:to="loc_us-gaap_InterestRateContractMember_cdb21a85-8ade-44a6-943e-4464e186e08b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_0cce1a57-b442-4502-97f4-b85d63187b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:to="loc_us-gaap_TreasuryLockMember_0cce1a57-b442-4502-97f4-b85d63187b46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_40aa0812-ba0e-4c2f-83a7-e1b686228ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:to="loc_us-gaap_InterestRateSwapMember_40aa0812-ba0e-4c2f-83a7-e1b686228ae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_18db2e72-1bad-4188-882d-fe3c223656da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_18db2e72-1bad-4188-882d-fe3c223656da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b51d75d6-efb6-46d6-8913-009c60ac907e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b51d75d6-efb6-46d6-8913-009c60ac907e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_eaa30af3-fb88-4751-b446-043a52a92edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b51d75d6-efb6-46d6-8913-009c60ac907e" xlink:to="loc_us-gaap_InterestExpenseMember_eaa30af3-fb88-4751-b446-043a52a92edb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended" id="i0b1f46d64c5a47139ee94acb5939449a_DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_98b115ee-1ffd-4c1a-b0a4-dc9ba48c25be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_98b115ee-1ffd-4c1a-b0a4-dc9ba48c25be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DerivativeNetAssetPositionAggregateFairValue_21de1bc4-0c72-480c-9a56-2911752b57b2" xlink:href="hr-20230331.xsd#hr_DerivativeNetAssetPositionAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:to="loc_hr_DerivativeNetAssetPositionAggregateFairValue_21de1bc4-0c72-480c-9a56-2911752b57b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:to="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d2a82292-84a2-4e39-a5d6-871f0f363e07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d2a82292-84a2-4e39-a5d6-871f0f363e07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember_6d9c27ad-7d90-424c-9733-6e3fa9ea1a81" xlink:href="hr-20230331.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:to="loc_hr_ActiveInterestRateSwapsMember_6d9c27ad-7d90-424c-9733-6e3fa9ea1a81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember_ba487cd5-32f5-4a0d-9761-1a1fea20aad1" xlink:href="hr-20230331.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:to="loc_hr_SettledInterestRateSwapsMember_ba487cd5-32f5-4a0d-9761-1a1fea20aad1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="extended" id="i1f530c3c9467424f94d0b138d445eeac_StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_34ee6a20-91ee-435f-94b8-fd02825bb83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:href="hr-20230331.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_34ee6a20-91ee-435f-94b8-fd02825bb83a" xlink:to="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca3225c5-8bac-4535-9254-213af899e497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca3225c5-8bac-4535-9254-213af899e497" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3633ff29-3bbf-4fe3-a293-c74da5491d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3633ff29-3bbf-4fe3-a293-c74da5491d82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9e43a95c-8387-402c-9c2c-261c7b8ee0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9e43a95c-8387-402c-9c2c-261c7b8ee0ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7721426f-9f36-4182-90f8-9b08a17afc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_34ee6a20-91ee-435f-94b8-fd02825bb83a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:to="loc_us-gaap_EquityComponentDomain_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d22665b5-c2d0-40fe-ac66-3abdb6e12e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:to="loc_us-gaap_EquityComponentDomain_d22665b5-c2d0-40fe-ac66-3abdb6e12e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9adf48fd-1033-44af-89a8-448f7e432ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d22665b5-c2d0-40fe-ac66-3abdb6e12e55" xlink:to="loc_us-gaap_CommonStockMember_9adf48fd-1033-44af-89a8-448f7e432ee0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityStockTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="extended" id="i9cf45affcb5a4a9e87396799fc267381_StockholdersEquityStockTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOfferingProgramAvailableForIssuance_cd9abde0-6d4e-41c0-b633-c2d5a52246f6" xlink:href="hr-20230331.xsd#hr_EquityOfferingProgramAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_EquityOfferingProgramAvailableForIssuance_cd9abde0-6d4e-41c0-b633-c2d5a52246f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_c9a7c4ef-2b45-4141-9c88-b6880c5e35f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_c9a7c4ef-2b45-4141-9c88-b6880c5e35f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a5a94d27-ab41-46b7-89a6-1d77d2f9497c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a5a94d27-ab41-46b7-89a6-1d77d2f9497c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_a8bdcb7c-0529-4293-8794-8aee98e104f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_a8bdcb7c-0529-4293-8794-8aee98e104f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4807e224-fc44-4258-ac01-d4906e386827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4807e224-fc44-4258-ac01-d4906e386827" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_86004718-000b-44ca-9cf3-6c700b453d6b" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_86004718-000b-44ca-9cf3-6c700b453d6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04a88952-0d21-4358-b232-608c230de9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04a88952-0d21-4358-b232-608c230de9ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c39174a0-1ffb-4964-ab38-6df7bd11f631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c39174a0-1ffb-4964-ab38-6df7bd11f631" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0ea3428b-1dfc-4528-aa41-59b627353f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0ea3428b-1dfc-4528-aa41-59b627353f71" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits_447044e1-d546-4587-829a-fe5d27cb9fb4" xlink:href="hr-20230331.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_PercentageOfRestrictedStockUnits_447044e1-d546-4587-829a-fe5d27cb9fb4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_973a3198-ecc0-4c9a-927c-c2d04f4a2607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_973a3198-ecc0-4c9a-927c-c2d04f4a2607" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_940aaf6a-f5a2-4d06-8c54-f1166a8ef88e" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_940aaf6a-f5a2-4d06-8c54-f1166a8ef88e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0866d259-4de7-45e3-a678-3908e3c15944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0866d259-4de7-45e3-a678-3908e3c15944" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cd72d4a0-428a-483c-ab31-9b86d9162c76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:to="loc_us-gaap_EquityComponentDomain_cd72d4a0-428a-483c-ab31-9b86d9162c76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce23defc-2964-47c7-9539-577bb1e1a4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:to="loc_us-gaap_EquityComponentDomain_ce23defc-2964-47c7-9539-577bb1e1a4f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e7d4e04d-dd9d-4bc0-b19c-78df7b601829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ce23defc-2964-47c7-9539-577bb1e1a4f5" xlink:to="loc_us-gaap_CommonStockMember_e7d4e04d-dd9d-4bc0-b19c-78df7b601829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0cb46c05-9e74-440c-a529-0e39d04e2a33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0cb46c05-9e74-440c-a529-0e39d04e2a33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_457a0fd2-865d-4748-94e0-2b49765abad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_457a0fd2-865d-4748-94e0-2b49765abad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bcf9b94b-bd82-4ebf-bc73-6abe1ff2f1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_457a0fd2-865d-4748-94e0-2b49765abad8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bcf9b94b-bd82-4ebf-bc73-6abe1ff2f1d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:to="loc_us-gaap_PlanNameDomain_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:to="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember_af7af487-a00d-42b6-a19a-85c41e0f3f30" xlink:href="hr-20230331.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:to="loc_hr_ExecutiveIncentiveProgramMember_af7af487-a00d-42b6-a19a-85c41e0f3f30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_6c580f94-54c9-4a02-800d-eed1bd95d80d" xlink:href="hr-20230331.xsd#hr_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:to="loc_hr_StockIncentivePlanMember_6c580f94-54c9-4a02-800d-eed1bd95d80d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9216f4ee-5903-47bc-9f88-e1162f270428_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:to="loc_srt_RangeMember_9216f4ee-5903-47bc-9f88-e1162f270428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:to="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a7e1d991-b84b-441d-8a43-8addab207b17" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:to="loc_srt_MinimumMember_a7e1d991-b84b-441d-8a43-8addab207b17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d1d950a6-2f32-4ad7-93ed-b1b68a23b523" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:to="loc_srt_MaximumMember_d1d950a6-2f32-4ad7-93ed-b1b68a23b523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_140ed673-92c0-4dfd-8e27-92662e9d0722_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_140ed673-92c0-4dfd-8e27-92662e9d0722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a1e3061-906e-44f0-b4a5-03c4ede90035" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a1e3061-906e-44f0-b4a5-03c4ede90035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember_c711077c-f895-46e6-9008-5bae8654c62c" xlink:href="hr-20230331.xsd#hr_DirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a1e3061-906e-44f0-b4a5-03c4ede90035" xlink:to="loc_hr_DirectorsMember_c711077c-f895-46e6-9008-5bae8654c62c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c0736bf-1e38-4807-a3ce-8992152f5428_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c0736bf-1e38-4807-a3ce-8992152f5428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_f3e78c57-ed7e-4813-b5db-2da3d18b1c1d" xlink:href="hr-20230331.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_f3e78c57-ed7e-4813-b5db-2da3d18b1c1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_8130f79d-8310-46c5-91bd-9df76685ee8d" xlink:href="hr-20230331.xsd#hr_NonVestedStockAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_hr_NonVestedStockAwardMember_8130f79d-8310-46c5-91bd-9df76685ee8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0e3911b3-25ba-4c61-affe-99aa1e65f126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_us-gaap_RestrictedStockMember_0e3911b3-25ba-4c61-affe-99aa1e65f126" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9dcb1992-740d-4210-a6ad-c33fb2382947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9dcb1992-740d-4210-a6ad-c33fb2382947" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_7b0f3500-011d-421d-b07f-8ee3a57ae85e_default" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:to="loc_hr_StockIssuanceProgramDomain_7b0f3500-011d-421d-b07f-8ee3a57ae85e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_46601860-21b1-4047-aa57-1c861e32580b" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:to="loc_hr_StockIssuanceProgramDomain_46601860-21b1-4047-aa57-1c861e32580b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:href="hr-20230331.xsd#hr_PerformanceConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_StockIssuanceProgramDomain_46601860-21b1-4047-aa57-1c861e32580b" xlink:to="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition1Member_e24e4e48-0421-4569-9f8e-bfda49be78d1" xlink:href="hr-20230331.xsd#hr_MarketCondition1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:to="loc_hr_MarketCondition1Member_e24e4e48-0421-4569-9f8e-bfda49be78d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member_4179c3c2-2721-47eb-9eac-763068403a23" xlink:href="hr-20230331.xsd#hr_MarketCondition2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:to="loc_hr_MarketCondition2Member_4179c3c2-2721-47eb-9eac-763068403a23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_986dadfb-e6f7-44ee-9ece-94a731fee60e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:to="loc_us-gaap_GranteeStatusDomain_986dadfb-e6f7-44ee-9ece-94a731fee60e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_71d505d2-1eed-45c8-a0d5-cec25d2649df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:to="loc_us-gaap_GranteeStatusDomain_71d505d2-1eed-45c8-a0d5-cec25d2649df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_686c5222-64b5-4f08-a00d-15013873ed16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_71d505d2-1eed-45c8-a0d5-cec25d2649df" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_686c5222-64b5-4f08-a00d-15013873ed16" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended" id="i27a99e916b434fa09a68d62536b328e5_StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d61864d-9ec4-4a5d-9b6d-e890d3b792db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d61864d-9ec4-4a5d-9b6d-e890d3b792db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_98782506-9083-4f02-9486-3f19858f0e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_98782506-9083-4f02-9486-3f19858f0e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7c351c2b-deff-425f-8173-9959907acb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7c351c2b-deff-425f-8173-9959907acb2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_519d320d-8575-4c3a-ab17-a081c7a11937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_519d320d-8575-4c3a-ab17-a081c7a11937" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a3dc4dc0-70e4-40d7-8b91-97ced99d128c" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a3dc4dc0-70e4-40d7-8b91-97ced99d128c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d61864d-9ec4-4a5d-9b6d-e890d3b792db" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:to="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_239cd08a-5882-4813-ae5c-57bbf036780a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_239cd08a-5882-4813-ae5c-57bbf036780a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_031253c8-d6dc-4475-a184-9e58befbdc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_031253c8-d6dc-4475-a184-9e58befbdc78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_4aca3ea4-e1f3-4018-9e10-413f7e1839cb" xlink:href="hr-20230331.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_4aca3ea4-e1f3-4018-9e10-413f7e1839cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails" xlink:type="extended" id="i2b7404cf5f09434da1766a77542f678a_StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75510010-2019-4f07-a4ae-863c1da25b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75510010-2019-4f07-a4ae-863c1da25b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_057c04bc-6574-4750-9362-5eca84d5e349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_057c04bc-6574-4750-9362-5eca84d5e349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4e6b9dd1-505a-4a2d-b5d8-93c04224e6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4e6b9dd1-505a-4a2d-b5d8-93c04224e6f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_c5d3daa1-b9f7-4135-bba9-05d440df2eb1" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_c5d3daa1-b9f7-4135-bba9-05d440df2eb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bd04b987-edbd-4dfb-9008-414bf772d37c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bd04b987-edbd-4dfb-9008-414bf772d37c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4e88b16-77f5-475a-a122-31c16084394f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ba67cc5f-7a5f-445c-9c3d-65dff46e4539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ba67cc5f-7a5f-445c-9c3d-65dff46e4539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5e1400bd-28c2-46a3-8160-b29c8c54430f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5e1400bd-28c2-46a3-8160-b29c8c54430f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_38c907cc-743b-41ca-a9c7-e82e996c0531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_38c907cc-743b-41ca-a9c7-e82e996c0531" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_6b7dc237-daa9-4970-99d3-b3b0d8ae2e88" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_6b7dc237-daa9-4970-99d3-b3b0d8ae2e88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c22cb9d-4edb-4629-9ee4-2c1f6efc1d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:to="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d847b040-41cd-47f6-904b-ce1c4d4b3923_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:to="loc_us-gaap_PlanNameDomain_d847b040-41cd-47f6-904b-ce1c4d4b3923_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7e1f550e-2e1a-40bc-96d1-3a0576485685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:to="loc_us-gaap_PlanNameDomain_7e1f550e-2e1a-40bc-96d1-3a0576485685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_412e387b-6b57-468a-adec-9f2af3bccd54" xlink:href="hr-20230331.xsd#hr_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7e1f550e-2e1a-40bc-96d1-3a0576485685" xlink:to="loc_hr_StockIncentivePlanMember_412e387b-6b57-468a-adec-9f2af3bccd54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:to="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05892119-6058-4629-b326-385fcacefeff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05892119-6058-4629-b326-385fcacefeff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d3603e7-e5a5-45aa-8751-327b046e2a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d3603e7-e5a5-45aa-8751-327b046e2a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_51c0797a-5fc3-4d96-8a90-cbe6cfd5fde3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d3603e7-e5a5-45aa-8751-327b046e2a05" xlink:to="loc_us-gaap_RestrictedStockMember_51c0797a-5fc3-4d96-8a90-cbe6cfd5fde3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="extended" id="i75ab2b45aba04a259764566757aa5c0c_StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_612927d9-aa4c-4257-9b32-309c4c2cfd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_612927d9-aa4c-4257-9b32-309c4c2cfd56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46e72a97-90ba-4062-bf88-9c4b7be646eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46e72a97-90ba-4062-bf88-9c4b7be646eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_928d9394-2e2a-4f67-8444-a36a92ccaa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_928d9394-2e2a-4f67-8444-a36a92ccaa4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83291ad4-88ab-47fb-9933-ad113b5def44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83291ad4-88ab-47fb-9933-ad113b5def44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4654161a-edc5-4d4f-b99c-39dde62a349e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4654161a-edc5-4d4f-b99c-39dde62a349e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f28b915e-34b8-4614-84cd-b124e2b2da58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f28b915e-34b8-4614-84cd-b124e2b2da58" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a9b5e762-d870-42c7-a23f-02288f61ce47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_612927d9-aa4c-4257-9b32-309c4c2cfd56" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:to="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7e91f57-f83d-471b-87dd-fb9ab79d141c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7e91f57-f83d-471b-87dd-fb9ab79d141c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e9995a6-e4f6-4a10-8afb-076087414c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e9995a6-e4f6-4a10-8afb-076087414c3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_c08f46fc-e9d8-4bf3-9e8e-e420a8eb41c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e9995a6-e4f6-4a10-8afb-076087414c3c" xlink:to="loc_us-gaap_EmployeeStockMember_c08f46fc-e9d8-4bf3-9e8e-e420a8eb41c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended" id="i9b554a953fc447edb396f68a45921924_FairValueofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_035ef4af-2342-4a4c-b500-990f81ab2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:to="loc_us-gaap_DebtInstrumentFairValue_035ef4af-2342-4a4c-b500-990f81ab2f7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_06c9ca58-885f-4149-91b2-7c30bb884f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_06c9ca58-885f-4149-91b2-7c30bb884f8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:to="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2e09a709-dc39-462e-b0b7-35c518eb2dcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2e09a709-dc39-462e-b0b7-35c518eb2dcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6d99b50f-0f4d-4646-bb67-b4c8aeec57ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6d99b50f-0f4d-4646-bb67-b4c8aeec57ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6d99b50f-0f4d-4646-bb67-b4c8aeec57ec" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_753acfc2-efd2-478c-9893-0db97801aad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_753acfc2-efd2-478c-9893-0db97801aad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1dec84a8-df95-4a30-9648-048ba400c767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1dec84a8-df95-4a30-9648-048ba400c767" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hr-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:388a749e-3c99-4328-89c5-127682212508,g:16eafbb3-991c-406c-96b0-65d8e7977cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_8f3dde4c-a9d9-4b0f-8864-24f39bfd6641_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_a3a654b2-85c7-4fa1-b7c9-fdc0f9045ae3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_784d9c39-ac77-43f6-82e7-94455396b5e5_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_9c7ea402-a215-49d6-9971-39cd3ccae3a2_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:to="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_2a011c7e-4b3d-4a9f-a719-fa1020d5ee9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_97bdf82b-4e8c-4524-8cf5-4b9089b02f66_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_463569b1-6e57-4bc4-948f-cdd0072a552a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_1b3f2a3f-5581-4c0c-b0bb-963e77cd3191_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5c3a172b-56c4-44b5-a358-db818050f9bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1d6e88cb-46f5-43ac-9aa1-22facffffb6d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_38864599-69ed-4e8d-b9d1-39fe745a4e4e_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill adjustment incomplete</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_2380714c-3007-48e2-9d35-273304ea061c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_89c9d5a9-b68b-4cad-a552-de22464b5979_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate investments</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8114bf6d-d1b4-4b28-a108-e5d9d1a93982_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_1f0ceae3-c418-4e98-9714-cacd38007619_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_a063c647-f62f-46b6-9d50-a7d5945c0514_terseLabel_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables and other assets</link:label>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_label_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables And Other Assets</link:label>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_documentation_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets" xlink:href="hr-20230331.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReceivablesAndOtherAssets" xlink:to="lab_hr_ReceivablesAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_8f5495ad-5033-45a3-a1ed-0ab01c5b1c1b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoandue2024Member_c5f1b03b-2a70-4fee-b464-a372ab0abc96_terseLabel_en-US" xlink:label="lab_hr_TermLoandue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million Unsecured Term Loan due 2024, net of issuance costs</link:label>
    <link:label id="lab_hr_TermLoandue2024Member_label_en-US" xlink:label="lab_hr_TermLoandue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2024 [Member]</link:label>
    <link:label id="lab_hr_TermLoandue2024Member_documentation_en-US" xlink:label="lab_hr_TermLoandue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2024Member" xlink:href="hr-20230331.xsd#hr_TermLoandue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoandue2024Member" xlink:to="lab_hr_TermLoandue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_92d3c47a-2ca8-4447-a661-ab6b28eeb989_terseLabel_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of prepaid ground leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_label_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases Prepaid</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_documentation_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases Prepaid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid" xlink:href="hr-20230331.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberofGroundLeasesPrepaid" xlink:to="lab_hr_NumberofGroundLeasesPrepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_5beb4520-9ede-4a36-a999-2abbfa29abef_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_30dc2c66-4e32-469c-8fab-fdaa021dcab3_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_ce6cb8f3-7aa5-4c0d-9990-a45f8f6193b1_verboseLabel_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Employee Stock Purchase Plan</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental common shares attributable to dilutive effect of employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:href="hr-20230331.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:to="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_dee33c84-48df-44f6-8120-e2e4d46a336d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities_264c547d-98cc-4090-aac6-880ff0cc7d0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_50ac7b23-847b-428e-bb67-0cb9a9dfdc2a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_4ae8fde9-cbe4-41c0-8399-6594e7a0f8a6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_4a15fb5b-ad74-431e-951e-9c757880f465_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_18b3938c-1a0d-4563-aacc-672c26446e1a_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate properties</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_bb8d1e71-a89d-4504-80ad-db876430e332_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investment property, at cost</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, at Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a5918377-c999-4358-b334-de6e82e1adcf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2de79c24-6dca-47f7-ad34-7c11fc75353c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7c22dad6-8b24-4d58-9d0c-cd4137fdb34b_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_5565b870-951a-4c90-88d6-73bc94fa2f68_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partner's capital, units outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_label_en-US" xlink:label="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Partners' Capital Account, Units Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:to="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_99582e63-1b1b-4103-b82f-3f239aec9225_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_STLouisMoMember_3f709434-8331-49e8-9dd9-dd2c5d9511bd_terseLabel_en-US" xlink:label="lab_hr_STLouisMoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">St. Louis, MO</link:label>
    <link:label id="lab_hr_STLouisMoMember_label_en-US" xlink:label="lab_hr_STLouisMoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Louis Mo [Member]</link:label>
    <link:label id="lab_hr_STLouisMoMember_documentation_en-US" xlink:label="lab_hr_STLouisMoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Louis Mo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_STLouisMoMember" xlink:href="hr-20230331.xsd#hr_STLouisMoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_STLouisMoMember" xlink:to="lab_hr_STLouisMoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d8653a39-4a7d-4051-b13a-e02d1ca1431c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f84bbb88-4f8a-48fe-9799-bdd26584b5c8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d9694e57-29ae-4a57-b10e-e456ccfc5180_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4c9078e5-04c8-4bfc-8b94-81dbd2757fd5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_e0f6185c-b7d0-416b-a1aa-ae1becefda52_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9ad7ceaa-f38d-4441-860f-da7fc37e3a69_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested share-based awards, net of withheld shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26d03dd2-4c16-4591-9638-6e76815b5f5e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_6d7bdc0e-3d24-4bfc-9c31-97d49f13b760_terseLabel_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET REAL ESTATE INVESTMENT</link:label>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_label_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Net Disposed of During Period</link:label>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_documentation_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investment net disposed of during the Period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:href="hr-20230331.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:to="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_0772ef3b-847f-4784-b15a-6141355c10a4_terseLabel_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="hr-20230331.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_ff8e7259-5e73-4304-90d2-acb107412f01_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecurityDepositLiability_72c2e40b-9991-4282-998b-c38defb989c9_terseLabel_en-US" xlink:label="lab_us-gaap_SecurityDepositLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security deposits</link:label>
    <link:label id="lab_us-gaap_SecurityDepositLiability_label_en-US" xlink:label="lab_us-gaap_SecurityDepositLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Deposit Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDepositLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDepositLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecurityDepositLiability" xlink:to="lab_us-gaap_SecurityDepositLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_a2a77cdf-ee46-4ec2-91ca-5fc25fbe3193_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional long-lived assets, net</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_6236a8bd-ac84-4d36-ab97-ebb18975e91e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implied shares of Legacy HR Common Stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_45f97420-e66c-4991-afc7-c0aeb8efec9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_a9ab67d6-ddc0-49ea-8944-64ef669161f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ConstructionActivityTotalFundingToDate_72e5f11f-73bf-4458-8277-d6076e315c8d_terseLabel_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project costs</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingToDate_label_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Activity, Total Funding to Date</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingToDate_documentation_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Activity, Total Funding to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingToDate" xlink:href="hr-20230331.xsd#hr_ConstructionActivityTotalFundingToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ConstructionActivityTotalFundingToDate" xlink:to="lab_hr_ConstructionActivityTotalFundingToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_640fc178-e544-4074-8700-6ebfa321a8cf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_46058ad0-e0aa-4ce5-9e8b-adbd3b267ec0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8baa1561-497f-4593-9b0c-5cf1033da4d1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_0712d768-be39-4862-be48-fcf33bc2d609_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MezzanineLoansTexasMember_58b683bf-837e-46c1-88da-0c25cd9d958a_terseLabel_en-US" xlink:label="lab_hr_MezzanineLoansTexasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine Loans Texas</link:label>
    <link:label id="lab_hr_MezzanineLoansTexasMember_label_en-US" xlink:label="lab_hr_MezzanineLoansTexasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine Loans Texas [Member]</link:label>
    <link:label id="lab_hr_MezzanineLoansTexasMember_documentation_en-US" xlink:label="lab_hr_MezzanineLoansTexasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine Loans Texas</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoansTexasMember" xlink:href="hr-20230331.xsd#hr_MezzanineLoansTexasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MezzanineLoansTexasMember" xlink:to="lab_hr_MezzanineLoansTexasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_8526b19d-c1c5-4c32-867b-adce1ed20eb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:to="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus_58ea0d69-1937-4da9-8754-d1dcbcc6bb1f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, nonaccrual</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Nonaccrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_61179d9e-1835-40e0-a799-71e9baca3f53_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average incremental shares of common stock excluded from the computation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_13f85206-68db-434b-a111-994d28bc061e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_50cfb67f-e9bf-4407-a388-08fce817e492_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_29243d71-03f1-409b-b6e7-3585d40a1d5e_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringMay12026Member" xlink:to="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_4cf2142a-1717-4c5a-933e-bae2023a82b4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2028Member_059082c9-77ec-4324-905d-2ee8ea3e2fef_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2028</link:label>
    <link:label id="lab_hr_SeniorNotesdue2028Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2028 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2028Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2028Member" xlink:to="lab_hr_SeniorNotesdue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_VariableInterestEntityMember_d348c2a9-6865-4375-828a-74332b13ac27_terseLabel_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_hr_VariableInterestEntityMember_label_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Member]</link:label>
    <link:label id="lab_hr_VariableInterestEntityMember_documentation_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember" xlink:href="hr-20230331.xsd#hr_VariableInterestEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_VariableInterestEntityMember" xlink:to="lab_hr_VariableInterestEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_dd4f9a66-93d4-4744-98a4-531a5e4dbe41_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_79d4d3e0-75f9-4e3b-bd0d-d9e217d8aee9_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties classified as held for sale</link:label>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_label_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Properties Classified as Held for Sale</link:label>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_documentation_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Properties Classified as Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:href="hr-20230331.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:to="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_ed9e08f3-4e98-4a1d-b129-55be9bf6838d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_5f810559-d8e9-4608-b481-91ea7ad33c30_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_e4d272ab-ecd4-40c3-a498-883ee121e4ec_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_6b15aea8-3cca-4bbe-8e2d-7455f3d423de_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OtherPropertyMember_9c199455-3151-49c6-a106-e76851923a3a_terseLabel_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking Garages</link:label>
    <link:label id="lab_srt_OtherPropertyMember_label_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OtherPropertyMember" xlink:to="lab_srt_OtherPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a276997f-4303-41f8-92d9-8dce7975e87a_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in dollar per share)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_f3bfb599-7da1-4a30-a867-7e393c9fe32f_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_446ab89b-5afe-44b4-b941-cc91937ac3ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_30f5a39c-66fc-48a7-acfa-76c62258239c_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_05161753-bc95-4fe3-b3c2-7f70fbee676f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_c6efb3aa-52d3-483a-8c32-5e3fe099f581_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BelowMarketLeaseNet_74bf812a-a8f4-4f38-9f6d-f1c548424314_terseLabel_en-US" xlink:label="lab_us-gaap_BelowMarketLeaseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Below-market intangible liabilities, net</link:label>
    <link:label id="lab_us-gaap_BelowMarketLeaseNet_label_en-US" xlink:label="lab_us-gaap_BelowMarketLeaseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Below Market Lease, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BelowMarketLeaseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BelowMarketLeaseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BelowMarketLeaseNet" xlink:to="lab_us-gaap_BelowMarketLeaseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8183e38f-922e-4316-9553-a3bc9af1dd37_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_96ed311b-68c6-499c-ac2f-59e19b71e71e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_9899cbc3-55ab-4634-bcf7-7571c7a2fbb7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_520abf09-e465-49b3-9ea1-1c5452536254_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0673afe4-4b09-4f34-a8ec-b22dd6fdbe86_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_ba147c09-d7e9-4458-899f-68ecb25c900e_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RecapitalizationExchangeRatio_1cd9bea5-d0a3-41ca-ae21-c53d586a448f_terseLabel_en-US" xlink:label="lab_hr_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange ratio</link:label>
    <link:label id="lab_hr_RecapitalizationExchangeRatio_label_en-US" xlink:label="lab_hr_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:label id="lab_hr_RecapitalizationExchangeRatio_documentation_en-US" xlink:label="lab_hr_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RecapitalizationExchangeRatio" xlink:href="hr-20230331.xsd#hr_RecapitalizationExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RecapitalizationExchangeRatio" xlink:to="lab_hr_RecapitalizationExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLineItems_90ba2aa4-2b55-44b1-b8cd-5226cd5a17a6_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstateLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLineItems" xlink:to="lab_us-gaap_RealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_5d69924d-d025-4e3c-9608-c3a9098423be_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4e843686-99e5-44c1-8a4c-258356e637c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d437f204-ca05-4eee-abae-157dda02d193_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b5a25c5f-5687-4bbb-9fb7-5f043ca356d3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f3ceaa89-b43c-4ce3-b3c5-be9aa3f93413_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_5f198ba8-564f-4415-8b0f-b946ec51e5cc_verboseLabel_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative net income attributable to common stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_label_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income Attributable to Common Stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_documentation_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative net income attributable to common stockholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:href="hr-20230331.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:to="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0292c3db-b744-4f26-b030-84142c7093bb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b1503261-33ce-4209-b613-23230b36c9cc_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4b863fe9-97ca-49d6-913c-55e772ecb5a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d0f3ef5a-fe80-4d4c-a402-dc168a326ca0_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_191e77ff-7012-4f45-a21f-1f8582b8bda9_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sales of real estate properties</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:to="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanFloridaMember_ca257b34-524a-414f-869a-47d67cbd5ee4_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanFloridaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Florida</link:label>
    <link:label id="lab_hr_MortgageLoanFloridaMember_label_en-US" xlink:label="lab_hr_MortgageLoanFloridaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Florida [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanFloridaMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanFloridaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Florida</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanFloridaMember" xlink:href="hr-20230331.xsd#hr_MortgageLoanFloridaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanFloridaMember" xlink:to="lab_hr_MortgageLoanFloridaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_94e9fa2f-1acf-4920-a9c9-ca1791c03e7b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_3894619e-9910-40fb-85ce-05f0a2bec2e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_1b415f23-3ea2-4fd9-96c6-9e034f745aa7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_4cde9967-716b-4a50-9951-0657ffe53013_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_a88b47b8-fc77-4f37-a5b8-63a50cc4f2d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_d643da38-61da-4a4f-b56d-4db3ea4e6f55_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_5eafc152-140f-4fde-bfb0-ce517d41cdb9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_6c6d23ef-0271-4e58-ae73-b16147d40688_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_24da91f0-199d-40bb-ae9e-3d12e1ede64e_totalLabel_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income applicable to common stockholders - basic</link:label>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_label_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</link:label>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_documentation_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:href="hr-20230331.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:to="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_8ba0388a-35d4-4890-b6cf-2b74585f8230_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_86d68fcd-ce48-45c0-8256-fc8227e2bdb8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_f2fdc5a9-9637-4ce9-ba45-d94fa2be77d3_verboseLabel_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investments</link:label>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_label_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Dispositions [Text Block]</link:label>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_documentation_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AcquisitionsAndDispositionsTextBlock" xlink:href="hr-20230331.xsd#hr_AcquisitionsAndDispositionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AcquisitionsAndDispositionsTextBlock" xlink:to="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_5ec66109-6291-4290-9c37-1a6b71f88078_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_b93e36cb-0795-426d-8404-98817fbb3d87_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_d8e30252-ae05-47a1-838e-371588bfc30f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5af16186-1b43-41a6-8770-8aca6bc1ce21_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average years remaining lease term (excluding renewal options) - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_be68408e-1180-45c9-9079-d3023b7e46e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_60f7cf66-3a9e-4161-8be0-9e97c7c6e82b_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_500b3552-7be1-4f9d-94cf-cb0e4fe740e0_terseLabel_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Interest Rate Swaps</link:label>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_label_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_documentation_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Interest Rate Swaps</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember" xlink:href="hr-20230331.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SettledInterestRateSwapsMember" xlink:to="lab_hr_SettledInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eb7ec70b-0f9a-44fa-ba31-333314992b3a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_677ff9a9-962b-46d2-ba24-7a611c3396f5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a7e9c547-03ef-4556-a248-1c2a8fd6d1b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest owned (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b38a3c00-16ce-497e-a0a0-3ab2dd521d99_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0f5f916a-73dd-4e9d-b2c4-bd52d7eea82d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_377d80fb-5146-4633-bdd1-5909455dbe44_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateTable_cf7a5419-b8d4-4898-83a2-2c41aab65357_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:label id="lab_us-gaap_RealEstateTable_label_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateTable" xlink:to="lab_us-gaap_RealEstateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_cddf9f4c-898c-4ce0-8f68-cc1c888d5b56_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum exposure to loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent_ddf2fdce-db52-4b21-9fea-0c260f89a154_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4f1f430c-3f1f-4734-99cf-c314566784c8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customers (topic 606)</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_05bf8bea-6dd3-42a8-9159-11f89e3f6f50_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_ed1b0dd7-ccbf-400e-b5e9-7673042942df_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_04b8b5f4-fe6b-4a07-bd10-82626c3beb5e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_f3fdd46d-26fc-4eca-b875-28c18f54dabc_negatedTerseLabel_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest from financing and notes receivable</link:label>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_label_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Financing Receivable, Noncash</link:label>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_documentation_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Financing Receivable, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash" xlink:href="hr-20230331.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestIncomeFinancingReceivableNoncash" xlink:to="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilities_f1c1569f-e0cd-4594-bcc3-9f33bbad56ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilities" xlink:to="lab_us-gaap_OtherSundryLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AmortizationofPrepaidRent_7d7b824c-04e1-45b7-af2b-e3b5080702ec_terseLabel_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prepaid rent</link:label>
    <link:label id="lab_hr_AmortizationofPrepaidRent_label_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Prepaid Rent</link:label>
    <link:label id="lab_hr_AmortizationofPrepaidRent_documentation_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Prepaid Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent" xlink:href="hr-20230331.xsd#hr_AmortizationofPrepaidRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AmortizationofPrepaidRent" xlink:to="lab_hr_AmortizationofPrepaidRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_282dda2e-980a-4d4d-b413-15d3c46cb410_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the activity under the incentive plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_cad97833-43f8-4edf-bc46-d7ca50b6363c_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ed2d3755-6f89-4ca1-a5bd-2d5836b9688f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, beginning of period, Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6261a69e-88c1-498d-bece-af537191435e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, ending of period, Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_d16e654b-09be-4995-be7f-5a682f55b2d3_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Bonds Payable</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_94b8679b-41ab-4cf6-8193-f790b8b5934e_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate properties, net</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_df99cd77-7683-4cde-82f7-55c217f19130_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_532d5dd0-5e99-42c4-85b5-92e8abe62b27_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b9df921a-0de0-4764-ab4d-b9c41556fe42_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StraightlineRentLiability_a29fbad6-67f0-4e23-9351-139263b6fe27_terseLabel_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of straight-line rent on operating leases (lessee)</link:label>
    <link:label id="lab_hr_StraightlineRentLiability_label_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line Rent Liability</link:label>
    <link:label id="lab_hr_StraightlineRentLiability_documentation_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rent liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability" xlink:href="hr-20230331.xsd#hr_StraightlineRentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StraightlineRentLiability" xlink:to="lab_hr_StraightlineRentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a1525150-e0a2-4644-9961-0dc110d95de5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_d4713d0a-07a2-484f-af7e-18e1d13f1f90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StraightLineRentReceivable_af2855b4-fccc-47fb-abb7-5578e8af4edf_negatedLabel_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of straight-line rent receivable (lessor)</link:label>
    <link:label id="lab_hr_StraightLineRentReceivable_label_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line Rent Receivable</link:label>
    <link:label id="lab_hr_StraightLineRentReceivable_documentation_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rent receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable" xlink:href="hr-20230331.xsd#hr_StraightLineRentReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StraightLineRentReceivable" xlink:to="lab_hr_StraightLineRentReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_7ee44f17-2213-4846-9ca5-383a4d447778_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_e838ad06-430d-4081-9480-bd5f99517638_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding of mortgages and notes receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_58e14f32-73ff-4468-b362-676af4bcf7cc_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a3650b80-6fd6-48a5-bc79-9557546cdffd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_6bc8415c-117d-4a3f-9f86-833c39c38d8a_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_c7b12896-c488-4a08-8d42-a153c88d6860_terseLabel_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Entities Not Determined to be VIEs</link:label>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_label_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Entities Not Determined to be VIEs [Member]</link:label>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_documentation_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Entities Not Determined to be VIEs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:href="hr-20230331.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:to="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_49fee695-e65a-4abe-8492-a1d3f2b804c1_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, after Year Four</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a9a4dcaf-ad57-4936-a4a6-ab7a33a0c563_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain)/loss recognized in AOCI on Derivative</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_05b72e0f-8689-4c03-903c-523476a92237_terseLabel_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Partnership Performance Units</link:label>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_label_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Partnership Performance Units [Member]</link:label>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_documentation_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Partnership Performance Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:href="hr-20230331.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:to="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_60235d06-f22b-4d92-8755-ed8b09c1ad9e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_77592454-aa84-4f08-b999-3df98313ecd8_terseLabel_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of real estate dispositions</link:label>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_label_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Dispositions [Table Text Block]</link:label>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_documentation_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetDispositionsTableTextBlock" xlink:href="hr-20230331.xsd#hr_AssetDispositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AssetDispositionsTableTextBlock" xlink:to="lab_hr_AssetDispositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_c2489190-be81-4bca-be85-c0f0483d6a21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_db6dec6a-2788-4b0b-8e0b-74a2e2983503_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HoustonTexasMember_88cec1a0-fdf8-4ea0-bfbd-1ca3ef850caf_terseLabel_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, TX</link:label>
    <link:label id="lab_hr_HoustonTexasMember_label_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, Texas [Member]</link:label>
    <link:label id="lab_hr_HoustonTexasMember_documentation_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, Texas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember" xlink:href="hr-20230331.xsd#hr_HoustonTexasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HoustonTexasMember" xlink:to="lab_hr_HoustonTexasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_3391b3a0-953e-4ec8-90c4-66a1a0a1e56e_verboseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cc9b85e1-5845-4717-9b12-40f6f637f3f6_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_7d35a50c-9bb3-4d0d-b3ac-e2bbb82c19d3_terseLabel_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust Incorporated</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_label_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust Incorporated [Member]</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_documentation_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust Incorporated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember" xlink:href="hr-20230331.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember" xlink:to="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_484c1842-c7df-4995-abc0-253d4ee03c0d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MedicalOfficeBuildingMember_6e190722-b01a-4d61-bb4b-66dabf139556_terseLabel_en-US" xlink:label="lab_hr_MedicalOfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical office building</link:label>
    <link:label id="lab_hr_MedicalOfficeBuildingMember_label_en-US" xlink:label="lab_hr_MedicalOfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office Building [Member]</link:label>
    <link:label id="lab_hr_MedicalOfficeBuildingMember_documentation_en-US" xlink:label="lab_hr_MedicalOfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember" xlink:href="hr-20230331.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MedicalOfficeBuildingMember" xlink:to="lab_hr_MedicalOfficeBuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_95d13318-ab71-442a-9405-6c8d9ad82123_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d07fa418-65ec-4804-ad7c-8ac537852832_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_ad1f06e8-8d2e-4240-bc67-80ebef968258_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_aef462f4-dad6-4d93-9b57-5a0f4da6dc7c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_bf1ff36a-4769-4faf-9b7b-11d76112e683_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_ba38e33d-7a58-4c76-a045-bae23b019ef8_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_210b4492-4d23-4612-a26c-75272c996daf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoandue2026Member_d3f8b1f6-e6d6-4396-9026-3aa22190a969_terseLabel_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$150 million Unsecured Term Loan due 2026, net of issuance costs</link:label>
    <link:label id="lab_hr_TermLoandue2026Member_label_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2026 [Member]</link:label>
    <link:label id="lab_hr_TermLoandue2026Member_documentation_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member" xlink:href="hr-20230331.xsd#hr_TermLoandue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoandue2026Member" xlink:to="lab_hr_TermLoandue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_9ccd0754-846e-415b-b94b-8dd30c36c857_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7e1105a3-307e-40b5-936b-9ea2688462fe_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeDividendsMember_49995f9d-91d6-4436-ba09-aead75e84dd4_terseLabel_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends</link:label>
    <link:label id="lab_hr_CumulativeDividendsMember_label_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends [Member]</link:label>
    <link:label id="lab_hr_CumulativeDividendsMember_documentation_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember" xlink:href="hr-20230331.xsd#hr_CumulativeDividendsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeDividendsMember" xlink:to="lab_hr_CumulativeDividendsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8dfffde1-4147-4ee2-8eb2-d9b743d356a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_964b9eca-6586-4c77-87ef-fc15fb25dbe1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_8ebc9b36-48c8-4a5b-9e12-a77d3e4f90d3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableGross_1dcb619d-cb6c-47d6-bf25-45b8b3ec8956_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REAL ESTATE NOTES RECEIVABLE, GROSS</link:label>
    <link:label id="lab_us-gaap_NotesReceivableGross_label_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableGross" xlink:to="lab_us-gaap_NotesReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_32b72b06-0e8e-4548-86ca-b19f4a9efbe5_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Company's Allowance For Credit Losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_84730abd-f687-44ba-bf82-fa04d9857b70_terseLabel_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles, CA</link:label>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_label_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles, California [Member]</link:label>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_documentation_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles, California [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember" xlink:href="hr-20230331.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LosAngelesCaliforniaMember" xlink:to="lab_hr_LosAngelesCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_58bc6fa3-f4cb-4080-9787-837f020c2e95_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5e3e7c4a-2c9d-443d-ab17-16a88dbb5c7c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock options, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6fbb339c-1c9b-427d-92ca-096b3bbd7af4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the activity under the incentive plan and restricted stock unit</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_5d04cfc0-113b-418c-a496-cf99dc1366d1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_35f76af8-4df9-41c6-ac08-5b8f3c10fdbb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a584b53b-b9c4-4ea7-bd8e-5f89aaf394b3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_de58a7cb-c766-47b4-9ce1-97c64435c140_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of derivative instruments in statement of financial position, fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_16a2e948-f73f-4970-892a-5989a0417892_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68df4077-a173-4f18-b950-4bdf05e44c09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_8e0edead-3307-4bad-9aa7-8779ea41d76f_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_977b936d-1fcf-4a24-8705-2fd8addd38a2_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Leases - Financing Receivables, Net</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_4502ff26-6f32-49ec-a5d5-4a31519f6b67_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c94c291a-0809-4206-bf5e-cd246845076d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_9a4ac7d0-a21e-40c3-82f8-722e7be58ad9_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ba77e303-253b-4a5a-8259-9f9df6dc00e4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_0806f0c6-1754-43db-9afd-6b6e8769397d_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_8b2accba-996c-46e8-8ad0-20910c89deb5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_fdc94fc6-ed36-4160-a608-253884f4c683_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid_34a855cc-b628-454a-91e1-e43aab004879_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund of transfer taxes paid</link:label>
    <link:label id="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid_label_en-US" xlink:label="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Refund of Transfer Taxes Paid</link:label>
    <link:label id="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Refund of Transfer Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRefundOfTransferTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:to="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_e62e778f-22f4-46c5-84d0-ddac13c24734_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_label_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:to="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b6f19667-424a-48dc-afef-d0a0b003474c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_263115fe-a2bb-4f96-a66c-bc553da7658f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_bbb21489-2a31-4258-a3d3-1b9a7d23dd8e_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_2b00156c-9b6e-4135-a80b-4309b0a89d18_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_261a6d6d-9728-40c8-b534-3de5158fbc35_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_b1c77b97-080b-41d3-9cab-3fb26819eef9_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MAXIMUM LOAN COMMITMENT</link:label>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_label_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Maximum Loan Commitment</link:label>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_documentation_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Maximum Loan Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment" xlink:href="hr-20230331.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableMaximumLoanCommitment" xlink:to="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesMember_f42254d1-833a-46aa-8bd9-94beee8cdaec_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages</link:label>
    <link:label id="lab_us-gaap_MortgagesMember_label_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesMember" xlink:to="lab_us-gaap_MortgagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_54b0fa1b-3e9d-42e2-a745-0d1611cc0892_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET PROCEEDS</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Real Estate Held-for-investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:to="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_6f170249-4e4d-4574-bd88-a9af20a80271_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate notes receivable</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_05829ed2-7a49-4031-8114-b38bc49c0b79_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_f0cd8036-446f-4a10-bdc8-641e64bef675_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_b603f332-1f61-46b4-903d-901c28722974_terseLabel_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New investments during the period</link:label>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_label_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</link:label>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_documentation_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:href="hr-20230331.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:to="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4b85d8e3-76f9-4c9f-ad2e-ff908b682a83_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageNote_555d37da-86cb-418d-9c12-6c8c1851af83_terseLabel_en-US" xlink:label="lab_hr_MortgageNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage note</link:label>
    <link:label id="lab_hr_MortgageNote_label_en-US" xlink:label="lab_hr_MortgageNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Note</link:label>
    <link:label id="lab_hr_MortgageNote_documentation_en-US" xlink:label="lab_hr_MortgageNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNote" xlink:href="hr-20230331.xsd#hr_MortgageNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageNote" xlink:to="lab_hr_MortgageNote" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_413c3598-ccd6-44b1-a66a-87d27d879370_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems" xlink:to="lab_us-gaap_RealEstatePropertiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_6e8868b6-b489-4a43-bdca-d8b19f940a5f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a2d94a7f-492d-4844-8241-d3376ff33aa1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_0ff84ffc-1349-4528-9fdb-a2d0f26f7c04_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, carrying amount</link:label>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_label_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Carrying Amount</link:label>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_documentation_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount" xlink:href="hr-20230331.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableCarryingAmount" xlink:to="lab_hr_NotesReceivableCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f97bbfd2-7ab3-411f-8341-f5d37948d56b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8a71f293-c35a-4a3d-9934-03a82c6def5f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_847b0b15-2492-448f-b9ea-02792abc2be7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_8436d39f-6068-4ddf-ae52-fb0429832795_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Land</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_4f1092a9-c050-40f4-a4a6-322b955f8184_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_950b04ec-48c3-444a-9dab-4e4232be7e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from notes receivable repayments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_00f9d6d4-756f-4147-8546-033b7a7d8d0f_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7a67b0c0-781e-4c0c-8ecc-3a898ac5ac87_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_24c878bc-3c3c-4fa5-aad6-d8e7067a8a0a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_30d66f81-5c65-4679-8321-ebb3c2ad2007_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_0817e7df-4dfd-4d34-8529-9fd1004286dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a3c39acd-19ff-481c-ae38-ae0d13103c55_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_776ac80e-444d-4494-bb55-6ea0bfed0610_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_be6ce52f-1eac-4130-91e2-7df80a208f23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Losses) gains arising during the period on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_483c21e7-7dd2-46d2-bae5-44e449b55f1d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) arising during the period on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_c4deee3e-c561-4b01-9069-45bb88c12c19_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_c747737a-90e7-443f-8522-104688a55b98_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d9486997-4c6e-4c89-b91a-22b26c147d3f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GroundLeaseModificationNet_63c7775e-840b-4741-b9b1-38a98b40653f_terseLabel_en-US" xlink:label="lab_hr_GroundLeaseModificationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables, net</link:label>
    <link:label id="lab_hr_GroundLeaseModificationNet_label_en-US" xlink:label="lab_hr_GroundLeaseModificationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Lease Modification, Net</link:label>
    <link:label id="lab_hr_GroundLeaseModificationNet_documentation_en-US" xlink:label="lab_hr_GroundLeaseModificationNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Lease Modification, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GroundLeaseModificationNet" xlink:href="hr-20230331.xsd#hr_GroundLeaseModificationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GroundLeaseModificationNet" xlink:to="lab_hr_GroundLeaseModificationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_efc33d80-4eaf-45b7-b7b6-ab3ff7679ea6_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_0a4de5c7-7716-45fb-86ec-1de179562fea_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_df0fef98-60c4-4b73-88f4-4d6622fa2a17_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_75fe3da7-6a2d-4920-a7a5-b3e42ab10b78_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other amortization</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_66ee5f53-03be-4a56-802e-bf71232cac54_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ccf7e844-4743-49dd-b691-1ebdc256d453_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_bf3032cf-42e0-49c2-9175-14bf934937ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_32f25fe6-a97f-4605-a673-35404b53fa46_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_e1021b43-28e1-47c8-8591-fd7919915f39_negatedLabel_en-US" xlink:label="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sales of real estate properties</link:label>
    <link:label id="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation</link:label>
    <link:label id="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_documentation_en-US" xlink:label="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:href="hr-20230331.xsd#hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:to="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_f77a86e7-220e-4754-940f-bb4d91469407_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c5cac1e8-33f1-488d-840d-e34edf1e788e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive loss attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_fa5fb63f-67e2-44b3-b355-cabebd8645b4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_75ef2aa8-ce4c-4b07-8543-c29099a9518b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_1fa6dea7-b7e2-4c57-bd05-85a349fcb6dc_terseLabel_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trustof America Holdings L P</link:label>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_label_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trustof America Holdings L P [Member]</link:label>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_documentation_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trustof America Holdings L P</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:href="hr-20230331.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:to="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9fc53bdf-abbf-4b12-b1dc-41c18cfab3f8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_e9986893-0e21-4812-8989-b78ddf1411a3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AccruedPropertyTaxes_e0536f9a-c8e6-45c5-9984-5565a4e7638c_terseLabel_en-US" xlink:label="lab_hr_AccruedPropertyTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued property taxes</link:label>
    <link:label id="lab_hr_AccruedPropertyTaxes_label_en-US" xlink:label="lab_hr_AccruedPropertyTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Property Taxes</link:label>
    <link:label id="lab_hr_AccruedPropertyTaxes_documentation_en-US" xlink:label="lab_hr_AccruedPropertyTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Property Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AccruedPropertyTaxes" xlink:href="hr-20230331.xsd#hr_AccruedPropertyTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AccruedPropertyTaxes" xlink:to="lab_hr_AccruedPropertyTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2027Member_163c0dee-2687-49c1-84df-ba4edd0709c2_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million Unsecured Term Loan due 2027, net of issuance costs</link:label>
    <link:label id="lab_hr_TermLoanDue2027Member_label_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2027 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2027Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member" xlink:href="hr-20230331.xsd#hr_TermLoanDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2027Member" xlink:to="lab_hr_TermLoanDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_af55c80a-8365-4b06-96e6-d7ea15da7fca_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_1a69815b-fe25-4f18-9de6-449c06657137_terseLabel_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate notes receivable</link:label>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_label_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Notes Receivable</link:label>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_documentation_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable" xlink:href="hr-20230331.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRealEstateNotesReceivable" xlink:to="lab_hr_NumberOfRealEstateNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f508d7ec-d2ff-46f3-b9aa-87bff2536c72_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates in the condensed consolidated financial statements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1f3aff4c-f442-480f-afe3-51c829816cd9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger with HTA</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_9c42d6e3-8b12-4bd8-86e1-d5f1d632e80e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_69c81667-fd05-4b31-921f-f436abc343e5_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_4326d9b3-ba0f-47ee-b661-691472f62353_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_280cc7b0-51c5-4bed-a68a-fd0c1e0e2fc4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross_86d29d0a-9995-4a09-9755-297ee900a5bf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangibles</link:label>
    <link:label id="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_47da21e2-07bd-44ef-ac87-6bcaa8a00ce9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5090c8e4-63b9-4133-9b80-c2fd7cb25a99_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_70d872d8-313f-4629-b7f3-99ef5bced323_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share - net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_97c696a6-96ef-41e4-a868-57d3c5604829_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate properties</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_630cc48e-95a0-45e2-a7f9-3cccd22b7538_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_36ef9b20-ef1f-42ae-968c-05a9aea1e0c3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_aaecb1c9-03ff-4971-884a-89399a00718f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0fd2700b-d586-4b57-8e8c-cfa70b731aac_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0b382520-60b5-4b0c-86e6-a51acccefa25_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_5f0d3157-d77d-4f39-949a-738b7bc1402f_negatedTerseLabel_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CLOSING ADJUSTMENTS</link:label>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_label_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Adjustments Disposed Entity</link:label>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_documentation_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity" xlink:href="hr-20230331.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ClosingAdjustmentsDisposedEntity" xlink:to="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_45e96d54-058c-4dfd-8ff7-07203e56f586_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NonVestedStockAwardMember_08ebc05d-2ffe-4c84-b62c-699f8e08c3d1_terseLabel_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested Stock Award</link:label>
    <link:label id="lab_hr_NonVestedStockAwardMember_label_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Vested Stock Award [Member]</link:label>
    <link:label id="lab_hr_NonVestedStockAwardMember_documentation_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Vested Stock Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember" xlink:href="hr-20230331.xsd#hr_NonVestedStockAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NonVestedStockAwardMember" xlink:to="lab_hr_NonVestedStockAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_4fe1a67f-b258-4eca-b49f-ded6ec3b361d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_74d0dee2-192a-48c5-960a-57a51dc77086_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f900d8c1-f6a9-4cb6-b727-33ccdf6e0a58_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_679050d3-aca0-4068-a7c4-4785425f0f2b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3c8984fe-cf4f-4ca2-a152-cc3d8c1976a3_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetIncomeMember_e7d9db85-32f7-4115-b9ed-de9db4cf47dd_terseLabel_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeMember_label_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income [Member]</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeMember_documentation_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember" xlink:href="hr-20230331.xsd#hr_CumulativeNetIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetIncomeMember" xlink:to="lab_hr_CumulativeNetIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2025Member_44613875-9097-45b8-8017-b0db08088199_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million Unsecured Term Loan due 2025, net of issuance costs</link:label>
    <link:label id="lab_hr_TermLoanDue2025Member_label_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2025 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2025Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member" xlink:href="hr-20230331.xsd#hr_TermLoanDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2025Member" xlink:to="lab_hr_TermLoanDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MiscellaneousMember_59aed0dd-3d2d-47b8-8ae8-c84e3ab09e4b_terseLabel_en-US" xlink:label="lab_hr_MiscellaneousMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous</link:label>
    <link:label id="lab_hr_MiscellaneousMember_label_en-US" xlink:label="lab_hr_MiscellaneousMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous [Member]</link:label>
    <link:label id="lab_hr_MiscellaneousMember_documentation_en-US" xlink:label="lab_hr_MiscellaneousMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MiscellaneousMember" xlink:href="hr-20230331.xsd#hr_MiscellaneousMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MiscellaneousMember" xlink:to="lab_hr_MiscellaneousMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_47d99906-6f51-4f6e-aa37-c93d99f2ec22_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_2f9faee5-78a3-4715-ab62-752e9ad08115_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b24e350b-c5ad-4c64-ad76-0fe39f6b4bc6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_c2114372-17fb-4224-8450-caa00987d4d0_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_251bf061-e990-4ee1-bc53-b41d4004615e_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2030, net of discount and issuance costs</link:label>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_label_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030, Net of Discount and Issuance Costs [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030, Net of Discount and Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:to="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fa832e05-5263-44c7-9004-6bb0f6904bc1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DirectorsMember_74859a46-5d3f-4f93-8644-7d0e5339cf3d_terseLabel_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_hr_DirectorsMember_label_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors [Member]</link:label>
    <link:label id="lab_hr_DirectorsMember_documentation_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember" xlink:href="hr-20230331.xsd#hr_DirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DirectorsMember" xlink:to="lab_hr_DirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_ce6d0bd8-04d1-4707-9247-840775e706af_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_d1b061e4-48e9-44f2-855c-efcff846d972_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to common stockholders (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_428088ee-feab-4228-9f26-37bc0f077563_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability adjustment, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_b1ef70ec-f1a1-4857-8020-5fb67b5724eb_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_badc9a79-78b3-4a5c-92fd-5b9b0422e197_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e7bfc599-dc6e-4342-821b-da3e01529c24_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIncentivePlanMember_8265f8a0-7b42-4929-b290-fb3789d9bab7_terseLabel_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incentive plan</link:label>
    <link:label id="lab_hr_StockIncentivePlanMember_label_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_hr_StockIncentivePlanMember_documentation_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember" xlink:href="hr-20230331.xsd#hr_StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIncentivePlanMember" xlink:to="lab_hr_StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_07c58921-0fcf-4da0-be98-6e60cac18e9f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_8bef01f1-334f-45ed-9282-df57e1772d49_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock redemptions</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_a4f505ee-a697-4131-a690-d59730a3bc50_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LeaseIntangibles_2d51ac1f-2012-4509-9993-d3dd8a7ab86c_terseLabel_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangibles</link:label>
    <link:label id="lab_hr_LeaseIntangibles_label_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Intangibles</link:label>
    <link:label id="lab_hr_LeaseIntangibles_documentation_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles" xlink:href="hr-20230331.xsd#hr_LeaseIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LeaseIntangibles" xlink:to="lab_hr_LeaseIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cf285996-7ef2-44b8-b986-54c86e828f37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ac68b565-ef22-4905-8310-fdf377687edd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MarketCondition1Member_2e2b555f-843e-427b-9f09-e44b19c338c1_terseLabel_en-US" xlink:label="lab_hr_MarketCondition1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute TSR Component</link:label>
    <link:label id="lab_hr_MarketCondition1Member_label_en-US" xlink:label="lab_hr_MarketCondition1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 1 [Member]</link:label>
    <link:label id="lab_hr_MarketCondition1Member_documentation_en-US" xlink:label="lab_hr_MarketCondition1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition1Member" xlink:href="hr-20230331.xsd#hr_MarketCondition1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MarketCondition1Member" xlink:to="lab_hr_MarketCondition1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_1747a88f-b942-43f8-b861-e6fcb093cad6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_3a94edd2-8f57-4653-9788-19761e4d2c93_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_74dccc5c-328e-4fdc-b6d5-71bd3e20f9e7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_143a0a9e-1ce7-4f34-a9e6-2ddb2583327b_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b5c59ff0-33cc-4fa9-8680-30b4ecec719c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PerformanceConditionsMember_5df82ffa-560a-4795-be85-99735890a3eb_terseLabel_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance conditions</link:label>
    <link:label id="lab_hr_PerformanceConditionsMember_label_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Conditions [Member]</link:label>
    <link:label id="lab_hr_PerformanceConditionsMember_documentation_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember" xlink:href="hr-20230331.xsd#hr_PerformanceConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PerformanceConditionsMember" xlink:to="lab_hr_PerformanceConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2031Member_aceb158b-97c5-4dd6-96cf-7e102382b29a_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031, net of discount and issuance costs</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2031Member" xlink:to="lab_hr_SeniorNotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_c05b673d-7cf1-405c-beb9-c4b81e42ec7a_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_1432eb1d-c68f-453f-bb83-db61bcfeaedd_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_c2ef8379-3dee-4f40-a3c5-c5bb9866e9cc_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DallasTXMember_1dba9d17-4f31-4783-8755-eab721f4e99a_terseLabel_en-US" xlink:label="lab_hr_DallasTXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dallas, TX</link:label>
    <link:label id="lab_hr_DallasTXMember_label_en-US" xlink:label="lab_hr_DallasTXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dallas, TX [Member]</link:label>
    <link:label id="lab_hr_DallasTXMember_documentation_en-US" xlink:label="lab_hr_DallasTXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dallas, TX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DallasTXMember" xlink:href="hr-20230331.xsd#hr_DallasTXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DallasTXMember" xlink:to="lab_hr_DallasTXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_cd281837-53d8-4ea8-a052-82f72f487f74_terseLabel_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate properties and credit loss reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_label_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate, Continuing and Discontinued Operations</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_documentation_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate, Continuing and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:href="hr-20230331.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:to="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_36fc01d6-562b-4704-8f9f-1513a3ebfb9f_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2026Member_d048f5bf-8e3a-4774-953c-b9b343f6b4db_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2026, net of discount and issuance costs</link:label>
    <link:label id="lab_hr_SeniorNotesDue2026Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2026 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2026Member" xlink:to="lab_hr_SeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f5c5da2e-9853-4199-87b7-e2f99c8ddad6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_c4a4c3f1-8892-4840-ab36-a365bcab6c8c_terseLabel_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period for maturity date</link:label>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_label_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period for Maturity Date</link:label>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_documentation_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period for Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:href="hr-20230331.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:to="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_5aa9ca95-142e-4076-9b2f-ba42aa7c810d_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_143f903b-04a5-43eb-971f-d78169311190_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_aa6561ae-ccd4-4c21-828b-40a79af7c764_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringDecember12027Member" xlink:to="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanCaliforniaMember_15dafc49-a565-496b-9cae-7ab992cf2150_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan California</link:label>
    <link:label id="lab_hr_MortgageLoanCaliforniaMember_label_en-US" xlink:label="lab_hr_MortgageLoanCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan California [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanCaliforniaMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan California</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanCaliforniaMember" xlink:href="hr-20230331.xsd#hr_MortgageLoanCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanCaliforniaMember" xlink:to="lab_hr_MortgageLoanCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c526568a-abec-4163-b3f5-d2644e9e4810_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_915f59e2-22be-4a5f-a490-21043a09c222_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_2f33aed0-7fd2-40a8-9d4d-09c5e8c9e85c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FiniteLivedCustomerRelationshipsNet_3d7f84f0-34fb-4b28-addc-c581edc584fc_terseLabel_en-US" xlink:label="lab_hr_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationship intangible assets, net</link:label>
    <link:label id="lab_hr_FiniteLivedCustomerRelationshipsNet_label_en-US" xlink:label="lab_hr_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Customer Relationships, Net</link:label>
    <link:label id="lab_hr_FiniteLivedCustomerRelationshipsNet_documentation_en-US" xlink:label="lab_hr_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Customer Relationships, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FiniteLivedCustomerRelationshipsNet" xlink:href="hr-20230331.xsd#hr_FiniteLivedCustomerRelationshipsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FiniteLivedCustomerRelationshipsNet" xlink:to="lab_hr_FiniteLivedCustomerRelationshipsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4a946395-5a5d-4979-a638-c316ae0de78c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_21c5ab44-b440-4451-b642-24d6e3b80524_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems_a090f1c3-ddeb-430d-bf3d-38b15dacf794_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Lived Assets Held-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets Held-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:to="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_1ad5d5c3-f7b6-44d2-b5e5-d8e9d9b9af3f_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_5053b321-aaac-4ba6-a5fc-7bcc4160fd81_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Lived Assets Held-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Lived Assets Held-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:to="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_8205571b-5584-4052-9281-ec723c9199c5_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_1e33f42c-e9d0-4887-bc3d-29dfa5398e23_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_label_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Building and Building Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:to="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2025Member_ef455a64-5beb-481a-8173-765db15f9780_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2025, net of discount and issuance costs</link:label>
    <link:label id="lab_hr_SeniorNotesdue2025Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2025 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2025Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2025Member" xlink:to="lab_hr_SeniorNotesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_7d65f06d-8574-4c72-b877-78eb9b12a1d2_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Condensed Balance Sheet</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_faa2b750-45e2-4fb4-81f4-8897082693f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_893b09f6-c95e-49f7-9091-acd4f6890e37_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanMember_c88d4cc6-a55b-4a9f-85ee-e8d1f3e5ebb0_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan</link:label>
    <link:label id="lab_hr_MortgageLoanMember_label_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember" xlink:href="hr-20230331.xsd#hr_MortgageLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanMember" xlink:to="lab_hr_MortgageLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2030Member_0b3014d2-5516-4d85-ae46-a7aae24bccb6_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2030, net of discount and issuance costs</link:label>
    <link:label id="lab_hr_SeniorNotesdue2030Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2030Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2030Member" xlink:to="lab_hr_SeniorNotesdue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2027Member_f81f7206-cf66-44f2-9c2d-6ce8c2338838_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2027, net of discount and issuance costs</link:label>
    <link:label id="lab_hr_SeniorNotesDue2027Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2027 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2027Member" xlink:to="lab_hr_SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_51b1930b-c8cd-486a-b8af-0b8eaf44fdd2_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_60062bc7-f88a-432e-a26c-8c5eba046f59_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TampaFLMember_dbd8a57d-5aa7-43f9-9cba-bca28e61fc5c_terseLabel_en-US" xlink:label="lab_hr_TampaFLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa, FL</link:label>
    <link:label id="lab_hr_TampaFLMember_label_en-US" xlink:label="lab_hr_TampaFLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa, FL [Member]</link:label>
    <link:label id="lab_hr_TampaFLMember_documentation_en-US" xlink:label="lab_hr_TampaFLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa, FL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMember" xlink:href="hr-20230331.xsd#hr_TampaFLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TampaFLMember" xlink:to="lab_hr_TampaFLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MarketCondition2Member_61b2ea0c-480b-4eb4-862e-ed35149a3e54_terseLabel_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relative TSR Component</link:label>
    <link:label id="lab_hr_MarketCondition2Member_label_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 2 [Member]</link:label>
    <link:label id="lab_hr_MarketCondition2Member_documentation_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member" xlink:href="hr-20230331.xsd#hr_MarketCondition2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MarketCondition2Member" xlink:to="lab_hr_MarketCondition2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_a1a923a8-9f48-41f6-b8fd-a170a1926f68_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</link:label>
    <link:label id="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_label_en-US" xlink:label="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services</link:label>
    <link:label id="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_documentation_en-US" xlink:label="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:href="hr-20230331.xsd#hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:to="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_0cacb8ec-9050-49b5-afd5-0375fc602618_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringDecember12026Member" xlink:to="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_98a0d668-b37f-49b8-8f44-299f16c548e1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_548607a9-24d4-441f-b07c-bac4e06736dd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6c9b9b71-3c9c-4b63-abee-c2eef004056c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1177bb05-d76e-4f9e-b733-fa94d4c32b06_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AccountsPayableAndCapitalExpendituresCurrent_b3f8faea-cf12-43b8-9450-080a129cc3ee_terseLabel_en-US" xlink:label="lab_hr_AccountsPayableAndCapitalExpendituresCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and capital expenditures</link:label>
    <link:label id="lab_hr_AccountsPayableAndCapitalExpendituresCurrent_label_en-US" xlink:label="lab_hr_AccountsPayableAndCapitalExpendituresCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Capital Expenditures, Current</link:label>
    <link:label id="lab_hr_AccountsPayableAndCapitalExpendituresCurrent_documentation_en-US" xlink:label="lab_hr_AccountsPayableAndCapitalExpendituresCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Capital Expenditures, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AccountsPayableAndCapitalExpendituresCurrent" xlink:href="hr-20230331.xsd#hr_AccountsPayableAndCapitalExpendituresCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AccountsPayableAndCapitalExpendituresCurrent" xlink:to="lab_hr_AccountsPayableAndCapitalExpendituresCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_b8072821-68cc-4f8b-8727-e753006275e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Properties [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Properties [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:to="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_56a174fe-6e17-4f33-9b94-80d8c5c5ce72_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9ee6d91c-8855-47b0-90f6-cc1d2edb8ba2_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures, beginning of period</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_41fd5740-85f5-4294-9a21-e863071009a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net LLC investments at the end of the period</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_4ec01f10-5fea-41f1-ab42-bc95e76ecdec_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2023Member_104468f7-d65d-4687-945d-aa321251169a_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$350 million Unsecured Term Loan due 2023, net of issuance costs</link:label>
    <link:label id="lab_hr_TermLoanDue2023Member_label_en-US" xlink:label="lab_hr_TermLoanDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2023 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2023Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2023Member" xlink:href="hr-20230331.xsd#hr_TermLoanDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2023Member" xlink:to="lab_hr_TermLoanDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ApproximateSquareFeetProvidedByCompany_0dd91968-c13a-4aec-ab6c-87992687f1c7_verboseLabel_en-US" xlink:label="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate square feet for which Nationwide property management services provided by company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetProvidedByCompany_label_en-US" xlink:label="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Square Feet Provided by Company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetProvidedByCompany_documentation_en-US" xlink:label="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate square feet for which Nationwide property management services provided by company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetProvidedByCompany" xlink:href="hr-20230331.xsd#hr_ApproximateSquareFeetProvidedByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ApproximateSquareFeetProvidedByCompany" xlink:to="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4f80ab8c-0b36-4980-bd3f-eca6b9cfed35_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AboveMarketLeaseIntangibleAssetsNet_446204de-6926-440b-affe-d4948fbd2aca_terseLabel_en-US" xlink:label="lab_hr_AboveMarketLeaseIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Above-market intangible assets, net</link:label>
    <link:label id="lab_hr_AboveMarketLeaseIntangibleAssetsNet_label_en-US" xlink:label="lab_hr_AboveMarketLeaseIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Above Market Lease Intangible Assets , Net</link:label>
    <link:label id="lab_hr_AboveMarketLeaseIntangibleAssetsNet_documentation_en-US" xlink:label="lab_hr_AboveMarketLeaseIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Above Market Lease Intangible Assets , Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AboveMarketLeaseIntangibleAssetsNet" xlink:href="hr-20230331.xsd#hr_AboveMarketLeaseIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AboveMarketLeaseIntangibleAssetsNet" xlink:to="lab_hr_AboveMarketLeaseIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d40fcf44-8d2a-4db0-a8cc-e43416ff5d9f_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c455f38b-9396-4ce8-a121-c062fe74ba23_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_7ed6e3b4-d5ae-4e81-82c6-97d4d0d61ac1_verboseLabel_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_72d2e573-936e-4b7f-86f6-79ff7adc02a9_terseLabel_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_label_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale and Discontinued Operations Net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_documentation_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale and discontinued operations, net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:href="hr-20230331.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:to="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_00c0ed55-538d-4be8-a171-d248d5988695_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_44eef486-33a2-405e-aa2e-921b3de3bd01_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a757eeb3-a3d7-42e0-9ffc-404cdea48041_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_269510f8-3f73-4250-b994-5da538126e76_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f0005a21-068d-445c-89f5-41eeb05cd64e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_afd32831-511b-4952-b4fe-44655f99ddfe_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from financing receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Interest Income, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e3c1a66d-3274-4068-a8c3-2944e5d5f86d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_f3125bbd-78a0-4beb-9cd4-c2a94488ab9b_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_33e28c73-8670-4d25-97e8-d9067f3a8282_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCosts_d9c03255-6280-4d43-95e8-ce0d334410c8_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and pursuit costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCosts" xlink:to="lab_us-gaap_AcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1f717837-21df-4dda-8b4a-b0de69aab1aa_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_75f1cdfd-9d43-4d84-b108-2c318643a005_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0063d1e-fb41-4037-9058-42b5220f3b93_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_afdab77d-bf2e-42de-b791-030c2a1f19d8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_17e5445d-6f8a-400d-a1a7-0a0da49a4ed1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_444397bd-aabc-4146-8f48-bee7c33dbbfa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReverseRecapitalizationNet_b23db56a-c89b-4b30-baae-e1951ed30215_terseLabel_en-US" xlink:label="lab_hr_ReverseRecapitalizationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of implied Legacy HR Common Stock issued</link:label>
    <link:label id="lab_hr_ReverseRecapitalizationNet_label_en-US" xlink:label="lab_hr_ReverseRecapitalizationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Net</link:label>
    <link:label id="lab_hr_ReverseRecapitalizationNet_documentation_en-US" xlink:label="lab_hr_ReverseRecapitalizationNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReverseRecapitalizationNet" xlink:href="hr-20230331.xsd#hr_ReverseRecapitalizationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReverseRecapitalizationNet" xlink:to="lab_hr_ReverseRecapitalizationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d14cef2e-8c18-484a-ae1d-50e0c27fcbc9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PersonalProperty_f7858655-4a43-4831-98e1-8a3527c89924_terseLabel_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal property</link:label>
    <link:label id="lab_hr_PersonalProperty_label_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Property</link:label>
    <link:label id="lab_hr_PersonalProperty_documentation_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty" xlink:href="hr-20230331.xsd#hr_PersonalProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PersonalProperty" xlink:to="lab_hr_PersonalProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases_4b23f5ce-668b-47df-a5a2-b050df4e9a32_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties subject to ground leases</link:label>
    <link:label id="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases_label_en-US" xlink:label="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Properties Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:to="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_a2d89595-ddf8-4b33-83a3-27faffac7543_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend per share to common Stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_04a2519d-3175-4a9a-a791-cc5b009ad8d2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid per common share, during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_62e86e6f-5300-437e-9b14-7bc1e0a41044_terseLabel_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment amount, total</link:label>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_label_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Real Estate Properties and Mortgage Notes</link:label>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_documentation_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in real estate properties and mortgage notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:href="hr-20230331.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:to="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIssuanceProgramAxis_5942de4e-a98c-41b1-b51e-24506e1baffe_terseLabel_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramAxis_label_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramAxis_documentation_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIssuanceProgramAxis" xlink:to="lab_hr_StockIssuanceProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ba9b2d7d-91f7-4861-9e0e-b1a84e0cc55d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,816 and 380,590 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e1560abb-7a66-4b65-a7d7-a38bcf4e6b92_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARRYING VALUE</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_422dd4dd-90f7-42b7-a312-125514b7478e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_6d5863d0-1b85-4cbb-b01c-03f21b9fe2ce_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_52e2aca2-730a-4c49-b750-c7dc6eedf106_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_36479c68-a1c2-437d-a108-0b863f8ec80c_totalLabel_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_label_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses and Cost of Goods Sold</link:label>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_documentation_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses and Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold" xlink:href="hr-20230331.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold" xlink:to="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_323cabef-43d0-44c0-b223-1f3f91228600_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8164274e-75cb-43a5-9c43-e85e5032cdfd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_d13a8296-2134-4cba-8246-9d738de433ff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous" xlink:to="lab_us-gaap_OtherAssetsMiscellaneous" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_b4ece0b7-eea7-4ecf-adf6-544a86cfda14_terseLabel_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity ownership for consolidation (percent)</link:label>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_label_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Ownership for Consolidation, Percent</link:label>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_documentation_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Ownership for Consolidation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent" xlink:href="hr-20230331.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityOwnershipForConsolidationPercent" xlink:to="lab_hr_EquityOwnershipForConsolidationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_b60dd95b-3ec8-498a-a3ae-6542198265ac_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_091fcfc1-039b-4333-9f7b-250c547101f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_f16506f4-c603-4e35-a891-4eebaea14b4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_2b098496-3918-45b3-a2fa-72996dd6e0d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_62c69168-4878-4809-bbae-9c8f42b8f0ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_61bbc5c7-6698-4729-bbfe-f063ba822629_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash flow hedges included in accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_78f35a64-232e-4a41-b145-a0c6fbc859ea_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CommonStockSharesWithheld_27f99239-cdd6-400b-9aba-4857b2e06517_terseLabel_en-US" xlink:label="lab_hr_CommonStockSharesWithheld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, withheld (in shares)</link:label>
    <link:label id="lab_hr_CommonStockSharesWithheld_label_en-US" xlink:label="lab_hr_CommonStockSharesWithheld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Withheld</link:label>
    <link:label id="lab_hr_CommonStockSharesWithheld_documentation_en-US" xlink:label="lab_hr_CommonStockSharesWithheld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Withheld</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockSharesWithheld" xlink:href="hr-20230331.xsd#hr_CommonStockSharesWithheld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CommonStockSharesWithheld" xlink:to="lab_hr_CommonStockSharesWithheld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_935e32f8-0206-4027-8e71-abc340b783eb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d5d29f7c-3f08-42bb-8b37-e655d739e700_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8aaab990-6051-4c5d-af57-1608ed8b4c87_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_885cb0de-296c-41aa-aa0d-85af731cab90_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_95a068d3-ab69-41d6-b65a-4b2970f31cc1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_6f118bde-7e90-4fa5-b7cd-ef851c1cfbb0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b10f2acb-1135-42df-b866-cea04402da84_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_09cd59f5-6599-46ff-8ee0-3c9919b71e81_terseLabel_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties Held in Joint Ventures</link:label>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_label_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties Held in Joint Ventures [Member]</link:label>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_documentation_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties Held in Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:href="hr-20230331.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:to="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_8cce1391-f9c5-4e89-bfb9-4e1a9f0ed641_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contractual accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivables, Gross Contractual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:to="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_ec2ddb79-ea41-4fdd-bb41-12956b822574_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d3a4bc10-573a-4219-ba09-4429218f8e25_verboseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invoices accrued for construction, tenant improvements and other capitalized costs</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessOverviewAbstract_7376a61a-48b6-455d-8e1f-3d461ef2deca_terseLabel_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview:</link:label>
    <link:label id="lab_hr_BusinessOverviewAbstract_label_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview [Abstract]</link:label>
    <link:label id="lab_hr_BusinessOverviewAbstract_documentation_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract" xlink:href="hr-20230331.xsd#hr_BusinessOverviewAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessOverviewAbstract" xlink:to="lab_hr_BusinessOverviewAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_466f989d-7e10-4f35-8937-b4257889ac7e_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Operating Lease Payments Receivable [Abstract]</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_05ce1bb8-b00c-4f82-96fa-5bd54a21e66a_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_88e1e34b-8103-4e91-920c-590405a2e8b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_5e5a6cab-986b-4ff7-b070-769d1ba4887b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwaps2017And2018Member_311bf21d-e13e-4280-95cd-cda63b05b1b0_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwaps2017And2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_hr_InterestRateSwaps2017And2018Member_label_en-US" xlink:label="lab_hr_InterestRateSwaps2017And2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps 2017 And 2018 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwaps2017And2018Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwaps2017And2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps 2017 And 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwaps2017And2018Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwaps2017And2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwaps2017And2018Member" xlink:to="lab_hr_InterestRateSwaps2017And2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d44c165f-958f-4b7d-bac8-ff084175589e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_893430ee-9bfc-448d-9159-0d0e445fb41c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_d8e5fd50-8b4d-4a73-83c5-6305bbc943eb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DispositionSalesPrice_f5fd2125-0604-4881-a7b7-7eb810036600_terseLabel_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SALE PRICE</link:label>
    <link:label id="lab_hr_DispositionSalesPrice_label_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition Sales Price</link:label>
    <link:label id="lab_hr_DispositionSalesPrice_documentation_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition Sales Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice" xlink:href="hr-20230331.xsd#hr_DispositionSalesPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DispositionSalesPrice" xlink:to="lab_hr_DispositionSalesPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityOfferingProgramAvailableForIssuance_d569977c-f73e-488c-9475-699e1007ad5c_terseLabel_en-US" xlink:label="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount remaining available for issuance under the new ATM</link:label>
    <link:label id="lab_hr_EquityOfferingProgramAvailableForIssuance_label_en-US" xlink:label="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Offering Program Available for Issuance</link:label>
    <link:label id="lab_hr_EquityOfferingProgramAvailableForIssuance_documentation_en-US" xlink:label="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Offering Program Available for Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOfferingProgramAvailableForIssuance" xlink:href="hr-20230331.xsd#hr_EquityOfferingProgramAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityOfferingProgramAvailableForIssuance" xlink:to="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_16f3e07a-11a0-414f-8cce-4c5b62427308_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_105e361e-2f16-431e-bd71-06030c4f8646_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_912595b2-d4b6-4c6a-92f4-7acff434600a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period for the acquired lease intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d90d94d2-facc-4206-9bb3-c909d909c090_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_157d4bbd-4ef1-4a6f-aedd-dbe17201c4d2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6455967f-3090-469e-bffd-d76aea1822d2_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9355a521-bdfb-4c68-b07d-4c6d49c52f0b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_540c36f9-b17b-4881-938d-53212d2f7b31_negatedLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate properties and credit loss reserves</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfRealEstate" xlink:to="lab_us-gaap_ImpairmentOfRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GrossContractualRealEstateNotesReceivableFairValue_2885812a-0faf-47e2-8141-81e692f51652_terseLabel_en-US" xlink:label="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contractual real estate notes receivable at fair value</link:label>
    <link:label id="lab_hr_GrossContractualRealEstateNotesReceivableFairValue_label_en-US" xlink:label="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Contractual Real Estate Notes Receivable, Fair Value</link:label>
    <link:label id="lab_hr_GrossContractualRealEstateNotesReceivableFairValue_documentation_en-US" xlink:label="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Contractual Real Estate Notes Receivable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:href="hr-20230331.xsd#hr_GrossContractualRealEstateNotesReceivableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:to="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c648a401-8b07-4a18-977d-6cd6dce1e5ea_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_bfe42d2e-8755-44bb-8c13-9547f3539d43_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ManagementFeeIncomeMember_ded1330f-cd09-43cc-a756-9b86f4f24825_terseLabel_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee income</link:label>
    <link:label id="lab_hr_ManagementFeeIncomeMember_label_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fee Income [Member]</link:label>
    <link:label id="lab_hr_ManagementFeeIncomeMember_documentation_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fee Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember" xlink:href="hr-20230331.xsd#hr_ManagementFeeIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ManagementFeeIncomeMember" xlink:to="lab_hr_ManagementFeeIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_72a3044f-8a1a-40ab-948c-3aa49bcaf8c2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_adacc917-2ce9-49bc-8e48-90d34dc28a76_verboseLabel_en-US" xlink:label="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property operating</link:label>
    <link:label id="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_label_en-US" xlink:label="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Costs of Leased and Rented Property or Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:to="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_c2131361-1fd6-443d-92e2-9098bbf8bfc8_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0c507829-f7c9-46c7-bca0-763f7577c281_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground lease, initial term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_7a499eee-623d-4351-ace2-33539fe1ce6a_verboseLabel_en-US" xlink:label="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square footage</link:label>
    <link:label id="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_label_en-US" xlink:label="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Purchase Price Allocation Square Footage</link:label>
    <link:label id="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_documentation_en-US" xlink:label="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Purchase Price Allocation Square Footage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:href="hr-20230331.xsd#hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:to="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_bf7609fd-6396-413a-8fc0-5b970e673c48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values of the Assets Acquired And Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_dd5c8b81-166b-46a2-bfb4-a9bae6ab17c4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAvailableForDevelopment_5820ce4e-70fb-4493-ac23-8362bd6c31e2_terseLabel_en-US" xlink:label="lab_us-gaap_LandAvailableForDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land held for development</link:label>
    <link:label id="lab_us-gaap_LandAvailableForDevelopment_label_en-US" xlink:label="lab_us-gaap_LandAvailableForDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Available for Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAvailableForDevelopment" xlink:to="lab_us-gaap_LandAvailableForDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d43f5111-8923-4577-a49e-ec96d7fc383e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and exercisable, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f8ca3d7-47c7-4760-84be-0a6e3e4c05e3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and exercisable, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NC_cb651c65-8140-48b8-b451-df1a367ec89d_terseLabel_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charlotte, NC</link:label>
    <link:label id="lab_stpr_NC_label_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NORTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NC" xlink:to="lab_stpr_NC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_ee3c85a6-317c-4aa7-b2ca-cd00ab3092fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9be64f7d-3909-4d74-b74d-9848c7cec9c8_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0abdd225-f464-4191-9a7f-7d37d450f610_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_d65b986a-b84c-4f70-96ae-02fdf124e884_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1de96ab4-ec83-4455-87e8-16d4ef59955e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_fe17b6d4-d4a4-4281-8e53-16d21a7149bc_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_9ba1b6cb-ad12-4e89-9874-9043889aabd8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:to="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d6bb7319-1a27-4037-824e-b1cbc4801a81_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows outflows related to operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_5c9c1228-328c-462c-98b7-0ffa32c60709_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_2b8fb6fa-6faf-490e-88cc-6e231aed92c8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options under the Employee Stock Option Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_7373015a-a33a-4f6a-8835-a493c9652994_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e1084073-11d1-4fc3-89b1-553224a43ee5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_4de44e88-824f-4045-88e2-d90572a6a9ba_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c62fb875-9883-432a-b3f5-ce0ecb622730_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (net change) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a5b1737e-5278-4adb-b5f3-750948dd54e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MergerRelatedCosts_d0ce2714-41e5-447b-bbf1-288f82f63dd2_terseLabel_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger-related costs</link:label>
    <link:label id="lab_hr_MergerRelatedCosts_label_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Related Costs</link:label>
    <link:label id="lab_hr_MergerRelatedCosts_documentation_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts" xlink:href="hr-20230331.xsd#hr_MergerRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MergerRelatedCosts" xlink:to="lab_hr_MergerRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a254ada0-afa4-4d64-abfc-45400f2cd1a6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_94f8c3eb-4d4a-4601-87e3-14f8f041e363_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2028Member_004d4e89-cd6e-445a-b54a-cd880ccef523_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million Unsecured Term Loan due 2028, net of issuance costs</link:label>
    <link:label id="lab_hr_TermLoanDue2028Member_label_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2028 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2028Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member" xlink:href="hr-20230331.xsd#hr_TermLoanDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2028Member" xlink:to="lab_hr_TermLoanDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_1cdad3b9-38a2-4239-8d32-5972b309b776_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_8d4c2415-4d8d-4e71-a6d9-cd91b50c4cbe_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_f35eaff3-bced-4dd3-82ef-f50a5b92b934_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c978720d-f3e2-4d79-b527-b2d37d7217f9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_eb0f89cd-b0b7-4120-8526-88c3b5aeb4cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating accruals</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5aa83bc0-21d5-4a2a-9940-d02ebff3a015_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_ef00820a-3ddf-4455-a278-255985436d71_terseLabel_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction activity and development properties</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_label_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Activity, Total Funding During the Period</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_documentation_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Activity, Total Funding During the Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:href="hr-20230331.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:to="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ca88d211-a826-4b24-9c35-f5e6a623c03e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_e5a1884a-4506-4a65-a5e1-74d879778c26_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsShareBasedCompensation_63312407-5cf8-438a-8faa-ad1f27eadece_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on nonvested share-based awards</link:label>
    <link:label id="lab_us-gaap_DividendsShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_DividendsShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsShareBasedCompensation" xlink:to="lab_us-gaap_DividendsShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_5d5aec43-fdbb-44d9-a74c-d3d68401f52f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableInterestRate_c0522c7f-4e18-4cc9-b86f-70227239a42a_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STATED INTEREST RATE</link:label>
    <link:label id="lab_hr_NotesReceivableInterestRate_label_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:label id="lab_hr_NotesReceivableInterestRate_documentation_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate" xlink:href="hr-20230331.xsd#hr_NotesReceivableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableInterestRate" xlink:to="lab_hr_NotesReceivableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_a661d805-c1de-4b44-b197-ba3f51a30bcc_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9a0c3c2b-8333-410a-b30c-c73266b2ace2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_cc91e130-a57a-4efe-9e58-ad9a00377e80_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_label_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031, Net of Discount and Issuance Costs [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031, Net of Discount and Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:to="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6b2a10af-6aab-445a-b5bf-12e58ea0732e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock redemptions</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_71d269f8-cfa7-41bd-aa12-f00f27f1ce41_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6f9f249-fcba-457a-9222-84c056eae856_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_bac9a3f8-1d3e-4bcd-b345-73dbcdb5ecc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Owner distributions</link:label>
    <link:label id="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_label_en-US" xlink:label="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:to="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_27481b58-5350-4dc5-bbed-22250f3cacde_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_779ae086-c969-4548-bc9b-6b3c2ef39d20_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a57f36bb-dc26-4c35-88da-117733a629bf_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_7ac0e68f-f5d1-40ac-a07d-25d45d60edc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthcareTrustOfAmericaIncMember_ff0b68a0-fb23-4fe8-934e-06bed16eaac9_terseLabel_en-US" xlink:label="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust Of America, Inc</link:label>
    <link:label id="lab_hr_HealthcareTrustOfAmericaIncMember_label_en-US" xlink:label="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust Of America, Inc [Member]</link:label>
    <link:label id="lab_hr_HealthcareTrustOfAmericaIncMember_documentation_en-US" xlink:label="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust Of America, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember" xlink:href="hr-20230331.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthcareTrustOfAmericaIncMember" xlink:to="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_bcb9cc83-e95b-4383-873a-4ef0b52801ab_terseLabel_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_label_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_documentation_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward" xlink:href="hr-20230331.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityMethodInvestmentsRollForward" xlink:to="lab_hr_EquityMethodInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a1d467d5-a4e2-4e9e-8d10-282ebf84c371_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_2230f8fb-571e-4bad-84c9-3a936a76e62c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share, during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanTexasMember_0c29dff5-746c-452b-a7ff-e32eafd893fb_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanTexasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Texas</link:label>
    <link:label id="lab_hr_MortgageLoanTexasMember_label_en-US" xlink:label="lab_hr_MortgageLoanTexasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Texas [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanTexasMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanTexasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Texas</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanTexasMember" xlink:href="hr-20230331.xsd#hr_MortgageLoanTexasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanTexasMember" xlink:to="lab_hr_MortgageLoanTexasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_0e866bff-ad51-47eb-a62a-d6a3345133dd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_b4b71a95-744d-4d45-afd2-b637852b517f_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_5645e359-1bb1-4475-887c-34d4e4d672ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_29be34d6-4f4e-476b-a890-8649e788d658_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_af6347d9-f2d0-4ac6-a55c-1bf6005d6a6b_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e44f1f26-df3f-4e5a-8953-c66a1f2102b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Employee Stock Purchase Plan activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_b36351e9-150d-43e2-a70e-32d23f4273cd_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_label_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:to="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_1c4b2d82-7245-4958-ae3b-4f634a3be7eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_0e55fa7c-daba-4352-82b6-f4cb26959a78_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of owned real estate properties</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cc90d7d0-ac2e-47b4-8c3f-8f3935487f3c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRentReceivablesNet_3560fe31-af9c-4d37-a2b8-b6f43c709424_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rent receivables</link:label>
    <link:label id="lab_us-gaap_DeferredRentReceivablesNet_label_en-US" xlink:label="lab_us-gaap_DeferredRentReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Receivables, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentReceivablesNet" xlink:to="lab_us-gaap_DeferredRentReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_48bc7165-28c9-4f4f-9ed7-d5159858657a_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangible assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_92b4cda9-cb89-4ef3-9270-519bfb439ded_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_138f9ecf-663d-47aa-b30d-ec8a79c95993_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_97f34208-93d1-446e-9a0e-24551baaf090_terseLabel_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Program</link:label>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_label_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Program [Member]</link:label>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_documentation_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember" xlink:href="hr-20230331.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ExecutiveIncentiveProgramMember" xlink:to="lab_hr_ExecutiveIncentiveProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e24ebf9a-17ca-47be-b890-ab075f38de77_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_461b53cc-1705-45b8-980e-be2a460f63d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_3e8a4eae-8125-4928-a5d9-85079affb587_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_f4e24290-a12b-412f-8920-65facf10fbe6_terseLabel_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-prepaid ground leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_label_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases, Excluding Prepaid Leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_documentation_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases, Excluding Prepaid Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:href="hr-20230331.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:to="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_6c8c953f-f81f-48cb-967d-e4451656c8bc_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_5f30a559-2839-4a8b-bcb4-e248cad93cf9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_898e3ef9-c248-4638-8ace-18ab0837963e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_8ae2d1bd-d1a0-406b-9dc4-47b6bd3879c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_64ec5fb1-6987-417a-a823-6964ca6955e8_verboseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_e849f49a-b3be-4693-b033-5e292d915804_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_2c669fa0-7b07-488f-a165-5abe90d2dba5_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_0bdea825-b273-4080-9e9b-3b16c25dc32b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_edc59063-d78d-46ee-989f-80c749253c71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in securities</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_68ca15ea-b70f-4737-aa86-945f6881a177_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Minimum Financing Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_4b1ec9fe-6499-49a3-b838-3cc4cdecf014_terseLabel_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows outflows related to financing leases</link:label>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_label_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Only Payments</link:label>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_documentation_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Only Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeasePrincipalOnlyPayments" xlink:href="hr-20230331.xsd#hr_FinanceLeasePrincipalOnlyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceLeasePrincipalOnlyPayments" xlink:to="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_da269916-999f-4444-80d3-93907f9718a7_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale_31c82953-76ae-4404-9cfb-23da20f15eda_terseLabel_en-US" xlink:label="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of land parcels classified as held for sale</link:label>
    <link:label id="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale_label_en-US" xlink:label="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Land Parcels Classified as Held for Sale</link:label>
    <link:label id="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale_documentation_en-US" xlink:label="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Land Parcels Classified as Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfLandParcelsClassifiedAsHeldForSale" xlink:href="hr-20230331.xsd#hr_NumberOfLandParcelsClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfLandParcelsClassifiedAsHeldForSale" xlink:to="lab_hr_NumberOfLandParcelsClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ParkingIncomeMember_2be4feac-17e9-482a-b8f5-f208726ba477_terseLabel_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking income</link:label>
    <link:label id="lab_hr_ParkingIncomeMember_label_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking Income [Member]</link:label>
    <link:label id="lab_hr_ParkingIncomeMember_documentation_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember" xlink:href="hr-20230331.xsd#hr_ParkingIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ParkingIncomeMember" xlink:to="lab_hr_ParkingIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_f61831b6-a9e6-4882-b162-8db2a7c1fe20_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_8dcd06cd-5ad0-4a8b-befe-5f87d69a4dc0_totalLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4fe0eebe-e1a5-4151-a267-3be21167ab81_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_729203bf-13d0-42a6-8daa-29d1785ca441_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_ce994c8f-e4bd-4ba7-9775-aa925bba032d_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_1564f7bb-257b-4cb1-a64f-bf44518d490d_terseLabel_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_label_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Four</link:label>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_documentation_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:href="hr-20230331.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:to="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanNorthCarolinaMember_3136fa8c-d94d-4791-a7f2-5fdb2e5913ad_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanNorthCarolinaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan - North Carolina</link:label>
    <link:label id="lab_hr_MortgageLoanNorthCarolinaMember_label_en-US" xlink:label="lab_hr_MortgageLoanNorthCarolinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan - North Carolina [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanNorthCarolinaMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanNorthCarolinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan - North Carolina</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanNorthCarolinaMember" xlink:href="hr-20230331.xsd#hr_MortgageLoanNorthCarolinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanNorthCarolinaMember" xlink:to="lab_hr_MortgageLoanNorthCarolinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_26317097-6543-4586-85a9-0f46322c4c09_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fe6a4273-fcf2-4935-b4a3-df3e383b6050_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average Common Shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfJointVentures_4f59b2c0-b230-458c-b29c-296474df9e1d_terseLabel_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of joint ventures</link:label>
    <link:label id="lab_hr_NumberOfJointVentures_label_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Joint Ventures</link:label>
    <link:label id="lab_hr_NumberOfJointVentures_documentation_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures" xlink:href="hr-20230331.xsd#hr_NumberOfJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfJointVentures" xlink:to="lab_hr_NumberOfJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_cd557943-40af-4ae3-beec-2dbdf15b3ee4_netLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GAIN/(IMPAIRMENT)</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_4cc2e861-3413-49f3-af5d-43f2ba77ddda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of employee stock purchase plan activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_7f202dc6-6d82-4bd0-9746-bbb51fcd2e39_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net borrowings on unsecured credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_d61cdb9b-f6dd-4f88-abcb-2c9e05d219c8_terseLabel_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company One</link:label>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_label_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company One [Member]</link:label>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_documentation_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember" xlink:href="hr-20230331.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LimitedLiabilityCompanyOneMember" xlink:to="lab_hr_LimitedLiabilityCompanyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_0806e80a-8259-4a2e-9307-a6e6ddde8e5e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_032a1775-2d20-485b-b527-92a5ef245903_terseLabel_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of restricted stock units</link:label>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_label_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Restricted Stock Units</link:label>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_documentation_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits" xlink:href="hr-20230331.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PercentageOfRestrictedStockUnits" xlink:to="lab_hr_PercentageOfRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_72442c1b-25c7-4149-9514-5492174ee53a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, including right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0e6b29f8-a717-4b63-9e79-2b6c0060df9e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_fa80d65a-599d-4818-a0f7-73e679d47e98_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_4e165779-7d3f-467f-93ce-5e5ff0e05e01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_751843a3-cfc3-4380-88cf-bbd280d35865_terseLabel_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 billion Unsecured Credit Facility</link:label>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_label_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Credit Facility One [Member]</link:label>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_documentation_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Credit Facility One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember" xlink:href="hr-20230331.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_UnsecuredCreditFacilityOneMember" xlink:to="lab_hr_UnsecuredCreditFacilityOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_2e46a5b1-6bae-40de-b231-9f7d424a95f5_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthCareRealtyTrustIncMember_5d313617-eb0c-4e98-a444-25a40926fd70_terseLabel_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust, Inc.</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncMember_label_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust, Inc. [Member]</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncMember_documentation_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncMember" xlink:href="hr-20230331.xsd#hr_HealthCareRealtyTrustIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthCareRealtyTrustIncMember" xlink:to="lab_hr_HealthCareRealtyTrustIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_0d9c30c1-5d43-4357-ae84-7bb7e84632b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a87b5476-605a-4a24-924e-2ce6fe8c5dbe_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f1276cb4-8544-4eb9-8d3a-c244f3b1b18a_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f77358f7-a9aa-40df-b2e3-18e39a14e98a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_e401e8f7-5247-4e7d-b5e3-7634ab47e008_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_c31e925d-4ae9-4f5b-9726-444e8531064b_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land held for development</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_0bed38a9-5bf0-467f-bb86-23ec256899cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unrecognized compensation cost, nonvested awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwaps20172018And2019Member_4130c681-b64b-48fe-ae5c-e739586a19d0_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwaps20172018And2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_hr_InterestRateSwaps20172018And2019Member_label_en-US" xlink:label="lab_hr_InterestRateSwaps20172018And2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps 2017 2018, And 2019 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwaps20172018And2019Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwaps20172018And2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps 2017 2018, And 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwaps20172018And2019Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwaps20172018And2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwaps20172018And2019Member" xlink:to="lab_hr_InterestRateSwaps20172018And2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_072f220e-96f8-41a6-a985-a01b9211b461_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture ownership (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_860b78d0-34a9-4de1-9454-14ddfb31d657_terseLabel_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Dispositions [Table]</link:label>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_label_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Dispositions [Table]</link:label>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_documentation_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of real estate dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable" xlink:href="hr-20230331.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable" xlink:to="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableFairValueDiscount_1b0cb560-6f2e-4048-896f-3caa4cd0df73_negatedTerseLabel_en-US" xlink:label="lab_hr_NotesReceivableFairValueDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair-value discount and fees</link:label>
    <link:label id="lab_hr_NotesReceivableFairValueDiscount_label_en-US" xlink:label="lab_hr_NotesReceivableFairValueDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Discount</link:label>
    <link:label id="lab_hr_NotesReceivableFairValueDiscount_documentation_en-US" xlink:label="lab_hr_NotesReceivableFairValueDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableFairValueDiscount" xlink:href="hr-20230331.xsd#hr_NotesReceivableFairValueDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableFairValueDiscount" xlink:to="lab_hr_NotesReceivableFairValueDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3dcd4813-ba34-44a4-ae41-357b346a0fda_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d9855366-224a-45d4-b050-f1ed06255327_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_5ad84ac6-8878-4722-9255-90af007367fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_7cc7965e-03fa-4874-a5cc-ef4abd85f737_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMOUNT</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_7a2dc7ed-f29a-4ad0-8fda-9283e551cd1a_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_18938968-2987-458d-8e07-085d6d1cb6b8_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustments for (gains) losses included in net income (interest expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9f56d6e7-8853-4205-9879-e13e6bca1e49_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss reclassified from AOCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_0f3e4bb6-ff6b-4e33-8e9b-fb89da7872b3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_42ec9be6-06d9-4f79-87df-1a5935f28695_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_ba69b839-dc6f-4ca8-ab29-8dc123762a6c_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_f8dffb87-b0ad-4924-b027-7a5b26d66b84_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete,Buildings and Improvements</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete,Buildings and Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_cf6106d3-19b8-45ca-87e6-377e4b36df4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03ed2264-7f9b-4e35-a8d1-3ba00c55a269_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d8b2ad3-9b12-4d68-bba2-fd1a3466354d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_f302f7d1-576b-4efc-8837-480c0bb511a8_terseLabel_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="hr-20230331.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_bbb5fd69-4783-4d0d-b4d7-f43a962c1786_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_4448d698-6ce8-4723-9001-c5b84dfa1cdd_verboseLabel_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate notes receivable, net</link:label>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_label_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Notes Receivable, Net</link:label>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_documentation_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Notes Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet" xlink:href="hr-20230331.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateNotesReceivableNet" xlink:to="lab_hr_RealEstateNotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d0515170-c77f-44ae-8d72-2eeba095961b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e5dfda56-87a5-4c19-b065-fdcac3b6fece_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_4ee6e4ad-1124-4f78-acbb-bcf23bc4bfa6_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Ratio</link:label>
    <link:label id="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_label_en-US" xlink:label="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio</link:label>
    <link:label id="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_documentation_en-US" xlink:label="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:href="hr-20230331.xsd#hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:to="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_333b6d3b-c543-42b2-b11c-5346cbe90a96_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_df84d424-267e-43c8-9e63-fce2e55a30c8_negatedLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_a4866316-107c-4c96-9e26-d2be660d15db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_48dcf0a6-20d1-49a1-b6f4-aa1a1420733a_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_63465d08-6113-4f04-8b66-2b22abc588b6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssets_b2eec8ba-0c92-4d9b-ab88-29e04b0e4661_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_32921b69-a7cb-4a5c-82ed-4bab0d3603e1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_e0f3a5fe-eb7a-40b5-aefa-4e9bd25c2b79_terseLabel_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of variable interest entities</link:label>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_label_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Variable Interest Entities</link:label>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_documentation_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities" xlink:href="hr-20230331.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfVariableInterestEntities" xlink:to="lab_hr_NumberOfVariableInterestEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_88dfa964-1a2e-4c73-ab2b-0df6b972dab3_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_8994d5aa-eaa5-46f1-a63a-558ff11ab2f6_terseLabel_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest Holders</link:label>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_label_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest Holders [Member]</link:label>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_documentation_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember" xlink:href="hr-20230331.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NonControllingInterestHoldersMember" xlink:to="lab_hr_NonControllingInterestHoldersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_1907cf0d-4d23-46f6-9601-e6941f03f5ae_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentInLease_8e812d34-bd55-4ef3-bc6d-96415173d30b_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment in lease</link:label>
    <link:label id="lab_us-gaap_NetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_NetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment in Lease, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentInLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentInLease" xlink:to="lab_us-gaap_NetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_052bc881-57d2-43f7-ac0c-f7b1c538f457_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsMember_15de6657-3ed8-4440-8b4f-a843b00316ac_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions</link:label>
    <link:label id="lab_hr_RealEstateDispositionsMember_label_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Member]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsMember_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsMember" xlink:to="lab_hr_RealEstateDispositionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateOther_2e11d7ce-a9e2-484d-bb39-8a9357e91713_terseLabel_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (including receivables)</link:label>
    <link:label id="lab_hr_RealEstateOther_label_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Other</link:label>
    <link:label id="lab_hr_RealEstateOther_documentation_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther" xlink:href="hr-20230331.xsd#hr_RealEstateOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateOther" xlink:to="lab_hr_RealEstateOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3d1cf824-4aad-4973-8d07-b9e4fe562a4f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_bb984f21-8718-4e2c-97df-7e49cfce1263_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_cb46d573-4e79-4393-ad69-62ca8a119667_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEASUREMENT PERIOD ADJUSTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_776d5fa5-1ca6-4e5d-ad6e-a7a3c68ef0c6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of real estate properties and additional long-lived assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property Held-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_a5c25d37-73fe-4fb6-8e3b-9487ab6704a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_7c5f89ce-a3f5-4db7-bc58-1e74840e32ff_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_3b2a30d4-2de7-4da3-be52-23944f97561b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_74d1592e-2da1-4522-85c0-8d17ccf40702_negatedLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revaluation of 2022 RSUs (net change) (in shares)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Probability Adjustment In Period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Probability Adjustment In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12b98ac7-f8e5-4135-85e0-abde3ffbd1d0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_88f38165-b055-4323-a144-5110e44b2fc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of common stock outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_81b028f7-7494-40ab-bf15-0d02eaf68a6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_e46bc59a-b430-4db7-893e-2b13775a1f0e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill expected to be tax deductible</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0824ecb0-802f-4aeb-8ca8-a7b67e63b001_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_b4879150-1e92-4d3b-a07b-09ab9f5c280a_terseLabel_en-US" xlink:label="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges on net real estate assets held for sale</link:label>
    <link:label id="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_label_en-US" xlink:label="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charge on Real Estate Assets Held for Sale</link:label>
    <link:label id="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charge on Real Estate Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:href="hr-20230331.xsd#hr_ImpairmentChargeOnRealEstateAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:to="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7d4f2d13-4e86-468f-8470-c1c4fff3ae27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f6cc3e05-b226-40c5-bfb6-b2ffb0a2a1f4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4d875630-4948-4281-8801-4259fc096fb0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share- net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_1e9e4bbb-84b0-47a6-8cce-c6e4cefc7c88_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate investments</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c5291851-d5ac-4831-a83b-b5d794ce8f8d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopmentInProcess_1824eaf4-972e-472a-81b3-6671dff51373_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopmentInProcess" xlink:to="lab_us-gaap_DevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_e3e982d7-bbba-4de3-9ace-6b0ae18c9cf1_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_2d74d7ff-d7f6-4cb9-af2f-946090824499_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c4995b7e-6a71-4d26-b601-fc3671510046_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_a0674e40-b8e9-454d-9441-7e35c1d1d20c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_335ccff9-a6f8-41c2-aa79-95c728298303_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_43170be1-3dfd-4e22-a593-23d1e9906835_terseLabel_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square feet subject to ground leases</link:label>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_label_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square Feet Subject to Ground Leases</link:label>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_documentation_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square Feet Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases" xlink:href="hr-20230331.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SquareFeetSubjecttoGroundLeases" xlink:to="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_83edbc0b-bc61-4d46-8f52-51546f8a2baf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TampaFLMiamiFLMember_d27242ad-b86f-4e77-bdf6-ae205c740336_terseLabel_en-US" xlink:label="lab_hr_TampaFLMiamiFLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa Fl &amp; Miami FL</link:label>
    <link:label id="lab_hr_TampaFLMiamiFLMember_label_en-US" xlink:label="lab_hr_TampaFLMiamiFLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa FL &amp; Miami FL [Member]</link:label>
    <link:label id="lab_hr_TampaFLMiamiFLMember_documentation_en-US" xlink:label="lab_hr_TampaFLMiamiFLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa FL &amp; Miami FL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMiamiFLMember" xlink:href="hr-20230331.xsd#hr_TampaFLMiamiFLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TampaFLMiamiFLMember" xlink:to="lab_hr_TampaFLMiamiFLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_2e329f05-b236-40b4-8e2f-3c7b687c9bc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_48aeee76-4b94-4fa4-95e8-d04585cde37f_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investments</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments [Abstract]</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_fc839132-25ce-44bb-ad6d-57be89159b39_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Minimum Operating Lease Payments Receivable</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfBuildingsOwnedByJointVenture_647c5b82-112f-45de-bcf8-d618ad7883f8_terseLabel_en-US" xlink:label="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of buildings owned by joint venture with TIAA</link:label>
    <link:label id="lab_hr_NumberOfBuildingsOwnedByJointVenture_label_en-US" xlink:label="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Buildings Owned by Joint Venture</link:label>
    <link:label id="lab_hr_NumberOfBuildingsOwnedByJointVenture_documentation_en-US" xlink:label="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Buildings Owned by Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfBuildingsOwnedByJointVenture" xlink:href="hr-20230331.xsd#hr_NumberOfBuildingsOwnedByJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfBuildingsOwnedByJointVenture" xlink:to="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_d4fb5ec5-10ed-4025-92e1-5256ea60c39b_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage note receivable taken in connection with sale of real estate</link:label>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_label_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Related to Property Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:to="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CommonStockFractionalShares_a0ce5585-33b6-495d-a7dd-c867afe23316_terseLabel_en-US" xlink:label="lab_hr_CommonStockFractionalShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, fractional (in shares)</link:label>
    <link:label id="lab_hr_CommonStockFractionalShares_label_en-US" xlink:label="lab_hr_CommonStockFractionalShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Fractional Shares</link:label>
    <link:label id="lab_hr_CommonStockFractionalShares_documentation_en-US" xlink:label="lab_hr_CommonStockFractionalShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Fractional Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockFractionalShares" xlink:href="hr-20230331.xsd#hr_CommonStockFractionalShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CommonStockFractionalShares" xlink:to="lab_hr_CommonStockFractionalShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_8b944582-c51a-4d27-9050-51c0fa9ccaeb_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6195196b-637b-41fc-9695-3c4fff6b6bd2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Minimum Operating Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_cc75eae0-700b-41a9-bdfc-17ef56917971_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6df19f5f-b6ce-4e49-bd7d-6f1268429a4e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_a97f8f30-2fad-49ec-85be-b12e5d98c502_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f05f524f-fd33-4f92-88dc-d035797c7ca5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_61499e9f-c9fc-4e9a-baa6-14f3a92f7427_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5f67c62c-ad92-4dc1-90cc-86bf3711cd8f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average years remaining lease term (excluding renewal options) - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e997d698-38fb-45a9-9c36-0a44490cdc9b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DerivativeNetAssetPositionAggregateFairValue_9bc42f7a-a916-4770-a90f-487444f3a968_terseLabel_en-US" xlink:label="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives in net asset position</link:label>
    <link:label id="lab_hr_DerivativeNetAssetPositionAggregateFairValue_label_en-US" xlink:label="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Net Asset Position Aggregate Fair Value</link:label>
    <link:label id="lab_hr_DerivativeNetAssetPositionAggregateFairValue_documentation_en-US" xlink:label="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Net Asset Position Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:href="hr-20230331.xsd#hr_DerivativeNetAssetPositionAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:to="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_fd9dfb59-c732-4ef6-b737-9c16f7fdd5e1_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5e82f23b-bcee-4be9-b63b-5373cb6f7ab0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_367f2ba2-62b1-4298-8308-fbe0c1b8923c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIssuanceProgramDomain_891cc2de-3d76-4abe-975f-e79de8333c60_terseLabel_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Domain]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramDomain_label_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Domain]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramDomain_documentation_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Stock Issuance Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIssuanceProgramDomain" xlink:to="lab_hr_StockIssuanceProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_5156960c-3232-4a30-a5fe-8873a053d915_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contractual real estate notes receivable</link:label>
    <link:label id="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_label_en-US" xlink:label="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount</link:label>
    <link:label id="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_documentation_en-US" xlink:label="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:href="hr-20230331.xsd#hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:to="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_d1ee9cf5-dd9d-4194-b5ef-fea425f15eec_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Line Items]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_label_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Line Items]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsLineItems" xlink:to="lab_hr_RealEstateDispositionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_bab6bbb3-a3a8-4098-88b5-00a55cc1dbff_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_1da57560-89b3-407b-8e26-ad4e363dd3a8_verboseLabel_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the beginning and ending common stock outstanding</link:label>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_label_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Common Stock Outstanding [Roll Forward]</link:label>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_documentation_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the beginning and ending common stock outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:href="hr-20230331.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:to="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_9fb74532-98d7-4cda-b92f-c617b7716759_terseLabel_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate properties</link:label>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_label_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Investments</link:label>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments" xlink:href="hr-20230331.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRealEstateInvestments" xlink:to="lab_hr_NumberOfRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ee620fa0-4504-49a8-b484-521a55d33a18_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeDividends_fba13ef5-3c6f-4685-99ca-9ee49a7f2004_negatedLabel_en-US" xlink:label="lab_us-gaap_CumulativeDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative dividends</link:label>
    <link:label id="lab_us-gaap_CumulativeDividends_label_en-US" xlink:label="lab_us-gaap_CumulativeDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeDividends" xlink:to="lab_us-gaap_CumulativeDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_c69cf9e1-736e-42a6-b5ef-56335104d06f_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partners ownership interest (in percent)</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9f7e9436-ff8e-4570-8474-b52f0dc5f87a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_be2406d3-4f8f-4abe-a24d-b1cea72b5145_terseLabel_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture, ownership (in percentage)</link:label>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_label_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Ownership Percentage</link:label>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_documentation_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage" xlink:href="hr-20230331.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_JointVentureOwnershipPercentage" xlink:to="lab_hr_JointVentureOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_9c60f39c-84ff-48a7-8a0f-c8217b2e44bf_terseLabel_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SQUARE FOOTAGE</link:label>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_label_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Covered Under Real Estate Investment Sold in Measurement Units</link:label>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_documentation_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area covered under real estate investment sold in measurement units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:href="hr-20230331.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:to="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_6f09fbfe-b38e-4951-8048-e88ae0fcc241_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_ae754469-f543-4868-85ce-5f84c1c6374f_verboseLabel_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that the company owns real estate in, whole units</link:label>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_label_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investments Property Owned in Number of States</link:label>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_documentation_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investments property owned in number of states.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:href="hr-20230331.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:to="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4fd9eb6e-7c4c-4c0c-adb6-2d2976892a76_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_7882e99e-f290-47c9-a6e2-8f7fad5bf8db_terseLabel_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of recognized lease financial receivables</link:label>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_label_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Recognized Lease Financial Receivables</link:label>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_documentation_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Recognized Lease Financial Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:href="hr-20230331.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:to="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_f9706196-c70f-4419-96ae-d4b57772248b_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_add9ea7a-8510-4a2d-81a3-4e07d052e662_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfNotesReceivable_48c16116-4bb0-472d-9d6d-be4215555d0a_terseLabel_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of notes receivable</link:label>
    <link:label id="lab_hr_NumberOfNotesReceivable_label_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:label id="lab_hr_NumberOfNotesReceivable_documentation_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable" xlink:href="hr-20230331.xsd#hr_NumberOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfNotesReceivable" xlink:to="lab_hr_NumberOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_e0d2e268-c82c-469a-a0a8-2e3c65b0a131_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3cde6779-eda8-4929-a80e-af4050d8a308_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld to pay estimated withholding taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_92089a1b-1ea3-4279-a61b-5164e3e88d3a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows outflows related to financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b4449dc7-42fc-458a-9f7a-bf3467c33aca_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_1eb24ee8-429a-4975-8bcf-b9ddb4d30d82_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJune12027Member" xlink:to="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_481bc2a5-42f6-4e0c-9834-35e222780a65_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_2ae7a2b4-cf09-4336-aa04-be7350991b26_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3661c307-396d-4f15-960b-8b3e5c1ee1e8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_77751adf-a5a9-41bf-90e1-4e18d14ea3ae_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6b0b7c76-d096-42fb-a145-8c4e9bbef163_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c275d6c4-3346-4b52-970d-a933b42c8c52_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_f53a7fbe-a2ef-4735-a50f-a6e3d6f32410_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_83476335-fd78-41b7-bb65-5be5a484640f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_702972f9-6666-4475-a385-b44885742be2_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ab38d090-2472-4f46-ac10-0cd0db563735_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_384cc8a1-ab1c-42e8-b2c9-a2ae215c05c2_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_cc66cd4f-4f6e-435b-8cad-bc83f8ec2809_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_58d2ac55-6a0e-4376-b906-829236b11098_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_78569f95-1e2a-4b90-a4e5-37ed547036a2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_89ed6af1-0034-4d84-ba11-bdfdd8f47b11_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_8d719c1a-9c81-4c0a-9be4-34d32a99af77_terseLabel_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Interest Rate Swap</link:label>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_label_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_documentation_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Interest Rate Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember" xlink:href="hr-20230331.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ActiveInterestRateSwapsMember" xlink:to="lab_hr_ActiveInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3f9667a1-ed20-4841-b76e-abb9fdf957ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_494bdd5d-46fe-4d38-af54-c4b5c152d3d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_784314f9-9ca4-4477-9f6e-6155752ce535_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_857255b9-5326-49fc-9664-c5133fa3faf9_terseLabel_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business overview</link:label>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_label_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Policy Text Block]</link:label>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_documentation_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Operations Policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NatureOfOperationsPolicyTextBlock" xlink:href="hr-20230331.xsd#hr_NatureOfOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NatureOfOperationsPolicyTextBlock" xlink:to="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_744a46fe-2f73-419a-a3b4-6d457847963a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_ea197d79-1cf2-4786-970e-1b8ac5d462c1_terseLabel_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss reserves</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_label_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Reserves</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_documentation_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:href="hr-20230331.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:to="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_e12174bd-5859-45ad-a9de-180f1f7ef603_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3cf6d1d1-659b-499d-a1c4-08e5137405d2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_8162b586-050a-4269-b81f-8cf344b895ee_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJune12026Member" xlink:to="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_3308398e-98e4-4715-8c4f-c9455e1419ca_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other information</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_82a98d90-563b-4ff5-a4f3-53d6353b9149_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_049504d9-1ef7-4745-a445-01c404e03e13_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e57521c4-0ebb-40ae-aa88-a91b282468a4_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_d00e0103-bdd9-4d9d-a154-8e0bfa5695c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0912a958-a808-404a-9edc-c6f4baea4fb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0e05a9b8-3472-4e96-84a4-33eea367bdeb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss recognized during the period</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_JointVentureCarryingAmount_c8a1617b-4dbc-4a41-a1e3-0a769b363249_terseLabel_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture, carrying amount</link:label>
    <link:label id="lab_hr_JointVentureCarryingAmount_label_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Carrying Amount</link:label>
    <link:label id="lab_hr_JointVentureCarryingAmount_documentation_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount" xlink:href="hr-20230331.xsd#hr_JointVentureCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_JointVentureCarryingAmount" xlink:to="lab_hr_JointVentureCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_6ebfb270-4318-4741-ba4f-a8e18f43748f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_881ddc31-6fcc-4701-ad4d-f0b427370bf9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_7e2384a9-1d5d-4f7b-9ece-b8ed21bd6ca4_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_90b0f019-92cc-43c5-b4c4-748280065781_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled treasury hedges</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_eee048ac-a03e-429e-9661-68eb6a04ee42_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_083ac836-10c5-4fb9-b09d-597eb8f65a4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_8a9bac2f-8fbf-4195-8bad-d2023a145353_verboseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_21681e35-f0e2-4d05-ae66-ce24dc109667_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_228f1fb6-c318-429c-8451-409202bf03eb_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_41c4fdce-cea9-480d-8948-f95134a58f91_terseLabel_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets and liabilities held for sale</link:label>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_label_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale [Table Text Block]</link:label>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_documentation_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:href="hr-20230331.xsd#hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:to="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertyDispositions_302d6fb4-ca2c-4743-afa8-991394fb2485_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertyDispositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of property dispositions</link:label>
    <link:label id="lab_hr_NumberOfPropertyDispositions_label_en-US" xlink:label="lab_hr_NumberOfPropertyDispositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Property Dispositions</link:label>
    <link:label id="lab_hr_NumberOfPropertyDispositions_documentation_en-US" xlink:label="lab_hr_NumberOfPropertyDispositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Property Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertyDispositions" xlink:href="hr-20230331.xsd#hr_NumberOfPropertyDispositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertyDispositions" xlink:to="lab_hr_NumberOfPropertyDispositions" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_36b24283-6bbc-4dc1-9fd3-e9c1f64deca9_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_6b0f95b0-1885-41e9-b366-79efeea43505_terseLabel_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Notes Payable</link:label>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_label_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Notes Payable, Net [Member]</link:label>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_documentation_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Notes Payable, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember" xlink:href="hr-20230331.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageNotesPayableNetMember" xlink:to="lab_hr_MortgageNotesPayableNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJanuary152024Member_fccedc88-692d-46a0-93aa-d7eb3bc95ccc_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring January 15, 2024</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJanuary152024Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring January 15, 2024 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJanuary152024Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring January 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJanuary152024Member" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJanuary152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJanuary152024Member" xlink:to="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceMortgageNotes_9ad3dc36-0ee3-4201-88ae-db1d8088a5ac_negatedTerseLabel_en-US" xlink:label="lab_hr_FinanceMortgageNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPANY-FINANCED MORTGAGE NOTES</link:label>
    <link:label id="lab_hr_FinanceMortgageNotes_label_en-US" xlink:label="lab_hr_FinanceMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Mortgage Notes</link:label>
    <link:label id="lab_hr_FinanceMortgageNotes_documentation_en-US" xlink:label="lab_hr_FinanceMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Mortgage Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceMortgageNotes" xlink:href="hr-20230331.xsd#hr_FinanceMortgageNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceMortgageNotes" xlink:to="lab_hr_FinanceMortgageNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_ab374394-1b54-4367-8fa7-4cba2afba3de_terseLabel_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate square feet invested in by company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_label_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Square Feet Invested in by Company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_documentation_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Square Feet Invested in by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany" xlink:href="hr-20230331.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ApproximateSquareFeetInvestedInByCompany" xlink:to="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hr-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:388a749e-3c99-4328-89c5-127682212508,g:16eafbb3-991c-406c-96b0-65d8e7977cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthcarerealty.com/role/Cover" xlink:type="simple" xlink:href="hr-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a53dac51-041c-4a5f-8ba7-203b08c494a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_DocumentType_a53dac51-041c-4a5f-8ba7-203b08c494a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4df58c7c-2b24-48fe-a6d5-95c6a6066a3a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_DocumentQuarterlyReport_4df58c7c-2b24-48fe-a6d5-95c6a6066a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_07ccf5ec-df24-4a0a-aa7b-dc1a30dd7ef7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_DocumentPeriodEndDate_07ccf5ec-df24-4a0a-aa7b-dc1a30dd7ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_cff30009-6ae3-49e9-bfed-f9f6634f3ace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_DocumentTransitionReport_cff30009-6ae3-49e9-bfed-f9f6634f3ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4d328667-832d-4ca1-b44d-b71d85d75ba0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityFileNumber_4d328667-832d-4ca1-b44d-b71d85d75ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_12e71636-d7a9-41b3-bfca-aa95b8b03c9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityRegistrantName_12e71636-d7a9-41b3-bfca-aa95b8b03c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_748b7d77-4a53-4796-9c50-4b4f79a366de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_748b7d77-4a53-4796-9c50-4b4f79a366de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8e728058-0e55-4369-adba-ad68efac270a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityTaxIdentificationNumber_8e728058-0e55-4369-adba-ad68efac270a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0d00c032-c881-4124-a4d6-1b29dab88307" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityAddressAddressLine1_0d00c032-c881-4124-a4d6-1b29dab88307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_6def813c-0ed9-45f3-8183-8151d032f408" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityAddressAddressLine2_6def813c-0ed9-45f3-8183-8151d032f408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0c3ef6c8-af36-4ba0-a42a-87b9bfe599d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityAddressCityOrTown_0c3ef6c8-af36-4ba0-a42a-87b9bfe599d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_308e9b19-adff-45d2-954d-81598ba65be4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityAddressStateOrProvince_308e9b19-adff-45d2-954d-81598ba65be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9ff82484-919f-4fce-90f3-887b0358c639" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityAddressPostalZipCode_9ff82484-919f-4fce-90f3-887b0358c639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0e29cbaf-eee9-4302-98b3-1f37ef44ffbd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_CityAreaCode_0e29cbaf-eee9-4302-98b3-1f37ef44ffbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_41d9997e-426e-4dcb-8df5-4b89e995d715" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_LocalPhoneNumber_41d9997e-426e-4dcb-8df5-4b89e995d715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0473acdb-0857-49f1-b373-a1daf40117a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_Security12bTitle_0473acdb-0857-49f1-b373-a1daf40117a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_033f06b0-3352-4dda-ad60-75131409ba53" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_TradingSymbol_033f06b0-3352-4dda-ad60-75131409ba53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_112db087-1d92-4dc8-b6a0-a347c48f90a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_SecurityExchangeName_112db087-1d92-4dc8-b6a0-a347c48f90a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a7f4649a-a364-484e-888e-f3be378284fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityCurrentReportingStatus_a7f4649a-a364-484e-888e-f3be378284fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1b442aa0-663f-4af8-92d0-01397df6afc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityInteractiveDataCurrent_1b442aa0-663f-4af8-92d0-01397df6afc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c00dfe8c-b384-4857-8a75-101b2c18e2e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityFilerCategory_c00dfe8c-b384-4857-8a75-101b2c18e2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a637d716-4f2c-40d2-ac4f-e28b6888c1d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntitySmallBusiness_a637d716-4f2c-40d2-ac4f-e28b6888c1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f853eec9-df8e-42df-bebe-f2c8fc61c1c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityEmergingGrowthCompany_f853eec9-df8e-42df-bebe-f2c8fc61c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_663c6016-697b-4f98-a08a-f59154f43784" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityShellCompany_663c6016-697b-4f98-a08a-f59154f43784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ca67ddb3-27be-48d7-a7a1-b59c62097898" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ca67ddb3-27be-48d7-a7a1-b59c62097898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e614c61e-cbe0-4c47-951e-47c37f3a84ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_EntityCentralIndexKey_e614c61e-cbe0-4c47-951e-47c37f3a84ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_676b3f07-255f-4c38-8e9b-61217c818788" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_CurrentFiscalYearEndDate_676b3f07-255f-4c38-8e9b-61217c818788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_323f76e8-c079-496f-b3c0-c4cec375bc10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_DocumentFiscalYearFocus_323f76e8-c079-496f-b3c0-c4cec375bc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_32cf61a4-4734-49ad-9d34-17e326862ce0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_32cf61a4-4734-49ad-9d34-17e326862ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_88dfff6c-9864-4ae3-9d2c-807ce81a1dfc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_755b9532-11b2-4610-9788-bf137af9400a" xlink:to="loc_dei_AmendmentFlag_88dfff6c-9864-4ae3-9d2c-807ce81a1dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5a5b815d-bc82-428f-940e-1896e70d14c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5a5b815d-bc82-428f-940e-1896e70d14c8" xlink:to="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_74a0671b-4a19-4d70-af49-bc30309f6c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_Land_74a0671b-4a19-4d70-af49-bc30309f6c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_ea5e11a9-0f84-455a-9f1f-bfd76ac344d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_ea5e11a9-0f84-455a-9f1f-bfd76ac344d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_83e1da35-47e3-42eb-b5a2-2f7e46fada79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_83e1da35-47e3-42eb-b5a2-2f7e46fada79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty_0235d18c-8191-4396-a18d-13d84c223d6c" xlink:href="hr-20230331.xsd#hr_PersonalProperty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_hr_PersonalProperty_0235d18c-8191-4396-a18d-13d84c223d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_8a81ab18-81ae-462b-bf9f-140a3d1541b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_NotesReceivableNet_8a81ab18-81ae-462b-bf9f-140a3d1541b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_d77e2691-933e-4b65-ab82-95eb61772b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_d77e2691-933e-4b65-ab82-95eb61772b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_1cec027e-1659-4aae-bc71-274002ce0463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_DevelopmentInProcess_1cec027e-1659-4aae-bc71-274002ce0463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_e21356d7-db82-4f1b-ae6e-805695ffeca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_LandAvailableForDevelopment_e21356d7-db82-4f1b-ae6e-805695ffeca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_7ddd5317-c540-430b-bfc7-70fc07cdcd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_7ddd5317-c540-430b-bfc7-70fc07cdcd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_b4094ba4-8488-492f-8f2e-86aa1a09edec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_c14f10a1-bd23-4ecc-8200-65f8a9441e88" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_b4094ba4-8488-492f-8f2e-86aa1a09edec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_b7dadd13-a0a5-4b63-b969-e11c3df0c6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_b7dadd13-a0a5-4b63-b969-e11c3df0c6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c333040-f5b0-4cfc-90ce-8d50d5d71836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c333040-f5b0-4cfc-90ce-8d50d5d71836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_fb50166f-9d8f-45ff-bb11-69ccfa1239a5" xlink:href="hr-20230331.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_fb50166f-9d8f-45ff-bb11-69ccfa1239a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_af77c36f-497d-40f3-aa08-3e8a6bdc91f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_af77c36f-497d-40f3-aa08-3e8a6bdc91f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_eda3910f-a396-4882-9a80-dd30915e6576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_eda3910f-a396-4882-9a80-dd30915e6576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d913bd71-c319-4a71-ab9b-9840ee50159b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_Goodwill_d913bd71-c319-4a71-ab9b-9840ee50159b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_5e708c68-4b75-40d9-8d89-f570f1a77eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_OtherAssets_5e708c68-4b75-40d9-8d89-f570f1a77eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_594ff54c-bf91-480a-8031-dbaf0200c9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbdc4cc-5d2f-42a0-8418-f8884680487d" xlink:to="loc_us-gaap_Assets_594ff54c-bf91-480a-8031-dbaf0200c9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5a5b815d-bc82-428f-940e-1896e70d14c8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:to="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_90afea92-c0b8-4db5-a4af-3e95b893016c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_LongTermDebt_90afea92-c0b8-4db5-a4af-3e95b893016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_cd61fee2-b274-4995-b9a3-01fd3ab9ba90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_cd61fee2-b274-4995-b9a3-01fd3ab9ba90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_eba43f1c-4786-42b6-9eeb-776d470a5ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_eba43f1c-4786-42b6-9eeb-776d470a5ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4b578b78-6528-4f06-8613-bd2285a6b12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_OperatingLeaseLiability_4b578b78-6528-4f06-8613-bd2285a6b12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_da653c9a-e9aa-4913-8d03-55421637d8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_FinanceLeaseLiability_da653c9a-e9aa-4913-8d03-55421637d8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_b8cbe449-5d9c-4130-b5e2-7b0612c5c8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_OtherLiabilities_b8cbe449-5d9c-4130-b5e2-7b0612c5c8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_82a411a3-c87b-49a9-9668-0f8596c67eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87691518-7754-4f94-b28b-44ae5891a86c" xlink:to="loc_us-gaap_Liabilities_82a411a3-c87b-49a9-9668-0f8596c67eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e031f7be-1df5-4f9b-8afd-fb9654bb3771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e031f7be-1df5-4f9b-8afd-fb9654bb3771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_633c1ad2-7622-463b-bf6e-30e456e517c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_633c1ad2-7622-463b-bf6e-30e456e517c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_42b4c06e-52c1-4892-ae32-48ed76f130da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_PreferredStockValue_42b4c06e-52c1-4892-ae32-48ed76f130da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3a7bbfda-7f39-44c3-bde8-f081bcac2583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_CommonStockValue_3a7bbfda-7f39-44c3-bde8-f081bcac2583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_968df9b1-21e5-42bf-90f4-000cacd9524f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_968df9b1-21e5-42bf-90f4-000cacd9524f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_66b17925-3b12-4050-bc07-8baa46252daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_66b17925-3b12-4050-bc07-8baa46252daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_1a1f0da5-fd16-45c8-bbfd-239946c9c71a" xlink:href="hr-20230331.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_1a1f0da5-fd16-45c8-bbfd-239946c9c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends_cfa7e6a2-5e91-4eec-9234-1f4c189ebbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_CumulativeDividends_cfa7e6a2-5e91-4eec-9234-1f4c189ebbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdc6c007-b4a5-4973-8afe-69fdd230b51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_StockholdersEquity_cdc6c007-b4a5-4973-8afe-69fdd230b51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a580e202-a77e-4518-a655-462188afc5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_MinorityInterest_a580e202-a77e-4518-a655-462188afc5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ebce6d15-4638-4abb-bff5-aa5c2f04fd07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_96c4cdc8-c944-4b04-af3d-ee129eda0a0e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ebce6d15-4638-4abb-bff5-aa5c2f04fd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7bc98dc1-c63a-4c9c-9d20-3b26cf2b0379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d96170a-0732-4f24-bca4-eef90b1d98df" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7bc98dc1-c63a-4c9c-9d20-3b26cf2b0379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f66c7780-1e2b-4684-a39b-054d794739a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f66c7780-1e2b-4684-a39b-054d794739a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_21081bb7-8da3-4d19-acf1-1550897f89ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_21081bb7-8da3-4d19-acf1-1550897f89ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5c9ba029-d8d7-4029-b819-8ab948540e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5c9ba029-d8d7-4029-b819-8ab948540e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_362ee580-614a-4c6b-92ab-001332c247a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_362ee580-614a-4c6b-92ab-001332c247a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a42ed1e0-195b-4550-a1ed-c5c8a40d9037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a42ed1e0-195b-4550-a1ed-c5c8a40d9037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_63fd8d15-4b79-45b1-b632-2a9f7dd0d4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_63fd8d15-4b79-45b1-b632-2a9f7dd0d4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_895521dc-638c-4abb-81ef-6718443a4786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_CommonStockSharesIssued_895521dc-638c-4abb-81ef-6718443a4786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d017916-20a9-40d1-847d-11c25f932ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d677b258-73bc-4588-a40a-6bf088c9567b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d017916-20a9-40d1-847d-11c25f932ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_65fc7284-2815-4b19-add3-03ce5e1c1a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_RevenuesAbstract_65fc7284-2815-4b19-add3-03ce5e1c1a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_e3b73e76-d945-4f53-9964-2fd5dff9b994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_65fc7284-2815-4b19-add3-03ce5e1c1a91" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_e3b73e76-d945-4f53-9964-2fd5dff9b994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_b191ce6e-916b-47b7-80e0-e5cb16267d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_65fc7284-2815-4b19-add3-03ce5e1c1a91" xlink:to="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_b191ce6e-916b-47b7-80e0-e5cb16267d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ec8586de-65dc-4859-aebe-371cfbb7c4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_65fc7284-2815-4b19-add3-03ce5e1c1a91" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ec8586de-65dc-4859-aebe-371cfbb7c4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_550161cc-a274-46b0-8334-6093e8bd233c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_65fc7284-2815-4b19-add3-03ce5e1c1a91" xlink:to="loc_us-gaap_Revenues_550161cc-a274-46b0-8334-6093e8bd233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_17d1cd5d-1e74-48f4-ba0d-981d8e46cdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:to="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_17d1cd5d-1e74-48f4-ba0d-981d8e46cdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_767510c2-ac02-4de6-a220-69183aca4716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_767510c2-ac02-4de6-a220-69183aca4716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_3db28ce3-feb1-49b2-b0d4-217e14ca456f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:to="loc_us-gaap_AcquisitionCosts_3db28ce3-feb1-49b2-b0d4-217e14ca456f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_d5376c3a-c4c2-4e36-8008-cd3668ab24f3" xlink:href="hr-20230331.xsd#hr_MergerRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:to="loc_hr_MergerRelatedCosts_d5376c3a-c4c2-4e36-8008-cd3668ab24f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3237b120-b72a-4292-bc0e-a2604043ba85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:to="loc_us-gaap_DepreciationAndAmortization_3237b120-b72a-4292-bc0e-a2604043ba85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_ce766c2e-7529-49aa-a99a-7b9a5432fa1f" xlink:href="hr-20230331.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a8c0bc2d-5101-4cca-9573-6a3044343d78" xlink:to="loc_hr_OperatingExpensesandCostofGoodsSold_ce766c2e-7529-49aa-a99a-7b9a5432fa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_48311226-eaff-4485-8d17-1f7677fb2480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_48311226-eaff-4485-8d17-1f7677fb2480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d553da70-ee02-4544-8546-0408e5ee78e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_InterestExpense_d553da70-ee02-4544-8546-0408e5ee78e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b056b941-ecea-41c4-9732-63bfb7b5b442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b056b941-ecea-41c4-9732-63bfb7b5b442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_e9fb5a02-8e48-428a-81ae-b287e8f5afc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_e9fb5a02-8e48-428a-81ae-b287e8f5afc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_11c83042-6e2c-4f2c-83dd-ddc39366e6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_11c83042-6e2c-4f2c-83dd-ddc39366e6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_218de140-dd55-43be-8f3a-efe2f54404f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_218de140-dd55-43be-8f3a-efe2f54404f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cb7948d8-5712-4b58-bd33-e380137b4e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cb7948d8-5712-4b58-bd33-e380137b4e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f184f15f-d5e5-4e5d-8fad-657a00874c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_ProfitLoss_f184f15f-d5e5-4e5d-8fad-657a00874c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f9ea660b-2696-4279-8127-92ca96287ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f9ea660b-2696-4279-8127-92ca96287ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a0ebf784-4433-4596-b258-dcfe6b70ecb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_309d618f-42e1-4894-a3a8-1acd2e1cc4ee" xlink:to="loc_us-gaap_NetIncomeLoss_a0ebf784-4433-4596-b258-dcfe6b70ecb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dd0c5e6c-8c8b-42f2-9204-e3b2cce931a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_EarningsPerShareBasic_dd0c5e6c-8c8b-42f2-9204-e3b2cce931a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ef6cb793-401a-4d66-a184-8190657da7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ef6cb793-401a-4d66-a184-8190657da7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3254f8f6-640f-40c6-b607-26e6d615704d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3254f8f6-640f-40c6-b607-26e6d615704d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6cdfef2d-9c7f-4374-9e17-7abd5d04aa02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6cdfef2d-9c7f-4374-9e17-7abd5d04aa02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_548c656b-343c-4e18-be9a-83aecfb7da61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7b6cf160-2f8e-48d9-853a-5e247944d8c3" xlink:to="loc_us-gaap_TypeOfRevenueExtensibleList_548c656b-343c-4e18-be9a-83aecfb7da61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de115d53-20f4-450a-b7b1-aa8d6d0d6544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de115d53-20f4-450a-b7b1-aa8d6d0d6544" xlink:to="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_084f4831-c449-4758-88d4-6d339fab9317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c4c31f9-1b42-4656-9e4f-6106fe8c6779" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_084f4831-c449-4758-88d4-6d339fab9317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_245332cc-da6f-4d8d-9662-2aea08dd9b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_084f4831-c449-4758-88d4-6d339fab9317" xlink:to="loc_us-gaap_InterestRateSwapMember_245332cc-da6f-4d8d-9662-2aea08dd9b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1860479c-e0dc-4976-a02c-57f3fd237ec3" xlink:to="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_af237bd7-3612-4827-9163-7c9a5a89e693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ProfitLoss_af237bd7-3612-4827-9163-7c9a5a89e693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_93a17d9b-62d7-4985-b168-d064b82cef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_93a17d9b-62d7-4985-b168-d064b82cef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e6493783-7f81-4a8a-8f7a-e62881d5241f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_8d47fa05-fe4a-419d-ae20-0a1e42e285ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e6493783-7f81-4a8a-8f7a-e62881d5241f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23c100a2-bb0d-4d40-a26b-2063cbefc60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ae91dc49-8b45-4d16-aa6e-b1340e0c4cc3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23c100a2-bb0d-4d40-a26b-2063cbefc60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1bf236b3-bdde-4861-94af-a3209a26a136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1bf236b3-bdde-4861-94af-a3209a26a136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d80e0c17-620e-4591-995f-227950eaa368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d80e0c17-620e-4591-995f-227950eaa368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddf5cd6c-7b17-4512-b2ac-6c5a646f2987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e00e5d77-5a0e-4811-a605-94983918eeac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ddf5cd6c-7b17-4512-b2ac-6c5a646f2987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2b12136a-5f40-44cc-b069-de84adef34f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2b12136a-5f40-44cc-b069-de84adef34f4" xlink:to="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a8d25458-789b-45b9-864c-ff87809fdccb" xlink:to="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:to="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dbde959b-5209-4c49-b405-78da5e523778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_us-gaap_CommonStockMember_dbde959b-5209-4c49-b405-78da5e523778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_989ecd89-1ee7-4c26-9fee-dd7dcba6ed7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_989ecd89-1ee7-4c26-9fee-dd7dcba6ed7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fa62934f-c056-4c2a-8f72-2bf42a944fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fa62934f-c056-4c2a-8f72-2bf42a944fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember_49c5a5c7-546b-42fd-a120-086059ed6d06" xlink:href="hr-20230331.xsd#hr_CumulativeNetIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_hr_CumulativeNetIncomeMember_49c5a5c7-546b-42fd-a120-086059ed6d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember_6e0aa36b-91ea-4878-b36a-8c441bafdfd0" xlink:href="hr-20230331.xsd#hr_CumulativeDividendsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_ba43c450-2577-466f-9007-3df7c79e69f5" xlink:to="loc_hr_CumulativeDividendsMember_6e0aa36b-91ea-4878-b36a-8c441bafdfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d49cbccd-ee50-444b-94ae-6a883cb287ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01f9a9fc-0e80-4040-9371-5ce87633b4f0" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d49cbccd-ee50-444b-94ae-6a883cb287ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_22aabc69-3f02-48fd-aaee-ae2edfbebf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bb68010-89f5-4ebe-b3dd-e10920d58183" xlink:to="loc_us-gaap_StatementLineItems_22aabc69-3f02-48fd-aaee-ae2edfbebf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22aabc69-3f02-48fd-aaee-ae2edfbebf17" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e022ba94-c1b4-4f7d-bf56-6886841a45bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e022ba94-c1b4-4f7d-bf56-6886841a45bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0693f512-119d-4a1b-b295-044936bc636f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0693f512-119d-4a1b-b295-044936bc636f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5470908-02c5-458b-b27a-6e856aa3ea6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5470908-02c5-458b-b27a-6e856aa3ea6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d3114ec-a4fe-48f6-9026-1ef36e6027bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d3114ec-a4fe-48f6-9026-1ef36e6027bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a97715d3-7e60-413d-8cab-bce850c5118d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_ProfitLoss_a97715d3-7e60-413d-8cab-bce850c5118d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_333ea94c-ce9e-4698-8c86-8bcc8189e142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_333ea94c-ce9e-4698-8c86-8bcc8189e142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ed4b44b7-8b73-4905-8a44-b33ec477a2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ed4b44b7-8b73-4905-8a44-b33ec477a2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3799c031-4e7f-4b54-b3c4-9ceadb1af9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_DividendsCommonStockCash_3799c031-4e7f-4b54-b3c4-9ceadb1af9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_36e45e3d-f19c-4dff-800a-05a849e554d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e07e9746-06be-4f3f-b094-c79d991c669a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_36e45e3d-f19c-4dff-800a-05a849e554d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofEquityParenthetical"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_abc5716f-a1d4-466b-a834-665f67265b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_7b87b12e-d8fd-4efe-8c22-de5c8527adfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_abc5716f-a1d4-466b-a834-665f67265b0d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_7b87b12e-d8fd-4efe-8c22-de5c8527adfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="hr-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c20dffe5-3f3c-4b5e-8f69-f1c5e48d9c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c20dffe5-3f3c-4b5e-8f69-f1c5e48d9c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_36fe32f0-2344-4fe7-98ac-9c60acf52b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c20dffe5-3f3c-4b5e-8f69-f1c5e48d9c01" xlink:to="loc_us-gaap_ProfitLoss_36fe32f0-2344-4fe7-98ac-9c60acf52b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c20dffe5-3f3c-4b5e-8f69-f1c5e48d9c01" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c5713808-2346-454c-b851-f99f2b37e35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c5713808-2346-454c-b851-f99f2b37e35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_54f4274f-5d29-4af1-b3d0-227fd16c1949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_54f4274f-5d29-4af1-b3d0-227fd16c1949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a74dbf92-7bb2-4753-815b-a44c6d818aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_ShareBasedCompensation_a74dbf92-7bb2-4753-815b-a44c6d818aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable_3e4fb3ca-16b4-4c00-b500-79bbeedc2928" xlink:href="hr-20230331.xsd#hr_StraightLineRentReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_hr_StraightLineRentReceivable_3e4fb3ca-16b4-4c00-b500-79bbeedc2928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability_fdce3618-f29f-4712-9ccc-cc0975c032d4" xlink:href="hr-20230331.xsd#hr_StraightlineRentLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_hr_StraightlineRentLiability_fdce3618-f29f-4712-9ccc-cc0975c032d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_2f660d67-5483-48d9-9389-4a1d21fe2647" xlink:href="hr-20230331.xsd#hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_2f660d67-5483-48d9-9389-4a1d21fe2647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6dff5082-ecf6-47a7-abfc-bace1f4140cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6dff5082-ecf6-47a7-abfc-bace1f4140cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_c1101a3f-8e9b-4175-ba66-31dc8ac41649" xlink:href="hr-20230331.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_c1101a3f-8e9b-4175-ba66-31dc8ac41649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_996c5b76-78d7-40ec-aa1b-4f715bb00908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_996c5b76-78d7-40ec-aa1b-4f715bb00908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4cd25009-e218-42c7-b304-58d717fede5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4cd25009-e218-42c7-b304-58d717fede5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash_c43d7eb2-ff87-46e4-b73c-644dae3a7fc0" xlink:href="hr-20230331.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_hr_InterestIncomeFinancingReceivableNoncash_c43d7eb2-ff87-46e4-b73c-644dae3a7fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f9062038-7fcc-4bca-ad91-d9e97c514b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f9062038-7fcc-4bca-ad91-d9e97c514b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_099d583b-cdd4-4cf5-aaa6-defe5dd9f50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f9062038-7fcc-4bca-ad91-d9e97c514b34" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_099d583b-cdd4-4cf5-aaa6-defe5dd9f50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f1fed017-fc57-4ee4-92b1-8c3b583bc7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f9062038-7fcc-4bca-ad91-d9e97c514b34" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f1fed017-fc57-4ee4-92b1-8c3b583bc7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c8cbe361-f8a4-436c-83bd-d8df3fa915b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f9062038-7fcc-4bca-ad91-d9e97c514b34" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c8cbe361-f8a4-436c-83bd-d8df3fa915b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cf352197-b06c-4656-a15d-6f632447f73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e5d7ece-c250-431f-b5d1-0f72ce9df79d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cf352197-b06c-4656-a15d-6f632447f73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_6352fd1e-ab77-4de6-a4e2-af394ffa65f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_6352fd1e-ab77-4de6-a4e2-af394ffa65f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_63be0acd-623c-48d3-bacd-a5f4f7fa6c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_63be0acd-623c-48d3-bacd-a5f4f7fa6c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_b104b78f-6731-43d6-b01a-7137f0081cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_b104b78f-6731-43d6-b01a-7137f0081cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_65dfd8fd-dcb0-4227-bb86-0a1eba03247a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_65dfd8fd-dcb0-4227-bb86-0a1eba03247a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_1bedae23-a9c9-4783-8575-b19312366cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_1bedae23-a9c9-4783-8575-b19312366cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_447ab3a9-1547-4d63-82c4-03e12d46c043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_447ab3a9-1547-4d63-82c4-03e12d46c043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_469e7ce2-7060-42e4-9172-f78bb5182ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_469e7ce2-7060-42e4-9172-f78bb5182ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6d0f00e1-eb6f-4758-ab31-a73f8d300a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6d0f00e1-eb6f-4758-ab31-a73f8d300a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_13881cb7-ebdb-4aa5-bd70-6f5e7d786d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_13881cb7-ebdb-4aa5-bd70-6f5e7d786d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5161c69b-047b-43ef-bbfb-0b7bfe2e0c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_83658ab5-3f52-4bc9-8345-07357553f6fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5161c69b-047b-43ef-bbfb-0b7bfe2e0c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_71e1fb06-14a2-4a07-a039-90cc60424a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_71e1fb06-14a2-4a07-a039-90cc60424a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f2ed2ee2-c679-47f1-8532-48e080a812a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_RepaymentsOfDebt_f2ed2ee2-c679-47f1-8532-48e080a812a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_fed53ac1-cab5-4c48-9c4c-40baea5bf7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_fed53ac1-cab5-4c48-9c4c-40baea5bf7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_06d23c2c-d04d-404b-8174-5fb8e185d48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_06d23c2c-d04d-404b-8174-5fb8e185d48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_abec946f-430a-470f-9942-6df44c611632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_abec946f-430a-470f-9942-6df44c611632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_412a8a01-f08f-4b3e-b066-d0fef35135d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_412a8a01-f08f-4b3e-b066-d0fef35135d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_22762b23-c941-49c8-abef-1bfd34380146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_22762b23-c941-49c8-abef-1bfd34380146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_26253a03-ca84-40df-86ad-ba59bac12c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_26253a03-ca84-40df-86ad-ba59bac12c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6bc3ad90-38c0-4a96-be76-bd07b1ca15c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6c102d71-8bd3-47e5-a974-7b4215d153a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6bc3ad90-38c0-4a96-be76-bd07b1ca15c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fff1c1bb-633c-46f4-aa90-a6a6f84b9efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fff1c1bb-633c-46f4-aa90-a6a6f84b9efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_42883553-6119-4970-82ff-362ed819d3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_42883553-6119-4970-82ff-362ed819d3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d61f335c-45c2-4709-900f-07a55dfdbfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d61f335c-45c2-4709-900f-07a55dfdbfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_82e865b2-adf5-47d1-bf1d-3555e85d5f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c5b3eb8-3755-416b-8536-f73736ebe6b4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_82e865b2-adf5-47d1-bf1d-3555e85d5f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_d7bfe9a4-501b-46a0-8473-33b274a5a26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_82e865b2-adf5-47d1-bf1d-3555e85d5f65" xlink:to="loc_us-gaap_InterestPaidNet_d7bfe9a4-501b-46a0-8473-33b274a5a26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1_9137c102-d79a-44a9-a5c5-7ba7b4df326a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_82e865b2-adf5-47d1-bf1d-3555e85d5f65" xlink:to="loc_us-gaap_MortgageLoanRelatedToPropertySales1_9137c102-d79a-44a9-a5c5-7ba7b4df326a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0dcdc9fa-6de6-4586-8fa5-30e381189794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_82e865b2-adf5-47d1-bf1d-3555e85d5f65" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0dcdc9fa-6de6-4586-8fa5-30e381189794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_8517a05e-f6ee-4b3b-bbd6-261d84099ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_82e865b2-adf5-47d1-bf1d-3555e85d5f65" xlink:to="loc_us-gaap_InterestPaidCapitalized_8517a05e-f6ee-4b3b-bbd6-261d84099ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ce5f614c-0348-4136-8836-e3087518c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_561a608a-2b2d-4890-8ea9-82144cf4405d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ce5f614c-0348-4136-8836-e3087518c9d5" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_561a608a-2b2d-4890-8ea9-82144cf4405d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTA" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTA"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d5904e43-a070-4189-b6dc-1dcda97ba0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2fcdaaa6-9b67-4d97-970a-06723f317083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d5904e43-a070-4189-b6dc-1dcda97ba0d0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2fcdaaa6-9b67-4d97-970a-06723f317083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestments" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6d15e530-f5d3-48d2-85d3-c64b0b07fc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AcquisitionsAndDispositionsTextBlock_cc3ac873-762b-4a7e-a961-7cb049614290" xlink:href="hr-20230331.xsd#hr_AcquisitionsAndDispositionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6d15e530-f5d3-48d2-85d3-c64b0b07fc9b" xlink:to="loc_hr_AcquisitionsAndDispositionsTextBlock_cc3ac873-762b-4a7e-a961-7cb049614290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/Leases" xlink:type="simple" xlink:href="hr-20230331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_00a07155-dd9a-4cf0-95a1-5a495f5ca000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_c39753c8-8c40-4e56-9cce-786f8ed2d082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00a07155-dd9a-4cf0-95a1-5a495f5ca000" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_c39753c8-8c40-4e56-9cce-786f8ed2d082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_6b125c9b-b839-4a47-8632-a5c06469ddc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00a07155-dd9a-4cf0-95a1-5a495f5ca000" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_6b125c9b-b839-4a47-8632-a5c06469ddc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilities" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ddfca218-f4b1-4995-83e3-ae65503bb995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_0070bbaa-7975-4de3-962f-a0300b1041b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ddfca218-f4b1-4995-83e3-ae65503bb995" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_0070bbaa-7975-4de3-962f-a0300b1041b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayable" xlink:type="simple" xlink:href="hr-20230331.xsd#NotesandBondsPayable"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5854121e-2ec0-4a94-bd21-a52e6c3573f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e286101f-1a9c-449f-a952-33c09d690b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5854121e-2ec0-4a94-bd21-a52e6c3573f7" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e286101f-1a9c-449f-a952-33c09d690b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b3febc31-d0a9-4b4c-b829-485451a17328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_871bc18f-6af4-4255-bfe5-9fdd913f6d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b3febc31-d0a9-4b4c-b829-485451a17328" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_871bc18f-6af4-4255-bfe5-9fdd913f6d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="hr-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_760c08a3-bb68-4a97-9e4f-005cdf93b209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ec8b093e-e1cd-41aa-a9b3-65c4bcbb73fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_760c08a3-bb68-4a97-9e4f-005cdf93b209" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ec8b093e-e1cd-41aa-a9b3-65c4bcbb73fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquity" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2f4ad323-de61-44b8-ac36-8b52fa73bb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ce6f092-75b0-4300-908b-d8e89d215666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2f4ad323-de61-44b8-ac36-8b52fa73bb53" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ce6f092-75b0-4300-908b-d8e89d215666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="hr-20230331.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_efdf1044-7a1b-4301-863a-df44f184b93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_ec1df06f-fb7c-4e40-8023-ece903db05ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_efdf1044-7a1b-4301-863a-df44f184b93c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_ec1df06f-fb7c-4e40-8023-ece903db05ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NatureOfOperationsPolicyTextBlock_a59422dd-afa9-457f-a6b5-e9b92e0d62f7" xlink:href="hr-20230331.xsd#hr_NatureOfOperationsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_hr_NatureOfOperationsPolicyTextBlock_a59422dd-afa9-457f-a6b5-e9b92e0d62f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a8281cf5-e332-4bda-a31b-5a0636159a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a8281cf5-e332-4bda-a31b-5a0636159a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_9c3f2878-d0e3-444d-98b1-068da7a443df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_9c3f2878-d0e3-444d-98b1-068da7a443df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_52922d99-ae20-4508-b84f-21c66c1f6508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_52922d99-ae20-4508-b84f-21c66c1f6508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fbe7a4ed-ae61-4fb4-808c-281b633957f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_UseOfEstimates_fbe7a4ed-ae61-4fb4-808c-281b633957f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d43b7a70-6514-46b1-9ff2-48992af61175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d43b7a70-6514-46b1-9ff2-48992af61175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_add6d78c-21c4-4f1f-8eb5-02a35db15066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_add6d78c-21c4-4f1f-8eb5-02a35db15066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_bf5c3cc5-fd6f-4488-afbc-939fcbffe4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_bf5c3cc5-fd6f-4488-afbc-939fcbffe4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_aa1a97c0-039b-4693-8703-7b73fbfa20f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39e33c7e-2924-4c90-b7b8-ca78dda21a55" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_aa1a97c0-039b-4693-8703-7b73fbfa20f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b9f6bf64-e2dd-4d6b-bfb1-e1d37ebefd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_20ccabe1-5931-4ff7-844a-9417fa888c0e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b9f6bf64-e2dd-4d6b-bfb1-e1d37ebefd95" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_20ccabe1-5931-4ff7-844a-9417fa888c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_e39e3b44-bfe4-43a0-95ce-458446a9f49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b9f6bf64-e2dd-4d6b-bfb1-e1d37ebefd95" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_e39e3b44-bfe4-43a0-95ce-458446a9f49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6856a6ac-f2aa-4a2b-b042-1a98a81f4dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b9f6bf64-e2dd-4d6b-bfb1-e1d37ebefd95" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6856a6ac-f2aa-4a2b-b042-1a98a81f4dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_b4e15676-5ef2-47e1-95f4-77aa186d9c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b9f6bf64-e2dd-4d6b-bfb1-e1d37ebefd95" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_b4e15676-5ef2-47e1-95f4-77aa186d9c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_17e16492-1dc4-4ea9-8b59-330638df3b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b9f6bf64-e2dd-4d6b-bfb1-e1d37ebefd95" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_17e16492-1dc4-4ea9-8b59-330638df3b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTATables" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTATables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f414bf5-ba8e-4d38-8b45-1bb376af79d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_9def80b2-291f-459b-ba5f-2fe1706594c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f414bf5-ba8e-4d38-8b45-1bb376af79d5" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_9def80b2-291f-459b-ba5f-2fe1706594c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_70ed10ce-09f9-4bce-aa26-d99c91eac432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f414bf5-ba8e-4d38-8b45-1bb376af79d5" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_70ed10ce-09f9-4bce-aa26-d99c91eac432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsTables" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f6a08de7-19fc-4766-ac70-27f6dc21e832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_58cbdece-9bd1-4bdb-8f8b-be3967508f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f6a08de7-19fc-4766-ac70-27f6dc21e832" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_58cbdece-9bd1-4bdb-8f8b-be3967508f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_baf8a0ba-bdb8-4bc9-a181-7de6479cbd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f6a08de7-19fc-4766-ac70-27f6dc21e832" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_baf8a0ba-bdb8-4bc9-a181-7de6479cbd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetDispositionsTableTextBlock_dfb29151-84da-4643-955f-500a468ab46d" xlink:href="hr-20230331.xsd#hr_AssetDispositionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f6a08de7-19fc-4766-ac70-27f6dc21e832" xlink:to="loc_hr_AssetDispositionsTableTextBlock_dfb29151-84da-4643-955f-500a468ab46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_1b555756-2ea7-4e18-9b52-1fa5402c35fd" xlink:href="hr-20230331.xsd#hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f6a08de7-19fc-4766-ac70-27f6dc21e832" xlink:to="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_1b555756-2ea7-4e18-9b52-1fa5402c35fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesTables" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5f62b3f9-41d0-411d-a633-35780a72c100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_b3499071-67de-4830-87d1-5ec238b0b6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f62b3f9-41d0-411d-a633-35780a72c100" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_b3499071-67de-4830-87d1-5ec238b0b6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_270888f0-a6c5-49aa-90d4-2ad25494c366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f62b3f9-41d0-411d-a633-35780a72c100" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_270888f0-a6c5-49aa-90d4-2ad25494c366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cdf7374b-58c5-400d-aa4c-bd092ff3784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f62b3f9-41d0-411d-a633-35780a72c100" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cdf7374b-58c5-400d-aa4c-bd092ff3784b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_690aeec8-3c7b-4efd-8edf-c2a08b4abe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f62b3f9-41d0-411d-a633-35780a72c100" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_690aeec8-3c7b-4efd-8edf-c2a08b4abe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63421145-9080-4b3b-bba2-111c2f102c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_2a0d3590-d44d-4662-bc38-af423593b5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63421145-9080-4b3b-bba2-111c2f102c33" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_2a0d3590-d44d-4662-bc38-af423593b5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_769899ba-9ec7-4172-84b5-613883eac400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63421145-9080-4b3b-bba2-111c2f102c33" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_769899ba-9ec7-4172-84b5-613883eac400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_ea233ddf-043d-464b-8233-0c97993d4c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63421145-9080-4b3b-bba2-111c2f102c33" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_ea233ddf-043d-464b-8233-0c97993d4c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableTables" xlink:type="simple" xlink:href="hr-20230331.xsd#NotesandBondsPayableTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b92018d7-803c-48b7-aae7-0de048a3540a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_8f18754e-1c31-440b-8c44-52bbd9a2f101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b92018d7-803c-48b7-aae7-0de048a3540a" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_8f18754e-1c31-440b-8c44-52bbd9a2f101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9b9f454e-60ae-4634-a78e-9acec10ce531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_73589a00-7072-485f-bc8d-5a4a4e73753e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9b9f454e-60ae-4634-a78e-9acec10ce531" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_73589a00-7072-485f-bc8d-5a4a4e73753e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_942c58cd-692f-4ce8-9dbd-e56e6b1ccd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9b9f454e-60ae-4634-a78e-9acec10ce531" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_942c58cd-692f-4ce8-9dbd-e56e6b1ccd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_c92d18ab-5ade-4ae2-b515-cb1fc22e9fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_c92d18ab-5ade-4ae2-b515-cb1fc22e9fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_22304e5c-f3e2-4bf8-abbd-002dcf9cef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_22304e5c-f3e2-4bf8-abbd-002dcf9cef1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_10ff1de4-c765-433f-8850-d55ce31c994b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_10ff1de4-c765-433f-8850-d55ce31c994b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_641e5810-0d54-4d29-9a74-0f46d7bb8f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_641e5810-0d54-4d29-9a74-0f46d7bb8f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_9a9ab4d9-1f31-498b-9c97-9dca834500cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_9a9ab4d9-1f31-498b-9c97-9dca834500cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_cf2e05ec-23ce-47b8-a182-0c0f64332bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae60b502-5c0c-468b-8987-d7daf031d860" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_cf2e05ec-23ce-47b8-a182-0c0f64332bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="hr-20230331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3bb87e3d-e49f-4a8d-a48c-4bf26d14d506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_ae9591a1-08e5-4410-b4c4-4b15271b5388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3bb87e3d-e49f-4a8d-a48c-4bf26d14d506" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_ae9591a1-08e5-4410-b4c4-4b15271b5388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22cd0c47-f76a-4991-8ffc-40e1eb94caff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22cd0c47-f76a-4991-8ffc-40e1eb94caff" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_300d2e83-87da-4647-ad66-3b587ad16858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ec6b5c6c-bf46-47e8-89c9-7b55462c7ce0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_300d2e83-87da-4647-ad66-3b587ad16858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_6e77a49c-9903-4970-ad07-14c80297d10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_300d2e83-87da-4647-ad66-3b587ad16858" xlink:to="loc_us-gaap_NotesReceivableMember_6e77a49c-9903-4970-ad07-14c80297d10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_452333f4-cf60-4294-92bf-43709dc04f11" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3c032649-b001-40cf-8971-66669fdaf47d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_452333f4-cf60-4294-92bf-43709dc04f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b2560230-8ac3-4a37-ae4b-7259fa9935a9" xlink:href="hr-20230331.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_452333f4-cf60-4294-92bf-43709dc04f11" xlink:to="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b2560230-8ac3-4a37-ae4b-7259fa9935a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6f7ae495-3daf-44d1-ae23-34282c68b361" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_cce00825-9b6a-4ea6-8178-4c5898b8972d" xlink:href="hr-20230331.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:to="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_cce00825-9b6a-4ea6-8178-4c5898b8972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_2a3ea44c-f0d3-42c9-9e01-aadc725ac6d7" xlink:href="hr-20230331.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f365fe7-f68e-43c5-9831-d8431eed00a7" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_2a3ea44c-f0d3-42c9-9e01-aadc725ac6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_645c298a-4647-4a41-9d07-3d4806d1d1fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_55f7acb9-e03c-44c0-9392-5a2bd4816e74" xlink:to="loc_srt_OwnershipDomain_645c298a-4647-4a41-9d07-3d4806d1d1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember_67ede1cc-5443-4e67-b483-3d0e25966318" xlink:href="hr-20230331.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_645c298a-4647-4a41-9d07-3d4806d1d1fa" xlink:to="loc_hr_NonControllingInterestHoldersMember_67ede1cc-5443-4e67-b483-3d0e25966318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a9c0114-228d-4024-aced-01898548cf99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_bd20bfae-ebdb-4fec-bee8-18591ad096f1" xlink:to="loc_dei_EntityDomain_8a9c0114-228d-4024-aced-01898548cf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_00edc63a-e475-4c5b-ab50-d7837d723c3b" xlink:href="hr-20230331.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8a9c0114-228d-4024-aced-01898548cf99" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_00edc63a-e475-4c5b-ab50-d7837d723c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9b70a556-e6da-4fd1-a95f-220bd735afea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_79bd5756-1f7f-4f6b-9d15-95d684a9b3d8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9b70a556-e6da-4fd1-a95f-220bd735afea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_3e813be0-0f18-4a9b-bc04-87ad54899f56" xlink:href="hr-20230331.xsd#hr_VariableInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9b70a556-e6da-4fd1-a95f-220bd735afea" xlink:to="loc_hr_VariableInterestEntityMember_3e813be0-0f18-4a9b-bc04-87ad54899f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_3729b680-2f2b-4255-a2b8-40e732051d40" xlink:to="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:href="hr-20230331.xsd#hr_BusinessOverviewAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_fcb11c78-1772-459e-be02-e93ad8605182" xlink:href="hr-20230331.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_fcb11c78-1772-459e-be02-e93ad8605182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments_84153479-9074-4f2b-aa16-81e55b0ada64" xlink:href="hr-20230331.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_NumberOfRealEstateInvestments_84153479-9074-4f2b-aa16-81e55b0ada64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_9fd96fb2-3cb0-4b7e-8781-bea3e3c8991f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_9fd96fb2-3cb0-4b7e-8781-bea3e3c8991f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_ffaf26e6-b28d-42db-938d-8d7fa11ddef5" xlink:href="hr-20230331.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_ffaf26e6-b28d-42db-938d-8d7fa11ddef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany_76bb29b6-ba4c-48e0-a9e5-857c1e45ec85" xlink:href="hr-20230331.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_ApproximateSquareFeetInvestedInByCompany_76bb29b6-ba4c-48e0-a9e5-857c1e45ec85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetProvidedByCompany_bc7f108f-8a6b-4a5e-a248-c01a82473ad6" xlink:href="hr-20230331.xsd#hr_ApproximateSquareFeetProvidedByCompany"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_ApproximateSquareFeetProvidedByCompany_bc7f108f-8a6b-4a5e-a248-c01a82473ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f7f7713f-0a5f-4460-abf9-1e72f569bd48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f7f7713f-0a5f-4460-abf9-1e72f569bd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfBuildingsOwnedByJointVenture_7095e200-5586-4eb5-86dd-bc238675f8ce" xlink:href="hr-20230331.xsd#hr_NumberOfBuildingsOwnedByJointVenture"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_NumberOfBuildingsOwnedByJointVenture_7095e200-5586-4eb5-86dd-bc238675f8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_c2ca8971-f762-4bda-855b-0fe3bc95df84" xlink:href="hr-20230331.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_NumberOfVariableInterestEntities_c2ca8971-f762-4bda-855b-0fe3bc95df84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent_6fb54c96-9a24-4557-bf9a-328cada67ead" xlink:href="hr-20230331.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_hr_EquityOwnershipForConsolidationPercent_6fb54c96-9a24-4557-bf9a-328cada67ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_799709d6-772c-4955-bddc-46db402f668e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_7cfcbaca-cf42-411e-95bb-c1b58e0644d9" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_799709d6-772c-4955-bddc-46db402f668e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5e5ed1d-c75a-4b82-8499-df653c5b0288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b5e5ed1d-c75a-4b82-8499-df653c5b0288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_93c5bac4-f575-4d21-b3b8-ff3f32e285e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_93c5bac4-f575-4d21-b3b8-ff3f32e285e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_ebd9d354-fc06-449d-a76b-f102e0797104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_ebd9d354-fc06-449d-a76b-f102e0797104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_efdff33a-fe01-4c7a-95b8-b9b6a4e967fc" xlink:href="hr-20230331.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_hr_NumberOfVariableInterestEntities_efdff33a-fe01-4c7a-95b8-b9b6a4e967fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_b076b125-244e-49b4-baba-55f8c7504870" xlink:href="hr-20230331.xsd#hr_NumberOfNotesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_hr_NumberOfNotesReceivable_b076b125-244e-49b4-baba-55f8c7504870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures_0419cd96-4df4-4dea-827b-7d7423576854" xlink:href="hr-20230331.xsd#hr_NumberOfJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95ac9fd-13a5-4797-85c6-9b3c519e1b07" xlink:to="loc_hr_NumberOfJointVentures_0419cd96-4df4-4dea-827b-7d7423576854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_85ab266b-583c-4a1e-bb79-6cda742e7b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_85ab266b-583c-4a1e-bb79-6cda742e7b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e069078e-af3e-4b58-8c77-de33b6524b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_85ab266b-583c-4a1e-bb79-6cda742e7b57" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e069078e-af3e-4b58-8c77-de33b6524b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_db952c29-1008-4d2e-8c93-bf3938b1f9e5" xlink:to="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_ec0749fd-9f44-40b8-bc63-98380df59bab" xlink:href="hr-20230331.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_ec0749fd-9f44-40b8-bc63-98380df59bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_dfb03872-53cf-4ac2-b414-5584a0dc92d2" xlink:href="hr-20230331.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_dfb03872-53cf-4ac2-b414-5584a0dc92d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_f9fee1be-3137-40c9-bf00-1ba499cd2f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_f9fee1be-3137-40c9-bf00-1ba499cd2f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_6270b7cb-dc46-492f-a5ef-e71a7f0f7ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_us-gaap_InterestIncomeOperating_6270b7cb-dc46-492f-a5ef-e71a7f0f7ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable_876915f6-c9a4-4f2f-b3a4-a3ccdbd281d4" xlink:href="hr-20230331.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_hr_NumberOfRealEstateNotesReceivable_876915f6-c9a4-4f2f-b3a4-a3ccdbd281d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus_70d94428-d8af-48b4-bb07-e09f44428613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1095ec58-fadc-492a-baea-cb135fe67143" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus_70d94428-d8af-48b4-bb07-e09f44428613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_46b565de-b843-4b4f-9290-86e2252139f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46b565de-b843-4b4f-9290-86e2252139f8" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bd9261ec-42eb-46d0-a670-acf581462818" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e1e44a92-52d0-4304-ad4d-94b3f8762651" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bd9261ec-42eb-46d0-a670-acf581462818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_116250d8-09ee-4ffd-bef2-8c378622c538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_bd9261ec-42eb-46d0-a670-acf581462818" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_116250d8-09ee-4ffd-bef2-8c378622c538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aac612-1ef2-4962-8498-7819c10c7fbc" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:to="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_b4d70471-01b3-42ae-9e56-48c6f374399d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_b4d70471-01b3-42ae-9e56-48c6f374399d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_11128bda-d94a-4665-ae2a-035c0607c9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_11128bda-d94a-4665-ae2a-035c0607c9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_a5235f82-957f-4698-bf0e-4fc7df715013" xlink:href="hr-20230331.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_hr_ReceivablesAndOtherAssets_a5235f82-957f-4698-bf0e-4fc7df715013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_47d6e7c8-cd47-415d-a9b8-79f1df8f94d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d3c72387-77fd-45f0-b6e5-f59d5a21b569" xlink:to="loc_us-gaap_Assets_47d6e7c8-cd47-415d-a9b8-79f1df8f94d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a14d2d8f-21f5-402b-948d-148234049b9d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_f8beeb3d-5efb-41e2-9557-2d161dad4dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_f8beeb3d-5efb-41e2-9557-2d161dad4dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_579d9f4e-b02c-4da2-a67c-746e1ccec13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:to="loc_us-gaap_StockholdersEquity_579d9f4e-b02c-4da2-a67c-746e1ccec13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2b2808c-e9ea-4d31-ad6c-57125be7d975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4f1f15b0-937c-4d68-b056-23a083611074" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2b2808c-e9ea-4d31-ad6c-57125be7d975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_00bed21e-8b3e-4fee-9f4b-e2b191509c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_00bed21e-8b3e-4fee-9f4b-e2b191509c64" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:to="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_64f05bd6-a719-4852-95a5-62e2e310b538" xlink:to="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember_ace3985b-dc1d-4c2c-8d9d-831802e7e05c" xlink:href="hr-20230331.xsd#hr_HoustonTexasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:to="loc_hr_HoustonTexasMember_ace3985b-dc1d-4c2c-8d9d-831802e7e05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_ccff0db5-c7ec-4e54-9a09-3e571f6ff483" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NC"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:to="loc_stpr_NC_ccff0db5-c7ec-4e54-9a09-3e571f6ff483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_b070a3b8-0c86-4af4-bb70-a25fe4007635" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e568ef41-7ccb-47cc-9909-d85aaed2c4bb" xlink:to="loc_stpr_TX_b070a3b8-0c86-4af4-bb70-a25fe4007635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d8e696a2-1773-47e8-8744-89b03bd380c3" xlink:to="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_e06c9ae4-b103-4771-97ac-5ce09ec24f0f" xlink:href="hr-20230331.xsd#hr_VariableInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:to="loc_hr_VariableInterestEntityMember_e06c9ae4-b103-4771-97ac-5ce09ec24f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c0f66147-d409-43b6-a364-9ff459755b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66e7d7c0-6919-4fea-b2fb-e565a525d7d8" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c0f66147-d409-43b6-a364-9ff459755b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_df0673a5-9f69-4a67-b567-0c515106ec69" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount_44f70e6a-0267-4b58-ace2-04988e1de01e" xlink:href="hr-20230331.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_hr_NotesReceivableCarryingAmount_44f70e6a-0267-4b58-ace2-04988e1de01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount_2817443e-2aff-4307-a16f-11e93355250b" xlink:href="hr-20230331.xsd#hr_JointVentureCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_hr_JointVentureCarryingAmount_2817443e-2aff-4307-a16f-11e93355250b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f6a4dec-f588-4791-9f84-c4759924af3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f6a4dec-f588-4791-9f84-c4759924af3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_f32092ba-18bf-4d43-9bfb-dc0df9c488f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d3fcbc6a-d800-410a-8709-209cecc0328c" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_f32092ba-18bf-4d43-9bfb-dc0df9c488f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5ba4f221-b934-487b-ac2c-82bbb8a51e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5ba4f221-b934-487b-ac2c-82bbb8a51e5c" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_e3c01c6a-afca-4d77-9a05-3c97b43ffda0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoansTexasMember_6700a232-3bc8-4ad8-a165-f11943071495" xlink:href="hr-20230331.xsd#hr_MezzanineLoansTexasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MezzanineLoansTexasMember_6700a232-3bc8-4ad8-a165-f11943071495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanTexasMember_a8f94bdd-e1b1-4501-8bff-ca4420f63a1c" xlink:href="hr-20230331.xsd#hr_MortgageLoanTexasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanTexasMember_a8f94bdd-e1b1-4501-8bff-ca4420f63a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanNorthCarolinaMember_f0dbd689-0a9e-44d4-88fe-14a21ca24cd6" xlink:href="hr-20230331.xsd#hr_MortgageLoanNorthCarolinaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanNorthCarolinaMember_f0dbd689-0a9e-44d4-88fe-14a21ca24cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanFloridaMember_8d3905fb-d474-4d30-8812-804129103c32" xlink:href="hr-20230331.xsd#hr_MortgageLoanFloridaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanFloridaMember_8d3905fb-d474-4d30-8812-804129103c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanCaliforniaMember_7a39f2ea-2c90-4c63-bfe6-7a68eae6e7b7" xlink:href="hr-20230331.xsd#hr_MortgageLoanCaliforniaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanCaliforniaMember_7a39f2ea-2c90-4c63-bfe6-7a68eae6e7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember_2feec5a1-fdb9-4e77-8d04-845ce534c84b" xlink:href="hr-20230331.xsd#hr_MortgageLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f11e5e88-7724-4267-a51f-b5eee50ca3c7" xlink:to="loc_hr_MortgageLoanMember_2feec5a1-fdb9-4e77-8d04-845ce534c84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1608c170-d5f0-4452-869a-d6e9dcbd663a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2556544a-ac27-47ad-89e0-0c28d3fdd3d0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1608c170-d5f0-4452-869a-d6e9dcbd663a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_be5ef049-041f-4a95-81e7-c37405d1d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1608c170-d5f0-4452-869a-d6e9dcbd663a" xlink:to="loc_us-gaap_OtherAssetsMember_be5ef049-041f-4a95-81e7-c37405d1d24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a7ee455d-3ca3-4b6e-8ae1-7d9b5276c9ae" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate_f3aa7d70-b567-406b-b091-86d469cb3271" xlink:href="hr-20230331.xsd#hr_NotesReceivableInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_hr_NotesReceivableInterestRate_f3aa7d70-b567-406b-b091-86d469cb3271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment_f3d97cfa-cb3b-4292-a7ad-7cc2e5818178" xlink:href="hr-20230331.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_hr_NotesReceivableMaximumLoanCommitment_f3d97cfa-cb3b-4292-a7ad-7cc2e5818178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_9ba5c761-d801-4bc5-807b-7b7bff17a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_NotesReceivableGross_9ba5c761-d801-4bc5-807b-7b7bff17a7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_3786adde-3f80-46ee-9f3e-7842cebe7df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_InterestReceivable_3786adde-3f80-46ee-9f3e-7842cebe7df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_41dcb55c-6904-454d-bc8f-d6f98a270089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_41dcb55c-6904-454d-bc8f-d6f98a270089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableFairValueDiscount_35aeca0f-5100-43d0-8bac-8569804a79b2" xlink:href="hr-20230331.xsd#hr_NotesReceivableFairValueDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_hr_NotesReceivableFairValueDiscount_35aeca0f-5100-43d0-8bac-8569804a79b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_d15126f7-94e5-4771-a5b9-821699554380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d2af6d4d-115f-4ecf-b443-1a4e8847c5d6" xlink:to="loc_us-gaap_NotesReceivableNet_d15126f7-94e5-4771-a5b9-821699554380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_689f3c97-bd00-4fa8-bacc-2dd9c47a5500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_037ba80d-5347-47ef-b3bf-04703b8e8922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_689f3c97-bd00-4fa8-bacc-2dd9c47a5500" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_037ba80d-5347-47ef-b3bf-04703b8e8922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_8e0f35e6-afd0-49de-9adf-71a2183ecc75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_037ba80d-5347-47ef-b3bf-04703b8e8922" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_8e0f35e6-afd0-49de-9adf-71a2183ecc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_73575f21-c0c9-4e73-b25f-e37bc65b114d" xlink:href="hr-20230331.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_037ba80d-5347-47ef-b3bf-04703b8e8922" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_73575f21-c0c9-4e73-b25f-e37bc65b114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_375d6e36-bc66-433f-9d83-20658d532d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_037ba80d-5347-47ef-b3bf-04703b8e8922" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_375d6e36-bc66-433f-9d83-20658d532d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_208f7a06-3e33-494a-bcb8-a1e7a83c37d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_208f7a06-3e33-494a-bcb8-a1e7a83c37d7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:to="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ca509a42-70dd-4a70-8c44-94b30384f4b4" xlink:to="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember_c23bbafe-c265-442c-b3c0-21afc33f0066" xlink:href="hr-20230331.xsd#hr_ParkingIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:to="loc_hr_ParkingIncomeMember_c23bbafe-c265-442c-b3c0-21afc33f0066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember_5ddc9d92-070c-45be-a1e2-94272471eaf3" xlink:href="hr-20230331.xsd#hr_ManagementFeeIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:to="loc_hr_ManagementFeeIncomeMember_5ddc9d92-070c-45be-a1e2-94272471eaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MiscellaneousMember_e15a2e71-0fb4-4bb1-9399-c12bfd4f37b2" xlink:href="hr-20230331.xsd#hr_MiscellaneousMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_81e0016b-b6b1-4cb7-aed3-c45d5aed29b3" xlink:to="loc_hr_MiscellaneousMember_e15a2e71-0fb4-4bb1-9399-c12bfd4f37b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_65c5c1b9-bcd1-4138-86c0-debdd37069f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c94322c9-3d3f-4b1c-b1f8-9e843cd8e243" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_65c5c1b9-bcd1-4138-86c0-debdd37069f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d852bc45-02f3-400c-8563-5d89fbefe8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_65c5c1b9-bcd1-4138-86c0-debdd37069f9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d852bc45-02f3-400c-8563-5d89fbefe8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTANarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18682b36-824c-4e63-a3b3-6a3a4f24be78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18682b36-824c-4e63-a3b3-6a3a4f24be78" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_99031e97-ec4b-4ac3-8a76-e982242c4e08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_23788676-057f-403c-9ceb-26195cccb057" xlink:to="loc_dei_EntityDomain_99031e97-ec4b-4ac3-8a76-e982242c4e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:href="hr-20230331.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_99031e97-ec4b-4ac3-8a76-e982242c4e08" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncMember_718c9c0b-6e2e-4090-a01a-54a60978ab7b" xlink:href="hr-20230331.xsd#hr_HealthCareRealtyTrustIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:to="loc_hr_HealthCareRealtyTrustIncMember_718c9c0b-6e2e-4090-a01a-54a60978ab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_bda3901a-dd0a-4290-993b-9e81ca743805" xlink:href="hr-20230331.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_565ae89f-e36e-48a4-b359-f8d855a7c33e" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_bda3901a-dd0a-4290-993b-9e81ca743805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8713d9b2-0f27-402e-bdc6-1b336d7785f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b0e477ef-308a-4972-bdbb-e19a0462340d" xlink:to="loc_us-gaap_ClassOfStockDomain_8713d9b2-0f27-402e-bdc6-1b336d7785f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d2a55588-b38c-4d6d-9f07-5ced1484c594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8713d9b2-0f27-402e-bdc6-1b336d7785f8" xlink:to="loc_us-gaap_CommonClassAMember_d2a55588-b38c-4d6d-9f07-5ced1484c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b415339e-9229-4021-b0a9-018a4716610d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2ee0110e-18f0-4e85-ab41-9e2b36fd9344" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b415339e-9229-4021-b0a9-018a4716610d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7279f6c9-393f-47c4-aa56-7e007148b748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b415339e-9229-4021-b0a9-018a4716610d" xlink:to="loc_us-gaap_SubsequentEventMember_7279f6c9-393f-47c4-aa56-7e007148b748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7836c2fd-4203-4615-b46f-c6e3361297c3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_878cc4e2-a246-45ba-bc12-0bc79c0be45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_878cc4e2-a246-45ba-bc12-0bc79c0be45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_a4e74cca-d28b-4e8f-8798-43f38bdb4b34" xlink:href="hr-20230331.xsd#hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_a4e74cca-d28b-4e8f-8798-43f38bdb4b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_dd5fdbba-00b3-42a4-83df-c97f3d1ce9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_dd5fdbba-00b3-42a4-83df-c97f3d1ce9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_49d5c3ff-26b3-44cc-a5a2-7b251718103f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_Goodwill_49d5c3ff-26b3-44cc-a5a2-7b251718103f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0aab3cd1-081c-4708-98de-35dce34f605f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0aab3cd1-081c-4708-98de-35dce34f605f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_2146219a-395a-477a-bb37-76a2b7aa6701" xlink:href="hr-20230331.xsd#hr_MergerRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_hr_MergerRelatedCosts_2146219a-395a-477a-bb37-76a2b7aa6701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_e2d540a8-a280-4c83-a7c3-7af1e964d85f" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRefundOfTransferTaxesPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d45bb8b5-2911-424b-ab00-299b41a54a7d" xlink:to="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_e2d540a8-a280-4c83-a7c3-7af1e964d85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTADetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_978aac97-f842-4db3-9bd4-fb3268c889ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_978aac97-f842-4db3-9bd4-fb3268c889ac" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:to="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5c34b539-1636-4469-93d5-b06f4f1d70b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_669f8aad-7075-4b0b-b4b5-1ce25d64e75c" xlink:to="loc_dei_EntityDomain_5c34b539-1636-4469-93d5-b06f4f1d70b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_d6019852-6ced-4cc0-8909-6e61bd7eec54" xlink:href="hr-20230331.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5c34b539-1636-4469-93d5-b06f4f1d70b2" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_d6019852-6ced-4cc0-8909-6e61bd7eec54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:to="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23fb2b13-8c3e-41bb-a194-611a91b9f740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c9df8f56-1e8d-4f7c-a76f-6bcc8cb2389c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23fb2b13-8c3e-41bb-a194-611a91b9f740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_966573a2-065d-4493-b699-c78cd764ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23fb2b13-8c3e-41bb-a194-611a91b9f740" xlink:to="loc_us-gaap_RestrictedStockMember_966573a2-065d-4493-b699-c78cd764ce9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cf909cd5-db6d-4899-9f05-17fe19154d89" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_47974867-719f-4403-92fa-dbff672e221d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_47974867-719f-4403-92fa-dbff672e221d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RecapitalizationExchangeRatio_cb0c6fb4-9ae0-467d-990f-224fe51f0cdc" xlink:href="hr-20230331.xsd#hr_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_RecapitalizationExchangeRatio_cb0c6fb4-9ae0-467d-990f-224fe51f0cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8ceb72c2-6bfc-48a9-8445-09b481dd1a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8ceb72c2-6bfc-48a9-8445-09b481dd1a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_4da23d21-99e1-40e8-b3d4-9a70acb84edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_4da23d21-99e1-40e8-b3d4-9a70acb84edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReverseRecapitalizationNet_5437287b-5f9b-46c3-80f7-b99965f4affe" xlink:href="hr-20230331.xsd#hr_ReverseRecapitalizationNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_ReverseRecapitalizationNet_5437287b-5f9b-46c3-80f7-b99965f4affe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_243d53fa-9c83-47c6-b80c-f5482f54d53f" xlink:href="hr-20230331.xsd#hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_243d53fa-9c83-47c6-b80c-f5482f54d53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_afe04cc1-ac0f-421e-b079-1aa1d6d4d7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_afe04cc1-ac0f-421e-b079-1aa1d6d4d7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockFractionalShares_9f05be45-c420-4d51-ab9a-4e027206260f" xlink:href="hr-20230331.xsd#hr_CommonStockFractionalShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_CommonStockFractionalShares_9f05be45-c420-4d51-ab9a-4e027206260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockSharesWithheld_f580110d-6644-4fa0-ac45-79a724d922ca" xlink:href="hr-20230331.xsd#hr_CommonStockSharesWithheld"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ad21f7c8-6f31-4760-98de-9ec69b0b4be6" xlink:to="loc_hr_CommonStockSharesWithheld_f580110d-6644-4fa0-ac45-79a724d922ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e1630cbe-e4d9-4ab1-bb94-bc5c48638f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e1630cbe-e4d9-4ab1-bb94-bc5c48638f4d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:to="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_e4371af6-c54c-47f3-9b12-a369c23d37bf" xlink:to="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_c2e9296f-3b8b-4b4a-af31-c3e41ee814fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_c2e9296f-3b8b-4b4a-af31-c3e41ee814fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_a64fc554-b462-4f0e-8072-5cd3c9bfb178" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_9450b944-998f-44d2-87c2-84cce380ab55" xlink:to="loc_srt_RestatementAdjustmentMember_a64fc554-b462-4f0e-8072-5cd3c9bfb178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_265b5198-f437-40d1-8551-ed0557b9f766" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_447bef18-e82e-4432-b4c7-f218ee664687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_447bef18-e82e-4432-b4c7-f218ee664687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_c29f7662-75b5-4136-a2a1-6e21316ac3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_c29f7662-75b5-4136-a2a1-6e21316ac3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_42c6540c-195d-49e0-8dbb-a0eb9e4b6fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_42c6540c-195d-49e0-8dbb-a0eb9e4b6fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_1b0a327d-7c71-4b7e-87ce-efa91bd8ffac" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_1b0a327d-7c71-4b7e-87ce-efa91bd8ffac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_b837c41c-63e1-4f5d-b8f1-97840f8d4e9a" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_b837c41c-63e1-4f5d-b8f1-97840f8d4e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_a2743674-b20e-4f84-8e23-0638217fb7fc" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_3ff2eabd-07eb-4fb2-ba94-91147040eb5c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_a2743674-b20e-4f84-8e23-0638217fb7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_f2244a2b-57d0-4735-ab3b-dc70d0208200" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_f2244a2b-57d0-4735-ab3b-dc70d0208200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_6d935908-2809-4d8d-a489-84204b863917" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_6d935908-2809-4d8d-a489-84204b863917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_ff0ddef2-9524-4ad8-8741-2af20c12786d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_ff0ddef2-9524-4ad8-8741-2af20c12786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6eac72b6-773c-4dc5-b866-c684c6bd7816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6eac72b6-773c-4dc5-b866-c684c6bd7816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f646426d-e31f-42c6-b98d-abfa8fef3639" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f646426d-e31f-42c6-b98d-abfa8fef3639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41eed182-401f-409b-9894-f1bd359910ad" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41eed182-401f-409b-9894-f1bd359910ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_ea0f282f-728d-4480-bd56-0aceba998896" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_ea0f282f-728d-4480-bd56-0aceba998896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8605b46d-ca7d-4423-b324-5d1456f167f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_a896a03c-c8e0-45c2-ab2a-7e5b79389ad8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8605b46d-ca7d-4423-b324-5d1456f167f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_415b67ff-84ef-4ff8-b6af-7fef483b1b28" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_415b67ff-84ef-4ff8-b6af-7fef483b1b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_0ed00778-be84-4dc8-83f2-ecd5e6604a90" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_0ed00778-be84-4dc8-83f2-ecd5e6604a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f6c5f4d4-447f-4e02-9915-5110fcf63e2b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f6c5f4d4-447f-4e02-9915-5110fcf63e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_b9664412-f677-4dae-be17-5bdd6d93f2ab" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_b9664412-f677-4dae-be17-5bdd6d93f2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_d0cdac7c-36cb-4451-8362-3424c9dbd9c4" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_d0cdac7c-36cb-4451-8362-3424c9dbd9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_cad76b9c-f907-4d71-aca0-915b956cb2ae" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_cad76b9c-f907-4d71-aca0-915b956cb2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_86176227-166f-42f7-9414-16d9cc2638a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_56f160e6-7057-4bf0-9835-ce1fdc44796c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_86176227-166f-42f7-9414-16d9cc2638a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e7c00dad-ad61-4779-940f-950fa11651fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e7c00dad-ad61-4779-940f-950fa11651fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_79529127-0e47-4ff3-bebe-44ce6ab5bca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_79529127-0e47-4ff3-bebe-44ce6ab5bca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37f18891-ff45-4095-a99e-e49978ab0d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_Goodwill_37f18891-ff45-4095-a99e-e49978ab0d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5d91a797-d6ef-4be4-bb71-eee9a85a9f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5d91a797-d6ef-4be4-bb71-eee9a85a9f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_aa928bac-6deb-4057-8432-866154af0455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_aa928bac-6deb-4057-8432-866154af0455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_05284ce3-5e83-4cfd-a5fb-62a1a0ab477b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_05284ce3-5e83-4cfd-a5fb-62a1a0ab477b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_dafce0f9-2b66-46a9-a9bf-70769de6ada6" xlink:href="hr-20230331.xsd#hr_GrossContractualRealEstateNotesReceivableFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_dafce0f9-2b66-46a9-a9bf-70769de6ada6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_588fe433-69c8-4305-82ef-be11b335c801" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_588fe433-69c8-4305-82ef-be11b335c801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_390c2c11-1e27-454f-8a83-c7579a04eb48" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_782e9967-ddc0-45da-8c25-16369371b1f7" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_782e9967-ddc0-45da-8c25-16369371b1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_d2ad10b8-e95f-434f-b156-3c931d42da65" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_d2ad10b8-e95f-434f-b156-3c931d42da65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_1f7ff269-1fe0-4c74-a547-de0109f6169e" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_1f7ff269-1fe0-4c74-a547-de0109f6169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_42b905ac-4dae-4fe8-adc3-f5f55cd5833f" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_42b905ac-4dae-4fe8-adc3-f5f55cd5833f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_4857151f-d287-4a4d-8545-a1f771ef98cf" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_4857151f-d287-4a4d-8545-a1f771ef98cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_7c1c2d3a-1d7c-4620-a30c-ab09f1523b3d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_7c1c2d3a-1d7c-4620-a30c-ab09f1523b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_6a0a33a8-20eb-45f1-abdb-d3d87ec59a91" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_6a0a33a8-20eb-45f1-abdb-d3d87ec59a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_148dc1ec-19f0-49d4-9f4b-9592492f8143" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_148dc1ec-19f0-49d4-9f4b-9592492f8143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_d874913b-c574-4065-9451-0582d8468100" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_d874913b-c574-4065-9451-0582d8468100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_05dbfd5b-6c45-4991-8847-5055f65db87c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_05dbfd5b-6c45-4991-8847-5055f65db87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_faab4061-486e-446e-ab74-81ccaacff45d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_faab4061-486e-446e-ab74-81ccaacff45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_24bdd917-b3ae-41fc-98b6-775f19bbfbbf" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_24bdd917-b3ae-41fc-98b6-775f19bbfbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_4c712920-6953-4787-9a25-76a83f389b1d" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_4c712920-6953-4787-9a25-76a83f389b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_8cdcd678-3430-4656-a4fe-b510b6de31e4" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_8cdcd678-3430-4656-a4fe-b510b6de31e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_76a1494f-3458-41cb-ba48-8e3e7b954948" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_76a1494f-3458-41cb-ba48-8e3e7b954948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_5b1f154b-9f53-46d7-abdd-036cd62f21a1" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_5b1f154b-9f53-46d7-abdd-036cd62f21a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_f5ba2513-afa4-4030-aacc-f882fdfebf95" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_f5ba2513-afa4-4030-aacc-f882fdfebf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_9643e30e-e8e2-410e-a836-b0f499aba760" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_9643e30e-e8e2-410e-a836-b0f499aba760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_576d157b-0b26-4eee-bb78-af8a2629fa5c" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_576d157b-0b26-4eee-bb78-af8a2629fa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_20ff998a-15c8-4974-896a-5b9cf29ba51b" xlink:href="hr-20230331.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_2f6ff95f-4071-4f15-8745-8d61c7d9215e" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_20ff998a-15c8-4974-896a-5b9cf29ba51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_17da0252-c588-43a9-9fba-ae0ec3bb5179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_17da0252-c588-43a9-9fba-ae0ec3bb5179" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:to="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_835df273-4840-48f6-b497-47e97fba0913" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_30771e77-780d-441e-9d9b-f4f3c63aef26" xlink:to="loc_srt_SegmentGeographicalDomain_835df273-4840-48f6-b497-47e97fba0913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMember_cf69e31c-444a-451d-83ea-59a8fd40e078" xlink:href="hr-20230331.xsd#hr_TampaFLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_835df273-4840-48f6-b497-47e97fba0913" xlink:to="loc_hr_TampaFLMember_cf69e31c-444a-451d-83ea-59a8fd40e078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a4ce094b-e4e7-4dbd-b95a-40d86dbcb976" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d025e3dd-880f-4024-8151-2077c1366507" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a4ce094b-e4e7-4dbd-b95a-40d86dbcb976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember_abb06fbb-fd64-4e56-962b-176afc40aa7b" xlink:href="hr-20230331.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a4ce094b-e4e7-4dbd-b95a-40d86dbcb976" xlink:to="loc_hr_MedicalOfficeBuildingMember_abb06fbb-fd64-4e56-962b-176afc40aa7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_979532c7-6747-49d5-936d-94bd896b8046" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8b0e4be9-c355-4bc8-8369-659b2ec9c0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8b0e4be9-c355-4bc8-8369-659b2ec9c0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_32d297dd-88aa-49bc-8c26-be00dfa88d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_32d297dd-88aa-49bc-8c26-be00dfa88d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d23a17fe-e87e-4c6c-a208-b9793c9e2e02" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d23a17fe-e87e-4c6c-a208-b9793c9e2e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_d0eb4321-7431-4cb9-8292-b1b098743768" xlink:href="hr-20230331.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_d0eb4321-7431-4cb9-8292-b1b098743768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_1de7c77d-0e3e-4d5d-b00a-61232c3fb47f" xlink:href="hr-20230331.xsd#hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7acb4196-543f-40ed-a021-762fad4ef9d1" xlink:to="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_1de7c77d-0e3e-4d5d-b00a-61232c3fb47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6d081a6b-95d4-4fec-ae50-7307a51eed9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6d081a6b-95d4-4fec-ae50-7307a51eed9e" xlink:to="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_add61fbf-bb91-42df-a233-9826c3dc16d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5558e8f-64ac-44f6-8e6a-64cd76c8fcb6" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_add61fbf-bb91-42df-a233-9826c3dc16d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_723f1068-3263-4321-88e4-db66a74ad60b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_add61fbf-bb91-42df-a233-9826c3dc16d3" xlink:to="loc_srt_OtherPropertyMember_723f1068-3263-4321-88e4-db66a74ad60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d93b1085-92c8-4f21-9c82-701d341ab6a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_cb5b84d8-dfb6-489b-92ad-bd7ebb8c7d34" xlink:to="loc_srt_SegmentGeographicalDomain_d93b1085-92c8-4f21-9c82-701d341ab6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_27a8d476-76be-47ad-a396-e8dd530b88c3" xlink:href="hr-20230331.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d93b1085-92c8-4f21-9c82-701d341ab6a9" xlink:to="loc_hr_LosAngelesCaliforniaMember_27a8d476-76be-47ad-a396-e8dd530b88c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8a3a4235-cd4a-414e-b5c9-bfb9e1a2dd87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_0e267693-6d8a-455a-84c9-a46ac871a931" xlink:to="loc_srt_OwnershipDomain_8a3a4235-cd4a-414e-b5c9-bfb9e1a2dd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember_20fc3040-8afd-4296-94fa-a3ac2e7678d0" xlink:href="hr-20230331.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_8a3a4235-cd4a-414e-b5c9-bfb9e1a2dd87" xlink:to="loc_hr_LimitedLiabilityCompanyOneMember_20fc3040-8afd-4296-94fa-a3ac2e7678d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cada6d2f-349c-4b92-b4ee-eda04ff2a4b3" xlink:to="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:href="hr-20230331.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:to="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_55e75180-84a2-42a7-aaf1-d57b9e62898e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_55e75180-84a2-42a7-aaf1-d57b9e62898e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_c268b3d3-3e81-4e46-866e-e28c09a36ffc" xlink:href="hr-20230331.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_c268b3d3-3e81-4e46-866e-e28c09a36ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_02325c36-68ef-44cf-9913-7b10fec1e276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_02325c36-68ef-44cf-9913-7b10fec1e276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_177df562-1388-4044-8fc8-37a618cf2782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_177df562-1388-4044-8fc8-37a618cf2782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8437605-8ccf-4d95-ae2f-cdaa6649c4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_6eda57d2-a348-49ba-8ce6-57175008227b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8437605-8ccf-4d95-ae2f-cdaa6649c4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_867446d9-7ff6-4796-ad10-0ebbaa4aa8a6" xlink:href="hr-20230331.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_5be409bf-b153-46c3-87c4-2c7563a82ebe" xlink:to="loc_hr_JointVentureOwnershipPercentage_867446d9-7ff6-4796-ad10-0ebbaa4aa8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsDispositionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_89e273db-3607-42cb-b9ed-c9f1250e6b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:href="hr-20230331.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_89e273db-3607-42cb-b9ed-c9f1250e6b96" xlink:to="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:to="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_bd1fba70-d3fd-49bd-81ab-0cc4507da223" xlink:to="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMiamiFLMember_4dad9c6b-e3dd-4ebc-af28-c1c962cc39be" xlink:href="hr-20230331.xsd#hr_TampaFLMiamiFLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_TampaFLMiamiFLMember_4dad9c6b-e3dd-4ebc-af28-c1c962cc39be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DallasTXMember_25ac5488-97d2-47d9-bc21-921e5e14d149" xlink:href="hr-20230331.xsd#hr_DallasTXMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_DallasTXMember_25ac5488-97d2-47d9-bc21-921e5e14d149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_STLouisMoMember_90a46d34-9166-4fa1-9519-65772e4f363d" xlink:href="hr-20230331.xsd#hr_STLouisMoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_STLouisMoMember_90a46d34-9166-4fa1-9519-65772e4f363d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_c1cff59f-f219-49d9-a806-5c3f9ad19ee4" xlink:href="hr-20230331.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a7695bbc-9cf6-4768-a4de-be05dda8a74c" xlink:to="loc_hr_LosAngelesCaliforniaMember_c1cff59f-f219-49d9-a806-5c3f9ad19ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2cf83f19-96dd-4d01-ac52-09b4bbba3b2c" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_79e3d79c-8c89-44c7-85fc-7f4d5d4924c4" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2cf83f19-96dd-4d01-ac52-09b4bbba3b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember_c1b6b6a5-fdb1-4a63-8fee-3196cc921d36" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2cf83f19-96dd-4d01-ac52-09b4bbba3b2c" xlink:to="loc_hr_RealEstateDispositionsMember_c1b6b6a5-fdb1-4a63-8fee-3196cc921d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:href="hr-20230331.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_00b7b002-9c52-42d8-b2ca-ed62bdeadaea" xlink:to="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice_4c6567ed-f75a-466c-86d5-5b0a63e8bc72" xlink:href="hr-20230331.xsd#hr_DispositionSalesPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_DispositionSalesPrice_4c6567ed-f75a-466c-86d5-5b0a63e8bc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity_11106f57-bf11-4ee0-949e-76d9d1cafc39" xlink:href="hr-20230331.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_ClosingAdjustmentsDisposedEntity_11106f57-bf11-4ee0-949e-76d9d1cafc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceMortgageNotes_0b190c45-5f5f-484f-96c0-c82578cafc77" xlink:href="hr-20230331.xsd#hr_FinanceMortgageNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_FinanceMortgageNotes_0b190c45-5f5f-484f-96c0-c82578cafc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_4fac5f5e-eac3-4bb0-a0c0-54d50b2c9d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_4fac5f5e-eac3-4bb0-a0c0-54d50b2c9d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_41b97500-a495-4fbb-9ec9-86619379ff88" xlink:href="hr-20230331.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_41b97500-a495-4fbb-9ec9-86619379ff88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther_46ceb9bf-c2fd-4ad9-9d56-df942db16989" xlink:href="hr-20230331.xsd#hr_RealEstateOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_RealEstateOther_46ceb9bf-c2fd-4ad9-9d56-df942db16989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_11e71946-71e1-4fc6-a207-43f33cb4adbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_11e71946-71e1-4fc6-a207-43f33cb4adbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_0bc8caa5-cd47-4919-9633-aa3bca75b324" xlink:href="hr-20230331.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_0bc8caa5-cd47-4919-9633-aa3bca75b324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_00496a90-950a-4ff2-9c71-fd7d914f631b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_00496a90-950a-4ff2-9c71-fd7d914f631b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertyDispositions_331fced8-6cc9-49a8-a378-4d0ed40d46d7" xlink:href="hr-20230331.xsd#hr_NumberOfPropertyDispositions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_NumberOfPropertyDispositions_331fced8-6cc9-49a8-a378-4d0ed40d46d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_93d5681a-913d-42ed-aa31-8d0b57f65544" xlink:href="hr-20230331.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_JointVentureOwnershipPercentage_93d5681a-913d-42ed-aa31-8d0b57f65544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNote_156506b3-66a5-4d11-a1c7-6d4ee266fee0" xlink:href="hr-20230331.xsd#hr_MortgageNote"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_cfc46541-fffe-494f-af00-514a9b1f1b70" xlink:to="loc_hr_MortgageNote_156506b3-66a5-4d11-a1c7-6d4ee266fee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b753333f-d017-43ce-a79a-5ae741108fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b753333f-d017-43ce-a79a-5ae741108fe5" xlink:to="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6cd36677-e96a-4f8a-aae2-7cda4f77d862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_517651ad-f443-4e46-af33-9b382a30c517" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6cd36677-e96a-4f8a-aae2-7cda4f77d862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ee5fb1dc-b948-4f37-884c-9977d2b91894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6cd36677-e96a-4f8a-aae2-7cda4f77d862" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_ee5fb1dc-b948-4f37-884c-9977d2b91894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_f3c278b8-95a4-42eb-a456-ecb28b07f37d" xlink:to="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_2df7ccaa-d390-46f6-8e22-760065bf813a" xlink:href="hr-20230331.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_2df7ccaa-d390-46f6-8e22-760065bf813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfLandParcelsClassifiedAsHeldForSale_c879c2b7-f089-4269-8be8-d649e37f0363" xlink:href="hr-20230331.xsd#hr_NumberOfLandParcelsClassifiedAsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_NumberOfLandParcelsClassifiedAsHeldForSale_c879c2b7-f089-4269-8be8-d649e37f0363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_d92f1c67-7741-4e68-801d-956887456686" xlink:href="hr-20230331.xsd#hr_ImpairmentChargeOnRealEstateAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_d92f1c67-7741-4e68-801d-956887456686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_37212aad-6841-424b-bd0d-555536295108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_Land_37212aad-6841-424b-bd0d-555536295108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_fc0f4217-ff01-4da3-9b14-965ee31a1a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_fc0f4217-ff01-4da3-9b14-965ee31a1a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_22bd2285-3a04-4461-a691-8ee7a2597a7a" xlink:href="hr-20230331.xsd#hr_LeaseIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_LeaseIntangibles_22bd2285-3a04-4461-a691-8ee7a2597a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_17a0001d-99c7-4c9b-937f-ccd60993446f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_LandAvailableForDevelopment_17a0001d-99c7-4c9b-937f-ccd60993446f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d2648ea1-dd6e-4be0-88c0-6ec27b60f0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d2648ea1-dd6e-4be0-88c0-6ec27b60f0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_91183ae9-e100-483f-8aaf-4243fea9f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_91183ae9-e100-483f-8aaf-4243fea9f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_999ed601-2d51-4c3b-a643-35fdb7004fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_999ed601-2d51-4c3b-a643-35fdb7004fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_fb324d1a-7ed7-4a2d-b9a5-172b918f0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_fb324d1a-7ed7-4a2d-b9a5-172b918f0e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_ae1229ab-9c4a-4406-8282-886cd6b4992d" xlink:href="hr-20230331.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_ae1229ab-9c4a-4406-8282-886cd6b4992d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_51e0b40e-48ea-4da9-b164-589e9a2bb116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_51e0b40e-48ea-4da9-b164-589e9a2bb116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_c8b1120d-d828-4fea-8103-b102f312df61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_c8b1120d-d828-4fea-8103-b102f312df61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_24d65f88-d1cd-4f93-b0b6-a0944e0aa62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_dd7f8d84-a656-4c59-929e-6709a7a183dc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_24d65f88-d1cd-4f93-b0b6-a0944e0aa62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_63d5cd67-be14-4a4a-8a57-7edaa6abcbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_63d5cd67-be14-4a4a-8a57-7edaa6abcbed" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:to="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1c903f38-d3e6-4a8b-8f81-7cf456f5c687" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_81289260-ffec-486d-a183-d4ec2fab470e" xlink:to="loc_srt_SegmentGeographicalDomain_1c903f38-d3e6-4a8b-8f81-7cf456f5c687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_54bafa3b-76a2-43c5-b02c-a2287ddb6804" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1c903f38-d3e6-4a8b-8f81-7cf456f5c687" xlink:to="loc_stpr_TX_54bafa3b-76a2-43c5-b02c-a2287ddb6804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_b00a78eb-4ebc-48e5-9bab-86e4c746abe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_14969bba-211e-45c6-82e0-fc5ef49292d7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_b00a78eb-4ebc-48e5-9bab-86e4c746abe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_fcc1843d-608c-4768-841c-0fa1f3e0fd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b00a78eb-4ebc-48e5-9bab-86e4c746abe0" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_fcc1843d-608c-4768-841c-0fa1f3e0fd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesLessorAccountingDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1e56597b-e23b-4b9f-b6be-d71f6e869324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1e56597b-e23b-4b9f-b6be-d71f6e869324" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_a27a1940-14e0-4b56-9cc7-4b8e62309757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_a27a1940-14e0-4b56-9cc7-4b8e62309757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_717f36ae-d78c-4ea1-a06e-dcc974e8bb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_717f36ae-d78c-4ea1-a06e-dcc974e8bb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_d4e787a7-b20a-4d46-95e9-4dc3550b4d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_d4e787a7-b20a-4d46-95e9-4dc3550b4d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_37dc0a81-239c-4d93-8a3c-996309ec1628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_37dc0a81-239c-4d93-8a3c-996309ec1628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_877e56ac-802d-499d-aefe-7806d815e9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_877e56ac-802d-499d-aefe-7806d815e9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_8b1ac89e-ed88-4da2-ad5d-75c53c16fc07" xlink:href="hr-20230331.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_8b1ac89e-ed88-4da2-ad5d-75c53c16fc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_5fc72eae-6836-452a-b00a-799e7d76760c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_ec945fd0-2e32-4a7e-8963-cd89b5680db3" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_5fc72eae-6836-452a-b00a-799e7d76760c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesGroundLeasesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b47a2e4d-d9b1-4f95-af85-cb3ac7314f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b47a2e4d-d9b1-4f95-af85-cb3ac7314f5c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:to="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_077959dc-117c-4d43-9494-c775fcd664aa" xlink:to="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cf86ab05-e7aa-4968-bfa1-88c13ad5ceac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:to="loc_srt_MinimumMember_cf86ab05-e7aa-4968-bfa1-88c13ad5ceac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ba7058d-8f25-4850-ac9a-eb6ac2b9ba0a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c73a0e1f-c692-4dbd-ae8a-54495ec8d74a" xlink:to="loc_srt_MaximumMember_2ba7058d-8f25-4850-ac9a-eb6ac2b9ba0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_087a7808-be9b-4404-a53f-a2ff48e86d5c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_30af4dc8-7801-423f-adff-0eefcadd36cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_30af4dc8-7801-423f-adff-0eefcadd36cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases_4de716be-cfa3-415a-a550-e853dab87da4" xlink:href="hr-20230331.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_SquareFeetSubjecttoGroundLeases_4de716be-cfa3-415a-a550-e853dab87da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3018fcd3-ee7c-4244-8c17-b4a0127a28a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3018fcd3-ee7c-4244-8c17-b4a0127a28a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid_8177f0b7-834f-4b6a-a061-3d03d7c968e9" xlink:href="hr-20230331.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_NumberofGroundLeasesPrepaid_8177f0b7-834f-4b6a-a061-3d03d7c968e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent_abf10120-eb5d-45f2-a930-b944575a56c6" xlink:href="hr-20230331.xsd#hr_AmortizationofPrepaidRent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_AmortizationofPrepaidRent_abf10120-eb5d-45f2-a930-b944575a56c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_4569caa2-45c4-4ec2-a891-7f33beb8704e" xlink:href="hr-20230331.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4b0d1b5f-b6d1-4095-a775-364ef8661998" xlink:to="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_4569caa2-45c4-4ec2-a891-7f33beb8704e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5d7066a0-76a4-4a85-9c6d-f19b284511d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d7066a0-76a4-4a85-9c6d-f19b284511d9" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4bdfc15e-c90f-4b36-9683-69b2f05e9ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4bdfc15e-c90f-4b36-9683-69b2f05e9ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a0010828-c468-4f2b-8b0f-b7043a4329c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a0010828-c468-4f2b-8b0f-b7043a4329c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d85e462d-3576-4f12-97c3-f6348dd63b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d85e462d-3576-4f12-97c3-f6348dd63b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0bccc827-cbb3-4b0a-a591-cc9d1debdf61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0bccc827-cbb3-4b0a-a591-cc9d1debdf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_be1d9aeb-5787-431b-94ad-387f08b42fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_be1d9aeb-5787-431b-94ad-387f08b42fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_b0118d37-8e8f-4e12-b2e1-a3432836cc3b" xlink:href="hr-20230331.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_b0118d37-8e8f-4e12-b2e1-a3432836cc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d7f5f4c4-27a2-4912-8c16-3fbeba5c5e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d7f5f4c4-27a2-4912-8c16-3fbeba5c5e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ce259566-4168-4800-aeae-ce27268e0882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ce259566-4168-4800-aeae-ce27268e0882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_eb2385f7-777e-4a76-90bf-59b91ce848e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5d9e9974-6e38-41b4-820c-70bd7cd065f2" xlink:to="loc_us-gaap_OperatingLeaseLiability_eb2385f7-777e-4a76-90bf-59b91ce848e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d7066a0-76a4-4a85-9c6d-f19b284511d9" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_cdce99b9-34f4-4737-816b-5a3c9e76d674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_cdce99b9-34f4-4737-816b-5a3c9e76d674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d0f0f1b4-8c2e-4846-9d0b-d33049c951c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d0f0f1b4-8c2e-4846-9d0b-d33049c951c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2e92f161-7ed3-4d10-aa0e-a2387b0c00cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2e92f161-7ed3-4d10-aa0e-a2387b0c00cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2a0e0afc-21ec-4d65-83fb-5cfd6c4f0275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2a0e0afc-21ec-4d65-83fb-5cfd6c4f0275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa8e8078-0050-49ee-a072-321980a9ba72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa8e8078-0050-49ee-a072-321980a9ba72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_86e2a2a1-875c-43aa-9cd7-38191560cd58" xlink:href="hr-20230331.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_86e2a2a1-875c-43aa-9cd7-38191560cd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b127f227-efce-4001-a596-6cc4b220de63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b127f227-efce-4001-a596-6cc4b220de63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ce1922cf-e469-4b9b-818e-47b3f6730428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ce1922cf-e469-4b9b-818e-47b3f6730428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d80b688e-b394-446f-9f50-8d4896be49c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_25f55fb9-b81f-4aff-993a-6c2b69bde9e1" xlink:to="loc_us-gaap_FinanceLeaseLiability_d80b688e-b394-446f-9f50-8d4896be49c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4b5c0d06-7eb6-4870-a1d2-8763a0e5ea12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_829b522e-5500-4275-9c2b-d7afe53d6cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b5c0d06-7eb6-4870-a1d2-8763a0e5ea12" xlink:to="loc_us-gaap_LeaseCostAbstract_829b522e-5500-4275-9c2b-d7afe53d6cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f32eb8ba-7880-44be-ac27-91d77e214800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_829b522e-5500-4275-9c2b-d7afe53d6cf2" xlink:to="loc_us-gaap_OperatingLeaseCost_f32eb8ba-7880-44be-ac27-91d77e214800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_2731352c-3d4f-4699-b9fc-2665a4cea285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_829b522e-5500-4275-9c2b-d7afe53d6cf2" xlink:to="loc_us-gaap_VariableLeaseCost_2731352c-3d4f-4699-b9fc-2665a4cea285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f7fd899e-9f70-49df-bba0-7cea077c31c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b5c0d06-7eb6-4870-a1d2-8763a0e5ea12" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f7fd899e-9f70-49df-bba0-7cea077c31c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_69911ef6-90cc-4ccb-ab5d-79f59b54554d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f7fd899e-9f70-49df-bba0-7cea077c31c0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_69911ef6-90cc-4ccb-ab5d-79f59b54554d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b48d503e-5c12-4ffe-80dc-32b49b8cf342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f7fd899e-9f70-49df-bba0-7cea077c31c0" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b48d503e-5c12-4ffe-80dc-32b49b8cf342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_3222c6ed-e5d3-4ab9-b5d3-f27d973d4ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f7fd899e-9f70-49df-bba0-7cea077c31c0" xlink:to="loc_us-gaap_LeaseCost_3222c6ed-e5d3-4ab9-b5d3-f27d973d4ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b5c0d06-7eb6-4870-a1d2-8763a0e5ea12" xlink:to="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_500ff34b-298a-48ec-b336-ebf0d4cb28ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_OperatingLeasePayments_500ff34b-298a-48ec-b336-ebf0d4cb28ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_22f1d6bb-b849-47cb-9f86-0c1d80f235aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_22f1d6bb-b849-47cb-9f86-0c1d80f235aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeasePrincipalOnlyPayments_d68cbf30-7cc1-4007-939b-5cf7c9a72b12" xlink:href="hr-20230331.xsd#hr_FinanceLeasePrincipalOnlyPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_hr_FinanceLeasePrincipalOnlyPayments_d68cbf30-7cc1-4007-939b-5cf7c9a72b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_8997a7a1-5033-4657-9a0a-faeb7e9beedb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_8997a7a1-5033-4657-9a0a-faeb7e9beedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5a85b74a-4ff0-4334-8a71-c0a6ba51c529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5a85b74a-4ff0-4334-8a71-c0a6ba51c529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9755dc00-bf5a-4a7d-9080-fe523b906653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9755dc00-bf5a-4a7d-9080-fe523b906653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d8384729-3438-426d-b6a7-d6b7a80d2754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d8384729-3438-426d-b6a7-d6b7a80d2754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_be216ac3-d8d0-4981-af9a-e113907750bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5ad07b24-bafb-4024-9edc-3ea88c1bebdf" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_be216ac3-d8d0-4981-af9a-e113907750bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet_d5cf8025-4274-468f-8d9d-89954e42ca48" xlink:href="hr-20230331.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_hr_RealEstateNotesReceivableNet_d5cf8025-4274-468f-8d9d-89954e42ca48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_8399477b-320a-4aef-965f-eb34dbf56205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_8399477b-320a-4aef-965f-eb34dbf56205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_66ad87a6-4429-4f36-a74b-38d237027352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_66ad87a6-4429-4f36-a74b-38d237027352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AboveMarketLeaseIntangibleAssetsNet_8b152bd0-61cd-4704-aaf2-73df3a4888e4" xlink:href="hr-20230331.xsd#hr_AboveMarketLeaseIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_hr_AboveMarketLeaseIntangibleAssetsNet_8b152bd0-61cd-4704-aaf2-73df3a4888e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_7ef164b7-70a1-4c5f-abac-1a08e455e190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_AccountsReceivableNet_7ef164b7-70a1-4c5f-abac-1a08e455e190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_4c28f6b4-140d-424d-b438-76b0f9b894f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_NoncurrentAssets_4c28f6b4-140d-424d-b438-76b0f9b894f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_cc07353f-5bd1-4025-805e-a0ad6cb83f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_DerivativeAssets_cc07353f-5bd1-4025-805e-a0ad6cb83f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_6aba89b7-5209-4616-869c-594ca3a26ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_OtherReceivables_6aba89b7-5209-4616-869c-594ca3a26ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GroundLeaseModificationNet_ee2eef30-7a89-4657-b79d-3f9946b34927" xlink:href="hr-20230331.xsd#hr_GroundLeaseModificationNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_hr_GroundLeaseModificationNet_ee2eef30-7a89-4657-b79d-3f9946b34927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_824035ad-65c4-4282-a44e-102d3f6b0a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_824035ad-65c4-4282-a44e-102d3f6b0a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingToDate_21568d7e-f75d-4ddb-b0d6-38f814c61073" xlink:href="hr-20230331.xsd#hr_ConstructionActivityTotalFundingToDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_hr_ConstructionActivityTotalFundingToDate_21568d7e-f75d-4ddb-b0d6-38f814c61073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentInLease_5cafcfde-2301-41f4-ae22-3f0a28a1a2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_NetInvestmentInLease_5cafcfde-2301-41f4-ae22-3f0a28a1a2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FiniteLivedCustomerRelationshipsNet_369d3b47-5de8-412c-a604-4f4ab72a7328" xlink:href="hr-20230331.xsd#hr_FiniteLivedCustomerRelationshipsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_hr_FiniteLivedCustomerRelationshipsNet_369d3b47-5de8-412c-a604-4f4ab72a7328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_450c5d80-a59c-4ba8-baf7-15401b19aa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_450c5d80-a59c-4ba8-baf7-15401b19aa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_b97af27a-23bb-412c-a2a4-85188bf48661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e7cf587-712b-4b30-a1ce-d58ca0c09a0a" xlink:to="loc_us-gaap_OtherAssets_b97af27a-23bb-412c-a2a4-85188bf48661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_027c4dd1-cfb0-48c7-8a23-d999a5679736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AccruedPropertyTaxes_c6ef26b4-665e-4cc8-ade2-ff9c990296d4" xlink:href="hr-20230331.xsd#hr_AccruedPropertyTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_027c4dd1-cfb0-48c7-8a23-d999a5679736" xlink:to="loc_hr_AccruedPropertyTaxes_c6ef26b4-665e-4cc8-ade2-ff9c990296d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AccountsPayableAndCapitalExpendituresCurrent_6edc9448-7ddf-47e2-9a77-6ea69f28c69a" xlink:href="hr-20230331.xsd#hr_AccountsPayableAndCapitalExpendituresCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_027c4dd1-cfb0-48c7-8a23-d999a5679736" xlink:to="loc_hr_AccountsPayableAndCapitalExpendituresCurrent_6edc9448-7ddf-47e2-9a77-6ea69f28c69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_21bbfff6-e22e-4ec4-b807-bcdbe8130f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_027c4dd1-cfb0-48c7-8a23-d999a5679736" xlink:to="loc_us-gaap_InterestPayableCurrent_21bbfff6-e22e-4ec4-b807-bcdbe8130f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_9a61f129-66c9-432a-a080-117551007476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_027c4dd1-cfb0-48c7-8a23-d999a5679736" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_9a61f129-66c9-432a-a080-117551007476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_f762c91f-ec99-4756-b660-43c50dcf5699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_027c4dd1-cfb0-48c7-8a23-d999a5679736" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_f762c91f-ec99-4756-b660-43c50dcf5699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#OtherAssetsandLiabilitiesOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BelowMarketLeaseNet_78dfe0f4-fa81-4724-9389-9d7978870396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BelowMarketLeaseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:to="loc_us-gaap_BelowMarketLeaseNet_78dfe0f4-fa81-4724-9389-9d7978870396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8d156900-22ca-4166-bf39-a9bd2e8dc7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8d156900-22ca-4166-bf39-a9bd2e8dc7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityDepositLiability_4529a5b2-b25a-4ca2-8d15-ad489a2884ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDepositLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:to="loc_us-gaap_SecurityDepositLiability_4529a5b2-b25a-4ca2-8d15-ad489a2884ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cbeae0a0-8201-495e-b14b-26170420704c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:to="loc_us-gaap_DerivativeLiabilities_cbeae0a0-8201-495e-b14b-26170420704c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilities_1714ab66-c783-4165-8b73-e94745c07bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:to="loc_us-gaap_OtherSundryLiabilities_1714ab66-c783-4165-8b73-e94745c07bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_838522f6-a8c8-4c12-979a-a4f17a3db529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e688fc36-c39d-4851-a7d5-fcab366e1d53" xlink:to="loc_us-gaap_OtherLiabilities_838522f6-a8c8-4c12-979a-a4f17a3db529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#NotesandBondsPayableDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6ed37731-09d0-4ced-bddc-fa2cb4544f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6ed37731-09d0-4ced-bddc-fa2cb4544f9d" xlink:to="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c4bc1576-3765-4c63-b7e0-f819939bab49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e3a2f47e-8e87-49bc-9117-734d3a4054dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_LineOfCreditMember_e3a2f47e-8e87-49bc-9117-734d3a4054dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_f080f428-7850-444c-a95b-6decae6dfda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_MediumTermNotesMember_f080f428-7850-444c-a95b-6decae6dfda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_457f1bd5-253a-448a-9b89-062fc89006b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_SeniorNotesMember_457f1bd5-253a-448a-9b89-062fc89006b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_bc73d965-04fe-4a9b-8b27-41fa41c88be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed1003c-b612-4793-9de1-d1707febd9f2" xlink:to="loc_us-gaap_MortgagesMember_bc73d965-04fe-4a9b-8b27-41fa41c88be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4e02d1f1-c618-4420-81ba-03779a90a1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_71789274-4489-4c1e-997a-69e3f72c2765" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4e02d1f1-c618-4420-81ba-03779a90a1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_df12bb03-0913-4cc3-b1c8-ee754585fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4e02d1f1-c618-4420-81ba-03779a90a1e6" xlink:to="loc_us-gaap_MortgagesMember_df12bb03-0913-4cc3-b1c8-ee754585fa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f97fcef1-3d41-4714-b8d1-cbc5b2d042e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember_a26fede4-6195-4ed1-97fe-99f8bb3cb1b6" xlink:href="hr-20230331.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_UnsecuredCreditFacilityOneMember_a26fede4-6195-4ed1-97fe-99f8bb3cb1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2023Member_1f2e8082-7979-47a9-bbbb-9ce49dbec98b" xlink:href="hr-20230331.xsd#hr_TermLoanDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2023Member_1f2e8082-7979-47a9-bbbb-9ce49dbec98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2024Member_7978d559-40e1-4ad3-ae77-904d4312af8e" xlink:href="hr-20230331.xsd#hr_TermLoandue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoandue2024Member_7978d559-40e1-4ad3-ae77-904d4312af8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member_6ef00867-4863-45e2-b4b2-b2a8e38eeedb" xlink:href="hr-20230331.xsd#hr_TermLoanDue2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2025Member_6ef00867-4863-45e2-b4b2-b2a8e38eeedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member_b9fd2e58-d9e9-429b-9f80-8b7a78a2bf24" xlink:href="hr-20230331.xsd#hr_TermLoandue2026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoandue2026Member_b9fd2e58-d9e9-429b-9f80-8b7a78a2bf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member_88db1519-51cf-4dd1-b012-30f7490e7c9a" xlink:href="hr-20230331.xsd#hr_TermLoanDue2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2027Member_88db1519-51cf-4dd1-b012-30f7490e7c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member_709332f4-a5ff-4b71-abb3-43225f1877f3" xlink:href="hr-20230331.xsd#hr_TermLoanDue2028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_TermLoanDue2028Member_709332f4-a5ff-4b71-abb3-43225f1877f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member_d16684a5-1cca-4f58-b11b-d0be64c88849" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2025Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesdue2025Member_d16684a5-1cca-4f58-b11b-d0be64c88849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member_4d377c5d-33da-4e8e-9d43-cad93d0380c6" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2026Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2026Member_4d377c5d-33da-4e8e-9d43-cad93d0380c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member_25ace3d0-ce2d-4e8a-9336-e53075f62282" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2027Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2027Member_25ace3d0-ce2d-4e8a-9336-e53075f62282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member_3f890823-23c3-40fa-a359-8cbad5efcdf2" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2028Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesdue2028Member_3f890823-23c3-40fa-a359-8cbad5efcdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_6924f099-7a9b-4501-b1bb-81c88aa9444c" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_6924f099-7a9b-4501-b1bb-81c88aa9444c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member_7c0675af-069a-4b43-b69a-f5cd5bf02a01" xlink:href="hr-20230331.xsd#hr_SeniorNotesdue2030Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesdue2030Member_7c0675af-069a-4b43-b69a-f5cd5bf02a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member_1fc70efa-852b-432d-94c3-9b14f0e6a0d6" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2031Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2031Member_1fc70efa-852b-432d-94c3-9b14f0e6a0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_b4af4054-d962-42d1-b8f6-65ba8c19591e" xlink:href="hr-20230331.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_b4af4054-d962-42d1-b8f6-65ba8c19591e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_b0fb4673-7c11-497c-9f45-539dfe7df86f" xlink:href="hr-20230331.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b500a768-3213-4486-b281-8bb0146dc6d3" xlink:to="loc_hr_MortgageNotesPayableNetMember_b0fb4673-7c11-497c-9f45-539dfe7df86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_527266ae-e213-4fa5-a165-2551585783d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_292e5241-c6ef-4e3e-a394-3b35b430d722" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_527266ae-e213-4fa5-a165-2551585783d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_81008ed3-3a4c-4fa7-9e43-bef23dbdfaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_527266ae-e213-4fa5-a165-2551585783d1" xlink:to="loc_us-gaap_SubsequentEventMember_81008ed3-3a4c-4fa7-9e43-bef23dbdfaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b862e8c3-687a-43fe-97ac-b52929393957" xlink:to="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32c1b79f-c958-4206-9d88-629d445d68a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:to="loc_srt_MinimumMember_32c1b79f-c958-4206-9d88-629d445d68a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a0a81991-760d-4407-a771-13e19cdb0b8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4aaf8672-1d0c-4922-93a3-e0637ece9c65" xlink:to="loc_srt_MaximumMember_a0a81991-760d-4407-a771-13e19cdb0b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c74e6277-ac60-4b6a-b053-6c9632de1ebb" xlink:to="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cdc9a388-f51f-48ad-87da-cb0c0349ff50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_LongTermDebt_cdc9a388-f51f-48ad-87da-cb0c0349ff50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d34b0071-1fb1-4fe8-b240-6d6d3a3c7d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d34b0071-1fb1-4fe8-b240-6d6d3a3c7d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_24606955-cc48-4a90-ad6d-d78ec7c2e283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_24606955-cc48-4a90-ad6d-d78ec7c2e283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fea3ff72-ef60-4727-9424-3e81e9ef945c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fea3ff72-ef60-4727-9424-3e81e9ef945c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_a6dceee3-ff3a-4003-aec4-914798c5b3f3" xlink:href="hr-20230331.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_a6dceee3-ff3a-4003-aec4-914798c5b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_fe2579a6-18b1-43c2-b1be-70970ba3ed8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_496ce7e8-ced8-49b3-a6b4-63935e1a047b" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_fe2579a6-18b1-43c2-b1be-70970ba3ed8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3163601a-845e-47a5-b4a2-805883d9b1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3163601a-845e-47a5-b4a2-805883d9b1ee" xlink:to="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_559d8399-e9a6-4126-86e0-1c01377c678b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_90293ad0-95b1-41a0-b47b-61777dc37453" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_559d8399-e9a6-4126-86e0-1c01377c678b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_559d8399-e9a6-4126-86e0-1c01377c678b" xlink:to="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJanuary152024Member_e9e65653-05a2-470f-899e-9f5fb64dce0e" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJanuary152024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringJanuary152024Member_e9e65653-05a2-470f-899e-9f5fb64dce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member_b0aad2b4-4e49-4fb0-ba5d-4b4d6c134cb0" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringMay12026Member_b0aad2b4-4e49-4fb0-ba5d-4b4d6c134cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member_3d5e32d7-74d9-42c3-a463-4707d8909a21" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringJune12026Member_3d5e32d7-74d9-42c3-a463-4707d8909a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member_4784ef2e-014b-4a8c-998f-ba6fcd9b861b" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringDecember12026Member_4784ef2e-014b-4a8c-998f-ba6fcd9b861b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member_249baffe-bbe1-484e-9b64-e28eb5c22d65" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringJune12027Member_249baffe-bbe1-484e-9b64-e28eb5c22d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member_38c8608d-dd61-437e-a8c8-c8897f1c8656" xlink:href="hr-20230331.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_9e909c12-f2e6-47dc-82f7-c615e7090a35" xlink:to="loc_hr_InterestRateSwapExpiringDecember12027Member_38c8608d-dd61-437e-a8c8-c8897f1c8656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_05bb7242-55f5-4b04-a1eb-a3608060b566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1875444b-ad2d-45ee-9418-76ce7252f0ee" xlink:to="loc_us-gaap_HedgingRelationshipDomain_05bb7242-55f5-4b04-a1eb-a3608060b566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4ff8a4de-a948-4264-ac2a-2be1488ee54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_05bb7242-55f5-4b04-a1eb-a3608060b566" xlink:to="loc_us-gaap_CashFlowHedgingMember_4ff8a4de-a948-4264-ac2a-2be1488ee54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_69b1dc3f-e958-4f0d-b2f6-d2b8ce845c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d176b5d0-6bc1-4454-9ccf-09ac99eea2b1" xlink:to="loc_us-gaap_HedgingDesignationDomain_69b1dc3f-e958-4f0d-b2f6-d2b8ce845c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bac70c62-73cb-476d-ab6d-006c14a468e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_69b1dc3f-e958-4f0d-b2f6-d2b8ce845c46" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bac70c62-73cb-476d-ab6d-006c14a468e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2746ffc3-4c5a-4688-853e-a7204138aaff" xlink:to="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5acd3134-0a85-496d-96c1-7c736a7bd132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5acd3134-0a85-496d-96c1-7c736a7bd132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_47d9c252-546f-4112-a198-a55b09d009a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_DerivativeNotionalAmount_47d9c252-546f-4112-a198-a55b09d009a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_73f4ee70-60e2-43f6-b5bd-3908a6e09b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9d79e694-044e-4e90-9e42-27854009c023" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_73f4ee70-60e2-43f6-b5bd-3908a6e09b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_44bc979c-9ea0-461e-a450-9b5a6f02547c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_44bc979c-9ea0-461e-a450-9b5a6f02547c" xlink:to="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_feed0e94-8678-44f4-a159-385872aec5a0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_ebb137e8-a856-427b-b4c1-1f3e53672d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:to="loc_us-gaap_OtherLiabilitiesMember_ebb137e8-a856-427b-b4c1-1f3e53672d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_9d52cc2e-6cc0-4542-b742-15de37072f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a8c6241b-87b2-485d-ac7e-f05760830426" xlink:to="loc_us-gaap_OtherAssetsMember_9d52cc2e-6cc0-4542-b742-15de37072f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_931fa55e-cb43-474d-8803-4b5459700706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3d9e1084-fc7d-47cc-a647-b97c0fd708a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_931fa55e-cb43-474d-8803-4b5459700706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac2979f0-3f67-4242-af65-c152abd7837b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_931fa55e-cb43-474d-8803-4b5459700706" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac2979f0-3f67-4242-af65-c152abd7837b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_dd1f7b4b-d91b-45bd-8f0d-54b9cbb172d2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwaps2017And2018Member_3b55b656-5555-4c2c-996f-7bb29e4bbb21" xlink:href="hr-20230331.xsd#hr_InterestRateSwaps2017And2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:to="loc_hr_InterestRateSwaps2017And2018Member_3b55b656-5555-4c2c-996f-7bb29e4bbb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwaps20172018And2019Member_c8346721-fb29-42ed-8bba-c1db161f06a7" xlink:href="hr-20230331.xsd#hr_InterestRateSwaps20172018And2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:to="loc_hr_InterestRateSwaps20172018And2019Member_c8346721-fb29-42ed-8bba-c1db161f06a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_85d61f9a-b81e-44d3-9725-e59cdaa79ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_397d97d6-219e-4ea2-a88d-377338d4c9db" xlink:to="loc_us-gaap_InterestRateSwapMember_85d61f9a-b81e-44d3-9725-e59cdaa79ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f9ce0962-54db-4f33-97aa-7dc1d32df6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_837700c8-cb79-4fdf-8464-96c7225cfa01" xlink:to="loc_us-gaap_DerivativeLineItems_f9ce0962-54db-4f33-97aa-7dc1d32df6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0493b3c0-d5b0-4d7e-81e9-2fb88f4d4232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f9ce0962-54db-4f33-97aa-7dc1d32df6d9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0493b3c0-d5b0-4d7e-81e9-2fb88f4d4232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fa66e5c1-468c-4a9e-af6f-42784cee55e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fa66e5c1-468c-4a9e-af6f-42784cee55e5" xlink:to="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8a085541-5a4d-485d-9751-65ae68725577" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_cdb21a85-8ade-44a6-943e-4464e186e08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:to="loc_us-gaap_InterestRateContractMember_cdb21a85-8ade-44a6-943e-4464e186e08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_0cce1a57-b442-4502-97f4-b85d63187b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:to="loc_us-gaap_TreasuryLockMember_0cce1a57-b442-4502-97f4-b85d63187b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_40aa0812-ba0e-4c2f-83a7-e1b686228ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11b2cb2c-2b3e-4afd-93e2-c98fce0ac4e1" xlink:to="loc_us-gaap_InterestRateSwapMember_40aa0812-ba0e-4c2f-83a7-e1b686228ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b51d75d6-efb6-46d6-8913-009c60ac907e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_18db2e72-1bad-4188-882d-fe3c223656da" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b51d75d6-efb6-46d6-8913-009c60ac907e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_eaa30af3-fb88-4751-b446-043a52a92edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b51d75d6-efb6-46d6-8913-009c60ac907e" xlink:to="loc_us-gaap_InterestExpenseMember_eaa30af3-fb88-4751-b446-043a52a92edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_433c0832-1723-4c0d-8a6b-65ad6ccfec3f" xlink:to="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_24e7b48d-aa7d-44da-9205-11e021c01fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_24e7b48d-aa7d-44da-9205-11e021c01fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b68aeafb-af1a-43fb-a03c-a46049024bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4144ce4e-8bc1-4fe9-99c9-d676203a5f75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b68aeafb-af1a-43fb-a03c-a46049024bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4a80ec32-b909-4a98-99e2-154a90478b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4a80ec32-b909-4a98-99e2-154a90478b73" xlink:to="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d2a82292-84a2-4e39-a5d6-871f0f363e07" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember_6d9c27ad-7d90-424c-9733-6e3fa9ea1a81" xlink:href="hr-20230331.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:to="loc_hr_ActiveInterestRateSwapsMember_6d9c27ad-7d90-424c-9733-6e3fa9ea1a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember_ba487cd5-32f5-4a0d-9761-1a1fea20aad1" xlink:href="hr-20230331.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_372610f7-3341-4a7d-b6b8-7578c283a64d" xlink:to="loc_hr_SettledInterestRateSwapsMember_ba487cd5-32f5-4a0d-9761-1a1fea20aad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1910f0f4-8921-40fe-ba2b-59dc4e6353c3" xlink:to="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_98b115ee-1ffd-4c1a-b0a4-dc9ba48c25be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_98b115ee-1ffd-4c1a-b0a4-dc9ba48c25be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DerivativeNetAssetPositionAggregateFairValue_21de1bc4-0c72-480c-9a56-2911752b57b2" xlink:href="hr-20230331.xsd#hr_DerivativeNetAssetPositionAggregateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bdf688f5-b3ad-4414-834f-0a0fe8808c86" xlink:to="loc_hr_DerivativeNetAssetPositionAggregateFairValue_21de1bc4-0c72-480c-9a56-2911752b57b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e23dc85b-c96d-4207-bdd7-9ffaaf692bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_e09f1fc9-953f-4cd0-bce5-76bce3a62c5c" xlink:href="hr-20230331.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e23dc85b-c96d-4207-bdd7-9ffaaf692bef" xlink:to="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_e09f1fc9-953f-4cd0-bce5-76bce3a62c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3e83a8f4-1525-477c-8575-829a8668fcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3e83a8f4-1525-477c-8575-829a8668fcd4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d22665b5-c2d0-40fe-ac66-3abdb6e12e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62f6f759-5a4e-41e7-acbb-cbb1a6907d3c" xlink:to="loc_us-gaap_EquityComponentDomain_d22665b5-c2d0-40fe-ac66-3abdb6e12e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9adf48fd-1033-44af-89a8-448f7e432ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d22665b5-c2d0-40fe-ac66-3abdb6e12e55" xlink:to="loc_us-gaap_CommonStockMember_9adf48fd-1033-44af-89a8-448f7e432ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_34ee6a20-91ee-435f-94b8-fd02825bb83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a28dc882-93f0-4789-9d10-b8277d298e46" xlink:to="loc_us-gaap_ClassOfStockLineItems_34ee6a20-91ee-435f-94b8-fd02825bb83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:href="hr-20230331.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_34ee6a20-91ee-435f-94b8-fd02825bb83a" xlink:to="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca3225c5-8bac-4535-9254-213af899e497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca3225c5-8bac-4535-9254-213af899e497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3633ff29-3bbf-4fe3-a293-c74da5491d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3633ff29-3bbf-4fe3-a293-c74da5491d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9e43a95c-8387-402c-9c2c-261c7b8ee0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9e43a95c-8387-402c-9c2c-261c7b8ee0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7721426f-9f36-4182-90f8-9b08a17afc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_6ec2dd7c-2924-49db-8c87-63218215c748" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7721426f-9f36-4182-90f8-9b08a17afc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityStockTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e241040c-0755-4fed-b131-8dd294cf94ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e241040c-0755-4fed-b131-8dd294cf94ac" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce23defc-2964-47c7-9539-577bb1e1a4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd72d4a0-428a-483c-ab31-9b86d9162c76" xlink:to="loc_us-gaap_EquityComponentDomain_ce23defc-2964-47c7-9539-577bb1e1a4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e7d4e04d-dd9d-4bc0-b19c-78df7b601829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ce23defc-2964-47c7-9539-577bb1e1a4f5" xlink:to="loc_us-gaap_CommonStockMember_e7d4e04d-dd9d-4bc0-b19c-78df7b601829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_457a0fd2-865d-4748-94e0-2b49765abad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0cb46c05-9e74-440c-a529-0e39d04e2a33" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_457a0fd2-865d-4748-94e0-2b49765abad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bcf9b94b-bd82-4ebf-bc73-6abe1ff2f1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_457a0fd2-865d-4748-94e0-2b49765abad8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bcf9b94b-bd82-4ebf-bc73-6abe1ff2f1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ba7ec4b4-c31c-4bfb-9d25-e6ddeeefdee3" xlink:to="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember_af7af487-a00d-42b6-a19a-85c41e0f3f30" xlink:href="hr-20230331.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:to="loc_hr_ExecutiveIncentiveProgramMember_af7af487-a00d-42b6-a19a-85c41e0f3f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_6c580f94-54c9-4a02-800d-eed1bd95d80d" xlink:href="hr-20230331.xsd#hr_StockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fe4114bc-b0a2-47ab-b342-56bb1a7ad9cc" xlink:to="loc_hr_StockIncentivePlanMember_6c580f94-54c9-4a02-800d-eed1bd95d80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9216f4ee-5903-47bc-9f88-e1162f270428" xlink:to="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a7e1d991-b84b-441d-8a43-8addab207b17" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:to="loc_srt_MinimumMember_a7e1d991-b84b-441d-8a43-8addab207b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d1d950a6-2f32-4ad7-93ed-b1b68a23b523" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_43ee0c58-a9eb-448b-9464-3df6a23103db" xlink:to="loc_srt_MaximumMember_d1d950a6-2f32-4ad7-93ed-b1b68a23b523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a1e3061-906e-44f0-b4a5-03c4ede90035" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_140ed673-92c0-4dfd-8e27-92662e9d0722" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a1e3061-906e-44f0-b4a5-03c4ede90035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember_c711077c-f895-46e6-9008-5bae8654c62c" xlink:href="hr-20230331.xsd#hr_DirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a1e3061-906e-44f0-b4a5-03c4ede90035" xlink:to="loc_hr_DirectorsMember_c711077c-f895-46e6-9008-5bae8654c62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6c0736bf-1e38-4807-a3ce-8992152f5428" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_f3e78c57-ed7e-4813-b5db-2da3d18b1c1d" xlink:href="hr-20230331.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_f3e78c57-ed7e-4813-b5db-2da3d18b1c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_8130f79d-8310-46c5-91bd-9df76685ee8d" xlink:href="hr-20230331.xsd#hr_NonVestedStockAwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_hr_NonVestedStockAwardMember_8130f79d-8310-46c5-91bd-9df76685ee8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0e3911b3-25ba-4c61-affe-99aa1e65f126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_us-gaap_RestrictedStockMember_0e3911b3-25ba-4c61-affe-99aa1e65f126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9dcb1992-740d-4210-a6ad-c33fb2382947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3adaa0b3-fff4-4115-bae5-4ad2bc78023b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9dcb1992-740d-4210-a6ad-c33fb2382947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_46601860-21b1-4047-aa57-1c861e32580b" xlink:href="hr-20230331.xsd#hr_StockIssuanceProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_StockIssuanceProgramAxis_7b0f3500-011d-421d-b07f-8ee3a57ae85e" xlink:to="loc_hr_StockIssuanceProgramDomain_46601860-21b1-4047-aa57-1c861e32580b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:href="hr-20230331.xsd#hr_PerformanceConditionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_StockIssuanceProgramDomain_46601860-21b1-4047-aa57-1c861e32580b" xlink:to="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition1Member_e24e4e48-0421-4569-9f8e-bfda49be78d1" xlink:href="hr-20230331.xsd#hr_MarketCondition1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:to="loc_hr_MarketCondition1Member_e24e4e48-0421-4569-9f8e-bfda49be78d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member_4179c3c2-2721-47eb-9eac-763068403a23" xlink:href="hr-20230331.xsd#hr_MarketCondition2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_PerformanceConditionsMember_052bc5fa-bf8b-4b2b-aacb-25bc6324210a" xlink:to="loc_hr_MarketCondition2Member_4179c3c2-2721-47eb-9eac-763068403a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_71d505d2-1eed-45c8-a0d5-cec25d2649df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_986dadfb-e6f7-44ee-9ece-94a731fee60e" xlink:to="loc_us-gaap_GranteeStatusDomain_71d505d2-1eed-45c8-a0d5-cec25d2649df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_686c5222-64b5-4f08-a00d-15013873ed16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_71d505d2-1eed-45c8-a0d5-cec25d2649df" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_686c5222-64b5-4f08-a00d-15013873ed16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ebb1cd6a-8026-45c7-9083-5aa74fe26792" xlink:to="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOfferingProgramAvailableForIssuance_cd9abde0-6d4e-41c0-b633-c2d5a52246f6" xlink:href="hr-20230331.xsd#hr_EquityOfferingProgramAvailableForIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_EquityOfferingProgramAvailableForIssuance_cd9abde0-6d4e-41c0-b633-c2d5a52246f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_c9a7c4ef-2b45-4141-9c88-b6880c5e35f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_c9a7c4ef-2b45-4141-9c88-b6880c5e35f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a5a94d27-ab41-46b7-89a6-1d77d2f9497c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a5a94d27-ab41-46b7-89a6-1d77d2f9497c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_a8bdcb7c-0529-4293-8794-8aee98e104f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_a8bdcb7c-0529-4293-8794-8aee98e104f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4807e224-fc44-4258-ac01-d4906e386827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4807e224-fc44-4258-ac01-d4906e386827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_86004718-000b-44ca-9cf3-6c700b453d6b" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_86004718-000b-44ca-9cf3-6c700b453d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04a88952-0d21-4358-b232-608c230de9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04a88952-0d21-4358-b232-608c230de9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c39174a0-1ffb-4964-ab38-6df7bd11f631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c39174a0-1ffb-4964-ab38-6df7bd11f631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0ea3428b-1dfc-4528-aa41-59b627353f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0ea3428b-1dfc-4528-aa41-59b627353f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits_447044e1-d546-4587-829a-fe5d27cb9fb4" xlink:href="hr-20230331.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_PercentageOfRestrictedStockUnits_447044e1-d546-4587-829a-fe5d27cb9fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_973a3198-ecc0-4c9a-927c-c2d04f4a2607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_973a3198-ecc0-4c9a-927c-c2d04f4a2607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_940aaf6a-f5a2-4d06-8c54-f1166a8ef88e" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_940aaf6a-f5a2-4d06-8c54-f1166a8ef88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0866d259-4de7-45e3-a678-3908e3c15944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e86bdb1f-6242-4f71-b673-734844088b99" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0866d259-4de7-45e3-a678-3908e3c15944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_e8e696a7-f091-4c92-85e7-7e2f2bdc81ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_e8e696a7-f091-4c92-85e7-7e2f2bdc81ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_868a814b-2078-4c77-81a2-5a987faae0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_868a814b-2078-4c77-81a2-5a987faae0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a488d59-47d6-47d0-87fb-c6c17089b3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a488d59-47d6-47d0-87fb-c6c17089b3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_e146d431-8b71-4a7a-a9c1-e7e917cb5a0d" xlink:href="hr-20230331.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_e146d431-8b71-4a7a-a9c1-e7e917cb5a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_db336d05-351a-445f-a186-54019f76d5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bd375245-b636-42c7-a308-9dccc25933c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_db336d05-351a-445f-a186-54019f76d5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d0753029-63ac-49b4-b5f4-a536cb32546a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:to="loc_us-gaap_NetIncomeLoss_d0753029-63ac-49b4-b5f4-a536cb32546a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsShareBasedCompensation_bdb0816b-6b6f-403e-9568-09440b4a5a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:to="loc_us-gaap_DividendsShareBasedCompensation_bdb0816b-6b6f-403e-9568-09440b4a5a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_a5b9304d-1885-43df-ad50-2d3d570c5846" xlink:href="hr-20230331.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:to="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_a5b9304d-1885-43df-ad50-2d3d570c5846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2c49493d-35a4-476e-8d2c-435d79ea9226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:to="loc_us-gaap_EarningsPerShareBasic_2c49493d-35a4-476e-8d2c-435d79ea9226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_99fb1881-a59e-4ec7-b039-35b48161eb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec80e346-5d20-4e8e-91e4-f7c2b1f96b3d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_99fb1881-a59e-4ec7-b039-35b48161eb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ded6e13d-b425-4d8c-b84f-59363ce599de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ded6e13d-b425-4d8c-b84f-59363ce599de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:to="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_239cd08a-5882-4813-ae5c-57bbf036780a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_031253c8-d6dc-4475-a184-9e58befbdc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_031253c8-d6dc-4475-a184-9e58befbdc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_4aca3ea4-e1f3-4018-9e10-413f7e1839cb" xlink:href="hr-20230331.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4369be7f-13cd-49cb-93e1-c613a4981866" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_4aca3ea4-e1f3-4018-9e10-413f7e1839cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d61864d-9ec4-4a5d-9b6d-e890d3b792db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b56316-e131-440b-b4b4-897ac4022ce1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d61864d-9ec4-4a5d-9b6d-e890d3b792db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d61864d-9ec4-4a5d-9b6d-e890d3b792db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_98782506-9083-4f02-9486-3f19858f0e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_98782506-9083-4f02-9486-3f19858f0e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7c351c2b-deff-425f-8173-9959907acb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7c351c2b-deff-425f-8173-9959907acb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_519d320d-8575-4c3a-ab17-a081c7a11937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_519d320d-8575-4c3a-ab17-a081c7a11937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a3dc4dc0-70e4-40d7-8b91-97ced99d128c" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_99ace8c6-5fc0-496e-85e7-82b19168ec94" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a3dc4dc0-70e4-40d7-8b91-97ced99d128c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f60a15bf-d22c-4c68-9477-6ec728f6e4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f60a15bf-d22c-4c68-9477-6ec728f6e4bf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:to="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7e1f550e-2e1a-40bc-96d1-3a0576485685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d847b040-41cd-47f6-904b-ce1c4d4b3923" xlink:to="loc_us-gaap_PlanNameDomain_7e1f550e-2e1a-40bc-96d1-3a0576485685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_412e387b-6b57-468a-adec-9f2af3bccd54" xlink:href="hr-20230331.xsd#hr_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7e1f550e-2e1a-40bc-96d1-3a0576485685" xlink:to="loc_hr_StockIncentivePlanMember_412e387b-6b57-468a-adec-9f2af3bccd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:to="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d3603e7-e5a5-45aa-8751-327b046e2a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_05892119-6058-4629-b326-385fcacefeff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d3603e7-e5a5-45aa-8751-327b046e2a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_51c0797a-5fc3-4d96-8a90-cbe6cfd5fde3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d3603e7-e5a5-45aa-8751-327b046e2a05" xlink:to="loc_us-gaap_RestrictedStockMember_51c0797a-5fc3-4d96-8a90-cbe6cfd5fde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8783deec-7257-4393-90ff-a66b28f0de10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75510010-2019-4f07-a4ae-863c1da25b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75510010-2019-4f07-a4ae-863c1da25b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_057c04bc-6574-4750-9362-5eca84d5e349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_057c04bc-6574-4750-9362-5eca84d5e349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4e6b9dd1-505a-4a2d-b5d8-93c04224e6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4e6b9dd1-505a-4a2d-b5d8-93c04224e6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_c5d3daa1-b9f7-4135-bba9-05d440df2eb1" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_c5d3daa1-b9f7-4135-bba9-05d440df2eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bd04b987-edbd-4dfb-9008-414bf772d37c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bd04b987-edbd-4dfb-9008-414bf772d37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4e88b16-77f5-475a-a122-31c16084394f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a91d6b2-0f3f-4ae8-b8a0-5cb7dbb5f144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4e88b16-77f5-475a-a122-31c16084394f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d561b65-8e44-4fd7-b48f-384889307f65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ba67cc5f-7a5f-445c-9c3d-65dff46e4539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ba67cc5f-7a5f-445c-9c3d-65dff46e4539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5e1400bd-28c2-46a3-8160-b29c8c54430f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5e1400bd-28c2-46a3-8160-b29c8c54430f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_38c907cc-743b-41ca-a9c7-e82e996c0531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_38c907cc-743b-41ca-a9c7-e82e996c0531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_6b7dc237-daa9-4970-99d3-b3b0d8ae2e88" xlink:href="hr-20230331.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_6b7dc237-daa9-4970-99d3-b3b0d8ae2e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c22cb9d-4edb-4629-9ee4-2c1f6efc1d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1d130b7b-8439-4c93-9ee2-f1cf245d1ed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c22cb9d-4edb-4629-9ee4-2c1f6efc1d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a4ee721a-34d3-44fc-b21d-caad15d7e8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a4ee721a-34d3-44fc-b21d-caad15d7e8b0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:to="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e9995a6-e4f6-4a10-8afb-076087414c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b7e91f57-f83d-471b-87dd-fb9ab79d141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e9995a6-e4f6-4a10-8afb-076087414c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_c08f46fc-e9d8-4bf3-9e8e-e420a8eb41c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e9995a6-e4f6-4a10-8afb-076087414c3c" xlink:to="loc_us-gaap_EmployeeStockMember_c08f46fc-e9d8-4bf3-9e8e-e420a8eb41c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_612927d9-aa4c-4257-9b32-309c4c2cfd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53caa18b-a44d-4741-84ee-acfb9555bbc8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_612927d9-aa4c-4257-9b32-309c4c2cfd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_612927d9-aa4c-4257-9b32-309c4c2cfd56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46e72a97-90ba-4062-bf88-9c4b7be646eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46e72a97-90ba-4062-bf88-9c4b7be646eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_928d9394-2e2a-4f67-8444-a36a92ccaa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_928d9394-2e2a-4f67-8444-a36a92ccaa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83291ad4-88ab-47fb-9933-ad113b5def44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83291ad4-88ab-47fb-9933-ad113b5def44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4654161a-edc5-4d4f-b99c-39dde62a349e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4654161a-edc5-4d4f-b99c-39dde62a349e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f28b915e-34b8-4614-84cd-b124e2b2da58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f28b915e-34b8-4614-84cd-b124e2b2da58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a9b5e762-d870-42c7-a23f-02288f61ce47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a49d150b-e687-4659-a633-c6320ab6ed47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a9b5e762-d870-42c7-a23f-02288f61ce47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_e62e5502-f832-4b59-8956-fb798a62f494" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_e62e5502-f832-4b59-8956-fb798a62f494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_ec9a8200-06f4-4985-9d1c-c4b594b1e61a" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_ec9a8200-06f4-4985-9d1c-c4b594b1e61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_b7794b5d-790c-4e27-81c6-b7e133bd305a" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_b7794b5d-790c-4e27-81c6-b7e133bd305a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_f5438311-a29c-4944-84bf-3ee691a176f5" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_f5438311-a29c-4944-84bf-3ee691a176f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_44c18aab-0887-42dd-be1c-fe14ba6748f6" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_44c18aab-0887-42dd-be1c-fe14ba6748f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_39f1003f-ea77-49c7-bc9f-bf9ebeff2ab2" xlink:href="hr-20230331.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_39f1003f-ea77-49c7-bc9f-bf9ebeff2ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_46fb035e-dc80-4ca4-9eba-7ea2e58613ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6269482b-5998-4b33-8aac-095423ab537e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_46fb035e-dc80-4ca4-9eba-7ea2e58613ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="hr-20230331.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a764d3bf-84b0-4a21-a3ea-2799f955a614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a764d3bf-84b0-4a21-a3ea-2799f955a614" xlink:to="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6d99b50f-0f4d-4646-bb67-b4c8aeec57ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_2e09a709-dc39-462e-b0b7-35c518eb2dcb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6d99b50f-0f4d-4646-bb67-b4c8aeec57ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6d99b50f-0f4d-4646-bb67-b4c8aeec57ec" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_753acfc2-efd2-478c-9893-0db97801aad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_753acfc2-efd2-478c-9893-0db97801aad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1dec84a8-df95-4a30-9648-048ba400c767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d8cc02a7-b2d0-4beb-8edf-35ccfc225400" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1dec84a8-df95-4a30-9648-048ba400c767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_94e5035e-4a75-4deb-9a06-a5270d76a5b8" xlink:to="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_035ef4af-2342-4a4c-b500-990f81ab2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:to="loc_us-gaap_DebtInstrumentFairValue_035ef4af-2342-4a4c-b500-990f81ab2f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_06c9ca58-885f-4149-91b2-7c30bb884f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_625e07db-04e1-40b9-b89a-33405b994baa" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_06c9ca58-885f-4149-91b2-7c30bb884f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783938384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHCARE REALTY TRUST INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-4738467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3310 West End Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269-8175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.01 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,816,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001360604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678784975424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNetAbstract', window );"><strong>Real estate properties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 1,412,805<span></span>
</td>
<td class="nump">$ 1,439,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">11,196,297<span></span>
</td>
<td class="nump">11,332,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Lease intangibles</a></td>
<td class="nump">929,008<span></span>
</td>
<td class="nump">959,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PersonalProperty', window );">Personal property</a></td>
<td class="nump">11,945<span></span>
</td>
<td class="nump">11,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Investment in financing receivable, net</a></td>
<td class="nump">120,692<span></span>
</td>
<td class="nump">120,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Financing lease right-of-use assets</a></td>
<td class="nump">83,420<span></span>
</td>
<td class="nump">83,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Construction in progress</a></td>
<td class="nump">42,615<span></span>
</td>
<td class="nump">35,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAvailableForDevelopment', window );">Land held for development</a></td>
<td class="nump">69,575<span></span>
</td>
<td class="nump">74,265<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">13,866,357<span></span>
</td>
<td class="nump">14,057,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(1,810,093)<span></span>
</td>
<td class="num">(1,645,271)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">12,056,264<span></span>
</td>
<td class="nump">12,412,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">49,941<span></span>
</td>
<td class="nump">60,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">3,579<span></span>
</td>
<td class="nump">18,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">336,112<span></span>
</td>
<td class="nump">336,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">327,746<span></span>
</td>
<td class="nump">327,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">260,822<span></span>
</td>
<td class="nump">223,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">534,420<span></span>
</td>
<td class="nump">469,990<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,568,884<span></span>
</td>
<td class="nump">13,849,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">5,361,699<span></span>
</td>
<td class="nump">5,351,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">155,210<span></span>
</td>
<td class="nump">244,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">279,637<span></span>
</td>
<td class="nump">279,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease liabilities</a></td>
<td class="nump">73,193<span></span>
</td>
<td class="nump">72,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">232,029<span></span>
</td>
<td class="nump">218,668<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,102,045<span></span>
</td>
<td class="nump">6,167,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,816 and 380,590 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">9,591,194<span></span>
</td>
<td class="nump">9,587,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(8,554)<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CumulativeNetIncomeAttributableToCommonStockholders', window );">Cumulative net income attributable to common stockholders</a></td>
<td class="nump">1,219,930<span></span>
</td>
<td class="nump">1,307,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeDividends', window );">Cumulative dividends</a></td>
<td class="num">(3,447,750)<span></span>
</td>
<td class="num">(3,329,562)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">7,358,628<span></span>
</td>
<td class="nump">7,571,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">106,211<span></span>
</td>
<td class="nump">108,742<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">7,464,839<span></span>
</td>
<td class="nump">7,679,818<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 13,568,884<span></span>
</td>
<td class="nump">$ 13,849,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets held for sale and discontinued operations, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CumulativeNetIncomeAttributableToCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative net income attributable to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CumulativeNetIncomeAttributableToCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PersonalProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Personal property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PersonalProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative cash dividends distributed to shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAvailableForDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of land available for development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAvailableForDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of finite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherFiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783842528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (shares)</a></td>
<td class="nump">380,816,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (shares)</a></td>
<td class="nump">380,816,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783970880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental income</a></td>
<td class="nump">$ 324,093<span></span>
</td>
<td class="nump">$ 138,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss', window );">Interest income</a></td>
<td class="nump">4,214<span></span>
</td>
<td class="nump">1,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Other operating</a></td>
<td class="nump">4,618<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">332,925<span></span>
</td>
<td class="nump">142,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment', window );">Property operating</a></td>
<td class="nump">122,040<span></span>
</td>
<td class="nump">57,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,935<span></span>
</td>
<td class="nump">11,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition and pursuit costs</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerRelatedCosts', window );">Merger-related costs</a></td>
<td class="nump">4,855<span></span>
</td>
<td class="nump">6,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">184,479<span></span>
</td>
<td class="nump">54,041<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_OperatingExpensesandCostofGoodsSold', window );">Expenses</a></td>
<td class="nump">326,596<span></span>
</td>
<td class="nump">129,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain on sales of real estate properties</a></td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">44,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(63,759)<span></span>
</td>
<td class="num">(13,661)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfRealEstate', window );">Impairment of real estate properties and credit loss reserves</a></td>
<td class="num">(31,422)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss from unconsolidated joint ventures</a></td>
<td class="num">(780)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other income (expense), net</a></td>
<td class="nump">547<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(94,407)<span></span>
</td>
<td class="nump">29,293<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(88,078)<span></span>
</td>
<td class="nump">42,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interests</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to common stockholders</a></td>
<td class="num">$ (87,125)<span></span>
</td>
<td class="nump">$ 42,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">378,840,420<span></span>
</td>
<td class="nump">148,963,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">378,840,420<span></span>
</td>
<td class="nump">149,051,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Revenue, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_OperatingExpensesandCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses and Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_OperatingExpensesandCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense incurred and directly related to generating revenue by lessor from operating lease of rented property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period to reduce the carrying amount of real property to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from financing receivable before allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783774064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (88,078)<span></span>
</td>
<td class="nump">$ 42,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Interest rate swaps</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for (gains) losses included in net income (interest expense)</a></td>
<td class="num">(2,284)<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">(Losses) gains arising during the period on interest rate swaps</a></td>
<td class="num">(8,541)<span></span>
</td>
<td class="nump">5,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">(10,825)<span></span>
</td>
<td class="nump">6,245<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive (loss) income</a></td>
<td class="num">(98,903)<span></span>
</td>
<td class="nump">48,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive loss attributable to non-controlling interests</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income attributable to common stockholders</a></td>
<td class="num">(97,819)<span></span>
</td>
<td class="nump">48,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Interest rate swaps</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">(Losses) gains arising during the period on interest rate swaps</a></td>
<td class="num">$ (8,541)<span></span>
</td>
<td class="nump">$ 5,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678779378432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders&#8217; Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Cumulative Net Income</div></th>
<th class="th"><div>Cumulative Dividends</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 2,185,116<span></span>
</td>
<td class="nump">$ 2,185,116<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="nump">$ 3,972,917<span></span>
</td>
<td class="num">$ (9,981)<span></span>
</td>
<td class="nump">$ 1,266,158<span></span>
</td>
<td class="num">$ (3,045,483)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">22,661<span></span>
</td>
<td class="nump">22,661<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">22,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3,699<span></span>
</td>
<td class="nump">3,699<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">42,227<span></span>
</td>
<td class="nump">42,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for (gains) losses included in net income (interest expense)</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains (Losses) arising during the period on interest rate swaps</a></td>
<td class="nump">5,159<span></span>
</td>
<td class="nump">5,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders (in usd per share)</a></td>
<td class="num">(46,860)<span></span>
</td>
<td class="num">(46,860)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,860)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">2,212,882<span></span>
</td>
<td class="nump">2,212,882<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">3,999,060<span></span>
</td>
<td class="num">(3,736)<span></span>
</td>
<td class="nump">1,308,385<span></span>
</td>
<td class="num">(3,092,343)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">7,679,818<span></span>
</td>
<td class="nump">7,571,076<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">9,587,637<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">1,307,055<span></span>
</td>
<td class="num">(3,329,562)<span></span>
</td>
<td class="nump">108,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(1,484)<span></span>
</td>
<td class="num">(1,484)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1,483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">4,992<span></span>
</td>
<td class="nump">4,992<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(88,078)<span></span>
</td>
<td class="num">(87,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(953)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for (gains) losses included in net income (interest expense)</a></td>
<td class="num">(2,284)<span></span>
</td>
<td class="num">(2,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains (Losses) arising during the period on interest rate swaps</a></td>
<td class="num">(8,541)<span></span>
</td>
<td class="num">(8,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders (in usd per share)</a></td>
<td class="num">(119,635)<span></span>
</td>
<td class="num">(118,188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,188)<span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 7,464,839<span></span>
</td>
<td class="nump">$ 7,358,628<span></span>
</td>
<td class="nump">$ 3,808<span></span>
</td>
<td class="nump">$ 9,591,194<span></span>
</td>
<td class="num">$ (8,554)<span></span>
</td>
<td class="nump">$ 1,219,930<span></span>
</td>
<td class="num">$ (3,447,750)<span></span>
</td>
<td class="nump">$ 106,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787956176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividend per share to common Stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678779487936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (88,078)<span></span>
</td>
<td class="nump">$ 42,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">184,479<span></span>
</td>
<td class="nump">54,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Other amortization</a></td>
<td class="nump">11,104<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">4,992<span></span>
</td>
<td class="nump">3,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StraightLineRentReceivable', window );">Amortization of straight-line rent receivable (lessor)</a></td>
<td class="num">(9,783)<span></span>
</td>
<td class="num">(1,587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StraightlineRentLiability', window );">Amortization of straight-line rent on operating leases (lessee)</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation', window );">Gain on sales of real estate properties</a></td>
<td class="num">(1,007)<span></span>
</td>
<td class="num">(44,784)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations', window );">Impairment of real estate properties and credit loss reserves</a></td>
<td class="nump">31,422<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss from unconsolidated joint ventures</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions from unconsolidated joint ventures</a></td>
<td class="nump">2,542<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InterestIncomeFinancingReceivableNoncash', window );">Non-cash interest from financing and notes receivable</a></td>
<td class="num">(1,385)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets, including right-of-use-assets</a></td>
<td class="num">(8,360)<span></span>
</td>
<td class="num">(2,563)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(66,954)<span></span>
</td>
<td class="num">(12,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">7,901<span></span>
</td>
<td class="nump">1,830<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">69,190<span></span>
</td>
<td class="nump">43,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Acquisitions of real estate</a></td>
<td class="num">(30,725)<span></span>
</td>
<td class="num">(121,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development of real estate</a></td>
<td class="num">(6,707)<span></span>
</td>
<td class="num">(3,754)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Additional long-lived assets</a></td>
<td class="num">(60,159)<span></span>
</td>
<td class="num">(23,326)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Funding of mortgages and notes receivable</a></td>
<td class="num">(6,230)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Investments in unconsolidated joint ventures</a></td>
<td class="num">(3,824)<span></span>
</td>
<td class="num">(49,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireFinanceReceivables', window );">Investment in financing receivable</a></td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Investment in financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sales of real estate properties and additional long-lived assets</a></td>
<td class="nump">149,171<span></span>
</td>
<td class="nump">84,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable', window );">Proceeds from notes receivable repayments</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">41,560<span></span>
</td>
<td class="num">(113,267)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Net borrowings on unsecured credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of notes and bonds payable</a></td>
<td class="num">(667)<span></span>
</td>
<td class="num">(17,573)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Redemption of notes and bonds payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,184)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(118,052)<span></span>
</td>
<td class="num">(46,768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">22,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock redemptions</a></td>
<td class="num">(1,729)<span></span>
</td>
<td class="num">(852)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to non-controlling interest holders</a></td>
<td class="num">(1,272)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments made on finance leases</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(121,770)<span></span>
</td>
<td class="nump">79,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="num">(11,020)<span></span>
</td>
<td class="nump">9,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">60,961<span></span>
</td>
<td class="nump">13,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">49,941<span></span>
</td>
<td class="nump">22,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">75,082<span></span>
</td>
<td class="nump">16,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoanRelatedToPropertySales1', window );">Mortgage note receivable taken in connection with sale of real estate</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Invoices accrued for construction, tenant improvements and other capitalized costs</a></td>
<td class="nump">28,138<span></span>
</td>
<td class="nump">13,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Capitalized interest</a></td>
<td class="nump">$ 570<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of Real Estate, Continuing and Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InterestIncomeFinancingReceivableNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Financing Receivable, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InterestIncomeFinancingReceivableNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StraightLineRentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Straight-line rent receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StraightLineRentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StraightlineRentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Straight-line rent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StraightlineRentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarlyRepaymentOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarlyRepaymentOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoanRelatedToPropertySales1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage loan related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoanRelatedToPropertySales1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783935392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March&#160;31, 2023, the Company had gross investments of approximately $13.9&#160;billion in 681 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 681 real estate properties are located in 35 states and total approximately 39.9&#160;million square feet. The Company provided leasing and property management services to approximately 39.5 million square feet nationwide.   As of March&#160;31, 2023, the Company had a weighted average ownership interest of approximately 44% in 34 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Holdings, L.P. (the "OP") is 98.8% owned by the Company.  Holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of March&#160;31, 2023, there were approximately 4.7&#160;million, or 1.2%, of OP Units issued and outstanding held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had three consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"><tr><td style="width:1.0%"/><td style="width:67.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,079&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,517&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">51,935&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,010&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">39,925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">51,935&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"/><td style="width:21.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,839&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,639&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">66,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">66,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.  See Note 3 below for more details regarding the Company's unconsolidated joint ventures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Reclassifications </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets. </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">                                            &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Redeemable Non-Controlling Interests</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company accounts for redeemable equity securities in accordance with Accounting Standards Codification Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheet.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.  As of March&#160;31, 2023, the Company had redeemable non-controlling interests of $2.0&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In accordance with ASC 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 &#8220;Receivables&#8221;.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of March&#160;31, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $147.3&#160;million.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"><tr><td style="width:1.0%"/><td style="width:25.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loan</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19,367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,150&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101,517&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair-value discount and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,542)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,326&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the three months ended March 31, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote.  Consequently, the Company recorded a credit loss reserve of $5.2&#160;million for the three months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"/><td style="width:62.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the three months ended March&#160;31, 2023, the Company recognized the related income from two financing receivables totaling $1.5&#160;million based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company recognized interest income of $2.0&#160;million related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of March&#160;31, 2023, the Company placed two of its real estate notes receivable with a principal balance of $54.1&#160;million on non-accrual status and accordingly did not recognize any interest income for the quarter. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Revenue that is accounted for under Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.896%"><tr><td style="width:1.0%"/><td style="width:49.994%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.354%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,618&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.           </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678779263248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Merger with HTA</a></td>
<td class="text">Merger with HTA <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022 (the &#8220;Closing Date&#8221;), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the &#8220;Merger Agreement&#8221;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the &#8220;Legacy HR Common Stock&#8221;), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the &#8220;Special Dividend&#8221;) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the &#8220;Legacy HTA Common Stock&#8221;), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP.  The Company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For accounting purposes, the Merger was treated as a &#8220;reverse acquisition&#8221; in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The implied consideration transferred on the Closing Date is as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"><tr><td style="width:1.0%"/><td style="width:77.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands, except for per share data</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exchange ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Implied shares of Legacy HR Common Stock issued</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjusted closing price of Legacy HR Common Stock on July 20, 2022</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Value of implied Legacy HR Common Stock issued</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,569,057&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Consideration transferred</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,576,463&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Preliminary Purchase Price Allocation </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"/><td style="width:36.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.748%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MEASUREMENT PERIOD ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Real estate investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">985,926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">992,211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,960,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(121,413)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,839,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible assets</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">831,920&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">833,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(6,744)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate investments</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,844,747&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(116,879)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,727,868&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">707,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7,946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">699,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,123,647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,122,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">216,047&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b) (c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">209,163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,840)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">205,323&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total assets acquired</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,177,186&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(100,723)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,076,463&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">LIABILITIES</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,227,570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,244,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24,738&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">173,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">184,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(855)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,865&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">203,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,544)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">191,666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total liabilities assumed</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,635,425&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,209&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,646,634&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,541,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(111,932)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,429,829&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">145,404&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">111,932&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">257,336&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c)  Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.</span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The cumulative measurement period adjustments recorded through March&#160;31, 2023 primarily resulted from updated valuations related to the Company&#8217;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $111.9&#160;million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had not finalized the determination of fair value of certain tangible and intangible assets acquired and liabilities assumed, including, but not limited to real estate assets and liabilities, notes receivables and goodwill. As such, the assessment of fair value of assets acquired and liabilities assumed is preliminary and was based on information that was available at the time the Condensed Consolidated Financial Statements were prepared. The finalization of the purchase accounting assessment could result in material changes to the Company&#8217;s determination of the fair value of assets acquired and liabilities assumed, which will be recorded as measurement period adjustments in the period in which they are identified, up to one year from the Closing Date.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A preliminary estimate of approximately $257.3&#160;million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger.  None of the goodwill recognized is expected to be deductible for tax purposes. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Merger-related Costs</span></div>The Company incurred Merger-related costs of $4.9 million during the three months ended March&#160;31, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services.  Subsequent to March&#160;31, 2023, the Company received a refund of $17.8&#160;million for transfer taxes paid during the year ended December&#160;31, 2022 in connection with the Merger.  The Company will record this as a reduction of Merger-related costs in the second quarter of 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678786049680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AcquisitionsAndDispositionsTextBlock', window );">Real Estate Investments</a></td>
<td class="text">Real Estate Investments<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Acquisition Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's real estate acquisition activity for the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"/><td style="width:28.808%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.459%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CASH<br/>CONSIDERATION </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">REAL <br/>ESTATE </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,499&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,596&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(97)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,867&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Unconsolidated Joint Ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three months ended March&#160;31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.993%"><tr><td style="width:1.0%"/><td style="width:71.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.784%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">49,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(780)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(345)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,546)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,746&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">211,195&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">This was an additional investment in an existing joint venture representing a 40% ownership interest in a property in Dallas, Texas. Also, see 2023 Real Estate Asset Dispositions below for additional information.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Real Estate Asset Dispositions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions for the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">COMPANY-FINANCED MORTGAGE NOTES</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL &amp; Miami, FL</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93,250&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,875)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,375&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,302&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(888)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">224,037&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(141)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,069&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36,691&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(188)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,079)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(803)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,900)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">208,810&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,639)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,171&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">215,920&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,596)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,153)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">451,471&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes straight-line rent receivables, leasing commissions and lease inducements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes two properties, sold in two separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company entered into a mortgage note agreement with the buyer for $45&#160;million.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Assets Held for Sale</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had three properties and one land parcel classified as assets held for sale as of March&#160;31, 2023. The net real estate assets held for sale includes $5.1&#160;million of impairment charges.  As of December 31, 2022, the Company had one property classified as assets held for sale as of December&#160;31, 2022, which was sold in the first quarter of 2023.  The table below reflects the assets and liabilities classified as held for sale as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,434&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,183)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,251&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">328&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,579&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,893&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">437&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AcquisitionsAndDispositionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions and dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AcquisitionsAndDispositionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678785273968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three months ended March&#160;31, 2023 was $324.1 million.  Lease income for the Company's operating leases recognized for the three months ended March 31, 2022 was $138.5&#160;million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"/><td style="width:42.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">695,787&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">833,006&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">720,985&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">620,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">539,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,854,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,263,784&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of March&#160;31, 2023, the Company had 242 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of March&#160;31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#8217;s rental expense for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,188&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,827&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,933&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">939,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,010,442&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">406,838&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(730,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(333,645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">279,637&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">73,193&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"><tr><td style="width:1.0%"/><td style="width:75.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.458%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">172&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">918&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,549&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,698&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,960&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,797&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">40,589&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">61.9</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three months ended March&#160;31, 2023 was $324.1 million.  Lease income for the Company's operating leases recognized for the three months ended March 31, 2022 was $138.5&#160;million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"/><td style="width:42.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">695,787&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">833,006&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">720,985&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">620,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">539,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,854,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,263,784&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of March&#160;31, 2023, the Company had 242 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of March&#160;31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#8217;s rental expense for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,188&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,827&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,933&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">939,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,010,442&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">406,838&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(730,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(333,645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">279,637&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">73,193&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"><tr><td style="width:1.0%"/><td style="width:75.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.458%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">172&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">918&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,549&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,698&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,960&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,797&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">40,589&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">61.9</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678786049680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Other Assets and Liabilities</a></td>
<td class="text">Other Assets and Liabilities<div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other Assets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022 are detailed in the table below:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,326&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">99,643&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">98,923&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">88,868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">88,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">81,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Above-market intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">85,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">80,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,676&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">47,498&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional long-lived assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">22,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swap assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in securities</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other receivables, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,962&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,977&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Project costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,337&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net investment in lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Customer relationship intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,961&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">534,420&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">469,990&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">This amount includes an allowance for credit losses.  See Note 1 for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">This amount represents the value of the Company's preferred stock investment in a data analytics platform.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Accounts Payable and Accrued Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued property taxes</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,629&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">78,185&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and capital expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35,128&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">50,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other operating accruals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,970&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">58,459&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">155,210&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">244,033&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Below-market intangible liabilities, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">96,214&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">97,935&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">90,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">87,325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Security deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">29,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swap liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,927&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">618&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">232,029&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">218,668&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678875879632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes and Bonds Payable</a></td>
<td class="text">Notes and Bonds Payable<div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of March 31, 2023 and December 31, 2022.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"/><td style="width:39.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATES </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 3/31/2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">3/31/2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1.5 billion Unsecured Credit Facility </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.76&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$350 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/23</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/24</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,728&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$150 million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,362&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,869&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">573,410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">571,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">480,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">479,553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">567,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">565,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,671&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">636,819&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">632,693&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/23-12/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">83,612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84,247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.57%-4.84%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,361,699&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351,827&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.</span></div>2Subsequent to March 31, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678867002768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Cash Flow Hedges of Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"/><td style="width:41.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.859%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(11,927)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,160)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">   </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three months ended March&#160;31, 2023 and 2022 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"/><td style="width:24.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.940%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended March 31,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,541&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,159)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,433)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,541&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,159)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,284)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company estimates that an additional $9.5 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Credit-risk-related Contingent Features</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender due to the Company's&#160;default on the indebtedness.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$7.0&#160;million. As of March&#160;31, 2023, the Company has not posted any collateral related to these agreements and was not in breach of any agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678867063040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Development and Redevelopment Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the first quarter of 2023, the Company funded $16.9&#160;million toward the development and redevelopment of properties.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678791149600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the three months ended March&#160;31, 2023 and the twelve months ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,457,433&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">229,618,304&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">223,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">514,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,816,429&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">At-The-Market Equity Offering Program</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:130%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company has equity distribution agreements with various sales agents with respect to the at-the-market (&#8220;ATM&#8221;) offering program of common stock with an aggregate sales amount of up to $750.0 million.  As of March&#160;31, 2023, $750.0 million remained available for issuance under our current ATM offering program.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM offering program.</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Dividends</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company declared and paid common stock dividends totaling $0.31 per share.  On May 2, 2023, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on June 2, 2023 to stockholders of record on May 16, 2023.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Earnings Per Common Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.617%"><tr><td style="width:1.0%"/><td style="width:64.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.114%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,796,773&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,834,888&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,956,353)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,871,858)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,840,420&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">148,963,030&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,840,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">148,963,030&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of employee stock purchase plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,840,420&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,051,264&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income  attributable to common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(87,125)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends paid on nonvested share-based awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(605)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(605)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income applicable to common stockholders - basic</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(87,730)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">41,622&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The effect of OP units totaling 4,042,993 shares, non-vested stock awards totaling 401,937 shares, and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling 49,322 shares for the three months ended March&#160;31, 2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Incentive Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Restricted Common Shares</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $5.4&#160;million, which consisted of an aggregate of 270,494 non-vested shares with vesting periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI3NQ_6ca16896-73b0-44f5-a3a0-a5bc0b29e940">three</span> to eight years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A summary of the activity under the Company's share-based incentive plans for the three months ended March&#160;31, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"/><td style="width:64.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.149%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,795,128&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,562,028&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">282,540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">415,184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(101,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,365)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,503)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,296)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,955,445&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,951,551&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March&#160;31, 2023 and 2022, the Company withheld 38,632 and 6,727 shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Restricted Stock Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with three-year forward-looking performance targets. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $3.7 million, which consisted of an aggregate 165,174 RSUs with a five-year vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"/><td style="width:56.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:41.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining 57% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $22.55 per share.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following is a summary of the RSU activity during the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"/><td style="width:64.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.149%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, beginning of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">294,932&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165,174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">22.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested/Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,606)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Probability adjustment of 2022 RSUs </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(79,250)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,250&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28.57&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">LTIP Series C Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units are granted with three-year forward-looking performance targets, with a grant date fair value of $7.1&#160;million, which consisted of an aggregate 448,249 LTIP-C units with a five-year vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately 43% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"/><td style="width:56.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:41.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining 57% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $15.85 per share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. A summary of the activity under the ESPP for the three months ended March&#160;31, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"/><td style="width:64.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.149%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, beginning of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">340,976&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">348,514&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">255,960&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,421)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,486)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(132,999)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(140,633)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">183,426&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">427,802&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested shares issued as of March 31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"/><td style="width:48.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678875748640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Cash and cash equivalents</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value due to the short term maturity of these investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Real estate notes receivabl</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements.</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Senior Notes and Mortgage Notes payable</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#8217;s current interest rates for similar types of borrowing arrangements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Interest rate swap agreements</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"/><td style="width:26.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.540%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,361.7&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,185.0&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351.8&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,149.6&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">146.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678789926896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NatureOfOperationsPolicyTextBlock', window );">Business overview</a></td>
<td class="text">Business OverviewHealthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March&#160;31, 2023, the Company had gross investments of approximately $13.9&#160;billion in 681 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 681 real estate properties are located in 35 states and total approximately 39.9&#160;million square feet. The Company provided leasing and property management services to approximately 39.5 million square feet nationwide.   As of March&#160;31, 2023, the Company had a weighted average ownership interest of approximately 44% in 34 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Holdings, L.P. (the "OP") is 98.8% owned by the Company.  Holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of March&#160;31, 2023, there were approximately 4.7&#160;million, or 1.2%, of OP Units issued and outstanding held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had three consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"><tr><td style="width:1.0%"/><td style="width:67.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,079&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,517&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">51,935&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,010&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">39,925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">51,935&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"/><td style="width:21.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,839&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,639&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">66,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">66,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">As of March&#160;31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates in the condensed consolidated financial statements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Redeemable non-controlling interests</a></td>
<td class="text">Redeemable Non-Controlling InterestsThe Company accounts for redeemable equity securities in accordance with Accounting Standards Codification Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheet.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Investments in Leases - Financing Receivables, Net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In accordance with ASC 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 &#8220;Receivables&#8221;.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of March&#160;31, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $147.3&#160;million.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"><tr><td style="width:1.0%"/><td style="width:25.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loan</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19,367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,150&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101,517&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair-value discount and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,542)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,326&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the three months ended March 31, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote.  Consequently, the Company recorded a credit loss reserve of $5.2&#160;million for the three months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"/><td style="width:62.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the three months ended March&#160;31, 2023, the Company recognized the related income from two financing receivables totaling $1.5&#160;million based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div>During the three months ended March&#160;31, 2023, the Company recognized interest income of $2.0&#160;million related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of March&#160;31, 2023, the Company placed two of its real estate notes receivable with a principal balance of $54.1&#160;million on non-accrual status and accordingly did not recognize any interest income for the quarter.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from contract with customers (topic 606)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. </span></div>Revenue that is accounted for under Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NatureOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature Of Operations Policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NatureOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783973760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Condensed Balance Sheet</a></td>
<td class="text">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"><tr><td style="width:1.0%"/><td style="width:67.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,079&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,517&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">51,935&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,010&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">39,925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">51,935&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text">, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"/><td style="width:21.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,839&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,639&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">66,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">66,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"><tr><td style="width:1.0%"/><td style="width:25.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loan</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19,367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,150&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101,517&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair-value discount and fees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,542)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,326&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Company's Allowance For Credit Losses</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"/><td style="width:62.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of revenue</a></td>
<td class="text">Below is a detail of the amounts by category:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.896%"><tr><td style="width:1.0%"/><td style="width:49.994%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.354%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,618&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678786286768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock', window );">Schedule of Consideration Transferred</a></td>
<td class="text">The implied consideration transferred on the Closing Date is as follows: <div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"><tr><td style="width:1.0%"/><td style="width:77.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands, except for per share data</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exchange ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Implied shares of Legacy HR Common Stock issued</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjusted closing price of Legacy HR Common Stock on July 20, 2022</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Value of implied Legacy HR Common Stock issued</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,569,057&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Consideration transferred</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,576,463&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.</span></div>(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Values of the Assets Acquired And Liabilities Assumed</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"/><td style="width:36.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.748%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MEASUREMENT PERIOD ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Real estate investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">985,926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">992,211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,960,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(121,413)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,839,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible assets</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">831,920&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">833,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(6,744)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate investments</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,844,747&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(116,879)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,727,868&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">707,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7,946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">699,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,123,647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,122,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">216,047&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b) (c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">209,163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,840)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">205,323&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total assets acquired</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,177,186&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(100,723)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,076,463&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">LIABILITIES</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,227,570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,244,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24,738&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">173,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">184,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(855)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,865&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">203,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,544)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">191,666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total liabilities assumed</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,635,425&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,209&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,646,634&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,541,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(111,932)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,429,829&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">145,404&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">111,932&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">257,336&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c)  Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.</span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The cumulative measurement period adjustments recorded through March&#160;31, 2023 primarily resulted from updated valuations related to the Company&#8217;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $111.9&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678789840208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Acquisitions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's real estate acquisition activity for the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"/><td style="width:28.808%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.459%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CASH<br/>CONSIDERATION </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">REAL <br/>ESTATE </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,499&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,596&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(97)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,867&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of equity method investments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three months ended March&#160;31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.993%"><tr><td style="width:1.0%"/><td style="width:71.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.784%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">49,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(780)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(345)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,546)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,746&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">211,195&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">This was an additional investment in an existing joint venture representing a 40% ownership interest in a property in Dallas, Texas. Also, see 2023 Real Estate Asset Dispositions below for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetDispositionsTableTextBlock', window );">Schedule of real estate dispositions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions for the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">COMPANY-FINANCED MORTGAGE NOTES</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL &amp; Miami, FL</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93,250&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,875)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,375&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,302&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(888)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">224,037&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(141)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,069&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36,691&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(188)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,079)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(803)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,900)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">208,810&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,639)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,171&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">215,920&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,596)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,153)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">451,471&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes straight-line rent receivables, leasing commissions and lease inducements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes two properties, sold in two separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company entered into a mortgage note agreement with the buyer for $45&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock', window );">Schedule of assets and liabilities held for sale</a></td>
<td class="text">The table below reflects the assets and liabilities classified as held for sale as of March&#160;31, 2023 and December&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,434&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,183)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,251&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">328&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,579&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,893&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">437&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetDispositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetDispositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Assets and Liabilities Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678789836032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Future Minimum Operating Lease Payments Receivable</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"/><td style="width:42.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">695,787&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">833,006&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">720,985&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">620,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">539,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,854,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,263,784&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future Minimum Operating Lease Payments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,188&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,827&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,933&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">939,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,010,442&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">406,838&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(730,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(333,645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">279,637&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">73,193&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Future Minimum Financing Lease Payments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,188&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,827&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,933&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">939,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,010,442&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">406,838&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(730,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(333,645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">279,637&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">73,193&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Cost</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"><tr><td style="width:1.0%"/><td style="width:75.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.458%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">172&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">918&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,549&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,698&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,960&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,797&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">40,589&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">61.9</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787094288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022 are detailed in the table below:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,326&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">99,643&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">98,923&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">88,868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">88,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">81,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Above-market intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">85,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">80,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,676&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">47,498&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional long-lived assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">22,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swap assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in securities</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other receivables, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,962&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,977&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Project costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,337&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net investment in lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Customer relationship intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,961&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">534,420&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">469,990&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">This amount includes an allowance for credit losses.  See Note 1 for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">This amount represents the value of the Company's preferred stock investment in a data analytics platform.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued property taxes</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">48,629&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">78,185&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and capital expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35,128&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">50,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other operating accruals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,970&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">58,459&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">155,210&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">244,033&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Below-market intangible liabilities, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">96,214&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">97,935&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">90,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">87,325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Security deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">29,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swap liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,927&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">618&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">232,029&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">218,668&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678786325664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of March 31, 2023 and December 31, 2022.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"/><td style="width:39.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATES </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 3/31/2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">3/31/2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1.5 billion Unsecured Credit Facility </span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.76&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$350 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/23</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/24</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,728&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$150 million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,362&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,869&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">573,410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">571,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">480,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">479,553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">567,863&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">565,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,671&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">636,819&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">632,693&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/23-12/26</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">83,612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84,247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.57%-4.84%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,361,699&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351,827&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.</span></div>2Subsequent to March 31, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678786215968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of cash flow hedges included in accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of March&#160;31, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"/><td style="width:41.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>The table below presents the effect of cash flow hedge accounting on AOCI during the three months ended March&#160;31, 2023 and 2022 related to the Company's outstanding interest rate swaps.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"/><td style="width:24.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.940%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended March 31,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,541&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,159)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,433)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,541&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,159)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,284)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of derivative instruments in statement of financial position, fair value</a></td>
<td class="text">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of March&#160;31, 2023.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.859%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT MARCH 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(11,927)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,160)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787418512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Reconciliation of common stock outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the three months ended March&#160;31, 2023 and the twelve months ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,457,433&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">229,618,304&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">223,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">514,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,816,429&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings (loss) per share</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.617%"><tr><td style="width:1.0%"/><td style="width:64.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.114%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,796,773&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,834,888&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,956,353)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,871,858)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,840,420&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">148,963,030&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,840,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">148,963,030&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of employee stock purchase plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,840,420&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,051,264&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income  attributable to common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(87,125)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends paid on nonvested share-based awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(605)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(605)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income applicable to common stockholders - basic</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(87,730)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">41,622&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of the activity under the incentive plan and restricted stock unit</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A summary of the activity under the Company's share-based incentive plans for the three months ended March&#160;31, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"/><td style="width:64.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.149%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,795,128&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,562,028&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">282,540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">415,184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(101,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,365)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,503)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,296)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,955,445&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,951,551&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following is a summary of the RSU activity during the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"/><td style="width:64.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.149%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, beginning of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">294,932&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165,174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">22.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested/Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,606)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Probability adjustment of 2022 RSUs </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(79,250)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,250&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28.57&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of stock options, valuation assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"/><td style="width:56.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:41.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"/><td style="width:56.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:41.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Summary of employee stock purchase plan activity</a></td>
<td class="text">A summary of the activity under the ESPP for the three months ended March&#160;31, 2023 and 2022 is included in the table below.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"><tr><td style="width:1.0%"/><td style="width:64.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.149%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, beginning of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">340,976&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">348,514&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">255,960&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,421)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,486)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(132,999)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(140,633)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">183,426&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">427,802&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of unrecognized compensation cost, nonvested awards</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested shares issued as of March 31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"/><td style="width:48.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678790150432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"/><td style="width:26.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.540%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,361.7&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,185.0&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351.8&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,149.6&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">146.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678788285904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br> $ in Thousands, shares in Millions, ft&#178; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>financing_receivable </div>
<div>state </div>
<div>variable_interest_entity </div>
<div>joint_venture </div>
<div>property </div>
<div>building </div>
<div>note_receivable </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InvestmentInRealEstatePropertiesAndMortgageNotes', window );">Gross investment amount, total</a></td>
<td class="nump">$ 13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRealEstateInvestments', window );">Number of real estate properties | property</a></td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates', window );">Number of states that the company owns real estate in, whole units | state</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ApproximateSquareFeetInvestedInByCompany', window );">Approximate square feet invested in by company | ft&#178;</a></td>
<td class="nump">39.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ApproximateSquareFeetProvidedByCompany', window );">Approximate square feet for which Nationwide property management services provided by company | ft&#178;</a></td>
<td class="nump">39.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfBuildingsOwnedByJointVenture', window );">Number of buildings owned by joint venture with TIAA | building</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityOwnershipForConsolidationPercent', window );">Equity ownership for consolidation (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract', window );"><strong>Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRecognizedLeaseFinancialReceivables', window );">Number of recognized lease financial receivables | financing_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable', window );">Income from financing receivables</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRealEstateNotesReceivable', window );">Number of real estate notes receivable | financing_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus', window );">Financing receivable, nonaccrual</a></td>
<td class="nump">$ 54,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfNotesReceivable', window );">Number of notes receivable | note_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfJointVentures', window );">Number of joint ventures | joint_venture</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=hr_NonControllingInterestHoldersMember', window );">Non-Controlling Interest Holders | Healthcare Trustof America Holdings L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding', window );">Limited partner's capital, units outstanding (in shares) | shares</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding', window );">Limited partner's capital, units outstanding (in shares) | shares</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest', window );">Limited partners ownership interest (in percent)</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember', window );">Property Entities Not Determined to be VIEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest owned (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember', window );">Healthcare Trustof America Holdings L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest owned (percent)</a></td>
<td class="nump">98.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember', window );">Real Estate Properties Held in Joint Ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Joint venture ownership (percent)</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ApproximateSquareFeetInvestedInByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Approximate Square Feet Invested in by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ApproximateSquareFeetInvestedInByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ApproximateSquareFeetProvidedByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Approximate square feet for which Nationwide property management services provided by company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ApproximateSquareFeetProvidedByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessOverviewAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Overview [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessOverviewAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityOwnershipForConsolidationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Ownership for Consolidation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityOwnershipForConsolidationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InvestmentInRealEstatePropertiesAndMortgageNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in real estate properties and mortgage notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InvestmentInRealEstatePropertiesAndMortgageNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfBuildingsOwnedByJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Buildings Owned by Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfBuildingsOwnedByJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRealEstateNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Real Estate Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRealEstateNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRecognizedLeaseFinancialReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Recognized Lease Financial Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRecognizedLeaseFinancialReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfVariableInterestEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Variable Interest Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfVariableInterestEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate investments property owned in number of states.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of financing receivable on nonaccrual status. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5111-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919258-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (2)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of limited partner units outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from lease receivable of sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_NonControllingInterestHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_NonControllingInterestHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustofAmericaHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustofAmericaHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787885408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Consolidated balance sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Real estate assets held for sale, net</a></td>
<td class="nump">$ 12,056,264<span></span>
</td>
<td class="nump">$ 12,412,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">49,941<span></span>
</td>
<td class="nump">60,961<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,568,884<span></span>
</td>
<td class="nump">13,849,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity</a></td>
<td class="nump">7,358,628<span></span>
</td>
<td class="nump">7,571,076<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">13,568,884<span></span>
</td>
<td class="nump">$ 13,849,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable interest entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Real estate assets held for sale, net</a></td>
<td class="nump">48,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReceivablesAndOtherAssets', window );">Receivables and other assets</a></td>
<td class="nump">2,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">51,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">12,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity</a></td>
<td class="nump">39,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 51,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReceivablesAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables And Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReceivablesAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678882235888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Variable interest entity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_HoustonTexasMember', window );">Houston, TX | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableCarryingAmount', window );">Notes receivable, carrying amount</a></td>
<td class="nump">$ 30,839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum exposure to loss</a></td>
<td class="nump">31,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NC', window );">Charlotte, NC | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableCarryingAmount', window );">Notes receivable, carrying amount</a></td>
<td class="nump">5,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum exposure to loss</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureCarryingAmount', window );">Joint venture, carrying amount</a></td>
<td class="nump">66,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum exposure to loss</a></td>
<td class="nump">$ 66,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_HoustonTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_HoustonTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678784683488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued interest</a></td>
<td class="nump">$ 1,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="num">(5,196)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableFairValueDiscount', window );">Fair-value discount and fees</a></td>
<td class="num">(4,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Investment in financing receivable, net</a></td>
<td class="nump">120,692<span></span>
</td>
<td class="nump">$ 120,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Investment in financing receivable, net</a></td>
<td class="nump">$ 147,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoansTexasMember', window );">Mezzanine Loans Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">STATED INTEREST RATE</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">$ 54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanTexasMember', window );">Mortgage Loan Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">STATED INTEREST RATE</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">$ 31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanNorthCarolinaMember', window );">Mortgage Loan - North Carolina</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">STATED INTEREST RATE</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanFloridaMember', window );">Mortgage Loan Florida</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">STATED INTEREST RATE</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">$ 19,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanCaliforniaMember', window );">Mortgage Loan California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">STATED INTEREST RATE</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember', window );">Mortgage Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">147,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">$ 101,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableFairValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Fair Value Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableFairValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableMaximumLoanCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Maximum Loan Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableMaximumLoanCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (c)<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 80<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922355-210448<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (2)<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1404<br> -Paragraph (a)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoansTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoansTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanNorthCarolinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanNorthCarolinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanFloridaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanFloridaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783740128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">5,196<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (c)<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783980992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">$ 4,618<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_ParkingIncomeMember', window );">Parking income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">2,391<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember', window );">Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_MiscellaneousMember', window );">Miscellaneous</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_ParkingIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_ParkingIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_MiscellaneousMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_MiscellaneousMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787980768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 02, 2022</div></th>
<th class="th"><div>Jul. 20, 2022</div></th>
<th class="th"><div>May 09, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share, during the period (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 257,336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260,822,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,202,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be tax deductible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerRelatedCosts', window );">Merger-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,855,000<span></span>
</td>
<td class="nump">$ 6,116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRefundOfTransferTaxesPaid', window );">Refund of transfer taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember', window );">HealthCare Realty Trust Incorporated | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncMember', window );">HealthCare Realty Trust, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember', window );">Healthcare Trust Of America, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio', window );">Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share, during the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRefundOfTransferTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Refund of Transfer Taxes Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRefundOfTransferTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678788472352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 20, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</a></td>
<td class="nump">228,857,717<span></span>
</td>
<td class="nump">380,816,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Implied shares of Legacy HR Common Stock issued (in shares)</a></td>
<td class="nump">228,520,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 24.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReverseRecapitalizationNet', window );">Value of implied Legacy HR Common Stock issued | $</a></td>
<td class="nump">$ 5,569,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices', window );">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,406,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,576,463,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember', window );">Healthcare Trust Of America, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</a></td>
<td class="nump">228,520,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RecapitalizationExchangeRatio', window );">Exchange ratio</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CommonStockFractionalShares', window );">Common Stock, fractional (in shares)</a></td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember', window );">Healthcare Trust Of America, Inc | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</a></td>
<td class="nump">336,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CommonStockSharesWithheld', window );">Common Stock, withheld (in shares)</a></td>
<td class="nump">215,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CommonStockFractionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Fractional Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CommonStockFractionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CommonStockSharesWithheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Withheld</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CommonStockSharesWithheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReverseRecapitalizationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReverseRecapitalizationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787726016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 20, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract', window );"><strong>Real estate investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand', window );">Land</a></td>
<td class="nump">$ 992,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings', window );">Buildings and improvements</a></td>
<td class="nump">6,839,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Lease intangible assets</a></td>
<td class="nump">833,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets', window );">Financing lease right-of-use assets</a></td>
<td class="nump">13,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress', window );">Construction in progress</a></td>
<td class="nump">3,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment', window );">Land held for development</a></td>
<td class="nump">46,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments', window );">Total real estate investments</a></td>
<td class="nump">8,727,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale', window );">Assets held for sale, net</a></td>
<td class="nump">699,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">67,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">37,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1,122,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">216,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets', window );">Other assets, net</a></td>
<td class="nump">205,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">11,076,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">3,991,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,244,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale', window );">Liabilities of assets held for sale</a></td>
<td class="nump">24,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">184,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities', window );">Financing lease liabilities</a></td>
<td class="nump">9,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">191,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">5,646,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="nump">5,429,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Non-controlling interest</a></td>
<td class="nump">110,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 257,336<span></span>
</td>
<td class="nump">$ 260,822<span></span>
</td>
<td class="nump">$ 223,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period for the acquired lease intangible assets</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount', window );">Gross contractual accounts receivable</a></td>
<td class="nump">$ 15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount', window );">Gross contractual real estate notes receivable</a></td>
<td class="nump">78,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_GrossContractualRealEstateNotesReceivableFairValue', window );">Gross contractual real estate notes receivable at fair value</a></td>
<td class="nump">74,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>MEASUREMENT PERIOD ADJUSTMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand', window );">Land</a></td>
<td class="nump">6,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements', window );">Buildings and improvements</a></td>
<td class="num">(121,413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets', window );">Lease intangible assets</a></td>
<td class="nump">1,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets', window );">Financing lease right-of-use assets</a></td>
<td class="nump">3,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress', window );">Construction in progress</a></td>
<td class="num">(6,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments', window );">Total real estate investments</a></td>
<td class="num">(116,879)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet', window );">Assets held for sale, net</a></td>
<td class="num">(7,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">11,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash', window );">Restricted cash</a></td>
<td class="num">(1,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">17,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet', window );">Other assets, net</a></td>
<td class="num">(3,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired', window );">Total assets acquired</a></td>
<td class="num">(100,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">17,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale', window );">Liabilities of assets held for sale</a></td>
<td class="num">(3,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">10,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities', window );">Other liabilities</a></td>
<td class="num">(11,544)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed', window );">Total liabilities assumed</a></td>
<td class="nump">11,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired', window );">Net identifiable assets acquired</a></td>
<td class="num">(111,932)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="nump">111,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract', window );"><strong>Real estate investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand', window );">Land</a></td>
<td class="nump">985,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings', window );">Buildings and improvements</a></td>
<td class="nump">6,960,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Lease intangible assets</a></td>
<td class="nump">831,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets', window );">Financing lease right-of-use assets</a></td>
<td class="nump">9,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress', window );">Construction in progress</a></td>
<td class="nump">10,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment', window );">Land held for development</a></td>
<td class="nump">46,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments', window );">Total real estate investments</a></td>
<td class="nump">8,844,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale', window );">Assets held for sale, net</a></td>
<td class="nump">707,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">67,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">26,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1,123,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">198,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets', window );">Other assets, net</a></td>
<td class="nump">209,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">11,177,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">3,991,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,227,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale', window );">Liabilities of assets held for sale</a></td>
<td class="nump">28,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">173,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities', window );">Financing lease liabilities</a></td>
<td class="nump">10,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">203,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">5,635,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="nump">5,541,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Non-controlling interest</a></td>
<td class="nump">110,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">145,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete', window );">Goodwill adjustment incomplete</a></td>
<td class="nump">$ 111,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete,Buildings and Improvements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Land</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_GrossContractualRealEstateNotesReceivableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Contractual Real Estate Notes Receivable, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_GrossContractualRealEstateNotesReceivableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of facility held for productive use including, but not limited to, office, production, storage and distribution facilities, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate acquired, at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783847328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Acquisitions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 10, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,576,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_TampaFLMember', window );">Tampa, FL | Medical office building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 31,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="nump">30,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty', window );">Real estate</a></td>
<td class="nump">30,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther', window );">Other</a></td>
<td class="num">$ (97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage', window );">Square footage | ft&#178;</a></td>
<td class="nump">115,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Purchase Price Allocation Square Footage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_TampaFLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_TampaFLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678780789376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, beginning of period</a></td>
<td class="nump">$ 327,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss recognized during the period</a></td>
<td class="num">(780)<span></span>
</td>
<td class="num">$ (345)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Net LLC investments at the end of the period</a></td>
<td class="nump">327,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Parking Garages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, beginning of period</a></td>
<td class="nump">327,248,000<span></span>
</td>
<td class="nump">161,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod', window );">New investments during the period</a></td>
<td class="nump">3,824,000<span></span>
</td>
<td class="nump">49,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss recognized during the period</a></td>
<td class="num">(780,000)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared', window );">Owner distributions</a></td>
<td class="num">(2,546,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Net LLC investments at the end of the period</a></td>
<td class="nump">$ 327,746,000<span></span>
</td>
<td class="nump">$ 211,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Parking Garages | Los Angeles, CA | Limited Liability Company One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityMethodInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityMethodInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity impact of cash distributions declared to unit-holder of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125520817&amp;loc=d3e70191-108054<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_LimitedLiabilityCompanyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_LimitedLiabilityCompanyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678788086784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Dispositions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 23, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 12, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>disposition_transaction </div>
<div>property</div>
</th>
<th class="th">
<div>Jul. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property</div>
</th>
<th class="th">
<div>Feb. 10, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MortgageNote', window );">Mortgage note</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember', window );">Real Estate Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">Other (including receivables)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,153)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_TampaFLMiamiFLMember', window );">Tampa Fl &amp; Miami FL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">Other (including receivables)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(888)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertyDispositions', window );">Number of property dispositions | disposition_transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_DallasTXMember', window );">Dallas, TX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">Other (including receivables)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_STLouisMoMember', window );">St. Louis, MO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">Other (including receivables)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember', window );">Los Angeles, CA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="num">(8,079)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="num">(45,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="nump">21,921<span></span>
</td>
<td class="nump">20,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="nump">88,624<span></span>
</td>
<td class="nump">20,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">Other (including receivables)</a></td>
<td class="num">(803)<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="num">$ (20,900)<span></span>
</td>
<td class="num">$ (188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="nump">147,078<span></span>
</td>
<td class="nump">37,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area covered under real estate investment sold in measurement units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ClosingAdjustmentsDisposedEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ClosingAdjustmentsDisposedEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DispositionSalesPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposition Sales Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DispositionSalesPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceMortgageNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Mortgage Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceMortgageNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MortgageNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MortgageNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertyDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Property Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertyDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateDispositionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateDispositionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate investment net disposed of during the Period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateInvestmentNetDisposedOfDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_TampaFLMiamiFLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_TampaFLMiamiFLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_DallasTXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_DallasTXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_STLouisMoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_STLouisMoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678779661552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Assets Held for Sale (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>property </div>
<div>land_parcel</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleLineItems', window );"><strong>Long Lived Assets Held-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertiesClassifiedAsHeldForSale', window );">Number of properties classified as held for sale | property</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfLandParcelsClassifiedAsHeldForSale', window );">Number of land parcels classified as held for sale | land_parcel</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale', window );">Impairment charges on net real estate assets held for sale</a></td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">1,412,805<span></span>
</td>
<td class="nump">$ 1,439,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Building and improvements</a></td>
<td class="nump">11,196,297<span></span>
</td>
<td class="nump">11,332,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAvailableForDevelopment', window );">Land held for development</a></td>
<td class="nump">69,575<span></span>
</td>
<td class="nump">74,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Real estate investment property, at cost</a></td>
<td class="nump">13,866,357<span></span>
</td>
<td class="nump">14,057,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(1,810,093)<span></span>
</td>
<td class="num">(1,645,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Real estate assets held for sale, net</a></td>
<td class="nump">12,056,264<span></span>
</td>
<td class="nump">12,412,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">3,579<span></span>
</td>
<td class="nump">18,893<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleLineItems', window );"><strong>Long Lived Assets Held-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Building and improvements</a></td>
<td class="nump">1,736<span></span>
</td>
<td class="nump">15,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LeaseIntangibles', window );">Lease intangibles</a></td>
<td class="nump">2,242<span></span>
</td>
<td class="nump">1,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAvailableForDevelopment', window );">Land held for development</a></td>
<td class="nump">3,251<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Real estate investment property, at cost</a></td>
<td class="nump">7,434<span></span>
</td>
<td class="nump">18,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(4,183)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Real estate assets held for sale, net</a></td>
<td class="nump">3,251<span></span>
</td>
<td class="nump">18,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets, net</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">3,579<span></span>
</td>
<td class="nump">18,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets held for sale and discontinued operations, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Charge on Real Estate Assets Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentChargeOnRealEstateAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LeaseIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LeaseIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfLandParcelsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Land Parcels Classified as Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfLandParcelsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertiesClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Properties Classified as Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertiesClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAvailableForDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of land available for development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAvailableForDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsHeldForSaleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsHeldForSaleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678790077024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental income</a></td>
<td class="nump">$ 324,093<span></span>
</td>
<td class="nump">$ 138,489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787325072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lessor Accounting (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract', window );"><strong>Future Operating Lease Payments Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 695,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">2024</a></td>
<td class="nump">833,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">2025</a></td>
<td class="nump">720,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">2026</a></td>
<td class="nump">620,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">2027</a></td>
<td class="nump">539,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">1,854,402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total</a></td>
<td class="nump">$ 5,263,784<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Operating Lease, Payment to be Received, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783978208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Ground Leases (Details)<br> ft&#178; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property </div>
<div>lease</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfPropertiesSubjectToGroundLeases', window );">Number of properties subject to ground leases</a></td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_SquareFeetSubjecttoGroundLeases', window );">Square feet subject to ground leases | ft&#178;</a></td>
<td class="nump">17.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberofGroundLeasesPrepaid', window );">Number of prepaid ground leases | lease</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AmortizationofPrepaidRent', window );">Amortization of prepaid rent | $</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberofGroundLeasesExcludingPrepaidLeases', window );">Number of non-prepaid ground leases</a></td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Ground lease, initial term</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Ground lease, initial term</a></td>
<td class="text">99 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AmortizationofPrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Prepaid Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AmortizationofPrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberofGroundLeasesExcludingPrepaidLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Ground Leases, Excluding Prepaid Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberofGroundLeasesExcludingPrepaidLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberofGroundLeasesPrepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Ground Leases Prepaid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberofGroundLeasesPrepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_SquareFeetSubjecttoGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Square Feet Subject to Ground Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_SquareFeetSubjecttoGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfPropertiesSubjectToGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of separate real estate development properties located on land subject to ground leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfPropertiesSubjectToGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787390048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>OPERATING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 11,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">15,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">14,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">14,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">14,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">939,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">1,010,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Discount</a></td>
<td class="num">(730,805)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">279,637<span></span>
</td>
<td class="nump">$ 279,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>FINANCING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">1,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">396,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">406,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Discount</a></td>
<td class="num">(333,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">$ 73,193<span></span>
</td>
<td class="nump">$ 72,939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678780547456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 5,107<span></span>
</td>
<td class="nump">$ 1,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">388<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">8,549<span></span>
</td>
<td class="nump">2,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows outflows related to operating leases</a></td>
<td class="nump">5,960<span></span>
</td>
<td class="nump">2,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows outflows related to financing leases</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceLeasePrincipalOnlyPayments', window );">Financing cash flows outflows related to financing leases</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for new finance lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 40,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average years remaining lease term (excluding renewal options) - operating leases</a></td>
<td class="text">47 years 4 months 24 days<span></span>
</td>
<td class="text">47 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average years remaining lease term (excluding renewal options) - finance leases</a></td>
<td class="text">58 years 8 months 12 days<span></span>
</td>
<td class="text">61 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - operating leases</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - finance leases</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceLeasePrincipalOnlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Principal Only Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceLeasePrincipalOnlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787628896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateNotesReceivableNet', window );">Real estate notes receivable, net</a></td>
<td class="nump">$ 147,326<span></span>
</td>
<td class="nump">$ 99,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Straight-line rent receivables</a></td>
<td class="nump">98,923<span></span>
</td>
<td class="nump">88,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Prepaid assets</a></td>
<td class="nump">88,694<span></span>
</td>
<td class="nump">81,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AboveMarketLeaseIntangibleAssetsNet', window );">Above-market intangible assets, net</a></td>
<td class="nump">85,100<span></span>
</td>
<td class="nump">80,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">48,676<span></span>
</td>
<td class="nump">47,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Additional long-lived assets, net</a></td>
<td class="nump">22,173<span></span>
</td>
<td class="nump">21,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate swap assets</a></td>
<td class="nump">9,767<span></span>
</td>
<td class="nump">14,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Investment in securities</a></td>
<td class="nump">6,011<span></span>
</td>
<td class="nump">6,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_GroundLeaseModificationNet', window );">Other receivables, net</a></td>
<td class="nump">5,962<span></span>
</td>
<td class="nump">7,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs, net</a></td>
<td class="nump">5,449<span></span>
</td>
<td class="nump">5,977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingToDate', window );">Project costs</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentInLease', window );">Net investment in lease</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FiniteLivedCustomerRelationshipsNet', window );">Customer relationship intangible assets, net</a></td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneous', window );">Other</a></td>
<td class="nump">8,505<span></span>
</td>
<td class="nump">8,961<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other Assets</a></td>
<td class="nump">$ 534,420<span></span>
</td>
<td class="nump">$ 469,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AboveMarketLeaseIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Above Market Lease Intangible Assets , Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AboveMarketLeaseIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ConstructionActivityTotalFundingToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Construction Activity, Total Funding to Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ConstructionActivityTotalFundingToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FiniteLivedCustomerRelationshipsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Customer Relationships, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FiniteLivedCustomerRelationshipsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_GroundLeaseModificationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ground Lease Modification, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_GroundLeaseModificationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateNotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real Estate Notes Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateNotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental income recognized over rental payment required by lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123408481&amp;loc=SL77919140-209958<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123394697&amp;loc=d3e40879-112712<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123415192&amp;loc=d3e39927-112707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123415192&amp;loc=d3e39896-112707<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919306-209978<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneous">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneous</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678789868208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AccruedPropertyTaxes', window );">Accrued property taxes</a></td>
<td class="nump">$ 48,629<span></span>
</td>
<td class="nump">$ 78,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AccountsPayableAndCapitalExpendituresCurrent', window );">Accounts payable and capital expenditures</a></td>
<td class="nump">35,128<span></span>
</td>
<td class="nump">57,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">28,483<span></span>
</td>
<td class="nump">50,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Other operating accruals</a></td>
<td class="nump">42,970<span></span>
</td>
<td class="nump">58,459<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 155,210<span></span>
</td>
<td class="nump">$ 244,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AccountsPayableAndCapitalExpendituresCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable and Capital Expenditures, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AccountsPayableAndCapitalExpendituresCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AccruedPropertyTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Property Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AccruedPropertyTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787372272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BelowMarketLeaseNet', window );">Below-market intangible liabilities, net</a></td>
<td class="nump">$ 96,214<span></span>
</td>
<td class="nump">$ 97,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">90,979<span></span>
</td>
<td class="nump">87,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDepositLiability', window );">Security deposits</a></td>
<td class="nump">29,020<span></span>
</td>
<td class="nump">28,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swap liability</a></td>
<td class="nump">11,927<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilities', window );">Other</a></td>
<td class="nump">3,889<span></span>
</td>
<td class="nump">618<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">$ 232,029<span></span>
</td>
<td class="nump">$ 218,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BelowMarketLeaseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of leases acquired as part of a real property acquisition at below market lease rate with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BelowMarketLeaseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDepositLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents money paid in advance to protect the provider of a product or service, such as a lessor, against damage or nonpayment by the buyer or tenant (lessee) during the term of the agreement. Such damages may include physical damage to the property, theft of property, and other contractual breaches. Security deposits held may be interest or noninterest bearing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDepositLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678788090528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 09, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,361,699,000<span></span>
</td>
<td class="nump">$ 5,351,827,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DebtInstrumentExtensionPeriodForMaturityDate', window );">Extension period for maturity date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt fees</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage Notes Payable | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage Notes Payable | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.84%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | $1.5 billion Unsecured Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,000,000<span></span>
</td>
<td class="nump">385,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $350 million Unsecured Term Loan due 2023, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,494,000<span></span>
</td>
<td class="nump">349,114,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $200 million Unsecured Term Loan due 2024, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,728,000<span></span>
</td>
<td class="nump">199,670,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $300 million Unsecured Term Loan due 2025, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,941,000<span></span>
</td>
<td class="nump">299,936,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $150 million Unsecured Term Loan due 2026, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,532,000<span></span>
</td>
<td class="nump">149,495,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $200 million Unsecured Term Loan due 2027, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,397,000<span></span>
</td>
<td class="nump">199,362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $300 million Unsecured Term Loan due 2028, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,974,000<span></span>
</td>
<td class="nump">297,869,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2025, net of discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,206,000<span></span>
</td>
<td class="nump">249,115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2026, net of discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 573,410,000<span></span>
</td>
<td class="nump">571,587,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2027, net of discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,578,000<span></span>
</td>
<td class="nump">479,553,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,995,000<span></span>
</td>
<td class="nump">296,852,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior notes due 2030, net of discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 567,863,000<span></span>
</td>
<td class="nump">565,402,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior notes due 2030, net of discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,479,000<span></span>
</td>
<td class="nump">296,385,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2031, net of discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295,671,000<span></span>
</td>
<td class="nump">295,547,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636,819,000<span></span>
</td>
<td class="nump">632,693,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember', window );">Mortgages | Mortgage Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,612,000<span></span>
</td>
<td class="nump">$ 84,247,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DebtInstrumentExtensionPeriodForMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Period for Maturity Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DebtInstrumentExtensionPeriodForMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_UnsecuredCreditFacilityOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_UnsecuredCreditFacilityOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoandue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoandue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoandue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoandue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678784659792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of instruments | derivative</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.17%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJanuary152024Member', window );">Interest Rate Swap, Expiring January 15, 2024 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">1.21%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member', window );">Interest Rate Swap, Expiring May 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">2.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member', window );">Interest Rate Swap, Expiring June 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member', window );">Interest Rate Swap, Expiring December 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.84%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member', window );">Interest Rate Swap, Expiring June 1, 2027 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">4.13%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member', window );">Interest Rate Swap, Expiring December 1, 2027 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.79%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJanuary152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJanuary152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678780559008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Settled interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="num">$ (2,160)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other liabilities | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="num">(11,927)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets | Designated as hedging instrument | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="nump">$ 9,767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwaps2017And2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwaps2017And2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwaps20172018And2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwaps20172018And2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783893856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on Derivative</a></td>
<td class="nump">$ 8,541<span></span>
</td>
<td class="num">$ (5,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) loss reclassified from AOCI into income</a></td>
<td class="nump">2,284<span></span>
</td>
<td class="num">(1,086)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) loss reclassified from AOCI into income</a></td>
<td class="num">(2,284)<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on Derivative</a></td>
<td class="nump">8,541<span></span>
</td>
<td class="num">(5,159)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) loss reclassified from AOCI into income</a></td>
<td class="num">(2,433)<span></span>
</td>
<td class="nump">937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Settled treasury hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on Derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Settled treasury hedges | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) loss reclassified from AOCI into income</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Settled interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on Derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Settled interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) loss reclassified from AOCI into income</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678790271136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DerivativeNetAssetPositionAggregateFairValue', window );">Derivatives in net asset position</a></td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember', window );">Active Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</a></td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember', window );">Settled Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</a></td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DerivativeNetAssetPositionAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Net Asset Position Aggregate Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DerivativeNetAssetPositionAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678783957360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="nump">$ 16.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ConstructionActivityTotalFundingDuringthePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Construction Activity, Total Funding During the Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ConstructionActivityTotalFundingDuringthePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678779373440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward', window );"><strong>Reconciliation of the beginning and ending common stock outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares)</a></td>
<td class="nump">380,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares)</a></td>
<td class="nump">380,816,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward', window );"><strong>Reconciliation of the beginning and ending common stock outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares)</a></td>
<td class="nump">380,589,894<span></span>
</td>
<td class="nump">150,457,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">3,130<span></span>
</td>
<td class="nump">229,618,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Nonvested share-based awards, net of withheld shares (in shares)</a></td>
<td class="nump">223,405<span></span>
</td>
<td class="nump">514,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares)</a></td>
<td class="nump">380,816,429<span></span>
</td>
<td class="nump">380,589,894<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of the beginning and ending common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678781175536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Stock Transactions - Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Nov. 02, 2022</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid per common share, during the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share, during the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 15.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Performance conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 20.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Absolute TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Relative TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 22.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Performance conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 20.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Absolute TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Relative TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Operating Partnership Performance Units | Share-Based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">448,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Non-vested Stock Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">165,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Directors | Share-Based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Grant date fair value</a></td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Minimum | Non-vested Stock Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Maximum | Non-vested Stock Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember', window );">Stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282,540<span></span>
</td>
<td class="nump">415,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember', window );">Stock incentive plan | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld to pay estimated withholding taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,632<span></span>
</td>
<td class="nump">6,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options under the Employee Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average incremental shares of common stock excluded from the computation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options under the Employee Stock Option Plan | Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,042,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options under the Employee Stock Option Plan | Non-vested Stock Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityOfferingProgramAvailableForIssuance', window );">Amount remaining available for issuance under the new ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityOfferingProgramAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Offering Program Available for Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityOfferingProgramAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PercentageOfRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Restricted Stock Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PercentageOfRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_PerformanceConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_PerformanceConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_MarketCondition1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_MarketCondition1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_MarketCondition2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_MarketCondition2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=hr_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=hr_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678785258800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average Common Shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">380,796,773<span></span>
</td>
<td class="nump">150,834,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Non-vested shares (in shares)</a></td>
<td class="num">(1,956,353)<span></span>
</td>
<td class="num">(1,871,858)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">378,840,420<span></span>
</td>
<td class="nump">148,963,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan', window );">Dilutive effect of employee stock purchase plan (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">88,234<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">378,840,420<span></span>
</td>
<td class="nump">149,051,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (87,125)<span></span>
</td>
<td class="nump">$ 42,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsShareBasedCompensation', window );">Dividends paid on nonvested share-based awards</a></td>
<td class="num">(605)<span></span>
</td>
<td class="num">(605)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic', window );">Net (loss) income applicable to common stockholders - basic</a></td>
<td class="num">$ (87,730)<span></span>
</td>
<td class="nump">$ 41,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share - net income (in dollars per share)</a></td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share- net income (in dollars per share)</a></td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental common shares attributable to dilutive effect of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind dividends declared for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678784964384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)<br></strong></div></th>
<th class="th">
<div>Jan. 04, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.42%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice', window );">Stock price (in dollar per share)</a></td>
<td class="nump">$ 20.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.42%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice', window );">Stock price (in dollar per share)</a></td>
<td class="nump">$ 20.21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787942288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Summary of the activity under the incentive plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, beginning of period (in shares)</a></td>
<td class="nump">294,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">165,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(17,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod', window );">Revaluation of 2022 RSUs (net change) (in shares)</a></td>
<td class="num">(79,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, ending of period (in shares)</a></td>
<td class="nump">363,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based awards, beginning of period, Weighted average grant date fair value</a></td>
<td class="nump">$ 33.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">22.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">33.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue', window );">Probability adjustment, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">31.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based awards, ending of period, Weighted average grant date fair value</a></td>
<td class="nump">$ 28.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember', window );">Stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Summary of the activity under the incentive plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, beginning of period (in shares)</a></td>
<td class="nump">1,795,128<span></span>
</td>
<td class="nump">1,562,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">282,540<span></span>
</td>
<td class="nump">415,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(101,720)<span></span>
</td>
<td class="num">(24,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (net change) (in shares)</a></td>
<td class="num">(20,503)<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, ending of period (in shares)</a></td>
<td class="nump">1,955,445<span></span>
</td>
<td class="nump">1,951,551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Probability Adjustment In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787167440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details) - Employee stock purchase plan - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of the Employee Stock Purchase Plan activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding and exercisable, beginning of period (in shares)</a></td>
<td class="nump">340,976<span></span>
</td>
<td class="nump">348,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">255,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(3,130)<span></span>
</td>
<td class="num">(10,553)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(21,421)<span></span>
</td>
<td class="num">(25,486)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(132,999)<span></span>
</td>
<td class="num">(140,633)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding and exercisable, end of period (in shares)</a></td>
<td class="nump">183,426<span></span>
</td>
<td class="nump">427,802<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787595072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 10.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths', window );">2024</a></td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo', window );">2025</a></td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree', window );">2026</a></td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour', window );">2027</a></td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total</a></td>
<td class="nump">$ 44.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140678787191616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">CARRYING VALUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Notes and bonds payable</a></td>
<td class="nump">$ 5,361.7<span></span>
</td>
<td class="nump">$ 5,351.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Real estate notes receivable</a></td>
<td class="nump">147.3<span></span>
</td>
<td class="nump">99.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">FAIR VALUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Notes and bonds payable</a></td>
<td class="nump">5,185.0<span></span>
</td>
<td class="nump">5,149.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Real estate notes receivable</a></td>
<td class="nump">$ 146.4<span></span>
</td>
<td class="nump">$ 99.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>hr-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:hr="http://healthcarerealty.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hr-20230331.xsd" xlink:type="simple"/>
    <context id="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i79bdc2ed21874d32b1b6f9ffbc9c5869_I20230502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1f84228478ae4a859a0b69e3a29bee8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74af96c8371f491da33ef31859b5690b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1641a82fd53448279f743e919d3e08b3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i14ee4952dd5042e1985f1a054d1950b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia75cc38ea5ec4ad8850297f36dd63583_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b0a185d73934641a877bc76aa2044db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if468b8ca453d4bf19389e61cd9809e62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb2002d8c6d84f4da515c0db9530384d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6e5da7ae82734c4db38e815b5c361e35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if01ffbea98ac470eb82da6fd52cf6386_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2adb5feae81642dab43ef13b1005c686_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29d03d95236f4962848c499be4324419_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i47eddaebce784587828578e94ddc1b60_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5e911b72c3da4719a3d272ba0d92cf3e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i181797bf9c4c415f87f43a136f4c8ecb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0bdf82ba6dfa4a2ab45ab2a25b586dda_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1d5339011cdb49409add3e0359d4d234_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9fe7ed1db8704e09b2408dfbcbe34ff2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i870fd274e1024059a5692743eaf92e98_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1dd49fc556404cc88d55daa4ab3d7340_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3d5b61f7901043e3a556d968f6d61ded_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if7c65d76e0814dcabee7dac8d1342535_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i87844637281d4d8b9949441898948c60_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6d8e2030aa445ce95661811675e94d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a0ab9ea386f4d648d280a8e0986c84e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i888e6ab385484db59802ccaa138669cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i290d83ded5944529b00324bf10c29c5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icedac472c8ec4dcfb0431ac1e84e3e61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0f1ddce63b34147a4e501072582d084_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf4fe5a5fedc449b89509f79262e0912_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86534f62dd7648db9d787382c8966202_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a37fba94472444e866a3ce898b6e671_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id1c951ed7666477093b2d8cac71d81e7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3e5855b50bdc47b6a5bbbd3d256a70a0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0cf73c42f4034daf8884c9aa069853fd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8cad1329072a4ad9aed8fa84a66de166_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iba23fc68cdfa4c51b94dfc9b1cd39211_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8453ec6e13a4ca9b4aaea77eb059be6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i45b6af45f46f4248a7942a21c71bdd30_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i38c470fb138540ceae43a17b211a2504_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied1e48d84ca64c058e35c69ae07d90c4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i755c42838b7b431480fbfbdf30a6e9ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hr:RealEstatePropertiesHeldInJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i51484a2f360e4b42bdb84e7d753ea660_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:PropertyEntitiesNotDeterminedToBeVIEsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0322c2eebd454faf9eed6b856d8741ba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5aac4bb4c06647b5ad4f91577c69c51e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i82ce96e024674f9b87df4e61c55f6764_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0458b77080714c6888c6e3f362854f15_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4fee5ed06fc349219d14427a4e38fc89_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i892f855ceda549059585643902bde99c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i33a33b3d8f3f49099605a5a0d1738e6b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i12840b99f3724aff95ff5318afa01dd3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoansTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i62b0d5e420094983ab1ab22d723321e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanNorthCarolinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanFloridaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7a56f63d400c4079a7e865561ecc32b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic44363c5ccfa4dff9ff72967d841833c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5e0ace30abe440c2bd816870af7d7806_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i62b0486b528146ec8fdc0d6d9e4c4d6c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05be39577b12415cba92b235a157f559_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if8415018b6934f1cb08cc146d7ceb279_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibf0cfc90ab23411db24b52116a274e8c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i838dbabd027b451d9500ea47a7f339ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i568f996d95dc4950803db835d3ec9a81_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic3f3967d66744ae79640534476f9540f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia98275e8045c4a51b9dd61d72cdae95d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idfe566f51e494b1d8cc1a790d694cd86_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i083d3ca006554b74ba98857c37529cb4_I20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="i38dceeb615dc429ea313b8089bb30136_D20220720-20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="icb262bbfd5c64c4b80a95b4c0088494d_I20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="i2b8bd90675e2482da72656d93ecd84ff_I20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="ia43b38198f184947bc8289aeeeea08a6_I20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="i5d73087fbab144d6b3552bf9cf41f68f_D20220720-20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="i087f313f8ce8406b9f00ee7f55180463_I20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="i84e0ee7220bb44c8a851edf13b274871_D20220720-20220720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="ic08326621b774b35a49a98cb55264ae0_D20230401-20230509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <context id="ia68c69926be842d69e158e3aa65f496d_D20230310-20230310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-10</startDate>
            <endDate>2023-03-10</endDate>
        </period>
    </context>
    <context id="icc48b9d4935147f39fab2c5a1786b320_I20230310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="idf9b62f2ccf74d1caf0fe1cb85aa8f53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice4cd843d7ed430a94355ee7d8beda1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i56812fb447b14ad19ca71a303ab09954_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i07320f4bb515447592164daec5eb7b4f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia37031f8ec15470d97f1001738e8c72e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i01f64aacd4d546bb928367d1fc3b2934_I20230112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-12</instant>
        </period>
    </context>
    <context id="i725103bec26f4bffb5131168df379059_D20230112-20230112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-12</startDate>
            <endDate>2023-01-12</endDate>
        </period>
    </context>
    <context id="ia3a0a3d843eb40aaacaf37e42141819f_I20230130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-30</instant>
        </period>
    </context>
    <context id="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-30</startDate>
            <endDate>2023-01-30</endDate>
        </period>
    </context>
    <context id="i68ab3bb9fe8d450ba5d5454fae157789_I20230210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-10</instant>
        </period>
    </context>
    <context id="ibfe535f3ab724e7f8cc93404389ae2d3_D20220729-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="i8cdf6d5c68bf451d8dd949582d91f420_I20230323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-23</instant>
        </period>
    </context>
    <context id="i8a3ca7980f634d5a877d7ea584c4b463_D20230323-20230323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <context id="i2af2c84b56b24addb398070e5b1786eb_I20230330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-30</instant>
        </period>
    </context>
    <context id="ic8386a9bdaee48faab027ec1bc916259_D20230330-20230330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="i529066ab980943059fbf1ea25e1ecf1a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic5bcc13d9ac1449aafbef97302a864de_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0fbb705c06f14ee2aba7350a87fa6205_I20230330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-03-30</instant>
        </period>
    </context>
    <context id="icdfe172a798c48d69a472a992f819b18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i520bdadf3a0e4877a0654af6dea318b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iedc8351cf7d14a358450c7736f9cb778_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i916dc090ae94426d8365fc31b03034ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idf083f5601064f69b4d4536ff89ad8f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id093a3a1c949408d9c5b971d33e5ce57_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58696a25f6f645418747fe03e651cd67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12ab1a1468da462cb3ba734034491aa2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6153dc8f1005474aafde2cd37e112967_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i40d414655d314601a88d81663bcb05c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib2e5ddf6b16b48c1ba4b6ccbd0e86c5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iada6b4520347441c86e7b036a38806a3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9996d5e89ffb48608cdbb710a8391d3e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3797ac41724d4c88869e5d72d41a8977_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b8e9ac04b994ee090d110a7cb42566c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4c13532ed774effa341fc31c9a9b88a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i947183f1bc48403a94ac6a0e12abb930_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc42205d2ec44d118886e5720e43151a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if239ca1557c647539fcb388cfb1692af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e35fb4f52e34980a36f861ff287417b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1c2524e41edf4411a107a30240fcf406_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i48cbfe26eacb4823b267d3ad193c58c3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie8628a7ba5394269893e6d58812b1de8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaee5360caf654c3984323ba0ea3efdd6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibea6204a6cfe4280a12e77772723e04e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2fcf72f9e010488e953762beaa4a3236_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9641fb3901af4361a7453aa207869a13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if8faa35bf9c54ffda60fcf39d1de6969_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifb93c500efca462290474ea705de1cc7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i208a8c86222841e7aa4e2d3d1eb58ff6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic657cdc8fa32443a98553b45427e1d49_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5456995c1764da0b948401cfc09b9a0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i42ab89d4ecf44dfeb1d870f49ac25015_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05db10f2ba654b51b0c0030478bf971b_I20230509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-09</instant>
        </period>
    </context>
    <context id="ic1986a74cc37403c9b2e18925bc459c4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJanuary152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3ab4351c9c9144c7a0456de49fc1c374_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6634c65cb6af485bafe3b895bca1c259_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib55a92723cb045e5b3f7b226e366666a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i300d1ad46f444edcb5259c5aa4ad9337_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9626e0785d714a62aa74354221bfd9f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3e9005e1dd794d208a4b797ae4621183_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e64e9ed9c9e4205bdf1ad560e251d42_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwaps2017And2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24b1c53bc0034d898edcf92852e6d9c1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwaps20172018And2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i650c8e7c68644e95a14ecf31d3e81688_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i550aa973ad90483f8a3c4a0347e5a824_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib038cb82071844b18a5969f43fb847cc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i418ef205b37644f6bf094af1cdb1378e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5358b41917b54b188e9b758ea6d034d1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52ecd11079f348afb8d796b899502b99_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i343a27ce736844daa7c02c4fc4bd7e3e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0ecdde728be4819bf1b77c1ef19342c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i46a708e51b4c414fa037bdb830248ffc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie4e75ffc38cf443b8a2bb92046cf883d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i955d126813cf4d4ca1a06c68c07ebe2e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80188dd2e888438dabd7b24526b877bb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic07f754abe7f444f8948c8f16a37eeba_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib0caf5935d6d4f239926e7d14b5e7270_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:ActiveInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i862a64f8ce9a48429a007343ae162af5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:SettledInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic21e61620e9b4d199d0bd8544198530a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3247f43eeeb46f2a5e62592bb20c4af_D20221102-20221102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-11-02</startDate>
            <endDate>2022-11-02</endDate>
        </period>
    </context>
    <context id="ib953f604b4cf42b7b51ce9268a732918_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5cc16940055742359e8967874631f262_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i66c615d105954779b0ea4386c88b686c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i976d48bf9470465e96587107d27c128b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0c00c677ede345b0a56c5a63cb8ec5b8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0de73055e02748f88fb8b29c46b0f7cd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5dbd3d23d82a4283a8336822e94b019b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35005495bb2d4a14950ce05e7d3751b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if554654baa2c4fab887bd8e8ce1280d5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7d92d2b7a9d842d6a5b22b3d68c57a01_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3514f2b646db4405a1eec8c9a17c0ba3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04f3449a44e04c04843366fd629f5f2f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i479dcf12323a45868421febd4b7d7c82_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i026d56f8612c468fb9c1628088387b24_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i54f3253796ed4156b94a25fac13c6991_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic19e24e6e4d646fcacc85aeea31d807b_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i165032ae420b46b7bbba8d14fe0aba12_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3fdfd62e90e34b9f8d96116f557c9787_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iad26162143ea47dfa49d4366d8a0dba7_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i0c057c6178b345c9b3e881d858993552_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="iad942920f150409cad42db1a3f7dc7c2_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i1917ae1a54ca4c99b9c7f284e6873fa3_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i000748c9059c48ff9b5003e987126ae1_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i32164c0659084310957f7adb36c144a1_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i0eb8d9ba9fcb4cd3a86450f082750fed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9eb54b7f31d5417da8f8112e9b8c756e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24141fc9eb4b43ab8baf38ba6ac04b2e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i896e8bc913c24d9fb4ecb2ce94992aee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iacf810aaefd344b08133b9065f0521e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6b5e1cd5751f4fd29eaceeb6e25007d8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b140e579a2c4968935d45253779bfed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i786dc6592f45460895333b89bf32a577_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="property">
        <measure>hr:property</measure>
    </unit>
    <unit id="state">
        <measure>hr:state</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="building">
        <measure>hr:building</measure>
    </unit>
    <unit id="variable_interest_entity">
        <measure>hr:variable_interest_entity</measure>
    </unit>
    <unit id="note_receivable">
        <measure>hr:note_receivable</measure>
    </unit>
    <unit id="joint_venture">
        <measure>hr:joint_venture</measure>
    </unit>
    <unit id="financing_receivable">
        <measure>hr:financing_receivable</measure>
    </unit>
    <unit id="disposition_transaction">
        <measure>hr:disposition_transaction</measure>
    </unit>
    <unit id="land_parcel">
        <measure>hr:land_parcel</measure>
    </unit>
    <unit id="lease">
        <measure>hr:lease</measure>
    </unit>
    <unit id="derivative">
        <measure>hr:derivative</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM180LTEtMS0xLTE1ODU1Mg_5b63d404-babf-462f-80f2-797a804e76f2">0001360604</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM181LTEtMS0xLTE1ODU1Mg_046bffd5-d57e-45e5-9acb-7c3ac5170140">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM185LTEtMS0xLTE1ODU1Mg_5085633e-e2b4-4857-95ef-610d640620ac">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM18xMC0xLTEtMS0xNTg1NTI_095e12fb-e490-4a44-988f-906c67328116">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80L2ZyYWc6MGVjODQ4NzhhMzE4NDQ2MWI4ZjljNzRkZWE1NDdhZmQvdGFibGU6ZmQ5OTUwMzgwZDk0NDZiNjg4MGE5NjA3YTEwNGUxYjMvdGFibGVyYW5nZTpmZDk5NTAzODBkOTQ0NmI2ODgwYTk2MDdhMTA0ZTFiM18xMS0xLTEtMS0xNTg1NTI_21664c4b-a8d2-4c27-8c4e-669694258ee4">false</dei:AmendmentFlag>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0wLTEtMS0xNTg1NTI_40306376-6a4c-4b48-9029-df11dce3de2c">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0wLTEtMS0xNTg1NTI_c64a5623-d436-4d99-b18b-fd81af6432d4">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0c00c677ede345b0a56c5a63cb8ec5b8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI3NQ_6ca16896-73b0-44f5-a3a0-a5bc0b29e940">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTky_cfb0a455-cf66-4b4a-a712-d357235f7200">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWNiMjViODEzYjhkNGJkM2FjM2I4MDNiOGFhY2ExYjEvdGFibGVyYW5nZTo1Y2IyNWI4MTNiOGQ0YmQzYWMzYjgwM2I4YWFjYTFiMV8xLTAtMS0xLTE1ODU1Mg_37d65366-e7fa-4832-9b42-2b11b53b1c28">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWNiMjViODEzYjhkNGJkM2FjM2I4MDNiOGFhY2ExYjEvdGFibGVyYW5nZTo1Y2IyNWI4MTNiOGQ0YmQzYWMzYjgwM2I4YWFjYTFiMV8yLTItMS0xLTE1ODU1Mg_ec1da167-b223-47e0-aff5-e6c2b113b390">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWNiMjViODEzYjhkNGJkM2FjM2I4MDNiOGFhY2ExYjEvdGFibGVyYW5nZTo1Y2IyNWI4MTNiOGQ0YmQzYWMzYjgwM2I4YWFjYTFiMV80LTAtMS0xLTE1ODU1Mg_b9090e5a-eb7d-4d9b-8920-2c85d84f57a8">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg4_004dabde-6416-4177-8b7c-83defcd15f3b">001-35568</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg5_93310f2f-09b9-4f72-a2d3-128514bd01b4">HEALTHCARE REALTY TRUST INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MzFiM2NhODAwOTkxNGUzZjlhODNlMzYwMmZhOWQzYWIvdGFibGVyYW5nZTozMWIzY2E4MDA5OTE0ZTNmOWE4M2UzNjAyZmE5ZDNhYl8wLTAtMS0xLTE1ODU1Mg_88c3cb53-750b-49bc-8208-6d3912d1e754">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MzFiM2NhODAwOTkxNGUzZjlhODNlMzYwMmZhOWQzYWIvdGFibGVyYW5nZTozMWIzY2E4MDA5OTE0ZTNmOWE4M2UzNjAyZmE5ZDNhYl8wLTItMS0xLTE1ODU1Mg_de791eac-c9a1-4a12-a009-1f0bbeffe3ac">20-4738467</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTkx_abfbc504-6f9d-4a8f-816c-7bf11aa9c483">3310 West End Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg1_84c12b27-ff29-418e-80aa-9ae426b5a995">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTkz_dfc10ba2-5e10-4824-90ed-d89f31d90b4d">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg2_06831646-805b-4f86-b09c-85656231b3fd">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTg3_619aa54c-2d25-45b3-bdd7-fb9ca6b1cc4c">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTk0_e2f97c36-d2fb-4668-86c8-83061592e017">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTk1_404bfed3-f3c4-4b7d-80dd-ee09149fc41f">269-8175</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MTQ5ZjI2YjAzMzc5NDYwYzk1NDY5ZTM0NTVhYzZhN2MvdGFibGVyYW5nZToxNDlmMjZiMDMzNzk0NjBjOTU0NjllMzQ1NWFjNmE3Y18xLTAtMS0xLTE1ODU1Mg_e3303f09-ab3e-4005-8b4e-5a238b76f80b">Class A Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MTQ5ZjI2YjAzMzc5NDYwYzk1NDY5ZTM0NTVhYzZhN2MvdGFibGVyYW5nZToxNDlmMjZiMDMzNzk0NjBjOTU0NjllMzQ1NWFjNmE3Y18xLTItMS0xLTE1ODU1Mg_6c9abe29-a412-41ac-909e-253b69406a3e">HR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6MTQ5ZjI2YjAzMzc5NDYwYzk1NDY5ZTM0NTVhYzZhN2MvdGFibGVyYW5nZToxNDlmMjZiMDMzNzk0NjBjOTU0NjllMzQ1NWFjNmE3Y18xLTQtMS0xLTE1ODU1Mg_87633ac3-fba1-4d10-8eaa-ecd18fd733ff">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NWY2YThiNmIxODQwNGJlMmI4Y2RhMzE4Y2YyZTk5MDYvdGFibGVyYW5nZTo1ZjZhOGI2YjE4NDA0YmUyYjhjZGEzMThjZjJlOTkwNl8wLTItMS0xLTE1ODU1Mg_35d51315-e0b8-4b65-9dac-30d0a0f980e3">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6YWE5ODNhZjFkZDBjNDY0N2FiN2FkZTA4NjEzN2FkZTYvdGFibGVyYW5nZTphYTk4M2FmMWRkMGM0NjQ3YWI3YWRlMDg2MTM3YWRlNl8wLTItMS0xLTE1ODU1Mg_f0d41c6e-1c6d-4622-a82b-fb29ad3206f9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6ZjI4NWZkMDUwNTE0NDg5OThlZDQwYzYzN2RhZjU0NGUvdGFibGVyYW5nZTpmMjg1ZmQwNTA1MTQ0ODk5OGVkNDBjNjM3ZGFmNTQ0ZV8wLTItMS0xLTE1ODU1Mg_f1a1ec67-4af7-4af6-8b81-a779c7923204">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NzE5OTYwZDdkMjMwNDAxNWEzYjkzMTQwOTBiN2ZhMjkvdGFibGVyYW5nZTo3MTk5NjBkN2QyMzA0MDE1YTNiOTMxNDA5MGI3ZmEyOV8wLTEtMS0xLTE1ODU1Mg_2aa28a0b-0903-4a45-a7ac-c7d52bdcbc8f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6NzE5OTYwZDdkMjMwNDAxNWEzYjkzMTQwOTBiN2ZhMjkvdGFibGVyYW5nZTo3MTk5NjBkN2QyMzA0MDE1YTNiOTMxNDA5MGI3ZmEyOV8wLTMtMS0xLTE1ODU1Mg_3dacaa27-99ec-4ad3-86fd-ecd7fd4dcece">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6OTAzZDI4MTIxODUxNDI5ODliNTY2NjllZjU4ZjMwM2IvdGFibGVyYW5nZTo5MDNkMjgxMjE4NTE0Mjk4OWI1NjY2OWVmNThmMzAzYl8wLTEtMS0xLTE1ODU1Mg_a05fe72e-cc87-41b3-8f3d-36842dcc20fd">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGFibGU6ZTBkZjM3ZWY1YTYyNGJjMDhkNzIxMTI3OGRjYmQwZDIvdGFibGVyYW5nZTplMGRmMzdlZjVhNjI0YmMwOGQ3MjExMjc4ZGNiZDBkMl8wLTEtMS0xLTE1ODU1Mg_9ec5116c-a2ab-4d0a-aa4e-cd49c4cdd079">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i79bdc2ed21874d32b1b6f9ffbc9c5869_I20230502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8xL2ZyYWc6ODQ5NGU4YjA0Nzc5NDdhOGFlMDlhMjRiMDZkY2Y5MTgvdGV4dHJlZ2lvbjo4NDk0ZThiMDQ3Nzk0N2E4YWUwOWEyNGIwNmRjZjkxOF8xOTQ4_23a6ea0d-3063-40d3-babd-da255fc6160a"
      unitRef="shares">380816937</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Land
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMy0xLTEtMS0xNTg1NTI_c6639493-c181-4781-a215-f556dd199944"
      unitRef="usd">1412805000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMy0yLTEtMS0xNTg1NTI_a3df23b9-30d7-4a77-962f-7d41c9c5a764"
      unitRef="usd">1439798000</us-gaap:Land>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNC0xLTEtMS0xNTg1NTI_e796b76d-e623-435a-ae53-e157aacc22cd"
      unitRef="usd">11196297000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNC0yLTEtMS0xNTg1NTI_03c76dd0-2b76-479d-959f-9e6444af0530"
      unitRef="usd">11332037000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNS0xLTEtMS0xNTg1NTI_55e18a9e-5b80-496b-a4a7-53f633e9fd01"
      unitRef="usd">929008000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNS0yLTEtMS0xNTg1NTI_3a2cda13-0e8c-4ada-aca2-37305d152053"
      unitRef="usd">959998000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <hr:PersonalProperty
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNi0xLTEtMS0xNTg1NTI_cfb428fa-db2b-45f2-b884-ba9d53db460f"
      unitRef="usd">11945000</hr:PersonalProperty>
    <hr:PersonalProperty
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNi0yLTEtMS0xNTg1NTI_84bf7934-e053-47d9-a42a-6f2b77aa3b5d"
      unitRef="usd">11907000</hr:PersonalProperty>
    <us-gaap:NotesReceivableNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNy0xLTEtMS0xNTg1NTI_b8153e02-31b3-4e87-ab1d-95e28c6e6159"
      unitRef="usd">120692000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNy0yLTEtMS0xNTg1NTI_fa19e92e-093d-41e9-94e5-b935af229b45"
      unitRef="usd">120236000</us-gaap:NotesReceivableNet>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOC0xLTEtMS0xNTg1NTI_3090b890-e370-47a2-b9ba-3e5092645b5b"
      unitRef="usd">83420000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOC0yLTEtMS0xNTg1NTI_d0d1e643-c6a8-4e94-8e99-5d02d63f2af9"
      unitRef="usd">83824000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:DevelopmentInProcess
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOS0xLTEtMS0xNTg1NTI_9f6b6541-4090-4191-9c3b-5e4cc119779a"
      unitRef="usd">42615000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfOS0yLTEtMS0xNTg1NTI_e1ffe3f8-c697-4dbc-b45e-b52a1672dc0f"
      unitRef="usd">35560000</us-gaap:DevelopmentInProcess>
    <us-gaap:LandAvailableForDevelopment
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTAtMS0xLTEtMTU4NTUy_ddf5be8b-dd33-4103-b949-522f5b72f033"
      unitRef="usd">69575000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:LandAvailableForDevelopment
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTAtMi0xLTEtMTU4NTUy_2497dabd-d6db-4c13-926b-8973f21e0c1c"
      unitRef="usd">74265000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:RealEstateInvestmentPropertyAtCost
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTEtMS0xLTEtMTU4NTUy_1699f234-b087-423a-9dc1-14135fd61fb4"
      unitRef="usd">13866357000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAtCost
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTEtMi0xLTEtMTU4NTUy_a26353f5-4010-4a97-9ea4-0b1002ed810a"
      unitRef="usd">14057625000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTItMS0xLTEtMTU4NTUy_d90736e3-a5e8-4566-81b4-6649fdbb1e9c"
      unitRef="usd">1810093000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTItMi0xLTEtMTU4NTUy_8da1b87a-e938-44dd-972a-41d0a0e0685d"
      unitRef="usd">1645271000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTMtMS0xLTEtMTU4NTUy_e692a36f-c9e1-4344-9a4f-ae65c8dffe4e"
      unitRef="usd">12056264000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTMtMi0xLTEtMTU4NTUy_64ea4b8a-0765-48f5-b74c-b8475293524d"
      unitRef="usd">12412354000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTQtMS0xLTEtMTU4NTUy_dfb07543-93bf-4a94-999b-6bfc25ccfd20"
      unitRef="usd">49941000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTQtMi0xLTEtMTU4NTUy_0899e774-3d7a-4532-b4c4-bda83d55090c"
      unitRef="usd">60961000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTctMS0xLTEtMTU4NTUy_393c2cac-4ed6-4390-9bb1-aba04efda5c4"
      unitRef="usd">3579000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTctMi0xLTEtMTU4NTUy_c0897e06-4b2d-4da8-a9a2-256c079485c5"
      unitRef="usd">18893000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTgtMS0xLTEtMTU4NTUy_e449c823-9d2c-4ec3-8d92-08740063d4f5"
      unitRef="usd">336112000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTgtMi0xLTEtMTU4NTUy_06387a0a-74c1-4a9c-a4ab-09ae7c665428"
      unitRef="usd">336983000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTktMS0xLTEtMTU4NTUy_46a7d1d2-5c11-4555-bea0-5c8e8516f9fe"
      unitRef="usd">327746000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMTktMi0xLTEtMTU4NTUy_5b23ffe9-1027-44de-af28-fc4e7d538665"
      unitRef="usd">327248000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjAtMS0xLTEtMTU4NTUy_ee0d7404-e8ac-4cbc-b0f1-a12b78c1d9a2"
      unitRef="usd">260822000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjAtMi0xLTEtMTU4NTUy_cf789062-7a04-49eb-8d20-b8bfcdfb1a8e"
      unitRef="usd">223202000</us-gaap:Goodwill>
    <us-gaap:OtherAssets
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjEtMS0xLTEtMTU5NzU2_a8704174-679c-421d-8060-eaf8fc4c8a11"
      unitRef="usd">534420000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjEtMi0xLTEtMTU4NTUy_9087d373-fc4b-464e-b9ac-e1ef615d566f"
      unitRef="usd">469990000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjItMS0xLTEtMTU4NTUy_afa2167f-223b-4dad-b6d0-dafc67dbd647"
      unitRef="usd">13568884000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjItMi0xLTEtMTU4NTUy_9a4f4d3e-b1e9-465c-a3d3-dc7049a220be"
      unitRef="usd">13849631000</us-gaap:Assets>
    <us-gaap:LongTermDebt
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjYtMS0xLTEtMTU4NTUy_bc803403-5051-41ec-9994-c4e919031490"
      unitRef="usd">5361699000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjYtMi0xLTEtMTU4NTUy_ae9fc30b-1f7d-4782-aac6-5a459554d874"
      unitRef="usd">5351827000</us-gaap:LongTermDebt>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjctMS0xLTEtMTU4NTUy_3b3aa480-bc8a-465f-ad45-fd2feae73a5c"
      unitRef="usd">155210000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjctMi0xLTEtMTU4NTUy_02b4904c-5873-46b2-b88a-8a3e88fd2cfe"
      unitRef="usd">244033000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjgtMS0xLTEtMTU4NTUy_c77bf960-922b-4107-832b-42d75d05f5f7"
      unitRef="usd">277000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjgtMi0xLTEtMTU4NTUy_8d70a995-1d53-4549-9308-4d6c56a555ce"
      unitRef="usd">437000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjktMS0xLTEtMTU4NTUy_68435a2f-54b5-41e9-825a-20828f4c0952"
      unitRef="usd">279637000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMjktMi0xLTEtMTU4NTUy_07dbbd54-a8e2-4270-8daf-204d9b34bd50"
      unitRef="usd">279895000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzAtMS0xLTEtMTU4NTUy_3e065015-2a56-4bcf-8130-e280a3861611"
      unitRef="usd">73193000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzAtMi0xLTEtMTU4NTUy_89f1120b-5b5c-40ba-b4b8-06c6152f3061"
      unitRef="usd">72939000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OtherLiabilities
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzEtMS0xLTEtMTU4NTUy_fbd95560-f691-466e-8a7c-b4ea5b9c56cf"
      unitRef="usd">232029000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzEtMi0xLTEtMTU4NTUy_0316ba12-ba12-4447-8818-4eae3b285f68"
      unitRef="usd">218668000</us-gaap:OtherLiabilities>
    <us-gaap:Liabilities
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzItMS0xLTEtMTU4NTUy_84253429-27b5-46f8-a8f6-2d4d42fc3c3c"
      unitRef="usd">6102045000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzItMi0xLTEtMTU4NTUy_60f8d9cb-a8b4-4505-a0d2-fc848fc45082"
      unitRef="usd">6167799000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzMtMS0xLTEtMTU4NTUy_241811cb-c059-4d2b-b30c-9fb2aac3323e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzMtMi0xLTEtMTU4NTUy_3054bae9-6d14-417c-a372-248c5dcca376"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzQtMS0xLTEtMTczMDU2_61f5bf2b-902b-4c92-afe9-6463a93f8a26"
      unitRef="usd">2000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzQtMi0xLTEtMTczMDY1_9135933a-2a35-484f-84ef-69319dcc2fa8"
      unitRef="usd">2014000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfMjE_1efb1316-62d5-4fbf-baea-17c1c9fe5feb"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfMjE_c94579a3-4768-4db4-b293-de5bf88fec7c"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNDU_219385bd-af9d-459f-b116-44dc8f0bc99a"
      unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNDU_f74cfaed-f92d-42ab-8aff-c626cbee207f"
      unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_1349f189-91c0-46a2-bb10-53001ca82949"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_7ffe9bda-6e84-4f1c-a715-60f1c2542f02"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_a012d737-4ee6-4f4e-8ad7-23563c51d42c"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246OGNiYzg0NWI3Zjc2NDQ3ZWI4YjI3OWU2Nzc2ZDRiZDVfNjc_b5d9486a-f2a2-4541-9a9f-9e56943c7fcc"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMS0xLTEtMTU4NTUy_164d942b-2eb2-4040-a49e-858bd23f2daa"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzUtMi0xLTEtMTU4NTUy_a8592f19-2238-4250-a66b-1ed661426aaf"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfMjY_e42160d9-6315-48fc-a8b6-de95068c4471"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfMjY_f59288cd-271f-4529-a188-3c0d67909600"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNTA_855c0e91-13f5-49e2-9ab5-3af44fca0b9f"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNTA_ecc99c74-ac88-413c-9e22-d1905ad0e1fe"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzI_70124e60-7080-4de6-8763-6a24f78e2cc5"
      unitRef="shares">380816000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzI_cc2ed2ad-b8ab-4b03-9952-c6dc7a11de5d"
      unitRef="shares">380816000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzk_478f57fb-f0e0-459b-85d5-7f8a37fc644a"
      unitRef="shares">380590000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjE1Y2Q5MzM1ODAxNDQ2NWI0MTY3NmExNjhmYjk0ZGNfNzk_5e0e4109-b83c-4b65-b8d0-371e392723a5"
      unitRef="shares">380590000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMS0xLTEtMTU4NTUy_52d150a6-de85-43d7-9c73-8879cd3cc5ad"
      unitRef="usd">3808000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzYtMi0xLTEtMTU4NTUy_5dfa93df-95ba-4236-b601-a79e7687cc66"
      unitRef="usd">3806000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzctMS0xLTEtMTU4NTUy_92b0c6a6-2806-4640-8d21-f4f16e568208"
      unitRef="usd">9591194000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzctMi0xLTEtMTU4NTUy_36c8db95-3f25-4e72-b4d6-6626870cbbf0"
      unitRef="usd">9587637000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzgtMS0xLTEtMTU4NTUy_7f5e28ec-47fc-47b9-8df1-aa087001f34f"
      unitRef="usd">8554000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzgtMi0xLTEtMTU4NTUy_a7fa4da7-6909-42e8-90a5-49db0becd86d"
      unitRef="usd">-2140000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <hr:CumulativeNetIncomeAttributableToCommonStockholders
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzktMS0xLTEtMTU4NTUy_180def0d-61c4-4573-a95e-bda7097b72af"
      unitRef="usd">1219930000</hr:CumulativeNetIncomeAttributableToCommonStockholders>
    <hr:CumulativeNetIncomeAttributableToCommonStockholders
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfMzktMi0xLTEtMTU4NTUy_dfbdfb6a-3aa9-4622-b125-53e2cd3ad671"
      unitRef="usd">1307055000</hr:CumulativeNetIncomeAttributableToCommonStockholders>
    <us-gaap:CumulativeDividends
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDAtMS0xLTEtMTU4NTUy_c1b5797a-aaf2-4cd4-84fa-56d3a0696e5d"
      unitRef="usd">3447750000</us-gaap:CumulativeDividends>
    <us-gaap:CumulativeDividends
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDAtMi0xLTEtMTU4NTUy_a4356598-335d-49bd-8c7d-0801b4b3a98b"
      unitRef="usd">3329562000</us-gaap:CumulativeDividends>
    <us-gaap:StockholdersEquity
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDEtMS0xLTEtMTU4NTUy_95a91f03-e484-4ece-97c8-4136712c8cae"
      unitRef="usd">7358628000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDEtMi0xLTEtMTU4NTUy_e5feaf4a-f6c5-4910-b5f5-53dcd89d237b"
      unitRef="usd">7571076000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDItMS0xLTEtMTU4NTUy_5c2d7b3c-3ede-4922-ae4e-e1c8a80f46e6"
      unitRef="usd">106211000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDItMi0xLTEtMTU4NTUy_de7808a8-4187-4a4a-9df7-de084447a46b"
      unitRef="usd">108742000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDMtMS0xLTEtMTU4NTUy_b7ea6524-c0f7-40af-9f13-1f3e846ab222"
      unitRef="usd">7464839000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDMtMi0xLTEtMTU4NTUy_8a16784e-1f22-494c-afba-b0cc2e55528c"
      unitRef="usd">7679818000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDQtMS0xLTEtMTU4NTUy_48592c67-d38c-44dd-831e-e2feabe2464d"
      unitRef="usd">13568884000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yMi9mcmFnOmM3Y2I4NTA2NTNiZDRkNDk5NzUxZTVhZGJkNzMxYWQxL3RhYmxlOmU3YTcyZTg5YzdiYzQ4MjFhZGRhNGE0NzZhMmFkZjRlL3RhYmxlcmFuZ2U6ZTdhNzJlODljN2JjNDgyMWFkZGE0YTQ3NmEyYWRmNGVfNDQtMi0xLTEtMTU4NTUy_9d509371-4bef-45ac-8af3-5ad259152720"
      unitRef="usd">13849631000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMy0xLTEtMS0xNTg1NTI_e92a349a-9ce1-46e9-9524-8ed51005c4cd"
      unitRef="usd">324093000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMy0yLTEtMS0xNTg1NTI_d5d9e8b7-3a7a-4096-8fce-3e5005b9bea2"
      unitRef="usd">138489000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNC0xLTEtMS0xNTg1NTI_3f2d90d6-2660-4c5c-990e-dbe82ba91085"
      unitRef="usd">4214000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNC0yLTEtMS0xNTg1NTI_91bf66fb-c859-4706-8027-4a96bd00ab38"
      unitRef="usd">1930000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0xLTEtMS0xNTg1NTI_367036a4-9136-4818-8264-8c71cd2e58d8"
      unitRef="usd">4618000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNi0yLTEtMS0xNTg1NTI_792d14ed-6bd1-469f-a4b1-bc1b6c0da8ae"
      unitRef="usd">2475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNy0xLTEtMS0xNTg1NTI_41c66b04-3e17-481a-beb3-ab932bbcca91"
      unitRef="usd">332925000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNy0yLTEtMS0xNTg1NTI_2581ec8d-d523-4866-b64f-2a4f722ea20b"
      unitRef="usd">142894000</us-gaap:Revenues>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfOS0xLTEtMS0xNTg1NTI_3c4c1841-cfc9-400b-99d3-7419efbdb05f"
      unitRef="usd">122040000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfOS0yLTEtMS0xNTg1NTI_e564a425-72c6-4200-9f5b-6352512bf0fd"
      unitRef="usd">57464000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTAtMS0xLTEtMTU4NTUy_6e0df6f4-72b9-4795-81d9-84bb6290dcf7"
      unitRef="usd">14935000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTAtMi0xLTEtMTU4NTUy_2cc0330e-ffa5-40f9-824a-97b3b9df29ee"
      unitRef="usd">11036000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AcquisitionCosts
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTEtMS0xLTEtMTU4NTUy_bec59a7a-4f44-4ba6-8203-a8f372459598"
      unitRef="usd">287000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTEtMi0xLTEtMTU4NTUy_cd26fffd-e404-4898-a719-63a3efe23bdb"
      unitRef="usd">1303000</us-gaap:AcquisitionCosts>
    <hr:MergerRelatedCosts
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTItMS0xLTEtMTU4NTUy_21f754e9-10e8-4c03-ada3-1d8a939f1165"
      unitRef="usd">4855000</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTItMi0xLTEtMTU4NTUy_c4bd0dfd-6cbf-4883-bfe5-d868e6e01e53"
      unitRef="usd">6116000</hr:MergerRelatedCosts>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTMtMS0xLTEtMTU4NTUy_ec7f0fa2-e534-49b2-ae66-b60a5dd424a2"
      unitRef="usd">184479000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTMtMi0xLTEtMTU4NTUy_2a7562f3-983a-4955-96e2-d54ccf665e37"
      unitRef="usd">54041000</us-gaap:DepreciationAndAmortization>
    <hr:OperatingExpensesandCostofGoodsSold
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTYtMS0xLTEtMTU4NTUy_a16498d3-1590-496a-a625-24089504c447"
      unitRef="usd">326596000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTYtMi0xLTEtMTU4NTUy_7ed06c89-8b1f-4328-bcc1-c4ceee09efdd"
      unitRef="usd">129960000</hr:OperatingExpensesandCostofGoodsSold>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTgtMS0xLTEtMTU4NTUy_ff97e0e9-34ab-455b-b022-ea2179d6d785"
      unitRef="usd">1007000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTgtMi0xLTEtMTU4NTUy_f4ab2853-038c-4731-98ea-a909f3021b83"
      unitRef="usd">44784000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:InterestExpense
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTktMS0xLTEtMTU4NTUy_00dc63f1-db8a-4495-ae81-0ca38ec989bb"
      unitRef="usd">63759000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMTktMi0xLTEtMTU4NTUy_510afbb7-3650-45f4-8ac9-2a8099bdee30"
      unitRef="usd">13661000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjAtMS0xLTEtMTU4NTUy_c04e7872-ee53-4067-a2fd-17cfefe14225"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjAtMi0xLTEtMTU4NTUy_44668297-f04a-4136-98d5-b3c934af5ca9"
      unitRef="usd">-1429000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ImpairmentOfRealEstate
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjItMS0xLTEtMTU4NTUy_3d2f4daa-568c-4b42-9f9d-ea4968a5f624"
      unitRef="usd">31422000</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:ImpairmentOfRealEstate
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjItMi0xLTEtMTU4NTUy_222ae55d-3515-4638-9ab9-df3feb9865c9"
      unitRef="usd">-25000</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjMtMS0xLTEtMTU4NTUy_c46c7518-3284-4ab9-aa52-8b463c1f7011"
      unitRef="usd">-780000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjMtMi0xLTEtMTU4NTUy_f050df2d-5eea-4046-9419-2d44129db885"
      unitRef="usd">-345000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjQtMS0xLTEtMTU4NTUy_fdad30ff-d164-4862-b3b4-24e4e9abd783"
      unitRef="usd">547000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjQtMi0xLTEtMTU4NTUy_dd356d44-29d6-4f2c-aaf8-2b4b0cef903e"
      unitRef="usd">-81000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjUtMS0xLTEtMTU4NTUy_f02d6d82-b28f-4406-8ac5-07431eb19792"
      unitRef="usd">-94407000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMjUtMi0xLTEtMTU4NTUy_23df8e5e-7a0c-4c5c-8266-835f3478856d"
      unitRef="usd">29293000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:ProfitLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzItMS0xLTEtMTU4NTUy_2b7cdb89-fcad-44b5-8b90-0a2e71fee35e"
      unitRef="usd">-88078000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzItMi0xLTEtMTU4NTUy_9fefed9a-38ef-4f33-97f3-8f959bdd23a8"
      unitRef="usd">42227000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzMtMS0xLTEtMTU4NTUy_3126ac08-f746-4d4e-9432-9cc4d357d462"
      unitRef="usd">-953000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzMtMi0xLTEtMTU4NTUy_710263a2-7a3f-45ee-b6e5-0b296ed1f687"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzQtMS0xLTEtMTU4NTUy_01c527f5-866a-4d69-869d-4697dc5d3149"
      unitRef="usd">-87125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzQtMi0xLTEtMTU4NTUy_1da45b59-d927-42b1-aded-98af24770982"
      unitRef="usd">42227000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzgtMS0xLTEtMTU4NTUy_7f164331-53f2-4d9e-bd52-e05b87b6278f"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfMzgtMi0xLTEtMTU4NTUy_4f980585-e5ab-4fb5-9dcf-93b7f89e2aef"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDEtMS0xLTEtMTU4NTUy_a0083771-1e47-494f-9164-2b10cb876d05"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDEtMi0xLTEtMTU4NTUy_40b6ec3f-488b-4354-8af3-20c9306d6598"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDMtMS0xLTEtMTU4NTUy_acd3c4c3-d6af-4ef6-bfbe-81eae9f1ee07"
      unitRef="shares">378840000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDMtMi0xLTEtMTU4NTUy_fd3058ef-444f-4d85-8991-5645e789b29e"
      unitRef="shares">148963000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDQtMS0xLTEtMTU4NTUy_f6ecaf06-48ee-4f51-9ef3-9580a2edb868"
      unitRef="shares">378840000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8yOC9mcmFnOjYxYzgyYWU4YjNmYTRiNWY5OWUxYzM1YzUxODExYTcyL3RhYmxlOmE4MmRiNjYzYWM1ODQ0ZjM4NGYyMWFhZmYyZDMyM2YyL3RhYmxlcmFuZ2U6YTgyZGI2NjNhYzU4NDRmMzg0ZjIxYWFmZjJkMzIzZjJfNDQtMi0xLTEtMTU4NTUy_59b2b956-0653-443a-9a7e-ef3b8f9b2c7b"
      unitRef="shares">149051000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMi0xLTEtMS0xNTg1NTI_2b7cdb89-fcad-44b5-8b90-0a2e71fee35e"
      unitRef="usd">-88078000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMi0yLTEtMS0xNTg1NTI_9fefed9a-38ef-4f33-97f3-8f959bdd23a8"
      unitRef="usd">42227000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfNy0xLTEtMS0xNTg1NTI_471de02c-afaa-43e7-8944-d775040e0fd8"
      unitRef="usd">2284000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfNy0yLTEtMS0xNTg1NTI_fd32510e-2bd8-48d0-a24c-f73e9cb9e2e9"
      unitRef="usd">-1086000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1641a82fd53448279f743e919d3e08b3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfOC0xLTEtMS0xNTg1NTI_f561489b-328c-4e4e-a6a0-b2b8f54b3d25"
      unitRef="usd">-8541000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i14ee4952dd5042e1985f1a054d1950b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfOC0yLTEtMS0xNTg1NTI_a7275e45-c5fc-483b-8353-d35301db87ac"
      unitRef="usd">5159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTAtMS0xLTEtMTU4NTUy_466442fb-8883-41e7-9827-082570a328dc"
      unitRef="usd">-10825000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTAtMi0xLTEtMTU4NTUy_94386271-33ac-4541-aa4c-e452c64b2300"
      unitRef="usd">6245000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTEtMS0xLTEtMTU4NTUy_6d7a1dbe-f6fb-467b-8830-349b1bfd2c1a"
      unitRef="usd">-98903000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTEtMi0xLTEtMTU4NTUy_e54cfa05-9c3d-498f-a33e-ed93c9a7c97d"
      unitRef="usd">48472000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTItMS0xLTEtMTU4NTUy_3aa462e0-876b-49dd-8fbc-e2358c668958"
      unitRef="usd">-1084000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTItMi0xLTEtMTU4NTUy_065b9a50-d7f0-4d85-9ac4-bd0607bcb7f8"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTMtMS0xLTEtMTU4NTUy_5f7a47a6-0951-4602-a192-b1eb4852d915"
      unitRef="usd">-97819000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zMS9mcmFnOmY3NjkxYzYxYjNiODQ5YThiNWQwOWRkMTc0ZjY0MjY0L3RhYmxlOjg2NDE4NWQ5OWQ1YTRiNTA4OGU5ZDFhYzcyNDY5OWNhL3RhYmxlcmFuZ2U6ODY0MTg1ZDk5ZDVhNGI1MDg4ZTlkMWFjNzI0Njk5Y2FfMTMtMi0xLTEtMTU4NTUy_a91c8e21-e6bf-4679-9dcf-33005833cb5d"
      unitRef="usd">48472000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia75cc38ea5ec4ad8850297f36dd63583_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS0xLTEtMS0xNTg1NTI_00315c69-8fc6-4fbf-94e6-dabac7eebfa8"
      unitRef="usd">3806000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b0a185d73934641a877bc76aa2044db_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS0yLTEtMS0xNTg1NTI_42bf9091-fc80-4d3d-83d6-2cd64af18824"
      unitRef="usd">9587637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if468b8ca453d4bf19389e61cd9809e62_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS0zLTEtMS0xNTg1NTI_cb931b47-7172-45ce-9da6-c3f70ade8623"
      unitRef="usd">2140000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb2002d8c6d84f4da515c0db9530384d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS00LTEtMS0xNTg1NTI_929c655e-edf8-4029-8a76-b2fc00fc2d8a"
      unitRef="usd">1307055000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e5da7ae82734c4db38e815b5c361e35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS01LTEtMS0xNTg1NTI_deabf90f-cf27-4c77-8dec-2dc692885f51"
      unitRef="usd">-3329562000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if01ffbea98ac470eb82da6fd52cf6386_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS02LTEtMS0xNTg1NTI_acfec3ee-169a-415e-af4a-af0ccae171eb"
      unitRef="usd">7571076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2adb5feae81642dab43ef13b1005c686_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS03LTEtMS0xNTg1NTI_5c23ada8-dbbf-4526-b26e-977038ee64b0"
      unitRef="usd">108742000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMS04LTEtMS0xNTg1NTI_254c66e1-be49-488b-a077-596d5300861a"
      unitRef="usd">7679818000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i29d03d95236f4962848c499be4324419_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMi0yLTEtMS0xNTg1NTI_2730ebcf-956f-4dde-864d-4a539529fa40"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMi02LTEtMS0xNTg1NTI_57c50924-10a5-43a0-9f77-2b22e05ab94d"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMi04LTEtMS0xNTg1NTI_bfe88237-b2b8-4e67-9454-336e3f6af728"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS0xLTEtMS0xNTg1NTI_d52a845e-d606-40e4-9d7a-375708b7a532"
      unitRef="usd">1000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i29d03d95236f4962848c499be4324419_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS0yLTEtMS0xNTg1NTI_537ce650-6ee6-466d-8b86-603130c51ad0"
      unitRef="usd">1483000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS02LTEtMS0xNTg1NTI_32bd58ad-1f60-486e-8ad6-2b8c4ae2d75c"
      unitRef="usd">1484000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNS04LTEtMS0xNTg1NTI_08256c11-1119-4552-9605-d8b6425edca9"
      unitRef="usd">1484000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi0xLTEtMS0xNTg1NTI_3d4c452e-8c8f-441b-bd8a-914ee886ae6f"
      unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i29d03d95236f4962848c499be4324419_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi0yLTEtMS0xNTg1NTI_7f36270b-1156-4d77-9a85-4deffd33cfb8"
      unitRef="usd">4989000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi02LTEtMS0xNTg1NTI_262d66c1-7609-484c-8a5c-a9313ce0324e"
      unitRef="usd">4992000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfNi04LTEtMS0xNTg1NTI_202095ff-924b-40f7-89bf-395a40feadb3"
      unitRef="usd">4992000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i5e911b72c3da4719a3d272ba0d92cf3e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC00LTEtMS0xNTg1NTI_ae92f20c-49c1-463c-a7f1-59395736a9d8"
      unitRef="usd">-87125000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC02LTEtMS0xNTg1NTI_a76c1583-3ddb-48a4-be3a-9289f2187511"
      unitRef="usd">-87125000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC03LTEtMS0xNTg1NTI_803c9a62-1416-4d99-aab4-fbfce6708809"
      unitRef="usd">-953000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOC04LTEtMS0xNTg1NTI_3bf0c038-61f8-4543-a374-a06facdb5564"
      unitRef="usd">-88078000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i181797bf9c4c415f87f43a136f4c8ecb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS0zLTEtMS0xNTg1NTI_8ebee2d7-d9a9-4a02-8374-7bb5ead7bc1d"
      unitRef="usd">2256000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS02LTEtMS0xNTg1NTI_95d39036-d2ee-4dc6-b243-5c7d6a5d2c98"
      unitRef="usd">2256000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS03LTEtMS0xNTg1NTI_3ffce4eb-8c53-498d-916f-9e80fc509b92"
      unitRef="usd">28000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfOS04LTEtMS0xNTg1NTI_0a4c1181-854c-479e-972f-9b818748da19"
      unitRef="usd">2284000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i181797bf9c4c415f87f43a136f4c8ecb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtMy0xLTEtMTU4NTUy_5878aa2e-32bf-4255-9f07-7d5a6b63699d"
      unitRef="usd">-8438000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtNi0xLTEtMTU4NTUy_13f64bae-9cd7-4c5f-837d-0171e6bdd7df"
      unitRef="usd">-8438000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtNy0xLTEtMTU4NTUy_6d780c7f-2fac-4ead-8ece-4a04731f500a"
      unitRef="usd">-103000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTAtOC0xLTEtMTU4NTUy_67d098cb-c3a1-4e7b-a991-a665c83cc8e1"
      unitRef="usd">-8541000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246NjNhYWJlMTRmMzFiNGFiOTgwNzRjNTI2N2IwNDNlYmRfNDA_45458d9f-c347-41f8-9aaa-9ec9146475fd"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0bdf82ba6dfa4a2ab45ab2a25b586dda_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtNS0xLTEtMTU4NTUy_56d54150-edd9-478e-af7b-d35a3a78a776"
      unitRef="usd">118188000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i47eddaebce784587828578e94ddc1b60_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtNi0xLTEtMTU4NTUy_33da2cbd-26e7-481e-8a46-08a24daffbc7"
      unitRef="usd">118188000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4751729c16e047a68e5b139a8919f6e8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtNy0xLTEtMTU4NTUy_57097e93-6300-44cf-8451-4bb36c249e5c"
      unitRef="usd">1447000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTEtOC0xLTEtMTU4NTUy_41bcdfac-7379-4118-9df8-656838d8180f"
      unitRef="usd">119635000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItMS0xLTEtMTU4NTUy_c015dbc2-d6d2-499b-92b8-98b261d21d1e"
      unitRef="usd">3808000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fe7ed1db8704e09b2408dfbcbe34ff2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItMi0xLTEtMTU4NTUy_50540f64-f288-4bc3-842c-f0cd8520a270"
      unitRef="usd">9591194000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i870fd274e1024059a5692743eaf92e98_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItMy0xLTEtMTU4NTUy_25467466-ec8a-4b13-8780-1aae8dd56cf3"
      unitRef="usd">-8554000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1dd49fc556404cc88d55daa4ab3d7340_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNC0xLTEtMTU4NTUy_83519e89-6938-4669-94c9-9353aaab231f"
      unitRef="usd">1219930000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d5b61f7901043e3a556d968f6d61ded_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNS0xLTEtMTU4NTUy_d980afb6-795f-46b2-8d9d-ad97b6b646b5"
      unitRef="usd">-3447750000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7c65d76e0814dcabee7dac8d1342535_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNi0xLTEtMTU4NTUy_e3040c21-1236-4c85-acec-e622b049678b"
      unitRef="usd">7358628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87844637281d4d8b9949441898948c60_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItNy0xLTEtMTU4NTUy_8a42ef87-53c9-40eb-aff2-ce4ae63b2692"
      unitRef="usd">106211000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTItOC0xLTEtMTU4NTUy_463be242-6b18-442f-9aef-2c62ee2b9c63"
      unitRef="usd">7464839000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtMS0xLTEtMTU4NTUy_1b004711-43b9-4274-8767-374fb0595787"
      unitRef="usd">1505000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6d8e2030aa445ce95661811675e94d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtMi0xLTEtMTU4NTUy_bd624373-e179-43fe-81c0-288db09877a3"
      unitRef="usd">3972917000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a0ab9ea386f4d648d280a8e0986c84e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtMy0xLTEtMTU4NTUy_23efae9a-e352-44bd-9fa8-16a1356ebf47"
      unitRef="usd">-9981000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i888e6ab385484db59802ccaa138669cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNC0xLTEtMTU4NTUy_c3593be8-3f7f-46d1-8299-eb461f927d4b"
      unitRef="usd">1266158000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i290d83ded5944529b00324bf10c29c5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNS0xLTEtMTU4NTUy_c207c8cc-9ac5-4385-9109-e039c7161659"
      unitRef="usd">-3045483000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icedac472c8ec4dcfb0431ac1e84e3e61_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNi0xLTEtMTU4NTUy_44d9b77c-9d8f-4fe5-ac52-0ae0f58414c2"
      unitRef="usd">2185116000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0f1ddce63b34147a4e501072582d084_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtNy0xLTEtMTU4NTUy_1be410b1-ded2-4b6d-b3b3-9557ee802d7c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf4fe5a5fedc449b89509f79262e0912_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTUtOC0xLTEtMTU4NTUy_211f602c-0408-4e8e-babb-071c3466ad03"
      unitRef="usd">2185116000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i86534f62dd7648db9d787382c8966202_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtMS0xLTEtMTU4NTUy_2df91390-1e5e-44b2-954d-12267124cc87"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtMi0xLTEtMTU4NTUy_6a009327-9ab6-4f81-888a-a6975ba90b6b"
      unitRef="usd">22654000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtNi0xLTEtMTU4NTUy_a82ab346-aa77-4e84-aab4-24ed69d1d863"
      unitRef="usd">22661000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTYtOC0xLTEtMTU4NTUy_aea7072b-f974-43a4-b74b-50c0faca059c"
      unitRef="usd">22661000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTctMi0xLTEtMTU4NTUy_ae1a1d37-2fd8-4fa8-8e4b-1384ce3ccda2"
      unitRef="usd">206000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTctNi0xLTEtMTU4NTUy_a77a3bd5-a8f5-497c-b776-aa3d04b2e835"
      unitRef="usd">206000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTctOC0xLTEtMTU4NTUy_12b2e08f-97f6-4457-b15b-283d6a9763fc"
      unitRef="usd">206000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i86534f62dd7648db9d787382c8966202_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtMS0xLTEtMTU4NTUy_73609e21-3bcc-4148-a64e-f2e59a7e0f2a"
      unitRef="usd">4000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id4280ff5eb4b47ef9e2ba479a2cc505b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtMi0xLTEtMTU4NTUy_241e93cb-6cfc-470f-8a28-ea205366c242"
      unitRef="usd">3695000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtNi0xLTEtMTU4NTUy_66c79b2a-5c1e-461d-9078-59a2d7312079"
      unitRef="usd">3699000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTgtOC0xLTEtMTU4NTUy_bbf71021-f393-4a03-93b9-0d6b55c37ab9"
      unitRef="usd">3699000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i0a37fba94472444e866a3ce898b6e671_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTktNC0xLTEtMTU4NTUy_32bf9990-f61f-4316-b220-ad5570ff5e40"
      unitRef="usd">42227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTktNi0xLTEtMTU4NTUy_defd96ae-2bc5-4945-a869-a5e6b14b265d"
      unitRef="usd">42227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMTktOC0xLTEtMTU4NTUy_2ca8434f-5fb2-489f-94fc-60b98f6700e0"
      unitRef="usd">42227000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id1c951ed7666477093b2d8cac71d81e7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjAtMy0xLTEtMTU4NTUy_955ea93a-81c8-4563-9ef4-fb5bfdcc65b2"
      unitRef="usd">-1086000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjAtNi0xLTEtMTU4NTUy_ebc05bab-1ea3-4d33-8714-6403c16f5282"
      unitRef="usd">-1086000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjAtOC0xLTEtMTU4NTUy_f676d1e3-b1d9-4eac-ace1-1d60a4f124e9"
      unitRef="usd">-1086000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id1c951ed7666477093b2d8cac71d81e7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjEtMy0xLTEtMTU4NTUy_930b1439-cf46-4e13-8b13-5dc2ce400cc2"
      unitRef="usd">5159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjEtNi0xLTEtMTU4NTUy_72ea57f2-8d80-4c30-bcf9-0cbdb337d9a2"
      unitRef="usd">5159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjEtOC0xLTEtMTU4NTUy_3d346725-a1d4-4d14-9046-4c75e92885e7"
      unitRef="usd">5159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItMC0xLTEtMTU4NTUyL3RleHRyZWdpb246MGVhMWY5YjU0ZDU4NDU3YzhlMzVhNDJiYjQ3ODA4YzlfMzk_eb0afa17-e6c7-41a9-babc-1eed6318b8fc"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3e5855b50bdc47b6a5bbbd3d256a70a0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItNS0xLTEtMTU4NTUy_0bb0cd31-32a0-4a64-b300-75e5344e3cc2"
      unitRef="usd">46860000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5583814e5c624465ab5d8496e099e1e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItNi0xLTEtMTU4NTUy_0b7c9dd3-420f-4c78-8ac0-72e02e994759"
      unitRef="usd">46860000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjItOC0xLTEtMTU4NTUy_9d3f92dd-82bb-4077-9450-ad862df2a4e4"
      unitRef="usd">46860000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cf73c42f4034daf8884c9aa069853fd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtMS0xLTEtMTU4NTUy_8bb493fa-c8c5-4030-bfab-c849bb240028"
      unitRef="usd">1516000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cad1329072a4ad9aed8fa84a66de166_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtMi0xLTEtMTU4NTUy_24d7d740-ef54-4e80-ab52-ef01f09cfc7a"
      unitRef="usd">3999060000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba23fc68cdfa4c51b94dfc9b1cd39211_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtMy0xLTEtMTU4NTUy_cae1f5f2-3de9-4b32-8c41-b20cbc2b7090"
      unitRef="usd">-3736000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8453ec6e13a4ca9b4aaea77eb059be6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNC0xLTEtMTU4NTUy_d1c35b66-0b2c-41cd-aab7-60ce10ce0c44"
      unitRef="usd">1308385000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45b6af45f46f4248a7942a21c71bdd30_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNS0xLTEtMTU4NTUy_f223f65f-0bf9-4f53-b30e-fcbb9963d200"
      unitRef="usd">-3092343000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38c470fb138540ceae43a17b211a2504_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNi0xLTEtMTU4NTUy_cdf192db-b3e9-4dd8-8a62-0823fb3dc3e4"
      unitRef="usd">2212882000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied1e48d84ca64c058e35c69ae07d90c4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtNy0xLTEtMTU4NTUy_5e337e3d-d3ae-48dc-aeb4-8bd18c67c984"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF8zNC9mcmFnOjExYTIyZDcwZjIzYjQwNDM4MWU0Y2FlZjNjMjM3MWI4L3RhYmxlOjk0ZmIxMjc0ODVjNDQ1NjJhOWVmYjQyNmZmYTkyMmMyL3RhYmxlcmFuZ2U6OTRmYjEyNzQ4NWM0NDU2MmE5ZWZiNDI2ZmZhOTIyYzJfMjMtOC0xLTEtMTU4NTUy_3fa9b015-1a5c-4520-9cfe-421af8fe6e78"
      unitRef="usd">2212882000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMy0xLTEtMS0xNTg1NTI_307a632c-a88e-47df-8ebd-d5c9a9616d61"
      unitRef="usd">-88078000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMy0yLTEtMS0xNTg1NTI_b834835c-45fe-42da-80cc-931e4457304e"
      unitRef="usd">42227000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNS0xLTEtMS0xNTg1NTI_68142f0b-c4ec-4292-9b5e-1070056d6470"
      unitRef="usd">184479000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNS0yLTEtMS0xNTg1NTI_9b04e518-8c3f-4f77-bf12-e35ded566dde"
      unitRef="usd">54041000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNi0xLTEtMS0xNTg1NTI_dbf80b36-3ed9-471e-b754-aea548122ce1"
      unitRef="usd">11104000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNi0yLTEtMS0xNTg1NTI_218eaf6e-c3b4-4f37-8af7-ad5d489dc505"
      unitRef="usd">1192000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNy0xLTEtMS0xNTg1NTI_9fcf7dca-909b-44cc-a80c-9823738388ce"
      unitRef="usd">4992000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNy0yLTEtMS0xNTg1NTI_2b0a91d4-61e8-41f7-82f3-f7f4fb2ff0d8"
      unitRef="usd">3699000</us-gaap:ShareBasedCompensation>
    <hr:StraightLineRentReceivable
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOC0xLTEtMS0xNTg1NTI_408747cb-9a4f-4fc1-aa2e-d70954b1b812"
      unitRef="usd">9783000</hr:StraightLineRentReceivable>
    <hr:StraightLineRentReceivable
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOC0yLTEtMS0xNTg1NTI_9d6d0f8d-e572-4aaf-8184-34f4ce3a88e9"
      unitRef="usd">1587000</hr:StraightLineRentReceivable>
    <hr:StraightlineRentLiability
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOS0xLTEtMS0xNTg1NTI_bb07ff41-1f6f-4bb3-947e-0e4fecd2009e"
      unitRef="usd">1537000</hr:StraightlineRentLiability>
    <hr:StraightlineRentLiability
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfOS0yLTEtMS0xNTg1NTI_caeaa854-ab3b-4313-bc70-0ad8e1abbd5b"
      unitRef="usd">378000</hr:StraightlineRentLiability>
    <hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTAtMS0xLTEtMTU4NTUy_dc562749-3a2e-4bcf-a5b5-55338796496a"
      unitRef="usd">1007000</hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation>
    <hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTAtMi0xLTEtMTU4NTUy_65b93f5c-0bc9-4e60-adf8-9d38a467a019"
      unitRef="usd">44784000</hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTEtMS0xLTEtMTU4NTUy_e77d0dde-afab-4b68-851e-6ffad6e559ad"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTEtMi0xLTEtMTU4NTUy_aae4d75f-fcc2-41a1-9d7c-286a621afb92"
      unitRef="usd">-1429000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTItMS0xLTEtMTU4NTUy_565da261-b5c5-4de0-a289-40bea967f032"
      unitRef="usd">31422000</hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations>
    <hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTItMi0xLTEtMTU4NTUy_55b68680-f19e-4feb-8135-0d04740d3962"
      unitRef="usd">-25000</hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTMtMS0xLTEtMTU4NTUy_7d8dc339-752a-45dd-92c2-f5b842bc3abe"
      unitRef="usd">-780000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTMtMi0xLTEtMTU4NTUy_b46b54c1-6cf0-4577-9c3f-95e289244546"
      unitRef="usd">-345000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTQtMS0xLTEtMTU4NTUy_cf5d7425-83c9-43e2-827a-5eed6b39b309"
      unitRef="usd">2542000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTQtMi0xLTEtMTU4NTUy_b2bc61fd-bc09-4707-b9b3-912dc448b3e5"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <hr:InterestIncomeFinancingReceivableNoncash
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTYtMS0xLTEtMTU4NTUy_4add8969-c090-4a77-8104-c4272db2feb6"
      unitRef="usd">1385000</hr:InterestIncomeFinancingReceivableNoncash>
    <hr:InterestIncomeFinancingReceivableNoncash
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTYtMi0xLTEtMTU4NTUy_4dcc8bd1-2a77-4f16-853b-f2d950a822ab"
      unitRef="usd">199000</hr:InterestIncomeFinancingReceivableNoncash>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTgtMS0xLTEtMTU4NTUy_6dd60b83-73c6-49ba-9cc8-1628b1163793"
      unitRef="usd">8360000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTgtMi0xLTEtMTU4NTUy_157be315-a0cf-4025-a11c-6d095d59004f"
      unitRef="usd">2563000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTktMS0xLTEtMTU4NTUy_80f6fa99-26fc-442d-aff4-34c83d5eddb4"
      unitRef="usd">-66954000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMTktMi0xLTEtMTU4NTUy_ee69079e-b846-450c-9fcd-12acc9f21901"
      unitRef="usd">-12212000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjAtMS0xLTEtMTU4NTUy_27ac68eb-4e8e-4160-bbfe-9750475dce52"
      unitRef="usd">7901000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjAtMi0xLTEtMTU4NTUy_87624d60-a57b-44ef-ad16-a78f9fd63e45"
      unitRef="usd">1830000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjEtMS0xLTEtMTU4NTUy_4b985a4f-7f99-4f4a-920f-738f7c64682e"
      unitRef="usd">69190000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjEtMi0xLTEtMTU4NTUy_8f872acd-48a2-4e18-beb3-b2e70419c483"
      unitRef="usd">43771000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjQtMS0xLTEtMTU4NTUy_3a3a51d5-09fd-42e1-bcdb-2febd959b0db"
      unitRef="usd">30725000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjQtMi0xLTEtMTU4NTUy_24850c99-4797-4506-a89b-70e4255b151a"
      unitRef="usd">121964000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjUtMS0xLTEtMTU4NTUy_d985c344-1de5-45a2-a39d-cd2f3d715fa0"
      unitRef="usd">6707000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjUtMi0xLTEtMTU4NTUy_0208d6bd-a236-4a94-9986-dbaea14c7cfd"
      unitRef="usd">3754000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjYtMS0xLTEtMTU4NTUy_d85878fb-f304-437f-a471-d23338aafa08"
      unitRef="usd">60159000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjYtMi0xLTEtMTU4NTUy_1ba74173-4e46-489e-9b8a-8ce2527246c6"
      unitRef="usd">23326000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjctMS0xLTEtMTU4NTUy_cbffbc7c-a607-44b0-ad87-2f57f66ffc30"
      unitRef="usd">6230000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjctMi0xLTEtMTU4NTUy_0c933797-adac-4d0b-98c5-efb6b0f9a516"
      unitRef="usd">0</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjgtMS0xLTEtMTU4NTUy_36d3b1c7-28dd-4a4a-b9c5-76323c647316"
      unitRef="usd">3824000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjgtMi0xLTEtMTU4NTUy_f8eb3746-39d4-4847-8253-9ebfa4700ecc"
      unitRef="usd">49598000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireFinanceReceivables
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjktMS0xLTEtMTU4NTUy_62096fac-bf3c-41a8-9dc5-300f2873f00a"
      unitRef="usd">302000</us-gaap:PaymentsToAcquireFinanceReceivables>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMjktMi0xLTEtMTU4NTUy_eb7d7233-33f5-4896-a0dc-a8f2298a2405"
      unitRef="usd">492000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzAtMS0xLTEtMTU4NTUy_79d3199f-e0b7-4bb6-8ba8-3511676b7fe4"
      unitRef="usd">149171000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzAtMi0xLTEtMTU4NTUy_1f41931d-7734-4945-9422-6855f8d886a5"
      unitRef="usd">84883000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzEtMS0xLTEtMTU4NTUy_65e14ef7-3563-4c5c-821e-7741c9b90eaf"
      unitRef="usd">336000</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzEtMi0xLTEtMTU4NTUy_fe6ad553-6423-42bf-b2c5-3adf79acbafc"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzQtMS0xLTEtMTU4NTUy_8b7bd9ff-eadb-4c62-8b51-50ff07e5109c"
      unitRef="usd">41560000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzQtMi0xLTEtMTU4NTUy_3a3ffaa2-8419-4e84-a4c1-1a557a4cf3e2"
      unitRef="usd">-113267000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzctMS0xLTEtMTU4NTUy_31977a19-57bc-4f19-9525-f72e06b44bdc"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfMzctMi0xLTEtMTU4NTUy_bdaece3e-260e-4a92-a626-b9d811663308"
      unitRef="usd">124000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfDebt
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDEtMS0xLTEtMTU4NTUy_0341059f-0ca7-439c-b0ad-50386fd4912b"
      unitRef="usd">667000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDEtMi0xLTEtMTU4NTUy_70bf571b-405b-49d4-9857-e961e44c331a"
      unitRef="usd">17573000</us-gaap:RepaymentsOfDebt>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDMtMS0xLTEtMTU4NTUy_80bf0f7a-7306-4585-8df4-93e3bbf8ed7e"
      unitRef="usd">0</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDMtMi0xLTEtMTU4NTUy_11ce40bd-f94d-4569-a321-2caabe4f1add"
      unitRef="usd">2184000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDQtMS0xLTEtMTU4NTUy_198e114a-deeb-4207-b082-8ef182977c15"
      unitRef="usd">118052000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDQtMi0xLTEtMTU4NTUy_f7d3ef75-e360-467c-b046-18b70c1cc82f"
      unitRef="usd">46768000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDctMS0xLTEtMTU4NTUy_04107cb4-212a-41c1-aae0-d96b931e1829"
      unitRef="usd">51000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDctMi0xLTEtMTU4NTUy_45bcfc49-d323-47be-b560-bf09951363bb"
      unitRef="usd">22649000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDgtMS0xLTEtMTU4NTUy_1ba6533b-e0b8-470e-bc30-50112003e4fc"
      unitRef="usd">1729000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDgtMi0xLTEtMTU4NTUy_3faa6f24-56f0-42ee-b369-3cfddf00612b"
      unitRef="usd">852000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDktMS0xLTEtMTU4NTUy_b72c5fcd-35c3-44ae-825a-cdbbf759c156"
      unitRef="usd">1272000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNDktMi0xLTEtMTU4NTUy_eb3d7d9d-2d7c-4118-b964-7df7686ca392"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTMtMS0xLTEtMTU4NTUy_034816df-62f9-4719-8e3c-a2ae7c276eea"
      unitRef="usd">101000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTMtMi0xLTEtMTU4NTUy_53fda7cf-f0c0-4181-bcd6-6c6ca905f2aa"
      unitRef="usd">257000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTQtMS0xLTEtMTU4NTUy_6151fd91-921d-44a0-99fa-5b02f45e6cee"
      unitRef="usd">-121770000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTQtMi0xLTEtMTU4NTUy_eeaeff19-4feb-41fd-9d24-a4838900e6ec"
      unitRef="usd">79015000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTYtMS0xLTEtMTU4NTUy_18158ec1-a2f4-48ee-8f42-09f9f2aaeda9"
      unitRef="usd">-11020000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTYtMi0xLTEtMTU4NTUy_adcda859-ca50-4864-9d05-65245efad681"
      unitRef="usd">9519000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTctMS0xLTEtMTU4NTUy_2ca91659-a85f-4830-b10f-f3ec9cc1d7d9"
      unitRef="usd">60961000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icf4fe5a5fedc449b89509f79262e0912_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTctMi0xLTEtMTU4NTUy_af479666-1b4e-4c1c-897b-1359574ae235"
      unitRef="usd">13175000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTgtMS0xLTEtMTU4NTUy_718bc399-2e17-4b52-85b3-678c40bd33fb"
      unitRef="usd">49941000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNTgtMi0xLTEtMTU4NTUy_08e9c107-8255-415d-89dd-9d76d2a46b0a"
      unitRef="usd">22694000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjEtMS0xLTEtMTg0MDc0_2a2175ae-2dfa-4a64-8a73-f0a2c0237229"
      unitRef="usd">75082000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjEtMi0xLTEtMTg0MDc0_44ee1e8a-a5a1-4de3-8042-32f58134a3bc"
      unitRef="usd">16227000</us-gaap:InterestPaidNet>
    <us-gaap:MortgageLoanRelatedToPropertySales1
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMS0xLTEtMTg3Nzg2_fb4ddc6b-9760-44d0-8a21-9d137a67a031"
      unitRef="usd">45000000</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:MortgageLoanRelatedToPropertySales1
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMi0xLTEtMTg3Nzkw_a5291c24-d955-40db-b030-a331ab4c4c2a"
      unitRef="usd">0</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMS0xLTEtMTg0MDc0_2f3cd66d-090d-4681-8392-a89a6f3353c6"
      unitRef="usd">28138000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjItMi0xLTEtMTg0MDc0_9a51d6da-6fb8-468b-81c3-65d8fbcf56fe"
      unitRef="usd">13516000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjAtMS0xLTEtMTU4NTUy_b3d24ec7-5eb5-4f5d-8ab4-db4d7349237d"
      unitRef="usd">570000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80MC9mcmFnOjAwMjBlMjIyNTQ4YzQzYWQ4OTZlZjI5NmUwMTMzNDMzL3RhYmxlOjJiMzY4MTU1NWU1YTQ1NzRiMTQ5NzlmOWQ5ODU5NGYxL3RhYmxlcmFuZ2U6MmIzNjgxNTU1ZTVhNDU3NGIxNDk3OWY5ZDk4NTk0ZjFfNjAtMi0xLTEtMTU4NTUy_0aeba30b-9451-4828-94cd-3da557a878aa"
      unitRef="usd">38000</us-gaap:InterestPaidCapitalized>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80My9mcmFnOjM2NGEzNGM4NDBjNjQ4OWNhNDAyZGI2NjdmMDU4MTJiL3RleHRyZWdpb246MzY0YTM0Yzg0MGM2NDg5Y2E0MDJkYjY2N2YwNTgxMmJfNTQ_0ad4a241-2657-446a-b22b-65687c178c10">Summary of Significant Accounting Policies&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Business Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March&#160;31, 2023, the Company had gross investments of approximately $13.9&#160;billion in 681 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 681 real estate properties are located in 35 states and total approximately 39.9&#160;million square feet. The Company provided leasing and property management services to approximately 39.5 million square feet nationwide.   As of March&#160;31, 2023, the Company had a weighted average ownership interest of approximately 44% in 34 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#x2019;s review. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For purposes of this Quarterly Report on Form 10-Q, references to the &#x201c;Company&#x201d; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#x201c;VIEs&#x201d;). Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#x2019;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#x2019;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#x2019;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#x2019;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#x2019;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#x2019; activities based upon the terms of the respective entities&#x2019; ownership agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Holdings, L.P. (the "OP") is 98.8% owned by the Company.  Holders of operating partnership units (&#x201c;OP Units&#x201d;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of March&#160;31, 2023, there were approximately 4.7&#160;million, or 1.2%, of OP Units issued and outstanding held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had three consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Receivables and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;51,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;39,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;51,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.  See Note 3 below for more details regarding the Company's unconsolidated joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Use of Estimates in the Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Reclassifications &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%"&gt;                                            &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Redeemable Non-Controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company accounts for redeemable equity securities in accordance with Accounting Standards Codification Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#x2019; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheet.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#x2019;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.  As of March&#160;31, 2023, the Company had redeemable non-controlling interests of $2.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Investments in Leases - Financing Receivables, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In accordance with ASC 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 &#x201c;Receivables&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#x2019;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of March&#160;31, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $147.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;19,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Fair-value discount and fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the three months ended March 31, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote.  Consequently, the Company recorded a credit loss reserve of $5.2&#160;million for the three months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Lease Financing Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For the three months ended March&#160;31, 2023, the Company recognized the related income from two financing receivables totaling $1.5&#160;million based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the three months ended March&#160;31, 2023, the Company recognized interest income of $2.0&#160;million related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of March&#160;31, 2023, the Company placed two of its real estate notes receivable with a principal balance of $54.1&#160;million on non-accrual status and accordingly did not recognize any interest income for the quarter. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Revenue that is accounted for under Topic 606 is segregated on the Company&#x2019;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.896%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Type of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Parking income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Management fee income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Miscellaneous&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.           &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <hr:NatureOfOperationsPolicyTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4Mzc_80ab03bb-7d4b-47bf-bbbe-aef5bb146409">Business OverviewHealthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March&#160;31, 2023, the Company had gross investments of approximately $13.9&#160;billion in 681 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 681 real estate properties are located in 35 states and total approximately 39.9&#160;million square feet. The Company provided leasing and property management services to approximately 39.5 million square feet nationwide.   As of March&#160;31, 2023, the Company had a weighted average ownership interest of approximately 44% in 34 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#x2019;s review.</hr:NatureOfOperationsPolicyTextBlock>
    <hr:InvestmentInRealEstatePropertiesAndMortgageNotes
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzgw_8ee08961-76a6-40bb-af68-d837fffc9562"
      unitRef="usd">13900000000</hr:InvestmentInRealEstatePropertiesAndMortgageNotes>
    <hr:NumberOfRealEstateInvestments
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzg2_8c19e761-e973-437f-bf81-3cb520b16c3d"
      unitRef="property">681</hr:NumberOfRealEstateInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODI2ODE2_5061c7c2-31ec-4dce-9c26-0dc8c7b7f3c2"
      unitRef="property">681</us-gaap:NumberOfRealEstateProperties>
    <hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNjIy_488d8c58-d949-4e7d-8eac-a79041fe437d"
      unitRef="state">35</hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates>
    <hr:ApproximateSquareFeetInvestedInByCompany
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNjU2_61c52399-7f81-4389-b653-033bbfc08401"
      unitRef="sqft">39900000</hr:ApproximateSquareFeetInvestedInByCompany>
    <hr:ApproximateSquareFeetProvidedByCompany
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNzUx_9c04e084-f44f-4e96-a7fa-edbf540e2468"
      unitRef="sqft">39500000</hr:ApproximateSquareFeetProvidedByCompany>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i755c42838b7b431480fbfbdf30a6e9ed_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfODYx_33f2f703-b8c4-4157-850a-a8047a7fca35"
      unitRef="number">0.44</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <hr:NumberOfBuildingsOwnedByJointVenture
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfODY3_06fa3aa9-c3a2-4a43-a7c3-26e8501492a9"
      unitRef="building">34</hr:NumberOfBuildingsOwnedByJointVenture>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NTg_c2671386-beda-40c8-b08e-91a822c69c75">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For purposes of this Quarterly Report on Form 10-Q, references to the &#x201c;Company&#x201d; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NTI_66114f00-f67c-4fe1-abb7-0c6bd0ac3406">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#x201c;VIEs&#x201d;). Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#x2019;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#x2019;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#x2019;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#x2019;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#x2019;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#x2019; activities based upon the terms of the respective entities&#x2019; ownership agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Holdings, L.P. (the "OP") is 98.8% owned by the Company.  Holders of operating partnership units (&#x201c;OP Units&#x201d;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of March&#160;31, 2023, there were approximately 4.7&#160;million, or 1.2%, of OP Units issued and outstanding held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had three consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Receivables and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;51,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;39,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;51,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i51484a2f360e4b42bdb84e7d753ea660_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTU5_a1a750bf-3cd8-4a3b-abad-794fbf3b27a2"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <hr:EquityOwnershipForConsolidationPercent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTcw_2f8ffb65-f8a0-47da-9035-784449bf8c33"
      unitRef="number">1</hr:EquityOwnershipForConsolidationPercent>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i0322c2eebd454faf9eed6b856d8741ba_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjIw_ab5a3522-a1a2-4508-90b6-3111ae8bb89a"
      unitRef="number">0.988</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding
      contextRef="i5aac4bb4c06647b5ad4f91577c69c51e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUyMA_8fd08fed-9ddf-4cd6-b48a-b0645ffc3786"
      unitRef="shares">4700000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest
      contextRef="i82ce96e024674f9b87df4e61c55f6764_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTgx_41441c74-d6ac-48ca-a2a0-eb97bc7b6383"
      unitRef="number">0.012</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest>
    <hr:NumberOfVariableInterestEntities
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MTQ1_289bfeac-1db1-4384-82ee-97c7b390c64d"
      unitRef="variable_interest_entity">3</hr:NumberOfVariableInterestEntities>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUzMg_770b36dd-590c-4634-b467-0a8985009b1e">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.342%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Receivables and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;51,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;39,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;51,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfMi0xLTEtMS0xNzY4NTg_f013481d-3d12-4b9a-9660-0f787ae20200"
      unitRef="usd">48079000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfMy0xLTEtMS0xNzY4NTg_0b8efa2b-ee6c-4b9d-84b3-ee04ad2461fe"
      unitRef="usd">1517000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <hr:ReceivablesAndOtherAssets
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfNC0xLTEtMS0xNzY4NTg_65b14429-b45b-4987-a2b3-4ddf0040c188"
      unitRef="usd">2339000</hr:ReceivablesAndOtherAssets>
    <us-gaap:Assets
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfNS0xLTEtMS0xNzY4NTg_c640d5b7-b4b6-4377-82b1-85ca71943335"
      unitRef="usd">51935000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfNy0xLTEtMS0xNzY4Nzk_3edff36e-d843-4f3b-9716-af88a978def1"
      unitRef="usd">12010000</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:StockholdersEquity
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfOC0xLTEtMS0xNzY4Nzk_c3e5bd90-16c5-4160-8399-a3b0f4823569"
      unitRef="usd">39925000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0458b77080714c6888c6e3f362854f15_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjc1MGYzOTE0OTkwMjQ0MDE5YzcwNWMyZDM3ODFiMjM4L3RhYmxlcmFuZ2U6NzUwZjM5MTQ5OTAyNDQwMTljNzA1YzJkMzc4MWIyMzhfOS0xLTEtMS0xNzY4Nzk_ac1a1c9f-e3b4-4ad7-90f8-7b8b7667bb92"
      unitRef="usd">51935000</us-gaap:LiabilitiesAndStockholdersEquity>
    <hr:NumberOfVariableInterestEntities
      contextRef="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjMy_f76b6895-9a9a-408e-a263-aa164982ede6"
      unitRef="variable_interest_entity">3</hr:NumberOfVariableInterestEntities>
    <hr:NumberOfNotesReceivable
      contextRef="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjQ0_ee203329-f0a6-49c9-8fbe-b583fc68d717"
      unitRef="note_receivable">2</hr:NumberOfNotesReceivable>
    <hr:NumberOfJointVentures
      contextRef="i4fee5ed06fc349219d14427a4e38fc89_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjU0_75ccb7b4-c218-478c-bf1c-e3a6900a6aaf"
      unitRef="joint_venture">1</hr:NumberOfJointVentures>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUzMw_82cbfe76-2a9e-4373-b031-2459de600a88">, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <hr:NumberOfNotesReceivable
      contextRef="i48620ef7041b4cc4a9b7ba74702c1f69_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODM2MjY0_4a2b6864-e023-4e1e-8b93-1ba5a9fce1b0"
      unitRef="note_receivable">2</hr:NumberOfNotesReceivable>
    <hr:NotesReceivableCarryingAmount
      contextRef="i892f855ceda549059585643902bde99c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMS0zLTEtMS0xNzcwMzU_b0c11410-0188-4cd1-89d5-a2270b1e667e"
      unitRef="usd">30839000</hr:NotesReceivableCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i892f855ceda549059585643902bde99c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMS00LTEtMS0xNzcwMzU_a9d6bf0c-e2db-45bc-ad36-d2b50492ed3f"
      unitRef="usd">31150000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <hr:NotesReceivableCarryingAmount
      contextRef="i33a33b3d8f3f49099605a5a0d1738e6b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMi0zLTEtMS0xNzcwMzU_ba2c5ff0-ca99-4c39-9fec-a5ecacfe286d"
      unitRef="usd">5639000</hr:NotesReceivableCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i33a33b3d8f3f49099605a5a0d1738e6b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMi00LTEtMS0xNzcwMzU_cd7a5799-b722-483f-b013-61e103f502ca"
      unitRef="usd">6000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <hr:JointVentureCarryingAmount
      contextRef="i12840b99f3724aff95ff5318afa01dd3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMy0zLTEtMS0xNzcwMzU_9b1c366a-6cb7-411a-88b9-cd27b36a2c45"
      unitRef="usd">66038000</hr:JointVentureCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i12840b99f3724aff95ff5318afa01dd3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjJkMWY1NTc4ZmI3ODRmOTY4NGE1OTI3YmFhYzczZTZkL3RhYmxlcmFuZ2U6MmQxZjU1NzhmYjc4NGY5Njg0YTU5MjdiYWFjNzNlNmRfMy00LTEtMS0xNzcwMzU_7f4359c2-8842-49b4-b5c6-c2092d531fdf"
      unitRef="usd">66038000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i12840b99f3724aff95ff5318afa01dd3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODQzNjIy_c9256e47-54f0-4558-a64c-90983d9b58e2"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NzA_20c782ac-9239-4c82-9407-e7eb5a913e8f">As of March&#160;31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:UseOfEstimates
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI3OTM_ced0f2bd-4675-4543-9064-5a3e228f7666">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Use of Estimates in the Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NDM_1c2c7db8-1e2a-45d5-9e26-0984f3636a47">Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwOTY5Mw_e52079ec-b865-4fbf-88f7-b18cc21fcd76">Redeemable Non-Controlling InterestsThe Company accounts for redeemable equity securities in accordance with Accounting Standards Codification Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#x2019; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheet.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#x2019;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfNTQ5NzU1ODQwMTc5_e952bf27-20c5-4d12-99d6-2f5e71968765"
      unitRef="usd">2000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:LessorLeasesPolicyTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4MTI_1d51e52f-5f7d-4e88-a09f-2639720e8ad5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Investments in Leases - Financing Receivables, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In accordance with ASC 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 &#x201c;Receivables&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#x2019;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of March&#160;31, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $147.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;19,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Fair-value discount and fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the three months ended March 31, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote.  Consequently, the Company recorded a credit loss reserve of $5.2&#160;million for the three months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Lease Financing Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For the three months ended March&#160;31, 2023, the Company recognized the related income from two financing receivables totaling $1.5&#160;million based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;During the three months ended March&#160;31, 2023, the Company recognized interest income of $2.0&#160;million related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of March&#160;31, 2023, the Company placed two of its real estate notes receivable with a principal balance of $54.1&#160;million on non-accrual status and accordingly did not recognize any interest income for the quarter.</us-gaap:LessorLeasesPolicyTextBlock>
    <hr:RealEstateNotesReceivableNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfOTQwNg_ed82ff77-d838-492d-af06-f8ca245b5156"
      unitRef="usd">147300000</hr:RealEstateNotesReceivableNet>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkwODUzNg_f1c4a77a-2d08-4c72-9be2-48235e0462b0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;19,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Fair-value discount and fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <hr:NotesReceivableInterestRate
      contextRef="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMi0zLTEtMS0xNzcyOTk_066aae2e-16d1-499a-9004-c23feecaac25"
      unitRef="number">0.0800</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment
      contextRef="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMi00LTEtMS0xNzcyOTk_fdc2e0be-c2a6-4679-a989-593df2eaaf42"
      unitRef="usd">54119000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:NotesReceivableGross
      contextRef="i4bbd798ba5444a64bcdadcdbad11e57c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMi01LTEtMS0xNzcyOTk_970a1e0b-5f12-45c1-8a42-dca2095ffd44"
      unitRef="usd">54119000</us-gaap:NotesReceivableGross>
    <hr:NotesReceivableInterestRate
      contextRef="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi0zLTEtMS0xNzczMDM_9b281f02-93de-4fe8-a7bd-b82edf1adb93"
      unitRef="number">0.0700</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment
      contextRef="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi00LTEtMS0xNzczMDM_14168f6e-563c-4502-aba1-8c11e2e2b510"
      unitRef="usd">31150000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:NotesReceivableGross
      contextRef="icd4bf8482aba4014b6ccc58c4d1a7cc2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi01LTEtMS0xNzczMDM_c8bc0526-e632-4f4a-bd9b-b54d93b4c659"
      unitRef="usd">31150000</us-gaap:NotesReceivableGross>
    <hr:NotesReceivableInterestRate
      contextRef="i62b0d5e420094983ab1ab22d723321e0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi0zLTEtMS0xODY2MjE_a9725947-3c77-40b9-9769-a3ad29497c0c"
      unitRef="number">0.0800</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment
      contextRef="i62b0d5e420094983ab1ab22d723321e0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi00LTEtMS0xODY2MjQ_c535be47-c62e-488f-8054-93ff4d653c93"
      unitRef="usd">6000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:NotesReceivableGross
      contextRef="i62b0d5e420094983ab1ab22d723321e0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNi01LTEtMS0xODY2MjY_fb4bd3b1-437b-4a53-af98-d61e3136b3cc"
      unitRef="usd">6000000</us-gaap:NotesReceivableGross>
    <hr:NotesReceivableInterestRate
      contextRef="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNy0zLTEtMS0xNzczMDM_e4a6b01b-835c-4855-b13f-7a423cc1bee3"
      unitRef="number">0.0600</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment
      contextRef="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNy00LTEtMS0xNzczMDM_e6193c44-a57a-4c5d-8e5d-96f83dce1631"
      unitRef="usd">65000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:NotesReceivableGross
      contextRef="i18b3fc8fa4e64cbbabe82d5eb880f471_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfNy01LTEtMS0xNzczMDM_618ea7e3-5ce6-4760-9600-99fd176ed24f"
      unitRef="usd">19367000</us-gaap:NotesReceivableGross>
    <hr:NotesReceivableInterestRate
      contextRef="i7a56f63d400c4079a7e865561ecc32b1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC0zLTEtMS0xODE0NzA_3d32ca54-9a5f-4fe6-bdac-c92707e015cc"
      unitRef="number">0.0600</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment
      contextRef="i7a56f63d400c4079a7e865561ecc32b1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC00LTEtMS0xODE0NzI_dbd9f2c0-5c35-4613-acce-d802ecaf7b71"
      unitRef="usd">45000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:NotesReceivableGross
      contextRef="i7a56f63d400c4079a7e865561ecc32b1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC01LTEtMS0xODE0NzQ_728f2fda-f04e-4e37-8287-5027bd287356"
      unitRef="usd">45000000</us-gaap:NotesReceivableGross>
    <hr:NotesReceivableMaximumLoanCommitment
      contextRef="ic44363c5ccfa4dff9ff72967d841833c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC00LTEtMS0xNzczMDc_f6c05e99-1b41-427c-b33f-2596b7aa2f0d"
      unitRef="usd">147150000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:NotesReceivableGross
      contextRef="ic44363c5ccfa4dff9ff72967d841833c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOC01LTEtMS0xNzczMDU_9d8ba264-c883-40f7-9d6e-af9da014c3f0"
      unitRef="usd">101517000</us-gaap:NotesReceivableGross>
    <us-gaap:InterestReceivable
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfOS01LTEtMS0xNzczMDU_64fbbd39-74ad-4aa7-9b1b-1deb5fb048ef"
      unitRef="usd">1428000</us-gaap:InterestReceivable>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMTEtNS0xLTEtMTg4NTIw_f129e33c-bbb8-43c5-bb08-4fb6554bf972"
      unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <hr:NotesReceivableFairValueDiscount
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMTAtNS0xLTEtMTc3MzA1_640405e8-8074-4554-b105-2d45cd8e766d"
      unitRef="usd">4542000</hr:NotesReceivableFairValueDiscount>
    <us-gaap:NotesReceivableNet
      contextRef="i5e0ace30abe440c2bd816870af7d7806_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjkyYmYzZGU1NGQ4YzQyZWRhZTQxNTExM2Y5NTM0MTVkL3RhYmxlcmFuZ2U6OTJiZjNkZTU0ZDhjNDJlZGFlNDE1MTEzZjk1MzQxNWRfMTEtNS0xLTEtMTc3MzA1_3b92ae49-13af-4021-94e2-21a71ef31e2f"
      unitRef="usd">147326000</us-gaap:NotesReceivableNet>
    <hr:FinancingReceivableAllowanceForCreditLossReserves
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMjc0ODc3OTEwNDAyMg_1ecaa382-3d60-46b2-8087-e1a672e896c3"
      unitRef="usd">5200000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMzI5ODUzNDkxNzc1NA_b1b9d12f-e5d2-4a98-8db2-be1900af953b">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMi0xLTEtMS0xODg1MjY_6dd2cd18-3c37-460c-b8a4-f5f3a043ee4d"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="icf4fe5a5fedc449b89509f79262e0912_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMi0yLTEtMS0xODg1MjY_e39386a9-b0cc-48cf-8057-a1834255714f"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <hr:FinancingReceivableAllowanceForCreditLossReserves
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMy0xLTEtMS0xODg1MjY_b34d8a87-1273-48b2-9319-01d906be3c91"
      unitRef="usd">5196000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <hr:FinancingReceivableAllowanceForCreditLossReserves
      contextRef="i62b0486b528146ec8fdc0d6d9e4c4d6c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfMy0yLTEtMS0xODg1MjY_2d38728f-e1a7-4e98-8084-b1660a04c426"
      unitRef="usd">0</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfNC0xLTEtMS0xODg1MjY_8ba3ec68-f640-4ef7-90ce-14b20ff65dfc"
      unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOjA4NTYzZWM2NzlhOTQwMjg5YTE3NmYzYzc0ZjRjZDQzL3RhYmxlcmFuZ2U6MDg1NjNlYzY3OWE5NDAyODlhMTc2ZjNjNzRmNGNkNDNfNC0yLTEtMS0xODg1MjY_252692f4-61e3-4362-bec4-9c5e6c516a2b"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <hr:NumberOfRecognizedLeaseFinancialReceivables
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfOTU1Mw_95837986-e7d5-4bed-9612-123d71c5d2fe"
      unitRef="financing_receivable">2</hr:NumberOfRecognizedLeaseFinancialReceivables>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfOTU4OA_6a98c200-7a54-4703-a7bf-ea5fb86d40c4"
      unitRef="usd">1500000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:InterestIncomeOperating
      contextRef="i05be39577b12415cba92b235a157f559_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTAzMjQ_44e609bb-c081-4408-a4d4-5f09574afcb4"
      unitRef="usd">2000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="if8415018b6934f1cb08cc146d7ceb279_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTAzMjQ_c46bf870-0f96-4a82-a8ac-d2000da24f3f"
      unitRef="usd">2000000</us-gaap:InterestIncomeOperating>
    <hr:NumberOfRealEstateNotesReceivable
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMjc0ODc3OTEwNDAzNQ_6bef788f-0c4d-4b96-887d-73f3d9b77efe"
      unitRef="financing_receivable">2</hr:NumberOfRealEstateNotesReceivable>
    <us-gaap:FinancingReceivableRecordedInvestmentNonaccrualStatus
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMjc0ODc3OTEwNDAwNw_0960a235-24cc-4274-a6ff-7daa75eead2b"
      unitRef="usd">54100000</us-gaap:FinancingReceivableRecordedInvestmentNonaccrualStatus>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4MjU_0627acf1-47a2-4bf5-abfe-9bb3d10bfaf5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. &lt;/span&gt;&lt;/div&gt;Revenue that is accounted for under Topic 606 is segregated on the Company&#x2019;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.The Company&#x2019;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RleHRyZWdpb246NzVhYjFjMDVlMmNmNGUxZWI0ZjlmMDQyZWFmNWJhM2RfMTI4NDg_c6524fda-6d2d-4011-aa80-9b5d7abeb0ac">Below is a detail of the amounts by category:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.896%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Type of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Parking income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Management fee income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Miscellaneous&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf0cfc90ab23411db24b52116a274e8c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfMy0xLTEtMS0xNTg1NTI_c642556d-73a9-4560-90ba-27ff0a476b9d"
      unitRef="usd">2391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i838dbabd027b451d9500ea47a7f339ec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfMy0yLTEtMS0xNTg1NTI_3c11666c-2db1-4a72-824f-6027fb42f487"
      unitRef="usd">1753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i568f996d95dc4950803db835d3ec9a81_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNS0xLTEtMS0xNTg1NTI_b90b67b7-94c2-4c55-b24c-bf389cf3037e"
      unitRef="usd">1973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3f3967d66744ae79640534476f9540f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNS0yLTEtMS0xNTg1NTI_7eb5b08f-bb59-49a6-9199-0b1a2e1a01df"
      unitRef="usd">655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia98275e8045c4a51b9dd61d72cdae95d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNi0xLTEtMS0xNTg1NTI_7b10d81c-7552-4a49-972f-9d7004d61f57"
      unitRef="usd">254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfe566f51e494b1d8cc1a790d694cd86_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNi0yLTEtMS0xNTg1NTI_4f6b44c3-42ee-420c-a835-02683b06253b"
      unitRef="usd">67000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNy0xLTEtMS0xNTg1NTI_0f2609ff-1ab2-49b5-8321-e2494e27af7e"
      unitRef="usd">4618000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80Ni9mcmFnOjc1YWIxYzA1ZTJjZjRlMWViNGY5ZjA0MmVhZjViYTNkL3RhYmxlOmU4MGEwYmE5N2UyYTQzNzZiZTYzNGFmMzUwMGYzZTBlL3RhYmxlcmFuZ2U6ZTgwYTBiYTk3ZTJhNDM3NmJlNjM0YWYzNTAwZjNlMGVfNy0yLTEtMS0xNTg1NTI_e983f081-6166-45fd-ba50-4f3fe39b5e7e"
      unitRef="usd">2475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwNw_6eea600a-2fec-47c7-aa15-82791321b882">Merger with HTA &lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On July 20, 2022 (the &#x201c;Closing Date&#x201d;), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the &#x201c;Merger Agreement&#x201d;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#x201c;Legacy HR&#x201d;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#x201c;Legacy HTA&#x201d;), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (&#x201c;Merger Sub&#x201d;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#x201c;Merger&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the &#x201c;Legacy HR Common Stock&#x201d;), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the &#x201c;Special Dividend&#x201d;) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the &#x201c;Legacy HTA Common Stock&#x201d;), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to &#x201c;Healthcare Realty Trust Incorporated&#x201d;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP.  The Company operates under the name &#x201c;Healthcare Realty Trust Incorporated&#x201d; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the &#x201c;NYSE&#x201d;) under the ticker symbol &#x201c;HR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For accounting purposes, the Merger was treated as a &#x201c;reverse acquisition&#x201d; in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The implied consideration transferred on the Closing Date is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands, except for per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exchange ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Implied shares of Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjusted closing price of Legacy HR Common Stock on July 20, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Value of implied Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,569,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,576,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Preliminary Purchase Price Allocation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MEASUREMENT PERIOD ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;985,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;992,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,960,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(121,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,839,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;831,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;833,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;13,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land held for development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,844,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(116,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,727,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;707,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(7,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;699,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;37,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Restricted cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,123,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,122,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;216,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;209,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;205,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,177,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(100,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,076,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,227,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,244,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;173,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;184,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(855)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;203,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(11,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;191,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,635,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,646,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,541,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(111,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,429,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;145,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;111,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;257,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(c)  Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The cumulative measurement period adjustments recorded through March&#160;31, 2023 primarily resulted from updated valuations related to the Company&#x2019;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $111.9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had not finalized the determination of fair value of certain tangible and intangible assets acquired and liabilities assumed, including, but not limited to real estate assets and liabilities, notes receivables and goodwill. As such, the assessment of fair value of assets acquired and liabilities assumed is preliminary and was based on information that was available at the time the Condensed Consolidated Financial Statements were prepared. The finalization of the purchase accounting assessment could result in material changes to the Company&#x2019;s determination of the fair value of assets acquired and liabilities assumed, which will be recorded as measurement period adjustments in the period in which they are identified, up to one year from the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;A preliminary estimate of approximately $257.3&#160;million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger.  None of the goodwill recognized is expected to be deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Merger-related Costs&lt;/span&gt;&lt;/div&gt;The Company incurred Merger-related costs of $4.9 million during the three months ended March&#160;31, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services.  Subsequent to March&#160;31, 2023, the Company received a refund of $17.8&#160;million for transfer taxes paid during the year ended December&#160;31, 2022 in connection with the Merger.  The Company will record this as a reduction of Merger-related costs in the second quarter of 2023.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i083d3ca006554b74ba98857c37529cb4_I20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODg1_d1d24760-1a71-4b07-89b5-a97f2cdbbdab"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio
      contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfOTk0_f1ed2dfe-16ce-49db-b3dd-2f5582b76f12"
      unitRef="shares">1</hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio>
    <hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio
      contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTA1OA_abcf0b91-04df-4c60-8910-33bd05752fe3"
      unitRef="shares">1.00</hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i38dceeb615dc429ea313b8089bb30136_D20220720-20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTE1MQ_1c736b69-ff10-45ee-b4eb-3b135e5d7535"
      unitRef="usdPerShare">4.82</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTI0Mg_cd05bf98-9b7b-4e42-bf39-673a4adfb879"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icb262bbfd5c64c4b80a95b4c0088494d_I20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTQ5NzU1ODI2OTM1_7b3c81fb-c50f-4021-a87c-4233f099b972"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwMw_6f72763f-3a62-46c8-95e0-f8e18f1700fe">The implied consideration transferred on the Closing Date is as follows: &lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands, except for per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exchange ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Implied shares of Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjusted closing price of Legacy HR Common Stock on July 20, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Value of implied Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,569,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,576,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.&lt;/span&gt;&lt;/div&gt;(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services.</us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfMS0xLTEtMS0xNTg1NTI_45663e16-e8f3-491f-9fcf-162523ae1bd2"
      unitRef="shares">228520990</us-gaap:CommonStockSharesOutstanding>
    <hr:RecapitalizationExchangeRatio
      contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfMi0xLTEtMS0xNTg1NTI_cd639986-e9f7-4cb0-b19e-38f06c5b348b"
      unitRef="number">1.00</hr:RecapitalizationExchangeRatio>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfMy0xLTEtMS0xNTg1NTI_03ff9aaf-a7c5-4aaa-91d5-dadd926aed8a"
      unitRef="shares">228520990</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNC0xLTEtMS0xNTg1NTI_48b3d697-ef86-4a67-b194-9795ad07473d"
      unitRef="usdPerShare">24.37</us-gaap:SaleOfStockPricePerShare>
    <hr:ReverseRecapitalizationNet
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNS0xLTEtMS0xNTg1NTI_d6f36a93-2e06-4f1a-83cb-552b04762323"
      unitRef="usd">5569057000</hr:ReverseRecapitalizationNet>
    <hr:BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNi0xLTEtMS0xNTg1NTI_9d90140c-1161-4c65-b1b1-376eece6b410"
      unitRef="usd">7406000</hr:BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjNmZjFmYTdmYjk4NDQzODdhNmMyYmQyNjEwNThjOTg0L3RhYmxlcmFuZ2U6M2ZmMWZhN2ZiOTg0NDM4N2E2YzJiZDI2MTA1OGM5ODRfNy0xLTEtMS0xNTg1NTI_e8eb889f-d480-4ce6-9e66-3ecb1a7947a6"
      unitRef="usd">5576463000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwNA_5ff85c87-02a3-4e6f-92c5-222a11c50908"
      unitRef="shares">228857717</us-gaap:CommonStockSharesOutstanding>
    <hr:CommonStockFractionalShares
      contextRef="i38dceeb615dc429ea313b8089bb30136_D20220720-20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzczMA_153433d7-869e-471a-9478-916d598fc9bf"
      unitRef="shares">192</hr:CommonStockFractionalShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia43b38198f184947bc8289aeeeea08a6_I20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzc4Mw_0e492517-d18d-40d5-ab57-ffbc6b817111"
      unitRef="shares">336535</us-gaap:CommonStockSharesOutstanding>
    <hr:CommonStockSharesWithheld
      contextRef="i5d73087fbab144d6b3552bf9cf41f68f_D20220720-20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzgzMg_9f06a64b-05cd-4e86-bbfc-3853e8ab0772"
      unitRef="shares">215764</hr:CommonStockSharesWithheld>
    <hr:RecapitalizationExchangeRatio
      contextRef="i6ff7189cb9774bab8a64d0d6b568c44d_I20220720"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMzk5OA_f307d46b-cbdc-4793-ab56-67723459dd15"
      unitRef="number">1.00</hr:RecapitalizationExchangeRatio>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfODIwNQ_4d0dac20-8b50-40a3-a5f6-115aaf0451f7">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MEASUREMENT PERIOD ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;985,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;992,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,960,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(121,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,839,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;831,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;833,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;13,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land held for development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,844,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(116,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,727,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;707,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(7,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;699,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;37,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Restricted cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,123,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,122,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;216,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;209,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;205,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,177,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(100,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,076,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,227,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,244,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;173,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;184,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(855)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;203,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(11,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;191,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,635,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,646,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,541,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(111,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,429,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;145,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;111,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;257,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(c)  Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The cumulative measurement period adjustments recorded through March&#160;31, 2023 primarily resulted from updated valuations related to the Company&#x2019;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $111.9&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMy0xLTEtMS0xODI4Mzc_2d526b1c-4bc0-4102-85d9-bf18e7a3d45f"
      unitRef="usd">985926000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMy0yLTEtMS0xODY2NDQ_1b013815-799c-4dbc-af79-0b25961457ae"
      unitRef="usd">6285000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMy0zLTEtMS0xODY2NTE_ba375375-f3bf-4efe-82ae-056efda5a4eb"
      unitRef="usd">992211000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNC0xLTEtMS0xODI4Mzc_1f968ca4-7acd-49be-8e73-afbeda95a225"
      unitRef="usd">6960418000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNC0yLTEtMS0xODY2NDQ_092839a7-0e8c-4495-aa40-bf7d982203fb"
      unitRef="usd">-121413000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNC0zLTEtMS0xODY2NTE_4886e680-e90a-499a-a5ec-6a7872c12cd3"
      unitRef="usd">6839005000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNS0xLTEtMS0xODI4Mzc_600f2c2c-a146-4247-a9b6-18fd8a24f7d7"
      unitRef="usd">831920000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNS0yLTEtMS0xODY2NDQ_d9019b1a-2336-4de2-80af-6df66d18024e"
      unitRef="usd">1847000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNS0zLTEtMS0xODY2NTE_dae64982-711b-4306-9f4e-c5e9c190adff"
      unitRef="usd">833767000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNi0xLTEtMS0xODI4Mzc_0e0ef474-80eb-48ff-a95d-9c9097ce9f45"
      unitRef="usd">9874000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNi0yLTEtMS0xODY2NDQ_24122245-be42-429f-b36c-da701e61539c"
      unitRef="usd">3146000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNi0zLTEtMS0xODY2NTE_4e0e2af3-e1e2-450c-90ad-63f4800c5d22"
      unitRef="usd">13020000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNy0xLTEtMS0xODI4Mzc_7268b132-a621-4a43-9cc0-734758bb6f7a"
      unitRef="usd">10071000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNy0yLTEtMS0xODY2NDQ_b2c8ca00-0993-413b-9973-665cea4f341f"
      unitRef="usd">-6744000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfNy0zLTEtMS0xODY2NTE_a22a3ac4-4ba3-4b4d-8fb0-a66d9e0d8e2a"
      unitRef="usd">3327000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOC0xLTEtMS0xODI4Mzc_30d20e86-525a-4f73-8284-060fe819c1f3"
      unitRef="usd">46538000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOC0zLTEtMS0xODY2NTE_b829c81c-ac5c-4d74-be8d-e2bd729ff109"
      unitRef="usd">46538000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOS0xLTEtMS0xODI4Mzc_0d2dd27c-06fd-4405-bcbb-40b163839ffe"
      unitRef="usd">8844747000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOS0yLTEtMS0xODY2NDQ_b3f79862-3693-4225-9433-46258f09ce7a"
      unitRef="usd">-116879000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfOS0zLTEtMS0xODY2NTE_f64ea953-5a6f-44af-bf33-a39d7bf9c1c3"
      unitRef="usd">8727868000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTAtMS0xLTEtMTgyODM3_0ff7d6fd-3f99-46a6-bbf3-04504e32a22f"
      unitRef="usd">707442000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTAtMi0xLTEtMTg2NjQ0_600f1866-0d5d-47e0-82d2-71680cc93f07"
      unitRef="usd">-7946000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTAtMy0xLTEtMTg2NjUx_160f3fdb-be0c-48e6-95d7-350b70d3951a"
      unitRef="usd">699496000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTEtMS0xLTEtMTgyODM3_eb6037c8-5e9f-46a2-83c4-abbf1032f9fa"
      unitRef="usd">67892000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTEtMy0xLTEtMTg2NjUx_24f85acd-5034-4fca-bd33-27dc8be4b847"
      unitRef="usd">67892000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTItMS0xLTEtMTgyODM3_a468c011-c71e-447f-9323-159ca47bdcfa"
      unitRef="usd">26034000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTItMi0xLTEtMTg2NjQ0_58abe307-30ac-4fe4-9d31-5ba8effa7235"
      unitRef="usd">11403000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTItMy0xLTEtMTg2NjUx_64ecb398-a70e-4008-8974-6fd201400a23"
      unitRef="usd">37437000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTMtMS0xLTEtMTgyODM3_11ad7af9-d042-40f4-b598-6a7ab0f6d73a"
      unitRef="usd">1123647000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTMtMi0xLTEtMTg2NjQ0_4c439055-6f78-47c9-bc87-5f278542a333"
      unitRef="usd">-1247000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTMtMy0xLTEtMTg2NjUx_5f24f763-81f7-40de-9630-9d49eea44d4c"
      unitRef="usd">1122400000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTQtMS0xLTEtMTgyODM3_b48017be-6b97-4197-a4c6-d699531d13d1"
      unitRef="usd">198261000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTQtMi0xLTEtMTg2NjQ0_58411fb8-93b3-4ed9-9039-217bbb4665e3"
      unitRef="usd">17786000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTQtMy0xLTEtMTg2NjUx_2065b5e9-c5f2-4a3b-bf79-ce39fd1239d4"
      unitRef="usd">216047000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTUtMS0xLTEtMTgyODM3_cb439496-6b03-4a3a-9586-7f7e4e33e5e5"
      unitRef="usd">209163000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTUtMi0xLTEtMTg2NjQ0_2df6deef-b4ac-4f4d-8e69-8c2d107c83a8"
      unitRef="usd">-3840000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTUtMy0xLTEtMTg2NjUx_bd5a7af1-a699-42a9-9baf-acbbfe23b8b4"
      unitRef="usd">205323000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTYtMS0xLTEtMTgyODM3_ef913ee3-3a66-46b3-9da5-6bac95b12e7d"
      unitRef="usd">11177186000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTYtMi0xLTEtMTg2NjQ0_e132fe0e-edd5-4ee7-bff1-56df878172bd"
      unitRef="usd">-100723000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTYtMy0xLTEtMTg2NjUx_46ac3e4b-23d8-4ce2-96b4-794d203cdfdd"
      unitRef="usd">11076463000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTktMS0xLTEtMTgyODQx_16dd7f0e-4b53-4192-bccd-03a4187c5f58"
      unitRef="usd">3991300000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMTktMy0xLTEtMTg2NjUz_80db88a4-3212-4527-8fef-fb149b143d66"
      unitRef="usd">3991300000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjAtMS0xLTEtMTgyODQx_0b2b71fd-ad1b-4e2f-b505-99c8b5e378eb"
      unitRef="usd">1227570000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjAtMi0xLTEtMTg2NjQ5_3db248ed-b0e5-4ce3-b51a-68bda2bf260a"
      unitRef="usd">17374000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjAtMy0xLTEtMTg2NjUz_3f6ad7dc-ea7c-433e-82de-02816f0a2e6b"
      unitRef="usd">1244944000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjEtMS0xLTEtMTgyODQx_28c2ebcb-2504-4f75-bf71-fb54faf1da3a"
      unitRef="usd">28677000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjEtMi0xLTEtMTg2NjQ5_3d8bc62e-b0f8-463e-ab20-5f6c7a82785f"
      unitRef="usd">-3939000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjEtMy0xLTEtMTg2NjUz_3c668898-56ff-4879-a331-d1b85e62344c"
      unitRef="usd">24738000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjItMS0xLTEtMTgyODQx_be8f199b-8323-4153-a703-800bfc61e465"
      unitRef="usd">173948000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjItMi0xLTEtMTg2NjQ5_2cf369be-0176-4dda-a2cb-ff86d32288b8"
      unitRef="usd">10173000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjItMy0xLTEtMTg2NjUz_71215ccd-fc9b-4506-a4dd-fff027631fa0"
      unitRef="usd">184121000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjMtMS0xLTEtMTgyODQx_10b1561d-a45b-4a21-ae20-d9a55f234153"
      unitRef="usd">10720000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjMtMi0xLTEtMTg2NjQ5_f20a4fc4-ccd0-4fc5-8b31-b873dd69eed1"
      unitRef="usd">-855000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjMtMy0xLTEtMTg2NjUz_e30b8080-4dd9-45eb-abb3-160a095da883"
      unitRef="usd">9865000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjQtMS0xLTEtMTgyODQx_54e9d913-98e0-4369-83ca-5d2ea13df129"
      unitRef="usd">203210000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjQtMi0xLTEtMTg2NjQ5_efe2b622-cb4a-4d6a-bec2-19eb2477b90f"
      unitRef="usd">-11544000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjQtMy0xLTEtMTg2NjUz_64d99a05-bb35-4b00-9536-73f53e2b6509"
      unitRef="usd">191666000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjUtMS0xLTEtMTgyODQx_d7e58d84-8f81-4741-8efc-66165bc8938c"
      unitRef="usd">5635425000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjUtMi0xLTEtMTg2NjQ5_1cf0fc09-c08e-4000-8e7f-fccb8a9790e2"
      unitRef="usd">11209000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjUtMy0xLTEtMTg2NjUz_57dbf7a2-2855-40d7-a8fb-0386b68ca412"
      unitRef="usd">5646634000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjYtMS0xLTEtMTgyODQx_f4ac25ee-56f4-4072-938c-b59be3688734"
      unitRef="usd">5541761000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjYtMi0xLTEtMTg2NjQ5_9b690d61-5da6-4905-a991-5dc1b371f667"
      unitRef="usd">-111932000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjYtMy0xLTEtMTg2NjUz_7c4714a4-1d2e-48b2-aa5a-14b0a592bfd7"
      unitRef="usd">5429829000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjctMS0xLTEtMTgyODQx_59c2d199-223d-45bd-99e3-99befd64d123"
      unitRef="usd">110702000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjctMy0xLTEtMTg2NjUz_6736492e-069f-4855-891c-a319a8119116"
      unitRef="usd">110702000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:Goodwill
      contextRef="i087f313f8ce8406b9f00ee7f55180463_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjgtMS0xLTEtMTgyODQx_33fbbef9-842f-41ef-836f-11f7daf48190"
      unitRef="usd">145404000</us-gaap:Goodwill>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjgtMi0xLTEtMTg2NjQ5_19594b42-6383-4a4d-b1d3-973c095c4653"
      unitRef="usd">111932000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:Goodwill
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjgtMy0xLTEtMTg2NjUz_79618943-0f2b-478b-8a75-e8bd4cd0dafd"
      unitRef="usd">257336000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i4f544397da7c45e799ed0ca427688ada_D20220720-20220720"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMjktMC0xLTEtMTgyODI0L3RleHRyZWdpb246NjAzNGNmNWM0MWE1NDM3OThiMzNhM2NjMzZkZjM5OGNfNTQ5NzU1ODE0MDA5_e6502daf-3034-4714-8f06-c0aacf90265e">P6Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMzAtMC0xLTEtMTgyODI0L3RleHRyZWdpb246OTM2MDA3YmQzOGIzNDA2NjllMTVmZGFjMjYyYTI0ZWRfNTQ5NzU1ODEzOTc0_2e52eec1-73db-4ff1-b08c-08a42f1cfdee"
      unitRef="usd">15900000</us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount>
    <hr:BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMzEtMC0xLTEtMTgyODI0L3RleHRyZWdpb246MDg5YmIzNzkzMDI1NDc4NjgwMzc5ZGJmMGM4YmI1NzBfNTQ5NzU1ODE0MTQ5_e082cca3-0c33-4216-846c-f08a193c15aa"
      unitRef="usd">78700000</hr:BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount>
    <hr:GrossContractualRealEstateNotesReceivableFairValue
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RhYmxlOjU0OTcyYzhjMjZhYjRhM2M4NWJiZTA4MWMxMzU1OWM5L3RhYmxlcmFuZ2U6NTQ5NzJjOGMyNmFiNGEzYzg1YmJlMDgxYzEzNTU5YzlfMzEtMC0xLTEtMTgyODI0L3RleHRyZWdpb246MDg5YmIzNzkzMDI1NDc4NjgwMzc5ZGJmMGM4YmI1NzBfNTQ5NzU1ODE0MTY2_2a010c12-f835-4e4c-a213-e45faa93eb3c"
      unitRef="usd">74800000</hr:GrossContractualRealEstateNotesReceivableFairValue>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete
      contextRef="i84e0ee7220bb44c8a851edf13b274871_D20220720-20220720"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTQ5NzU1ODI3NjQy_fe9650cd-28f7-4403-b215-937e167f1bc1"
      unitRef="usd">111900000</hr:BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete>
    <us-gaap:Goodwill
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTQ5Nw_04390739-f9f1-4ad3-b057-acce99465c50"
      unitRef="usd">257300000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i2b8bd90675e2482da72656d93ecd84ff_I20220720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNTk2Mw_72a2f05b-fb21-4521-a568-881ce3ef7fbd"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <hr:MergerRelatedCosts
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfNjEzOQ_b710b880-e9eb-496c-b86d-043ca155a697"
      unitRef="usd">4900000</hr:MergerRelatedCosts>
    <hr:BusinessCombinationRefundOfTransferTaxesPaid
      contextRef="ic08326621b774b35a49a98cb55264ae0_D20230401-20230509"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF80OS9mcmFnOjJjNzhkZjMxZjY1NzRlYzliZTdlNzVhOWI5NWQ3MzkzL3RleHRyZWdpb246MmM3OGRmMzFmNjU3NGVjOWJlN2U3NWE5Yjk1ZDczOTNfMTg2OTE2OTc2OTEwMTc_bd92e4d9-f278-4a6b-9ffb-1bee7c164b46"
      unitRef="usd">17800000</hr:BusinessCombinationRefundOfTransferTaxesPaid>
    <hr:AcquisitionsAndDispositionsTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMzI5ODUzNDg5MjMwMA_809de784-7e55-4472-9d7e-97d4b852abab">Real Estate Investments&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;2023 Acquisition Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's real estate acquisition activity for the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PURCHASE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CASH&lt;br/&gt;CONSIDERATION &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;REAL &lt;br/&gt;ESTATE &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa, FL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/10/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;31,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;115,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Unconsolidated Joint Ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's investment in and loss recognized for the three months ended March&#160;31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.993%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;161,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;New investment during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;49,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Equity loss recognized during the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Owner distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(2,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;211,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;This was an additional investment in an existing joint venture representing a 40% ownership interest in a property in Dallas, Texas. Also, see 2023 Real Estate Asset Dispositions below for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;2023 Real Estate Asset Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's dispositions for the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE DISPOSED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SALE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CLOSING ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;COMPANY-FINANCED MORTGAGE NOTES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET PROCEEDS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET REAL ESTATE INVESTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER (INCLUDING RECEIVABLES) &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;GAIN/(IMPAIRMENT)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa, FL &amp;amp; Miami, FL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/12/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;93,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;224,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dallas, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;36,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;St. Louis, MO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/10/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/23/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(8,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;88,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;147,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;208,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(14,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;215,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;451,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Includes straight-line rent receivables, leasing commissions and lease inducements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes two properties, sold in two separate transactions to the same buyer on the same date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt"&gt;The Company entered into a mortgage note agreement with the buyer for $45&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company had three properties and one land parcel classified as assets held for sale as of March&#160;31, 2023. The net real estate assets held for sale includes $5.1&#160;million of impairment charges.  As of December 31, 2022, the Company had one property classified as assets held for sale as of December&#160;31, 2022, which was sold in the first quarter of 2023.  The table below reflects the assets and liabilities classified as held for sale as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance Sheet data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;15,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land held for development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,183)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hr:AcquisitionsAndDispositionsTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjk5Nw_1cc74baa-02b3-4d68-8602-b81df397fa94">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's real estate acquisition activity for the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PURCHASE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CASH&lt;br/&gt;CONSIDERATION &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;REAL &lt;br/&gt;ESTATE &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa, FL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/10/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;31,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;115,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia68c69926be842d69e158e3aa65f496d_D20230310-20230310"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS0yLTEtMS0xNTg1NTI_1027103e-a9b2-4920-ad88-8914da75ca36"
      unitRef="usd">31500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia68c69926be842d69e158e3aa65f496d_D20230310-20230310"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS01LTEtMS0xNTg1NTI_beb9f3cd-00a2-4b5d-bbc5-aee41df59d16"
      unitRef="usd">30499000</us-gaap:PaymentsToAcquireBusinessesGross>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty
      contextRef="icc48b9d4935147f39fab2c5a1786b320_I20230310"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS02LTEtMS0xNTg1NTI_9b7eccea-66cd-4168-9468-f60c3b28cab1"
      unitRef="usd">30596000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther
      contextRef="icc48b9d4935147f39fab2c5a1786b320_I20230310"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS03LTEtMS0xNTg1NTI_7596e949-e9ae-4bee-8294-921dd96ab964"
      unitRef="usd">-97000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther>
    <hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage
      contextRef="icc48b9d4935147f39fab2c5a1786b320_I20230310"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjg0NjcwODdmM2RkNzRjZWY5MDg2OGM5MjFhNzcxODk0L3RhYmxlcmFuZ2U6ODQ2NzA4N2YzZGQ3NGNlZjkwODY4YzkyMWE3NzE4OTRfMS04LTEtMS0xNTg1NTI_5bf335d1-052e-4a6a-8a71-d2452e3d6ab2"
      unitRef="sqft">115867</hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMzAwMA_e5302cf7-10e7-4eb5-94b8-c2e05d281720">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's investment in and loss recognized for the three months ended March&#160;31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.993%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;161,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;New investment during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;49,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Equity loss recognized during the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Owner distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(2,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;211,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;This was an additional investment in an existing joint venture representing a 40% ownership interest in a property in Dallas, Texas. Also, see 2023 Real Estate Asset Dispositions below for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="idf9b62f2ccf74d1caf0fe1cb85aa8f53_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfMy0xLTEtMS0xNTg1NTI_bbc0e41f-5bc0-43d7-bbae-6513c3a06af5"
      unitRef="usd">327248000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ice4cd843d7ed430a94355ee7d8beda1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfMy0yLTEtMS0xNTg1NTI_cf503d8a-e183-4819-bc09-bcf97db9a8ac"
      unitRef="usd">161942000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod
      contextRef="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNC0xLTEtMS0xNTg1NTI_19a50626-6bb1-47e1-9d54-b2fac761b70e"
      unitRef="usd">3824000000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod
      contextRef="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNC0yLTEtMS0xNTg1NTI_92323744-22d8-4fe8-82aa-841c2745bd53"
      unitRef="usd">49598000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNS0xLTEtMS0xNTg1NTI_b553ef9d-d851-41c4-98ad-24faa975eaf2"
      unitRef="usd">-780000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNS0yLTEtMS0xNTg1NTI_34261443-9818-4fb0-9b04-152414cfd121"
      unitRef="usd">-345000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared
      contextRef="iecc334b7e1914fa489a0d5626367ec7d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNy0xLTEtMS0xNTg1NTI_92826ee9-af21-4200-aa0a-42c9aa228d41"
      unitRef="usd">2546000000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared
      contextRef="i898a404a3f734233af6f2b4ec9081bf4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfNy0yLTEtMS0xNTg1NTI_83fcbc2b-cad0-4342-bd81-f3a5fcc5af7b"
      unitRef="usd">0</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i56812fb447b14ad19ca71a303ab09954_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfOC0xLTEtMS0xNTg1NTI_41c152ac-6200-40ef-9003-b9578015803d"
      unitRef="usd">327746000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i07320f4bb515447592164daec5eb7b4f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjYxYzgxYjE5ZDYxMDQxODc5MjQwMDljM2U1YTFjNDJmL3RhYmxlcmFuZ2U6NjFjODFiMTlkNjEwNDE4NzkyNDAwOWMzZTVhMWM0MmZfOC0yLTEtMS0xNTg1NTI_969a4a3b-7aa0-45fa-b4eb-90e5b8d62a32"
      unitRef="usd">211195000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <hr:JointVentureOwnershipPercentage
      contextRef="ia37031f8ec15470d97f1001738e8c72e_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMTQwNQ_d63a7625-a2d8-46c1-909b-d021112d39e9"
      unitRef="number">0.40</hr:JointVentureOwnershipPercentage>
    <hr:AssetDispositionsTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjk3MQ_1288df7b-f6d8-4ae3-8d39-bffaa6d5a87e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's dispositions for the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE DISPOSED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SALE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CLOSING ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;COMPANY-FINANCED MORTGAGE NOTES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET PROCEEDS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET REAL ESTATE INVESTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER (INCLUDING RECEIVABLES) &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;GAIN/(IMPAIRMENT)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa, FL &amp;amp; Miami, FL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/12/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;93,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;224,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dallas, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;36,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;St. Louis, MO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/10/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/23/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(8,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;88,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;147,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;208,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(14,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;215,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;451,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Includes straight-line rent receivables, leasing commissions and lease inducements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes two properties, sold in two separate transactions to the same buyer on the same date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt"&gt;The Company entered into a mortgage note agreement with the buyer for $45&#160;million.&lt;/span&gt;&lt;/div&gt;</hr:AssetDispositionsTableTextBlock>
    <hr:DispositionSalesPrice
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS0yLTEtMS0xNTg1NTI_e8b2e492-ce82-4f27-a347-a8ce41a8a4ce"
      unitRef="usd">93250000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS0zLTEtMS0xNTg1NTI_cf0f8f67-3506-4e2a-b496-e72ed6d4f1f5"
      unitRef="usd">5875000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS00LTEtMS0xNzU2NTg_47c1c826-0a5b-4ca0-a71f-0e30775b9a01"
      unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="i725103bec26f4bffb5131168df379059_D20230112-20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS00LTEtMS0xNTg1NTI_2a2f4019-2005-492a-a3c6-3295407a4dab"
      unitRef="usd">87375000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS01LTEtMS0xNTg1NTI_42c4762f-fc8b-4ac4-8935-7d068a975380"
      unitRef="usd">87302000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS02LTEtMS0xNTg1NTI_e28c5512-b462-4622-a0f2-19f8661d5d7d"
      unitRef="usd">-888000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i725103bec26f4bffb5131168df379059_D20230112-20230112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS03LTEtMS0xNTg1NTI_24df2d00-719d-49c9-aa41-df0bf6cfd50a"
      unitRef="usd">961000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMS04LTEtMS0xNTg1NTI_00241005-9071-4362-a258-5eac6452ea54"
      unitRef="sqft">224037</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice
      contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi0yLTEtMS0xNTg1NTI_a379d805-5b7a-404a-9200-30a67752a7c2"
      unitRef="usd">19210000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity
      contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi0zLTEtMS0xNTg1NTI_0d443edf-5eef-4fca-8c44-95071d9aa3a5"
      unitRef="usd">141000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes
      contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi00LTEtMS0xNzU2Mzc_72cd05ec-9753-44c7-95dc-3bd7ede8aedf"
      unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi00LTEtMS0xNTg1NTI_e9407062-3726-4e72-be55-f27ff3e25173"
      unitRef="usd">19069000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod
      contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi01LTEtMS0xNTg1NTI_5cbaf3f3-f107-4131-8130-38bcc3856bf2"
      unitRef="usd">18986000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther
      contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi02LTEtMS0xNTg1NTI_16802499-06f8-4196-ae6e-6e53c63bd895"
      unitRef="usd">43000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi03LTEtMS0xNTg1NTI_b96e5e61-3a56-4352-abc7-13732286696f"
      unitRef="usd">40000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits
      contextRef="ia3a0a3d843eb40aaacaf37e42141819f_I20230130"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMi04LTEtMS0xNTg1NTI_73b37993-585e-4c3d-a62f-f307a47c8704"
      unitRef="sqft">36691</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice
      contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy0yLTEtMS0xNTg1NTI_ef584e75-8aca-44ae-9ab8-a91ed6329dca"
      unitRef="usd">350000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity
      contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy0zLTEtMS0xNTg1NTI_63421e70-ef97-4f77-be48-3894135cf794"
      unitRef="usd">18000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes
      contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy00LTEtMS0xNzU2Mzc_9d88730b-acf0-401e-a3ea-19fcc4f28c94"
      unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="ibfe535f3ab724e7f8cc93404389ae2d3_D20220729-20220729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy00LTEtMS0xNTg1NTI_779a3b0b-43dc-4007-86b6-81951111d7b4"
      unitRef="usd">332000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod
      contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy01LTEtMS0xNTg1NTI_6b814d7a-052d-4c22-bb4f-fe92fbee43bf"
      unitRef="usd">398000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther
      contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy02LTEtMS0xNTg1NTI_d311fd32-283e-4898-8275-2c6be6bc6997"
      unitRef="usd">0</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ibfe535f3ab724e7f8cc93404389ae2d3_D20220729-20220729"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy03LTEtMS0xNTg1NTI_69b2c21a-bf2b-41be-9dc6-bd71206ce705"
      unitRef="usd">-66000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits
      contextRef="i68ab3bb9fe8d450ba5d5454fae157789_I20230210"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfMy04LTEtMS0xNTg1NTI_fbf9ede1-19e6-4f04-9595-f1ad0ce529ae"
      unitRef="sqft">6500</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice
      contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC0yLTEtMS0xNTg1NTI_e0759a7f-eec9-41a7-84d4-cf0abc2770bb"
      unitRef="usd">21000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity
      contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC0zLTEtMS0xNTg1NTI_5c217a74-6452-4873-9697-3b74d9832d60"
      unitRef="usd">526000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes
      contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC00LTEtMS0xNzU2Mzc_f71c9c8d-2f16-40c2-b9b6-a1bd0dab819a"
      unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="i8a3ca7980f634d5a877d7ea584c4b463_D20230323-20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC00LTEtMS0xNTg1NTI_1308a905-bbec-43a3-b491-f4feadf14d43"
      unitRef="usd">20474000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod
      contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC01LTEtMS0xNTg1NTI_dcaa8008-9d10-435f-a9a1-a224c447d3f2"
      unitRef="usd">20610000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther
      contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC02LTEtMS0xNTg1NTI_76f0e2f4-3ddd-49e9-aa48-3dfe2c4ccce9"
      unitRef="usd">52000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i8a3ca7980f634d5a877d7ea584c4b463_D20230323-20230323"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC03LTEtMS0xNTg1NTI_0ff7f68b-4690-4264-9373-6bf2b3cd2db3"
      unitRef="usd">-188000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits
      contextRef="i8cdf6d5c68bf451d8dd949582d91f420_I20230323"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNC04LTEtMS0xNTg1NTI_811b3453-7c7c-4500-9e17-660f172a0e76"
      unitRef="sqft">37165</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice
      contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS0yLTEtMS0xNTg1NTI_2cbf0b2c-68ec-4a35-bff0-2314e8e76b3d"
      unitRef="usd">75000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity
      contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS0zLTEtMS0xNTg1NTI_df0a4b64-51b5-4873-b5d0-150955fe82bb"
      unitRef="usd">8079000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes
      contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS00LTEtMS0xNzU2Mzc_3b48e3bf-80ab-49a2-8c3a-bf7be13b268a"
      unitRef="usd">45000000</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="ic8386a9bdaee48faab027ec1bc916259_D20230330-20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS00LTEtMS0xNTg1NTI_59445be4-eea9-4df0-a8a7-6fa1cc7281ae"
      unitRef="usd">21921000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod
      contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS01LTEtMS0xNTg1NTI_960c98af-b03e-47bd-b405-d1dda7256380"
      unitRef="usd">88624000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther
      contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS02LTEtMS0xNTg1NTI_e859e36a-df6f-46b1-9558-ba680ac9a5ac"
      unitRef="usd">-803000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ic8386a9bdaee48faab027ec1bc916259_D20230330-20230330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS03LTEtMS0xNTg1NTI_df2bc436-df18-41f3-9cc8-be7542942dea"
      unitRef="usd">-20900000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits
      contextRef="i2af2c84b56b24addb398070e5b1786eb_I20230330"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfNS04LTEtMS0xNTg1NTI_4a1639ec-311b-4aa0-9689-fd95ea7f5b50"
      unitRef="sqft">147078</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice
      contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS0yLTEtMS0xNTg1NTI_75f974ac-ddd4-4c64-b688-c0dd0c0a6a48"
      unitRef="usd">208810000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity
      contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS0zLTEtMS0xNTg1NTI_083d76b6-5bed-40f1-a5bf-091a078e784d"
      unitRef="usd">14639000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS00LTEtMS0xNzczODU_4f1f5c69-f267-4d10-88fa-4f35aa0fd4fb"
      unitRef="usd">45000000</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="ic5bcc13d9ac1449aafbef97302a864de_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS00LTEtMS0xNTg1NTI_67faf0dd-54e5-4f67-b055-60297557fcc7"
      unitRef="usd">149171000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod
      contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS01LTEtMS0xNTg1NTI_2564aa3e-81a0-4cb0-91ac-72f479863a21"
      unitRef="usd">215920000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther
      contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS02LTEtMS0xNTg1NTI_dba5998d-07c3-4065-b572-1c7d5e452950"
      unitRef="usd">-1596000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ic5bcc13d9ac1449aafbef97302a864de_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS03LTEtMS0xNTg1NTI_3cec691c-47aa-409a-9aab-21d259318b97"
      unitRef="usd">-20153000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits
      contextRef="i529066ab980943059fbf1ea25e1ecf1a_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOmY2NDE3YWE5YjQ4NzQ4NjY4ZDEwYWNiZGM0OWJkYTU1L3RhYmxlcmFuZ2U6ZjY0MTdhYTliNDg3NDg2NjhkMTBhY2JkYzQ5YmRhNTVfOS04LTEtMS0xNTg1NTI_8c93bc72-e45c-4357-ad26-c4125f739282"
      unitRef="sqft">451471</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM1Nw_b55ebf54-be2f-4a30-8cea-755d591b0725"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <hr:NumberOfPropertyDispositions
      contextRef="i01f64aacd4d546bb928367d1fc3b2934_I20230112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM1Ng_1d60eefd-ede3-4b4d-a8a3-33a356bf0714"
      unitRef="disposition_transaction">2</hr:NumberOfPropertyDispositions>
    <hr:JointVentureOwnershipPercentage
      contextRef="i7cf98b9715e3467387110eeff1ec429c_D20230130-20230130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjEwMg_7d741d09-5654-4500-8d55-3717e52be1cc"
      unitRef="number">0.40</hr:JointVentureOwnershipPercentage>
    <hr:MortgageNote
      contextRef="i0fbb705c06f14ee2aba7350a87fa6205_I20230330"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMzg0ODI5MDcwNDIxNw_533d3fee-e152-4b2b-9c35-dfd2be8e5f73"
      unitRef="usd">45000000</hr:MortgageNote>
    <hr:NumberOfPropertiesClassifiedAsHeldForSale
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM3Mw_e599f0dc-bd3f-4a9b-862d-3a28837cb3b3"
      unitRef="property">3</hr:NumberOfPropertiesClassifiedAsHeldForSale>
    <hr:NumberOfLandParcelsClassifiedAsHeldForSale
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM3NA_f10f54a9-e05a-4ff9-8665-a539a7fa4063"
      unitRef="land_parcel">1</hr:NumberOfLandParcelsClassifiedAsHeldForSale>
    <hr:ImpairmentChargeOnRealEstateAssetsHeldForSale
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMTc1OTIxODYwNTQzOTk_cad5263e-fb9d-49bc-80d0-b4e8df35775e"
      unitRef="usd">5100000</hr:ImpairmentChargeOnRealEstateAssetsHeldForSale>
    <hr:NumberOfPropertiesClassifiedAsHeldForSale
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjE5OTAyMzI2NTM3NQ_8c112e0a-284e-4eae-9ae5-cab79b840b30"
      unitRef="property">1</hr:NumberOfPropertiesClassifiedAsHeldForSale>
    <hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RleHRyZWdpb246MmZhZDVmNjZiNDFkNGUwNjg1MGEyZWZjYzA1YWQ5M2ZfMjk3Mg_3f992f1f-c2dc-40e9-802d-8c2f664c7416">The table below reflects the assets and liabilities classified as held for sale as of March&#160;31, 2023 and December&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance Sheet data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;15,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land held for development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,183)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock>
    <us-gaap:Land
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMi0yLTEtMS0xNTg1NTI_a343ebca-9992-4f2b-81b8-bf013bcfc6c9"
      unitRef="usd">205000</us-gaap:Land>
    <us-gaap:Land
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMi00LTEtMS0xNTg1NTI_f32c0372-91c3-4940-b6bb-db96f3db8f80"
      unitRef="usd">1700000</us-gaap:Land>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMy0yLTEtMS0xNTg1NTI_eebd7296-14f6-49e8-b26e-b8ceb1f16b3b"
      unitRef="usd">1736000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMy00LTEtMS0xNTg1NTI_95d08fef-20ea-42d8-ace1-c53e622a6a6a"
      unitRef="usd">15164000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <hr:LeaseIntangibles
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNC0yLTEtMS0xNTg1NTI_b2da23f6-2399-46b1-b47b-9692795931f8"
      unitRef="usd">2242000</hr:LeaseIntangibles>
    <hr:LeaseIntangibles
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNC00LTEtMS0xNTg1NTI_88fa0b12-f2ec-47ba-9b0d-eae218c144ca"
      unitRef="usd">1986000</hr:LeaseIntangibles>
    <us-gaap:LandAvailableForDevelopment
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC0yLTEtMS0xNzQyMzc_15a39ea7-4117-4d14-be7b-2dc77bf3b7a4"
      unitRef="usd">3251000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:LandAvailableForDevelopment
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC00LTEtMS0xNzQyMzc_99b16896-2324-452a-b322-619338111dc7"
      unitRef="usd">0</us-gaap:LandAvailableForDevelopment>
    <us-gaap:RealEstateInvestmentPropertyAtCost
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNy0yLTEtMS0xNTg1NTI_259803b1-f9d8-460b-99ad-c634bb0bcb54"
      unitRef="usd">7434000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAtCost
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfNy00LTEtMS0xNTg1NTI_9c2d3386-8d75-43c3-9f81-a167077d5e12"
      unitRef="usd">18850000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC0yLTEtMS0xNTg1NTI_ddc47e04-6a30-4bda-bf9d-efc713a5e984"
      unitRef="usd">4183000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOC00LTEtMS0xNTg1NTI_3ed8909e-1324-4a22-bfc9-7522ccb3135a"
      unitRef="usd">0</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOS0yLTEtMS0xNTg1NTI_342e4198-223a-49d6-961d-714af01b293f"
      unitRef="usd">3251000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfOS00LTEtMS0xNTg1NTI_dfdcdd71-4194-48a2-a18c-feb101dbe435"
      unitRef="usd">18850000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTEtMi0xLTEtMTU4NTUy_9a06debd-4a92-4e2b-b896-e781ff1d98c0"
      unitRef="usd">328000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTEtNC0xLTEtMTU4NTUy_6ea7ccb4-f36d-4f00-bbaa-2feb60a7d8ad"
      unitRef="usd">43000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTItMi0xLTEtMTU4NTUy_c89c9fb8-d80b-4356-97e1-0bf081817d54"
      unitRef="usd">3579000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTItNC0xLTEtMTU4NTUy_7909e128-c81c-461b-830c-e3d824369b18"
      unitRef="usd">18893000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTQtMi0xLTEtMTU4NTUy_93953301-114e-41cb-8b90-f1ff071779fa"
      unitRef="usd">277000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTQtNC0xLTEtMTU4NTUy_5603198c-6848-4caa-8eb4-20f7a9d866fb"
      unitRef="usd">282000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTctMi0xLTEtMTU4NTUy_673a721a-be27-4caf-ac0a-d12a99fc43d9"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTctNC0xLTEtMTU4NTUy_5259f1fb-56f0-4866-adc0-df35d9052e85"
      unitRef="usd">155000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="icdfe172a798c48d69a472a992f819b18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTgtMi0xLTEtMTU4NTUy_7ff84873-56e7-45cf-b1bb-039a4db8471e"
      unitRef="usd">277000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ia9c9d92cd2ee48a68b634a7ee7442252_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81Mi9mcmFnOjJmYWQ1ZjY2YjQxZDRlMDY4NTBhMmVmY2MwNWFkOTNmL3RhYmxlOjRjYzE5MzNmOTFjZDQwYWI5YTczZWU2NzUxMWQ0NWFjL3RhYmxlcmFuZ2U6NGNjMTkzM2Y5MWNkNDBhYjlhNzNlZTY3NTExZDQ1YWNfMTgtNC0xLTEtMTU4NTUy_4288ee81-33e8-499d-8a50-40cf40a13d9e"
      unitRef="usd">437000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3MA_408889f8-8594-4dbb-9559-ef328414755f">Leases&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#x2019;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three months ended March&#160;31, 2023 was $324.1 million.  Lease income for the Company's operating leases recognized for the three months ended March 31, 2022 was $138.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;695,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;833,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;720,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;620,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;539,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,854,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,263,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessee Accounting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#x2019;s ground leases. As of March&#160;31, 2023, the Company had 242 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#x2019;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of March&#160;31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#x2019;s rental expense for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;939,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,010,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;406,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(730,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(333,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;279,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;73,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;40,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;61.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3MQ_e3776140-6d3b-451d-8605-a9fde89e4a0d">Leases&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#x2019;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three months ended March&#160;31, 2023 was $324.1 million.  Lease income for the Company's operating leases recognized for the three months ended March 31, 2022 was $138.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;695,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;833,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;720,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;620,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;539,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,854,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,263,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessee Accounting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#x2019;s ground leases. As of March&#160;31, 2023, the Company had 242 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#x2019;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of March&#160;31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#x2019;s rental expense for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;939,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,010,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;406,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(730,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(333,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;279,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;73,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;40,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;61.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMTM3MQ_fbc39013-9bb4-46de-a115-715866e3aee5"
      unitRef="usd">324100000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMTUxNA_c1494214-211a-4b37-9f3e-a6ec8f4795ef"
      unitRef="usd">138500000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3NA_028d70f8-749f-47bd-a7e5-f51983fc7344">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;695,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;833,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;720,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;620,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;539,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,854,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,263,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfMS0xLTEtMS0xNTg1NTI_d7a7e463-e8fe-4567-8257-506f809bfacf"
      unitRef="usd">695787000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfMi0xLTEtMS0xNTg1NTI_7fbbe295-2901-4fc6-8c6f-fe6774f98e54"
      unitRef="usd">833006000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfMy0xLTEtMS0xNTg1NTI_dc53ebec-c831-4a82-8d6c-a7f095a7759e"
      unitRef="usd">720985000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNC0xLTEtMS0xNTg1NTI_9a136dce-a7c6-4e34-b360-1ad077f901f4"
      unitRef="usd">620118000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNS0xLTEtMS0xNTg1NTI_2430f8de-b5e1-41c7-89af-d64907632c3b"
      unitRef="usd">539486000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNi0xLTEtMS0xNTg1NTI_dd26b15a-983c-470b-ab16-5ca94723aa69"
      unitRef="usd">1854402000</hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOmE2MTZhNDY4ODhkOTQ2ODQ5MmUxMzk0M2NiODBiZWMwL3RhYmxlcmFuZ2U6YTYxNmE0Njg4OGQ5NDY4NDkyZTEzOTQzY2I4MGJlYzBfNy0xLTEtMS0xNTg1NTI_c840e231-5e7f-4772-b747-37d9b7c99b6d"
      unitRef="usd">5263784000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:NumberOfPropertiesSubjectToGroundLeases
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjI5NA_58b7295f-917c-491e-92ef-50fdea78c37d"
      unitRef="property">242</us-gaap:NumberOfPropertiesSubjectToGroundLeases>
    <hr:SquareFeetSubjecttoGroundLeases
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjMxNw_7904b269-f091-4a5f-a0cb-c5443eacbad3"
      unitRef="sqft">17800000</hr:SquareFeetSubjecttoGroundLeases>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i520bdadf3a0e4877a0654af6dea318b7_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjU0MA_e2a8560e-51c7-4b8b-951e-595893cc6b89">P40Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iedc8351cf7d14a358450c7736f9cb778_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjU0Ng_2e18af8d-355e-4501-b85b-9ac0ef467e0c">P99Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <hr:NumberofGroundLeasesPrepaid
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjcxMA_d078e269-f597-4b78-b459-c84992bd8332"
      unitRef="lease">75</hr:NumberofGroundLeasesPrepaid>
    <hr:AmortizationofPrepaidRent
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjg2MQ_7fcd20c0-0330-4360-b90e-1fdae4eb0241"
      unitRef="usd">300000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMjg2OA_bafc4944-fc0e-434d-af16-ad9db0c53603"
      unitRef="usd">100000</hr:AmortizationofPrepaidRent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI3Nw_fd957f5f-c1c5-4d58-9435-8fde9ca2ec41">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;939,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,010,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;406,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(730,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(333,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;279,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;73,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI4NQ_52b73c8a-b701-4386-8413-5598eb8db40d">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 167 non-prepaid ground leases) as of March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;939,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,010,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;406,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(730,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(333,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;279,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;73,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <hr:NumberofGroundLeasesExcludingPrepaidLeases
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzA5NQ_1a5b3a74-8c50-4825-9fce-34f2cbe64246"
      unitRef="property">167</hr:NumberofGroundLeasesExcludingPrepaidLeases>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMS0xLTEtMS0xNTg1NTI_7ad9b2d5-a8c1-4328-9c43-2a7be19fa3f7"
      unitRef="usd">11188000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMS0yLTEtMS0xNTg1NTI_96ddfe08-c3d5-40cd-aac1-c79a00fd74b0"
      unitRef="usd">1491000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMi0xLTEtMS0xNTg1NTI_8d8b435d-2df4-48ae-a37c-a11800d9899d"
      unitRef="usd">15239000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMi0yLTEtMS0xNTg1NTI_db5959a5-b06e-42a8-a0bf-b765175cf23b"
      unitRef="usd">2182000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMy0xLTEtMS0xNTg1NTI_c3c8a0f8-7626-47df-98df-f3b802a96c85"
      unitRef="usd">14827000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfMy0yLTEtMS0xNTg1NTI_d92eba19-71c0-4c87-ac54-ae6845bbf529"
      unitRef="usd">2218000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNC0xLTEtMS0xNTg1NTI_d2b20319-5fda-44e9-bf73-97e6f76de1a8"
      unitRef="usd">14863000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNC0yLTEtMS0xNTg1NTI_7e7c5e0d-b91c-414c-9634-e187ee76d153"
      unitRef="usd">2255000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNS0xLTEtMS0xNTg1NTI_d0200b11-300d-49c8-8483-0159a2f9382e"
      unitRef="usd">14933000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNS0yLTEtMS0xNTg1NTI_086f5104-4b20-4eb2-a283-84f40697d4c1"
      unitRef="usd">2294000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNi0xLTEtMS0xNTg1NTI_7f62f893-cb0e-4fc1-b8ac-7640215faeb4"
      unitRef="usd">939392000</hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <hr:FinanceLeaseLiabilityToBePaidAfterYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNi0yLTEtMS0xNTg1NTI_9495fa7e-0718-411c-9f5d-f8217fc799e5"
      unitRef="usd">396398000</hr:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNy0xLTEtMS0xNTg1NTI_821eae9e-d540-4c44-b7f4-47475619742c"
      unitRef="usd">1010442000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfNy0yLTEtMS0xNTg1NTI_894f6929-e4e7-4281-a985-99269d21a9a7"
      unitRef="usd">406838000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOC0xLTEtMS0xNTg1NTI_8afe8e38-7810-4fc3-88be-dea0c8603536"
      unitRef="usd">730805000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOC0yLTEtMS0xNTg1NTI_310c31bf-4e80-4e3f-948e-c7f37c353a62"
      unitRef="usd">333645000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOS0xLTEtMS0xNTg1NTI_b7ad7897-0f01-46ef-8c26-8c4f9dc482d4"
      unitRef="usd">279637000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjk2MWFiMDk4YmMyZTQyNzc4NGVlZWIzOTRiZDM0NmE5L3RhYmxlcmFuZ2U6OTYxYWIwOThiYzJlNDI3Nzg0ZWVlYjM5NGJkMzQ2YTlfOS0yLTEtMS0xNTg1NTI_ca475f03-aaf1-458d-b379-6c4353c603a1"
      unitRef="usd">73193000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RleHRyZWdpb246NzkzZTk4MDBjMjIzNDYxM2I4NjYzZTM3MjE5MDE2MDBfMzI4Mw_04399857-2e90-404b-90cd-fcdedff4c204">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.259%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;40,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;61.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMy0xLTEtMS0xNTg1NTI_f2515288-82a3-4f92-a092-3b2b0234e203"
      unitRef="usd">5107000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMy0yLTEtMS0xNTg1NTI_702d5c2c-cc57-4f71-850a-ef3ad30509ed"
      unitRef="usd">1215000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNC0xLTEtMS0xNTg1NTI_0317912c-1011-474b-a310-5a4ea74e675c"
      unitRef="usd">2136000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNC0yLTEtMS0xNTg1NTI_1400f9bb-d847-46f4-a2f4-3785ae45a8f0"
      unitRef="usd">1024000</us-gaap:VariableLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNy0xLTEtMS0xNTg1NTI_c54eb0d4-2ff3-4a50-a6be-a70c3a846f7d"
      unitRef="usd">388000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfNy0yLTEtMS0xNTg1NTI_11c35288-8f04-466e-a583-2552f2420cb0"
      unitRef="usd">172000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOC0xLTEtMS0xNTg1NTI_74b95696-5e7f-4d0b-b743-0f0bbf5a0c90"
      unitRef="usd">918000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOC0yLTEtMS0xNTg1NTI_4a33b5ab-df17-45e1-9a02-730a41100176"
      unitRef="usd">287000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOS0xLTEtMS0xNTg1NTI_7c1dbdc0-2015-444d-ae67-bae6a5983ef6"
      unitRef="usd">8549000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfOS0yLTEtMS0xNTg1NTI_6d3a0af5-77cf-4b39-bd63-175e030a7df8"
      unitRef="usd">2698000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTItMS0xLTEtMTU4NTUy_6c236a3a-7d5a-4dfb-81be-de51e556e8d0"
      unitRef="usd">5960000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTItMi0xLTEtMTU4NTUy_9b27af37-f913-4a8d-ad75-bfbadc634110"
      unitRef="usd">2797000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTMtMS0xLTEtMTU4NTUy_6899285a-d833-40dc-8bb3-20d4f89defd1"
      unitRef="usd">553000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTMtMi0xLTEtMTU4NTUy_2a8cf01c-1a3a-489e-8f87-55af1782f974"
      unitRef="usd">258000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <hr:FinanceLeasePrincipalOnlyPayments
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTQtMS0xLTEtMTU4NTUy_37473488-725f-4926-ae97-5de1a7ef6c58"
      unitRef="usd">101000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTQtMi0xLTEtMTU4NTUy_089e1026-20db-453f-9cce-5efd9558efda"
      unitRef="usd">257000</hr:FinanceLeasePrincipalOnlyPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTUtMS0xLTEtMTU4NTUy_9aa7b44f-0c68-468d-9412-9629b8f46386"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTUtMi0xLTEtMTU4NTUy_5b277c58-3db4-4640-b37a-e9aefd89aceb"
      unitRef="usd">40589000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTgtMS0xLTEtMTU4NTUy_6d071692-3ed0-4a3c-948d-2ec634e114bf">P47Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTgtMi0xLTEtMTU4NTUy_faadff33-8dfb-4e2a-8f9b-0969ffb41421">P47Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTktMS0xLTEtMTU4NTUy_057af760-801b-4cbf-9232-ed44769a9d54">P58Y8M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMTktMi0xLTEtMTU4NTUy_97765c37-5ac8-4190-8341-0b1ece7f29ea">P61Y10M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjAtMS0xLTEtMTU4NTUy_45bd1b56-96e9-4fc6-8d3c-8e32553a3121"
      unitRef="number">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjAtMi0xLTEtMTU4NTUy_6daf6fc7-a64e-4016-a931-e26883f9c4d3"
      unitRef="number">0.056</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjEtMS0xLTEtMTU4NTUy_e644bcc7-45e5-4589-8ca3-8cbe1b935466"
      unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ie0a3d6af7aef4e6eb829ef02df08cef8_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81NS9mcmFnOjc5M2U5ODAwYzIyMzQ2MTNiODY2M2UzNzIxOTAxNjAwL3RhYmxlOjdiMmJmNzVmZjAyODQwMzhiOTJkYzRhOGY5MTI2NTBhL3RhYmxlcmFuZ2U6N2IyYmY3NWZmMDI4NDAzOGI5MmRjNGE4ZjkxMjY1MGFfMjEtMi0xLTEtMTU4NTUy_f523b400-a91a-435b-841e-2a0a062ed8ec"
      unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTA5_c5051520-71f8-44bb-93ec-7c2af6b57b90">Other Assets and Liabilities&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022 are detailed in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;99,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Straight-line rent receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;98,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;88,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Prepaid assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;88,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;81,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Above-market intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;85,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;80,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;47,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Additional long-lived assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;22,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;21,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investment in securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Debt issuance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Project costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net investment in lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Customer relationship intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;534,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;469,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;This amount includes an allowance for credit losses.  See Note 1 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;This amount represents the value of the Company's preferred stock investment in a data analytics platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;78,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;35,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;57,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;50,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other operating accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;42,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;58,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;155,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;244,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Below-market intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;96,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;97,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;90,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;87,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;29,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;232,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;218,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTEw_8daf13b5-528c-41b0-a0fc-9183f8767219">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022 are detailed in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;99,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Straight-line rent receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;98,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;88,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Prepaid assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;88,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;81,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Above-market intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;85,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;80,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;47,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Additional long-lived assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;22,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;21,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investment in securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Debt issuance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Project costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net investment in lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Customer relationship intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;534,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;469,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;This amount includes an allowance for credit losses.  See Note 1 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;This amount represents the value of the Company's preferred stock investment in a data analytics platform.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <hr:RealEstateNotesReceivableNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMS0yLTEtMS0xNTg1NTI_09c3087e-d7de-47fb-b82b-669200ea1f35"
      unitRef="usd">147326000</hr:RealEstateNotesReceivableNet>
    <hr:RealEstateNotesReceivableNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMS00LTEtMS0xNTg1NTI_4eeec86e-2c60-4a05-9aa8-b3b9742656d3"
      unitRef="usd">99643000</hr:RealEstateNotesReceivableNet>
    <us-gaap:DeferredRentReceivablesNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMi0yLTEtMS0xNTg1NTI_ff924b36-15c0-4eb1-ac74-1fcfb5fe1873"
      unitRef="usd">98923000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMi00LTEtMS0xNTg1NTI_58a921e9-72ec-4081-b733-b81413ec5cb0"
      unitRef="usd">88868000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMy0yLTEtMS0xNTg1NTI_de3ad6ee-66b6-45ff-998a-2df9901317f6"
      unitRef="usd">88694000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMy00LTEtMS0xNTg1NTI_ac1f1a4a-e11b-43b8-b4a5-d7bd7ee3fd96"
      unitRef="usd">81900000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <hr:AboveMarketLeaseIntangibleAssetsNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNC0yLTEtMS0xNTg1NTI_04bf1f63-89fa-4491-a6b8-528fecc38eda"
      unitRef="usd">85100000</hr:AboveMarketLeaseIntangibleAssetsNet>
    <hr:AboveMarketLeaseIntangibleAssetsNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNC00LTEtMS0xNTg1NTI_971fe456-7770-4389-9198-d501cf5c7191"
      unitRef="usd">80720000</hr:AboveMarketLeaseIntangibleAssetsNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNS0yLTEtMS0xNTg1NTI_667e8136-2737-4862-a866-5781f1868e3e"
      unitRef="usd">48676000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNS00LTEtMS0xNTg1NTI_a0704fee-d5bc-4dd8-868d-c667b2366c00"
      unitRef="usd">47498000</us-gaap:AccountsReceivableNet>
    <us-gaap:NoncurrentAssets
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNi0yLTEtMS0xNTg1NTI_b271758f-d023-4016-b29d-d5dc5b47afa9"
      unitRef="usd">22173000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNi00LTEtMS0xNTg1NTI_92ea52c2-fbd9-4f45-b7e0-d7d893bc3e85"
      unitRef="usd">21446000</us-gaap:NoncurrentAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNy0yLTEtMS0xNTg1NTI_a9e1ff94-ed1d-4327-9b50-eebb0184c2a7"
      unitRef="usd">9767000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfNy00LTEtMS0xNTg1NTI_604e3f84-d930-4049-8486-2ffa5b589dfa"
      unitRef="usd">14512000</us-gaap:DerivativeAssets>
    <us-gaap:OtherReceivables
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC0yLTEtMS0xNzY5NzA_0b0c42eb-e59c-40c8-b83f-96de74e34b42"
      unitRef="usd">6011000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC00LTEtMS0xNzY5NzM_964a2482-7a61-4d34-baef-f2f8a4e6652b"
      unitRef="usd">6011000</us-gaap:OtherReceivables>
    <hr:GroundLeaseModificationNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC0yLTEtMS0xNTg1NTI_7a75426a-4025-4d2e-86c4-4705f163b8ea"
      unitRef="usd">5962000</hr:GroundLeaseModificationNet>
    <hr:GroundLeaseModificationNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfOC00LTEtMS0xNTg1NTI_b3468e9d-44f5-4c4c-869e-258eef22ea94"
      unitRef="usd">7169000</hr:GroundLeaseModificationNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTAtMi0xLTEtMTU4NTUy_79bb9c1b-5b87-43d0-bed3-972fada7469d"
      unitRef="usd">5449000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTAtNC0xLTEtMTU4NTUy_9d95f85b-65d9-458d-a537-de545be8ea4f"
      unitRef="usd">5977000</us-gaap:DeferredFinanceCostsNet>
    <hr:ConstructionActivityTotalFundingToDate
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTEtMi0xLTEtMTU4NTUy_310df92f-449c-4403-a6d9-27d7f5c4bb08"
      unitRef="usd">4900000</hr:ConstructionActivityTotalFundingToDate>
    <hr:ConstructionActivityTotalFundingToDate
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTEtNC0xLTEtMTU4NTUy_305a6a7b-3502-44d4-8bfd-532659f2fe3a"
      unitRef="usd">4337000</hr:ConstructionActivityTotalFundingToDate>
    <us-gaap:NetInvestmentInLease
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTItMi0xLTEtMTU4NTUy_7a5e93e1-c493-4abc-a542-5f0742211cbd"
      unitRef="usd">1828000</us-gaap:NetInvestmentInLease>
    <us-gaap:NetInvestmentInLease
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTItNC0xLTEtMTU4NTUy_bf87e7db-7d65-4f82-a8c4-3c984432eba6"
      unitRef="usd">1828000</us-gaap:NetInvestmentInLease>
    <hr:FiniteLivedCustomerRelationshipsNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTMtMi0xLTEtMTU4NTUy_c1b034df-0684-485a-9d4a-72362761865e"
      unitRef="usd">1106000</hr:FiniteLivedCustomerRelationshipsNet>
    <hr:FiniteLivedCustomerRelationshipsNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTMtNC0xLTEtMTU4NTUy_927de071-5630-490c-8ceb-c7bcd186d3a1"
      unitRef="usd">1120000</hr:FiniteLivedCustomerRelationshipsNet>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTQtMi0xLTEtMTU4NTUy_87420a5c-35fd-4cbb-9cff-d9cc005912bc"
      unitRef="usd">8505000</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTQtNC0xLTEtMTU4NTUy_0a70192d-ffcb-437b-bf06-486500fdc878"
      unitRef="usd">8961000</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssets
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTUtMi0xLTEtMTU5NzYw_7762ff96-075c-4101-9691-e1c643e13304"
      unitRef="usd">534420000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmFjOTBmN2VjZDBhNTQ1ZDM5MzhhOGNlNWFkMWI4OGU5L3RhYmxlcmFuZ2U6YWM5MGY3ZWNkMGE1NDVkMzkzOGE4Y2U1YWQxYjg4ZTlfMTUtNC0xLTEtMTU4NTUy_9db07734-57fa-4e13-abe5-2a141aa5cc06"
      unitRef="usd">469990000</us-gaap:OtherAssets>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTEx_9a3a6338-99c7-4085-a873-7b4f63e79d2e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;48,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;78,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;35,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;57,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;50,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other operating accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;42,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;58,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;155,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;244,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <hr:AccruedPropertyTaxes
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMS0yLTEtMS0xNTg1NTI_f391c4e0-30ef-4f07-9f88-855f5ee1a35b"
      unitRef="usd">48629000</hr:AccruedPropertyTaxes>
    <hr:AccruedPropertyTaxes
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMS00LTEtMS0xNTg1NTI_afb2ad75-a53d-4aa4-8142-590c9b962a71"
      unitRef="usd">78185000</hr:AccruedPropertyTaxes>
    <hr:AccountsPayableAndCapitalExpendituresCurrent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMi0yLTEtMS0xNTg1NTI_9ca50ff1-d0ca-4f89-aafe-431ddc7cc6ec"
      unitRef="usd">35128000</hr:AccountsPayableAndCapitalExpendituresCurrent>
    <hr:AccountsPayableAndCapitalExpendituresCurrent
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMi00LTEtMS0xNTg1NTI_7d20b698-3f0f-4c48-a3cc-cbdc78ccff89"
      unitRef="usd">57352000</hr:AccountsPayableAndCapitalExpendituresCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMy0yLTEtMS0xNTg1NTI_489b2426-409c-4789-b117-72f85702e008"
      unitRef="usd">28483000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMy00LTEtMS0xNTg1NTI_e376be70-5ee6-421f-9c9c-cce90a7ed07a"
      unitRef="usd">50037000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfNC0yLTEtMS0xNTg1NTI_2d5f094c-e37d-4a7a-a9e8-96583a919e41"
      unitRef="usd">42970000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfNC00LTEtMS0xNTg1NTI_c72b2881-6098-46d1-aa31-f269f339b851"
      unitRef="usd">58459000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMTMtMi0xLTEtMTU4NTUy_142791d6-94df-4b6d-b3c7-60501f41875d"
      unitRef="usd">155210000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOjRhNDZjMzA1NjExODQ2NzE5NjFlZDAyNmEzMGRmMmJiL3RhYmxlcmFuZ2U6NGE0NmMzMDU2MTE4NDY3MTk2MWVkMDI2YTMwZGYyYmJfMTMtNC0xLTEtMTU4NTUy_a5107d14-c6c0-429e-b564-ef2bbe3722ac"
      unitRef="usd">244033000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RleHRyZWdpb246ZTAxYTIzNzQ5ZTUxNGQ2NThiNjYwYmZkNTI5MDZmNmFfOTEy_496d157d-0f9f-4dd6-81c8-9ea2d19df451">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Below-market intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;96,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;97,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;90,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;87,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;29,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;232,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;218,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:BelowMarketLeaseNet
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMS0yLTEtMS0xNTg1NTI_47b8a440-69df-4a54-a661-60dfb9a3f9ed"
      unitRef="usd">96214000</us-gaap:BelowMarketLeaseNet>
    <us-gaap:BelowMarketLeaseNet
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMS00LTEtMS0xNTg1NTI_dda512f0-63be-4e35-a197-f391b8d22c31"
      unitRef="usd">97935000</us-gaap:BelowMarketLeaseNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMi0yLTEtMS0xNTg1NTI_b1d5dff1-e3c6-4570-a75a-32bd9412d8f7"
      unitRef="usd">90979000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMi00LTEtMS0xNTg1NTI_6fb9ceee-ccd6-43f8-9711-d19bf3423bed"
      unitRef="usd">87325000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:SecurityDepositLiability
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMy0yLTEtMS0xNTg1NTI_5385996c-6915-49a1-a27d-3912b59cf759"
      unitRef="usd">29020000</us-gaap:SecurityDepositLiability>
    <us-gaap:SecurityDepositLiability
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMy00LTEtMS0xNTg1NTI_16ab1b91-f30f-494c-9ae3-9f0311413bc5"
      unitRef="usd">28521000</us-gaap:SecurityDepositLiability>
    <us-gaap:DerivativeLiabilities
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNC0yLTEtMS0xNTg1NTI_2e75f455-e8fe-492d-9d30-eaf9ae06c27b"
      unitRef="usd">11927000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNC00LTEtMS0xNTg1NTI_5ef4b084-3e02-4378-a5bf-6f097bf8fa8f"
      unitRef="usd">4269000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherSundryLiabilities
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNS0yLTEtMS0xNTg1NTI_6a11aa7b-4b90-40b0-b947-6eb49f6368cd"
      unitRef="usd">3889000</us-gaap:OtherSundryLiabilities>
    <us-gaap:OtherSundryLiabilities
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfNS00LTEtMS0xNTg1NTI_ba70f268-3e2a-4bed-bfd7-33ef25bd0dfb"
      unitRef="usd">618000</us-gaap:OtherSundryLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMTMtMi0xLTEtMTU4NTUy_9d79aa89-47b5-4b18-87d8-31bf22dae78f"
      unitRef="usd">232029000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF81OC9mcmFnOmUwMWEyMzc0OWU1MTRkNjU4YjY2MGJmZDUyOTA2ZjZhL3RhYmxlOmI0YTE3ZWI4MDVkMjQ4NzM4NTJmZGFiMmVjMzRmYTU1L3RhYmxlcmFuZ2U6YjRhMTdlYjgwNWQyNDg3Mzg1MmZkYWIyZWMzNGZhNTVfMTMtNC0xLTEtMTU4NTUy_3ed04ea3-2e72-45b9-996f-5faa6d0b32ce"
      unitRef="usd">218668000</us-gaap:OtherLiabilities>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfMzI5ODUzNDg5MjcwNw_e9de862e-d4fc-4339-9cb1-ce9191a2c512">Notes and Bonds Payable&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the Company&#x2019;s notes and bonds payable as of March 31, 2023 and December 31, 2022.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY DATES &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt; AS OF  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EFFECTIVE INTEREST RATE &lt;br/&gt;as of 3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;12/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$1.5 billion Unsecured Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$350 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$150 million Unsecured Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;573,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;571,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2027 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;480,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;479,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;567,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;565,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;636,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;632,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Mortgage notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/23-12/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;83,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.57%-4.84%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,361,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.&lt;/span&gt;&lt;/div&gt;2Subsequent to March 31, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfOTA4NA_7d14eb58-9d92-4771-99f3-0f251c9590a7">&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the Company&#x2019;s notes and bonds payable as of March 31, 2023 and December 31, 2022.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY DATES &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt; AS OF  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EFFECTIVE INTEREST RATE &lt;br/&gt;as of 3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;3/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;12/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$1.5 billion Unsecured Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$350 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$150 million Unsecured Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;573,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;571,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2027 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;480,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;479,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;567,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;565,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;636,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;632,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Mortgage notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/23-12/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;83,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.57%-4.84%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,361,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.&lt;/span&gt;&lt;/div&gt;2Subsequent to March 31, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjplNjNjNmZmN2I1Nzc0MmUzYWQ2NmYzMzViMDY1YTBiNl81_113fb67a-a8ed-4371-b125-c2d4c53a280f"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi0yLTEtMS0xNTg1NTI_e20a31da-560b-4c3e-8c4b-320dce910f02"
      unitRef="usd">385000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i916dc090ae94426d8365fc31b03034ac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi0zLTEtMS0xNTg1NTI_5c29c487-c308-4019-9bde-9c8eb0895fa9"
      unitRef="usd">385000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if299dbdcd6d2474d9767dd54fff4d1e9_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMi00LTEtMS0xNTg1NTI_41f4d882-7024-4afd-b74f-4bd187291e25"
      unitRef="number">0.0576</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjpkNzgxYmZmMjIxYWI0MzBiYmEzNGIzZTVjZDVhMThiNV81_91f7da15-f9b5-4502-a904-ee3cda941716"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS0yLTEtMS0xNTg1NTI_86170f8c-6a6d-4345-8cc9-f84e9e86ba44"
      unitRef="usd">349494000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idf083f5601064f69b4d4536ff89ad8f4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS0zLTEtMS0xNTg1NTI_7ed669ac-3034-4e78-9441-18ec1062f22e"
      unitRef="usd">349114000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ia0264a2f07b84dd6b41e97500bf5bfa8_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNS00LTEtMS0xNTg1NTI_f27a5425-8fa8-4edf-b847-091aa0d823a5"
      unitRef="number">0.0572</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id093a3a1c949408d9c5b971d33e5ce57_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjo5ZWUzZGZjMDIyYWI0OGU5OGUyZDMxMmE5MmQ0OWRlMV81_056c0e31-c564-4c50-94ab-0a55649fc949"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="id093a3a1c949408d9c5b971d33e5ce57_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi0yLTEtMS0xNTg1NTI_bb9d05db-51db-452d-aa1f-deb7a1464812"
      unitRef="usd">199728000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i58696a25f6f645418747fe03e651cd67_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi0zLTEtMS0xNTg1NTI_1a775d51-bdba-4d39-9336-3ec13a9fcd8a"
      unitRef="usd">199670000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id093a3a1c949408d9c5b971d33e5ce57_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNi00LTEtMS0xNTg1NTI_2733975a-cb65-48a6-8234-be44267c6838"
      unitRef="number">0.0572</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i12ab1a1468da462cb3ba734034491aa2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjo2ZDFiZGIzYjg1Zjg0Mjg5ODk1YWY3MmQxYmJlOGRlNl81_689a8027-1b5b-44c8-80df-8584332c13aa"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="i12ab1a1468da462cb3ba734034491aa2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy0yLTEtMS0xNTg1NTI_288c4faa-fc2b-44ee-8149-799e5f6722f9"
      unitRef="usd">299941000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6153dc8f1005474aafde2cd37e112967_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy0zLTEtMS0xNTg1NTI_b3399fed-bd80-42ae-8e3a-2fe0ea204702"
      unitRef="usd">299936000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i12ab1a1468da462cb3ba734034491aa2_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfNy00LTEtMS0xNTg1NTI_4eed99ec-ddad-4c06-89d8-27e8f2c2eb2a"
      unitRef="number">0.0572</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjoxZGY2MTY3YTRjYjQ0YTY0YjBiMTBjOWRjNDg3Yjc3Ml81_852eb03f-d556-4e60-8049-8c39da9def7d"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC0yLTEtMS0xNTg1NTI_b811a883-c920-4ade-8ca5-9c53dbccb30f"
      unitRef="usd">149532000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i40d414655d314601a88d81663bcb05c1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC0zLTEtMS0xNTg1NTI_a6ec362c-149f-4e1c-afa1-5a8c813263df"
      unitRef="usd">149495000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="idaf29eaea9d5439ea8b3f5b1a7e47077_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOC00LTEtMS0xNTg1NTI_c26c2a3b-d405-44ba-b698-355c3f228082"
      unitRef="number">0.0572</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS0wLTEtMS0xNTg1NTIvdGV4dHJlZ2lvbjoyNjIwMWI0YWUzYjg0ZjcyYThhNDU0OTgxYTBlNTcwY181_50b91894-3e34-464e-b617-abbf1d2c5079"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS0yLTEtMS0xNTg1NTI_713c40b8-d821-4fa6-8a2c-4713be2e5eea"
      unitRef="usd">199397000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib2e5ddf6b16b48c1ba4b6ccbd0e86c5b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS0zLTEtMS0xNTg1NTI_28d2be11-3057-4a8d-be78-74871c83c7cc"
      unitRef="usd">199362000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic4b6565ab7dc4a8f95f418cf7f79737b_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfOS00LTEtMS0xNTg1NTI_f934f05a-9e8c-4d43-a45b-07c4ea7bdb80"
      unitRef="number">0.0572</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iada6b4520347441c86e7b036a38806a3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtMC0xLTEtMTU4NTUyL3RleHRyZWdpb246M2FlY2M4ZDM2ZjUxNDQ1ZTk4OTc4OTYwZWRjZTgwZjNfNQ_aa9d58ad-d7ec-435b-aab1-31c66ca2736a"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="iada6b4520347441c86e7b036a38806a3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtMi0xLTEtMTU4NTUy_603c23f7-0259-4142-b96f-0341c2e5df2a"
      unitRef="usd">297974000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9996d5e89ffb48608cdbb710a8391d3e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtMy0xLTEtMTU4NTUy_01093940-73da-4940-8486-61e5f4a1a51e"
      unitRef="usd">297869000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iada6b4520347441c86e7b036a38806a3_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTAtNC0xLTEtMTU4NTUy_603ddc4c-e0e9-4960-9cf4-ee96f7140567"
      unitRef="number">0.0572</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="i3797ac41724d4c88869e5d72d41a8977_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTEtMi0xLTEtMTU4NTUy_44486053-9e26-42af-8039-44863a305853"
      unitRef="usd">249206000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7b8e9ac04b994ee090d110a7cb42566c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTEtMy0xLTEtMTU4NTUy_596f25ad-2916-45e3-895d-c6e8902ee255"
      unitRef="usd">249115000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i3797ac41724d4c88869e5d72d41a8977_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTEtNC0xLTEtMTU4NTUy_791bbc12-f774-4762-b3e5-3580c87a4aef"
      unitRef="number">0.0412</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="if4c13532ed774effa341fc31c9a9b88a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTItMi0xLTEtMTU4NTUy_de5fe4be-f119-4c09-a340-181da7d00e68"
      unitRef="usd">573410000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i947183f1bc48403a94ac6a0e12abb930_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTItMy0xLTEtMTU4NTUy_fac68d68-2f9d-40ed-84e3-361c9f81245a"
      unitRef="usd">571587000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if4c13532ed774effa341fc31c9a9b88a_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTItNC0xLTEtMTU4NTUy_718cfd4c-afca-493d-be8d-839396b9cbc0"
      unitRef="number">0.0494</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="icc42205d2ec44d118886e5720e43151a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTMtMi0xLTEtMTU4NTUy_de3facf7-0962-45a3-9e96-152e2f4500fb"
      unitRef="usd">480578000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if239ca1557c647539fcb388cfb1692af_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTMtMy0xLTEtMTU4NTUy_f4b228d7-8b36-4c86-b410-af733930d77f"
      unitRef="usd">479553000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="icc42205d2ec44d118886e5720e43151a_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTMtNC0xLTEtMTU4NTUy_7a4d37d6-ead9-4ac3-ae64-501c8aeed74b"
      unitRef="number">0.0476</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="i8e35fb4f52e34980a36f861ff287417b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTQtMi0xLTEtMTU4NTUy_9e9c9999-5737-4298-85f8-6d9591a8b61c"
      unitRef="usd">296995000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1c2524e41edf4411a107a30240fcf406_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTQtMy0xLTEtMTU4NTUy_a75c3f32-0a6b-4ea0-bf3e-5897c8576477"
      unitRef="usd">296852000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i8e35fb4f52e34980a36f861ff287417b_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTQtNC0xLTEtMTU4NTUy_0ed7a9d4-a81d-41c1-9c20-2e4c0e56f953"
      unitRef="number">0.0385</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="i48cbfe26eacb4823b267d3ad193c58c3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTUtMi0xLTEtMTU4NTUy_5e61e790-bc4f-456b-8dd6-08628aa2d2fb"
      unitRef="usd">567863000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie8628a7ba5394269893e6d58812b1de8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTUtMy0xLTEtMTU4NTUy_a0f17913-90e7-4aa4-a4a8-1714385c24bf"
      unitRef="usd">565402000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i48cbfe26eacb4823b267d3ad193c58c3_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTUtNC0xLTEtMTU4NTUy_55dea544-8dfc-4465-8de8-0b7ce17eb70b"
      unitRef="number">0.0530</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="iaee5360caf654c3984323ba0ea3efdd6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTYtMi0xLTEtMTU4NTUy_42c2692a-6059-4ee2-8f80-b6d37b734c7a"
      unitRef="usd">296479000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibea6204a6cfe4280a12e77772723e04e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTYtMy0xLTEtMTU4NTUy_597415a7-3ba2-4e0a-bd59-a8639b2d28ef"
      unitRef="usd">296385000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iaee5360caf654c3984323ba0ea3efdd6_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTYtNC0xLTEtMTU4NTUy_822b2c2e-7907-48ec-887c-3a1cfb369793"
      unitRef="number">0.0272</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="i2fcf72f9e010488e953762beaa4a3236_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTctMi0xLTEtMTU4NTUy_a475cd42-ed56-4c87-add0-02cd86db9377"
      unitRef="usd">295671000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9641fb3901af4361a7453aa207869a13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTctMy0xLTEtMTU4NTUy_49414ac3-874c-4937-a760-ec0299f6631b"
      unitRef="usd">295547000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i2fcf72f9e010488e953762beaa4a3236_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTctNC0xLTEtMTU4NTUy_175c4490-b679-43e2-b169-329c7e99d864"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="if8faa35bf9c54ffda60fcf39d1de6969_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTgtMi0xLTEtMTU4NTUy_c435a980-5ff5-4f85-a851-2c96e75965e6"
      unitRef="usd">636819000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifb93c500efca462290474ea705de1cc7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTgtMy0xLTEtMTU4NTUy_0553bb62-981a-4678-b67f-ba48b7ee52d7"
      unitRef="usd">632693000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if8faa35bf9c54ffda60fcf39d1de6969_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTgtNC0xLTEtMTU4NTUy_1cc8e5b1-2e33-4153-97da-562fe5c7cab7"
      unitRef="number">0.0513</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="i208a8c86222841e7aa4e2d3d1eb58ff6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktMi0xLTEtMTU4NTUy_86f64140-155a-46ed-85f3-8a38522b54c2"
      unitRef="usd">83612000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic657cdc8fa32443a98553b45427e1d49_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktMy0xLTEtMTU4NTUy_9f99d3bd-4891-40e5-a803-34de25e0ff8c"
      unitRef="usd">84247000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic5456995c1764da0b948401cfc09b9a0_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktNC0xLTEtMTU4NTUyL3RleHRyZWdpb246ZmViNjRkMGVmYWFiNDBjYWE4OGZhOWNkYzI4NTZlOTdfNTQ5NzU1ODEzOTAz_403c7715-ff67-4bc6-953b-eca20b7f0285"
      unitRef="number">0.0357</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i42ab89d4ecf44dfeb1d870f49ac25015_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMTktNC0xLTEtMTU4NTUyL3RleHRyZWdpb246ZmViNjRkMGVmYWFiNDBjYWE4OGZhOWNkYzI4NTZlOTdfNTQ5NzU1ODEzOTE0_5cca30dd-dcd6-47a4-a34a-d113a9260992"
      unitRef="number">0.0484</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMjAtMi0xLTEtMTU4NTUy_3c2acc65-db7a-4865-919e-ddb23c8b1a6f"
      unitRef="usd">5361699000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1f84228478ae4a859a0b69e3a29bee8a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RhYmxlOjVjNjk3Y2QyNzFmNDQzNzY4MjkwYTkyZmU3YzBlZTVhL3RhYmxlcmFuZ2U6NWM2OTdjZDI3MWY0NDM3NjgyOTBhOTJmZTdjMGVlNWFfMjAtMy0xLTEtMTU4NTUy_45b90581-e0b3-4779-a682-eabc3493f123"
      unitRef="usd">5351827000</us-gaap:LongTermDebt>
    <hr:DebtInstrumentExtensionPeriodForMaturityDate
      contextRef="ic08326621b774b35a49a98cb55264ae0_D20230401-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfMjE5OTAyMzI3NDU3NQ_958e912e-7050-44e2-a9a4-7b88dad4f7cb">P1Y</hr:DebtInstrumentExtensionPeriodForMaturityDate>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i05db10f2ba654b51b0c0030478bf971b_I20230509"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82MS9mcmFnOjQ0ODEzZjNkMDM1MDQ3ZDJiMjMxZTQ2N2NkNmJkZTRlL3RleHRyZWdpb246NDQ4MTNmM2QwMzUwNDdkMmIyMzFlNDY3Y2Q2YmRlNGVfMzI5ODUzNDkwMjAzMQ_ed503868-e035-4ffa-bf5b-054dd1515bdf"
      unitRef="usd">400000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDIxMQ_35a6ee83-965f-4328-9813-6be0f4720ed9">Derivative Financial Instruments&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Risk Management Objective of Using Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#x2019;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#x2019;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#x2019;s borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Cash Flow Hedges of Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EXPIRATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;WEIGHTED &lt;br/&gt;AVERAGE RATE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;January 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE AT MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;BALANCE SHEET LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(11,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the effect of cash flow hedge accounting on AOCI during the three months ended March&#160;31, 2023 and 2022 related to the Company's outstanding interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company estimates that an additional $9.5 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Credit-risk-related Contingent Features&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender due to the Company's&#160;default on the indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$7.0&#160;million. As of March&#160;31, 2023, the Company has not posted any collateral related to these agreements and was not in breach of any agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDIxMw_65140a0b-6b2b-4498-b628-81abfbaf3ba5">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of March&#160;31, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EXPIRATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;WEIGHTED &lt;br/&gt;AVERAGE RATE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;January 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The table below presents the effect of cash flow hedge accounting on AOCI during the three months ended March&#160;31, 2023 and 2022 related to the Company's outstanding interest rate swaps.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfMzI5ODUzNDg4ODI2Mg_a7166666-8049-41c5-9570-b6df9c5fa9d8"
      unitRef="derivative">14</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic1986a74cc37403c9b2e18925bc459c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMS0xLTEtMS0xNTg1NTI_5f95457c-e2a6-47f3-b1d6-851001dd65c8"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic1986a74cc37403c9b2e18925bc459c4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMS0yLTEtMS0xNTg1NTI_96f0965a-172f-43ed-94a7-bf0e83c50ea4"
      unitRef="number">0.0121</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3ab4351c9c9144c7a0456de49fc1c374_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMi0xLTEtMS0xNTg1NTI_ca5e5aa9-cb6c-4a33-b5b3-7e4ce3dc30b3"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3ab4351c9c9144c7a0456de49fc1c374_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMi0yLTEtMS0xNTg1NTI_8b9d292e-f3ad-4735-825c-d4ddea97f682"
      unitRef="number">0.0215</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6634c65cb6af485bafe3b895bca1c259_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMy0xLTEtMS0xNTg1NTI_b307bce0-0a85-4c9c-9d4d-05217361ccaf"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6634c65cb6af485bafe3b895bca1c259_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfMy0yLTEtMS0xNTg1NTI_920356eb-5bba-485b-af10-f65e9255bf59"
      unitRef="number">0.0383</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib55a92723cb045e5b3f7b226e366666a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0xLTEtMS0xODE1MDQ_3e862366-cde0-4d5e-bd7c-af597c37919f"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib55a92723cb045e5b3f7b226e366666a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0yLTEtMS0xODE1MDY_9cefb66b-962b-41eb-bb6e-96ee974a5cf2"
      unitRef="number">0.0384</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i300d1ad46f444edcb5259c5aa4ad9337_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0xLTEtMS0xODE1MDg_99d4504d-463f-43f3-a60f-dcb64fb1c42d"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i300d1ad46f444edcb5259c5aa4ad9337_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0yLTEtMS0xODE1MTA_3ec0eb2e-54ac-4c60-8b2a-24b34cca5193"
      unitRef="number">0.0413</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9626e0785d714a62aa74354221bfd9f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0xLTEtMS0xNTg1NTI_8393bb33-6cd0-436e-a4dc-bac8a4f761c3"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i9626e0785d714a62aa74354221bfd9f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNC0yLTEtMS0xNTg1NTI_31a5b9f9-5bdd-4215-a8d9-94e082e8c1ec"
      unitRef="number">0.0379</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3e9005e1dd794d208a4b797ae4621183_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0xLTEtMS0xNTg1NTI_20565404-d067-4120-9af0-229a9c10c69a"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3e9005e1dd794d208a4b797ae4621183_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmE0YzQzNDc1MTM5OTRlYWE4MjMxNTcwZTEzMDEwZDc5L3RhYmxlcmFuZ2U6YTRjNDM0NzUxMzk5NGVhYTgyMzE1NzBlMTMwMTBkNzlfNS0yLTEtMS0xNTg1NTI_0bebec82-6dd6-47b7-a762-617d8463033b"
      unitRef="number">0.0317</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDIzNA_3508b48d-e3fb-4ef6-9305-a7e49b0ef1c5">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of March&#160;31, 2023.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE AT MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;BALANCE SHEET LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(11,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2e64e9ed9c9e4205bdf1ad560e251d42_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmFmMDRjMzQ0NGVmZTRlZGQ4MTVmMzg3N2MyODU1ZWYyL3RhYmxlcmFuZ2U6YWYwNGMzNDQ0ZWZlNGVkZDgxNWYzODc3YzI4NTVlZjJfMy0yLTEtMS0xNTg1NTI_043a2076-29ff-4655-b2c4-095beddbc554"
      unitRef="usd">-11927000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i24b1c53bc0034d898edcf92852e6d9c1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmFmMDRjMzQ0NGVmZTRlZGQ4MTVmMzg3N2MyODU1ZWYyL3RhYmxlcmFuZ2U6YWYwNGMzNDQ0ZWZlNGVkZDgxNWYzODc3YzI4NTVlZjJfNC0yLTEtMS0xNTg1NTI_f8d41dcb-e9de-4621-a7fa-030975fdeaf3"
      unitRef="usd">9767000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i650c8e7c68644e95a14ecf31d3e81688_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOmFmMDRjMzQ0NGVmZTRlZGQ4MTVmMzg3N2MyODU1ZWYyL3RhYmxlcmFuZ2U6YWYwNGMzNDQ0ZWZlNGVkZDgxNWYzODc3YzI4NTVlZjJfNS0yLTEtMS0xNTg1NTI_48bf6036-f6c7-402f-a705-662b7ea64387"
      unitRef="usd">-2160000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i550aa973ad90483f8a3c4a0347e5a824_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi0xLTEtMS0xNTg1NTI_cbaaac4e-ab98-49e1-bde5-f5ec81501fd3"
      unitRef="usd">-8541000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib038cb82071844b18a5969f43fb847cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi0yLTEtMS0xNTg1NTI_8055cab7-596a-4f19-9f24-116a045b4404"
      unitRef="usd">5159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i418ef205b37644f6bf094af1cdb1378e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi00LTEtMS0xNTg1NTI_fb2f8f13-ccf4-40ae-ba56-d3c47f00e36d"
      unitRef="usd">-2433000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5358b41917b54b188e9b758ea6d034d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMi01LTEtMS0xNTg1NTI_dde19587-6a99-4f5f-9199-837452692431"
      unitRef="usd">937000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i52ecd11079f348afb8d796b899502b99_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy0xLTEtMS0xNTg1NTI_732f05cd-6133-46c3-9724-4daa49a0a9dd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i343a27ce736844daa7c02c4fc4bd7e3e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy0yLTEtMS0xNTg1NTI_f2282850-5ff2-4439-a8db-4578e63b7ee3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if0ecdde728be4819bf1b77c1ef19342c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy00LTEtMS0xNTg1NTI_7a554674-9a2b-4e30-929b-47e3de27f786"
      unitRef="usd">107000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i46a708e51b4c414fa037bdb830248ffc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfMy01LTEtMS0xNTg1NTI_3dfe7358-617c-4af7-8fa1-f5532bb06a83"
      unitRef="usd">107000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1641a82fd53448279f743e919d3e08b3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC0xLTEtMS0xNTg1NTI_c8382ff1-f06c-4855-aabc-62c6feaa12a0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i14ee4952dd5042e1985f1a054d1950b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC0yLTEtMS0xNTg1NTI_bb8e2823-f684-49e5-a2c7-a511c64ff1fc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie4e75ffc38cf443b8a2bb92046cf883d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC00LTEtMS0xNTg1NTI_91c5a1c0-1bd8-43ad-b134-efc48f7e1730"
      unitRef="usd">42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i955d126813cf4d4ca1a06c68c07ebe2e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNC01LTEtMS0xNTg1NTI_ca02f259-e475-4b71-b2b9-abf1ff6c430d"
      unitRef="usd">42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS0xLTEtMS0xNTg1NTI_2cd5bea2-a085-42f2-8e4d-d20498004144"
      unitRef="usd">-8541000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS0yLTEtMS0xNTg1NTI_4752369f-d557-4bbd-84ea-2228dda347db"
      unitRef="usd">5159000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i80188dd2e888438dabd7b24526b877bb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS00LTEtMS0xNTg1NTI_942d7307-9134-4403-98c8-36cb1b12c607"
      unitRef="usd">-2284000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic07f754abe7f444f8948c8f16a37eeba_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RhYmxlOjE1Njg3OTkxMWJkMzQ4ZTM5ZGQxZTRiMmM0ZTI1YzcwL3RhYmxlcmFuZ2U6MTU2ODc5OTExYmQzNDhlMzlkZDFlNGIyYzRlMjVjNzBfNS01LTEtMS0xNTg1NTI_a10f27c6-9a8a-488f-9911-61afb03ca858"
      unitRef="usd">1086000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ib0caf5935d6d4f239926e7d14b5e7270_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfMzI5Mw_6a8482ca-12a5-4288-9364-7b4a0ec4b2f6"
      unitRef="usd">9500000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i862a64f8ce9a48429a007343ae162af5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfMzQzMw_fd5ffc08-988a-4cdc-8dc8-c7b9f1065214"
      unitRef="usd">600000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <hr:DerivativeNetAssetPositionAggregateFairValue
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF82Ny9mcmFnOmNjZjQwNjg5MjhiODQ1MGU5MDdmYWIyYjFlZWY3ZTQ2L3RleHRyZWdpb246Y2NmNDA2ODkyOGI4NDUwZTkwN2ZhYjJiMWVlZjdlNDZfNDA4Nw_40a8fc9f-632e-40a6-a172-834ecd4524f1"
      unitRef="usd">7000000</hr:DerivativeNetAssetPositionAggregateFairValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83MC9mcmFnOmYwYmNlZTlhMGEwNzQ2YmFiOTE0Y2IwMGUxMTA1ZGIxL3RleHRyZWdpb246ZjBiY2VlOWEwYTA3NDZiYWI5MTRjYjAwZTExMDVkYjFfMjY3OA_a849f0d4-72da-4fcf-9146-734001ba9a0e">Commitments and Contingencies&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#x2019;s consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Development and Redevelopment Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the first quarter of 2023, the Company funded $16.9&#160;million toward the development and redevelopment of properties.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <hr:ConstructionActivityTotalFundingDuringthePeriod
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83MC9mcmFnOmYwYmNlZTlhMGEwNzQ2YmFiOTE0Y2IwMGUxMTA1ZGIxL3RleHRyZWdpb246ZjBiY2VlOWEwYTA3NDZiYWI5MTRjYjAwZTExMDVkYjFfMzI5ODUzNDg5MTIzMQ_74e95eeb-3469-4357-96ac-4e91ab679e26"
      unitRef="usd">16900000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI0OQ_cabef3cc-1210-43db-b8d1-7853a0fdbed3">Stockholders' Equity&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the three months ended March&#160;31, 2023 and the twelve months ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,457,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Issuance of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;229,618,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested share-based awards, net of withheld shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;223,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;514,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,816,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;At-The-Market Equity Offering Program&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:130%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company has equity distribution agreements with various sales agents with respect to the at-the-market (&#x201c;ATM&#x201d;) offering program of common stock with an aggregate sales amount of up to $750.0 million.  As of March&#160;31, 2023, $750.0 million remained available for issuance under our current ATM offering program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the three months ended March&#160;31, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM offering program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the three months ended March&#160;31, 2023, the Company declared and paid common stock dividends totaling $0.31 per share.  On May 2, 2023, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on June 2, 2023 to stockholders of record on May 16, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Earnings Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table sets forth the computation of basic and diluted earnings per common share for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.617%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,796,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,834,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,956,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,871,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,840,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;148,963,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,840,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;148,963,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;88,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,840,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,051,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Net (loss) income  attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(87,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividends paid on nonvested share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net (loss) income applicable to common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(87,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;41,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The effect of OP units totaling 4,042,993 shares, non-vested stock awards totaling 401,937 shares, and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling 49,322 shares for the three months ended March&#160;31, 2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Restricted Common Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the three months ended March&#160;31, 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $5.4&#160;million, which consisted of an aggregate of 270,494 non-vested shares with vesting periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI3NQ_6ca16896-73b0-44f5-a3a0-a5bc0b29e940"&gt;three&lt;/span&gt; to eight years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;A summary of the activity under the Company's share-based incentive plans for the three months ended March&#160;31, 2023 and 2022 is included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,795,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,562,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;282,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;415,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(101,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,955,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,951,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company withheld 38,632 and 6,727 shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with three-year forward-looking performance targets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $3.7 million, which consisted of an aggregate 165,174 RSUs with a five-year vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The remaining 57% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $22.55 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following is a summary of the RSU activity during the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;294,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;165,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;22.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested/Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Probability adjustment of 2022 RSUs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(79,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;31.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;28.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;LTIP Series C Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units are granted with three-year forward-looking performance targets, with a grant date fair value of $7.1&#160;million, which consisted of an aggregate 448,249 LTIP-C units with a five-year vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Approximately 43% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The remaining 57% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $15.85 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. A summary of the activity under the ESPP for the three months ended March&#160;31, 2023 and 2022 is included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;340,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;348,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;255,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(10,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(21,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(25,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(132,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(140,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;183,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;427,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table represents expected amortization of the Company's non-vested shares issued as of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FUTURE AMORTIZATION &lt;br/&gt;of non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI1Ng_c6785345-ca6a-4c26-80ab-c020cf71ee51">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the three months ended March&#160;31, 2023 and the twelve months ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,457,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Issuance of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;229,618,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested share-based awards, net of withheld shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;223,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;514,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,816,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia75cc38ea5ec4ad8850297f36dd63583_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMS0xLTEtMS0xNTg1NTI_37f8afab-5269-4fa7-ac4b-c694322aa15c"
      unitRef="shares">380589894</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMS0yLTEtMS0xNTg1NTI_aa1006b4-b251-4022-ad83-c0b13bbc0c28"
      unitRef="shares">150457433</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMi0xLTEtMS0xNTg1NTI_6ba62ecd-570d-4857-8765-0dba5c215232"
      unitRef="shares">3130</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic21e61620e9b4d199d0bd8544198530a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMi0yLTEtMS0xNTg1NTI_c5e11437-3649-4694-ae56-1155bff3b2f0"
      unitRef="shares">229618304</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i6e7100ad089a42ee88655c4ddce3ed3f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMy0xLTEtMS0xNTg1NTI_4409f06c-bc24-4c15-9ae3-2039ced07b03"
      unitRef="shares">223405</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ic21e61620e9b4d199d0bd8544198530a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfMy0yLTEtMS0xNTg1NTI_da066d42-a2ab-4050-8b18-adc96da80987"
      unitRef="shares">514157</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfNC0xLTEtMS0xNTg1NTI_70b1c27a-67aa-4d85-8365-aa627e31208a"
      unitRef="shares">380816429</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia75cc38ea5ec4ad8850297f36dd63583_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmU0Y2NmMjI2NjU1YTQ4ZDY5N2FhZTE5MDIzNTIyMGQzL3RhYmxlcmFuZ2U6ZTRjY2YyMjY2NTVhNDhkNjk3YWFlMTkwMjM1MjIwZDNfNC0yLTEtMS0xNTg1NTI_1f59dd4d-8478-43bc-b719-7695250210c7"
      unitRef="shares">380589894</us-gaap:CommonStockSharesOutstanding>
    <hr:EquityOfferingProgramAvailableForIssuance
      contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDQ1_7ab9963c-0cd6-4591-a73b-6361707c9fd7"
      unitRef="usd">750000000</hr:EquityOfferingProgramAvailableForIssuance>
    <hr:EquityOfferingProgramAvailableForIssuance
      contextRef="i1d5339011cdb49409add3e0359d4d234_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDYw_b623dc2c-6c3a-4537-a9d0-ad438a39a44d"
      unitRef="usd">750000000</hr:EquityOfferingProgramAvailableForIssuance>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNjUx_79216633-a14e-48ab-b04e-d050b70acfe6"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic3247f43eeeb46f2a5e62592bb20c4af_D20221102-20221102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNzU5_4afd4566-be4f-40f4-a3f7-4172932a3bc4"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI5NQ_7d97e2e3-63a0-4212-9236-f33f0b32c38a">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table sets forth the computation of basic and diluted earnings per common share for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.617%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,796,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,834,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,956,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,871,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,840,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;148,963,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,840,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;148,963,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;88,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,840,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,051,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Net (loss) income  attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(87,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividends paid on nonvested share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net (loss) income applicable to common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(87,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;41,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMy0xLTEtMS0xNTg1NTI_8e729c2c-a548-45f5-9ae4-305bfe0bc972"
      unitRef="shares">380796773</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMy0yLTEtMS0xNTg1NTI_47909c7d-bcc4-4e7b-ad8f-b9e2503c5701"
      unitRef="shares">150834888</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNC0xLTEtMS0xNTg1NTI_c7aa8feb-8e4f-445b-9c6f-dd2ee9cac57a"
      unitRef="shares">1956353</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNC0yLTEtMS0xNTg1NTI_3d2ea1bd-0f8d-41e0-9dc2-61ed4eda1239"
      unitRef="shares">1871858</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNS0xLTEtMS0xNTg1NTI_3019d1da-64ef-4f16-a890-7063e1f3f36e"
      unitRef="shares">378840420</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNS0yLTEtMS0xNTg1NTI_39a90d2f-1f4e-46ab-b58a-a37b6a112fab"
      unitRef="shares">148963030</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNy0xLTEtMS0xNTg1NTI_04007e15-642d-4800-aea0-81af2f426af8"
      unitRef="shares">378840420</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfNy0yLTEtMS0xNTg1NTI_d27a39ac-30c0-4126-9375-3b1a8c0acc44"
      unitRef="shares">148963030</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTAtMS0xLTEtMTU4NTUy_b962688e-3223-45ea-80b3-7e942107eacf"
      unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTAtMi0xLTEtMTU4NTUy_863ef4af-43eb-4d6b-af33-4d64ca57d58a"
      unitRef="shares">88234</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTEtMS0xLTEtMTU4NTUy_c3a05003-2878-4aa0-992d-4249fbf3b2a5"
      unitRef="shares">378840420</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTEtMi0xLTEtMTU4NTUy_7dd224b3-258a-4817-a0ba-4bb7810f0478"
      unitRef="shares">149051264</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTMtMS0xLTEtMTU4NTUy_01c527f5-866a-4d69-869d-4697dc5d3149"
      unitRef="usd">-87125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTMtMi0xLTEtMTU4NTUy_80c3c2e2-4dc6-4eaf-ae28-da1c08989a20"
      unitRef="usd">42227000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsShareBasedCompensation
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTQtMS0xLTEtMTU4NTUy_85ef1b32-8548-4e2d-a2fa-492205307bf8"
      unitRef="usd">605000</us-gaap:DividendsShareBasedCompensation>
    <us-gaap:DividendsShareBasedCompensation
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTQtMi0xLTEtMTU4NTUy_aeb02507-ac44-43df-a4a2-6c8486268920"
      unitRef="usd">605000</us-gaap:DividendsShareBasedCompensation>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTUtMS0xLTEtMTU4NTUy_2f3a2f9c-56df-4854-a61d-21179abe4d10"
      unitRef="usd">-87730000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMTUtMi0xLTEtMTU4NTUy_22f8f076-ecd9-4753-9125-7dd83f46b13f"
      unitRef="usd">41622000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjEtMS0xLTEtMTU4NTUy_ed14ae17-d59e-4f53-9483-b5f971b07177"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjEtMi0xLTEtMTU4NTUy_a49b9ac2-ce0d-42d3-b8aa-41eea60db735"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjQtMS0xLTEtMTU4NTUy_798380ac-219b-4f52-9b76-3479379db186"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i74af96c8371f491da33ef31859b5690b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjkzYWVkZDY4YjNjMDQxNmQ4ZGFhMWJjOWRlZTVjYjkxL3RhYmxlcmFuZ2U6OTNhZWRkNjhiM2MwNDE2ZDhkYWExYmM5ZGVlNWNiOTFfMjQtMi0xLTEtMTU4NTUy_7311a4ff-fc6b-42a3-b4b4-8d6a00aff0cc"
      unitRef="usdPerShare">0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="ib953f604b4cf42b7b51ce9268a732918_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTMxOTQxMzk1NDcxNjI_798ed710-b86a-49ee-9067-8ec692bbd237"
      unitRef="shares">4042993</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i5cc16940055742359e8967874631f262_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkyMTM_9d853eda-b529-455d-982e-4cab8ef1dd2c"
      unitRef="shares">401937</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i66c615d105954779b0ea4386c88b686c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkyMzk_1affcf91-b4a1-4b0c-b9b0-7f999f6e6c37"
      unitRef="shares">49322</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue
      contextRef="i976d48bf9470465e96587107d27c128b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjE4MQ_535b14d5-5756-4928-82bc-4ae06478eb08"
      unitRef="usd">5400000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i976d48bf9470465e96587107d27c128b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjIyMA_1aa22001-c34c-449d-9a2c-5c491f1af4d9"
      unitRef="shares">270494</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0de73055e02748f88fb8b29c46b0f7cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjI4MQ_186f7759-c062-4e20-a6b7-d972fb729fff">P8Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI0NQ_969ad1b0-9bcb-4a2b-9992-e9d81ce0065a">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;A summary of the activity under the Company's share-based incentive plans for the three months ended March&#160;31, 2023 and 2022 is included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,795,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,562,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;282,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;415,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(101,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,955,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,951,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following is a summary of the RSU activity during the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;294,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;165,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;22.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested/Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Probability adjustment of 2022 RSUs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(79,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;31.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;28.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5dbd3d23d82a4283a8336822e94b019b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMi0xLTEtMS0xNTg1NTI_023ccf28-4a7b-45f7-846c-cecc95dd09e9"
      unitRef="shares">1795128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i35005495bb2d4a14950ce05e7d3751b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMi0yLTEtMS0xNTg1NTI_61115a7a-83db-4e4d-ac1e-e279c64f85e8"
      unitRef="shares">1562028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMy0xLTEtMS0xNTg1NTI_018e25b6-6ac6-45c9-8919-de21649c8a12"
      unitRef="shares">282540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfMy0yLTEtMS0xNTg1NTI_7d3ba652-cfdc-4b5c-a343-2dd4894ddc11"
      unitRef="shares">415184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNC0xLTEtMS0xNTg1NTI_55c040a0-c590-4b81-879a-5cbc680d02d7"
      unitRef="shares">101720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNC0yLTEtMS0xNTg1NTI_44109bb7-2d0c-44a4-89f5-88528a0c04f4"
      unitRef="shares">24365</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i13c59f4c60774175b20f94ab17f79815_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNS0xLTEtMS0xNTg1NTI_da36e011-f78c-49c7-8ce7-4434cb57fdd4"
      unitRef="shares">20503</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i626c9146de7541a9a6c3ec2553cbc9f7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNS0yLTEtMS0xNTg1NTI_1a69bb0c-1106-4b5c-9d4c-6c54cf779776"
      unitRef="shares">1296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if554654baa2c4fab887bd8e8ce1280d5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNi0xLTEtMS0xNTg1NTI_f9a71110-b28b-44c8-8b69-8b5f9c569921"
      unitRef="shares">1955445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7d92d2b7a9d842d6a5b22b3d68c57a01_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjFjYjdhMjc2Y2QzMjRkY2U5ODBkNjllMDg1YzAzNDZhL3RhYmxlcmFuZ2U6MWNiN2EyNzZjZDMyNGRjZTk4MGQ2OWUwODVjMDM0NmFfNi0yLTEtMS0xNTg1NTI_d99c230e-6b1e-4a03-8da2-9f55d37bad8b"
      unitRef="shares">1951551</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i3514f2b646db4405a1eec8c9a17c0ba3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkzOTA_fca7f1dc-db04-4733-a713-f18f57bdac89"
      unitRef="shares">38632</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i04f3449a44e04c04843366fd629f5f2f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTkzOTQ_65996d82-001c-406f-9cb1-4fb3cf2c4868"
      unitRef="shares">6727</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI0OA_9e89b8c3-32a4-43d5-b781-c1bec69fb465">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue
      contextRef="i479dcf12323a45868421febd4b7d7c82_D20230104-20230104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzgxMQ_ef5e5243-ca0c-4920-a814-ed54a4f8a2ef"
      unitRef="usd">3700000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i479dcf12323a45868421febd4b7d7c82_D20230104-20230104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzg0Nw_846ae9a9-dadb-41df-94c8-95f6dba6779c"
      unitRef="shares">165174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI4Mw_0241e2d3-65ae-4f32-962b-d51bbee83d31">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNTk4_1b129d95-b5fb-43dc-a2df-3c705e0f152e"
      unitRef="number">0.43</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i026d56f8612c468fb9c1628088387b24_D20220101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDIyMw_a6d7e8e3-6af9-4eab-aa10-524ab9e01328"
      unitRef="usdPerShare">24.23</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i54f3253796ed4156b94a25fac13c6991_D20220101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDI2MQ_f08cd98d-80ff-4397-8b73-bffcbab938e3"
      unitRef="usdPerShare">27.84</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI3OA_04b2c136-548f-46f6-b1dc-b5172e3e3942">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfMS0zLTEtMS0xNTg1NTI_a1e0af3d-f49e-4cd6-b212-bbaf3bac4e54"
      unitRef="number">0.340</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfMy0zLTEtMS0xNTg1NTI_f4bd490d-2657-4c33-a7c0-c7cf87c0e2ba">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfNC0zLTEtMS0xNTg1NTI_43f21c1c-76c1-4d73-8081-fdf9f061ce49"
      unitRef="number">0.0442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjI1OWFmMjRjYzYxODRiMWJiOTYwMWEyYTUyNzc4YmQ0L3RhYmxlcmFuZ2U6MjU5YWYyNGNjNjE4NGIxYmI5NjAxYTJhNTI3NzhiZDRfNS0zLTEtMS0xNTg1NTI_4cfb1461-11c6-496e-86d2-bbff5070d074"
      unitRef="usdPerShare">20.21</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="ic19e24e6e4d646fcacc85aeea31d807b_D20230104-20230104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjA0_40061dd6-daf4-42c8-a150-37f06255941f"
      unitRef="number">0.57</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="ic19e24e6e4d646fcacc85aeea31d807b_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjE4_8db84743-e852-463c-8524-004c866bbe70"
      unitRef="usdPerShare">20.21</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNDcxNw_2f88d456-c14c-4df6-8dbd-ac0ba9ed01d5"
      unitRef="usdPerShare">22.55</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i165032ae420b46b7bbba8d14fe0aba12_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMi0xLTEtMS0xNTg1NTI_804a22f4-0b45-4240-8bdc-f0d56fe716a2"
      unitRef="shares">294932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i165032ae420b46b7bbba8d14fe0aba12_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMi0yLTEtMS0xNTg1NTI_e0227f6a-4548-444b-8f99-c932531d5364"
      unitRef="usdPerShare">33.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMy0xLTEtMS0xNTg1NTI_7a89b3f7-7e38-4106-ace1-8d7e93ef8c28"
      unitRef="shares">165174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfMy0yLTEtMS0xNTg1NTI_f01f3e2c-6a76-4ad3-a43e-77f8df0ead00"
      unitRef="usdPerShare">22.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNC0xLTEtMS0xNTg1NTI_edf1155c-8d5d-40b4-a4ce-c10a10415c2f"
      unitRef="shares">17606</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNC0yLTEtMS0xNTg1NTI_aa823400-c6b3-41a9-ad58-941a7dc265b2"
      unitRef="usdPerShare">33.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod
      contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNS0xLTEtMS0xNzQxMzE_2dfc255c-65e8-476c-899a-c883f7c32ff9"
      unitRef="shares">79250</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue
      contextRef="iafe5bb171b3b4638ad736f46f9cf98e9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNS0yLTEtMS0xNzgyODY_98051269-4391-49b4-aade-d2f3f68b7a26"
      unitRef="usdPerShare">31.68</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3fdfd62e90e34b9f8d96116f557c9787_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNS0xLTEtMS0xNTg1NTI_af786012-4a64-43a5-8a18-61c86196823b"
      unitRef="shares">363250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3fdfd62e90e34b9f8d96116f557c9787_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjY2OTg2OTQ3OGM5MzRiODQ4MzJhZDA3ZjAwZDFjYmVmL3RhYmxlcmFuZ2U6NjY5ODY5NDc4YzkzNGI4NDgzMmFkMDdmMDBkMWNiZWZfNi0yLTEtMS0xNzg0NjM_9691731c-99c9-405f-81dd-95a28c8a729f"
      unitRef="usdPerShare">28.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="iad26162143ea47dfa49d4366d8a0dba7_D20230101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjE5OTAyMzI3MDY4OA_3f9c39d5-b74b-4ce9-a869-2f1c32d10f89">P3Y</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i0c057c6178b345c9b3e881d858993552_D20230104-20230104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTg2Mjg_028e0e9b-3ba9-4bf4-82f5-578b0155f346"
      unitRef="usd">7100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iad942920f150409cad42db1a3f7dc7c2_D20230104-20230104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTIwOTQ2Mjc5MTg2NTA_c7162ba7-ba7a-4036-a34a-c458c9ae65e9"
      unitRef="shares">448249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iad942920f150409cad42db1a3f7dc7c2_D20230104-20230104"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzg0ODI5MDcxMTAxOQ_38058991-c15e-44d2-8981-8a9b0de49b28">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjEw_f16fea56-1ae0-42ba-93be-f4f96cf73216"
      unitRef="number">0.43</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i1917ae1a54ca4c99b9c7f284e6873fa3_D20220101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMjE5OTAyMzI3MjI1Mg_821558f6-0a6d-41d5-aac9-93a34d1b8fca"
      unitRef="usdPerShare">12.24</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i000748c9059c48ff9b5003e987126ae1_D20220101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTc1OTIxODYwNjEwOTc_0c729dcd-fff2-4b94-9228-a89b7038b3b3"
      unitRef="usdPerShare">13.98</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfMS0zLTEtMS0xOTAzODg_0b0a6c5c-ee58-4828-9e45-f1f78fccbcc2"
      unitRef="number">0.340</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfMy0zLTEtMS0xOTAzODg_9695ba87-11f4-4c8a-b449-05354385a271">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfNC0zLTEtMS0xOTAzODg_e569b12e-70e2-4cfa-a12f-ad001f4ba39b"
      unitRef="number">0.0442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice
      contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjQ3MjI4OTMwMWM4YzQ3NWJhZTIzYTk0ZmU2YjVkZjY3L3RhYmxlcmFuZ2U6NDcyMjg5MzAxYzhjNDc1YmFlMjNhOTRmZTZiNWRmNjdfNS0zLTEtMS0xOTAzODg_f1e3f012-ae49-47e0-acf9-dd8c7fe16220"
      unitRef="usdPerShare">20.21</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="i32164c0659084310957f7adb36c144a1_D20230104-20230104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjE0_70419c23-0fef-4407-989c-fcaa193df99b"
      unitRef="number">0.57</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i32164c0659084310957f7adb36c144a1_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTQ5NzU1ODMwNjM0_2badd980-2dc2-4d91-8d3a-e893d774e7ab"
      unitRef="usdPerShare">20.21</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="ia90eeb885d2b4385a7c38331488d953f_D20230104-20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMTc1OTIxODYwNjExMDY_00457edc-fd9a-4c1c-b323-984a9aca75a0"
      unitRef="usdPerShare">15.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfNTI4OQ_00ae3684-72d1-412c-901c-7c0595535558">A summary of the activity under the ESPP for the three months ended March&#160;31, 2023 and 2022 is included in the table below.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.464%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;340,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;348,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;255,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(10,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(21,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(25,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(132,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(140,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;183,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;427,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0eb8d9ba9fcb4cd3a86450f082750fed_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMi0xLTEtMS0xNTg1NTI_691fa834-952e-4d92-8484-db5cc9bcc89b"
      unitRef="shares">340976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9eb54b7f31d5417da8f8112e9b8c756e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMi0yLTEtMS0xNTg1NTI_cdf4ce65-4c6d-4ef7-a8cd-d3b0fe720ef8"
      unitRef="shares">348514</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMy0xLTEtMS0xNTg1NTI_18d1af6a-7725-442c-a994-cd8c01fcbb27"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfMy0yLTEtMS0xNTg1NTI_bdf42c80-ed87-4471-b678-ee14a7f27b7a"
      unitRef="shares">255960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNC0xLTEtMS0xNTg1NTI_90193e62-57f1-4e43-9e68-e8adb514b6df"
      unitRef="shares">3130</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNC0yLTEtMS0xNTg1NTI_fd6f4c5a-4fd0-4c7a-ad45-208159265405"
      unitRef="shares">10553</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNS0xLTEtMS0xNTg1NTI_071f90b5-11bc-4704-a485-5c17903a2bec"
      unitRef="shares">21421</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNS0yLTEtMS0xNTg1NTI_fa30710d-dd40-4688-93d9-8169b7a2283f"
      unitRef="shares">25486</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i571d11f0bd2a4600a47b7bf9b1d5c79b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNi0xLTEtMS0xNTg1NTI_360fdcac-e274-41c1-81a0-8083a607c1e5"
      unitRef="shares">132999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i3fffe843314d4755ac14fa69f8b7d53f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNi0yLTEtMS0xNTg1NTI_506ddb1c-2a59-4510-8b5f-afa6deed76b4"
      unitRef="shares">140633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i24141fc9eb4b43ab8baf38ba6ac04b2e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNy0xLTEtMS0xNTg1NTI_25fc0056-7569-4334-947e-28310eece845"
      unitRef="shares">183426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i896e8bc913c24d9fb4ecb2ce94992aee_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOjJkYzIyZDg0MGEwOTRjNjM5NzM5YmQyNWQwMjBkYTM3L3RhYmxlcmFuZ2U6MmRjMjJkODQwYTA5NGM2Mzk3MzliZDI1ZDAyMGRhMzdfNy0yLTEtMS0xNTg1NTI_1a7ea104-406c-4fd7-a06f-c6c36b59827b"
      unitRef="shares">427802</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RleHRyZWdpb246NDNkNjQ0ZTBhMjk4NDgwNWJjNGJkNzVkMTJkYmNmZWFfMzI5ODUzNDg5ODY2MA_f8b4c05e-13b2-42cd-a018-edbc72e9ac4b">&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table represents expected amortization of the Company's non-vested shares issued as of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FUTURE AMORTIZATION &lt;br/&gt;of non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfMS0xLTEtMS0xOTAyMDM_c3b4431f-6ede-4901-9218-2d081ce93ebc"
      unitRef="usd">10500000</hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear>
    <hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfMi0xLTEtMS0xOTAyMDM_158cf36d-f5be-489d-a5d6-7a72a750abc3"
      unitRef="usd">12500000</hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfMy0xLTEtMS0xOTAyMDM_85d5cd67-2ed3-403c-ad2e-6ee442605d78"
      unitRef="usd">10800000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNC0xLTEtMS0xOTAyMDM_fdec72a7-9abc-4b48-983f-352e6bcc7078"
      unitRef="usd">8100000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNS0xLTEtMS0xOTAyMDM_5ee43c83-7f4a-4551-a7a7-8aeb67472f2e"
      unitRef="usd">2400000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNi0xLTEtMS0xOTAyMDM_3ff192a1-0bce-4264-8755-897bd9b0e683"
      unitRef="usd">500000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i1216bf6ffe4c47e4b7485704ae8b212c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83My9mcmFnOjQzZDY0NGUwYTI5ODQ4MDViYzRiZDc1ZDEyZGJjZmVhL3RhYmxlOmM4MzUwMThmOTllZjRiNDg5MmQzNzgwZGIzOWEyMGZjL3RhYmxlcmFuZ2U6YzgzNTAxOGY5OWVmNGI0ODkyZDM3ODBkYjM5YTIwZmNfNy0xLTEtMS0xOTAyNDM_e5c33a83-74e3-4084-9071-2a93971e2e0d"
      unitRef="usd">44800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RleHRyZWdpb246MjBiZDA5NGFhMGMwNGU5NmJmYjM0YmNkZDVmMGE2ZmZfMTU2MQ_0b7f8984-664d-4cfd-b944-0579efdbc0d1">Fair Value of Financial Instruments&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - The carrying amount approximates fair value due to the short term maturity of these investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Real estate notes receivabl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements.&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Senior Notes and Mortgage Notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#x2019;s current interest rates for similar types of borrowing arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Interest rate swap agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,361.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,185.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,149.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;146.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Level 2 &#x2013; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RleHRyZWdpb246MjBiZDA5NGFhMGMwNGU5NmJmYjM0YmNkZDVmMGE2ZmZfMTU3Nw_2cf0a74a-07ee-48f2-a276-cf1bd850f07f">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,361.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,185.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,149.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;146.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Level 2 &#x2013; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iacf810aaefd344b08133b9065f0521e0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi0xLTEtMS0xNTg1NTI_3f3c7c4a-7e09-4a21-8c37-503fe78339fc"
      unitRef="usd">5361700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6b5e1cd5751f4fd29eaceeb6e25007d8_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi0yLTEtMS0xNTg1NTI_8a5fcc74-3db7-4b54-b548-353c040a10e9"
      unitRef="usd">5185000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9b140e579a2c4968935d45253779bfed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi0zLTEtMS0xNTg1NTI_e441888f-8c72-4ce4-80d0-1f2e661a301c"
      unitRef="usd">5351800000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i786dc6592f45460895333b89bf32a577_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMi00LTEtMS0xNTg1NTI_fdee90f8-01e0-42df-971b-9b24a7de69d4"
      unitRef="usd">5149600000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="iacf810aaefd344b08133b9065f0521e0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy0xLTEtMS0xNjI5ODg_8e6932be-6505-4ca6-a046-5043cdaec88e"
      unitRef="usd">147300000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i6b5e1cd5751f4fd29eaceeb6e25007d8_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy0yLTEtMS0xNjI5ODg_c2b9f843-f1f9-431c-8347-d77d5add95f8"
      unitRef="usd">146400000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i9b140e579a2c4968935d45253779bfed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy0zLTEtMS0xNjI5ODg_1cc57f13-6cc2-4eb4-9a5c-0a6c946c1752"
      unitRef="usd">99600000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i786dc6592f45460895333b89bf32a577_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdlZjMwYzliZDI5MjRmMTg5YmI4YzM1ZTEwNDliYjQwL3NlYzo3ZWYzMGM5YmQyOTI0ZjE4OWJiOGMzNWUxMDQ5YmI0MF83Ni9mcmFnOjIwYmQwOTRhYTBjMDRlOTZiZmIzNGJjZGQ1ZjBhNmZmL3RhYmxlOjMzNzNmNWMwMTlmMTQxMzhhNjM3MzFkNjdiMWNjY2Y2L3RhYmxlcmFuZ2U6MzM3M2Y1YzAxOWYxNDEzOGE2MzczMWQ2N2IxY2NjZjZfMy00LTEtMS0xNjI5ODg_df11d3ee-d8e6-4569-aa3e-f09261f2f488"
      unitRef="usd">99600000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  TTJ58'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  --*E6/,#@<>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)VU0,'1[43PI""XHWD(RNQML_I",M/OVIG6WB^@#>,S,+]]\
M ]/I*'5(^)Q"Q$06\]7D!I^ECAMV((H2(.L#.I7KDO"EN0O)*2K/M(>H](?:
M([2<WX!#4D:1@AE8Q97(^LYHJ1,J"NF$-WK%Q\\T+#"C 0=TZ"E#4S? ^GEB
M/$Y#!Q? #"-,+G\7T*S$I?HG=ND .R6G;-?4.([U*)9<V:&!MZ?'EV7=ROI,
MRFLLO[*5=(RX8>?)K^+N?OO ^I:WHN+7%;_=-ER*5G+Q/KO^\+L(NV#LSOYC
MX[-@W\&ON^B_ %!+ P04    "  --*E6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M  TTJ5;?GGT"] 4  ,P?   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9EK;^HV&,>_BL6F:9-*B1UN/6N1*(>NU7KA &=3-^V%20Q$)XF9XT#Y]K,3
M2&CE/&31R9N2V_.O?WY\^=N^WG'Q+5HS)M%;X(?136,MY>93JQ4Y:Q;0Z))O
M6*C>++D(J%2W8M6*-H)1-PD*_!:QK&XKH%[8&%PGSR9B<,UCZ7LAFP@4Q4%
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M(5+#@#%YL%+6[0K['1A?D;.7<?9*MDQ!U0R23 #%>82UEM2/C(D$PRH"]C/
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M[*D13Z1'Q^F-Y)OD]'7!I>1!<KEFU&5"?Z#>+SF7QQO]#[(#_,%_4$L#!!0
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M+GAM;+5<:7/;2)+]*Q4:]ZP= 5$BJ=-M.T*6U6W-6L=(\DQ/;.P'$"B2:(,
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M"/*1*FP_"?7 6)%2:E+ #ASK!(\;442MJ.4*(4G/S"KW7I@TW;5EL6O@Z_,
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M7^"X!'/FMI.AW95J]&L?<Q+P0Q^^Z@</]?C[.>J0F<V;.HRVC$:Y7+K22H"
M@.#%>L-9SYK<HUVF)=M?Q*VC49I]*4NA=J#<)K=FZCR3::=+;<NW*E#!P'?R
M6J@*KC15Y1L].@5O3@%M;EINIH<?-N%J A>Z5C#QF"&ZU,@L/JXZI1A?75^_
MO(7FRQWD[N+0LEK*"RY1QE$%I(>EWZ!&YQJF Z;;YPQ2^X@<3ASJZ3K2;$K@
M) ]DX:FQT@Y7V)K)_7EG&YP@R+:DS-(M)'A+X.OBS=ZH"WZ"G'9E?;:'F- G
M5A/0T12V\2<L?*S>O5%6"54+(E:G,\Y**7/9.+6I@[0%E],KOEFN;0HTYUL#
M*475W(P\S^-$K)5J+(X\.FLC6&OY'%D'[#"68H.R[6'/EW;LCN15+!S8QE_;
M&^D>&V+6>55^=7C0ZWN);3Y#W);^_ U-6[7@[HFE4[JX9V$B)<V/NFBL=IY;
M]DM#KSKG)\X)M+T64'RTCVQA@UXD_K9 %FQO+A.Z!O*/1]'Y_&KV\9.:W_L*
M<-N4+3T-]CQN98:TF" "=Q4@#CXX!-]F34IZQHWZKH/G-1-_G$QT5HJ;K(JV
MH<D]QB9@U7=*M(4Q2Y= 2F,+"?QA+DY)?[>-H\)INF19(:9G YX[D-5P6Z[F
M"I9[[C#D5.GZ]]=P=2EOHHACL<F8ZBR F7-J0]6Y>]:J=:$3X&IIG72Z(.V:
M9OF",<B.0! -,-HV7J1+=8;GGKH([J^HC<@UM[0=.0SOV^8W?UUB%<:_=P&!
M<'GU3<(4*7KGL3#$'J?_;>X 14DT\%:A@;3LUSW%/TPACZ?;!P]=$+?>:+10
MU&TV >I_JQX^WUU<J*N;ZX?/]^KB^M/%IRYV8\0F%](+D:=C\6V'6L"D030\
M[5.2'1T?#L/GF +B^_CV]'BHC@X/U56'_,'A@3HZIIZ5Z*A_PLL='!]B@K^@
M%A"4E.[A=6>NOM^DM=?U =@H^RL>7G$"#@?H8ETBR#VIJ@8/C-32 SV+5V^R
MEQ3-#\LS3I?B$4[A>O^6YMK[[<ZS#VW3$ZDL7AE2?Z%T_4#3[ND?34C;C,D#
M";G XZ?^W;(6"60SW38^K?&6C@4<X259=T:4F=:L>^M^*6(O^(&/&;4BT,^8
M4%\.V""_]>$_];^4<B8_$-(.EY]903P#0J,^W3&F[O>.#W>DG<R]@6?FGPL9
ME35\)[^<ZACRH0'XGIX/=6]H __[,1_^#U!+ P04    "  --*E6/V7."R8.
M  #=)0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6RE6FM3XS@6_2LJ
MAIJ"*G?P*W;2KZHT34\S10-%Z-F:W=H/BJTDFO8C8]G0S*_?<R7Y$1(8>O8+
MQ+)T=9_G/I*W]V7U3:V%J-GW/"O4NX-U76]>GYRH9"URKD;E1A1XLRRKG-=X
MK%8G:E,)GNI#>7;BNVYTDG-9'+Q_J]>NJ_=ORZ;.9"&N*Z::/.?5PP>1E??O
M#KR#=N%&KM8U+9R\?[OA*S$7]=?-=86GDXY**G-1*%D6K!++=P<S[_6'D/;K
M#;])<:\&GQE)LBC+;_1PGKX[<(DAD8FD)@H<_^[$J<@R(@0V_K0T#[HKZ>#P
M<TO]DY8=LBRX$J=E]B^9UNMW!Y,#EHHE;[+ZIKS_+*P\8Z*7E)G2?]F]V3L.
M#UC2J+K,[6%PD,O"_.??K1X&!R;N$P=\>\#7?)N+-)<?><W?OZW*>U;1;E"C
M#UI4?1K,R8*,,J\KO)4X5[__(JJ5J'!IO6:?;V=O3VH0I5<GB27PP1#PGR 0
ML"]E4:\5.RM2D6Z?/P$S'4=^R]$'_UF"7W@U8H'G,-_U@V?H!9V$@:87/$'O
M0Z.PHA0[+?.%++AQAB)E,Z7@]+/DST8JJ5?_,UNHNH*C_'>?'LPUX?YK*'A>
MJPU/Q+L#1(<2U9TX>/_S3U[DOGE&B+ 3(GR.^DO,]$,$V%7!?FVR!RA9*]IG
M1_5:L)]_FOB^^^8T*Z&S%8-'";WDO3EVV*:I5,.+FM4EH\VS524$XK/6VKS.
M>,'*);,7I3B:,JYHZ9-85 TBGOF3/9?9 QVU_L+%@Z;,\Q*\?!8\J]<)KP2[
MH8\/[+9">+#S(BFK35G1?0[C#.[SD-&Q=ID,>U1 W=_PIR"6/M_<GCOLXN)T
M:W\F<TD\9Y(O9"9Q05+F&UX\'+,CR^J%6/'D >=['@=L&7X@[RP7E4RX0[R-
M7LK3"\3;9>1VUG-"*KVZ=K3*/M]L^;7_ ])V=UB[S)M%?T>_QG+ZF!J'(H*R
M@%MT"G+,B^X9U(M:%@UY%:0E7E53W<D[6H#1B0%M:W:_+K/LX174 NJJ62B9
M2O(=Z+67>H\#M4R.R+7I[=")'29XLF9(2JK&-;2LUJ3K 57B,8>K,6!N\LUA
MA^[(]=B&5^R.9XU@&PAN#@TO[T^?FM-S.MUK[![2)KQ(D'8H'K0/%'>B(MUK
ME1&MBE('A54E$H$DQ<I"[#((L9., \AF6YPRC@!D2_D=%+5KT1EOY+I$D/Z/
MV#58IWMJ4>4Z(NGA<=PYPXM2@:LJXIBIC4@DSU@*8Z4" N#\83B:;$?QW.[Z
M:'>U&F"H&UZ@_"=D>]8*;(\90&>_'4CS)D*&LB&V@-6;TG"52J"_7#0Z9JQI
MX(VIJ+329*V(D;K \UIN6%-@!;#('_@B$VS@_N!"L]\>ILMQ,1T8T(.QRPKJ
MM$CL30TXCMAYG@LX?2VPND0TE/?$76\S9SNNK#?A_A?%M_;!-2\H>DFD@N>:
M^0X5]8ZA8?9LMFI_"6I9&T L %V::D0R:"6 4#B",!"P0JVVH_$>BQHVM$EP
M/]+!@"L\Y8(7^A#O][7)';XD5X7)3EV>LC:%*50#CZS7")W^PH5(2+IG(<@<
M'[%; ABK4!3()*B"?5,;:%I-/ZXC Z10A/9P+=H/1@446_&4 $3S<8FJ^'=4
MQ28:V-EW8\NMR+W\?7[616LO0BV3;T3U(5^@*&UEN>FLB9H8)752-H3K*RH.
M-J42RAEB"X%?C5;!E@*\)5,)^*R"JOL<U6I %E"_3-9#4VL,+=$'@#=APCC#
MV\R<KW#1T&-O]NT?<-H=HF)>A]\=KV39*+9$Y5=6$$$62=80)* &:6I6E'47
M3W7YFAW)8TV4(JJT*=;ZQJ+DE4;(%%=H:NV;1%>?(NWB<']D'\G]Q)4H)#2>
M\P*MDG;F'Z-+&@)M2QP5:BZ;G)RE4$M1508_Z-43&#9"N0P#PBO1[A@CKP&7
M)14Z&;)/@1Q'^ ^(KS5_G>![5.\,"P4;=C] T0:>B<*!#VG#V^L@$&6>1K6*
M&.[+!7!8FVG G"ST4Y52MC;ERVQ^RB;NV+$N60G-/AS$E*0EZ%*PX+3U>TXM
MA6KE3+NLTZ*P1%!C3Y/;=T59O-+0!9L9'BP4P@?!7/'@D%D60N>*52'_HG,U
MD935ED14;L-_I04$HQJ9;S*I/</$@JD[AS8O=TLE)HE%ZT7J-?N(#QQN+&DK
MH@1L@SOQ/1&;6JNXS\A@@K-Y!UU/Y.2M0L T"-N="!DQ_0,0"0:/^#'ST3:,
M\78Z=7L$,Y6.+G/.K9AJY^;MH@R2J0;[AO1F[46)5<$&[B>>H5'N]$V+8W;(
M_' 4Q.PW#<94*EB6GF?DD(V=<31UW'',/G6V>Z0Z<@?P1#S:<N\>$ ,5U2;A
MM;4'0OJ5A5UJ/B&%8D?),8N=T(UP_5,NH)F((R>, JUM<IRBR1>@0[#SM];4
MS:Z.-[XH4;I2#';(2JJ>C&,G]F+P6%,T_P/WV*WF,^KGO:FO3R^I8X=8/76=
MV$W]T)7>\%^8I-$YE2O3LV@R01 YXV"\G[,=[1\50D.O[XV=. I?>(K09"VR
M]/CYO*E$2Z\M?OK:;K\K.;KZ+R@>AW'1=@![FIQMXW6Q^[1!1MK%GTWWR[W.
MN]_I(0J-$G'QH!1^RA>VG$DGKH[A?QJP(QT5-\+ZK7I&@$>6M);1J6#9H$)D
M=T)C!UB =FS^;/G:[K+PWN:YK9.\SZE=/M][GKS5W$RR[XO]9##=:@$ G5\E
MJ'(IJ'R];BHX"7SL6JML!H!/S'Z*^4'9H,F:*2TRCFHKAHX0>)>Y+NIZO?7I
M?D\*W)O^ZIVXWI]LV/7-V<7YE_/+V<WO;/;EZNOE[9S=G)U>_7)Y_N^SC^SJ
MDMU^/F.G%U?S\\M?V,?9[1G[<C:;?[TY^W)V><NNSV[.KSZRV<=?O\YO:67^
M3RC.YO,SVH4*GN37B;(@*YK*Y(+$/&33R=B9^A$^18X_&=/*U'=\SV,?&ID1
MI)EF$/FA EB:LY$SC5PG]";LR/,]? B.L38)D!C<,9R13(;" .$MR3!6P835
MD\##=2[SG$D8XRD )"&5F-()2LWT63U=>%4N7S6J.SUU)G'( L<+(^8%C@LB
ME"+JJC'#<A@ '*)Q(IQU'3?VV%'DQ&%XC$.!'QN!"=)T#9"BH,_*C:Y+0X+3
MB2[U/?]-^WBKT;]Z0GV'#'DB#'%!C,]'G@?YX^FQ7H_]V)E$$S.N5?V=BF?(
M! 3'L8LD%R(5Q\XTC*"\Z=0)IQ$ZK/X&"-045 B5F32SR3]**!6!6-0-Q76$
M6Y!06K;MXVF;*G3.H/H/WJX)^I'C!B'S8# W8 $X0 %PT\.%/N YGA\X$:0Z
M\AP_C(_UBH\C+KO2;>/S9O*F$\>//.8AA4XB)!U<"F)7NO T>XP*"*()UWQW
MZGB4R0/HTZ7G,<P56/4_CLU#8M^+8\>;1%KOK@MU!\?FA6NK@HOSV8?SB_/;
M\[,YNRRIT26%+$J*S7;X<0BWF$X])X!@AYT2AZLSDSSZ([I+3Y*J$=L  47!
MXN/8):D#>"EI+H1E0W8QV$;%^QZ/H!ES%,>D@&D #_+A5'"_Q\K>NC#&WG!"
M?HZ/S)N$L)&W$T9;1TA/+CN:C,?'%$O1V-IDN,EW X2^2^[LC"ER/*@BBB)K
MC'V@2,58%(R=T!\;&\">9A%A%,'=+F%KFJ_5<BGY  T&)D4Y%WH  L]$$A B
M\(_U>NB#57\*(^[O.O25D,SUMVS8KOU2ENF]S#):"D'-#?5+?0&5P*CS4$MU
M1>2]_D*,D!Y%#)I6:IJJ6OYE4@[L(4MCMJX[(_ZS)^".NI(-(.F[SCS(H!%[
M$)SZ4G+]<]VP0Y&'WG@T93FXM'VSEA/U8:/'!=8%S9B5]->V=@/::JN/HJ#J
MJ<>343RDOJI*I;;N&")<H8-E>-ENK6&NISKG, Y'DY9X/[!LITQ] I:07GS?
MB(2*EQ*W9_05IQY406LU>F9LP)\V(S_'$J%\(D2JGBBU32.9-'F3<?KZE&9N
M"GBID=[:T#1K!F;-3%,/7:JR6:UI( GYVJ_SJ%3*C02FZJ$:HBISUFP,*)->
MM(,0J8S7_5S"ZD&[9?Q&;4G5!L'C4H,0QDX<L5D6YCML;;M%S?749/&PI>5'
MET([$-(0:SU4%H\+,]..TR!9Z.^862T '03-]+83E 8,E%F32OLXKEBU$44C
M=412[[IZW$+?IFVIS]GB=<U3/9JB44FF1P/T-A4TY6\K09#8]K<$XG 2H8LO
M\]W-HW#[N_+M;V9D+[".L^.+9DNK$ZT!&M/VDQ6EVL'7MDPO+3F!(<,R5M?4
MPP9CZ""FA:3Z_([+S$!M;0>C=EJ%@@E(3&=/AW7%IVYR->\G5[J?P^4;^N+!
M!)4U&Q^.#S=MB3X<FO628RUK'8K<B>"JHIM,\Z>>BI4=G]C%H1?;W0(6>:V=
M2^EXAZ;^!AIDU\'1FV[.B[4'W=2T:8TN:38D"GT+1B!O(&(7FF9[NQ(MS5:J
M.$1J&@4=;J_)YD(4A)'4 1F/[?VNRW/5=I-(,R^E=DQE&] [.S??5JO^,@ Y
M^_\,-^,Q@R%@AQQR=Q)D<@-UK \%0*I%PH4HQ)*^7 #^:B5V6FUGQ%U(,THC
MB=QHW:QPKJ+LJ=$4RJ9OR4PR2$H4#8K?=7W-!B&M,Q #JT69VT)-)529=0S
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MBJO^)OTDWO\? 8YSW3A,TWNHAF?C+"#;W_'[A3=M=Z^>&H_AVKTN\+=(61;
M^;W!;!L6[&#_1VOR)U!+ P04    "  --*E62R_0F2T$  "%"0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q-"YX;6R=5FUOVS80_BL'->TG51))42^M;<!O
M00,T61 ['89A'VB9MH5*HB?2=?/O=Z1D+QOBM-L7'4G=\_ Y\H[DX*C:KWHG
MI8'O==7HH;<S9O\A#'6QD[70@=K+!O]L5%L+@]UV&^I]*\7:@>HJI%&4A+4H
M&V\T<&/W[6B@#J8J&WG?@C[4M6B?)K)2QZ%'O-/ 0[G=&3L0C@9[L94+:1[W
M]RWVPC/+NJQEHTO50"LW0V],/DQBZ^\<OI3RJ)^UP4:R4NJK[=RLAUYD!<E*
M%L8R"#3?Y%16E25"&7_VG-YY2@M\WCZQ7[O8,9:5T'*JJE_+M=D-O<R#M=R(
M0V4>U/&3[./AEJ]0E79?.':^-/6@.&BCZAZ,"NJRZ:SXWJ_#,T 670#0'D"=
M[FXBIW(FC!@-6G6$UGHCFVVX4!T:Q96-W92%:?%OB3@SNE-&:A#-&B:J66NX
M%T]B5<E!:)#<NH1%3S3IB.@%(@:WJC$[#?-F+=?_Q(<HZJR,GI1-Z*N$MZ(-
M@!$?:$39*WSL'"ES?.P"WTRN#,Q*751*'UH)OX]7VK28%7^\%&S'%;_,92OE
M@]Z+0@X]+ 4MVV_2&[U[0Y+HXRM*X[/2^#7V_[(G_XL(ECL)QK56MBHQBXTH
M*PT&QZ>JWHOFZ=V;C)+THX;FS+%R'/N>0VA0&\!-*G;G77)N,UG(>B7;TR@-
MX':\?'RX6?X&L_%ROH#)^//X;CH' N,%_'(-\^OK^71Y\V4.-W?+^<-\L80'
M=(29JBK1:B@;5*8.6MCY6<A(Z"8CM&]2N"(!AU595;;0'QLM"]SA-4SQ4QJX
M%D59E>8)2!12#E? ,NY'4?2LQ8,T@;=PQ7B$5?9OGJ5L:_BL1 ,4TA"G9G'N
MQWGL+"&QA5,+QZ/P53@/:0PDS_V49LXF:70&LQ^ ._4447E,.LN2,YK\0'D2
MT@0(ZN6,.AOG_*=U8]"IT\ORWB;TYW6'&"S-4S]/8V>S)#^!%[(I50M=HJX/
MTB8,M\N$@:)&&B7.$L(A#L@E1 *9C8ZGS(\)+FA*?)ZEB, M>AF1=B'%6>3S
M-(,XQ77A#!$N#5Y"9*<X$C_/N;,9I\""C+^,8!%@@J*:Q$;,T'(_CNRRX> E
M!+,(RXV*G,4$!7IQK1AQ]8">'%.ILSQ.$4$OJ>H1"4/])$=+_21'=0%AB+A5
MK=GB9=R7_:G8<7G9>ZPWN]+,3W CLMBG.!$+>/KV?1QD,28"<,P+@G1YU^;$
MSW"1 RSTB:A$4T@HD=,>F(W!%&GPS8%GR!K/9'5H3'?*E%H?G&NA]&FH*:J#
MQLO;>B.\+@^U]N&XDWB,B_V^*@NK,GCIZ V?78VU;+?N :#!3=C=DN?1\QMC
MW%VM?[MW#Q0\Z[9EHZ&2&X1&0<H]:+M+O^L8M7<7[4H9O+9=<X?O)-E:!_R_
M4;BH?<=.<'YYC?X"4$L#!!0    (  TTJ5:]]V F^0@  ,T7   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;*58:V_;.!;]*X0G.]L KM^)TS8)X+Q:
M#_(HDK2SV,5^H"7:YD0679**F_GU>^ZE)$NQD^SL DUEB>1]GGMXR<.5L0]N
MKI07/Q=)ZHX:<^^7']MM%\W50KJ66:H4(U-C%]+CU<[:;FF5C'G1(FGW.IW]
M]D+JM'%\R-^^VN-#D_E$I^JK%2Y;+*1].E&)61TUNHWBPZV>S3U]:!\?+N5,
MW2G_;?G5XJU=2HGU0J5.FU18-3UJC+H?3P8TGR=\UVKE*K\%>3(QYH%>QO%1
MHT,&J41%GB1(/![5J4H2$@0S?N0R&Z5*6EC]74B_8-_ART0Z=6J2WW7LYT>-
M@X:(U51FB;\UJR\J]V>/Y$4F<?R_6(6Y^Y@<9<Z;1;X8%BQT&I[R9QZ'RH*#
MS@L+>OF"'ML=%+&59]++XT-K5L+2;$BC'^PJKX9Q.J6DW'F+48UU_OA,6?TH
M*3+B0J<RC;1,Q#AUWF8(O7>';0\M-+<=Y1)/@L3>"Q+[XLJD?N[$>1JKN+Z^
M#>M*$WN%B2>]5P5>2=L2_6Y3]#J]_BOR^J7+?9;7?]OEBJ-"IK'XHN*93F=B
M1%C17BLGSK2+$N,RJ\2_1A-,!X[^O2TJ0>E@NU*JK8]N*2-UU$#Q.&4?5>/X
MUU^Z^YU/K[@T*%T:O";]?\KB_R=1W&KW(*YDBLJE#^)F\H?B"A-F*KXYBN):
MAA/W<R5.S6(ITR>AG5 _E\:I6'@C(F4]R$-8"$06\*"U4VL68F+\7&@HFV3X
MJ)P3(",KJ9Q#OE1D4K/0D< SUOR]55.UM!JF+V62/*%JR%C' ED_<NK( DDU
MI\0C="O_1/:7^DA)J1,1"$;ZN379;)Y+9/>QB.1&!CA9KRYA5+>JL*0TG\4V
M!6Q-LIC<UZE7L,X+:%9-D>@?F8:#3TVV*+(*+[RJ22Z"3C4<G.2228"'.KDP
M6>J;PIG,1LJ%M7$6G"DLELZI'/V)EA.=!-C3.\G('"<T7L-A6L)!K^'0$G=+
M%>FICBC435Y:>*O(%T<NF3?E4#I"=*HIFDO/P% Y+#;C&^9@,L@8\EB_59'2
M2Z3&BJ5\*K(TS3S5\D-J5BE[F:4% B/IYGG07'#A4289^[^:ZPAC6!@K> ,B
M!G@1[UJ>ZEG^]9>#7G?XR;WM,XG-\FK(G8_U= K!,,T5[A39]!K:9YO)]%M4
M!R\1  03U0D5[&,>F9!E L$+\_*PN5H9695('XS=IG)B+,@+%B(:IR3D OL^
M$RM<@9GC(F*WD!)89%O03$$G['_F-HJB$M8002KD.!;.!Q _T8=R!?F5 C\,
MZS+*52:H36<%"_.H<G#?0W84P<1$PR,_UQ4#ZV!?5R,RZIY)="NYI(I#8&U)
M&?4I5--57J$-QZO94VL=N(JH6#D]2SD=D,HYFU*XYR'<.GTT"6!7JX8I$YV<
M) 6D7*@J"?+*2 <91\A&:**Y3!$G]'XU)Q?R@3E:_U3Q>S:G1 IB%N8F>JH*
M6,J952&48%H_1V^XEIU/R= LV.2)Q*8F)]M@'J@E0^U5T[U2E8IA7_-JS?TJ
M \'T9E!P%"%2#;W:>=)23'Z?@VD"1>CS:GK6X6WFA B2^9%)^$9,O"7BE-.-
M? :$S(ABH #-!.:%FJY0 R"%%!F+GHEB/XJB;)&%2KO!5,O!MVI._3!W+H"C
M$N\N(6U7O&N,;D['C5VVTF43IWYD"#=7:Y0@!F!FEKNM)G)^<1+RL-5I$[^#
M2% +A2D0'XVSAXB!E:F3>4L-DHJHAJ1-0\6/<D19M336YZ[ M"IKU#*IDT1,
M5-W,K85;*902;%3V"XFM.P_G<Q+9EN,1)PD])=PJFLIZ"<]E++H# 92"2]+-
M[;CF $."\?A&+6Y%QD=Q_H^OX]O1_?CF6IR-[L_%Z.KFV_6]^/U\_/G+_?F9
M^$VF&0Y+HKO'I@[$#AZ=9J?3$=U6KRO^!E<PRH/[HIL/]5K=/0S]EJ5J/;87
MQOJM@S[&SL 'BPEPM65\4%\[+,<&K>Z6M4/1*]<./V!\!P.=3O&I.\2G>SD!
MFFVUG49$+J2VXCMMLAR@%SKS/+LG,L'FJ<0='U9IT_!<[1,Z60KNJKF#P,"4
MY):;=R6Y?W][.^;"7N&82$\LA:0"FU&^V19H V>EQ$+XY4RB8TY^W4RY!6XM
M<3*Z'%V?(MOWXFIT>_JE'(+?@@C2 7BNG';WY?S\7ES>G :@7(S&M^+[Z/+;
M>:W%K@-PGA]EJHW&MBTDD$NU]=L1[[K=YH?></>5!7G;N",^-(?[0VR0'E'<
MSITO60,]O28.0+LO@(-B?,X,0V_/>@DB2*(:$FK^*EV^BAU5JGQ6P]P"5%02
MK>4L2>MP*%#4-/#95]'9]UG:F9SQH_=""P5LOLPY'/N6>/=Y-+[>;5_>W-V)
MV_/3F\_7XW^")<;7ST<N1W=WXXLQQBYN;Z[JL&)CV)#UKVV9WA$'S;U!EQ*U
MU^SN?:C@H:!ESN&@W]\E)/2'XDYYG_ NH23R^%2P'U-R[U/YW!#4[0SYKQ"P
MK7%Z4\B@1_\VS0[HW-A3V/C>P6 W$-;!?NV0AIEHY7QY_DBIO=1Y:[+SH;4G
M%MB\PMU4F<YPR;35^JU;'7=>C"04B4311!0XM74++%NK5/WTHMO+L59I39[9
MV&GM;[/1O1+BPDBT7M;K/S<L3.F,^I=-Q$F 3ZSO:<][7Y@"UJ1:HB[W0DG/
M1[W[6CD\ZQO19Z"<\K:Y0N.5OI7X"X=J/LZAH;4H]_?Y'1VJW#QJODSD9K/2
MVA0IAZ D)O=CRI$-[4NQ?%.OF21ZEM]&Z"GU/.MCYK.>5J?4?:B8CZV:3JZ1
M2NA:(1PCN6%6;%6<J4U>*&T(.T]5VFL=37T;K+(SAR?%_E00/TXNQC%R*K<0
ML-)F5:1,0N=>#"-D,OXC<YZ]IE-":E*TD'Q73'L@GV;J;.?JQP& :F?8ZA0X
M_>_Z,T=G!#*8=Q=.7$(Z+-W0O**-"F65KT8$)K8 %'M2S&MMNY!K5ZY8%\K.
M^"+9!>B%V];R:WE7/0I7M.OIX:(;OF$O=$CX%$L[K>%> X'BR^/PXLV2+VPG
MQGNSX)]SA3;7T@2,3XWQQ0LI*&_PC_\#4$L#!!0    (  TTJ58I#1IR#P,
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M'N$W,'Q[W1XTY]&.[QN3D86\5XRH,U"O;^DXPC)\.HSO'E78AN?8=(SA&UZ
M[@%P$1>JG7#I0'1"9%AQY()NKZP;!QJ!"\8CYCEC(["<K2]<"J'>[].Q@FA
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M@&XQ#A=HS]F) /9G%GYM)G) V_!/_@%02P,$%     @ #32I5DB\K,72%@
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M59K/U$V1I7&JC7KIWKUZ>U!A:UK@(+;;?)!M!ENV&:K+(J_F1IWGB4[:\P]
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M>%1)069+(3NK87(@U8E^=4_R&&+AI68LD*C)HR*RF6B2<Z8AEH9J$S#]4_&
MD%1VE/Y.?" U25)#VJ8I;)4ZE5W,4L<$:=VOY,884'A $PF@,0#Q;2WMA-$"
M;C3%AD;4%C(T(L*\4.2L2Z(OGD?Y3#N!A.=M2+,_7K5=VU,J8]GIIS?.\"S/
M:XQ=M^;_9B[2X$<=E8J\7*(^ @8L)K '&ZH&\.B0D#\!:XJS, #?W$16%XB7
MDRACI!9H,+B"E,0%\B9T8 XI1&J>4#X#D(40-M$4X=P:?R (\:]>+5LQ:9-"
M;..0=]K_;SY=;M0% %Q2\2CYHPX1'M0")\S(H<9U69(1@TG0/3X)8A%I>XY-
MC*'4BRB(U#1*RU8D"/CLCM<%&,=N24J_=ZR>[6)P4H!.LDBW&V%BN!W91K%W
M2%*"8NJ!3D,K$KR(*H&-9!8&@L A)WJ-531FE5=# 1L1(X7(D/((]1C<41-@
M:B*'](:$614V%S!\),H"4H.8Y3[%T3(E/-A@UE M.];F&#1X'%4V6!*T2FQ@
MN11DO%@ E!-:3LU7&09] Z"*L ! U:[ ?NP#^_'.B'S3>&QLVS*+3>']1Q8;
MA8N%R->K^H_$(N>GB5$VXACG!>VZ'962!LP+BCJ$6N%4ZPF4.(4R<2J7K^)$
MP=Q &A;BTG3RFB$L!E.JLLC,BL9QC29E.4@LL,$!R)3]94I@+9T^*GIA#$S:
M]C!/X[E;DE/4>$XFFKA43BTTM,8I '1&W1>BX03+7>)!B$"7<&C:KCAQ*;(F
MW4(<!C9(A63),!]A%;E&?$EM">4>3*$TJ]%&3^A+BZ5^NS@W%DB]ZH9U%L@E
M3X#*280)UV%8QF[>V=W(35/C8HF8=M+O=5848E(640)!)2 J)TDH;,<Q+A=*
M'LE4Y'0Z97:\3%^)H8#1_#-EJT5I)#(BA:V7T(&I8EW(HOBKG!\!N/3LM=R$
M* P,.X-WL(PEID)\<655S$F7>&5J(D*(8E>Z*, OTQ2A<(X4VH+)P5"OYQKR
M+A9@ Y2''1YAIX+.L^E DKI6;/6*XY*IIR0X+EP4K@PAA*SL%)!-(8GJ LX'
M4Q2J)P6E4JO!J5Y2K&EGIU9]4[U3B;S0^!2-ZC%M##V@R,Y,IS#,XH&X#U](
MM2I$ P.<9MYXR5I9[1 %?4-[/B$&2\^34B!S\F(HD$W-1#LIU9Z8HIP@_3><
MEY2V-*$M#ZIU<F*&"$L@)NS,V!>1*"#/P2@AK,WO #@8]F.!,A!"Y%W@G! ]
MJL;Z;63'5];8,<H?>(/,.A:R8T-,+TK1.K%_@K=3JD +U,R+?-_ZJ8QDU@QC
M5B1:+]A];!]G 0YY:SXC_?H7\A7ASR)Z]+"5:4AG*>DT58&,839Y?:R7!-C@
M^F%7](.^YQ#"IFEU=1'Z+8E\7#XEZ!65)>TC<4>0D\W:"."U59>8$278A[)
MJP^K>K=JW,99M\"B $;P$2@1(91%-NF^"S #5U(FC]NLLD.3 ZPQC6(;->*T
MC.L%D*ADS:PWC;&L6MY?L;K--K92]9(?C&3Y@*K9(]<$* G"WUE!6C*A.D%7
M"@.N((:PSBC.1RD"9]X0."A.F$C3KFJU#*OQSJFP1^)+*M5?H.S>3UZ*(C:0
M,.?P$NIXB&!=\*1:'D[+LFE*9JR3B^@/,34;?-PDR6E:J8S/7#C.M_(:P)*=
M20QQ:_UH(2OXC!FA! 86&T[K*-O!PD;#*=2FXN9%CUEQ+% 7)9JD&<?,PD,>
M/QU46A,)=8UNK1(Q8!I)TO4*",*6FF_&UE9H&![-2NU3[[5K@D^B1%"1S]V;
MKGI)R^Y=4_D!.GAZTCWYR0)':V"6 UV>B!T8FWL(& !'('-R2PX!7=]PF<.C
M)Y9>D%&)LFYSG:SKM)OUH%C-Y@C(N];+L:(;+>?ME/?Y'OB#*)ZZH^LYLKVZ
M),S5:3LBEEY4YL1#ILE%QZDGM.1:BJV95\73AQ21"ZEI&4JY.6I3GP5I7T@[
ML.0]?K1T.7Z+IBT6Y/^K(O[:X5 '5V^KA>!Z]4!I*N,12F.YE.OH#Z="(TQ-
MW+39&=2H9 :V9OB-A1Y[YI5U"#D >+D2#@FCR&W$$DFU[FI4JSP/?C[0GY6"
M>_>U*_RSQ^]W!S]U6IP(R*>R,B%VHMZ%CZ?$ HH\<,P>V_Y@=V+!CAU^6#(&
M+MVO+K#F4-9 P_7-#I:T;BP [/5*W86" (,F>P*'N\ ;2>\:O+3U#!+O0MVT
ME5T/&:P?8&3MO)M3EB:G<* 1ITL30A>E1N:9,W!X"G,B0^.2M+MY6+_D"!G,
ML6TEO6WJ,B&#.I[.BB&<W+Q(LT/ZIQ6)C42*[^M7J@.6QUS3E'J)Y6_'@[[9
MC"YN*@ULGT#%(N?-BMI@<_-*79[=CCXUI9@SOLU[HZYTM>72UJ@7ZO"DTWM]
MJD:1F0NFH3=D0C!*'M+O'/5?P]O[2T0Q $X?Y<)0#3K#X2GRTLJB1U[XJ-\Y
M'1ZISZF$+(26-\3=DDQ(?U^2PPR7RIIQF-P?='K]GEW2NM[A:>=T<&2_"X?3
M(G:,W_9'-'WEWHMUG2.+J=SUQ4.A7+UZA0_YB@ZUL9DOP;':-*B0@(4%=KOS
M9&LV N<4^YS]**-=&=%YO4.L*L0,'Z@<'H X5]ES)#U$0M$66V4GX8KB;8[Y
M(I$K!6YABZ&+/@2X/_G*QLBM<=1F4Y@20 ")+D/0M-!0ZT3N,IM+S"#O#LN<
MS[S.)"YVMYG.]>W%KQ=79^.+ZROU\6Q\KCY?C^33W?67V]&Y&IW=WO[[XNI7
M=79Y_>5J#%O[_>+RRZ4Z__WF^N[+[;D:7V/.W1TI6A_8AGIW$$?&OZN^W# U
M'(*2#GN=$UC,"U+-_E%/)HV0!V5%5>F.NAIMF';4.<:<XTZOQQ,&:JR_@]<#
M]8\68X\Q8GCB7OKD!NH%SD\BF=$U;;ZRKN#>7*_4W=U-VH!Z0*A0V&YFP"Q#
M66!P);VK>OK:5T]?[RQX_N9J:!<N>IY;8+JI>+I[K>==TC]Q\=W.704WB!UH
M:8^HC5.]EO)RGM+4]RRB=Z:DOP-^I10)PV(&M!I B$M90#Y<+T_2A*TU /NF
M >N[.'[B.7ZRDTM?#$,OL)J1D,<+L4>U3][ ;!+-LS8]7]WT1^K7-WR#&H5
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MI'L/Z7+:\+^MS1,RWPH"PPI]'7?31+B=?O/ ;+OWS61T.;F9S";C*;LK*]%
M>%Y2;:[YBV:+$\ BBBS#@6,GNR!V5T<-R;\>(2%@?DGDW24(! H9]P*3O':
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MP/I=":^_;2R.1Y2#_PU\OZ''"M%%B0=!T?U.*]I  UX9N$:8Z?D2?;??==[
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M$V$.X1RL$#@?D+1_&N*;1FF^O9B'2F[U]XZEK"J9Z^6&,YSHZ0*>$W@<'DA
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M&086+]B=X9_'4Z4EB>"OOAQ;B+ ?PBR, ]6P'(\&I'R%\AX'XS>OO-A]MR/
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MY1ZTW?7>=8S:NBMUH0Q>T*ZYP1>1;*T#_E\I7-1#QTYP>F,-_@%02P,$%
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MW&+J9^1[P\B.X>Q)VE%DWU$[BA$=^G:0(#(,[8!N3M"*LP4P!;+2,VE881O
M<'BX!1OMW"257#VZ^S(-OF\JTUXJ=6^[*[EQ>Q.UG=[>Y\%N >,:%7P!HM[0
MWH"I]HZL?3"R=O=2<VF,+-UPR1EDKYT WQ=2FLV#7:"[J+SX+U!+ P04
M"  --*E61=N8=RP#   9!P  &0   'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6R-5=MNVS@0_96!6A0MD$J6?$F:V@;L7-H ;1"X;1:+Q3Y0TM@B0I$J2=G-
MWW=(RJJWFWCW11S.Y? <7D;3G=(/ID*T\*,6TLRBRMKF/$E,46'-3*P:E!19
M*UTS2U.]24RCD96^J!9)-AA,DIIQ&<VGWG>GYU/56L$EWFDP;5TS_;A$H7:S
M*(WVCA7?5-8YDOFT81O\@O9;<Z=IEO0H):]1&JXD:%S/HD5ZOARY?)]PSW%G
M#FQP2G*E'MSDIIQ% T<(!1;6(3 :MGB!0C@@HO&]PXSZ)5WAH;U'O_;:24O.
M#%XH\0<O;36+SB(H<<U:85=J]Q$[/6.'5RAA_!=V7>X@@J(U5M5=,3&HN0PC
M^]'MP_\IR+J"S/,."WF6E\RR^52K'6B736C.\%)]-9'CTAW*%ZLIRJG.SJ\9
MUW#/1(N@UG#-)9,%9P)NI+&ZI=VW!EY_9;E \V::6%K1U25%A[X,Z-DSZ$/X
MK*2M#%S)$LM_UB?$M*>;[>DNLZ. GYF.89B>0#;(AD?PAKW\H<<;_K?\2VX*
MH4RKT<!?BYSDTXWY^RG- 7+T-*1[1>>F807.(GHF!O46H_FK%^ED\/X(X5%/
M>'0,_9#P0I9PP;1^Y'(37 ;HIL*MLF2YZ%+)TL =>W3G=P(KI(.],I99[))6
M6"#?AJ@K^-W[E/KC_+Y6"-:50NX>/#T0R[@P8,F_=MRW@2BCU8H]^<Y'+0:D
M9^"BN2??!/+>HQU_#/Q#GNZ9 K- EZ.H^MOA2RXIH<Y1[[U9_'O6OS+@4@G!
MM $NZ<$)0;W#P,5BM?KSYO8#W"\^?;N"Z\7-JC.?C]P^(R6%ES ^&4[2^-1;
MZ=DX'@3?.(W/@F_T+IZ$ WM.L(-)1Z?QT(^3>$3C.U?5#2E\PBT*R.#5B[,L
M3=]#K4H4;TO4U =+O^G,>G6D=%=QVA7#-Y*O><&D)6?3VL#_T.W/"DJ'07O$
M-/6-W%URSXGOVRRU*/V ]+MXZLHG!^VJ1KWQ3=E H5II0^?JO7W?7X1V]RL]
M_#3H,#><% A<4^D@/AU'H$,C#A.K&M_\<F6IE7JSHG\7:I= \;6B?>TF;H'^
M;SC_"5!+ P04    "  --*E6:YLT:N (  !7/@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6S%F^]OV[@9Q_\5PCML+9"+K1]Q[%YBP+'2-8>V%R2]
M[L4P%+1,Q]Q)HDO23C/<'S]2DD515ABK>[SV16K)XE?4QP_)YTM2%X^,_R%6
MA$CT+4TR<=E;2;E^T^^+>$52+$[9FF3JFR7C*9;JD#_TQ9H3O,@+I4G?'PR&
M_133K#>YR,_=\LD%V\B$9N26([%)4\R?KDC"'B][7F]WXHX^K*0^T9]<K/$#
MN2?R]_4M5T?]2F5!4Y()RC+$R?*R-_7>1.&Y+I!?\9F21U'[C/2CS!G[0Q_<
M+"Y[ UTCDI!8:@FL_MN2&4D2K:3J\;44[57WU 7KGW?J;_.'5P\SQX+,6/(/
MNI"KR]ZHAQ9DB3>)O&./[TCY0&=:+V:)R/^BQ_+:00_%&R%96A96-4AI5OR/
MOY4@#BG@EP7\1@'??Z9 4!8(#BT0E@7"G$SQ*#F'"$L\N>#L$7%]M5+3'W*8
M>6GU^#33O_N]Y.I;JLK)R7WQ>R.V1/?T(:-+&N-,HFD<LTTF:?: ;EE"8TH$
M>A41B6DB7J.?$,W0IQ7;")PMQ D2*\S5!>KD!YHDZN=4YY;RKW_QSD>_U,]>
M]*6JLKYQ/RZK=U54SW^F>@'ZP#*Y$N@Z6Y!%2_G(7=[S'0)]Q:H"YN^ 7?E.
MQ0^8GZ+ .T'^P _0[_<1>O73:_.T2YKA+%;<OG 2$[K%\X0@(;$D:(LYU8=?
M:":)XB6_$$58/J%_,W7FRU8=;3A!:ZX:-5>GYQN:+/0OD#%)++D<=PN,V>%5
M]W=5;V/JEHE(_)*,13:H0C'(=8-G=*\V0IT1 OVV)7RK&OB;MG@I-,)V#=U+
MOA%K')/+GNH&A=(AO8GZ:8:#7]IX08I%0&(6N[!B%[K4)W_G3.@&N%5AI7IE
MB7"JV^\)DDSBI(UCH3?,]?3@L)UXP7B@_UWTMW5&SAMW900D9C$ZJQB=.1E]
MW*1SPG5/IP;(!)&B59;-37=P?U9MKPU8(7Y6 S8<>0U6S@IT904D9K$:5JR&
M![)BCQE9?!^QX0'$G-7H2@Q(S")V7A$[/Y!83DD@N<)2_2$H9ND:9T^:I+!
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M72K^D4D4$<4LI7HOA&1H3M#GF^OV2 /U/:!J$92:3=;XGL"]F/+_Z%=!EV)
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MH&H1E)K-SQB<T+VP4\T4TWSO2BN]\T/VQAUT5>2N3=>G[=?>N%5)[T/^YK)
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M6%?WYJIC55[>52=TBJNL;"[H6P.U&T#O9XJ.EKKCKK_-UTO\ U!+ P04
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M!'&M-CDAUVA(!5<MJ?$;5%#W *KF0:GI,'/W0"[K'@BH>P!5\Z#4=-0G?Q:
M<0_D5>[!WEEE-.=P#R1W#P3,/9"R>VBIW%FD VH>H-1T.KEY(&<Q#Z1L'DRD
M0+T#E)I.*O<.I(IWN NY"!;FC #J'D#5/"@UG6'N'LAEW0,!=0^@:AZ4FHXZ
M=P\$QCT0HWLH?B]L[ZPRFG/8!9+;!0)F%TC9+K2:AHT.U"Y J>EX<KM SF(7
MB.%/#%VWU2ZB K4+4&KZ,8'<+KA5[,*0AL&2BR@PI@6[5-6]"E3-@U+3,>9&
MP;VL47!!C0*HF@>EIJ/.C8(+8Q1<HU$HI@5[9Y71G.7,S\FA'S"CX):-0L.0
M%NP=5L9S#J?@YD[!/8M3<,NG@8RH0*T"E)J.*K<*;@6K8(0":A% U3PH-9U=
M;A'<RUH$%]0B@*IY4&HZZMPBN':+4&7#:Y</>#7:Y2^#[3U6YG,.G^#F/L&U
M^X2?W?'*G@$[N(F+E;"]]\JL0$U#_>0X>')X?T+%*E#+,&1+)>_<M-5,$(?S
M\(<+R;?I"?%G+B7?I"_7C"Z82!JH]Y=<K>;C17+H//M?"?W_ %!+ P04
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MXX>L>WH]T:)R;7$MM&FR;EB8:Q"E#3#?<R'TX\1NT%ZLR1]02P,$%     @
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MJ7IP<[M0QR3@.D ]GS,FMP/]@N+@%?X'4$L#!!0    (  TTJ58,PFWBUP4
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M)\)D4+%$-]^NT&?T%3.&E3_0F4T$#B/^2;9^?[31V:^?QATA@RIIQR\"V'D
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M4"#U8H*9^@\V=5_' G').,EK8^%!GA75)WRM0;0,!L<,O-K VS/PQD<,_-K
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M(B@J'ME!?+\DA&]OY #-+Q:SOP%02P,$%     @ #32I5H O%'"W"P  ]&
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M1&%E@5AV!,UUC?5 A:S8=#.6134P-4$^5^OTTE$!ZC(]^ M02P,$%     @
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MVAG@^UPINQ&<@VX_%[\!4$L#!!0    (  TTJ5:*P";ME (  -$&   9
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MZ/3DP[]A?.U[-(]'\]C&#0_$O>E5+P!][T 0:]EF@V;D11\;)=$=5$#79,X
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M WU_Q;EZ.\EW+^K=JO!_4$L#!!0    (  TTJ5;/+D 07 0  #P1   9
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M-L^N#0F#?I[3FN=TE.<W)FEV>I-/.S.'WF3:HM<U(OXT[.>'G:;*../I42;
M50DI^PZU^+T5Q+GD-K\4VK'B@[J*S\R/$14)6JE^22#51Y4/'#(J(4:2(7:<
M2/MK*^ZLBC?UG=;2]5B18#JPMS!IE)#+*%F97'9"">DJ\=RVD*X1\8;V8%.A
M\6@]K%+MI72X/<4 MW5TC8@WM!Y-X<7CE?>IFS,1>U$=6Z'HJRX-WJ*$%FM
MZK"A0C72JZ,:<R*%X6XA[NRSKLG$\<+I@+"F6N/Q<OW3]-P07]-7M>.4@'>@
M7*^,OHXTG8;*R3FZ4BJS;:Q'.2B1*O^QC4XLIFL]ZTR-DYD$U?03E)>=*YF@
MF+[W82W/Q0KV6'X/U''4F@8"CQ;L"T;M:)_TQVR<BA=6DX=[G9@,QVP<R\<5
M%G9&%^ X:DT?@L<;D4[4XE1$;%M(I#8.G+N%RCETI6D.RXWCM4O^D)T_<&*:
M_@2/-R@G59RQI.4,TQ:UMH(35B5_^^ >F@-?F^NY0(91>;.K1^M/ '?FXML:
MO]>?!LS]MH$IORNH>]LZ+802M%*0SDV@3AXOK^KEBV0;<]M]85+=G<UC C0&
MK@W4[RO&Y/Y%3U!_,%G\#U!+ P04    "  --*E6$3)>KC0$  "&#@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6RMEVV/HS80Q[^*14_5G;2[8" \
M;)-(>UF=>E(?HMU>^Z+J"P><Q%UB4]M)KOWT'0-'"!CV*O5-PL/,^#?#V'][
M?A;R1>TIU>CSH>!JX>RU+N]=5V5[>B#J3I24PYNMD >BX5;N7%5*2O+*Z5"X
MON=%[H$P[BSGU;.U7,[%41>,T[5$ZG@X$/GW>UJ(\\+!SI<'3VRWU^:!NYR7
M9$>?J?Y4KB7<N6V4G!TH5TQP).EVX3S@^Q6.C4-E\2NC9]6Y1B:5C1 OYN9C
MOG \0T0+FFD3@L#?B:YH49A(P/%7$]1IQS2.W>LOT3]4R4,R&Z+H2A2_L5SO
M%T[BH)QNR;'03^+\/6T2FIEXF2A4]8O.C:WGH.RHM#@TSD!P8+S^)Y^;0G0<
M<#CBX#<._M<Z!(U#4"5:DU5I/1)-EG,ISD@::XAF+JK:5-Z0#>/F,SYK"6\9
M^.GESWI/)7I0BFJ%",_1#XQL6,$THPK=HJO7;Q^I)JQ0[^#%I^=']/;-._0&
M,8Y^V8NC F<U=S4PF<ANUHS_OA[?'QG_1R+O4(!OD._Y@<5]->W^2+/6W;]V
M=Z$2;3G\MAQ^%2\8*X?<$<[^(:;%;M!*<"4*EI.ZXZ Z:TD5Y;I^(+;H ^.$
M9XP4Z!D>4NAOJ-/O#QNE)33H'[9ZU "A'<#,VGM5DHPNG-*,)4_467[[#8Z\
M[VS5^9^"7=4J:&L53$5?/E%(FRJ3-^)"0[](FE%V(IN"WB!.M2W[.F14A31+
MS&F)PSCPH[E[ZN8U-$O3* Q:JRO@L 4.)X'AFIA9?6M> "S7'6)K[];Q9EV,
M)/6#'NS0*DF2*+'#SEK8V20L=%I)6(Y(-?=L<#/+L%$:]N L5CCU/#M<U,)%
MDW /&W&BM[#NOX#0,)@/?,>@A@WLZ,>/ABPSW&&IB2U67NR/$,<M<3Q-G&7B
M:";G5_1H/  (DRCNMZC%*@[3D:^>M)C)-&:>,[.VP,PJ!-]!IYYH_EI9DP&)
M[^.XWZ46*QR&D9TW;7G32=Z/7%-866 BF55 G4DYT;#I<#;%4=S#'!KA<(9]
M.R;V+C+GO0)Z DRS/AO!4C0[RDKCK(KE#1@B#^,>Z&M6UZ =/<:3H+7B=M:E
MT<_>!.H"S-+([V,.K6(<I2.8%YW$D]("PKN!2BIU!/FC*!-JHC^;4%>@89CV
M02U6:1R/@%Y$"D^KU%J*/V'+6"-:Z8+A1$X'BY+-*@C&Z"Z*A*<EZ:=J_>RV
M9D%A4VKE',H,3ORDS_F*U37G18SPM!JMJIUHU9A%M?E1>U;^AY4?#V4(8Z^_
MI%JMQE9^?!$K/*U6U92R4MD$R9OUJ2Q6:30VT2^"A*<5J;NUML+%@SW0+ A#
M?]"90[LP2M.T7S:W<T@P)S38>>\85]!P6W#T[F)(4-:'GOI&B[(Z-VR$AF]?
M7>[AH$BE,8#W6P&;ON;&'$7:H^?R7U!+ P04    "  --*E6Y(HI=08#   K
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970T."YX;6RMEF]OTS 0QK^*%28T
MI+'\;[K11NI:32"!J%8&+Q OW.3:6G/L8#OKQJ?GG&2A:[,Q)-ZLL7//Y7=/
M+N>-ME+=Z V (7<%%WKL;(PISUU79QLHJ#Z5)0B\LY*JH :7:NWJ4@'-:U'!
MW<#S!FY!F7#24;TW5^E(5H8S 7-%=%445-U? )?;L>,[#QM7;+TQ=L--1R5=
MPP+,=3E7N'*[+#DK0&@F!5&P&CL3_WR:V/@ZX"N#K=ZY)K:2I90W=O$A'SN>
M!0(.F;$9*/[<PA0XMXD0XV>;T^D>:86[UP_9+^O:L98EU3"5_!O+S6;L#!V2
MPXI6W%S)[7MHZXEMODQR7?\EVS;6<TA6:2.+5HP$!1/-+[UK?=@1^-$3@J 5
M!"\5A*T@K MMR.JR9M30=*3DEB@;C=GL1>U-K<9JF+!O<6$4WF6H,^EGLP%%
M)EJ#T82*G'QD=,DX,PPT>4L6V#5YQ8'(%9EDF:P$ALWI/5WBG@W'357!8]GQ
M# QE7+_!!->+&3D^>D.."!/DRT96&E5ZY!IDMP1NUG)>-)S!$YR?J#HEH7]"
M B\(>^33Y^4SR#IY\%CNHF.=;4%G6U#G"Y^R3:VI8+^H;<43,I5"2\YRVG0F
MVC)7H$&89@.]NV2"BHQ13A:X"?@9H(_?)TMM%#;RCSX_&H"H'\!^W.>ZI!F,
MG=(^2]V"D[Y^Y0^\=WWN_*=DC[P*.Z_"Y[*G#RU2*IP]RMP30^^@MP6:/(,Z
MCQT_MVDT' 1G(_=VMY;#J&3H#^,NZA%DU$%&?X-LFKO<:>Z,ELS@.X,[')HY
M,Y7JYVY2QSM$8>P'PSWNPZ@X">.@GSONN.,7F<N$ :0S?7CQP8.#830,]_ .
MHV+/"Y-^O$&'-W@6KQDO]KWCIR#6.+41E_)>%P<' %%PEGA[F(=1\3"*S_HQ
MDPXS^?>W3UMK^9_1UH>='+2C'\>!O\]]&!9$D1>&>^#NSBBWQRC.O343FG!8
MH= [3;!RU1Q-S<+(LI[N2VGPK*@O-WB:@[(!>'\EI7E8V .C^_\@_0U02P,$
M%     @ #32I5MH_;F$* P  ?P@  !D   !X;"]W;W)K<VAE971S+W-H965T
M-#DN>&ULK9;?;]HP$,?_%2NKIDYJF\2!$#J(U(*J5=HT5-;M8=J#"0=8=>S,
M-M#NK]\Y23,**=O#7L _[K[^W.5RSF"K](-9 5CRF MIAM[*VN+2]TVV@IR9
M"U6 Q)V%TCFS.-5+WQ0:V+QTRH5/@R#V<\:EEP[*M8E.!VIM!9<PT<2L\YSI
MIVL0:COT0N]YX8XO5]8M^.F@8$N8@KTO)AIG?J,RYSE(PY4D&A9#[RJ\'"7.
MOC3XRF%K=L;$13)3ZL%-;N=#+W! (""S3H'AWP9&((030HR?M:;7'.D<=\?/
MZC=E[!C+C!D8*?&-S^UJZ"4>F<."K86]4]L/4,?3=7J9$J;\)=O:-O!(MC96
MY;4S$N1<5O_LL<[#CD/8><6!U@[T7QVBVB$J ZW(RK#&S+)TH-66:&>-:FY0
MYJ;TQFBX=$]Q:C7N<O2SZ6>[ DVNC %K")-S\I&S&1?<<C#DG%3;NVNG8[",
M"_,.=^^G8W)Z\HZ<$"[)EY5:&U0P ]\BF)/WLQKBNH*@KT!\8OJ"1.$9H0&-
M6MQ'Q]W'D#7N]*6[C^EH<D*;G-!2+WHM)WK))/_%7)V=D9&21@D^9U7988HF
M&@Q(6RVH!;GADLF,,T&FN A8XYC+[U<S8S56Z8^V?%0 G78 ]^9>FH)E,/0*
M=Y;>@)>^?1/&P?NV[/PGL1>YBII<1<?4T[(/G&,#>,".PS$I<LEG HCX4S)G
M1()M2T*E')?*KMMLTGY,P\[ W^Q&UV+5ZT?=QNH%=J?![AS%'L,"M(8Y-J(-
MR#6TX54*W=V# SQZ#^_0*NE%]!6\;H/7/8HWA6RMN7W"AE0HPVWK.]4].)GV
M QKL\;58)5T:MO/%#5]\E.]66L!:LD1CO1.S947SP)_:4.,#B##LT]X>ZJ%5
MA\;]=M)>0]H[2EHVL#:DWL%A49+L/]Q#HSA,VH&2!BCY.]#NZ]$&EQS4/(VP
MN>WCM9B%21SO$_H[UX.[FK'=+KDT1, "'8.+'@:HJ^NNFEA5E#?&3%F\?\KA
M"K\00#L#W%\H99\G[A)JOCG2WU!+ P04    "  --*E6?6JH.CD*  !'9P
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MN&M[FV)A@8E9 -6P:8MF@>@,%@A/NR+$?68!* M U01*S?P(- M$6!:(H"P
M51,H-=-*S0(1C 7<2MXN6E@@SEA$+0/>P@+=Q2,V/0MH%HA@+.!6\N[_J2R
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MPXR^5%"[#;0^4\IN)JYYUM\^R6]02P,$%     @ #32I5K+#N1!A!   >AD
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MQE1BNKH6JX9517D5+96EBZW\S.A/ K6;0.,KI>R^X6ZWYM\D^@502P,$%
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M!ZCU*6-R-=$;-/\CQ'\ 4$L#!!0    (  TTJ5;&,CF]+@T  'NL   9
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MS"#L_-*:?=T&>ZWZ&&=QNAFG^^T=CCZ_0-4ME,:@- ZE"13-C)56MP%T88<
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ME9)U"IL-ZN?O\KQZOM-T\)@7W]J7<_E?4$L#!!0    (  TTJ5:#^:(T# 0
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MR+I%KQ^T**LN]TEHZ)FK80Z?-40: UA?":'W#^8%[8?2[#]02P,$%     @
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M".8 /&!(%#7OP;WW4;A^3X6;_]V-?P-02P,$%     @ #32I5I>*NQS
M$P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B
M#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z1
M0J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ
M0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?V
MD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  --*E6
M18'B.,L$   :*@  #P   'AL+W=O<FMB;V]K+GAM;,6:2W.;.A2 _XJ&37L7
MJ<TSCZD[D\;-;6;2-!.GV=Y10+8U <E7$DZ37U\!<7J([3/=G+(R" ,?0NC3
M.=+'1VT>[K5^8#^K4ME)L'1N=3(:V7PI*FX_Z)50_LA<FXH[OVL6([LR@A=V
M*82KRE$T'F>CBDL5?/JXN=:U&<$=[43NI%:^L"FXD^+1_C[>[+*UM/)>EM(]
M38)VNQ0!JZ22E7P6Q208!\PN]>-7;>2S5HZ7L]SHLIP$87?@3A@G\ZWB60-Y
MR^]M6^+X_0WW(),@&_L+SJ6QKOU'>WWN&=?"_[G;JYT^EZ439LJ=^-?H>B75
MHKF,?XH1>(RV'C:_726>F#^I1CV?RUQ,=5Y70KFN'HTH&T!EEW)E Z9X)2;!
MF5X+TSR/O\%%T3V;\U"@ILR)] ?,1='B4:*H0B@K"N:WK"YEX3D*]IF77.6"
M <@(@8P&A/PO I Q AD/ CEK</RI #)!(),!(7LUF2*0Z9"0,8#,$,AL2,@$
M0!XBD(=#0J8 \@B!/**%G-55Q<T3TW,VDPLE_6E<.7::Y[I63@+(8P3RF!;R
MFS +8=BC=$OV]?84=MYCK/<>TV+="%ZR+^WMV85:"^N:$RS$0^5";)=+P:WH
MT6 6"8DU\MTM_2L\M=;KG7%5L$O)VR&*[#-B$@F)+7+EAU8=W&?_[5IVS9]X
M2_ ;#]-'2.R/J3!RS9MA%3N7RMM7^O9WH:PS[9D0$Q-(2&Z0JI+=I]#6I>_]
MG!_L"<_;?]680$)B@\R<SA^6NBR$L>_8E_]K/U:&;)@W0F)QG'-IV!TO:]%T
MRUNO&F)BY@B'5$=O.!-B[@B)Y8%CP@%-A,DD(I;)&\>Q][=-UV/_@7R832)B
MF^R1W8838J+!"K%F.NGMK#W,+!&Q63#[>5B(B1DF(C;,'@'N>LF882)BPZ B
M[/4\$>:8: #'[&R9F&RB(673KTM,-M&@LH$17X3))AI4-C#FBS'9Q,2RP3$S
MB(DY)R9V#HYY"#$QY\3$SL$QCR FFB(C=A".>0PQ,0?%Q YZ.Q Z8%?<F*ZW
M?S^%P5B,.2@F=M#6>&TJ')=EKV./,?O$Q/;9KL>9OVI1EUU'#S$Q_\3$_MDW
MKCSP#=,;$V)B_HF)_;,?\X?*-4PPQYA_8F+_[,><2KO2, ^.^2<9)G/6O/1F
MB PQ,?\D?R6#YJG:#4^:ZTKL_-(3S#_)WXEY&DQKM7E-WJI%RPHQ,?\DQ/YY
MQ6RF_YH0Z"54>ZE.B(E.TA#[YQ7SO':U$>Q;,VU:5R]MX!IB8OY)B/WSIFV>
M:>MVMTS,00FQ@]"P]P!.<":8@Q)B!Z&8O1@HP1R4$#L(QX29K 1S4$+LH+U)
MA*YUPFE.S$$IL8/P) *LS11S4$KL(!P3!KXIYJ"4V$$X)@Q\4\Q!*;&#<$P8
M^*:8@U+RE0*;*93M&91^OYFB2P6(';0SP77 ;H0?$>?]+QVS4#I('JXM9;>&
M0TS,0BFQA?;4IF\+J]HS04S,0BEU)FXWYB:XA)B8A5+J3-P>S)<D"%S'@EDH
MH\[$89B]H4>&62BCSL3MQCRMM''R&7Y"&6:AC-A">#*[MW@)LU#66FBT68M8
MB+E4HKCRM["^/.=E?FU8\].MJDC29H)S7I?EF2_[KBXU+S9+&S?+,C_] E!+
M P04    "  --*E6)V75I0P"  "$)0  &@   'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QSS=D[;MM %(7AK0A<@$?W-;8#RU4:MX$W0,BC!RR)!(=![-U'
MD OI$"G2&#P5,21X^1?$!V+X]*L<VG'?G>INW]?%Q_%PJJMF-X[]CY3J>E>.
M;;WK^G(Z7]ETP[$=S\MAF_IV_=YN2]+E,J?A=D;S_'0[<_'ZV9?_F=AM-OMU
M^=FM?Q_+:?S'X/2G&][KKI2Q6;RVP[:,JR9]'*ZG:[H<Y.X\N5F\O*V:X>5-
MFC1WD$*0SA]D$&3S!SD$^?Q! 4$Q?U"&H#Q_T#T$W<\?] !!#_,'/4+0X_Q!
MLD09EP1)$ZP)M!;D6@B\%@1;",06)%L(S!9$6PC4%F1;"-P6A%L(Y!:D6PCL
M%L1;"/16U%L)]%;46PGTULG'-H'>BGHK@=Z*>BN!WHIZ*X'>BGHK@=Z*>BN!
MWHIZ*X'>BGHK@=Z&>AN!WH9Z&X'>AGH;@=XVV2PAT-M0;R/0VU!O(]#;4&\C
MT-M0;R/0VU!O(]#;4&\CT-M1;R?0VU%O)]#;46\GT-M1;R?0VR>;W01Z.^KM
M!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>@?J'01Z!^H=!'H'ZAT$>@?J'01Z!^H=
M!'K'Y&<E@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WAGUS@1Z9]0[$^B=4>],H'=&
MO?-WZEW'ST.IUYZO-3[_.ZD>S_>6Z^,ORZ^3DU?E@G.ZK:C/?P%02P,$%
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M9"U09"U09"U09"W^4]9G:Y=_'#\\\];4W2&?#?]VFKT!4$L! A0#%     @
M#32I5@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    "  --*E6/,#@<>X    K @  $0
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M965T-"YX;6Q02P$"% ,4    "  --*E6:0Y^Z\8#   5#0  &
M    @(&?'P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
M#32I5G41K'9P!P  *#,  !@              ("!FR,  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    (  TTJ5:(+>KY=@(  .\%   8
M          " @4$K  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    "  --*E6-?&=7C<)  #K*   &               @('M+0  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ #32I5E+<4FG]%P  2T8
M !@              ("!6C<  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    (  TTJ58_9<X+)@X  -TE   9              " @8U/  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ #32I5CAM I%?
M"   &1,  !D              ("!ZET  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    "  --*E6Z6*9*R<(   ")@  &0
M@(& 9@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  TT
MJ59$!95\5@4  '0-   9              " @=YN  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ #32I5DLOT)DM!   A0D  !D
M         ("!:W0  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    "  --*E6O?=@)OD(  #-%P  &0              @('/>   >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  TTJ58I#1IR#P,  -P&
M   9              " @?^!  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ #32I5E+V_OHZ#   4"4  !D              ("!184
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  --*E6\RPA
M;\\$  #\"P  &0              @(&VD0  >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    (  TTJ59(O*S%TA8  %9$   9
M  " @;R6  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
M#32I5H<IP4N0!@  L \  !D              ("!Q:T  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    "  --*E6"W2 E:0(   H%   &0
M            @(&,M   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    (  TTJ5:9Y&CF* @   P3   9              " @6>]  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ #32I5DW>4O@R!0
M)0\  !D              ("!QL4  'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    "  --*E6>*KU980%  !C#@  &0              @($O
MRP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  TTJ5;O
M()15/@0  &\)   9              " @>K0  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ #32I5GU*'5E[!   C H  !D
M     ("!7]4  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  TTJ5;!(@JK9P,  ,D,   9              "
M@1CR  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ #32I
M5@PIG:,=!@  H3   !D              ("!MO4  'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    "  --*E6),MRZL0"  !D!P  &0
M        @($*_   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   (  TTJ5;(<Y[80@,  (0-   9              " @07_  !X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ #32I5@S";>+7!0  5#
M !D              ("!?@(! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    "  --*E60 9XJ<H$  "]&   &0              @(&," $
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  TTJ5: +Q1P
MMPL  /1@   9              " @8T- 0!X;"]W;W)K<VAE971S+W-H965T
M,S<N>&UL4$L! A0#%     @ #32I5G!]<*0U P  L@L  !D
M ("!>QD! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    "  -
M-*E6'FH2:R$$  !Y$   &0              @('G' $ >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (  TTJ59Y&3C-7PL  !>*   9
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M970T-"YX;6Q02P$"% ,4    "  --*E6'OJI1,0#  "Y$@  &0
M    @(&F.P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (
M  TTJ5;/+D 07 0  #P1   9              " @:$_ 0!X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L! A0#%     @ #32I5A$R7JXT!   A@X  !D
M             ("!-$0! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"
M% ,4    "  --*E6Y(HI=08#   K"   &0              @(&?2 $ >&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (  TTJ5;:/VYA"@,
M '\(   9              " @=Q+ 0!X;"]W;W)K<VAE971S+W-H965T-#DN
M>&UL4$L! A0#%     @ #32I5GUJJ#HY"@  1V<  !D              ("!
M'4\! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    "  --*E6
M??%VQR,$  #0%@  &0              @(&-60$ >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;%!+ 0(4 Q0    (  TTJ5:(%@3^P0(   <)   9
M      " @>== 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%
M  @ #32I5K+#N1!A!   >AD  !D              ("!WV ! 'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    "  --*E6)A9-N]("  "G"
M&0              @(%W90$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+
M 0(4 Q0    (  TTJ59@WD*(3 (  .T$   9              " @8!H 0!X
M;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ #32I5HQT,I)6
M P  +PP  !D              ("! VL! 'AL+W=O<FMS:&5E=',O<VAE970U
M-BYX;6Q02P$"% ,4    "  --*E6QC(YO2X-  ![K   &0
M@(&0;@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (  TT
MJ5:#^:(T# 0  #0-   9              " @?5[ 0!X;"]W;W)K<VAE971S
M+W-H965T-3@N>&UL4$L! A0#%     @ #32I5JM*%ITL P  C@H  !D
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M=#8S+GAM;%!+ 0(4 Q0    (  TTJ59&P^ D.0,  ,@3   -
M  "  0V2 0!X;"]S='EL97,N>&UL4$L! A0#%     @ #32I5I>*NQS
M$P(   L              ( !<94! %]R96QS+RYR96QS4$L! A0#%     @
M#32I5D6!XCC+!   &BH   \              ( !6I8! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    (  TTJ58G9=6E# (  (0E   :              "
M 5*; 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  TT
MJ5;NU>T8Y@$  /4D   3              "  9:= 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@    !' $< :!,  *V? 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>214</ContextCount>
  <ElementCount>435</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>16</UnitCount>
  <MyReports>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity</Role>
      <ShortName>Condensed Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Merger with HTA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTA</Role>
      <ShortName>Merger with HTA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Real Estate Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestments</Role>
      <ShortName>Real Estate Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Other Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/OtherAssetsandLiabilities</Role>
      <ShortName>Other Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Notes and Bonds Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayable</Role>
      <ShortName>Notes and Bonds Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Merger with HTA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTATables</Role>
      <ShortName>Merger with HTA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/MergerwithHTA</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Real Estate Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsTables</Role>
      <ShortName>Real Estate Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/RealEstateInvestments</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/Leases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Other Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables</Role>
      <ShortName>Other Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/OtherAssetsandLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Notes and Bonds Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableTables</Role>
      <ShortName>Notes and Bonds Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/NotesandBondsPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/StockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Variable interest entity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Merger with HTA - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTANarrativeDetails</Role>
      <ShortName>Merger with HTA - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Merger with HTA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTADetails</Role>
      <ShortName>Merger with HTA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/MergerwithHTATables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Real Estate Investments - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails</Role>
      <ShortName>Real Estate Investments - Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails</Role>
      <ShortName>Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Real Estate Investments - Dispositions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails</Role>
      <ShortName>Real Estate Investments - Dispositions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails</Role>
      <ShortName>Real Estate Investments - Assets Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Leases - Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLeaseIncomeDetails</Role>
      <ShortName>Leases - Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Leases - Lessor Accounting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLessorAccountingDetails</Role>
      <ShortName>Leases - Lessor Accounting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Leases - Ground Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesGroundLeasesDetails</Role>
      <ShortName>Leases - Ground Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Leases - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Other Assets and Liabilities - Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Other Assets and Liabilities - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Notes and Bonds Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableDetails</Role>
      <ShortName>Notes and Bonds Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/NotesandBondsPayableTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails</Role>
      <ShortName>Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails</Role>
      <ShortName>Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails</Role>
      <ShortName>Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Commitment and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails</Role>
      <ShortName>Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Stockholders' Equity (Stock Transactions - Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Stock Transactions - Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/StockholdersEquityTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails</Role>
      <ShortName>Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails</Role>
      <ShortName>Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="hr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  hr-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="hr-20230331.htm">hr-20230331.htm</File>
    <File>hr-20230331.xsd</File>
    <File>hr-20230331_cal.xml</File>
    <File>hr-20230331_def.xml</File>
    <File>hr-20230331_lab.xml</File>
    <File>hr-20230331_pre.xml</File>
    <File>hr-2023331xex221.htm</File>
    <File>hr-2023331xex311.htm</File>
    <File>hr-2023331xex312.htm</File>
    <File>hr-2023331xex32.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="739">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>81
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hr-20230331.htm": {
   "axisCustom": 2,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 739,
    "http://xbrl.sec.gov/dei/2022": 31
   },
   "contextCount": 214,
   "dts": {
    "calculationLink": {
     "local": [
      "hr-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hr-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hr-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hr-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hr-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hr-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 678,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 128,
   "keyStandard": 307,
   "memberCustom": 62,
   "memberStandard": 37,
   "nsprefix": "hr",
   "nsuri": "http://healthcarerealty.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://healthcarerealty.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Merger with HTA",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://healthcarerealty.com/role/MergerwithHTA",
     "shortName": "Merger with HTA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hr:AcquisitionsAndDispositionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Real Estate Investments",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://healthcarerealty.com/role/RealEstateInvestments",
     "shortName": "Real Estate Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hr:AcquisitionsAndDispositionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://healthcarerealty.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Other Assets and Liabilities",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://healthcarerealty.com/role/OtherAssetsandLiabilities",
     "shortName": "Other Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Notes and Bonds Payable",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://healthcarerealty.com/role/NotesandBondsPayable",
     "shortName": "Notes and Bonds Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Derivative Financial Instruments",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://healthcarerealty.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://healthcarerealty.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hr:NatureOfOperationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hr:NatureOfOperationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Merger with HTA (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://healthcarerealty.com/role/MergerwithHTATables",
     "shortName": "Merger with HTA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Real Estate Investments (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsTables",
     "shortName": "Real Estate Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://healthcarerealty.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Other Assets and Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables",
     "shortName": "Other Assets and Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Notes and Bonds Payable (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableTables",
     "shortName": "Notes and Bonds Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Derivative Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://healthcarerealty.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "hr:InvestmentInRealEstatePropertiesAndMortgageNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "hr:InvestmentInRealEstatePropertiesAndMortgageNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealEstateInvestmentPropertyNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
     "shortName": "Summary of Significant Accounting Policies - Consolidated balance sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i0458b77080714c6888c6e3f362854f15_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RealEstateInvestmentPropertyNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "reportCount": 1,
      "unitRef": "property",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails",
     "shortName": "Summary of Significant Accounting Policies - Variable interest entity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i892f855ceda549059585643902bde99c_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "hr:NotesReceivableCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "us-gaap:LessorLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "us-gaap:LessorLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1f84228478ae4a859a0b69e3a29bee8a_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "ibf0cfc90ab23411db24b52116a274e8c_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Merger with HTA - Narrative (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
     "shortName": "Merger with HTA - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i2b8bd90675e2482da72656d93ecd84ff_I20220720",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i2b8bd90675e2482da72656d93ecd84ff_I20220720",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Merger with HTA (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://healthcarerealty.com/role/MergerwithHTADetails",
     "shortName": "Merger with HTA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i2b8bd90675e2482da72656d93ecd84ff_I20220720",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i2b8bd90675e2482da72656d93ecd84ff_I20220720",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i2b8bd90675e2482da72656d93ecd84ff_I20220720",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Real Estate Investments - Acquisitions (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails",
     "shortName": "Real Estate Investments - Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "ia68c69926be842d69e158e3aa65f496d_D20230310-20230310",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1f84228478ae4a859a0b69e3a29bee8a_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
     "shortName": "Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "idf9b62f2ccf74d1caf0fe1cb85aa8f53_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hr:AssetDispositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hr:FinanceMortgageNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Real Estate Investments - Dispositions (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
     "shortName": "Real Estate Investments - Dispositions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hr:AssetDispositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hr:FinanceMortgageNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hr:NumberOfPropertiesClassifiedAsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
     "shortName": "Real Estate Investments - Assets Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hr:NumberOfPropertiesClassifiedAsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Leases - Lease Income (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails",
     "shortName": "Leases - Lease Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Leases - Lessor Accounting (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://healthcarerealty.com/role/LeasesLessorAccountingDetails",
     "shortName": "Leases - Lessor Accounting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfPropertiesSubjectToGroundLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Leases - Ground Leases (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
     "shortName": "Leases - Ground Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfPropertiesSubjectToGroundLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Leases - Future Minimum Lease Payments (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails",
     "shortName": "Leases - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Leases - Lease Cost (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://healthcarerealty.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hr:RealEstateNotesReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Other Assets and Liabilities - Other Assets (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails",
     "shortName": "Other Assets and Liabilities - Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hr:RealEstateNotesReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hr:AccruedPropertyTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hr:AccruedPropertyTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BelowMarketLeaseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Other Assets and Liabilities - Other Liabilities (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BelowMarketLeaseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Notes and Bonds Payable (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
     "shortName": "Notes and Bonds Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "ic08326621b774b35a49a98cb55264ae0_D20230401-20230509",
      "decimals": null,
      "lang": "en-US",
      "name": "hr:DebtInstrumentExtensionPeriodForMaturityDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "derivative",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
     "shortName": "Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "derivative",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i650c8e7c68644e95a14ecf31d3e81688_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
     "shortName": "Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i650c8e7c68644e95a14ecf31d3e81688_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
     "shortName": "Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hr:DerivativeNetAssetPositionAggregateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "shortName": "Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hr:DerivativeNetAssetPositionAggregateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hr:ConstructionActivityTotalFundingDuringthePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Commitment and Contingencies - Narrative (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
     "shortName": "Commitment and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hr:ConstructionActivityTotalFundingDuringthePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1f84228478ae4a859a0b69e3a29bee8a_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
     "shortName": "Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "icf72d7a8f0bf4d0c82733fd3e5b39cc2_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Stockholders' Equity (Stock Transactions - Narrative) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
     "shortName": "Stockholders' Equity (Stock Transactions - Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails",
     "shortName": "Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
     "shortName": "Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i780b66b146554fec8c0ad2f30a9b343b_D20230104-20230104",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "icf4fe5a5fedc449b89509f79262e0912_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity",
     "shortName": "Condensed Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "icf4fe5a5fedc449b89509f79262e0912_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i165032ae420b46b7bbba8d14fe0aba12_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails",
     "shortName": "Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i165032ae420b46b7bbba8d14fe0aba12_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i0eb8d9ba9fcb4cd3a86450f082750fed_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
     "shortName": "Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i0eb8d9ba9fcb4cd3a86450f082750fed_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails",
     "shortName": "Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i1216bf6ffe4c47e4b7485704ae8b212c_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "iacf810aaefd344b08133b9065f0521e0_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Fair Value of Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails",
     "shortName": "Fair Value of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "iacf810aaefd344b08133b9065f0521e0_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hr-20230331.htm",
      "contextRef": "i6b84b265cb7546d28a97e6bf8e35f4cd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 100,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hr_AboveMarketLeaseIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Above Market Lease Intangible Assets , Net",
        "label": "Above Market Lease Intangible Assets , Net",
        "terseLabel": "Above-market intangible assets, net"
       }
      }
     },
     "localname": "AboveMarketLeaseIntangibleAssetsNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_AccountsPayableAndCapitalExpendituresCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable and Capital Expenditures, Current",
        "label": "Accounts Payable and Capital Expenditures, Current",
        "terseLabel": "Accounts payable and capital expenditures"
       }
      }
     },
     "localname": "AccountsPayableAndCapitalExpendituresCurrent",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_AccruedPropertyTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Property Taxes",
        "label": "Accrued Property Taxes",
        "terseLabel": "Accrued property taxes"
       }
      }
     },
     "localname": "AccruedPropertyTaxes",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_AcquisitionsAndDispositionsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions and dispositions.",
        "label": "Acquisitions and Dispositions [Text Block]",
        "verboseLabel": "Real Estate Investments"
       }
      }
     },
     "localname": "AcquisitionsAndDispositionsTextBlock",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hr_ActiveInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Active Interest Rate Swaps [Member]",
        "label": "Active Interest Rate Swaps [Member]",
        "terseLabel": "Active Interest Rate Swap"
       }
      }
     },
     "localname": "ActiveInterestRateSwapsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_AmortizationofPrepaidRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Prepaid Rent",
        "label": "Amortization of Prepaid Rent",
        "terseLabel": "Amortization of prepaid rent"
       }
      }
     },
     "localname": "AmortizationofPrepaidRent",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_ApproximateSquareFeetInvestedInByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Approximate Square Feet Invested in by Company",
        "label": "Approximate Square Feet Invested in by Company",
        "terseLabel": "Approximate square feet invested in by company"
       }
      }
     },
     "localname": "ApproximateSquareFeetInvestedInByCompany",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "hr_ApproximateSquareFeetProvidedByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Approximate square feet for which Nationwide property management services provided by company",
        "label": "Approximate Square Feet Provided by Company",
        "verboseLabel": "Approximate square feet for which Nationwide property management services provided by company"
       }
      }
     },
     "localname": "ApproximateSquareFeetProvidedByCompany",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area covered under real estate investment sold in measurement units.",
        "label": "Area Covered Under Real Estate Investment Sold in Measurement Units",
        "terseLabel": "SQUARE FOOTAGE"
       }
      }
     },
     "localname": "AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "hr_AssetDispositionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Dispositions",
        "label": "Asset Dispositions [Table Text Block]",
        "terseLabel": "Schedule of real estate dispositions"
       }
      }
     },
     "localname": "AssetDispositionsTableTextBlock",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for sale and discontinued operations, net.",
        "label": "Assets Held-for-sale and Discontinued Operations Net",
        "terseLabel": "Assets held for sale, net",
        "verboseLabel": "Assets held for sale, net"
       }
      }
     },
     "localname": "AssetsHeldForSaleAndDiscontinuedOperationsNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Purchase Price Allocation Square Footage.",
        "label": "Business Acquisition Purchase Price Allocation Square Footage",
        "verboseLabel": "Square footage"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationSquareFootage",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount",
        "label": "Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount",
        "terseLabel": "Gross contractual real estate notes receivable"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio",
        "label": "Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio",
        "terseLabel": "Conversion Ratio"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services",
        "label": "Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services",
        "terseLabel": "Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services"
       }
      }
     },
     "localname": "BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete",
        "label": "Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete",
        "terseLabel": "Goodwill adjustment incomplete"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net",
        "terseLabel": "Assets held for sale, net"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities",
        "terseLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale",
        "terseLabel": "Liabilities of assets held for sale"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired",
        "totalLabel": "Net identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments",
        "totalLabel": "Total real estate investments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete,Buildings and Improvements",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete,Buildings and Improvements",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets",
        "terseLabel": "Lease intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Land",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale",
        "terseLabel": "Assets held for sale, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities",
        "terseLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures",
        "terseLabel": "Investments in unconsolidated joint ventures"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development",
        "terseLabel": "Land held for development"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale",
        "terseLabel": "Liabilities of assets held for sale"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt",
        "terseLabel": "Notes and bonds payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments",
        "totalLabel": "Total real estate investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments [Abstract]",
        "terseLabel": "Real estate investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets",
        "verboseLabel": "Other assets, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessCombinationRefundOfTransferTaxesPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Refund of Transfer Taxes Paid",
        "label": "Business Combination, Refund of Transfer Taxes Paid",
        "terseLabel": "Refund of transfer taxes paid"
       }
      }
     },
     "localname": "BusinessCombinationRefundOfTransferTaxesPaid",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_BusinessOverviewAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Overview [Abstract]",
        "label": "Business Overview [Abstract]",
        "terseLabel": "Business Overview:"
       }
      }
     },
     "localname": "BusinessOverviewAbstract",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_ClosingAdjustmentsDisposedEntity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.",
        "label": "Closing Adjustments Disposed Entity",
        "negatedTerseLabel": "CLOSING ADJUSTMENTS"
       }
      }
     },
     "localname": "ClosingAdjustmentsDisposedEntity",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_CommonStockFractionalShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Fractional Shares",
        "label": "Common Stock, Fractional Shares",
        "terseLabel": "Common Stock, fractional (in shares)"
       }
      }
     },
     "localname": "CommonStockFractionalShares",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hr_CommonStockSharesWithheld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Shares Withheld",
        "label": "Common Stock, Shares Withheld",
        "terseLabel": "Common Stock, withheld (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesWithheld",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hr_ConstructionActivityTotalFundingDuringthePeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction Activity, Total Funding During the Period",
        "label": "Construction Activity, Total Funding During the Period",
        "terseLabel": "Construction activity and development properties"
       }
      }
     },
     "localname": "ConstructionActivityTotalFundingDuringthePeriod",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_ConstructionActivityTotalFundingToDate": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction Activity, Total Funding to Date",
        "label": "Construction Activity, Total Funding to Date",
        "terseLabel": "Project costs"
       }
      }
     },
     "localname": "ConstructionActivityTotalFundingToDate",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_CumulativeDividendsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Dividends [Member].",
        "label": "Cumulative Dividends [Member]",
        "terseLabel": "Cumulative Dividends"
       }
      }
     },
     "localname": "CumulativeDividendsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_CumulativeNetIncomeAttributableToCommonStockholders": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative net income attributable to common stockholders.",
        "label": "Cumulative Net Income Attributable to Common Stockholders",
        "verboseLabel": "Cumulative net income attributable to common stockholders"
       }
      }
     },
     "localname": "CumulativeNetIncomeAttributableToCommonStockholders",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_CumulativeNetIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Net Income [Member].",
        "label": "Cumulative Net Income [Member]",
        "terseLabel": "Cumulative Net Income"
       }
      }
     },
     "localname": "CumulativeNetIncomeMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_DallasTXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dallas, TX",
        "label": "Dallas, TX [Member]",
        "terseLabel": "Dallas, TX"
       }
      }
     },
     "localname": "DallasTXMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_DebtInstrumentExtensionPeriodForMaturityDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Period for Maturity Date",
        "label": "Debt Instrument, Extension Period for Maturity Date",
        "terseLabel": "Extension period for maturity date"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriodForMaturityDate",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hr_DerivativeNetAssetPositionAggregateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Net Asset Position Aggregate Fair Value",
        "label": "Derivative Net Asset Position Aggregate Fair Value",
        "terseLabel": "Derivatives in net asset position"
       }
      }
     },
     "localname": "DerivativeNetAssetPositionAggregateFairValue",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_DirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors",
        "label": "Directors [Member]",
        "terseLabel": "Directors"
       }
      }
     },
     "localname": "DirectorsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_DispositionSalesPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposition Sales Price",
        "label": "Disposition Sales Price",
        "terseLabel": "SALE PRICE"
       }
      }
     },
     "localname": "DispositionSalesPrice",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, after Year Four",
        "terseLabel": "2028 and thereafter"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Next Twelve Months",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EquityMethodInvestmentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments",
        "label": "Equity Method Investments [Roll Forward]",
        "terseLabel": "Equity Method Investments [Roll Forward]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsRollForward",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_EquityOfferingProgramAvailableForIssuance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Offering Program Available for Issuance",
        "label": "Equity Offering Program Available for Issuance",
        "terseLabel": "Amount remaining available for issuance under the new ATM"
       }
      }
     },
     "localname": "EquityOfferingProgramAvailableForIssuance",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_EquityOwnershipForConsolidationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Ownership for Consolidation, Percent",
        "label": "Equity Ownership for Consolidation, Percent",
        "terseLabel": "Equity ownership for consolidation (percent)"
       }
      }
     },
     "localname": "EquityOwnershipForConsolidationPercent",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hr_ExecutiveIncentiveProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Incentive Program [Member]",
        "label": "Executive Incentive Program [Member]",
        "terseLabel": "Executive Incentive Program"
       }
      }
     },
     "localname": "ExecutiveIncentiveProgramMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "2028 and thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_FinanceLeasePrincipalOnlyPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Principal Only Payments",
        "label": "Finance Lease, Principal Only Payments",
        "terseLabel": "Financing cash flows outflows related to financing leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalOnlyPayments",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_FinanceMortgageNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Mortgage Notes",
        "label": "Finance Mortgage Notes",
        "negatedTerseLabel": "COMPANY-FINANCED MORTGAGE NOTES"
       }
      }
     },
     "localname": "FinanceMortgageNotes",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_FinancingReceivableAllowanceForCreditLossReserves": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Allowance for Credit Loss, Reserves",
        "label": "Financing Receivable, Allowance for Credit Loss, Reserves",
        "terseLabel": "Credit loss reserves"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossReserves",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_FiniteLivedCustomerRelationshipsNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Customer Relationships, Net",
        "label": "Finite-Lived Customer Relationships, Net",
        "terseLabel": "Customer relationship intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedCustomerRelationshipsNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation",
        "label": "Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation",
        "negatedLabel": "Gain on sales of real estate properties"
       }
      }
     },
     "localname": "GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_GrossContractualRealEstateNotesReceivableFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Contractual Real Estate Notes Receivable, Fair Value",
        "label": "Gross Contractual Real Estate Notes Receivable, Fair Value",
        "terseLabel": "Gross contractual real estate notes receivable at fair value"
       }
      }
     },
     "localname": "GrossContractualRealEstateNotesReceivableFairValue",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_GroundLeaseModificationNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ground Lease Modification, Net",
        "label": "Ground Lease Modification, Net",
        "terseLabel": "Other receivables, net"
       }
      }
     },
     "localname": "GroundLeaseModificationNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_HealthCareRealtyTrustIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HealthCare Realty Trust, Inc.",
        "label": "HealthCare Realty Trust, Inc. [Member]",
        "terseLabel": "HealthCare Realty Trust, Inc."
       }
      }
     },
     "localname": "HealthCareRealtyTrustIncMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_HealthCareRealtyTrustIncorporatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HealthCare Realty Trust Incorporated",
        "label": "HealthCare Realty Trust Incorporated [Member]",
        "terseLabel": "HealthCare Realty Trust Incorporated"
       }
      }
     },
     "localname": "HealthCareRealtyTrustIncorporatedMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_HealthcareTrustOfAmericaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Trust Of America, Inc",
        "label": "Healthcare Trust Of America, Inc [Member]",
        "terseLabel": "Healthcare Trust Of America, Inc"
       }
      }
     },
     "localname": "HealthcareTrustOfAmericaIncMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_HealthcareTrustofAmericaHoldingsLPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Trustof America Holdings L P",
        "label": "Healthcare Trustof America Holdings L P [Member]",
        "terseLabel": "Healthcare Trustof America Holdings L P"
       }
      }
     },
     "localname": "HealthcareTrustofAmericaHoldingsLPMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_HoustonTexasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Houston, Texas [Member]",
        "label": "Houston, Texas [Member]",
        "terseLabel": "Houston, TX"
       }
      }
     },
     "localname": "HoustonTexasMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_ImpairmentChargeOnRealEstateAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Charge on Real Estate Assets Held for Sale",
        "label": "Impairment Charge on Real Estate Assets Held for Sale",
        "terseLabel": "Impairment charges on net real estate assets held for sale"
       }
      }
     },
     "localname": "ImpairmentChargeOnRealEstateAssetsHeldForSale",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment of Real Estate, Continuing and Discontinued Operations",
        "label": "Impairment of Real Estate, Continuing and Discontinued Operations",
        "terseLabel": "Impairment of real estate properties and credit loss reserves"
       }
      }
     },
     "localname": "ImpairmentOfRealEstateContinuingAndDiscontinuedOperations",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to dilutive effect of employee stock purchase plan.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Employee Stock Purchase Plan",
        "verboseLabel": "Dilutive effect of employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hr_InterestIncomeFinancingReceivableNoncash": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Income, Financing Receivable, Noncash",
        "label": "Interest Income, Financing Receivable, Noncash",
        "negatedTerseLabel": "Non-cash interest from financing and notes receivable"
       }
      }
     },
     "localname": "InterestIncomeFinancingReceivableNoncash",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_InterestRateSwapExpiringDecember12026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, Expiring December 1, 2026",
        "label": "Interest Rate Swap, Expiring December 1, 2026 [Member]",
        "terseLabel": "Interest Rate Swap, Expiring December 1, 2026"
       }
      }
     },
     "localname": "InterestRateSwapExpiringDecember12026Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwapExpiringDecember12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, Expiring December 1, 2027",
        "label": "Interest Rate Swap, Expiring December 1, 2027 [Member]",
        "terseLabel": "Interest Rate Swap, Expiring December 1, 2027"
       }
      }
     },
     "localname": "InterestRateSwapExpiringDecember12027Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwapExpiringJanuary152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, Expiring January 15, 2024",
        "label": "Interest Rate Swap, Expiring January 15, 2024 [Member]",
        "terseLabel": "Interest Rate Swap, Expiring January 15, 2024"
       }
      }
     },
     "localname": "InterestRateSwapExpiringJanuary152024Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwapExpiringJune12026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, Expiring June 1, 2026",
        "label": "Interest Rate Swap, Expiring June 1, 2026 [Member]",
        "terseLabel": "Interest Rate Swap, Expiring June 1, 2026"
       }
      }
     },
     "localname": "InterestRateSwapExpiringJune12026Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwapExpiringJune12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, Expiring June 1, 2027",
        "label": "Interest Rate Swap, Expiring June 1, 2027 [Member]",
        "terseLabel": "Interest Rate Swap, Expiring June 1, 2027"
       }
      }
     },
     "localname": "InterestRateSwapExpiringJune12027Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwapExpiringMay12026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, Expiring May 1, 2026",
        "label": "Interest Rate Swap, Expiring May 1, 2026 [Member]",
        "terseLabel": "Interest Rate Swap, Expiring May 1, 2026"
       }
      }
     },
     "localname": "InterestRateSwapExpiringMay12026Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwaps20172018And2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps 2017 2018, And 2019",
        "label": "Interest Rate Swaps 2017 2018, And 2019 [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwaps20172018And2019Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InterestRateSwaps2017And2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps 2017 And 2018",
        "label": "Interest Rate Swaps 2017 And 2018 [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwaps2017And2018Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_InvestmentInRealEstatePropertiesAndMortgageNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in real estate properties and mortgage notes.",
        "label": "Investment in Real Estate Properties and Mortgage Notes",
        "terseLabel": "Gross investment amount, total"
       }
      }
     },
     "localname": "InvestmentInRealEstatePropertiesAndMortgageNotes",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period",
        "terseLabel": "New investments during the period"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_JointVentureCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture, Carrying Amount",
        "label": "Joint Venture, Carrying Amount",
        "terseLabel": "Joint venture, carrying amount"
       }
      }
     },
     "localname": "JointVentureCarryingAmount",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_JointVentureOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture, Ownership Percentage",
        "label": "Joint Venture, Ownership Percentage",
        "terseLabel": "Joint venture, ownership (in percentage)"
       }
      }
     },
     "localname": "JointVentureOwnershipPercentage",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hr_LeaseIntangibles": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Intangibles",
        "label": "Lease Intangibles",
        "terseLabel": "Lease intangibles"
       }
      }
     },
     "localname": "LeaseIntangibles",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "2028 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Operating Lease, Payment to be Received, after Year Four",
        "label": "Lessor, Operating Lease, Payment to be Received, after Year Four",
        "terseLabel": "2028 and thereafter"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymenttobeReceivedafterYearFour",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_LimitedLiabilityCompanyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited Liability Company One",
        "label": "Limited Liability Company One [Member]",
        "terseLabel": "Limited Liability Company One"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyOneMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_LosAngelesCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Los Angeles, California [Member]",
        "label": "Los Angeles, California [Member]",
        "terseLabel": "Los Angeles, CA"
       }
      }
     },
     "localname": "LosAngelesCaliforniaMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_ManagementFeeIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management Fee Income [Member]",
        "label": "Management Fee Income [Member]",
        "terseLabel": "Management fee income"
       }
      }
     },
     "localname": "ManagementFeeIncomeMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MarketCondition1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Condition 1",
        "label": "Market Condition 1 [Member]",
        "terseLabel": "Absolute TSR Component"
       }
      }
     },
     "localname": "MarketCondition1Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MarketCondition2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Condition 2",
        "label": "Market Condition 2 [Member]",
        "terseLabel": "Relative TSR Component"
       }
      }
     },
     "localname": "MarketCondition2Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MedicalOfficeBuildingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Office Building [Member]",
        "label": "Medical Office Building [Member]",
        "terseLabel": "Medical office building"
       }
      }
     },
     "localname": "MedicalOfficeBuildingMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MergerRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Related Costs",
        "label": "Merger Related Costs",
        "terseLabel": "Merger-related costs"
       }
      }
     },
     "localname": "MergerRelatedCosts",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_MezzanineLoansTexasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mezzanine Loans Texas",
        "label": "Mezzanine Loans Texas [Member]",
        "terseLabel": "Mezzanine Loans Texas"
       }
      }
     },
     "localname": "MezzanineLoansTexasMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MiscellaneousMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Miscellaneous [Member]",
        "label": "Miscellaneous [Member]",
        "terseLabel": "Miscellaneous"
       }
      }
     },
     "localname": "MiscellaneousMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MortgageLoanCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan California",
        "label": "Mortgage Loan California [Member]",
        "terseLabel": "Mortgage Loan California"
       }
      }
     },
     "localname": "MortgageLoanCaliforniaMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MortgageLoanFloridaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Florida",
        "label": "Mortgage Loan Florida [Member]",
        "terseLabel": "Mortgage Loan Florida"
       }
      }
     },
     "localname": "MortgageLoanFloridaMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MortgageLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan",
        "label": "Mortgage Loan [Member]",
        "terseLabel": "Mortgage Loan"
       }
      }
     },
     "localname": "MortgageLoanMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MortgageLoanNorthCarolinaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan - North Carolina",
        "label": "Mortgage Loan - North Carolina [Member]",
        "terseLabel": "Mortgage Loan - North Carolina"
       }
      }
     },
     "localname": "MortgageLoanNorthCarolinaMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MortgageLoanTexasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Texas",
        "label": "Mortgage Loan Texas [Member]",
        "terseLabel": "Mortgage Loan Texas"
       }
      }
     },
     "localname": "MortgageLoanTexasMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_MortgageNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Note",
        "label": "Mortgage Note",
        "terseLabel": "Mortgage note"
       }
      }
     },
     "localname": "MortgageNote",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_MortgageNotesPayableNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Notes Payable, Net [Member]",
        "label": "Mortgage Notes Payable, Net [Member]",
        "terseLabel": "Mortgage Notes Payable"
       }
      }
     },
     "localname": "MortgageNotesPayableNetMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_NatureOfOperationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature Of Operations Policy.",
        "label": "Nature of Operations [Policy Text Block]",
        "terseLabel": "Business overview"
       }
      }
     },
     "localname": "NatureOfOperationsPolicyTextBlock",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic",
        "totalLabel": "Net (loss) income applicable to common stockholders - basic"
       }
      }
     },
     "localname": "NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_NonControllingInterestHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Controlling Interest Holders",
        "label": "Non-Controlling Interest Holders [Member]",
        "terseLabel": "Non-Controlling Interest Holders"
       }
      }
     },
     "localname": "NonControllingInterestHoldersMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_NonVestedStockAwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Vested Stock Award",
        "label": "Non Vested Stock Award [Member]",
        "terseLabel": "Non-vested Stock Award"
       }
      }
     },
     "localname": "NonVestedStockAwardMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_NotesReceivableCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Carrying Amount",
        "label": "Notes Receivable, Carrying Amount",
        "terseLabel": "Notes receivable, carrying amount"
       }
      }
     },
     "localname": "NotesReceivableCarryingAmount",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_NotesReceivableFairValueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Fair Value Discount",
        "label": "Notes Receivable, Fair Value Discount",
        "negatedTerseLabel": "Fair-value discount and fees"
       }
      }
     },
     "localname": "NotesReceivableFairValueDiscount",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_NotesReceivableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Interest Rate",
        "label": "Notes Receivable, Interest Rate",
        "terseLabel": "STATED INTEREST RATE"
       }
      }
     },
     "localname": "NotesReceivableInterestRate",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hr_NotesReceivableMaximumLoanCommitment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Maximum Loan Commitment",
        "label": "Notes Receivable, Maximum Loan Commitment",
        "terseLabel": "MAXIMUM LOAN COMMITMENT"
       }
      }
     },
     "localname": "NotesReceivableMaximumLoanCommitment",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_NumberOfBuildingsOwnedByJointVenture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Buildings Owned by Joint Venture",
        "label": "Number of Buildings Owned by Joint Venture",
        "terseLabel": "Number of buildings owned by joint venture with TIAA"
       }
      }
     },
     "localname": "NumberOfBuildingsOwnedByJointVenture",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Joint Ventures",
        "label": "Number of Joint Ventures",
        "terseLabel": "Number of joint ventures"
       }
      }
     },
     "localname": "NumberOfJointVentures",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfLandParcelsClassifiedAsHeldForSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Land Parcels Classified as Held for Sale",
        "label": "Number of Land Parcels Classified as Held for Sale",
        "terseLabel": "Number of land parcels classified as held for sale"
       }
      }
     },
     "localname": "NumberOfLandParcelsClassifiedAsHeldForSale",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfNotesReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Notes Receivable",
        "label": "Number of Notes Receivable",
        "terseLabel": "Number of notes receivable"
       }
      }
     },
     "localname": "NumberOfNotesReceivable",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfPropertiesClassifiedAsHeldForSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Properties Classified as Held for Sale",
        "label": "Number of Properties Classified as Held for Sale",
        "terseLabel": "Number of properties classified as held for sale"
       }
      }
     },
     "localname": "NumberOfPropertiesClassifiedAsHeldForSale",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfPropertyDispositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Property Dispositions",
        "label": "Number of Property Dispositions",
        "terseLabel": "Number of property dispositions"
       }
      }
     },
     "localname": "NumberOfPropertyDispositions",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfRealEstateInvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of real estate investments.",
        "label": "Number of Real Estate Investments",
        "terseLabel": "Number of real estate properties"
       }
      }
     },
     "localname": "NumberOfRealEstateInvestments",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfRealEstateNotesReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Real Estate Notes Receivable",
        "label": "Number of Real Estate Notes Receivable",
        "terseLabel": "Number of real estate notes receivable"
       }
      }
     },
     "localname": "NumberOfRealEstateNotesReceivable",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfRecognizedLeaseFinancialReceivables": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Recognized Lease Financial Receivables",
        "label": "Number of Recognized Lease Financial Receivables",
        "terseLabel": "Number of recognized lease financial receivables"
       }
      }
     },
     "localname": "NumberOfRecognizedLeaseFinancialReceivables",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberOfVariableInterestEntities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Variable Interest Entities",
        "label": "Number of Variable Interest Entities",
        "terseLabel": "Number of variable interest entities"
       }
      }
     },
     "localname": "NumberOfVariableInterestEntities",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberofGroundLeasesExcludingPrepaidLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Ground Leases, Excluding Prepaid Leases",
        "label": "Number of Ground Leases, Excluding Prepaid Leases",
        "terseLabel": "Number of non-prepaid ground leases"
       }
      }
     },
     "localname": "NumberofGroundLeasesExcludingPrepaidLeases",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_NumberofGroundLeasesPrepaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Ground Leases Prepaid",
        "label": "Number of Ground Leases Prepaid",
        "terseLabel": "Number of prepaid ground leases"
       }
      }
     },
     "localname": "NumberofGroundLeasesPrepaid",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_OperatingExpensesandCostofGoodsSold": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses and Cost of Goods Sold",
        "label": "Operating Expenses and Cost of Goods Sold",
        "totalLabel": "Expenses"
       }
      }
     },
     "localname": "OperatingExpensesandCostofGoodsSold",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_OperatingPartnershipPerformanceUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Partnership Performance Units",
        "label": "Operating Partnership Performance Units [Member]",
        "terseLabel": "Operating Partnership Performance Units"
       }
      }
     },
     "localname": "OperatingPartnershipPerformanceUnitsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_ParkingIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Parking Income [Member]",
        "label": "Parking Income [Member]",
        "terseLabel": "Parking income"
       }
      }
     },
     "localname": "ParkingIncomeMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_PercentageOfRestrictedStockUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Restricted Stock Units",
        "label": "Percentage Of Restricted Stock Units",
        "terseLabel": "Percentage of restricted stock units"
       }
      }
     },
     "localname": "PercentageOfRestrictedStockUnits",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hr_PerformanceConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Conditions",
        "label": "Performance Conditions [Member]",
        "terseLabel": "Performance conditions"
       }
      }
     },
     "localname": "PerformanceConditionsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_PersonalProperty": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Personal property.",
        "label": "Personal Property",
        "terseLabel": "Personal property"
       }
      }
     },
     "localname": "PersonalProperty",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_PropertyEntitiesNotDeterminedToBeVIEsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property Entities Not Determined to be VIEs",
        "label": "Property Entities Not Determined to be VIEs [Member]",
        "terseLabel": "Property Entities Not Determined to be VIEs"
       }
      }
     },
     "localname": "PropertyEntitiesNotDeterminedToBeVIEsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Dispositions and Mortgage Note Repayments [Axis]",
        "label": "Real Estate Dispositions and Mortgage Note Repayments [Axis]",
        "terseLabel": "Real Estate Dispositions and Mortgage Note Repayments [Axis]"
       }
      }
     },
     "localname": "RealEstateDispositionsAndMortgageNoteRepaymentsAxis",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Dispositions and Mortgage Note Repayments [Domain]",
        "label": "Real Estate Dispositions and Mortgage Note Repayments [Domain]",
        "terseLabel": "Real Estate Dispositions and Mortgage Note Repayments [Domain]"
       }
      }
     },
     "localname": "RealEstateDispositionsAndMortgageNoteRepaymentsDomain",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_RealEstateDispositionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate dispositions.",
        "label": "Real Estate Dispositions [Line Items]",
        "terseLabel": "Real Estate Dispositions [Line Items]"
       }
      }
     },
     "localname": "RealEstateDispositionsLineItems",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_RealEstateDispositionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Dispositions [Member]",
        "label": "Real Estate Dispositions [Member]",
        "terseLabel": "Real Estate Dispositions"
       }
      }
     },
     "localname": "RealEstateDispositionsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_RealEstateInvestmentNetDisposedOfDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate investment net disposed of during the Period.",
        "label": "Real Estate Investment Net Disposed of During Period",
        "terseLabel": "NET REAL ESTATE INVESTMENT"
       }
      }
     },
     "localname": "RealEstateInvestmentNetDisposedOfDuringPeriod",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate investments property owned in number of states.",
        "label": "Real Estate Investments Property Owned in Number of States",
        "verboseLabel": "Number of states that the company owns real estate in, whole units"
       }
      }
     },
     "localname": "RealEstateInvestmentsPropertyOwnedInNumberOfStates",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hr_RealEstateNotesReceivableNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Notes Receivable, Net",
        "label": "Real Estate Notes Receivable, Net",
        "verboseLabel": "Real estate notes receivable, net"
       }
      }
     },
     "localname": "RealEstateNotesReceivableNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_RealEstateOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate other.",
        "label": "Real Estate Other",
        "terseLabel": "Other (including receivables)"
       }
      }
     },
     "localname": "RealEstateOther",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_RealEstatePropertiesHeldInJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Properties Held in Joint Ventures",
        "label": "Real Estate Properties Held in Joint Ventures [Member]",
        "terseLabel": "Real Estate Properties Held in Joint Ventures"
       }
      }
     },
     "localname": "RealEstatePropertiesHeldInJointVenturesMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_RecapitalizationExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization Exchange Ratio",
        "label": "Recapitalization Exchange Ratio",
        "terseLabel": "Exchange ratio"
       }
      }
     },
     "localname": "RecapitalizationExchangeRatio",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hr_ReceivablesAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables And Other Assets",
        "label": "Receivables And Other Assets",
        "terseLabel": "Receivables and other assets"
       }
      }
     },
     "localname": "ReceivablesAndOtherAssets",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of the beginning and ending common stock outstanding.",
        "label": "Reconciliation of Beginning and Ending Common Stock Outstanding [Roll Forward]",
        "verboseLabel": "Reconciliation of the beginning and ending common stock outstanding"
       }
      }
     },
     "localname": "ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_ReverseRecapitalizationNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Net",
        "label": "Reverse Recapitalization, Net",
        "terseLabel": "Value of implied Legacy HR Common Stock issued"
       }
      }
     },
     "localname": "ReverseRecapitalizationNet",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_STLouisMoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ST Louis Mo",
        "label": "ST Louis Mo [Member]",
        "terseLabel": "St. Louis, MO"
       }
      }
     },
     "localname": "STLouisMoMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Assets and Liabilities Held for Sale",
        "label": "Schedule of Assets and Liabilities Held for Sale [Table Text Block]",
        "terseLabel": "Schedule of assets and liabilities held for sale"
       }
      }
     },
     "localname": "ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hr_ScheduleOfRealEstateDispositionsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of real estate dispositions.",
        "label": "Schedule of Real Estate Dispositions [Table]",
        "terseLabel": "Schedule of Real Estate Dispositions [Table]"
       }
      }
     },
     "localname": "ScheduleOfRealEstateDispositionsTable",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_SeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2026",
        "label": "Senior Notes due 2026 [Member]",
        "terseLabel": "Senior Notes due 2026, net of discount and issuance costs"
       }
      }
     },
     "localname": "SeniorNotesDue2026Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2027",
        "label": "Senior Notes due 2027 [Member]",
        "terseLabel": "Senior Notes due 2027, net of discount and issuance costs"
       }
      }
     },
     "localname": "SeniorNotesDue2027Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2030, Net of Discount and Issuance Costs",
        "label": "Senior Notes due 2030, Net of Discount and Issuance Costs [Member]",
        "terseLabel": "Senior notes due 2030, net of discount and issuance costs"
       }
      }
     },
     "localname": "SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2031",
        "label": "Senior Notes due 2031 [Member]",
        "terseLabel": "Senior Notes due 2031, net of discount and issuance costs"
       }
      }
     },
     "localname": "SeniorNotesDue2031Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2031, Net of Discount and Issuance Costs",
        "label": "Senior Notes due 2031, Net of Discount and Issuance Costs [Member]",
        "terseLabel": "Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2025 [Member]",
        "label": "Senior Notes due 2025 [Member]",
        "terseLabel": "Senior Notes due 2025, net of discount and issuance costs"
       }
      }
     },
     "localname": "SeniorNotesdue2025Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesdue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2028 [Member]",
        "label": "Senior Notes due 2028 [Member]",
        "terseLabel": "Senior Notes due 2028"
       }
      }
     },
     "localname": "SeniorNotesdue2028Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SeniorNotesdue2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes due 2030 [Member]",
        "label": "Senior Notes due 2030 [Member]",
        "terseLabel": "Senior notes due 2030, net of discount and issuance costs"
       }
      }
     },
     "localname": "SeniorNotesdue2030Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_SettledInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settled Interest Rate Swaps",
        "label": "Settled Interest Rate Swaps [Member]",
        "terseLabel": "Settled Interest Rate Swaps"
       }
      }
     },
     "localname": "SettledInterestRateSwapsMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period",
        "terseLabel": "Award performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Probability Adjustment In Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Probability Adjustment In Period",
        "negatedLabel": "Revaluation of 2022 RSUs (net change) (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Probability adjustment, Weighted average grant date fair value (in dollar per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price",
        "terseLabel": "Stock price (in dollar per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hr_SquareFeetSubjecttoGroundLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Square Feet Subject to Ground Leases",
        "label": "Square Feet Subject to Ground Leases",
        "terseLabel": "Square feet subject to ground leases"
       }
      }
     },
     "localname": "SquareFeetSubjecttoGroundLeases",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "hr_StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive Plan [Member]",
        "label": "Stock Incentive Plan [Member]",
        "terseLabel": "Stock incentive plan"
       }
      }
     },
     "localname": "StockIncentivePlanMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_StockIssuanceProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuance Program [Axis]",
        "label": "Stock Issuance Program [Axis]",
        "terseLabel": "Stock Issuance Program [Axis]"
       }
      }
     },
     "localname": "StockIssuanceProgramAxis",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hr_StockIssuanceProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Stock Issuance Program [Axis]",
        "label": "Stock Issuance Program [Domain]",
        "terseLabel": "Stock Issuance Program [Domain]"
       }
      }
     },
     "localname": "StockIssuanceProgramDomain",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_StraightLineRentReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Straight-line rent receivable.",
        "label": "Straight-line Rent Receivable",
        "negatedLabel": "Amortization of straight-line rent receivable (lessor)"
       }
      }
     },
     "localname": "StraightLineRentReceivable",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_StraightlineRentLiability": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Straight-line rent liability.",
        "label": "Straight-line Rent Liability",
        "terseLabel": "Amortization of straight-line rent on operating leases (lessee)"
       }
      }
     },
     "localname": "StraightlineRentLiability",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hr_TampaFLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tampa, FL",
        "label": "Tampa, FL [Member]",
        "terseLabel": "Tampa, FL"
       }
      }
     },
     "localname": "TampaFLMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TampaFLMiamiFLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tampa FL &amp; Miami FL",
        "label": "Tampa FL &amp; Miami FL [Member]",
        "terseLabel": "Tampa Fl &amp; Miami FL"
       }
      }
     },
     "localname": "TampaFLMiamiFLMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TermLoanDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan due 2023",
        "label": "Term Loan due 2023 [Member]",
        "terseLabel": "$350 million Unsecured Term Loan due 2023, net of issuance costs"
       }
      }
     },
     "localname": "TermLoanDue2023Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TermLoanDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan due 2025",
        "label": "Term Loan due 2025 [Member]",
        "terseLabel": "$300 million Unsecured Term Loan due 2025, net of issuance costs"
       }
      }
     },
     "localname": "TermLoanDue2025Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TermLoanDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan due 2027",
        "label": "Term Loan due 2027 [Member]",
        "terseLabel": "$200 million Unsecured Term Loan due 2027, net of issuance costs"
       }
      }
     },
     "localname": "TermLoanDue2027Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TermLoanDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan due 2028",
        "label": "Term Loan due 2028 [Member]",
        "terseLabel": "$300 million Unsecured Term Loan due 2028, net of issuance costs"
       }
      }
     },
     "localname": "TermLoanDue2028Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TermLoandue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan due 2024 [Member]",
        "label": "Term Loan due 2024 [Member]",
        "terseLabel": "$200 million Unsecured Term Loan due 2024, net of issuance costs"
       }
      }
     },
     "localname": "TermLoandue2024Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_TermLoandue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan due 2026 [Member]",
        "label": "Term Loan due 2026 [Member]",
        "terseLabel": "$150 million Unsecured Term Loan due 2026, net of issuance costs"
       }
      }
     },
     "localname": "TermLoandue2026Member",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_UnsecuredCreditFacilityOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Credit Facility One",
        "label": "Unsecured Credit Facility One [Member]",
        "terseLabel": "$1.5 billion Unsecured Credit Facility"
       }
      }
     },
     "localname": "UnsecuredCreditFacilityOneMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hr_VariableInterestEntityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity",
        "label": "Variable Interest Entity [Member]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityMember",
     "nsuri": "http://healthcarerealty.com/20230331",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r258",
      "r443",
      "r444",
      "r448",
      "r449",
      "r503",
      "r551",
      "r561",
      "r666",
      "r669",
      "r670",
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r258",
      "r443",
      "r444",
      "r448",
      "r449",
      "r503",
      "r551",
      "r561",
      "r666",
      "r669",
      "r670",
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r403",
      "r509",
      "r528",
      "r552",
      "r553",
      "r587",
      "r598",
      "r607",
      "r671",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r403",
      "r509",
      "r528",
      "r552",
      "r553",
      "r587",
      "r598",
      "r607",
      "r671",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r539",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r560",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of real estate property.",
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r560",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land and any structures permanently fixed to it.",
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OtherPropertyMember": {
     "auth_ref": [
      "r608",
      "r609",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property classified as other.",
        "label": "Other Property [Member]",
        "terseLabel": "Parking Garages"
       }
      }
     },
     "localname": "OtherPropertyMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r307",
      "r510",
      "r588",
      "r605",
      "r663",
      "r664",
      "r673",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r307",
      "r510",
      "r588",
      "r605",
      "r663",
      "r664",
      "r673",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r402",
      "r403",
      "r429",
      "r430",
      "r431",
      "r505",
      "r509",
      "r528",
      "r552",
      "r553",
      "r587",
      "r598",
      "r607",
      "r662",
      "r671",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r402",
      "r403",
      "r429",
      "r430",
      "r431",
      "r505",
      "r509",
      "r528",
      "r552",
      "r553",
      "r587",
      "r598",
      "r607",
      "r662",
      "r671",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r269",
      "r270",
      "r284",
      "r457",
      "r458",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r214",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r284",
      "r316",
      "r317",
      "r438",
      "r456",
      "r457",
      "r458",
      "r459",
      "r474",
      "r501",
      "r502",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r214",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r284",
      "r316",
      "r317",
      "r438",
      "r456",
      "r457",
      "r458",
      "r459",
      "r474",
      "r501",
      "r502",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r214",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r273",
      "r284",
      "r438",
      "r456",
      "r457",
      "r458",
      "r474",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r653",
      "r654",
      "r705",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r635",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Condensed Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r308",
      "r309",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r560",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r589",
      "r606",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r308",
      "r309",
      "r539",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r560",
      "r562",
      "r589",
      "r606",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r651",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NORTH CAROLINA",
        "terseLabel": "Charlotte, NC"
       }
      }
     },
     "localname": "NC",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas",
        "verboseLabel": "Texas"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r185",
      "r207"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "totalLabel": "Accounts payable and accrued liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.",
        "label": "Accounts Payable and Other Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r519",
      "r540"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r5",
      "r179",
      "r195"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Other operating accruals"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r26",
      "r28",
      "r674"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r27",
      "r28",
      "r125",
      "r502",
      "r529",
      "r530",
      "r622",
      "r623",
      "r624",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition Costs, Period Cost",
        "terseLabel": "Acquisition and pursuit costs"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r636",
      "r637",
      "r638",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r103",
      "r104",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r68",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Company's Allowance For Credit Losses"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average incremental shares of common stock excluded from the computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent consideration in asset acquisition.",
        "label": "Asset Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Consideration Transferred"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r177",
      "r194",
      "r220",
      "r257",
      "r298",
      "r301",
      "r305",
      "r314",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r443",
      "r448",
      "r463",
      "r604",
      "r667",
      "r668",
      "r716"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r146",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BelowMarketLeaseNet": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of leases acquired as part of a real property acquisition at below market lease rate with a finite life.",
        "label": "Below Market Lease, Net",
        "terseLabel": "Below-market intangible liabilities, net"
       }
      }
     },
     "localname": "BelowMarketLeaseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r439",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r106",
      "r107",
      "r439",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Equity interest owned (percent)"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill expected to be tax deductible"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.",
        "label": "Business Combination, Acquired Receivables, Gross Contractual Amount",
        "terseLabel": "Gross contractual accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivablesGrossContractualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]",
        "terseLabel": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r113",
      "r114",
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred",
        "verboseLabel": "Purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Merger with HTA"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]",
        "terseLabel": "MEASUREMENT PERIOD ADJUSTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of facility held for productive use including, but not limited to, office, production, storage and distribution facilities, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Lease intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of real estate acquired, at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r108",
      "r110"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "verboseLabel": "Invoices accrued for construction, tenant improvements and other capitalized costs"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "CARRYING VALUE"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r54",
      "r217",
      "r571"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r49",
      "r54",
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r49",
      "r168"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "(Decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r257",
      "r277",
      "r278",
      "r280",
      "r282",
      "r287",
      "r288",
      "r314",
      "r333",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r371",
      "r372",
      "r375",
      "r379",
      "r386",
      "r463",
      "r554",
      "r616",
      "r632",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r20",
      "r187",
      "r201"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r79",
      "r327",
      "r328",
      "r541",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends paid per common share, during the period (in dollars per share)",
        "verboseLabel": "Dividend per share to common Stockholders (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityParenthetical",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share, during the period (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r636",
      "r637",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, end of period (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)",
        "terseLabel": "Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)",
        "verboseLabel": "Common stock, outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r9",
      "r604"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,816 and 380,590 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r29",
      "r236",
      "r238",
      "r247",
      "r516",
      "r523"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income attributable to common stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r122",
      "r138",
      "r236",
      "r238",
      "r246",
      "r515",
      "r522"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less: comprehensive loss attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r120",
      "r138",
      "r236",
      "r238",
      "r245",
      "r514",
      "r521"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r123",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Redeemable non-controlling interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r126",
      "r128",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r388",
      "r389",
      "r400"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CumulativeDividends": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative cash dividends distributed to shareholders.",
        "label": "Cumulative Dividends",
        "negatedLabel": "Cumulative dividends"
       }
      }
     },
     "localname": "CumulativeDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r84",
      "r255",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r358",
      "r365",
      "r366",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Notes and Bonds Payable"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r178",
      "r181",
      "r192",
      "r258",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r473",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r170",
      "r172",
      "r342",
      "r473",
      "r583",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r356",
      "r462",
      "r583",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Notes and bonds payable"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Debt fees"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r17",
      "r170",
      "r370",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r19",
      "r258",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r473",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r19",
      "r89",
      "r92",
      "r93",
      "r94",
      "r169",
      "r170",
      "r172",
      "r191",
      "r258",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r367",
      "r473",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r171",
      "r672"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs, net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRentReceivablesNet": {
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r711"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of rental income recognized over rental payment required by lease.",
        "label": "Deferred Rent Receivables, Net",
        "terseLabel": "Straight-line rent receivables"
       }
      }
     },
     "localname": "DeferredRentReceivablesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r52",
      "r76"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r52",
      "r296"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r229",
      "r230",
      "r462",
      "r572"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate swap assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r25",
      "r148",
      "r173",
      "r228",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Liability derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Weighted average interest rate (percent)"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r147",
      "r149",
      "r153",
      "r155",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r161",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r144",
      "r147",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r229",
      "r230",
      "r462",
      "r572"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Interest rate swap liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "AMOUNT"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r139",
      "r141",
      "r142",
      "r144",
      "r145",
      "r151",
      "r153",
      "r156",
      "r157",
      "r159",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as hedging instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopmentInProcess": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current amount of expenditures for a real estate project that has not yet been completed.",
        "label": "Development in Process",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "DevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense incurred and directly related to generating revenue by lessor from operating lease of rented property and equipment.",
        "label": "Direct Costs of Leased and Rented Property or Equipment",
        "verboseLabel": "Property operating"
       }
      }
     },
     "localname": "DirectCostsOfLeasedAndRentedPropertyOrEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r399",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r98",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Summary of the activity under the incentive plan and restricted stock unit"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r75",
      "r78",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r3",
      "r77"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r3",
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r3",
      "r77"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared": {
     "auth_ref": [
      "r95",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity impact of cash distributions declared to unit-holder of limited liability company (LLC).",
        "label": "Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Declared",
        "negatedTerseLabel": "Owner distributions"
       }
      }
     },
     "localname": "DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends to common stockholders (in usd per share)"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsShareBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind dividends declared for award under share-based payment arrangement.",
        "label": "Dividend, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Dividends paid on nonvested share-based awards"
       }
      }
     },
     "localname": "DividendsShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.",
        "label": "Early Repayment of Senior Debt",
        "negatedTerseLabel": "Redemption of notes and bonds payable"
       }
      }
     },
     "localname": "EarlyRepaymentOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r248",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r275",
      "r277",
      "r280",
      "r281",
      "r282",
      "r284",
      "r458",
      "r459",
      "r517",
      "r524",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per common share (in dollars per share)",
        "verboseLabel": "Basic earnings per common share - net income (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r248",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r277",
      "r280",
      "r281",
      "r282",
      "r284",
      "r458",
      "r459",
      "r517",
      "r524",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per common share (in dollars per share)",
        "verboseLabel": "Diluted earnings per common share- net income (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r433"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "verboseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options under the Employee Stock Option Plan"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r88",
      "r213",
      "r239",
      "r240",
      "r241",
      "r259",
      "r260",
      "r261",
      "r263",
      "r270",
      "r273",
      "r286",
      "r315",
      "r387",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r457",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r502",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r31",
      "r48",
      "r52",
      "r208"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Distributions from unconsolidated joint ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Joint venture ownership (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r356",
      "r462",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "FAIR VALUE"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r162",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r162",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r162",
      "r165",
      "r356",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r356",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r477",
      "r482",
      "r603"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r479",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows outflows related to financing leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "FINANCING"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r476",
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Financing lease liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Future Minimum Financing Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Discount"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r478",
      "r485"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments made on finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r477",
      "r482",
      "r603"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r707"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r488",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r487",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average years remaining lease term (excluding renewal options) - finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLosses": {
     "auth_ref": [
      "r67",
      "r226",
      "r318",
      "r319",
      "r320",
      "r556",
      "r558",
      "r559",
      "r724"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentNonaccrualStatus": {
     "auth_ref": [
      "r69",
      "r322",
      "r557",
      "r558"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of financing receivable on nonaccrual status. Excludes net investment in lease.",
        "label": "Financing Receivable, Nonaccrual",
        "terseLabel": "Financing receivable, nonaccrual"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentNonaccrualStatus",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted average amortization period for the acquired lease intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r630",
      "r659",
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "netLabel": "GAIN/(IMPAIRMENT)"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r52",
      "r81",
      "r82"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "terseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": {
     "auth_ref": [
      "r525",
      "r526",
      "r527",
      "r626",
      "r627",
      "r630",
      "r725",
      "r726"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.",
        "label": "Gains (Losses) on Sales of Investment Real Estate",
        "terseLabel": "Gain on sales of real estate properties"
       }
      }
     },
     "localname": "GainsLossesOnSalesOfInvestmentRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r218",
      "r324",
      "r512",
      "r581",
      "r604",
      "r657",
      "r658"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r144",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfRealEstate": {
     "auth_ref": [
      "r630",
      "r660"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value.",
        "label": "Impairment of Real Estate",
        "negatedLabel": "Impairment of real estate properties and credit loss reserves"
       }
      }
     },
     "localname": "ImpairmentOfRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r31",
      "r52",
      "r71",
      "r188",
      "r208",
      "r297"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity loss from unconsolidated joint ventures",
        "terseLabel": "Equity loss from unconsolidated joint ventures",
        "verboseLabel": "Equity loss recognized during the period"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets, including right-of-use-assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r171",
      "r190",
      "r242",
      "r295",
      "r472"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income from financing receivable before allowance for credit loss.",
        "label": "Interest Income, Financing Receivable, before Allowance for Credit Loss",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r573",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r249",
      "r252",
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r572",
      "r595",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Settled interest rate swaps",
        "verboseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r620"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentBuildingAndBuildingImprovements": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.",
        "label": "Investment Building and Building Improvements",
        "terseLabel": "Building and improvements",
        "verboseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "InvestmentBuildingAndBuildingImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r619"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Net LLC investments at the end of the period",
        "periodStartLabel": "Investments in unconsolidated joint ventures, beginning of period",
        "terseLabel": "Investments in unconsolidated joint ventures"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r618"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land",
        "verboseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAvailableForDevelopment": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of land available for development.",
        "label": "Land Available for Development",
        "terseLabel": "Land held for development"
       }
      }
     },
     "localname": "LandAvailableForDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r489",
      "r603"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Other information"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Future Minimum Operating Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Discount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Ground lease, initial term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r494",
      "r496",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Lessor, Leases [Policy Text Block]",
        "terseLabel": "Investments in Leases - Financing Receivables, Net"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessor, Operating Lease, Payments to be Received, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future Operating Lease Payments Receivable [Abstract]"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Future Minimum Operating Lease Payments Receivable"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": {
     "auth_ref": [
      "r712"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r15",
      "r257",
      "r314",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r444",
      "r448",
      "r449",
      "r463",
      "r577",
      "r667",
      "r716",
      "r717"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r183",
      "r199",
      "r604",
      "r634",
      "r652",
      "r706"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities:",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r3",
      "r77",
      "r215",
      "r216"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Liabilities of assets held for sale",
        "verboseLabel": "Liabilities of assets held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest",
        "terseLabel": "Limited partners ownership interest (in percent)"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of limited partner units outstanding.",
        "label": "Limited Partners' Capital Account, Units Outstanding",
        "terseLabel": "Limited partner's capital, units outstanding (in shares)"
       }
      }
     },
     "localname": "LimitedPartnersCapitalAccountUnitsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsHeldForSaleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-Lived Assets Held-for-sale [Line Items]",
        "terseLabel": "Long Lived Assets Held-for-sale [Line Items]"
       }
      }
     },
     "localname": "LongLivedAssetsHeldForSaleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r6",
      "r181",
      "r197",
      "r355",
      "r369",
      "r583",
      "r584"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Notes and bonds payable",
        "verboseLabel": "Notes and bonds payable"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r19",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r24",
      "r182",
      "r198",
      "r257",
      "r314",
      "r333",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r463"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoanRelatedToPropertySales1": {
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan related to property sales in noncash investing and financing activities.",
        "label": "Mortgage Loan Related to Property Sales",
        "terseLabel": "Mortgage note receivable taken in connection with sale of real estate"
       }
      }
     },
     "localname": "MortgageLoanRelatedToPropertySales1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "terseLabel": "Real estate notes receivable"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.",
        "label": "Mortgages [Member]",
        "terseLabel": "Mortgages"
       }
      }
     },
     "localname": "MortgagesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r49",
      "r50",
      "r53"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r32",
      "r53",
      "r189",
      "r209",
      "r216",
      "r234",
      "r237",
      "r241",
      "r257",
      "r262",
      "r264",
      "r265",
      "r267",
      "r268",
      "r272",
      "r273",
      "r279",
      "r298",
      "r300",
      "r304",
      "r306",
      "r314",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r459",
      "r463",
      "r578",
      "r667"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net (loss) income attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r124",
      "r137",
      "r234",
      "r237",
      "r272",
      "r273",
      "r624"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net loss attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentInLease": {
     "auth_ref": [
      "r312",
      "r321",
      "r492",
      "r655"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.",
        "label": "Net Investment in Lease, before Allowance for Credit Loss",
        "terseLabel": "Net investment in lease"
       }
      }
     },
     "localname": "NetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r118",
      "r387",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Additional long-lived assets, net"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableGross": {
     "auth_ref": [
      "r225",
      "r312",
      "r321",
      "r323",
      "r556",
      "r557",
      "r579",
      "r580",
      "r655",
      "r730"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.",
        "label": "Financing Receivable, before Allowance for Credit Loss",
        "terseLabel": "REAL ESTATE NOTES RECEIVABLE, GROSS"
       }
      }
     },
     "localname": "NotesReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r311",
      "r323"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Investment in financing receivable, net"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r140",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of instruments"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfPropertiesSubjectToGroundLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of separate real estate development properties located on land subject to ground leases.",
        "label": "Number of Properties Subject to Ground Leases",
        "terseLabel": "Number of properties subject to ground leases"
       }
      }
     },
     "localname": "NumberOfPropertiesSubjectToGroundLeases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of real estate properties owned as of the balance sheet date.",
        "label": "Number of Real Estate Properties",
        "terseLabel": "Number of owned real estate properties"
       }
      }
     },
     "localname": "NumberOfRealEstateProperties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r483",
      "r603"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r285",
      "r493",
      "r500"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Rental income"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "OPERATING"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r480",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows outflows related to operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r488",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r487",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average years remaining lease term (excluding renewal options) - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r34",
      "r52"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Other amortization"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r176",
      "r193",
      "r219"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "totalLabel": "Other Assets",
        "verboseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r146",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets",
        "verboseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneous": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets.",
        "label": "Other Assets, Miscellaneous",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneous",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r231",
      "r232"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "(Losses) gains arising during the period on interest rate swaps",
        "verboseLabel": "Gains (Losses) arising during the period on interest rate swaps"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r231",
      "r232",
      "r450",
      "r451",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedLabel": "(Gain)/loss recognized in AOCI on Derivative"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r232",
      "r233"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Reclassification adjustments for (gains) losses included in net income (interest expense)",
        "terseLabel": "(Gain) loss reclassified from AOCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r88",
      "r235",
      "r238",
      "r244",
      "r464",
      "r469",
      "r470",
      "r513",
      "r520",
      "r622",
      "r623"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherFiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.",
        "label": "Other Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Lease intangibles"
       }
      }
     },
     "localname": "OtherFiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r186"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "totalLabel": "Other liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r146",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest and other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Investment in securities"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilities": {
     "auth_ref": [
      "r5",
      "r7",
      "r180",
      "r196"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements.",
        "label": "Other Sundry Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Common stock redemptions"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r41",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireFinanceReceivables": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith.",
        "label": "Payments to Acquire Finance Receivables",
        "negatedTerseLabel": "Investment in financing receivable"
       }
      }
     },
     "localname": "PaymentsToAcquireFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "negatedTerseLabel": "Investments in unconsolidated joint ventures"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Payments to Acquire Notes Receivable",
        "negatedTerseLabel": "Funding of mortgages and notes receivable"
       }
      }
     },
     "localname": "PaymentsToAcquireNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "negatedLabel": "Additional long-lived assets"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireRealEstate": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.",
        "label": "Payments to Acquire Real Estate",
        "negatedTerseLabel": "Acquisitions of real estate"
       }
      }
     },
     "localname": "PaymentsToAcquireRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopRealEstateAssets": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.",
        "label": "Payments to Develop Real Estate Assets",
        "negatedLabel": "Development of real estate"
       }
      }
     },
     "localname": "PaymentsToDevelopRealEstateAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Distributions to non-controlling interest holders"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred stock, authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r8",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock, issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "verboseLabel": "Preferred stock, outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r8",
      "r604"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrentAndNoncurrent": {
     "auth_ref": [
      "r184",
      "r205",
      "r227"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.",
        "label": "Prepaid Expense",
        "terseLabel": "Prepaid assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfFinanceReceivables": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection of receivables arising from the financing of goods and services.",
        "label": "Proceeds from Collection of Finance Receivables",
        "terseLabel": "Investment in financing receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "verboseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": {
     "auth_ref": [],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).",
        "label": "Proceeds from (Repayments of) Lines of Credit",
        "terseLabel": "Net borrowings on unsecured credit facility"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable).",
        "label": "Proceeds from Sale and Collection of Notes Receivable",
        "terseLabel": "Proceeds from notes receivable repayments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.",
        "label": "Proceeds from Sale of Property Held-for-sale",
        "terseLabel": "Proceeds from sales of real estate properties and additional long-lived assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyHeldForSale",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.",
        "label": "Proceeds from Sale of Real Estate Held-for-investment",
        "terseLabel": "NET PROCEEDS"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r216",
      "r234",
      "r237",
      "r250",
      "r257",
      "r262",
      "r272",
      "r273",
      "r298",
      "r300",
      "r304",
      "r306",
      "r314",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r442",
      "r446",
      "r447",
      "r459",
      "r463",
      "r518",
      "r578",
      "r600",
      "r601",
      "r624",
      "r667"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes.",
        "label": "Real Estate Investment Property, Accumulated Depreciation",
        "negatedLabel": "Less accumulated depreciation and amortization",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyAtCost": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.",
        "label": "Real Estate Investment Property, at Cost",
        "terseLabel": "Real estate investment property, at cost",
        "totalLabel": "Total real estate properties"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyAtCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyNet": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.",
        "label": "Real Estate Investment Property, Net",
        "terseLabel": "Real estate assets held for sale, net",
        "totalLabel": "Total real estate properties, net"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate Investment Property, Net [Abstract]",
        "verboseLabel": "Real estate properties"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Real Estate [Line Items]",
        "terseLabel": "Real Estate [Line Items]"
       }
      }
     },
     "localname": "RealEstateLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstatePropertiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Real Estate Properties [Line Items]",
        "terseLabel": "Real Estate Properties [Line Items]"
       }
      }
     },
     "localname": "RealEstatePropertiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateTable": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions.",
        "label": "Real Estate [Table]",
        "terseLabel": "Real Estate [Table]"
       }
      }
     },
     "localname": "RealEstateTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r629"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of notes and bonds payable"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r293",
      "r294",
      "r299",
      "r302",
      "r303",
      "r307",
      "r308",
      "r310",
      "r398",
      "r399",
      "r510"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Type of Revenue",
        "verboseLabel": "Other operating"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r401",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue from contract with customers (topic 606)"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r243",
      "r257",
      "r293",
      "r294",
      "r299",
      "r302",
      "r303",
      "r307",
      "r308",
      "r310",
      "r314",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r463",
      "r518",
      "r667"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r486",
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable": {
     "auth_ref": [
      "r285",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income from lease receivable of sales-type lease.",
        "label": "Sales-type Lease, Interest Income, Lease Receivable",
        "terseLabel": "Income from financing receivables"
       }
      }
     },
     "localname": "SalesTypeLeaseInterestIncomeLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r106",
      "r107",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r106",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of cash flow hedges included in accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in common stock outstanding.",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of common stock outstanding"
       }
      }
     },
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of derivative instruments in statement of financial position, fair value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable": {
     "auth_ref": [
      "r2",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description and amounts of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).",
        "label": "Schedule of Long-Lived Assets Held-for-sale [Table]",
        "terseLabel": "Schedule of Long Lived Assets Held-for-sale [Table]"
       }
      }
     },
     "localname": "ScheduleOfLongLivedAssetsHeldForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRealEstatePropertiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning real estate properties and units within those properties by ownership of the property.",
        "label": "Schedule of Real Estate Properties [Table]",
        "terseLabel": "Schedule of Real Estate Properties [Table]"
       }
      }
     },
     "localname": "ScheduleOfRealEstatePropertiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Fair Values of the Assets Acquired And Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of employee stock purchase plan activity.",
        "label": "Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]",
        "terseLabel": "Summary of employee stock purchase plan activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of stock options, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r89",
      "r90",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r221",
      "r222",
      "r223",
      "r287",
      "r371",
      "r372",
      "r373",
      "r375",
      "r379",
      "r384",
      "r386",
      "r587",
      "r616",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Schedule of unrecognized compensation cost, nonvested awards"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r127",
      "r130",
      "r132",
      "r134",
      "r135",
      "r443",
      "r444",
      "r448",
      "r449",
      "r506",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r127",
      "r130",
      "r132",
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDepositLiability": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents money paid in advance to protect the provider of a product or service, such as a lessor, against damage or nonpayment by the buyer or tenant (lessee) during the term of the agreement. Such damages may include physical damage to the property, theft of property, and other contractual breaches. Security deposits held may be interest or noninterest bearing.",
        "label": "Security Deposit Liability",
        "terseLabel": "Security deposits"
       }
      }
     },
     "localname": "SecurityDepositLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilitiesOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (net change) (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, Weighted average grant date fair value (in dollar per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Share-based awards, ending of period (in shares)",
        "periodStartLabel": "Share-based awards, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Summary of the activity under the incentive plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Share-based awards, ending of period, Weighted average grant date fair value",
        "periodStartLabel": "Share-based awards, beginning of period, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, Weighted average grant date fair value (in dollar per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding and exercisable, end of period (in shares)",
        "periodStartLabel": "Outstanding and exercisable, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Summary of the Employee Stock Purchase Plan activity"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderStockBasedIncentivePlansandRestrictedStockUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r404",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Share-Based Payment Arrangement, Nonemployee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Nonvested shares (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Grant date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Shares withheld to pay estimated withholding taxes (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r59",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r257",
      "r277",
      "r278",
      "r280",
      "r282",
      "r287",
      "r288",
      "r314",
      "r333",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r371",
      "r372",
      "r375",
      "r379",
      "r386",
      "r463",
      "r554",
      "r616",
      "r632",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r22",
      "r88",
      "r213",
      "r239",
      "r240",
      "r241",
      "r259",
      "r260",
      "r261",
      "r263",
      "r270",
      "r273",
      "r286",
      "r315",
      "r387",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r457",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r502",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r286",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r8",
      "r9",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Implied shares of Legacy HR Common Stock issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r8",
      "r9",
      "r88",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r8",
      "r9",
      "r88",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Nonvested share-based awards, net of withheld shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r8",
      "r9",
      "r88",
      "r95",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r8",
      "r9",
      "r88",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r8",
      "r9",
      "r88",
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Common stock redemptions"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r9",
      "r11",
      "r12",
      "r70",
      "r604",
      "r634",
      "r652",
      "r706"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total equity",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r118",
      "r119",
      "r136",
      "r213",
      "r214",
      "r240",
      "r259",
      "r260",
      "r261",
      "r263",
      "r270",
      "r315",
      "r387",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r457",
      "r464",
      "r465",
      "r470",
      "r502",
      "r530",
      "r531",
      "r634",
      "r652",
      "r706"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r256",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r387",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r471",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r471",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r471",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Other Assets and Liabilities"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/OtherAssetsandLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r21",
      "r257",
      "r314",
      "r463"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "terseLabel": "Redeemable non-controlling interests"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]",
        "terseLabel": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "verboseLabel": "Settled treasury hedges"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRevenueExtensibleList": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfRevenueExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r289",
      "r290",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates in the condensed consolidated financial statements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r129",
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Maximum exposure to loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r127",
      "r443",
      "r444",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable interest entity"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r484",
      "r603"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r276",
      "r282"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "verboseLabel": "Weighted average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average Common Shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r275",
      "r282"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "totalLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "negatedTerseLabel": "Non-vested shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 16
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),1(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.10)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39896-112707",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123394697&loc=d3e40879-112712",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919306-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123605564&loc=d3e23415-158514",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123605564&loc=d3e23439-158514",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123605587&loc=d3e23528-158515",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r611": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r612": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r613": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r614": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r615": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(14)(d))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>82
<FILENAME>0001360604-23-000043-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001360604-23-000043-xbrl.zip
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M5E8$(?'+H>5,4IAFHWRQTQP'L*5","F1IC9M2S%.8J]PD"^'IO.3YC(30M/
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MM:1RCD\GG7];($NB!RP)W/LH+!:6*8>M*8XYM!X%)<!/G'\]\+ORP!3CA-X
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M H_ @'.MK<EHX$@3P;CE=NFMHJ\800L37D83OI"[.9"[&X;>(X^#8#1SPBC
MSIIE*FB=<8^(%S02$W4A=RJ=IK"P\P\3M[1#L=?I#V0-?/'C3GN_$[H+XSYM
MX[X6?H1&^SC%/#9;13&IQ3K:%!7(+:O5.@HK.,,9 PL.GH+&F7;49APHZ3#6
M4FJS]):15^"%+PQW&0WW0J:>6*9N&.6 01'2J, H:YDQ;UT&_G;(+"<&"TF\
M2RM-E+_B8@9@^*48Y;3!H7(0&C[Q,DC F,L75OD)]I.M_#!Y(\7N-MJ=2QIE
MH4BFML.DOE(HD4*9U+] '[^<???^_V?O2YO:.K9V_XJ*]]2]297:Z6'UY)Q+
M%0$[X;Q!)#:."W]Q]0BR0>)(PC;^];=[2TR2L)&]-;J3<PA(VEN[A_6L9ZU>
M0^0VK1;RGK&DG3%+9C4D>D]I>D/2F!9O:UOH)I=%.Z^E=BZRM2C9:H_)%@4M
MO;$>>>$M D<8TE18I+1,=C,)V!&WM2VA2<429&N6*AKTNXM?++-^P%%W8,X:
MO=FJ"-!OFHEZX&C:A$S T8Q3LS*Z/E=S>%8MPVWXP750S<Y@M]LOL%0C+#V;
M5/E$:!TI V2Q2L8#909I[P@B0!B/7I!H<U8I:RHAFHS/&%\S(V[42 N*G-;*
M&XJ<+EA.Q^F#H8)Q%CD"3# "DRQ]'0P@;-.>H,$K@DV24VAB+IN"SD@A%B&G
M&^,("/U^P]R>/B6YN>BE;6YNVH*;.^=1F^T=^&G5*,/MLNS=696"3?5AT_X4
MMX'&DHG D.%!(>!"($4L("% 1V\M"=KERA0)HYI8LPEH^KDX#>8D<HO0_D7D
M%B!RXW1 >4.LD@8%S9+(@?=(2VH0$(\-#EBH*B2^*8 WJ20+%;GB2\B^A,<&
MRQ=#96'LH,0!UPI+!Y-,( A-#1,1.1T( @: M(&(3!#<*9]7-^1 X&2EB"85
M,\8(%6_"LH5T 7RB"&G=0CK.'00$ U89A*7@"%3D**&M0S8M+*>:<0J^$M)<
M3I+Q%13237$E[)K^:>4Q</F7\-_+]H>TM4NAN?II09[IG8[/_WEV.\T[@UW3
MZUVE:?S'G%V&@COUX<[?4]P$T6+)@2'-;,PNS$0.M+8H+;"CW+GH*=[:!MW4
M,&FPE.B"-=#K1<H6+V7CVATKK8.4@)B7!@%G%-F$G<AZHYCG'&OLMK8%;FJQ
M!"G[BN:^[BM3-<SZ8@W^[_OD>CS&VO"881FJV^C(OBG% FHOWS.<Y#_2'#_O
M]G)3[(2T>^U^_IIVYS+XPV0^5:[7?C&A:@59-TEEF&;).C<.0? " =,8:6L)
M,M9@"-$;[F!KFS6YU(7)K!.3*7*V5#D;)S,NL1D9<!(Q2SV"1&&0T88BRH7#
M4B<,=;FP@&JJ*<>*RR8S:Z.^1SNZU!589.7<ZSF?EN%<4*4^5#F9<DH!H)VB
M#&E/LPIW#"FO*<)*IOTAF(>8.[$ST22D5 !:*_U=Q&OQXC7A@1!,28,-DN!(
M]O.Y7)':(JQ-D$X(#E0-Q4NKHK5KJ-=7M0"^[+B[C8W?==N=0>-#>O>R5PK?
MS[%Q37^_LQ-C^ZR=IKW_\M+VV[YM>NW03U#3==6KR8#X3UZ.?T:K4?"G/OQY
M/ZG>01CIB:>(.Y+PAW..;# X_:F"XD1$'=..950V)2RA&MD/+7ZUM[(IXK=L
M\1M7_]Q2EO!5(X*IS*&) 9E(%8H.@O2<J<0 AN)'H93*_V:I^[W;]1_;9V=%
MM=>LVJ\GML!$;3#Q;DJM@1"P3^8VH 3[R0AWN6H)C@090JU4CGAMZ-8V%;BI
M:#'"UU)+%TF:BR1-.,FC5!H+BI+1#0ATL$AYBI%5-CH?+3$J;3Y*63,M6U&X
MW^PESUV81N[P<K@]%Y]XGN'A\5N!C/H@XU[6?WXF^M:HM#Q$ A)2)^5+B4<*
M"XR"B2KQ=*<,(5O;G$$IH+NNRK<(T[R$:5S_:JRD9Y)E"]<B$!"0U8G3!A*B
M(-QS(>+6-HC<&V[U"O!M7#K>] /KNA)YZACS?/)X_E7'D#<P9ZDF<E*@M&XH
MG5))P$23EDM&E*P5F^-]/++"8^1-=$)ZZP7(JAH1%ZJIU JF)A6H^8&AIB;J
M5J!F#E SP=H,1/ L<;7<K@@$=\@PSY!W23EH0RFV85CX#'13L!ES)1:8!7G]
ME:-=F[YKZVN^%IR_\\OI"M_[T<5Y?>;-*O_<W_EM_\_]H_UG+QL[K;W&RZ/#
MW?_]X_#/O6<O7O[?QK._7^T?'3_H"EK8A-[;<&O-XO]L&]L^:W^Q'N?,XW[$
MK'_+G3;%MUDUS*LRD6VWX_N-"W.5"P0_PBJMA;DLS _S$'&ICYBLI$NIKL+L
MW<[)4>B=[P5;8BAK9"?'DX:0=0HSP QQS$GNJ.ARKC0@!T$3C1D!C;>V>9,)
MTA1Z.4E&!0U69RC+*"5?T&!>:#!1_#7HZ!BVB$3I45HYBHQQ G$#7',.7DFH
MT("3IJ*E!_JW)S([U[W, =4C C0LY^I<[S+XQMDCB.D/=UI5EW=U-/%_#>=]
MI^-WAK-^QQK8O>SU0F>0WFMU.V[X1P&>^H!G6IZS9<: PBCQ$9.=)!$9#QQ%
M3V,P03+#<V57SIN4E'/BM53C1?)60O(FDJBH310?'.)*LB1YEB*KD@PJPX)2
M2?Y<3F*@ ,T$KD7A?W,Q]]M-WNC&T=GQ_4(F1=?7[4:XG?/#N-?N7W33-/_>
MZUY>['?<V66>R:GU%@JHS 0J4Q*?G90V:H&1IM3F_FX2*99_HUYRCWGD4290
MD4NP('YHP:K+(B^"M2#!FBS'+K'1FB/B>=+6'#32#"L$7C@N#.?<I?T(K)CF
MM14I*=;XHHJ37,/*5:'\]8'(E+QEH8!Q0R/B8'GV^6ND*#>(8D55!(<USQE1
M,H<C% V]EAJZ"-8B!&O"EI;>6L\!&15H(KL2(^5-3((%7EL&Z3T\%"RE5Z_W
MZMIHZ.?MCNFXHJ$7H:&'<QT*C,P)1CY/R5AF 0N."4?4\%R1T$6D",,H4(4-
M4X*(G#0E69,LHQCA#RU5-:GG(E7SEZH)TUE'0BBVB%ON$&!KD 6K$!9.$$XC
MPR)+%6UJMH0PETW1S</DY:*1YYR\?,<#5V"C/MB8TK<\6J\Y%QA%H0D"(0)2
M1KJ$'<%PJQT7+B9.SV@3TU*#>RVU<9&HN4K4A)7,$A :0E'U P D4HHHE 0J
M,$L5CT(EB2*J*<3JU>W:N#3FV71U:5 XKR/J@CKUH<Z4C-^D*C@#JA&5V>DM
MHD)&18&H!P\T.I;^W=H638*3)H<9O7.E8>BRY;'^D^TBC[7*XT1S4!R5U\XF
M*;2 @&..#/841:<@EP;B6-%*'H5LRED33TIOT!EZ@W;/S]NC\MY5B] J;.,D
M=-SC$B/'\Q7GHT0_]=M/.^VS_[<UZ.7.?F/M &^'D+L"WAU $<]'B.>4!ML4
MB"(DB:?#7"/PU"++L$,Z6FJ,8XRR2A+&I').&V4&="\;9;X;91S'&>9@3=!(
M>))PG,A<WD!21$$Y[IU+?X@'-\JF8.B+X$,XKQ)YTB!1WKR][ME9/J)LIWW<
M"_W2V:AVV^DHG%]T>Z9WE5O #JZN>[_NG.<T@YM Q+^ZO?Q .X-!KVTO!WF-
MCKHYN^!VC?:OEZA0OOJ@XFY?9O?Y8.\5?2M(Y#8F3:)QC@5VFB*3Z[<+$,QH
M%I6A"2J2^877/,7'=@>#[OGR))(NR7HJ$KGB$MF^*Y''Y*TFC&O&#**&<00*
M(E(0(A*:$9V4-XU&51))9JR ]FT2>2,W&U;9Y^6@Z]Z?=L^23=K_OXU0"<?R
M*_E\ZP3Z]H<E4*R_>B&&7B_D+99FL]GXUY< [J_0>WEJ>J$6H-MO/1]'NING
MJ9;V+],[[+T<Y'Y85>?YVV\? 10N /4(@'HU.-B];UVD^YV%/UY<O7GM+RP%
M<?A[*WW_"6Z]WF=OWCG:VOL[S4.:HW?[[/#U*]KZ[&@:4QI754+W+0G1$D8$
M$M0G?(LVHF2K&)2L%.)T##P&^V5-^=!&^B8.6S;2NFXDIX%+;1@"*7*VC05D
MJ6:)B21&JU0,3KJM[2=XLGK?Q N-"]-K?,BKV[@(O48_K^^OC0?W8/5^?S$X
M5NVU_L[EX+3;2]CL"_M:U3W9VGOUEA+-%+<^&5':(^ Z@1M)6 ?@G8K8.JW-
M%\!M^L::#ZZ5C;5.&RM*<-$$CZ+.S="IL4B9&)$35+B$+Q3+'/*$\51+?1+P
MACNM86Z6?Z7@[O!RT!^83J;"][=E;']*<_ Y]+IE1RYS1[YS;PD#'8G22!.'
M$0A#D;4$(\XP)LXHJD&O%-3M]_N7XS!7]M/*[">9^T9:;Y ("I)=0!PRDG D
M</J5<J 1TY7:3P6D5G]3&4RHETPB""&QL @Y4MA+1!D7S''B@;J9-]4\-5\!
MJ97>3Y9[#4H8%&G2=\"!(&T2R=>!"PW,R>C2?DI[*7R=@SV"I;6KW5"%@'1O
MT>;&35EY_<K994UGE_?%L?+U%#FL2P['8UF(@"1)U"(:;!(D#!@9T F=N;*>
MLDB]28;R__D?E5;PU_4^>5P[>:KIY+'(TQSE::)*<%HG&HG.S9,4 LJ3/ EA
M$0E>" )4&!.7*$\;=>RU>V;Z_<9.(T>N=3O?=?95EWTR?)1R7E&?C!U_E3NV
MWCTCQ_1O?I#FY'!OYU/BCC3Q2'QP=)SO]:GU[O3\^-U[_.;W5J[L_39 6FWL
M-1*,Y(/]Z'*<M4 ^:(Z%<@"2?-O!5UT&2=E%J[^+8L)YI9Q'5)*8+!"JD2%*
M(>:P%U)C+3!>Y*G7'!"LG$RLRX9,8WRK.'<X:(((BSQWH*?))+8<,1,!HDM8
MI./27"QE5ZWIK@K.:>TD(.,2N %A#J6=19$G&G/C<2"Y!#;)IUT+._&JR<\P
ML2<?="273;E"F_+S_EN)"84@,))8800^"*2D8$@8"E&J0)WCBSFB>,2NFN9)
M+AMJM3:4<S1XFAL=*V,16,R0UIPB)[R3AA ?N-_:9@HW%1&/P+CL*%Z$IBV@
MMBE[\/W;M/21RVA1Q 'GD"6+%/<<R:@,D]$)@-E#EN:UJPJHK?Z&X@$'(%@G
M4$NL#:S@Z3>/$9,D,$TE988/08WK&8C;]+.PAADT#DS/G388:3:RJJP^L1=<
M.+?)J!V]2IN-=(^+D&[Y(9Q=E1.T>7.0*>[^(J??*:?C9VB<>L*QR1Y$E2QO
MYB5*)A-#2DGM/$MDU&3VT%1X"26;?FAYJE_]%7FJ7Y[&S]"XCT8S'Y'FUB"@
M3" K,$%&ZB"%DLX),92G22Z^KB=HB^^RF9XSSY@Y:UR8MD?M3L.9B_; G)5D
M_+K[:MY,]5]IIO<[N\-YOH,J!5#J Y0I'30UM=B)I*!I@@P$ G+O 4I0A$A$
MX$)1K+:V=>+!I$GT0M)YBY*NO8=FD;+%2ME$M1OAE+>:(Q9IHL%!4F3!"R0$
M34H;.VLCKJ1,R>4TS]D8U>W<Y?GE68X):'2KFN*N>W[1"Z>ATT^RW/CIK-OO
M_]QH=]++H;'9ZORGY?3)OI[_JCSR[MW9WZ]F_<^T GLAIL?UOX5.^F7P5WZ[
MV]GI#*_YJ]L?],*@W0NYXM9?9VD.6F%P&(_,IP)3]<'4E/Z;,O) 57 (9,P_
MK$YD(";KPN"$4IA$!G%K6S4YGR0"/Q<.L&(<H)^&FWXK(KK.(CH11"NC 6\D
M$AIK!#0HI+')02W>8AN<5\+GTCL$EE ,:U-8Q.Y00#)AZ(3!-5LP=RI/-0;=
MS"QN8FM'57HVFU LD$^<]I[>+D*"EB$NW:_]=<=\&4U_P9[ZL&=* U"BL \1
M>R2(R[67)4-&\X!LPB.LI94T!_"3)B6ZJ=F:%^-;.XG[3E]!D;@5D+AQ;>^C
M3?\3!C%CDK87E")+*$><!>H\,U[D>'S29%@V,2^]0>O0^+[]H>U#QV^X,E^&
M=^!VEO>N)[D 2%T TMJ;TA/4$<NEEB:9\)$B<!Z0@F@0%PD]L-!B&+W7!)!-
MR2=5=K'JYR52=9V_%Y&:LTA-6.# N.!:(<:X3W:W]4@YZ1%6F%BPS&AELT@Q
MJIM<T(6*U(_6A*P_2X7<978_6DF+H2:M?M<>&%;P+@A4'P)-Z2VJN=$D8H8"
MY#)4P06DI:M2D)(]0)UR)FU#V61<-06=,;#N1^I)MLE%]8M4SEDJQWE!K@IM
M(A@4A<O^>(*1Y3';ZMYYI3UETF:IY)(TL9PQ/*]T)GN\"FP]T$IGL^WY)2C^
M@W:GVTO <MUVHP!,?0 SI14I=]1+RQQBP8<$,)2BI"(""L0IHW $$<36-L&B
M2<ED:87B?%]AYWN1J(5(U(1[/4B%D^PDYJPD I.4M_91I@G&*C<8-R!LEBC5
ME#!IR"_;N;YQUOP*V^^KV;UX;@;\MS3=*EA5'U9-Z:QJ93""4T .)X0";"+2
MD3!$(@L*A+&4TFQ>@("F8BO8^+B(\E*L_B+*2Q?E<=JA#!%2)>9.8N+PH,$A
M$ZU!%N=B&YQSJEP692%U4Y$5]-_]:,3DK&UL^ZP]:(=AK_/I1*4N1*MC#N8#
M:/^J8\@;"-XU\; _;[?93L<7!^X\8?GO288%N3ZQ$\G\8\KE=E@>*48""C0&
M8P--S,HG:Y UN5!-I6;,A5P0Q2H@]*."4$T,LH#00D%HG!MJS[%FDB"P(=?.
M-2XW46.(&T^Y)IQ*BBL04J";@LWHYUT8.?RELB^NJQ>E']=/<&YZ)^T.&K9L
M?BJ2%(Q>R<\T;$+\2)_O;N@,+GM72<+&A$M_3;2@8G:GH6%<S@XUG=QMO-'I
M#D*_V1AT3T*5./JQ/3AMI-\:K?Q&3OC(?^QV.]6451FFS]L=TW'MQ!"K,M0Y
M%ZJ?LT62P97>;7=&5U1?4=6UE[_V&SN=SF6ZXD6X2 99(PGU\R1/#8+1_V;)
MJBZY"J;7")U\D^LJ4<-EO2T597KI\3O5V=9)KRI4D6\6\^7]T(@W#]:_>; G
M]RM*W5F3T;Q(FB;NHMNO4L6?]L(PK.S7CVT_.+W&HSM7C980WUYB;)J:R\'#
MEXQOI-%B;__;]G[9?O#Q:KUJ42>1U;$_>?#I)L5@AE'>_9GO62&M#)%AIZVG
MFD)N>F>M<HP'@B']"O@M55O7%YWV;MW4)P'97C#ODPF:C/^GYNRCN>IO_7+_
M:=.CC@8F6'K6\?7]XH(L8=[_;1;X=<.52PJPVS.5&.362EN-TUY6R__S]74A
M+(%1E5.6Q'<WJ_0DK/_^Q3R\M2<VSU?WRC<L0QUA+W\$<S8X=1FK7N1?KQI'
MO<O^H)%S2WH7>;Z"_^[]\D6BI;YNYU=/FN;=ATX_ >X]@+\#ZVEQ#B_"<(G[
MJ_'0ST?JXBCMM= X2)\_[3>>56JCJC=X3V<,BPYFY='XVL::615_791$Q39&
M+^3[/<T%2-KN$9MHY[Q[.=2K:;#=RW1[G]1T^.1"(B@W30$::<',>@WL5<=<
M^O8T$7CPL8>YI_?)7'K\,W/1#T^O?_G5M_L79^;J:;M3?6EUT:_W02,_\QB+
MJV!L^/8(X(5Z@H%F/!WY^D9?/(+_)Q74CC',T97RB5+JP;?Q$_+@>U^Z+8$G
M@/E\;BL?>]LI#L_K":^0?^9//C+N"C>&>V#B[N+6\6K<^Y->$A>/[F_JT5;)
M1OUTXC_Z0&^X/6_?CM4_7_+8NI /#<8WTW ?31>TT3UGAD7^1#X.%X_^>/'L
M6>/@L'7TQ\O&L];>L[U&I1EOBK ^>,0\WX5Z5"S=5 OK2]/YK2YP\:BYS)KC
M$=.U5@.BW[C^M>V4>V;X6I^/O @?0N<R/)PK.?.@'R$]]=UI(<"]\@&S+Q*$
MF[-1F8M'Q#/5XC!>6!C?0_[B^OS!JQB1**P"2P5W5G(0GBJC91 VJL!X!.??
M[E5G4@03]+C#J9'QTSGY,YA^J'X,2P2LAT/X<'?D$'YW_.GX\\G5\>M7</RN
M=7Y\]*+=>GW,#]/G\_<<?W[UZ7#OV:?L +YU"#^#@_/TN7?'GX]?YPKS?Z?O
M.H#6[\?9N7OZYOSXZLW>P=4!/;X:=P@?'YU<O?E]G[;>M4[3O:&UE\;U^21=
MO__I^/7S\S?O_O/^X//^Y_3?>' U<@:_Q)]:1R>D=;3_-FAJ&&B#M L$@0@:
MZ1P%I(+G:5-PE]9R:YM1:&+-EA+T6P!B=88R T!(,%$+IY@D$33QAK$0&5%<
M6RXTMA5 T&N H 4@5@,@KL8!PG.O@[(2,2,- JP%4M$%Q )/\&"U#8;F R/5
M!#5C5&#=47^%=]V7UNMPNP>8UP^;35$[=[F>Z"$>C4[M.B<O@@OM#]D[]EM(
M$!5VSLZZ']-;X7FWM]M+YM$@%T(L\%47?+5V)_D-B]1K[ 6B0F $CCND-0[(
MVZ"H-9I@Q;>VH4E)J3V^WOR@".&J".$$A]#$1B&B12XM+P*)$X? -&=$:6$]
MQL8RE<N,+;VHWX(8Q/?=?+F?W!1R=.\;TUT<:G]"I^EQ0N=I$? O"7@;?QP7
M<, ,"R8%$@9ROSO(58.I1CX2XEU@/E!7IKS6*7<"#!>4(0],(/!:(TN41=$K
M8J( 1CUL;5?5M!O=:]/Y!D;O_^='YR*U&P2C8XOGO>YYCKC)C_"Z/3C=O>P/
M$C?I/?LTRIG:Z?=#^I]?F[KF:R(MDV: D)@E<$*:9&E11"%%!>3*:L1Y&KCR
M*IL!8M9TJ&(&K)@94$1ON:(W0?ZEIIY \"A1_7S"H",R8 FRCECAL#<J5Q.C
M39!+J"^\[,/Y+\3(/WB\7)*;%Z2^BU>@/F"8<O0(Q EA,2 6B,PZV2 ;+$/&
M:D:M=<YHLK7-&&UJ.B,TE'H#2Q;)>:GU(I)UBN2$KJ9<D>"41YXGRQ*4R.U_
M(2)J($I*@Z$X%RP"VE2S]NI<M$BNG[]KWK%TSSY=Y!2$Q\32?4.H:8F&>R2*
M)CB^2,]R-<4K\Z,;@[43N;UV+[C!;K<_Z!_&*F3$[W1\CD<,_GH=#GLY\?@B
M9^$4Y5*7<CE\.<4'X\ 1!02YZ#1*F\4BK3U#$H@.T7J+>6[O1&D3+Z.YW(\L
M>+73M2)XRQ.\"587N  #E"-)G4! ,48Z<HL$XY03:B..?FN;5[7=?@@7S-IP
MA=]#)^3L^YQ::?QYN]/N#WI5VGSA#//B#*,Y3W"U<V_&1_2Y0%5MT:9'4QI*
MB8!]%!$25MD<*J(Y4L1KE!;9"JJQ=U%F"[2IV9+=Q3^:H-7.$8J@+5+0Q@L!
M4>?2$N& 8LSMG7%,,D9S@6IIF=4^4AW2YB2DB=F,O20**9@O*=AQB38/2^)4
MQ.#BLM>_; _2F/J##6\JN4Q><&?:*[NF0-!,$#2ESY0-CNLJJR0"(+!&) C"
M#!D5F:3 -==J:YLJ613]6BOZ2<DIFKU&L1K7[,Y3$6/T* !.8J6T0D82G<Q]
MDQ8R4&:]'39U7DY"9U'L#\CH0>B=Y"(IN3)>\$6?ST>?G_:>#B?ZQ7">"R35
M#$E36DM1$M.J!8T(#@J!RTH^Z15$?%I&IB,AHLK"4LOH,?\C2U5MNKY(U?RE
M:D+1@_78)T4OG(U)T2N&; P<>254$ &3P-G6MF@FZ2J*?I44_5ZXZ"4A,#<F
MO#G/S5,^5R\4C3^W:( [TYZ]CG<FO2!5?4@UI;E4<#+B:"A*B 2YIWUN+5D%
MEV'#O0<*51$)!4V02RXB\:-)6?U'_T7*%B1E$RY]([F@D2&MF$E2QCG2(E#D
M.3@7A>"!R:UM#DT,2^[?6O*LR]!*@LSZ,:EDY=V4X;H.)T[\-1M[W?A[M^O[
M+[MGOL!\?3!_/$FF#!&@E6>(<(T3S N#C* <4<!*<PP.0.:2?:+)]8R&7\F;
MV92\F2*I2Y#4<4(F@\=I,352ED0$C"IDG2/(@0LA8!VBSQW?J&YJ,6/$<TFG
M678ZS;"TQK"T7N.G,)2QGTMRS7(#9DV[DWM>]1-P53U5>B$W?J^Z5#4NAH'G
M[2^D0/UHUG_]T;-I ?JYHEKH'W9>YE4XC/N=#VD%<IQ_[M+SK%J,HGGJTSPG
MDQPQQK2..&C$P%@$G%MD$U] P5 BM1=>YK*'I(EQ":Y9;W=;$;BE"-PXU8M)
MSJCB#.&JN:]D!&D5DF6FL8X,4V(5V]H&:,I9&_L6)C=?RG!3)7E$X3:;&_RT
M"G622X1_[9#T?I(#8.R=8)$@;Y5! )HC$Q1!V!FF@M.Y5>36MF!-R2?/W"8,
MF:+_ZQ&JN=4]+D(U#Z$:U_.<8!-M;H<@.$[$.@)2QFE$C<):6Q\"&_;/%F+R
MC&U10E54_'WYS/0X>P72\Z7GO6SW3S,WSNX!'^Q@LQ7^RC@#GMV;_,.XEZ;^
M/EC%]J?@T>?0ZQ:<F@6GWDW)HW48@E0R6?PA&26 A42&1H^(=#'$0(!2OK5=
M-8VGOQ87P+I1@'X:>/KM.P6NL(/OE+IQ=@ @A*):HH@A4>Y<:U@KSY%E3K.T
MZMP9G=UN0)?'N$N R@_#>_;/+TR[=\UUIA^%5/''KFJ$TCC+/"G9$J'W8=//
M2);K![E9E\-8/+3SP.8I.4C,TPC>&,2%JGI44*2C]B@8T$(9'@6%K6V6P9D6
M=\CZ'(<\0(4>DK$B1K.)T420,:4F<.X1XX0C$$PA;6QN]<)BL%HEF$P49]:"
MS6M*<M:&">1*>X.KH8*/O>YYDLDDAU7(4)5K_*[;3B3A0Y*6RUY1_;6J_H?P
MJ0H<RK9:;E4Q7)^#,#CM^MO3VU)C9#:XFI)YY$ XR8E"C"I D)'*&$Z1L@FZ
M'(D2$[*U+=5D^%U1^6OG_B@R-1>9FHAUP!S[2#WB(>26T""0!J(1]0"$:F]5
M#BYB,,D!-LS'L3;J_R;&(1O[W:F!J\U&)Y2CD+F9_%6T<*O;N2GZ/L2JFT/;
M@DDS8-+?4P(>O?$,QX@\$;GHD:#(,@N(0H"0#!0O<_P5AQ+NN"G*ODA4O1(U
MKN6]9UPDC8Z21A<((G6).4>%J 6+78@:L[01U<9'.91TU#6RJK^ !\6Y7A=8
MO)JB?C'UPJND=*F*""!W>#>.(RR!D6")EIIN;6MHPI2$@X< HV2C;DHV:A'/
MQ8KGA-.>^02N/"!IL$/@N,OMCY.,)KQE().]+OS6-M5-JF>L";JA>:BK%Y-0
MAE:&ME(/7(;V0P_M0>"GD/\=!_Y5SN1OA4'CIWPT^O.U5W1693=ES%-I81TC
MGP\K_%<=0UX3!KP:IFH:3FP/\F%5(;^UD=_/TXI/6^F\51I%9WRR32U'RFJ,
ML*$A&38AK61V9*DFENK[;=/I\/>MO+< SR8!SS)-[P(W<X*;<5M;Y_P:KPUB
M*D0$D3&D961(19T6SWO*C-K:!MJD=,;#J 5A3CE%?T!\,T^L(NC,8-!KV\N!
ML6>A,>@VTF!1EMY>]RQ==9)8Y/"X?<,#Z5:"1J5%N0W[V;FS,$?=5K=S9U6N
M8R *PLV$<%-BZABAPCBL4)0@$'@(2 .C2#L'GG'I061G/U]R>Z'OE3';'0RZ
MY\L FJ6ZZ&>7IY+#6X^<392/))@*9BB2AB4FP4- 5@2.L*5:!$^B4'*A.;PW
M$E&<3G-P.HVSBO3B>2YE..BZ]Z?=LS3P"3Y1S,--,@]7PR]U3P$46[$^A)\2
MM8B)XU1&CI00)C$IH=-OVB,06GK'/2.@M[:5;)(I"57%-56P9R-<4P5QYH<X
MXYPR+1=PRS7RFDH$U!)D?&+L6IE(04JL%2W>J94^F"U#NQW:]4>NL8Q6(;B+
MK+M>2K3/J&E^,_VV:P33ZZ3'[3<N0N_&TCDUO0?/WFOG$0MSDSY$(^JC":N1
M^?%7Z+W,*UBOI4(?-%2>C;;0]?=6&^N&(>#"$![!$*:4CI>1"$B+@#B+--DD
M.B#K.44!<ZND%52JN+6=5/RD>W?.F1\%"59G*-\ !-]I-] B_W.1_XD:=E$K
MS!5'@>?6$=%RI+V+2#,KH]*!FC"4_\E@F4TL\;)ZU+<,;8/8\%[[[#(7X"E\
M>!VUX$KSX='6*AIQ!HW8VGLVI>$FQHFT2()( (E 0U*&N<H M02[Q(F%Q[PP
MXA\="U:0$1<$^$8$F.#$V(K@<A"&4HD3,YZ[/D265L5IAH477*L-Y,3%N[IV
M?/)U]4<BE"8]DCD)][ADO]&]'/0'II/'TD -FRWF'S1&=3@A\R[[=+T<.\/5
M:%V>V] [C!4Z]P]O%V/DNRA'GW6!^)2P5>,\<^ 8\L(D) ]1(!MM0(H$$W0D
M(>#<-UVJIH(9NS&O6NCJ&HI>[5$%1?26)WH3%2,]P[Q*AX%D/(%7'"FM">("
M>)!*6ZK3;B6@FEHL.6J\$(KO(!1^:' 42K%X2C&R]2;@K2!;?<@VK>YDL@M-
MQ")9AB$@B)P@G?06TESE_&)OE5"%5&PZJ2C"MQ#AFVC&F8B#U5P@+'*3.V &
M:2,#2FML54QO.FDSK=!-S"?K5*XOK?BERA%)__7M#]O_3C^NKS@WO9-V!PWS
M=)Z*)%&C5W)4YM"#,ARM[?VR?3/RF>ZB;^[R" C8K1I*7"69'Q-W_35AARSL
M1Z>A85PB'.G;KC+#Z'0'H=]L#+HGH2IB_;$].&VDWQJM_$9.FLE_[-[M;/&\
MW3$=US9GC9>Y 4Q5 CYGW)Q=^O1NNS.ZHOJ**I5*_MIO['0ZE^F*%^&BVQOD
MSJ'/DQ@W"$;_FP6ZNN0JF%XC=/)-]H(+&0>&&XJ19B.#2;.13^_2-.5LX)->
MNMV%Z56-N-+E_="(-P_6OWFP)P^NR6A>)$T3=]'MM_,.?MH+9V:00/;7CVT_
M.+U&R#M7C980WUYB;)J:A%4/7C*^Q1^W96J]:E'\EN:QTQG$8(91WOV9[UD!
MO$S A)VVGFH*D>0&W,HQ'@B&]"O@MTG]7%]TVKN%HI. ;"^8]\C$0>@]-6<?
MS55_ZY?[3YL>=30PP=*SCJ_O%Q=D"?/^;[/ KQNN7-*[W5Q[,HE!!:F-TUYF
M"?_S]74A+(%1E9>7Q'<W,XQ.3NXW,V#H5_?*-RS#=Q*J:AW^".9L<.HR5N4V
M68.KQE'OLC]HY(R,WD6>KSOVW+<^Z!=35-37,R:K)TWS[G.M4'\?X._ >K4X
MYQ>]<)H^EW"Q,4PK68W'?SY2'$=IUX7&0?K\:;_QK%(@!Z;G3N]I#U9U:LAJ
MI/&U+79?M=<B5*+*WQB]D._WM#U(L.<>L9UVSKN70PV;!MN]3+?W_?4:P:N.
MN?3M:;O^P<<>INS>SX-)CW]F+OKAZ?4OOU[3N7:G^M+JHE_OXT1^YC%*62'7
M\.T1IFOV1+(*0D?NI=$7CQ#_2?76&)T=OB?%$Z;D@V_C)^3!][YT6Y(NY&(^
MMWWTTR[+@??@R:2XS5HW[OU)+\F%1_<W]6BK9(??].JYHP_TAMOS]NU8_?.E
M='<7<GF&64I:C.XY,_[Q)_)Q 'CTQXMGSQH'AZVC/UXVGK7VGNU5NG"(>Q4$
M-A+Z/>@[G.]J/<HS.W.9D&\M(B >-:%93SQBNM9J0/0;UW\^)2:^6L]ZO2I,
M/"9S\QN*W:]Y!O=71KPF"=RK43QBS:H,?CYX.7)]GA^SUKOWGXX_'W\Z?M=J
M'^;/')VV6Z___GCX^L7[@R.7[G.,#]+_;UR?[TYHTF*0/L,/7_]-*G?IT0X<
M_OZ*O]E[?GK\V5VU]K+[M'4Z[OH\W$OW.CHA;_;>I\_^<]KZ?9\<[)W FZ.S
M]P>OG[]K?=['Z7GX,7T>;]R>+_&G5KJF=;2_@)JF<ROE7T!G<T"G%#3=.*BY
M&H>:!=4SW9C6(6L3V5$UT,OA''<<9@\0Q<T(XEV]++8RM)GEJ8(!.?0YK*QH
MW?3;S>[S1O^CN7BX%/!:B]2TQ2%TZ'Q=V=5Y$=R9Z??;,3U-15N,?W<YZ@Y>
MG>_^=&+:G60V9^,YW#\M[B2C^KIU\G69Y\9U#^7-CGM;L(4YI=OKO<.=VY)A
MNZ9_^ORL^_&/X$_"[VGI\HOCB[R3CTZ/S*="%NLBBZVK2;L4)/$!YU:QT1@$
M+$BD- #R4G(,..#H$UE,7%'!TOK&;H0PKDX+YB*4*R:4$Q9<](QR@@.BUBL$
MRF-D*#@4)0O:61UHT%O;I(F5V* @N0TC+3_]69&1GQL5-VF87KN?(^+\92__
M)P<67*0[=WV.5FO/0#\W @UGH29$ #&*1L\9@*)21YGTE";:LX"59=_N_)X9
M#G\+"?9" <5Y@^+A[B13B5P04-HB1I5#$" @(PQ&EEH5.5CF*=_:5DT.R^MP
MOQ&R.8MH0@B@.?4^D44:B%8\$H,Y>*(YMGQF'W&1R-65R F:8B25/ !'CL<D
MD8K9W)^:(9]^8.*MDL9M;?,FX?J'H"FKYZE;7#C.+?)]J<'XUT\)5Q(6Z>J<
MUW\)(%MA<!@+ZM5YO':T,YE!"$( T)C 3BF&@ 2)=**E""O*)3:)GO@$>P0W
M51T](.9QL+;YPKK,<^XBH@L7T8F6GL"4H)(@QDQB)LDD0,: 0XFL4"<2-#.,
MM[9%D\*DA'Y;SX0U/O_^TIC6+(+R?C+)EV,I9T3#]07$%8HVG(**UXBX7YW9
MI=G]J]NK3+B9.QD6%/T>%)U21E-X:9(9%U 4B>V D)GR,(P8:$ML]-01L[6M
M55/CQQ?2G!%M%L1UUERZETEWBDROLDR/,Z/ P46#.=*.>01:191W  I>,Z>-
M=%KZK6U039"T/FJTQNQHVF.+%3]Z^C/T^T_' @5+'_1O@LNE<*&"DXO%R?TI
M+=.3O2AHP$A)D;B/]AZI:),%21E73@BEN1H>P4_&Q90B41O"7S:AF_KZB. X
M5<&"6VTX1EY&/*Q!J8T#9#T66%J7N]LLM)OZTKG(+-ZG=773S*&I^H^0GO;%
M\:Y)<MK*^Z@*YZH/\*?4^^91&I!&(*PY02 P189HBBP)%A2G7A.^M:UE4Y')
M@()E'JP5 -H, %I1&EI@IU;8&>>91A.G B4HZX_LYM;#_HF,8<P58\[R.;C$
M5ML?]OB"I0NK+?K5NFH/%%&%4O^TU#_=H/JG; 8YF'_]4RCU3^?Q=6M2_W3L
MXMGQMM1%?:@NZK/_7K8'5ZOQP-]8"76]RHA.*X3:;(1/+B1REIO\#KO[IK4R
M\X2CN11"773%TX3B3S#^II*G-$V ?/CM;ZU-RI\(6G\A5?4$2ZC]KOJ)QKKV
MN\HG@O YS(!B:DWN*I^P^<PK?=Q^_1%+GNY6[ON*0[S,+OR-*G^ZDQXTLS-S
M5@WP+]/V:'\XV%USD7%[LX;KW.7YY5E%I/(8JT#WX6CO.J^J5_9')5=RT/O#
M95;6<19VAW.03ZZJD>:JK?LS5^%:IW%6P]QK?V@GUNIGJ8NT^H,\Z@Y&POOR
MS@'CR*U2O3[&PS=AT*VQJ*_]KT9]K>,H;Y=VRA+^,#6E?S-GIN/RL?J-UZ]Q
M[? KU:6_8<2;=Y1E)'>.J6!X<&"\4AS37#!4>"\85^SM?MXLA'[M!.LN@@Y%
M;G/COULW'?AR=[W]JS=[[N.;=_N?\_U:>P=P\/H5/J;/TS.TWAV\.V 'K_?A
M]K#K/7YSOO_IX)W#AWO_O&OM_4U:[_YS>OCZG_-T_57K_,WY\='[JX/S@XD.
M?(='+])GGEVU/O\-K=<'N+7WBAZ</^-O7K]IM_;VZ9OS-Z?IV:^./_\GWIRO
MWTG9QY@1[H1&*CJ!(-J(- 2!O+'&R1!LS+5A65/A&2L+E5+4!:'FAE#*8D,4
M]Y)I!E4U("FMD\(8B@&\+0BUM@@U450$J(T::X*B4SGJDWFDF!>(.B_ 1*(4
MA:UMW>1*-@5;R0+6<T2I6>GT&J/4:@QU!I2*()15S@!G'FPDFBD=!'%>*YQ^
MH06EUA:E/H^CE+.:$0L222(I NX"TMX(Y%B4V/B@!&6Y;"J9M8?X7!#J1I0*
M0OW0"&4MQ9AZY817$,$;GHP![*WF##,%OB#4VB(4GN@"0K43G.?,WJ@0)),>
M*2,%LC0ZC*-+V\#D!#:&91/S[RF#4E"JH%2]N1V!>R--4%0R<,F^8RHHPBUW
M3)# ^,,P]4!*1\&KE<,K,HY7/IAL^$7D(I4(G)1(I;E%U#NAJ5(\<I(]4XPF
MVT],!F(OM$=:@:H-AJI93#Y,8K3!:&4<2!RLHLD*B)Y3%P53HA"JM04H.E'M
MUL7@6 B("&T0D$2M3 23?F#G3""2!+NU+9M<DB:6J^ ^+RA54"JC%#7>\A@2
MH2("$D!98"$29M.-N!,%I=88I=@X2G%'F?%&(6]S,ANGV>(3 6DIDXD?@@"+
M<W%:U93P/=EL!:,*1M6)420JH%2!5": 45P;;(4.S%!M0U"F8-3:8A1,],+F
MX(0(!-D &H%2%AF<[#VNA><,8R5R74G9%%(W%9ELA[ULE-J4?K+[_?YE%1S6
MC??*K#2KIHGIQ?;U!UQWXVO"C>H(E=I=\R2BVF/F-:=,1- BP;URH!/  Z,
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M?2Q&%R!8I!QG"+3R2!,1D0X*QUQ]U&J:Y&VQ'HD?6MAJ#U\LFF\5)7$RY=F
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MJ"3B+!E^@(-%)D:*7  3!+-4Y,I]!(MD!$XF[!2<*CBU/%<5)<)&$6, !S*
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ME.KKWR=,'JC",?)@P8(,40=J#4AMJ',<<SLO82H:OD9)&W>4"(.Q9E0B;:Q
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M5@0AR<R4(8TAM@>Y$U-1[O4I]_>3Q389M5%KC5$4)")@1"";%@@9S[FL?,>
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MW=ZC.MI9Q "%*+RA@B!;I([)/H!?015X&-@&HX6,F($Z8DD?-=ERS\['G\,
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M!$?*2(8B-M3!>DF:"&]DL8[58H'=8\0O&[6P.H_RE.>VC5IX2+70F5,+G(=
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M(8SO6=VDCGS5=^PD15>Z0<=689 9HY+^S$:'UA<HPVU4VR3"=N-O /K]%L#
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M:!(EBD*0X!RCMG&*'E.][[V:/21ZC5,C*N89=2;%C$T14_Z<0-8;AYRF$LN
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MVBS56H^?[B8\8X\L,G/Q5T)OVE;L8DSY>PZV5N1*SU-7'7>\[X852X5;;]D
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MF>KY>%E#A;<*5'BZH<)KJ/#NGPKO!M1V*V%LEH_^>@AP$3*(H*60@45K"U[
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MY.T?/U1U@YAUQ>6S.FVI$3)%(V0.(9!%U"M.:\8Y2[R3,[79^OAY^\-.#1C
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MN%Z)Z()-5RNYI6NY$+&:"6+_D,&DW1X,5PE3"Y-/V]\L(*J JOW#B]VM&CO
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MQH[ME1+JSY#.7PU=J??ZR #U:9+>.ZXQ42XB, , * +_6.XE"M(8P4@@+!
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MQ0J0,:3*EE'C7H+*2CW*$VJ#E<.^.H_R+-8ORUCRM+'D9EYW>:!Q<%I;CAA
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M?3(8L#^N;5P!Q\"T-BIY_+KK5\ !'O?J?-K]7@%:W3P+L5OY[\</L&+6B5V
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MG" "D$D82B0/-GH1G7(\]8L[5P*42FXZ$RA-+B-*8R$=<4A!;HBX2!9!.N(
MF:)P.DAJ&84DD9 J,9,3A$L'I643U]G5 >;:F/P,=J2OFJC _E&C6SFWW0K<
M33X@VZ=M3FQGK<2?D/OFY=,;E+S2B:> -;EE$GQD*[>")."/RQV0;O;!9 HS
MDG2$ ,\5#D8EP%JBF([:*QKOF6/;J;\;J<,8!;]B9K-[U#C]&#MYDU_1\F6
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M#3&_E&!=&IY/:=M,O4O848^DSA-DE@GD4L*(,L*C!C!W+*QM*%$NC#YY/K(
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MC=QJ82QVTD2 5.-BU/TU(4"W,M ]&:9].M">$!JQ13 P$?%H(S(V"N2M4P;
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MQ5MPQ0/"@-M*L?D='C9V/-R2/8S_G[TO;6HK6;;]*PK>O>^>$Z&B:Q[<)XC
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M]_CXT:,=4=_\+K13U(B$#%% R@R)R-"8D, I1*NT!\P"6X5/TK'KN;?]3A;
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M<N;N75,8@]<,[IE4(-PRH;G 7BDFDP%D4KJ<POE,8?W@.XU$VZ0#8D+DR#5
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M6!A"G5_;T%6!1:GE5U4$YQG"7XK@$XO@A'['5F%B:$ I^5SL6#GD$I:YAI?
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M+/$&N O6P7CAC"*!L2A\%*HTP!<JN_<&J'3$_K<OE_L?8*2V=BZR ;[[X8N
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M*_DZI,EP131+Q'FN.6;6<.NEQ3&7WG"&X=)L6KHTC9M-"69(!ZD1328@CF-
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M=IM^\#[#://DS!8R]3QG]C]CW1@ LHN6>X:C=YYPG8P+-@C/<=2:>6GI0(/
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MCP ;<$Y&>!NC4=P*GVC! 6Y+D"XYP//@ -=\ *K4_R,_)<:!V,!EXIS'X)T
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MP7[1&@,\"P:XFV[5&.!IU@"&.L2(%<XD@X0+ *8IR6UN@D&&1ZQIU)Y$G]<
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M!9U+]J1S7!SUNC_;_<J(P-G%Z5X;+C?2-2-?J!.RH(2LW;U2FHKAZ9/W[3J
M#"7HZ!?M5$EF+Q[9L_S(PZXKY;TZ9S#TU0%M^-O!A!S&/IS5S^U 8B?VRCER
M9^4IG5@^7SB)$VT]JFM</-)A^>OH)2>%\ODG=;6?!V-*&Y/E\O&3;?>*G[D)
M5#YLM,M9.8F'\?BB&_!9,6P=DC6V<U)V-X$1[)V,:KX[R;I[\3-,K W[)_WC
M<EK *A=@4(YBK[3/AQZ\&>C)6",5T/I1X;.#@9_''1%*I$LRI<@]5Y$[Q;50
MF-NH'274W^2.]GHC?;+ H:SF#IG_#%Y_=1>>#F3OLH%6[6^F^1LXCC=/=SBV
M.GF3D&0T9OH>B2Q1%&G&HP]<4)[(TCNU,MGHZHJ_62EN$.6A(=D#KW+8/<[2
M6K;H*VU+)PM8#T#-=:*6<=#IX&P0_]R<I;)YI1@/CQMO_#&U5T\YT2HFAKUQ
M@9K\DMHXIST3D6 .'SG>47CI^LXH1-^A-<JUGDW?O&A?-4?I@@?7*\5 Z9HG
M!W A_P")!5?Q'DS:0;LT#OW5PW#A)SWXDLLF6BVXXQ^=KO_QO K$&N^'"K1U
MNG70[&RW.GN-CW#-\T]TZ^!#>[.UCK?HQBDHTZ]&:Y5L?]SX-:Y V_M_M+?H
MM\[F]_73K=8J T5I@]*)1NOS_M;^*BC3.MSSVP]0PM38WV*;JSL08)B$ X04
M-&3B0Y]99[A$@*\Q)LX"UI[HH"6#8\P*D9B)/"5AB;1)1@' W 5L]!+$JMX>
MP4P<@_T&U'(Y#Z4:7)F)H6(.A& L*)_:>^;&^S]D+Z#'@G)_@Y7OY,5#'V-V
M9PL.V@#1+%?@^KA]4,$7^.\RF+*?W<[/"E"!'Q_ IL*"ZZT:E)7FL]N#5[2]
M$HCU^B4<<"=P0,8UQ=6[E ;2GMJJO5W^#K!ZZ>^[O;*)&EC80[C?R,UR> E/
MDL#^]JN'L;LVMTP=-=W+Q6D) O<L #Q;Y)647AMFP(:\E'O9U^UP]*2R-D']
M7D+/<KFK-.\)W@5D%TX>@I;E?&L ;J43Z1YEU%>"1WCDBRYQ"QQ6K,6?L=,]
M*F%45M#/,8Q\LYJ7#0"B+:" KEWVUTOM'DSX_YY K  0&Z9ATGFGD[)3R3Q8
M[[[I;:.@#\Q>[N);WG,XIN7V]8>34L"KEX$'_@?&HAM>!.Y[>K=UOB$VU[Z>
M-]< 7[8VSAN?=E1N71NC0XQ+@S@3"AEI/8*OB752F4@S5X!<F4SCN+KH<-P%
MLQ-*D0EC&M&[HA$@71!S'L4R+'U(R,86&[*91X=L7XX!B>UU.Q L]M?_]P0T
M)-]X =':,-S9_W2^O;:%FQ^_@NAFT?S$053;6^>?X;Z>;*^MGVU__&M_^^#;
MWKC8-]>:/YK[G_!VZX^]QOX/"'=V3YO?_]IO?OSK1_/\VX]&ZZ\?H%('V]\_
MI"8\S^:G'6\=R)#W"&)0#*(>''(Z$*2T8!:GX&)@$VC-2&%XKEHR'&;%&$54
M7DXEWDDOK1Q':Z-3\-]%-0EW 6DWWO;J8YJ,WES$H!>4"XBEJ?<XF,22)%9B
M]R) 74:Z, #E$%:V9?+?B;%[3'7R>S&<=.)FJIZL?+#-RP:RGR%V_=#M9;-7
M-M=\P^I%FKL[7F9%X@)YFUG@/95(8^N0QQ3[I$B,@HRKRV( H8RA$TQF][3$
M0V7GS7)9-,2\==.+(%F^W6E7"CI8P701GO:P6DH+Q0!E]_< >I<XUE?"W,\R
M<Z7K<.KVYFUI7!Y^&@&<7SU^+?IXX&+ORBGTMSOOS([N^.:5P78Z>_).I$JM
M&$WNTHE4B!6F;M?6<JYNF69%ZX>_;&X9*N9JPGGGAINWHG)9L,YAK3\_KZ\7
MC<UFZ\\OQ7IS;7VM:*Q^?O]G,52,6W12>T%O^WW][V]CK[NV_GZ]\<?ZY^$;
MO\E&:G_83MZ+6!ZQMCE\*$.\VY?AWYG>_076!%<>:"P0MTIXSW2T(GIN@]8"
M4Z,2DR%()C0K-UTHH5?C[XWFAVF+P@,@]*6\T0@<NEW(C5\F.*J2UPZ^XKS-
MTMC?H,W]KV2K]8G#-423?MB#YQ*-M8US $-GC8^?SL>3U[9S.$ZWSAKP;[/U
M;:^YM@< ZP?;^OZATVC].&WL-PA<]W1[K9D:4ZK$F$K:)H!3F<T<\605LIX#
MNI*&,TJM)<(OO6,:+PMMEK693+==@-9@M8K.5%% R#0HJQ-VB0?L-56,I<"B
M<,QX3TL5);6*+HZ*3I1$@0YB+!U'C@J".%A4!+:600#D"'/.8T]S?JG RURH
MJ3U1GEM%7PL3X$:_?U+F,(P%8K> #&_&X,BHX#0;L#:6TQBUED)X'H*/+ :6
M;EB<GV)Y2IN3AWZ8^U<MQ5=6J!E/RY_ZM0UZ,!LTI7>H=%;F+A%(*!PRCY]"
M6DF!<'!6>$H$911@PC)ALY(Z:F:>1W/QE$1)),71N$S>9P)V00O.,Z4?P^-U
M)[?P];7&/;G&37A]+R(AG"G$) =@#G <V2@D(D0(EQ)S-.&E=Y2:94GT,L-S
M O/:K5^J6[-[B'[&,G>L5##D;#_G*^05^/YRF1()#C_GQ.[%3A@NQM9._]F<
M_F>8K%[;PX25AZWFB6K&X\WTH=M+L5VF6]?6Z<&LTY3>09QC4U+Z.I\[!GDB
MD+&1P>Q"5!D#5@ZS;)W8,L>3=3 U(GA5B*!6QR=6QPFP$"R6,G"*++4.@<IA
MI!W1R 9O9+ :&ZV6W@G"EXEXANX<B\/3]]C,)Q<;"_$PW'U+X4F(?1>@AGZJ
M\2)!,&8PR>V>N0$_ V_.(F;"!!XHX],K.>H5RV<R1]-8_Q5VQ%-ED536(@ZN
M!VDF,_6_I"HR0K&VU::")G*9TUDY@ O"YU1K:;WU]_*U= (TD 0F%6PJTEQE
MJFT':%X1@Y0T@L)T$NS50VW]/0DWQ46J[VA2Y )E]*\>H]9>1 W;^Q&/!TF<
MQ69*L<R7!T7>[=F#X6@^6(K:G ]9W"W-:ZZ$SP>L@,FU?[$:R=#.88@[J6I=
MQHJ9?UH 8B?]H@\F(Y<Z7_X")N<H%YD,BG_M,8+_H(-JDOZ5BTTH_GVUU2@_
MD=__#;!N,&-'U8Q-I.65E\W,"L.RT>%=#W+I=#[\Y"C?;J[ZUONBHKW>;Y7$
M#05N(&^K/VV[DQ4(@K7A_M8+J7)XZGS4M4]D1UEGC&0>81\DXL(09!5S2#))
M%%;>I !&4PD\I;JUN"ALO:ZRM9:*%R856Z<[3E(6 *<AZ1D 7L$4LB9@B+\Y
MTY89RWFX22K $!W8=JZBL\/!+Y-ZV\--YXI'H7O2*_Q)KU<6@;4:$]9H#DJ"
MY[+?(P5BM\M6OEHQ%@!$Y'K$?NQTREK$879TKRCII#(U0;?\(559]*7Y'?4(
M)8$)G#PCK1H>JGNRNU<24-QBB*<7%\TWZ#=P7PV&3U$X?UC>^%M9V Z1P"##
M>8#B1\X:W!1?GF(=8+"3X]FGC,.OVSW>@Y[U5%L_988L,7.HRQRO.?KO7N]R
M+6TWHDPR\ /93,WWF^V<VK/^TG^NWACN.GA("1(R,5?7#NXSC&%9I)*5*)>0
M9_VZ:4CO6B#T ,_:W&RM?RE:FT7KS_7B_69S;;WY97TM?_JR^??&VFH+_OBP
MT5QMOM]8_;OXTH(O&NO-UI?ETN_.3_<R6S:FUF?=6&\U5I_%0"JTA& M4<.3
M<(YHC1/76&N?6<IFUF>I!:W/*M;:N3SF,"QBY?U]_=:0YBC7WAS9=KCJ=<+P
MS<$]Y:&#.UT+!?^)O7+!Y&&+HZ]?H;F8G>'-,V/;/_ J+WTQYN[P;__KKQUE
M*)&2,60)CXAKZY##\"E@@9W"UJ<H,\$:F^RTD7<(*AP"4<'F(4C164&OEYYA
M/7WG;+H #?D=+L/-N\B19Y2KQ%F,T7&9J!41#(VASE'LN:VV]"DAF*+AAWO(
MT=K@[=ZN')U_%3LPK($+*9&+/"$.EAQ9EA3B1%'#J&7.\QOE"$S+6>61#XN_
M3@[C4)Q*U#M21IP%(Y<@ C[N5G)'9'7DXG)BK-M>+M;I%R WQ=!OY)=>0&\Q
MNDIUTB\98G.Y91>55);%03S>ZX9!['%TDKEWRDRC.'S%/*%#_2[CE"ND+/^=
M.5FN25LJLB1D@A30LVPU2KH^WSZRY8WZ$4+(=LG?=W32R_'EQ?K7^!.N%,]3
M&SV<ZJ&%^,/VVW[U,*RU<P#SYBNC1?/3C@HPOC0R))G%B%-"D:%,HL18PHY1
MS[1].971_0CA-D3LQQ5+9*45%Z71+D]_B9Q")0"S%>4NI=#9A=UQY611"ISY
MBB3J+@7.DJ]PQ1Z^P%FN$/)(E^6WO>R4;)/A@(,5NZ%[S[0C[ULT+2_WDJW_
ML=L#B!;0546[;4.<BA>>7/Z<RO^[+EVFXEN?IT!Y<,VYG;P8<?)WKLB^13'V
M/>;HENE$UXW.W18K9#FI-P"@Z9OT:]EL]/H5Q.^>P.5SAG+\Y2.(P24$#/;8
MOJI*]E=7FC]1>?\,QNKE5?-/3[K[7OY1;IS$GMV-5V'S*$O*+4;\EH-R"U:,
MA[O2D[BL!9KFZ;;O :;Y#>:"WW,]$(]':,-96*TF 0)!%WN;J<K=JC+$RU#M
M#>1N[?\XW_K^[0><Q[?VF_MPW5_-@T]\^^.'O09$;IO?/W>V6]_VM_9__!K/
MW=IL-?>VOW^&B&^OW: ->(=UNKVV]V/K>^Y!E/L6?>LTOS?;FZT/4^LO=%34
MY UG*[A&7*2R_H(CAH5+$3MO%*URMY21RTK-61->UV#<6^_NV<2VUKM%T+LI
M[6D--EX%Y+SGB$?E,A=#0LY$*C#S0F%2<3%HQI>UUL^K=S6$N+[2L_^ZD<+L
MEJO/#Q7&BL9JL_509FM:0897UNH4'=+EQA(7#ADO$\HM=J/Q%NR6S2T*C9#+
M3$R"A5DM56N<<'^M>U*@4&O=XVG=!%A@H%V6N(!PT@%Q$C$RP5,D20P\!DLH
M,UGKM(+_B4FH\%1:]QS+32^[S//V2Q$%JK:NZA+0104B(_5F=0#UL#9Q&M\D
M)B: DT.21T BB4ADM<%(8<DB22PQ"<+*E%[6'"]S.B>=5%T:^OS:^Z2 IM;>
M1]3>241CK,&!)@0S&Q&7.=%1:(LL4TY:0FBR#A -U\M&LF4\+QG<4VOO P.?
ML6H-0LM]G0=C5W_80^L%H4<#<B\X=JUQVENT]%,VF##(AXI$ $ZCF? 38V2C
MQ4@3FVCB5-JD[X'3ZH6C&F;5RC=0ODDZ+ZIRT;!'#'N,.*$2&:8$8HY8[;'U
MGO-[P*P%AU&/<_'G/?+MOMJ+@8)E80%8]8NFLZF(!T>=[EF,@P*KHY.>W[/]
M6, 8'-8X\.%QX%[OMXU#WRNK]&UG4"]6WG#UN*)V*:L^NL.I6B]G:C.M#^:I
MW-/X9S!+_\ D7753J?TK!G0>>]W:0\V3!]%:/;YH'=/ZRINMKV<[SD@JM8Z(
M4<H0%]$BC1U#*AI."4!'Z]/2N[)5,_V]QH8O%!L^LD+6N/&>6MD>TTHM89YA
M[A%GT2$>I$,V,98_<6^%"B(3+VJ]3-DS\,77>XY/MN<X*)*K=QT7;S5K4,#Z
M%LDNG\PTKD\"%L\L%A@S1'5FN[06(V/RTA;E)KG<3\.*>N/Q12OP$ZV(U0K\
M) H\CFU4")1R"#%HWG'DFBADL8-/SBE-<,)<Y39XW"QC09:I7$"ZVGKO\64M
M.#TBI*O8R#+#;*?;[_^[:!\"G(M%84?BJDS),<KP,R!NN05"GVKG'V*Y[5%B
MV_^ZS1N]C#!]=N[O)'GK/?$FRB(/+PZ?QAT7R-5&*4]_@VS=SBVQVBW=PBTU
M)G$E)EY0E0324N9>!]+ )Q-RQS85O @,/!*$W&J9T,E&2(^<X5M;AL5YE3D,
MPSUQ;#8,M3UX*GLPL02'/?,T4C %7B(>;4(V4HV")1YKHXVE>.D=I\N4/D,G
MII>-QQY[ W!(P%F2<X*.PEO.)%A[W?M_3XQCKIJKBXD8$K_%D%GOXF&_I .K
M;=1<-NK3)&;1(B;B&$6Z9 ^(-"!+$Z 7 ]Y$,*Q<3NZ24SHWUH6 CZ1$#^[S
M:R5Z8"4:=_0V.DP%5LAZSA%G 1P]MQ3!)'*=-\=-=O3/J43U'MN\>VR3"S+V
MZ*@##S=[-6967OA#K<X_Q! ]SN+\K.!LKE=^(1L1S[NNL]>[&L*E7O<@-UMH
M'Y[ 0&X>Q5YIT_L777N.NR-DVP-!G2-OM_8)M_$)7R>!%4T,@)3Q2$AP!QS@
M%;*2!$0)4<:ZR /!Y6*0FI*S.\LM/-'.1&VP7I/!>@[H69NI!353X]"5TJ03
M5A)%'PSB2C!D"!5(A:!9XM(1EI;><;(L,TGI&]I%?>Y<^OK5ZKWO-SZ9S_T8
M]0KY;%!1^N9K&B^@LH-)%3G760HO=&'R<?J*T9G)"E,;O=3I<O-@O/TI^:XQ
M$&XC42@($Q%/&>-QS9 3R2CBL")*Y5Y2],G9_FI+L#BO<@=#<,]PD=;Z_RCZ
M/[$]P8TSUE/D(\Y9[@%47UN;:0BCE3@XQ42I_V^#HGCQ0&']:J\(&:_=V)2L
MQL8OPR,N-#8>B%GM'>?RCE,R8)313&/K$27&971,D7%*(L:58<H$1[2LT?%;
MMP4+B(YK"W!'"S!13L8(L3PEE+P$"T MX&/N.-)!6HQM2MC[5X>/_U/6%;T;
M=#C]SY5>O@O4&O:2@6?SGU+I^L5Q-[=(/-PMYBL)=4:P)#%,K$^<.N4$\=%0
MJ:UBU!"]LS'-(4]I7EXJGQO/HEOM]>SA;DF/\<?9Y2'_V+/\U6I.%-X\*O<\
MF\-4XJN\:J^Z9O3._8T;K<:OS=:G7XWS'Z2YYG\U]S>RQXY!$0Q1;*ZS,3$B
M@Z5".GJ9N]('RM32.[Z,.5TV9M)M#W@2EJ^TS2YIG08-L^\H8<)[(@W(LA"*
M4R9,U$8JK;AD)%%):PE;3 G;. 4)HXU]+QJM'V<@<3LF:,%BL,@):A 7(B"C
M:43<6Z=C(B%0\ @<DV6 B+/E*[>3[E93 J(38M6+^K)M^Y ;IRBS'HHA.TZ1
MZ7&*?^5CE]:__///TK]SPN$%Y=C5:XSF(=Y5<*7TDHA L#""*V4<CI8S#=A%
M.PG_N2%HF2+!JX?'[3!@ OIRT6%^_9?OG(08/I39(!=-O2<[O*\>=$\.CVMY
MO96\GO_8(0!2?#($<(LEB#OLD8-91"H98Y*,TI<6T2RS*5D<0]J8.7NEG\9>
MS.V&RQDM<H)/U:S==OQ)YZ)9^[!%>\ZDG5P)<=';DX%(#SS]J>V#WARWT5!\
MBG!2)MSF8\JKE+?R%\E$H&'#;**\IG+2Z\'M DA<;B>_9\M>R.UNN&U+=S:K
MA_M\"TDW9&Y==L0NKSBMZ_-$6C++F&CC,#?NSL.2C41_YDLM\"M<-AXJJIRO
MXLO5!FS73]!3(M"UH1C=5BN61ZUSL0L..[_F;)Q19$";36< 50([6<YL-Z6V
MSQ%LZ3_@@KWB(&9'WL\:U8^';=#4 WMH*S!0'C;DI^P7I^WCO<)6]\[=OV.1
M;+M7_+2=DWSIXK_FR <T2@:N73)<82Y%-%)H %XJ4.4)U>ZF_&4QD@\XO?AD
M$M3\,0YJUO_WI'U\MG$(4G.2O^QOYB%I[=G# =SY6 WSQN$_I::WLA/\ ._\
M+;_R[9R(?&M.!)ZE\6E',.$(#P())62N^=)(4^<1MQ%+KG1T6"^]$RNS"%1
MR3KPUW)QNM?V>UEV^NU2S$'.0#_M[FXO[F81A+_G@R3WE+Q9H/KQY*\_%+\:
MM4P7N(VSQBH %4LIADGSC(.8<0/ VE*/A.>&)( Q/)BE=U3A96XFA>Z*(:U
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M97]]SP_6[639@B]FM89\Q6;EH1A8SC=;JSO)6Y5(\"@XS!%7C"$ "0PEHI,
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M<^T'Q$,-MKD&<0_$0O <I]L'S=PE[-<( _!98ZVQXYGCG)&$9 P1<0,0V%"
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M,7_3NW9]X'AFM^TU."KS;%SYB<ZA<K<J8'_:4FTM5Z11=RG5IG*%,OG@I=J
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M3T2V2G+?%F=U ),M(;28JVD<U]S&A&R?97:(%/;$',9#$0F=I!Y. B[Q?F.
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MB'B_V[E^!,(:A'[@4;'XDQ4^,4ZA+A(P9H5S2155\Z<(3!1MBT5!L#D*JO9
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MZ1LIQ!(:&)GV-S^Q:"P:;)JIIM1KOY+/"Y^.N6Y'2L,GD%^H+(?L4*'Q76\
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MQPZ0U &QGW32IC6 BI#85:&<:#X!VL2#:-0$T1CU3D0N\]SGE)8;B[9Y*&0
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M]-S)4CO75^#_?OSFU#O93ZQ]!M,I>0'[*93W7(&D'X)R@[=;/?>9^^T]AO
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MZ7"[FJZ\GSO"PU5ZU)L%[F5E^9 L'\JEMTVU;C15LQRE:6^,H\V6VMP0A92
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MC+:[!$M?11X2"5=LZK&^G4QRR8QVF5>!B!4SY;1SO%1U><=T%C)F^SNF:O%
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M5_,XY+K^I)N0FYUMN&J0ASWX^[O-(Q=:C7<;J4@WBI"1X))U=[%Z-5>-U#4
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M Q0]JGQ*?YG^I'_Z\(&^+<[#T#7F/XH;P;[[S##VVINEK71-^9VBIJ[#_RI
M->\>OP8'@()G@F)_' X(!U:P9*L$2K[7Y:_.@1*RGF+\(B*X6P^VF,J_Y_OT
MLQ].T%GZ3Q0+YL"@CW!BN1+8$XQD]2PP]E18!XU.3IL> ]=47+WV8I,K@FO*
MCN4F%E\8S#?PAVRD"8Q$A+T)]_ B,DBC<\]C2_,*G,O$[J3\?K!\(\FC("6E
M\-R-@+>=&?+OT _LX>R00@FHA(@27 ) (L-!LK-Y2WN>_.P("OTT%(8Q%&(2
MRB\8AAG!,/RP@B(^*(/$G1@"P<';H@ <4.'+R,9WI3QO'IT2,30Z:.1.8'2
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M@J/JN'(7E/M"@=29^GP$2A8<IEF > R)R$A@VB)67%/"ZVFG$$(YV4?IR9:
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MA-XF#(CXO0'5>JJ)14^] KLHYF[")H2!T\PET6+S2PW8;=@(B==- C\CC+W
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MC%;#];^86JY)U?(SDIUW1=.8S8W-30H]<ZD7J$IWYS7].\M5%/))GL)&[.U
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M7.K^ZGG$ 2&>XF0QO_Y-%;A8"GM'2"N)]S/B9XOGW7PQTCD:%A*""DZ"\JY
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M5R$WJ&50L;4?L@W'+J2QWP9ICE9#N\TDBKF>?0CC2;6)/W:S-60CGK.P45$
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M"Y_/5 GEG%&)0<FU\7H]">B2X%#0<YTE4@35NC/9?B?63A4J#(DY!^IG 'G
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MGM4:WR:7&FBM/TI=78IW0_7Y"+U"GE@!H6O>4#$+ 96'Y)+,@E9B[5L7#N\
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M@')90]2\ *8DO-;1);:9$NZ;]5]'/(2Z^]_%+&A(G '.BIL\5G7CM+)9%"-
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MXA['F=1$E%O XW Y'*<6<8%07:31!2T4XY!.SZ1K A&'[)3DB)FQT#I%^I&
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MD)13<CZ&X")IN"'Y')&IK'14N13)5J>&[/;^PYRGMP3<^OUT1,7JN+_(IU7
M2=9,)@6DQ&FRT)S V'HZV0HR#CC6:K/1R=>?<?)IF._P]=WPXN+E</1;&.6>
MP1RTS37[4M4"BU@G'Z$!;;G5C#DAMCC=-K_G^(&!0P5ZYS!KS,8.<CCN4/5J
M\(P.W8L^+7S\_BJ.^[D?1K/@US!-/WTVN+>7B"T:K>:.@5-!@!+!0@B%0Z[)
M\VB$\ZXUS@\B^'A@ZD#XP\>27%N-Z3[=@_PL?PF#A!^&NZ[AU?6$\5X2QD69
M)4ATG-0"9>J@9P04+C$?I"EE<S%K<[+. 6N/+JZ&_H7;?4.Z"VFQX_%+XN :
MQO4('4(G:<"X.K1>I0+><PDV<E8PU=JSUA'.K0@[!U1U)XF&>11S(E_T:X_J
M>%69_'/(!/S7_<O^Y+;9W=?GP\O/8?#U]>OG,S.E]K*^^U>D9Z:+4 NKN;6Y
M:". 2T?,8HK,X9(<2!L,=ZD(ZQ:SUPX%54/RSPEZCR75#I(W#M,#HJN)2'4H
M=**-I;+7$% 42#D$8Y1/*BRV/3DA#6XGQ>/N<][\-L#1^%/_,]U)B3ZJ23C.
M6*5,]F!+,:"L-U"G8 +#2/:G(A,T+![YRVK$AI<\:6NF)0,;ZI3+*YV%35+(
MP6116]#Y!"K6W#N%I&?DP%0I(JBX5<AX+R/\J#E(K63<@I.GD%FTI[<Z::T=
MN@)&U4F(BD#LT 3Z-F5K$AWJL5-?_TE&*P_"PN'!R%UD\LBAHFU(_1:,;"OQ
M V)&^XCKL8.1.1M>ZID>/5G.(A<(0DKP3M#YGA,WN442U$D@JWTP\EC VD5*
MC0$UK3R8DW0=-+-"%LX,V2/"D")0*Q*<0P4Y&A.L"MFP%NT$5KSZQ..3NXAI
MV(['C3.SUN<)IJC)NLL.<HFDCCL?P8N0(69+"KE+-LO%SO1GD47=2F-IP]G&
M&5+K4PRW(>J/EB2]DZ"V2I7=A\M'2Y+.7D;.G":2:L^[0L>03TZ 99S(XB&:
MX)^>Z/=*DFXO^5V8VS9B]GHX?C;XB!<X?AXN^F4X&O3#]<4C;'!960/6T.&H
M+*TP2&\ 7<Y:LNA<VCP7=OWS3R5]>B?>#ULSKO&-?>,ZFP*5H3#6> DFNYK4
MK4/M=^,A*!.2LSQXN56/A$WJV=V7/O6;>7\.-@P0W2/D&J?;D-+P#EYX_?%O
MW@,$L4J<!W"QM2&U0)(+,B@A-:1<2R^XJA-\B*18HD<>1,ZN12'#403ZP'W:
MC3QW85[CFW-U4._- .?7 "M),L7 A9+)"*0;P*L2Z"X(2: UUN7-7?\WO>6X
MM^A!W!]VP[I'3L9]T1]_'G:2<KOJR5TFUFY<R4+ZK"B&1:PI%&CJO [O) OH
MA'-*"<'\ZO3956_9>P_><<_=>>QMH"J5I(Q6'$HII(G5F5&A, ::J^#K-)UH
M-V_!#2\YX BY\[PZT&T\[>/04\EH8S%#L36EW9@$SF0-.K)@)+J8[.8^1"L?
M?=0LBY:RN7-V',ZSABHWT?/\@J@9?+S3I65&(>:?!A,ZVWJ<<V:*MG0H\IJ2
MAHS.,H]D'&2?>0ITTBT:SLOBW/26<Y!L4TZVO>MG,[EP[@;^93A!4F$B]ZS.
M4=>E#B9PM$QO$@,R'K5UE1R[J+<M"W;5D\]!F =SK(/LS+>C84+,TXS >G:\
M*;>+KW,UR8COWUQ4/=(W$M%)%F-(D@S(R" P(E:KK%D4R6>[E8M[EP:#NQ#X
MY%'2O5C:MKY:I<[\@I/Y(?6FO+@B0C]>9R(K'GU-%22+QFM0M;+,(ZG&SACN
MI?6EN,W]!G9ZY9,'1*<\;I@=>8_.64,V91+&FA&51#580O;@LS:0BU<B1VZ\
MVWS)+SSTO.2Y.Y^6);;WY-;Y4?-7XD+-"7\SN+/*^6AETB_0<J\,6(YUR% R
MM8FD!26+E"D2M7%Q OVA)_Z#!#UY +1G^S(F#IEJ^HSLXN?#+V0>YU_)L!VM
M.GW>#R_RJ\'/&,97HVDXZ%<20E5E$BDL8>KYJ'TS. '92 DAR)B"U5&*S:/9
M]W__DX?&\;B_#)F]9X7.\?S+5>7573WE.F>C#C)E3'D3/-DFFI$I6HH GRPQ
M)]OLN2I&+LV#._04>8B>)X^4YDQ?!L0ADS7G9,VS=NXNO$=[O23,#DPBM43Y
MX"!(ZT!EAEFQ7&<X;SPE'GK#DY=N2PXN"_:0<9&;*A*\),7%\0">R^JCKOTW
M@^3@,HO:%J.UVGP#G$Q)1W?B;<G'%5Z=0WQW=[T3/:Z-9B9*,(8N%I4YA\!K
M8ZRL$(4Q!7&SK_CN$\]!>'MS:(6D#G' W?8U6[W06<R?L6@C8_7LU[7PG(Z-
M*%( S$;$C"$'#!M%N-6KNJZ^Z4ZB[3EY"E4YZY.U8N8E!LL@RVIQ^IB!#IL(
M+"6EF<U!B";-/4\E4[4;$6^5NKH+JX^6M[@-47^TU-6=!+55 N,^7#X:!((U
M7L>8".G3VE%#.J3*6&?5Z)R#"U9M-6'JM$2_5^IJ>\GOPMQN^OOVPV7_IH^M
MRB'[9"),6P,J),)"$0X23]Z(E*1?ZHZUOLWOW2>?2KKJ3OQ>[O:[-[/:1LU?
MD-83QA_^,<_WT2%IY1SXVG-!D<T.,=5$7,%1(R=54VUVG]]_YA.7UP$,:KO+
MWG]X/;SJCW\>7E/B62";6RHRUPRMIP0B0O,Z%\Y:@:I((Q>=Y"MT[/L/?>*R
M.H1%#</<#R>ETYXN1?L"1?#J2"$$!<<,Z"2+#YE[Q,WNBM//YM]3A(T8UU7
M^:[V_FR0[UKE[_#S]:R^Z05O/9WEUM=I?,[7CD86G"X);*F3?Y07*FT6\QXO
M/BLSYPB\;[OO=Z3V>J]L0^\:T^A@S#R&470,L>Z-H -DTO;"WX]ND8J391J'
MJZID9AQ"W7#,1Q5C#)(VW5/"T!KKZBE :!=1' ,Z-_=H-+$ZCDN.'%0P$EQ!
M!,E]C>T(GN7F%E@/O>$$_.U-1;,)!WOP]9%K)68)']<Y?375K_$H^G6/[W0>
M_59K6BB=P$Q& )(]D+E03GHR%*1QBC05+YS/><U0^G6O.BR;X?5P\/%U_POF
MV^>_G#W_-MB0LRTN.P7!:%*KDR8("X]@+//!!NYD;CVD?0NRVH7M^Z3XD[T]
M[I=^?>&=E_5$+C:E$"!+ST"9:6L7(< :QHR.Q7&Y.:BT]>N.W\2OM?C71_8;
M,;FM)VI.X^LPR&_IH7BQELCDZ H7T4)A]187QH.+Z" ;1?>[+8P,^ZV1L/E]
M9PF%QFQNW#[\\G/HC^I9^_Q3&'W$NYU^EEC2RUX4GHP%:U4M1S$.'.,9O#;.
M6:6-<9L5FIU>>5:(Z([9'92.5-CVI!5<A)"!KNK:U4E%B)EET/0_:837G"VF
M]!]\"=)[ST?J>W.S@][;MWK5?! 0*>_S+PF;H^$7G#4)+XD5)3B=1X7T=96#
M!!^Y(AU>(TH>>)"M.VMO3=SY8:,;N;2M_GB-84R*^20,/O;C!8Y[0L0LA-,@
M U-DWQNRZXSGI,.@#4)[2ZO>[%Q?>.KYR/90EG50"5*/H&=?R'JJ3F):Y O\
M@A?#S],2,VX#8]/+Q2=+2ZS]G4CO@)2R8=Y+(K9T<,ZO(>=\8-":]PV+09:[
M"-V>0S>-/B?/A^-)+PNC' 8..1L$%9&!<XF!P21L-*RPO%53I;U:?Z^CZOQ
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M.4"*+#&I?"FZN:?TSOL?(3&X@7R7;*A].=I!VMW]];TB&VN$X\F[,,&?:J[
MI/\%[\PRS9)L1V8Y\%)[<1>LPR84 Y--ED$FF[GN%-4;"#P/?'0GDR["*[3D
M-^7Y"'-_\C*D6DWZ]?IN_'$X&@U_ZP\^/@^?Z2>3KSVA##->:TBI)K37@=:!
MR(1L'2:;! K7NC/++O2=!WPZDT@'?6?OKY^HQ6>7M<E"KV"0I5@!6 P#984E
M<T@HD.@X>BQ>-??<K:/E/%#1A--M8S/W2?JIZG358*:SK3^LY:(_A\G5B$#Z
M@DZ^7C Y(:*$4B291XS1VC'5&63*>I=TE&5S<_)=WOBTQ=XE>QL&<]:@$V_!
M*;3UP0!W]7*324#D$<$R;UD,DABR50;W_L< GO,IL!>?.XCAW"=KYH].5J$1
MUI(A7<^E&C..3$LPR1LI,G*,W5I01XW9="_LW;GZV#&:N_;2Y-I>^D!_,_67
M)A43U]: M$:#2D9"M+6.P7'O92V$61JIVL(27:3CL2(Y!\MVA4UZ$(^[,"T6
M:+K.AMZ&JH[:)ZRFZ'%Z)APNL0T0.(#=QP,#8N:DK"2(AM?!P5Z")Z1#YI;9
M@C'[TKHEPC%!L*$/PK$PL N7._8QS$OC91!%602'SM9[,9&JRBU8J;(,BFF5
M6[=U6J;B<1J"'2J?!]P%>S"W Y_DST3*U67UD$[]]M=$%>;J/(R:+:[I=E,J
M0? Z@LF8 II<<FCM.UI)R%D(_7 6=[#-W^.@/QS=)4AI6WC,&H2N5JER 7QT
M'I@1)3G/F(FM:U66B#@+>1_&V@X<?_,QHG-R8K(R>[JOF"I8_9 17!1T^/ 2
M%$_.16S=&W>!A+.0\R%L[6 (U4^_UV3__[^]+VUN\T;6_7[_2U=A7[[<*B=V
MSLFMQ$XEF9F/*BP-6V=DTH>4,O&_OPU*U,)%Y$L"W.R9*<<C.^2#[@= =Z.7
MN^OII^JE?"AUI?<#@[EU7M@Z&*?.P$L<:U.; ,:C+%8D0:9+8W6OPW(I'EP3
M67?8Z:MP/6/[-N@Z>7.O(SN.5]=&BUM08T\5=+C^-Z!4R$3FA4,RW!%4P<#Q
M&(!):WWP+/#F-\0Q"++!XSL&/X9(O@,O%N^T7+B(D4E@GDM:::I=KI.K96-:
M::<+W7*79BJTU- &DV&(>+LGI,RH7;PM"4LM%ZN3-"U7$%VFQ<:DH\A,"6S>
MEWX)Q:68"7O*MX.1^!+1^_!YSNIM</7JD[L&TY':X^ZILU<IL*? >S0X78<O
MZMKRS#B0HAY-RAF(PG%R:2+CRN1D<O/!3@<EPJ:VMP?BP1 Y-]3_I\G5/T93
M3'<3S"_3ESZ,YNG:09B"&148[C4H<I6!)%!MG4+H9(H\;J[:W?0MQW[KWU45
MXSYR;-M[HP8=?QF'T=L[K'IYP,.+0,>< .LMF:^VSLVA_X!/J'R.F+Q;-.J6
M];KRH\]?F?M+K.TFG>/),SSJ 0_!<%EK@L*03J*0:P81V2B>U6(F+D)92M59
MK\$7'WTY&MQ=8FT;7KQDE'[ 8[ PYHRM#>)H<1H%1!7I%Q$<2H>(>>@>U)>F
MP=TEUC9W\B6CS#S<ZTL6J!UDCT0K4:=+%T?.8*RUO4'$(C;W+5KYT9>CP=TE
MUK:)Q4M&V0<\SN7(-?>@>2J@,MW+M"H!DA6K/$.;_&+QW:8]:"]-@[M+K&'J
MXA(>-S_5F9=2E%H]7VJO&\LAD$4%2@JA"W?6;I&HO/*C+TV#NTAL68-FGSYP
M3\^B^<7!GKDQ3M4)M"G5:0]T0$3.(V06T:CDG%O*+ES1 &[-IY^_'IO(;5F5
M.X^L?PGI[8L37F5I;=(9I,P$"1TY.;6Z/H7L:_\IQ[;H\[3NTR]*E;O+;5F5
M.X^'7P5I?M0+'1+2=T-"D2ND '1R&$ MF=7%".$6D_VV4.7%W(]-Y+:LRIW'
MN*\Z*.9GOBS.D_,J0<A$2V0E0)#D"KD40]984E[*V]SB@+V8B[*)W%9X_7LU
M35V@EV3O\78V-G0V%_G-*/\\G=Z%4<(?Q]/;^7.2\4(5YCW8FGRB-..ULB2"
MJ]DG(?B:939XSV[UU1?%@DX27T&1?2)#B[25;&[B)6:L#@68\7291+I'8OU=
MT2GK6)@(;/$);_-VGW_Z12EZ=[FMT.4^,:(E\O''P&.R#.G@<5K$:J1G\"K5
MX7J<>(<FL#S<H)I_^D7I<G>YK=#E/M&B94S;'"11A5*3O2%[(T")ZEF[8L#H
M&%SB7GN^.:*[TU=?(@M:2WP%1?8)1\W30&:0'UKD$.0Y,%:B,E:"39R#\C:!
M+TJ#ECX7M+DXLSB0;9D*KW[%^:N\G017J';O$ML_[N(4__>N5H+_51-)YM5"
MP@O40M74(2SD&T@D@](KD%%JNFY8MJ)U =4:*)>28=-"TAU*[%? >N#[-L Z
MY=FL!76<1)LFJMM,ASWDWJ/L9BU +:PP)B#@[" L04/@II:,:*Z=MD[FUHEW
M!R;$AH2;P_)AB+C[\V#^O,(9<Y@ER*!2!67!8W5#L B98RX!6W?@6 GD\/9!
M(T6]KOX=I-RX^>=3"]KHC$!''HEQEIQ-6=.!;$@0-?'=2_JO;C$P[^A=L%M=
M^+M+K^$[Y&(_TVU@7%[WZT'"7],]>1?)->ZB_!R."H%\ BN 9T9'@A<"O P2
MD!EI,:%/VY7('5N!6W6_;J&_(0)KK+>7G9RE2#Q:7R!Y[<B+9P9\=@Z,\%DI
MG8T++31W(MVO!XE];??K(3)K? &^[.0<6*A],CA8PW(=@V#K< P.7"+W*4<6
M79/6Y:?1_7IGY>TLL[4[KWGWZ[<XN?XKU&ZI/UV/PBA=AYNG6W_Z8YA^^NEF
M_)__QOP1I^/RO,WJ[]?3?^_<)[O-US;JJ-U!!@N]MQW9O"XHD534Q!\3@W21
M832,A2RYNFH#8=^*DCF&7QX[J_EL/1IRVIA22#Z<9]7D%B"LTXHQGTBIC1V;
M%3!:S3Y]+K>GKYG^-][D*QT2:4+22H/3=;) !F]2'1]LI0DV9BY;A_BV@'6,
M@.]^+%@WY[25[+M44\[AO!]7X8:;AX:/RF:?A!:@E2F@.!?DPGI7)W-&YC.M
M?#L;92?VO\1R_D1H(N4NA71/1^_?F)_S],K*HA M \.PS@4OAHSMF$%ZYH)!
MYF.'5NYKX5P2!_:3=8<.'$_0[F,=PA(;2TT?2IJ<+4-FMM,UA&D%4UPZL@D7
M'_/:J?[ 755[*7FX)$^EF^K3&I[,L&IIS?QPS\C;#IE$HFL?8!X81&4C&&ZM
MS4E:I?L91<MXCA<AW$//:SFSI[R[7A#S*<S/HMS;8.M6?K\>U[%*\%MI<2T]
M&JG@T#31VF<GO0>L_<,5%P8<W6G $^,U@]S8I<K=\Z/'QL+\8[!CB.0[L.*Y
MB?/'?\*7AV"0IQO5)[)TBT!"12L$)XJMK6DTV4">!=G:L%R-Y)@VY;[:&C<7
M==LB_D5 [_[^<CVY'GW\?V%T%R9?N7Y6YHQD;FFC)3!=AT1;5L!YC^"++M&H
MG)!M3B,<\(6'UWL+]8R[R[9M$X!U*'\-7_GS^EH60A:QS@57'E2)=/B%.BX^
MJFP2ERK%Q8%QVRO_Y7==JM[WD&C;K@%KB7DWPN<(9=8H1;9@5:XUU60W!U7K
MXRVSV9%L@MB<[+_EEUVJTO>1:=M. ^L0OL4T@_8<I;).(0D &%<15' )O'>%
M"&I*RCXZPS=WD!CPA9>J_7UEV[93P2:./I89*A_)$4:(L?8S(;C@Z1("% ZC
M3D+DI8R%X?O^:-6:A]WWN\BT;7>#;;@Y1RE=<H:Y##F;.C[*(A _'23GO"V<
M_E!O+@D:\(67JOU]9=NP.\)KKNWTOTADOXRGTQ^^UG=; OX[WH2J@.FGZR\S
MIY<[JY6B@XILE5P[XQ!O%7=@ZS@KH45AS=-&=T-ZJ2'&QCKJ\"RQ M:#J[P-
ML$Z1Q[6@3B?LV%JSXYYJZ1!W6@^0Z1BM4 *T+IH<(J8@<"2\D@Y09EC4IG6+
M\ /S98<XY-'H,D0;'6CR/+.H>M$/5G0I+JA,YZJO\XX%F5(AB0""S"OE'*)6
MK>^EE4 .;\$T4M2XM90[9+T\@'F+T^N/H]EJ9S3/W)JH,P,3$UE22BOP*14@
MYSEYCQA$;%W.M!K))=@<#63<H9?X,JH'CF^#JZ])L83I.!9%"[UMI,(>0N]G
M,"SC,S[RG&0!G"6=%Y8ABF(@B^@2.J63ZF0O'(@,&\R%0W)AB*R[/&'? \+\
M9OJ \<E$FD?60[(L&0%6IDC.O,D0(OW"F$E<!3H?L7U*W$981[,4]M3ADH_:
M5@%KS88#UQ'\%*XG_PPW=S@N*ZWO\>CV$_X0;FJKCS\^(=YV*BS8&<=!*@W:
M2&FA] ")%-GHPECTRB;E@V*HBT]*ZBBTVU!ZL#.F]K4(A!E9;?FB52;B%REK
M^5L FQ//4N1B<NMAYAUJ$9Z)>R[:#^7Y]X0XFT)PQ927428&64<&*M=)LQP]
MB!*=*RHKT;P@85MLIY&(/(0/KR0BM]-"U]*$>V?$26L9JX'M6.<9E%S *7(<
MO4E6")W*<HNX"\I*;J/QX9(\E:SDY^?L+_5OSXW1@I@9>@7.V#K:K+:)YMJ#
M=-I9$9 \U\4$DGUIL0[+J;CM@_0[[B#G#O;Y*ESSJ51;(.ODNJ]'=1SGO8WV
MMJ#$'J(_+#F"(W]!\0C.1@'*:7(9$MUDA6EKF)-,B=8N_*%)L<&)/S0GADB\
M Q<^D%$^F1LQUX]3*S%&+BTZ"$X;4,)&B"IQX$6BEL:*O-0:?%\>K$9R> .R
ME:[&S07=P6J<H7HSG>)CSTR?M4A)()A$MJS22D"T] O7&:5E5A37VG=: G%9
M2M]9O >)W<[.-ID]<N84E&0SD/.?(!AE(7J;6,F6;=EBY6*><O:Q"1O(N%]Z
MR'(4<AM<W_)3SB"];1N^WT7HAWS*\9*7H#42_U7-BE89G&/TNZB5]K0U+/L6
MGW*Z<&&(K(_TE!.2\-87!K+4Z7PUN2$4HR%Q+4+,EH[+]D6)Y_24,TB'.SSE
M#%% U^#BBH+,G'FQ447(GM<!&9'67M^RM(H^D7E+-FR_\//I%KGO8T(TDW>'
MG)!7JS*WP?:]R'VP%H>4,>^B@D,7N4MO,_W/@."^-@T)=)PYEX&VC)0NJ^27
M1N.>'SWV*7+OQHXADN];X3H5C-LWHTS_>)S&%;6.1AO0]!]02=2:+%/ QB@\
MJDC_&%[IN/P])U;)/D@EZXM>]I1GWX+V&;B*[!Z@?P"8G%3&"@Z% )%9@[E.
M!0EDUN3(#2_,A,46V5LJ?.F[+ECI^\GU<*TLG,[TW3Y =)S6K')]E!4:4/N4
M0[ ><:N&Z -._;-H9;$+%QJ*>FVPZ<"I7^]*P70[+@LY\*26#S_^W"G-:ZOO
M/$A*U_#5+Z1O6<-=]!$Q^JS0*Y\]!LTQ*Z;KP*L-Z5M;?7_[5"W%E4JHD,ZG
MFAQ;T-,5E3QD8XU@,NAB^_5-_*55JM8LSO_C^/.7"7ZJYE^UZ4CO6.N$7K3D
M?2P>PC*>T.Y)-V$ZO2[7#^^,H_QG^/M**"3;CPX VJBU_W,.X 73P#DR4?O;
MD)1Z/,&T6L!I)'T-8=;*=YNCZ+/7&]^0Q2PMH] =4Q<2C0L82H10^&RL /V.
MR51;9S#EF5"QA&,3<QWX;Y"43?38-31P'RE34B;FI  R96OQ%/FY+I@(1H=L
M4J)[25YP ]5]*+&/)$\E5?'5.(@+S&FM..B@\OWCN[>:UP6A<631:MO:93B'
MV/(@/0^)+0^1]Z&#AMM@^QY;'JS%(='#751P:)IP'D6B_X&(DES?4 BC1 ')
MNY*0A:2P7^+[.<26N[%CB.0[1YWFZ.;QL!P%KQ,C7,@U'!(,>%4Q*D.8:M_0
MYDUUUZ,YL>C3(*V]$GW:0^0=G)X_)QBF=Y.OOXS3OQ\0L920!VTA*B5 :2:(
M]T5!K,$RR1WY:*US6I917)#R]Q3QX>+.B@4Z\KB &!C69Y "3@8+R,D1,D*0
M,Z2^Q;ASJYV_HZ@[)#G>.\1_W!*H>N6]R-_GCDXDK+/98J!KC]?N'$YD*"B3
M$-)HDUL'+UZ!<PF>1"MI'XX(CYVW-H/KY$F\"NPXKD0S-6Y'CSUTT.7*> UD
MU#Q;NKH 2S2@#/W.>2ZASK4Q=$!Z9ENWMSH"038X$\?AQQ#1=S0EWOW]A<0T
MG^^)(4@6BH1:TPVJ>DUDZ1A@2@8M@A?8/&]I)9!C-&QMIJPUEL3NDCZ5WB4K
MVUX\9?>&A>F<G9ZT=T1QD$?N%A):>/9FD9=*N-IS35DN/:)7(47MI5?*;WKV
MWA%1^X?PF(MQKFB(LIZDBBNRG%4!%EA!YUAM6WSZ#^$O @*KWJ3^'/_P[)D4
M\]N[VJCY/2F5BU]KBYCI>[R]\BYR7OMF\D).B4H\0&1!04X^!N62T+']O=L"
M^6F\,@[ATJLAG<-HL&WJX9- ",>L]O*W\?1>"1\_3O CK>NQD\N5X)E<TZ2
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M%.<U*(.&,#$'.@9TAIQX(Q:#DBO&J;[\T,/>_EUE/VXBN!YI/C6UO<Y^NF\
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M(;1BK1O&'.G\V<[.;:_?/0Z@(<KIX#O]&":3KS6E ;\0:,SW0E@/UVH9*B[
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MGU<%__M],=?/*&^T"[+Z_JF8S]\6RZ]T*68D8T+AB$$D,8<HB1#$7&E#A)$
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M3Y"F:0@I2UF$I60$V^Y.=PPS-1ZL137\]E@+"+Y40M>YL/8TUX7L6;+SA-?
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M!-162  I2A16:4AB%MJ1D7?9ID=;&]&!K&0WYK=LI*^)##PV\H-'?2/X*5\
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MH]V6W$"3ZOJ9Y. _C.C@J9']16H%6[\8?9RP24WWBSAG%]<+WGN!GF,!*C#
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M.RW]$9>LX^(73>RK8K[:]7$R*1%280:C*(R-:9A"PFD"8QQ3)!#*LLRJV<'
M<D[-2ZRC3N<[ 5\DW^M@-L\R^53F:."U8* \KWK6;<HOC3KK+Y+I=\GL_]C9
M?O9OP4LE_)V:FU&2_@X&_Q$3_TXA.%#RW\GA/.T+5>'%+5-6XAA3$:00Q8&
M*, A) @'D(E$$9*$61IC'QM">^-.="?H[7J;N61\L"_T2Q.+W:\XK/4L]-S_
MZ0/JRVW\U)'M%I[8Y?L])X 9:J-G?[B7W>$YH?S9K9U3]WEBGHK9FN/\_*GA
MPEF"98A4',$L5@HBE&+(XC2":992A1A7&>=VFSQN T]PUT>(W"P== [FIHK
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M56=2\S7P6K71=9OZUZY_UU:JJCT&:I7KHF7EU?-B9T;MBGF_RU7K+/H*5"]
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M4L/,F'_M3<QQ>Y/8A%8UZDG<_D!'WN1LM=X4V3A5?EL,99)H$@(L$@Q0DE)
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M%?J 0J&@J730T#K@/X+F<S4%<:'Z35U-LJ%]=9-P:_0/*@!N@A*"(A&K &'
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MW!RJ#\7DS':B=JGU<Q%I-ULW.'XCF[;ROFLI,"@D#O8B!Z7,]@;L>HCJ YU
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M;1_SA8C"$,5I!,)4<X"B" &", 2",0@I2262T)>5KXL@<S,GYG-#_N1\G8;
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MT\]Z[F&I2:0U SB!#*"48L 5P8#2-,:$0A:[<?*=[V9N%K$A:B!VLCH[S^<
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MSRH>'4K.J R+U-T0H-1L04B*,5",IU&HD:+.)R2O6YZ;,U%*=Q,\_*?S0G
MU<55O3L 8R>I['3W/\DX ,%YO>H.QD0KBL,'X6/>3^O;:H /'I_*1)Z6LF'$
M6A[P-C-W3\\LVQ2&3']1;/DNMPQF;\I$&&/5;E?R=&+,0LB(A&;W!' L"4"*
M$< @MD6@=!II1%*=.M5_ZB/$W(S77A%[B+LQJ@2JT"5XWJR-U,7M)'ND*S9*
M9MM@N3:>DA% ;;Y[\()V'[.+IG&2D1C9BKX>!*M%4*IAJSO4BA2CT"OSLM=
M.)OG209D(DL^WL#X+ "]$6U=*[JW/-6RTEOWQ@K4OZUN">H%,Y92-E;[DK]=
M/[%LM8@3+6 H$X"3B!OO&") --4@Q&%LLR@U]ZOE<Z*/N2TUE8A!*6/P>RFE
M)ZWM*2S/KQ$#(33R$N +CG<&]QGU!\K./M7#I)G79U0\S*H^]VCO),$HJ;<T
M$!&-N09$Q39=.D6 XE@ 3GF,8IUP)%W3I=OZF-LD/Y&Q%26C)@GNT+Z<D#(
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MRC(I)4PB[;6A&(=0OVH1C,W9HY(AEPFU"U;["S&]>+42#ZA*/F>F*M=)Z#Q
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MT]*0HL[2.(V#$%-(XYA"I!*JC4J,3?UMS+,$1UEFE0_38^RIF9E2?+,ONU,
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MI)1GEME[G8--S8#L! :EQ.!6@5IF4SW(K5/&NF$^;45\@S>P">G"S3WGKAM
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M>U/?NW%S-CPV@'BR-2>'&M6\V"C]WJ)8W>/.L/I#\LU*6Z,P8O?Y>BY-5]1
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MZ: H,C%0&#&(PDA!DD4!3+"B7(6!8C*QW%RR'W5JQF&7G[Y8+N!S)2IX*/4
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M-JFMQ'OC\^;?^EF9*K24;QV?QJA]VLA9Q),D4]I)25F@+1 A"E)#%H#UX[)
M1()1[-(%I&M I\]OK&8>8+,0>5&&Z+(^B@0-9Z7;M]F)M]UWZQ/%@;_I6M2]
MP.;*>#!,@N\T]_C-VP+CR1YT#C>JK;!5_KT=L;ZOGXUYGU;U<5GN=.F'F\+%
M7)3!UW)Q;^A2=AV] B:D]G4P9%$:ZQ")!#"3&8,Q"Q,>8<'CR(F>M9<44W,&
M?O!'*385G]<;L<']BBZ*BH#&S2+UFQT[,S4XY@/;KKU<3],3J%'AW03\46HQ
M#)'K63AZ,G7]9!C5_IT%TWNC>-[#>F[(KQ_EJL4=-9."XRQ(8BA2(G2 (R7,
M2*8@"7B*L@C'/ V==N+?#3 U^[8K\ 3Y A05Y9[[;O%[&"VWB<\ 9^C]82-:
MF][-X[;P$:U][0>_?_RX&\%'E-O; 3YVG<>HZE>Z+@DDWZVD">$TQ))"E@8*
MHM2P/5*2P QAE1 2TM"M&LYA[*E]_5\VA@H!_)HO\J?-T]ZQ^W=_$=>1N3@C
M^#H?X8O%85]T:*MCW'](N@*-&H.Z,ST '#)>.S+RY4.WTY!817$=CW!.>VP/
M\GV5Z\_SF<YO%_-MN#A#+)0\4Q(F*,L@RF@,&8D)C#E'7$BN@M!J3]9FL,D9
ML*W%XK1X!&J^_+, R\VZ^F$EYR7QRWH)U-N<1/M\LV[\3]LPWZB.:[2VX@(C
MK^."8(6>=9Z=5Q1'RI [$TV7E#9K>(XFHW4_8:PT,FM=6@E@]O>X4_']X')!
M5_GR^TJ^Y,M-,7^]D\_+E38M#2D(C9(L"[4/F>E8$>G_TP&CB&$69T&JLC0D
MU,JEM!EL:B9X)R=H!+5GY.M$]K1Q]8W7P,;U %0>B55<P#B#J:]SB-$8^VR5
M;3/W6=_3L_CP5IDSPN_Z1CDORO+&7.527!>_R+GXLES]H',YBT-.(M.?.4VH
MU.8B0##CBL$HUH8D4#HX%;8$X/:C3LUN[(JXYJ;*_[D2'O"M]( 6X%'+#]1R
M!0JM@6/!G-54=#IOPP \L*'986O$!K7<X.,;;']IL/TQ$+:.Q8B^,1Z]&/%L
MK-VK$5TPZZA&M'K4N-6(+MKM52,ZW>QL[?5S_[LI'I"UKQ(QB92DAD!'ZD"<
M1%0'X@I#%04DC1)&D=W&XN''3\U^UR*"O)31VGX< J[3")\)Q]!N78U$)9X[
MY> A2*QMYYG0C&0D72%RL80G$#AJ\@[=,Y9M.R%ORXB=NNJ<,Q+387Y[['(]
MGR__-&&SMH<?5U+DZZ_+HI#%W:X'_4PE(8E#ED":R<3DHT60A4D$B6 137FH
M9&1%PWJ>&%.S?KN-QYT:5V"K2+G65ZH HPOXP^@":F4<J7=Z3IS+V<J0TS'*
MCJ7WF>AYQM(72*_'+<Y"7.#DI2]0AP]A>C^M9ZF +(KEZFT5TZXPX8.L9)%B
M1@070<(%Q%0$=6&G5!)B15*19!0)'K@D\]H.[&0NQTKJ=4RJM\78SLX-@=S
MEJT2^0KLU2JV2Y*8!(WH'A/Y'<'RE>QO.^RX!0&.8.P5#;C>W],F[4I]KQ>B
MI%1[7,[U_45%Z+_C>54RD)))*$.*(0IQ"&F4I#!F,@K#)*6,A(XE3I9#NWQ;
M(Y5!W5Q_N/EZ<W_S^0>X_O8)_+B__?C__'+[]=/GNQ__!C[_G]]N[O_A:+9L
MIR&-LBB(F8)A;):&B";:I:841ID(4X(Y1<@ITW"(21BEW&HG]_\>"&K+%6(
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M[C3*H@[*W0TV)$<NGGETBY\E\1#LLMF>"7:I@Z/+2)>:GXLGW2=J[B8U+-U
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MS.(4!@0AI$0B9W8APUV3S4WL:5I!02QH4&N=FVV$LZ&T<H3>U+)I,'#V@L@
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MA+UGRVP69N+3J.835(Q6^67T61[:!5#<UKEC);\73Q/5-,NZ)"1X%/N&O+T
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M&#-:E_;480N7NYW8[^JF]DJ7;]"@?J<.=_Y!F;&+B(B,1!1!)@,,41RGD)
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MD=* 9BQ+(0]PJF_U*"0A2F#.D,"4"AFFL75@ZWSXFYL@;<MX/M^'E8[HPWJ
MZP(<BN)6B($",J Q QHT4* &OEY2-21A>TM!/K,E?_$FP)-_J!,?4_YZ!4_R
MC<ZHK_"H+V'V[8>'<?<OTJ5XU-+Z:V8\CLR!*DZ5N'\M>_G:M3%6)#<O6)0E
M/&4(QC'2><A)!'$6<$AP'%,4L9PE5G40G%$V.[6B42O!1,78=>H8544 6S7
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M$"4W;+HL(:>?_;*8I\MN9BD;7A %,<K6@E"O(?H@@?&29;7K@W^NRO8@.^A
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M<^V2CJOU:F*D3#QDTK!&U%Y%LF8C&P3)4&F#FMO4NIRE_2[Z<>0&P_'(HN_
M&GO(V$.V?2T,NCA4JM-$DE=T.46FZDS*3,+@PF,.++#6=G_;'?3C8PX&^A%%
MWH6^_W"U\H81V[17):)*C(ZI%JD^W7H! 2MG'69K"EG,N74ZQ"-DC-T1:SQ<
M+-J*J N<W6IHO=V!##;&D@/8(CW9ZZD&==!!88[3Z4U"N]96P7T:QGXO[P9A
M1PFG"WB]RGF3:!!F'\(TOYV_#E^FY&S=VA@QB*X!'SD(CKK&H$N=ZZJ ,48[
MREX+U3IT^S)5XYJ5'4&PL0#[ .5-^=LF"E6'/BSQ#.>KZ5<D3B_.\=UBM7J#
M93K'_ /.Z8OUA_IC8OQ\^V_J;.(EKJ?+36K-AUG8U!:\+Y_"[Q-C(K=>:)"1
MD^IGFI'=PRRX&((R0HL<6M_3 V]I7(.SI^/0$71&K< \6TY>;SE!&R?RMWN_
M*X=;2N)2>A,>>"$32$/)=0*3KB,=Z4(#(;U7)OED^?VC\;"^Z8"%QWUBZ0#
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M*J?KFE8\(9[Q5*=3T0U-3JFM$5Q&/BKJ%+D1QF;>6AT=1?#8 Z8;(O!T@NL
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M'\SY#ER#-[B<?MU4W;R=$S,N-MEAT]5_O/I]NIJ(I)+DQ0./JDZHUH8N>57
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M9:R ]TJ R:7VE^+<R-;9T2\2U>5SVRGLLN-%U(=7<'F4?EHL;R:'WMV3JG9
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M;+\]L45AF7.N,.)ITJ!\".!95B!"%EIYE63S1/<#R.RJ/?RQ@!Q21!V@\/8
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MLM'/6I."3M$#;DJY56)UB+H 39=^5HX;M&J7F^P%Y^W.HN.F7@X9$3B<M[V
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M9SP=)8M^('5)O"B(20<.)4</"LFQ<9F1>E4ZH98J.?7R(^G#SQVW97W/\#F
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M\/*.1]SVP/L8XN_NYO-@)M3>^+^N#J WL^^X/GQN>")+$1AB!F:1#)42!<1
M[K?G7%FF&,8[!8H[EN</06X?F!\;FELZ XR.DV=VB+P-LSQ1RD8LW &Z.A9$
M25J_2A:*X [1&&7<8X.[QCXZZAI&&^C2*4H'/'CVALPSVS*_7! 6IK//2W*$
M5X:K $O6;9V$:B"(P.MT'2ZY"4GFVU>(/>V;ZX6,-N3FWV_S' :>9[:#WLPR
MENEL>HYOI]_KE^=A]GEZ_;<3)9+1BB7@OM96>;(:7)T@$DA,'E4T);<NA#OA
M\L9)_/ZWW&TM@?9\G*;7](!9(B7T%L,2/TP_?SE_5_ZQO&(*CRQ(83/89#FH
M:+%& A&PU%+)[$JYTV!I6*_I<7K'R7GO?COUBYGGLY%JTN3YXF*5&_=F]GXQ
M_TSH6TZBDS8IGL#(6I502+5$5SAXZQ0K+BOTVS/+AJ=SG,* ?[>-TP CSV?#
M5-?Q[WB67\\7K_ [GLV_57E-@K!*&JL@"D;.9'$*' H)S$@GN"W1EM.>./?3
M.4[9PK_;AFF D>>S8>Z5UJ0(H500$;3-#)25=5B5C)"399D)YFA%X\>U^ZBB
M_C>*9^^%B\/WR/P\G/6T1]:_<JDR:JGHQ&0OM6<.A&,>5'89@G*UO%@P%9V1
MGM^.9P^[/^Z0V$?Q]_/<&\?AX?F<'1N:X<WL'[-$ANC\;)IK4_;_G$]GY_]%
M/[FHU3REL)RQ"/!:*% D(7+>% <1BF")"^O,[3SX8;?+KI3W4>[^/'?1(.AY
M9G'LEV'YA7Y0!TM])SU3CV"#(5D1#5@KZQCBI,FO,P:2<2J9F*WC0[72&F9%
M?;0/Z&2/=0BBYW->W13'5Y9,BE%&"9,!):]UQ[7LW=>3.Y;@"A9)Q_:)G9Q-
M^OKH8=#)ON@'"<]G.[S[MJK&?RCB7C/M,W<"%*M,83Z"=UY!X3&3L>LY"Z<U
MVAZGMX]."L]SNS1$RI/</N%>IIQ_P<4E!S"P(IPH8$5M5ZP<@YBU 182QN"]
M(QD.M5>V$=='XX@GOS&:8N#@7? =%W'>H:-RR0-GF(Z*#M(4;.6!D! E.6TZ
M<Z5-X<:6_DL$^NBLT<F&Z00L(P:3!\EPW?C.E7162V9(/AG3%E0LM6N*U)"0
MEYR4LMZ<8.Q8RR7U<3_3=8W-L4!XDN;4_9R8SSY_PL775QC/R:+4D;8_"44A
M692E.(@FT-%*SIAR,O(H;I\C ]_7;U#W?,IHCD;?0!?TAT+A^>R&%RG5><;+
M]^''ZB]F]3N+BY]$-F&8&;.6&().U2B> R>+ $Q9HS%,!7_:6_I=J.[C4'C&
MNZ<Y=)[/KMKXSKMR]Q:WF*2+RL0/9<NJU2!XSS5HSEE)Q4@4MUM\#'SJ/$KO
M\[GB[W0G-83+\]E#/\<"-W5*]+4](Q=0C"6)Y8"D7;@%'7.N"1)%A--NGP=)
M?3[7^IWNG#8@>3Z;YN?BADU^9)9R2#:!-"F2)M&<#F(C0"JADL\Q^[1]=NE)
M2'T^]_2=;IHV('D^FV857-]D0PK9FN@3%,^J[K"U97@@09&+Z#6Q1H3M<RR&
MI/#Y7-EWND6.@L0SRPW;9(,SW!HA+'!C:@)#L> 55_0EJ88DC'2A]1BJ@9;R
M?*[Q6VVAGK#SS*YAZD ?M(FQ'#*$;&JS>NMI^:R UZP$SHWF=TK#>MHZN\Y?
M&F?.6R_7+/L*ND^<;["XCOQ9+C]]"3/.V'M<)&+'[_.:1'U.=- S/[^9T;&%
MR_/K!OH3Z[7PG.3 4-D:29?D>L7:6R>A"5''%$XP"N>X1?3AN9\"ZR<4=@>&
MT=_F\_S'].QL(FWASGD.I2A=<\DT!.]K?WOOK0N19=$:I%?O[L/!;8ZM@UC;
M 21>/]Q6Y0/6CL*$^Q=?YXOSR^E\ZS&@?**SY\%Z"]G4"\.("F(DOP 1?7 Z
MU%'LC1%T(*E]N(O- 7<*P76 SX=T]J*FER><?J^VR?)OBWG]E=G*_K\(9[3P
MBUIL'KQP,20PN9;!5V_ U19WSABN52A,[39EH,%9O N]?7AE)SMVFXNPNZ#<
MS3*ORKQ_GY_C\F;5#RR::>'(@I"@L8Z*3(7,:5TB&!%X8"&267W0'<^!]/21
MV]P,E^/):ER WE[ @RN]L6]S* E9\2"B,:!,\&3,Q *66>,SF;@Y;,^XW_^]
M?>0&MP3<P+SO3O.]7\R_$^_JK,DWLS)?? WKQDG$3=HYZ]P9,E"NK.:;D1-O
MR.&J _;.<:*=*ZBD!..3 R69!B?(9HG(>912)\?X(5JP 6V[)2>RIX30#H38
MI[FY(Q=NUGS#AYN0M"BF%*]KW59MK%>XKM7U]"$;GFSV@NL3M$)ML93=H/\L
M9CJ<7/)/58W?<&#55-S2#O?>D(N94ZV R0%<$AJXD<9+RR,O!_7M.8B:[O+(
M3X^J%DK^"!$_?51?=_M^,<MOOGZC/\=UIZXL0N8L.L"5+"0IG,BU 9F\Y%D)
M,M%N!QB&0?I#%':7!_[4T=\$"D]_1VSKR$W;OQ1A//!2BR"35>05*U(7R#CS
MQ7#C#THB:DUH'[>ZSVA_M 3&T]\F-\+9TGA;B>B9#FF=JZL*.@@Y22BZ:)VR
M=E+>GIP\S'[9E>(^KHB?T<89!"K/:0<]T(%;.6VYY@6R<.3S!97!:1)9($UC
M.1;OTJEW3D]]VO\M=DP#:#RGG7)_5V&;>!)9!N#9DO(P@D&0+$&(=.YR+624
M!W6::DUH'_?USW*?' ^,[MI-'\&-.[6&-7_1!!:D#(Z07^^;=>'$AQPAR^PL
M)NV#'_+285<Z^T@5>):;Y&A8/*>CY+*K:?UGL[,I5RXGCG7@5B$OSF<%OJ@(
M7GNAO"B.*WEJH^M>2OM(77B6^Z0!-)[33KG5[)34@O)<1DC:*I*3T>!K12'3
M3F2GC..'S?9H1F$?.1;/<F<< 87GM".V]#-E.L>2=023:J*T]QR<4Q8TT[H8
M^J&S!TV+&HSB3I(^GN66:8B59[6%;CJ?5BNTA!!)?Y"4G*E%)O0A1-(ICJ<4
M0JH5!Z=VX7^FL)/DD.>Y10['PG/:$C_7(4Z$BCE[;B'*&@WG)8%WJY$+Y*/Y
M& O]?Q1__8K"W;;$7U?P)\;"LPID[=*+3B7+A1<,C-<2E'46?! :K E.%NE\
MY*<^.YHU,N1_W=!W@9OG=,YL:4OG4D[96 =220;*: -!%82H.8LFH^1X4$>I
MP2C>;2/]=6,_,E:>TQ9ZN#\=*0^NO"K$$>WHI$X18E .'$JTT6OZV4&=IX<@
M=K>-\]?%_7@(>4Y[YN'V=#IR$E*-I)=Z$)MLZQ54!B8-:1=1! ^GOID\KHLA
M_^L2?SR$/*<]<Z=?7=&13%0N(910(^YTZH:0$A3G1,D%(PEQC#C9WCODKQO\
MD^/A.6V,NRVZ)MXHB9(AH$-!YRI]1GZ<@<B*\C[$8,VI[R7O4KG;YOCKVGX$
M3#RGN-GO>/YPA[N)MB9S;2.P* PH1*R-<ASI$!>$$;X$?>K[R4<)WFW3_'6C
M/RY2GM/^N>YY)AB)R+L 7-<B?U^OH;P)H*-/1?@8-#^H7TT#VG8K@/SKTOYD
M\F]F7_V?_[@CTK?TC=6/5C^I?_4!R_^J__[CPYOKYW_!<';^)9'\%O6S'_^;
M5K9^Q;WYT1N=!I:O\#Q,SY8_KV4YK8QY'-\[/_D_;NB_O;++%_R$S]9KP3_/
M<9;I,&G?M6VVGDBY0<(UFKG-@0DM(&E7FX0$3RYL#!"089(Q:FYOSX@?HD_;
MPQ0>VU;D8_J"^>(,WY5[^E<L?_FQ\=6G>L!,O/5:BF3!V-I8U&<-7IH,7L5,
M6RLZIFXW7CJ6(_O2V%UCA58(N]T99%#AC>AN+A?GDX]50:QT.<X_+\*W+]-$
M6O_/Z7(B6:V1LA:L8W5N+$?PV4<HJLAD9, B=D(@O64#??35#?(>)6!<> TK
M\WEK 8R-(OQ\>PFOYK4'Z<1)G8NP$I13C#X4\BK)/@!ET5O:@,SSVX4"!Z'H
M(0+&05%#P<Y;<WG<^-:G\/5;>/WV-_P:<3%)Q7B4/!$35 "E>08GD>Q&'US)
MBB&SVZ\!?WKDB/)N(YUY U:-K U^FR_./X?/^'8>9LMWLQM#]!4NTV+Z;:4T
MZ3GO"OD>WW!Q_F.U+3*=SR@SK<NQZM>(FLNH.<G;VL2E,9K=[AIUB*HXC+IQ
M^^B<[#0Z@>AZ!>?OX2M>+:HN\7+S!I60$=L %=;11S%#])IV(,O.Y)BBMRW,
MH#W)&D_-G0(ANP"R@;C&/0E_PUS/B'>E3--U5ZE+91]B9*9$,@FR4:!0&_!&
M1.#6A)(4"V&'_L^/O*!#^+20Y[PY<SOJ2'IOPTL;4E3<&]!*UFV%&<C-Y6"-
M*"$K+#[?S@EI%3BYCYYQNVF=Y)1L+I:.(+812ZD=5:9YE9Q%W%K09EU3QB<N
M,E01/22I-:BXFFEN/!CMH\#D$TLGF.3U('U]1*6.1\7V[K1M1'0P_+[C(LX;
M ?!]^+$*3W^:7]ZI72WW<BS$1(HLO%V9#X&4OX^IMALE/PH9RR6X>NW1&'3;
M:.JCLV9SH#4517>Y- >/MJN&RI5Y,LE"!FY+S9>P""J9!$$P1Y:)]3)Y%,C$
M5O-L*.KZZ&C9#)>]R/%)0CG<QX+;+3FO)TYLW#/3'ZZ2Z,AOPZADE9&2G%@4
M/3CA!40>F7?T36L.2M0_"?5]]*CL8"N<%@=];)4-MK^_6*0O84G^)7F#+\Y6
M?T[?_OBO"Q+DZ_G\G!S2"<]HD[49&$I2!EF3I\E8 ,,%^0BR1&5W+R3>\^5]
MM(8< JA#2J&AZ7JJ7))_U'&BR_G9--/W\W_.I[/S_Z+O7RQPN"R3_=XY;/[)
M$>L?)S/%9.9X,+5]55:UV2Z9"*@96,ELT!PQW^EC_K0R4V[$M(Z)I#I6*HM:
M=^43^8Y5QRLD$RD'IDH10<6=+FSW6/ M$OKPX ? QVU7ZQC6]WJ+\O@M0-):
M.W0%C*K]JU4QX-"0=E<I6Y-<27'0RY3CK_@&P]U18#C^!F\?R?2*O8>N$'(V
MO,0",7HR744NY.5)"=X)DV1.W.06*2C/_09O+X0<<X.WA[A&1N+*-;I:PN7M
MDA6R<&8<2&$DK%PFYU!!CL8$JT(V[/;5W2%HN^?5'2*JA8CG[?@]=I;<@QEA
M*>KH5':02S2@G"=[0@1R?;+%&%VR6>XT3'W07,O!8MFMCKXV_!T;) ^FD64O
M(V=.$^FUR*(0TGUR BSC1#X/T82=DN2?4RKE7H+=*95R'RZ/&^AZ.U^^F'W&
M,UR^#&?3,E_,IN%2*0H;7%;6@#4105GB2)#> +J<M631N;2]/??#S^\QR7(O
MN<U;,W%L0^2/&3WGR_3;:E,P%,8:+\%D5U-%=0"GDH>@3$C.\N#E3I>EVTR0
MS9>.>^O4Z@0YG(^] . JY3C(H(34D'+-%N:J-ILBTF.)'GD0.;L6N;2W7CN>
M7CA"</>)_P NCGP63+].SV_Z]OUX.?_Z+<Q^O)OAE3)C)4FF&+A0,IG<I,>\
M*H$T6D@"K;$N;V_[L.TM'<C_$,G-AV%C!XE=-WKQYD)'1U3,Q]5TTMHD*$EP
M-BD0R6HC@Q,86T>T[R%CW*O9%N=%*QZ/JSCJY([J2Y]_F>>->YH/\[.SU_/%
M'V&1)X:XH&T6!')5B[MC'?6,!K3E5C/FA-@A&7G[>WH)OQXHQ?E0+.U C6RL
MXLWL12FD&XE1RX\7<3G-T[!8YQ3,T^J[+V8_W>L1&S5:S1WI3!4$Z<Q@(83"
M(6M+RM@(YUUKA7,4P>, <0#@S,>2XL&0_8:+Z3R3N[\X/U:Q_;S:67Z1OX=9
MPD_S?5?^9O9^1=4D">.BS!(D.@X*E0%G#!T2PB7F@S2E;.\'U)RL<4)WPZ%U
M=-%UH6_3_"N^G2^7KXGC#S!Z0L@2.DD#QF$!I5(![[D$&SDKF#B*W2K3]M*K
M.Q V3BC@%/JSM52ZR+U_-:W#JN)%%=!O(=,V>\ +>OOVY=H+JD.M-O]J^0K3
M6:B-L+BUN6@C@,O:98,I!:XD!](&PUTJPKK;B=''0K(A^>/X),,#=RP)[P]O
MOX;W##_7]+!/G1BPT=7T5J:)X[2;5?8: I*SF'((QI#'J,+MV$G_!FSS;-+>
M#=A]I'BD ?OK+!]KOF[2?AW<(FLF55%^QHDS5BF3/=A2#"CK#83,&3",,005
M@@NW#_^[QNB6E_1R*WRT1]Z2F4^N?1WI\6_S01*+[WORL.G#6]<R3I*P\V35
MR1Q!&F;)-ZZS"CQF2+YPH1F:Z%M;XJ=)$J:]<U-4O9$HMB&&=0"5L6@C8P)\
MTC4ZD!U$D0)@-B)F##E@V*J.=GK5D\H.W@<8&_JJ/<_'3FIY,($C9EYBL RR
MK!<J/F9P/$1@*2G-; Y"-.D/UE>7N6%DO%,JU#X,'QLU#R9[!&N\CC$16U8'
MMG$05,9:@ZQSIN/:JIUZ$#RG5*B]!+M3*M0^7.ZCJ]PT?)U>=TQ3.62?3(15
MWR&%M)!0A(/$DS<B)>GO7'0^W%QN\\D]IC_M):N[/>8.9MRX<G\5SL["\M/_
MO;J=UR%IY1SXZF$J2Q9]3#413'#4R%7FZG:&Y%V)__S,<7R@061]!+/&E?+'
M3V_G9%K]-K^DW+- WII4X+FA]9= 1&M>VYM8*U 5:>3V2::W'CI.T'H0.1_#
MKFXS6DGWE*)]@2*(=.4)K<$Q SK)XLE9][C#N,TC,UJ;AWX'$7\C)HZ+A/MM
M8G*UKDI-?I^?XP?\=MFL9F4 64_GE?6U'8WS]>;%@M,E@2VUC%QYH=)VB!SP
MXM%N8(=S(4X@@2>%K\L=*5)QLM#6\:8:1IEQ")6IS$<58PR2&-L:86,Z'*>
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M8_1M(6E<S T$A+L-")I)I6^0768OF92E,=8"DH-)GJ4+9"2B )MR4,7:[,P
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M)'KTJ<N1;J_FNB#I/XYGY>KCR_GRO,7\W\WG##']]T$ZARG14E$GEID!B]&
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M>KZX_UJ3K$,;;.! ]C_9=D;30@,+4 )&BSXBYM;=$PXF=NR.NNW5U6GDU@%
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MB[3R?F[9!18+-RH2?UC@H!*IYQ!# AX8D:\U<M\Z*?9>0D;N\SRZ$CM>.AU
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M"OCN+^-'(7,@P\<MROO';%F3B3"O8TJO0UIE$KV;X:6N#,(4S*C <*]!D>L
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M3E%S&;L)+AFA> 1G(QD73F<(R2(4IJUA3C(E6@=,'Z9F7.2TD?8.$#J ]1V
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M5_6-+>-Q[\&/W['6<L^^?@J+U8P^D2Z'3[@H\\5YF"7\[]ET=67=BT3KDK:
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M.0!+%J"L2^"=E\!R]-8Q'D)N7>>V(XGC8G$PJ,R/)[<.8/ENN9J>4[3^L;R
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M'ZO,PC6-KOQ/W^.]?JM&A%5Q;34/;=<48[0T.UCNH;UH<%XI5*G2W>V&^W=
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M^@=02P$"% ,4    "  --*E6#=DE)[(B @#XD!@ #P              @ $
M    :'(M,C R,S S,S$N:'1M4$L! A0#%     @ #32I5O&LLT*A&P  A5$!
M  \              ( !WR(" &AR+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    (
M  TTJ59LOQ1>YS,  *LH @ 3              "  :T^ @!H<BTR,#(S,#,S
M,5]C86PN>&UL4$L! A0#%     @ #32I5O OE#+'=P  #3 % !,
M     ( !Q7(" &AR+3(P,C,P,S,Q7V1E9BYX;6Q02P$"% ,4    "  --*E6
M0%](2SU) 0 +[@T $P              @ &]Z@( :'(M,C R,S S,S%?;&%B
M+GAM;%!+ 0(4 Q0    (  TTJ5;!+7+_SKT  -2,"  3              "
M 2LT! !H<BTR,#(S,#,S,5]P<F4N>&UL4$L! A0#%     @ #32I5H: "#U[
M P  "!<  !0              ( !*O($ &AR+3(P,C,S,S%X97@R,C$N:'1M
M4$L! A0#%     @ #32I5FX<O?.0"   /2T  !0              ( !U_4$
M &AR+3(P,C,S,S%X97@S,3$N:'1M4$L! A0#%     @ #32I5D^L13.B"
M9BT  !0              ( !F?X$ &AR+3(P,C,S,S%X97@S,3(N:'1M4$L!
M A0#%     @ #32I5F O;(=P!0  BQT  !,              ( !;0<% &AR
G+3(P,C,S,S%X97@S,BYH=&U02P4&      H "@"% @  #@T%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
